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PREFACE 
A Record of Research directed towards 
ENHANCEMENT OF THE SAFETY OF CLINICAL ANAESTHESIA. 
i 
Clinical Anaesthesia is an indispensable adjunct to the surgical treatment of disease. It directly 
affects the lives of a great number of people since every year no fewer than one in every twenty-five persons 
in the population is required to undergo a procedure which necessistates it. Of itself non-therapeutic, 
clinical anaesthesia must, above all else. be safe for the patient. Any adverse outcome to clinical 
anaesthesia and factors relevant to its administration results, at best, in postoperative morbidity for the 
patient and, at worst, his demise. 
Identification and examination of the factors and circumstances which have a material influence on 
the safety of anaesthesia for the patient, provided the motivation for and is the central theme of this 
collection ofresearch publications which was submitted to the University of Cape Town in fulfilment of the 
requirements for the award of the Degree of Doctor of Science (Medicine). 
The publications submitted report the results of forty years of endeavour. In terms of their subject 
matter, these publications may be broadly grouped into the following five fields of interest:-
}) The Epidemiology of Death Attributable to Anaesthesia. 
2) Pharmacogenetic States of concern to the Anaesthetist -
a) The Malignant Hyperthermia Myopathy. 
b) The Acute Porphyrias. 
3) The Effects of Anaesthetics on the Liver-
a) Studies of Hepatic Drug Metabolism of relevance to post-Halothane Hepatitis and the 
hepatotoxicity of anaesthetic agents. 
b) The treatment ofFulminant Liver Failure. 
4) Heat Homeostasis during Anaesthesia-
a) Inadvertent Hypothermia during anaesthesia. 
b) Induced Hypothermia during anaesthesia. 
5) Miscellaneous. 
Within these fields of interest. papers have been grouped in terms of related aspects of the main 
topic they cover. Editorial comment is included where appropriate. The nature and scope of many of the above 
investigations was such as to require, for their satisfactory conclusion, collaborative interdisciplinary 
research combining the endeavours of other clinicians and paramedical scientists. Appropriate recognition 
of such collaboration has resulted in the multiple authorship registered for many of the publications in this 
collection. 
I) THE EPIDEMIOLOGY OF DEATH ATTRIBUTABLE TO ANAESTHESIA. 
The most fundamental index of the safety of anaesthesia for the patient is the incidence with which 
factors relevant to the anaesthetic and its administration cause or are significantly contributory to the 
death of a patient. Based on this premise, I commenced in 1956 a surveillance study of all peri-operative 
deaths associated with anaesthesia at Groote Schuur Hospital. 
The primary objectives of this study were:-
1) to establish the incidence of Death Attributable to Anaesthesia. 
2) to identify the mechanisms responsible and the hazard situations from which they arose. 
3) to formulate appropriate strategies for their prevention. 
ii 
When finally concluded, this surveillance study had acquired data from a population of three quarters 
of a million anaesthetics and covered a time span of thirty years. It had become the longest running and 
largest descriptive epidemiological study of Anaesthetic Associated Mortality conducted in a single academic 
institution under the same individual direction yet reported. In a field of interest in which lack of 
uniformity - in taxonomy, criteria for case inclusion and assessment as well as peri-operative time period 
studied - invalidates any precise 'between study' comparisons, the characteristics of this study do serve 
to validate 'within study' inferences and conclusions. 
During its course, major analyses of the data captured by this ongoing study were published every ten 
years (Papers 1.1, I. 5, I. 7) - the first earning the award of the Hamilton-Maynard medal of the Medical 
Association of South Africa. All enjoyed wide international recognition as providing authoritative estimates 
of the incidence of the commoner causes of Death Attributable to Anaesthesia. Subject to journal editorial 
comment and republication in the Year Books of Anesthesiology and some others, data and conclusions from 
these publications have been widely cited internationally by authors in this field. 
Broad reviews of this topic are provided in the two book chapters which conclude this group of 
publications (Papers 1.8, 1.9). 
Considerable changes occurred in the clinical practice of anaesthesia during the thirty year period 
of this study- changes consequent on advances in knowledge, the development of a more versatile drug 
armamentarium, improved professional training standards and, in particular, the advent and ready 
availability of sophisticated monitors of vital functions, including biochemical parameters. The enhancement 
of the safety of anaesthesia for the patient brought about by these improvements in practice is reflected in 
the publications presented by the six fold decrease in the incidence of Death Attributable to Anaesthesia 
reported over the duration of this study. This incidence today is less than one death per ten thousand 
anaesthetics - a 'rare event' level that has important logistic implications for the statistical design of 
future surveillance studies. The need for the latter remains, for as improvements in anaesthetic technique 
and safety permit surgical advance, this itself presents an ever greater challenge to the anaesthetist in the 
type of patient presented for anaesthesia for operations of increasing scope and complexity. 
2) PHARMACOGENETIC STATES OF CONCERN TO THE ANAESTHETIST. 
Of the pharmacogenetic states of relevance in clinical anaesthesia, two are of particular concern 
because the abnormal drug responses that characterise them may be immediately life threatening. Further, 
both are covert, their presence revealed only by family history backed by sophisticated diagnostic tests. 
These conditions are a) the Malignant Hyperthermia Myopathy and b) the Acute Porphyrias. 
Motivating research directed towards the enhancement of the Safety of Anaesthesia for those 
genetically susceptible to these states has been the concept that prevention of acute crises would follow:-
1) the identification of the genetically susceptible individuals, 
2) the identification of those drugs which provoke the abnormal reaction and their avoidance in 
the above subjects, 
3) the corollary, identification of those drugs which were safe to use in the susceptible individual. 
The research publications presented in this section are largely a product of my long association with 
two MRC sponsored research units established at the University of Cape Town - the Liver Researcl1 Unit and the 
Porphyria Research Unit. Of recent years these units have been combined and upgraded to MRC Researcl1 Centre 
status as the MRC/UCT Liver Research Centre. In addition much of the early investigation of Malignant 
Hyperthermia was made possible by assistance from the UCT Department of Chemical Pathology, in which was 
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PARTJ 
The EfTects of Anaesthetics of the Liver -
a) Studies of Hepatic Drug Metabolism of Relevance to Post-Balothane Hepatitis and the 
Bepatotoxicity of Anaesthetic Agents 
b) The Treatment of Fulminant Liver Failure 
3.1 Post-operative Jaundice with Special Reference to Halothane. (Bruk I.) S.Afr.Med.J. 1966; 
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PART4 
Heat Homeostasis During Anaesthesia 
a) Inadvertent Hypothermia 
b) Induced Hypothermia 
4.1 Temperature changes in Children during General Anaesthesia. (Bull AB, Schmidt HJ.) 
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a) The Malignant Hyperthennia Myopathy. 
First recognised in 1960, the syndrome ofMalignant Hyperthermia soon came to confront the clinical 
anaesthetist as something of a nightmare. Though rare, its occurence was unpredictable, its pathogenesis an 
enigma and its course fulminant. There was no effective treatment and the acute syndrome was, almost 
invariably, fatal. Since that time, knowledge of the syndrome and its underlying myopathyhas progressed to 
the stage that today its pathogenesis and characteristic biochemical disturbance is well recognised; the 
site of the responsible genetic functional lesion in skeletal muscle - the sarcotubular ryanodine receptor 
calcium channel - is known, as is its DNA sequencing in MH susceptible swine; the factors which trigger the 
acute attack in susceptible individuals are recognised; pharmacological control of the established syndrome 
and its prophylaxis is available and reliable methods for the diagnostic screening of those suspected of 
possessing the MH gene(s) are established. 
The contributions to this exicting story which emanated from the publications presented here were, in 
summary:-
!) The identification of Stress Susceptible Swine as a valid animal experimental model of the Human 
MH syndrome and myopathy. (Papers 2.1, 2.2, 2.7) 
2) Localisation of the basic functional lesion responsible to skeletal muscle and formulation of the 
earliest diagnostic method for identifying swine susceptible to MH (Papers 2.2, 2.6, 2.8) 
3) Characterisation of the fundamental biochemical reactions underlying the acute crisis (Paper 2.5) 
4) The identification of agents which triggered the MH reaction and the consequent establishment 
of anaesthetic .techniques safe to use in MH susceptible individuals (Papers 2.2, 2.21 - 2.27) 
5) The establishment of effective therapy and prophylaxis for the acute MH syndrome:-
a) Earliest attempts (Paper 2.2) 
b) Procaine (Papers 2.8, 2.9) . 
c) Dantrolene (Papers 2.14 - 2.20) 
Dantrolene proved to offer specific and complete control of the syndrome as well as 
prophylaxis. The very specificity of its action served to assist in the further elucidation 
of the myopathy's underlying sarcotubular dysfunction. Consequent on its introduction 
into clinical practice, the mortality from the acute MH syndrome has been reduced from 
its rate of70 -· 80%, during the first decade after it was described to a level of virtually 
zero today in cases treated timeously. 
d) Beta adrenergic blocking agents (Paper 2.29) For observations of the action of alpha 
adrenergic blocking agents - see Paper 2.2. 
6) Identification and investigation of dysfunctional 'unit membrane' other than sarcoplasmic 
reticulum (Papers 2.12, 2.28, 2.29) 
The original serendipitous observations which led to the identification of Stress Susceptible Swine 
as a valid animal experimental model of the MH syndrome and myopathy (Papers 2.1, 2.2) were to prove seminal 
in its investigation internationally. They were made during a program of surgical research in swine directed 
towards liver transplantation - a program which involved an interdisciplinary team of surgeons, 
anaesthetists, physicians and technicians. I was primarily responsible for the material in these two papers 
but in wishing to give credit to all who were part of the original discovery and whose ideas and services had 
contributed to the final outcome, all active members of the team were included in the list of authors. Paper 
2.2 was subsequently designated a 'Citation Classic' by Current Contents (Paper 2.3). 
The characterisation of the biochemical reactions underlying the fulminant MH syndrome (Paper 2.5) 
must still stand as one of the most fundamental contributions to an understanding of the pathogenesis of this 
condition. Though I was indeed the 'mover', it was the biochemical expertise ofM. Berman that provided the 
authority behind this investigation. We extended our collaboration in this work to the investigation 
described in Paper 2.6. In this, knowledge gained in the first investigation was applied 'in vivo' to identify 
skeletal muscle as the source of the biochemical changes observed and the putative site of the functional 
iv 
lesion underlying the syndrome. J. Terblanche and R.Hickman were responsible for provision of the isolated 
perfused preparation of skeletal muscle on which the observations were made. 
All the subsequent publications in this section, Papers 2. 7 - 2.30, report the outcome of 
investigations that were motivated, planned and undertaken by myself or by postgraduate students or junior 
colleagues working under my direction. Finally, the whole subject of the Porcine and Human Malignant 
Hyperthermia myopathy is reviewed in the five book chapters (Papers 2.31 - 2.34a & b) which conclude this 
group of publications. 
b) The Acute Porphyrias. 
Although not encountered commonly, the Acute Porphyrias are of partirular concern to the anaesthetist 
since anaesthetic agents - in particular intravenous induction agents - have featured among those drugs most 
strongly incriminated in initiating acute attacks. 
South Afiica boasts the highest incidence in the world of one of the acute porphyrias, Variegate 
Porphyria (VP). Here the average anaesthetist can anticipate being presented with about two such cases per 
year to anaesthetise. 
The first three papers (2.35 - 2.37) in this group report the screening for porphyrinogenicity, in 
the DOC primed rat model ofVP, of various intravenous anaesthetic agents introduced into clinical practice 
over the last three decades. These investigations which provided information of importance to the safe 
practice of anaesthesia, were essentially collaborative projects. I was responsible for the 'in vivo' aspects 
of the experiments, the paramedical scientists for the biochemical assays and their evaluation. The 
manuscripts, though managed in each case by the first author, were ultimately joint affairs. 
The fourth paper in this group (2.38) if of importance for it reports the first ever prospective 
controlled clinical and biochemical drug trial conducted in a group of porphyric individuals. In this 
instance the trial was of the new intravenous anaesthetic agent Propofol. Our trial confirmed the lack of 
porphyrinogenicity of this drug, first displayed in the experimental animal modeL and its potential for safe 
use in susceptible patients. 
As with previous sections, this group of publications is rounded off with a review of the 
porphyrinogenic potential of drugs currently commonly used in anaesthetic practice (Paper 2.39). 
3) THE EFFECTS OF ANAESTHETICS ON THE LIVER. 
a) Studies ofHepatic Drug Metabolism of relevance to post-Halothane hepatitis and the 
hepatotoxicity of anaesthetic agents. 
Halothane, introduced into clinical practice in 1956, was soon to replace in usage all the 
inhalational agents that preceded it. However, spearheaded by a letter to the Lancet from J. Barton of 
Pietermaritzburg (I), widespread reports of post-Halothane juandice-many of which proved fatal - soon cast 
serious doubts on the safety of what otherwise appeared to be an ideal anaesthetic. The need to monitor our 
own practice for this problem motivated the epidemiological survey of postoperative/anaesthetic jaundice 
which introduces this group of publications (Paper 3 .1) This showed the entity of post-Halothane hepatitis 
to be rare, as did other more comprehensive contemporaneous and later studies. (2). 
An important question that emerged from these swveys was the role of multiple exposures to Halothane 
in the pathogenesis of this new syndrome. In order to isolate the effects of drug exposure alone from all the 
many other potential causes of liver dysfunction associated with the clinical situation, we chose to 
investigate this problem in a preparation of isolated perfused rat liver. This study, the first to be so 
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documented, is reported in Paper 3 .2 - a collaborative project of which J.F. Biebuyck was the chief executor. 
And indeed, this study did show a depression ofliver function to follow multiple exposures to Halothane that 
was not apparent after single exposure, nor after multiple exposures to diethyl ether. This theme was pursued 
further eighteen years later in studies documented in publications 3.13, 3.14 .. 
The fundamental discovery, reported by Van Dyke and associates in 1964 (3,4), that all volatile 
anaesthetic agents are biotransformed to a greater or lesser extent, directed attention to the possibility 
that the mechanism of anaesthetic hepatotoxicity might have a biochemical basis not previously considered. 
On this premise I planned the extension of the above investigation to studying 'in vivo' the effects of 
multiple anaesthetic exposure on liver function and histology as affected by enhancement of drug 
biotransfonnation induc.ed by microsomal enzyme induction. These experiments, reported in Paper 3 .3, produced 
the surprise finding that Fluroxene anaesthesia, in the presence of microsomal enzyme induction, caused a 
predictable, repeatable, fulminant and lethal necrosis of the liver in experimental animals. Even in the 
absence of enzyme induction, histological evidence ofliver damage was apparent. At this time, Fluroxene was 
considered to be so innocuous in terms of its effects on the liver as to merit its recommendation as the 
anaesthetic of choice for liver transplantation (5). Our further investigation (publications 3.4, 3.5, 3.6) 
demonstrated this effect to be the direct outcome of the generation of highly reactive toxic intermediates 
during the hepatic microsomal Cytochrome P450 metabolism ofFluroxene. These observations together with 
those reported contemporaneously by Cascorbi and Singh-Amaranath ( 6) later confirmed by others, and the 
report by Reynolds and associates (7) of a human fatality following the Fluroxene anaesthesia of a patient 
on enzyme inducing medication, led to the withdrawal ofFluroxene from clinical practice after twenty years 
of use. 
This series of investigations heralded a long and fruitful collaboration with K. Ivanetich and the 
Department ofMedical Biochemistry. The main thrust of this research was into aspects of the hepatic 
microsomal metabolism of volatile anaesthetics that were considered to have relevance to an understanding 
of post-anasethetic liver dysfunction or the possible protection against such. In most instances the studies 
reported in these publications (3. 7 - 3 .13) featured as thesis topics for postgraduate M Sc and Ph D students 
supervised by K. lvanetich with myself as co-supervisor in two instances. In general, I was responsible for 
maintaining the clinical relevance of the studies, for the performance and/or supervision of ' in vivo' 
aspects of the experiments and for the histology data where relevant. Concerning the manuscripts, I was 
entirely responsible for those in which I am listed as first author and for the aspects recorded above in the 
remainder. Though elucidation of the pathogenesis of post-Halothane hepatitis - now thought to be based on 
an immunological response to a nontoxic intermediate speciesofthecytochromeP450 oxydativemetabolism of 
Halothane - eluded us, these studies contributed much new and original knowledge to the detail of the 
microsomal biotransformation of the volatile anaesthetics and related xenobiotics. A general review of 
matters relevant to the safe anaesthesia of patients suffering liver disease and for surgery of the liver 
(Paper 3 .15) concludes this section of publications. 
b) The Treatment ofFulminant Failure. 
Three papers in this group, 3 .16 - 3 .18, report the outcome of inovative and radical attempts at 
treating end-stage fulminant liver failure by cross circulation between patient and animal liver ' in vivo' 
and 'in vitro'. This project was conceived and directed by SJ. Saunders. The patients treated did manifest 
some short term beneficial effect from the cross circulation and biochemical improvement was observed. 
However, the fear of patient infection with an endemic encephalitic virus from the baboons and the regular 
occurrence of xenogenic thrombocytopoenia when use was made of isolated perfused pig liver, forced our 
abandonment of this treatment. 
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4) · HEAT HOMEOSTASIS DURING ANAESTHESIA. 
a) Inadvertent Hypothennia. 
General Anaesthesia renders the patient poikilothennic. Control of the patient's body temperature 
is, therefore, an important factor in the maintenance of his general physiological homeostasis while 
anaesthetised. The introduction into clinical practice of Halothane coincided with that of the air 
conditioning of operating theatres. This coincidence of the introduction of cooler operating theatre 
temperatures with an anaesthetic that is characterised by its vasodilatory properties combined to produce 
the circumstances that could result in inadvertent hypothennia in the anaesthetised infant. Paper 4. I 
documents the first published study of these effe~s on children. 
Massive transfusion of the anaesthetised patient with cold stored blood is another common 
circumstance which can lead to dangerous levels of inadvertent hypothennia. This may be avoided by 
pretransfusion wanning of blood. Paper 4 .2 describes an apparatus for the rapid wanning of stored blood by 
radio frequency emission and evaluates the degree of resultant red cell damage. The method used to assay red 
cell survival 'in vivo' was novel. 
b) Induced Hypothermia during Anaesthesia - Anaesthetic poblems posed by radical tumour 
radiosensitisation techniques. 
The remaining papers (4.3 -4.6) describe attempts at enhancing the radio seensitivity of malignant 
tumours by the reduction of the hypoxic cell populations of tumour cores. Increased tumour sensitivity to 
radiation and consequent increase in cure or control rates had been demonstrated to follow irradiation of 
certain malignant tumours underconditionsofbyperbaricoxygenation (3AtA) (8). This response was presumed 
to follow from an increase in tumour radiosensitivity secondary to a reduction in the hypoxic cell 
populations at tumour cores. The achievement of further reduction in hypoxic cell populations by the exposure 
of the patient to higher pressures of oxygen is barred by the convulsive threshold of 4 - 5 AtA oxygen. We 
sought to circumvent this problem by the addition of total body cooling (hypothermia) to hyperbaric oxygen 
exposure of the patient in order to reduce tissue oxygen utilisation. The target patient core temperature 
chosen was 30°C. This brought with it the need to subject the patient to general anaesthesia with 
neuromuscular blockade and intermittent positive pressure respiration together with the hazards which 
accompany hypothermia. Further, all was subject to the solution of the grave logistic difficulties posed by 
having to achieve these conditions safely within the confines of a single patient pressure vessel. These 
publications describe our preliminary developmental studies using pigs and thereafter their appiication to 
humans. 
While some improvement in patient life expectancy did follow irradiation of squamous carcinomas of 
the mouth in these circumstances, the risk of hypothermic ventricular fibrillation and the grave difficulties 
of its effective management when it occured with the patient in the pressure vessel, led us to seek a safer 
method of applying these same principles to enhance tumour radiosensitivity. In this attempt we abandoned 
the pressure vessel cooled the patient to 16°C. while on femoral artery- femoral vein cardiopulmonary bypass 
and irradiated the tumours while the patient was exposed to oxygen at normal ambient pressure i.e. I AtA This 
project was ultimately abandoned when the initial therapeutic results produced by this method failed to match 
those of the original. Funher, both methods had proved to be unacceptably costly in terms both of staff and 
time requirements. 
5) MISCELLANEOUS. 
This final group of publications is diverse and contains some papers that are now largely of historical 
interest. The first (5.1) documents the first clinical experience of the use ofHalothane as the anaesthetic 
for cardiopulmonary bypass surgery. Paper 5.2 records another situation in which the particular properties 
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ofHalothane - in this case its depression of pharyngo-laryngeal reflexes and quick recovery time - were 
applied to solve problems peculiar to paediatric radiotherapy. 
Papers 5.3 and 5.4 describe the effects that certain circumstances associated with open heart surgery 
have on the pharmacokinetic behaviour of drugs. These are Valvular Heart disease (5.3) and Extracorporeal 
Circulation itself (5.4). 
Of the following two papers ( 5 .5 and 5. 6) which concern Obstetrical Anaesthesia and factors affecting 
the establishment of sustained foetal respiratiqn after Caesarean section. the first has a degree of 
historical interest. It reports the first investigation to demonstrate the lack of correlation between the 
duration of anaesthesia (per se) and the time to sustained foetal respiration after delivery. At the time, 
the mistaken concept that there was such a correlation had led to the adoption of the so called 'smash and 
grab' technique of anaesthesia for Caesarean section. 
The next two papers are concerned with aspects of Anaesthetic circuits. Paper 5. 7 is of historical 
interest in that it documents the first direct observations of the performance of the classical Boyle 
semi-open circuit relevant to the elimination of Carbon Dioxide from the circuit. 
The final publication. 5.9, was written at a time when Respiratory Intensive Care, as we know it 
today, was in its infancy. Based on an investigation conducted on patients in the immediate recovery phase 
after open heart surgery and experience in the clinical postoperative management of other patients with 
respiratory impairment, it defined the indications for postoperative ventilatory support. Its 
recommendations are still valid. 
The publications in this collection report four decades of investigations of increasing complexity 
and sophistication as the range of research techniques available was advanced. At one extreme they 
demonstrate that research which can contribute significantly to knowledge can be performed with the minimum 
of technical equipment and resources. For example, a stop-watch alone was all that was needed for the 
investigation which examined the "Effect of duration of Anaesthesia on Apnoea Neonatorum after Caesarean 
Secion" (Paper 5 .5), while a simple clinical thermometer sufficed for the study of "Temperature Changes in 
Children during Gegneral Anaesthesia" (Paper 4 .1) At the other extreme they illustrate how the advances in 
physico-chemical technology now applied to biological research have rendered the collaboration of the 
paramedical scientist in clinical research highly desirable, often indispensable. In this regard many of 
these publications are a tribute to the high degree of cooperative interdisciplinary collaboration that has 
characterised research at this medical school. At the same time they highlight one of the great shortcomings 
of our university departments of Anaesthesiology and, by contrast, the prophetic insight displayed by Sir 
Robert Macintosh, the inaugural professor of Anaesthetics at Oxford University. As far back as 1940, 
Macintosh insisted on the appointment to the staff of the nascent Nuffield Department of Anaesthetics at 
Oxford of a paramedical scientist (Dr. H.G. Epstein - a physicist), together with a support technician 
(R.SaltX9). His example was later followed by other academic departments then developing in the United 
Kingdon and North America. Within twenty years the inclusion of posts for paramedical scientists on the staff 
establishment of university departments of Anaesthesia had become the norm in these countries. Regrettably 
this practice, so essential to the sound and balanced development of research in our discipline, has not been 
followed in South Africa. Though comment on this defiency is pertinent, discussion of its causes and possible 
resolution have no place here. 
Thirty years ago the Lancet stated in an editorial that " ... the most obvious risks of operation are 
those associated with Anaesthesia" (10). Data presented in the first group of these publications show 
convincingly that this statement can no longer be supported. In· fact, the major factors affecting 
perioperative death now are related to the patient's disease and surgery itself - these factors being 
responsible for approximately 9()0/o of all perioperative deaths (11 ). Over the last three decades the incidence 
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of Death Attributable to Anaesthesia itself at Groote Schuur Hospital has declined progressively to 
approximate 1 or less per 10000 anaesthetic administrations. Parallel reductions have occurred at similar 
institutions in Australia and England. This is a level which represents a six fold increase in the safety of 
anaesthesia for the patient. It is my belief that the data and conclusions that have emanated from this 
collection of publications have, in their way, all made some contribution to this "Enchamcement of the Safety 
of Anaesthesia". 
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PART I. 
THE EPIDEMIOLOGY OF DEATH ATTRIBUTABLE TO ANAESTHESIA. 

R.•rwint,d from tit• ''S .A . M,dical Journal" , Val . 41. ]j May anti II Jun, 1968. paftrs $1' • $/8 and $44 · $49 
ANAESTHETIC CONTRIBUTORY DEATH-ITS INCIDENCE AND CAUSES* 
PART I. INCIDENCE 
G. G. HARRISON, M.D. (CAPE TOWN), F.F.A.R.C.S. (ENG.), Senior Lecturer, Department of Anaesthetics, University 
of Cape Town and Groote Schuur Hospital 
A learned judge once said, 'It is a fact that to anaesthetize 
a human being, to deprive him of consciousness outright, 
is to take a considerable step along the road to killing 
him' .1 Yet, in South Africa, in any one year, at least one 
in every 30 persons of the total population requires to be 
anaesthetized for some surgical operation.' In the past, 
official disquiet has been voiced because of the impression 
that the incidence of death due to anaesthetics was high. 
A commission appointed by the Minister of the Interior 
'to investigate the causes of the high death rate in the 
Union from anaesthetics . . .' published its report in 
1936.1 The report of the National Health Services Com-
mission, published in 1944.' contains in the section on 
'Recommendations regarding the administration of anaes-
thetics' the statement. 'We are impressed by the evi-
dence showing that there is an unnecessary mortality from 
this cause (anaesthetics)', though what this evidence was 
or what the incidence of death due to anaesthesia was, is 
not quoted. 
The most fundamental index we have of the safety of 
anaesthesia is the incidence with which factors related to 
the anaesthetic cause, or are contributory to, the death of 
a patient. To ascertain this incidence, about which there 
existed little relevant modem information, especially in 
South Africa, I commenced a contemporary survey in 
1956 of all mortality associated with anaesthetics at 
Groote Schuur Hospital. the principal teaching hospital of 
the University of Cape Town Medical School. This paper 
is a report of the findings of this survey from its inception 
until the end of I 966. Though this survey has proceeded 
for 11 years, I report on the data for 9 years only, namely 
1956 - 1960 inclusive and 1963 • 1966 inclusive. Data for 
the years 1961 and 1962 were incomplete and are omitted. 
THE SURVEY 
The detailed survey was confined to mortality occurring 
during the period of anaesthesia and the 24 hours imme-
diately thereafter. I have called this 'immediate operative 
mortality'. This 24-hour period was chosen arbitrarily as 
being the period most likely to reveal those cases relevant 
to the anaesthetic, without the study becoming unmanage-
ably diffuse. Clinical information was obtained from the 
anaesthetist concerned on all patients who (a) died during 
•Partly based on a lhe,;is submitted for lhe dearee of Doctor of Medicine . 
University of Cape Town. Date received : 1S December 1967. 
the administration of an anaesthetic, (b) died within 24 
hours of receiving an anaesthetic, and (c) having been 
conscious before anaesthesia, died without regaining con-
sciousn~ thereafter, regardless of the postanaesthctic 
time lapse. 
Where possible, clinical documentation was completed 
by the findings at autopsy. 
The results were then examined, assessed and classified. 
In this assessmE:nt, though the final opinion was my own, 
the opinions of members of the Department of Anaes-
thetics of this Hospital were sought, a regular weekly 
departmental meeting providing the forum for discussion. 
Where relevant, the opinion of the surgeon concerned was 
also sought. 
In any biological study where the observations are com-
pounded from the interaction of many variables, the clas-
sification of data into meaningful groups from which valid 
inferences can be made, is frequently a most difficult 
problem. As Treloar rather despairingly rernarlcs, "Ibe 
causation of a given death is always multiple, so that the 
necessity of selecting a single cause for purposes of tabu-
lation has become a distressing problem'.' 
Deaths associated with . anaesthesia result ultimately 
from a combination of circumstances which may be 
broadly grouped as follows: 
I. The patient's disease. which is often coincidental and 
not directly associated with the lesion ncceuitating 
surgery. Such disease, even if not itself directly re-
sponsible for the death of the patient, will, by its 
deleterious effects on the patient's physiological 
homeostatic mechanisms, render the administration 
of an anaesthetic and the immediate pre-operative 
and postoperative surgical care more criticaJ. 
2. Factors associated with the surgical lesion and the 
operation itself, including the magnitude of the 
operation and mishaps or errors in the surgicaJ pro-
cedure. 
3. The conduct of the anaesthetic. 
.For the data from this survey I adopted a very simple 
classification and, in so doing, did not allow for the com-
binations and permutations of the above factors which arc 
a feature of the classifications adopted by many worten 
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I. Anaesthetic Contributory Death 
In this group I classified all deaths to which the admin-
istration of the anaesthetic itself, or factors within the 
ambit of the anaesthetist's responsibility, were considered 
to have been a significant contributory factor. 
2. Deaths Due to Other Causes 
In this group I classified those deaths which resulted 
primarily from the patient's disease or factors directly 
related to the operation. Though, from its very nature, 
there are few deaths which occur in association with 
anaesthesia to which it can be said the anaesthetic made 
no contribution, there are such deaths where the conduct 
of the anaesthetic appears to have been faultless, where 
any contribution appears to have been minor and where 
other circumstances appear to have provided adequate 
reason for death. 
3. Inevitable Deaths (Last-Ditch Surgery) 
This is a group of not uncommon cases which require 
separate identification. They are deaths from which the 
anaesthetic and its management, though apparently clini· 
cally faultless, cannot be excluded as a significant contri· 
butory factor. This may be because death occurred dur-
ing anaesthesia, or it may be that the final collapse of 
circulatory homeostasis in a patient, moribund before 
anaesthesia, appears to have been unavoidably precipitated 
hy the known effects of anaesthetic drugs, e.g. vasodila-
tation. These deaths may be regarded as those to which 
anaesthesia was unavoidably or necessarily contributory. 
Precision of assessment of clinical cause is often impos-
sible. All deaths which followed cardiac arrest during 
anaesthesia. where the contributory role of the anaesthetic 
appeared to be minor and where the conduct of the 
anaesthetic appeared to be faultless, were also classified 
in this group, even though death may have occurred in 
the postoperative period after termination of the anaes-
thetic. 
The phrases 'death associated with anaesthesia' and 
·death to which anaesthesia was considered a significant 
contributory factor' are cumbersome, and will hereafter 
be abbreviated to 'anaesthetic associated death' and 
·anaesthetic contributory death', respectively. The former 
term has no implication as to the precise cause of the 
death and includes all deaths associated with an anaes-
thetic, be they due to the patient's disease, the operation 
or the anaesthetic per se. The second term refers only to 
those deaths occurring in association with an anaesthetic, 
which have been caused in large measure by factors for 
which the anaesthetic and its management were responsible. 
Ideally, all deaths specifically due to anaesthesia are 
preventable. Macintosh states. 'I hold there should be no 
deaths due to anaesthesia·." All anaesthetic contributory 
deaths in this survey were further examined and classified 
as 'probably preventable·. ·possibly preventable', or 'no 
verdicf. The first 2 subdivisions include those cases best 
described (as suggested by Morton)" as 'those deaths for 
which a reasonably satisfactory explanation can be pro-
vided and for which countermeasures are practicable·. 
The last subdivision includes those cases 'which cannot 
at present be fully explained and for which counter-
measures are either lacking or largely empirical'. 
THE INCIDENCE OF ANAESTIIETIC CONTRIBUTORY DEATH 
During the 9 years covered by this survey, 177,928 anaes-
thetics were administered at Groote Schuur Hospital. Of 
the 2,026 patients who died following surgery, 414 (20%) 
constituted the group defined here as 'immediate operative 
mortality' (Table I). 
TABLE I. OPERATIVE MORTAUJ'Y INCIDENCE IN 177,928 OPEllA110NS 
AND ANAESTHmC:S, GROOTE SCHUUR HOSPITAL (1956-60, )963~) 
No. of D«zths per 
deaths 1,000 anaes. 
Total operative 
mortality 2,026 11-38 
Immediate operative 414 2-33 20% of total op. 
mortality mortality 
Group 1 (anae1.) 58 0·33 14% or immed. 
Group 2 261 1-47 op. mortality 
Group 3 95 0·53 
To 58 of these deaths the anaesthetic and its adminis-
tration were considered to have been significantly contri-
butory. This results in an over-all incidence of anaesthe-
tic contributory death of 0·33 deaths per 1,000 anaesthe-
tics. The majority of these deaths (54 - 93%) were 
considered to have been either probably or pos.~ibly pre· 
ventable. 
Considered in the perspective of the total care of the 
surgical patient, it can be said that the anaesthetic and its 
management were responsible, in a way that was possibly 
preventable, for 2·1 % of the total operative surgical 
mortality. 
Such an estimate of the incidence of anaesthetic contri-
butory death immediately poses two questions: How do 
our standards of clinical anaesthesia, judged on the basis 
of mortality, compare with other medical centres in the 
world? Have the advances claimed for clinical anaesthe-
sia over the years resulted in a greater safety for the 
pati~nt? 
For purposes of comparison, surveys were examined of 
anaesthetic contributory mortality published in the 25 
years preceding the commencement of the present study, 
i.e. surveys published since 1930. Such examination 
showed that a great number of variables influenced the 
estimates of incidence of anaesthetic contributory death, 
to an extent that rendered all but the very broadest 
c,omparisons invalid. These factors were: 
1. The criteria by which data were assessed. 
2. Differences in the classification of data used. 
3. Differences in the peri-operative period included in 
the surveys. 
4. Differences in the type and scope of surgery covered. 
5. Limitation of the techniques of anaesthesia included 
in the survey. 
6. Failure to enumerate the parent surgical population. 
For purposes of comparison, two groups of surveys are 
presented here. These are grouped in terms of the peri-
operative period : · 
(a) Those which included the period of operation and 
an arbitrary postoperative period (usually 24 hours), 
together with the inclusion of those patients who 
failed to regain consciousness after anaesthesia. The 
I.I 
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present study belongs to this group. (Authors as in 
Fig. 1.) 
(b) Those which included the period of operation only 
-so-called 'operating-room deaths'. (Authors as in 
Fig. 2.) 
Estimates from these surveys of the incidence of anaes-
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Fig. 2. Incidence of anaesthetic contributory operating-
room death. ORD = operating-room death, FRC = failed 
to regain consciousness. 
histograms in Figs. I and :!. They are arranged in chro-
nological order. 
Jt should be noted that the: incidence of anaesthetic 
contributorv mortalitv that emerges from the Groote 
Schuur Ho~pital surv~y. when selected on the basis of 
'operating-room deaths ' only, is less than one-half of that 
which results when the 24-hour postoperative period is 
included in the period surveyed. This demonstrates the 
fallacy inherent in the common method of surveying 
·operating-room deaths' only, when attempting to estimate 
the incidence of anaesthetic contributory mortality. 
A wide disparity is evident in these estimates of the 
incidence of anaesthetic contributory death. No general 
trend is apparent. Of the 1:! surveys presented in the first 
group, all but 2 estimate the incidence of anaesthetic con-
tributory death as 1 death or less/1,000 anaesthetics, while 
one-half (including this present Groote Schuur Hospital 
survey) give an estimate of 0·5 or less/ 1,000 anaesthetics. 
In the second group of 15 surveys of 'operating-room 
deaths', all but 3 estimate an incidence of anaesthetic 
contributory death that does not exceed 1 death/ 1,000 
anaesthetics, while from half of the surveys (including this 
survey) this estimate of anaesthetic contributory death 
does not exceed ().5 deaths/1,000 anaesthetics. 
Though only the broadest comparisons are possible, it 
would appear that, judged on the basis of mortality, the 
standard of clinical anaesthesia practised at Groote Schuur 
Hospital compares more than favourably with that of 
other centres. 
In attempting to answer the second question on evi-
dence of progress towards greater safety for the patient 
of anaesthesia and operation, I have confined my attention 
to conditions in South Africa. Besides the present study 
at Groote Schuur Hospital, 5 other surveys of anaesthetic 
associated mortality have been undertaken in this country 
within the last 30 years. (Of these, only 3 have been 
published.) Details of these are presented in Table II and 
TABLE Il. INCIDENCE OF ANAESTHETIC ASSOCIATED AND 
ANAESTHETIC CONTRIBUTORY DEATHS IN SOUTH AFRICA 
Years 
I""*"" ,,.r I l)OO -lwtiu 
included A,,.s,ltetic A-Jtlwtic 
Author in auociar,d contributory 
-~y deaths dftltJu 
Oreallein Committee> 1931-1935 1•57 0·12 
Melzer" 1941-1945 ::?-85 
Wbitel..a 
Non-White 6·7 
Barlow n al." 1945-1951 6·23 2·29 
JohaDDCSbura 
Hospil&l" 1951-1952 1'17 0-94 
White HI 
Non-White 2·70 
Kok and Mullan" 19~1962 0-94 0"49 
Groote Schuur 1956-1960 2-491 0'43t Hospilal and j2·32 0·33 
1963-1966 2-18 0·23J 
arc graphically illustrated in Fig. 3. It will be seen that 
there is no real difference between the incidence of anaes-
thetic contributory death reflected by the findings of the 
Orenstein Committee of 1936' (0·8 deaths/1,000 anaes-
thetics), and that computed from a survey of the Johan-
nesburg Teaching Hospitals Groupn conducted 15 years 
later (Q.94 deaths/ 1,000 anaesthetics). At the same time 
the incidence of anaesthetic associated death is shown to 
have increased slightly. 
1.1 
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A survey conducted by Melzer' during the war years 
in the time between these 2 previous surveys, showed a 
marked increase in the number of anaesthetic associated 
deaths, that among non-Whites being disturbingly high, 
6· 7 deaths/ l ,000 anaesthetics. Melzer dealt only with the 
broad category of anaesthetic associated deaths and did 
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Fig. 3. Anaesthetic associated and anaesthetic contribu-
tory mortality in South Africa. 
His findings were confirmed by the survey of the years 
1945 - 1951 conducted by Barlow, Ginsberg and Gottlieb 
at the Coronation non-White Hospital in Johannesburg ... 
Anaesthetic contributory deaths taken over the whole 
period of the survey bad an incidence well over twice as 
high as that computed for South Africa by the Orenstein 
Committee. This fact must be taken to indicate a distinct 
inadequacy in anaesthetic services available at this hos-
pital at that time. As the position ameliorated during the 
period of the survey. both anaesthetic associated and 
anaesthetic contributory mortality rates dropped. The 
subsequent survey in the Johannesburg Teaching Hospitals 
Group 1951 - 1952" showed a decrease in the deaths asso-
ciated with anaesthesia from that found by Melzer, both 
over-all (1 ·87 / l,000 anaesthetics as against 2-85 / l,000) 
and in the incidence for the individual racial groups 
(White 1-l / l ,000 anaesthetics and non-White 2· 7 / 1,000 
anaesthetics as against White 148 / l,OOO and non-White 
6,7 /1,000). This decrease in the anaesthetic associated 
mortality rate in the non-Whites is particularly striking. 
However, the incidence of both anaesthetic associated 
death and anaesthetic contributory death at this time 
showed no improvement over that computed for South 
Africa in 1936. 
This disappointing and static picture is relieved by the 
facts that emerge from the 2 most recent surveys of 
anaesthetic associated mortality quoted. These contem-
porary surveys, that of the CSIR Anaesthetic Deaths 
Research Unit" and the present Groote Schuur Hospital 
survey, do present evidence of an unprovement in the 
safety of anaesthesia. A general analysis by the CSIR 
Unit of anaesthetic associated deaths at 150 South African 
hospitals shows a progressive decrease in incidence be-
tween the years 1956 - 62" (see Fig. 4). The incidence of 




Fig. 4. Anaesthetic associated deaths ai 150 South Afri-
can hospitals. 
detailed examination of the data from the survey of Kok 
and Mullan" shows an incidence (0·49 deaths/ 1,000 
anaesthetics), less than two-thirds of that found for South 
Africa by the Orenstein Committee in 1936.' 
At the same time, this indication of a measurable in-
crease in the safety of anaesthesia is further borne out by 
the incidence of anaesthetic contributory death that 
emerges from my study (0·33 deaths/ 1,000 anaesthetics), 
an incidence of two-fifths of the 1936 figure. A 
slight difference in the method of selection of cases in the 
Groote Schuur Hospital survey from that of the other 
South African surveys quoted, accounts for the slightly 
higher incidence of anaesthetic associated death shown in 
this study-2·3 deaths/1,000 anaesthetics. as compared with 
Kok and Mullan's 0.94/1,000 anaesthetics. Whereas all 
cases dying within an arbitrary 24-hour period or who 
failed to regain consciousness after operation were in· 
eluded in the Groote Schuur Hospital survey, the other 
surveys used Section 86 of the Medical, Dental and Phar-
macy Act of 1928 as their criterion for the selection of 
case~. When examined on an annual basis, the incidence 
of anaesthetic associated death at Groote Schuur Hospital 
shows no marked trend (Fig. 5). The incidence of anaes-
thetic contributory death, however. shows a progressive 
1.1 
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diminution, the figure for the last year reviewed being 
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Fig. 5. Anaesthetic associated and anaesthetic contribu-
tory deaths at Groote Schuur Hospital. 
Such advance towards the goal expressed by Macintosh 
that 'there should be no anaesthetic deaths"' is gratifying, 
but the fact that anaesthetic contributory deaths do still 
occur and that of these the majority (94 % in the Groote 
Schuur Hospital survey) are preventable, must keep us 
from any self-satisfied complacency. The figures quoted 
here reflect but a segment of the total population at risk 
throughout the country. It must be our goal that the 
patent benefits of advances in clinical anaesthesia in safety 
for the patient are further spread by the continued supply 
of more and better-trained clinical anaesthetists. In out-
lying areas away from the larger centres which are now 
becoming specialist-orientated, it becomes important to 
increase the training and skill of those practitioners who 
administer anaesthetics. It must be borne in mind that 
the major proportion of anaesthetics given for routine sur-
gery in this country is administered by general practi-
tioners.' Possible practical measures to increase their skill 
are: 
1. Provision for short-term attachment as a 'super-
numerary staff' member to recognized teaching depart-
ments of anaesthetics. Such a scheme does exist at this 
Medical School, but it is not widely known. 
2. The provision by teaching departments of what may 
be called 'visiting demonstrators' who would visit selected 
country hospitals for periods of up to a week, giving prac-
tical demonstrations of accepted techniques of safe anaes-
thesia for routine surgery. 
Fifty years ago Paul Wood said, 'given a properly 
trained and equipped anaesthetist, mortality and mor-
bidity will fall regardless of the agent, the technique, or 
the patient's condition'.'° We must provide such men. 
1.1 
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PART II. CAUSES 
'I have at the same time and with even more earnest efforts 
labored to impress on the minds of those as yet un-
familiar with their use, the lessons of caution and watch-
fulness without which, I know, these agents (anaesthetics) 
are, and must be, ministers of death' (Gilman 1851).
01 
Though undertaken primarily to establish the incidence 
of anaesthetic contributory death, t an important corollary 
to this survey of immediate operative mortality was the 
accumulation of clinical data on the mechanisms and 
causes of anaesthetic contributory death and the clinical 
errors and pitfalls from which it may result. 
In this communication I shall report on the cause of the 
58 deaths that were classed as anaesthetic contributory 
deaths. Although anaesthesia was not considered contri-
butory to the 95 deaths in group 3, I shall comment briefly 
on aetiological aspects of some of these. 
Fundamental Causes 
In general, the fundamental causes of death during 
anaesthesia may be thought of in terms of the following 
concept (Fig. 6): Death is the ultimate result of anoxic. 
ANOXIA DIRECT CAUSES 
Anoxic ~7 







Fig. 6. Cause of death. 
Reflex. HypotMrmio . 
Drugs. 
Surg: handling etc. 
cerebral cellular damage. This may have resulted directly 
from a general state of anoxia but more usually follows 
cardiac arrest. Cardiac arrest itself may result from anoxia 
or from certain direct causes such as drugs, hypothermia, 
etc. Many of these causes have a greater tendency to cause 
cardiac arrest in an environment of anoxia. The state of 
cellular anoxia which arises when the cellular utilization 
of oxygen exceeds the amount avai!able. may result from 
a decrease in arterial oxygen saturation-anoxic anoxia-
or from poor tissue perfusion for some or other reason-
ischaemic anoxia. 
Based on this concept, the following classification of 
causes of anaesthetic contributory death was used. 
•Partly based on a thesis submitled for the dearcc Doctor of Medicine . 
University of Cape Town. 
t Sec part I for terminoloi:y. 
I. Anoxia : 
(a) Anoxic 
(b) lschaemic 
2. Cardiac arrest : 
(a) Direct causes other than anoxia 
(b) Uncertain aetiology 
3. Miscellaneous 
Cases of 'cardiac arrest' were classified in relation to the 
type of anoxia considered causal. Those cases for which 
some direct cause other than anoxia was responsible, or 
where the aetiology was uncertain, were classified under 
the separate heading 'cardiac arrest'. Though the state of 
anoxia is stressed, it must be remembered that almost 
invariably there must have been associated acidosis (respi-
ratory in the case of anoxic anoxia, and metabolic in the 
case of ischaemic anoxia) which contributed towards the 
death. 
Within the framework of this general classification, the 
deaths were then further classified with regard to the more 
precise clinical fault or 'departure from accepted practice"' 
which was considered causal. The causes of the 58 anaes· 
thetic contributory deaths are presented in Table III. 
DEATHS DUE TO ANOXIC ANOXIA 
Not surprisingly, deaths due to anoxic anoxia constitute 
the greatest proportion (47%) of this group of anaesthetic 
contributory deaths. Of these, more than half were due to 
respiratory obstruction, that most basic and obvious cause 
of anaesthetic contributory death. 
Complications of Endotracheal Intubation 
An unpleasant surprise for the clinical anaesthetist is the 
fact that half of this group (8 cases) followed the acute 
complications of endotracheal intubation. These compli-
cations are simple and mechanical. Yet they may be 
rapidly catastrophic before the anaesthetist, lulled into a 
false sense of security of the airway by the very presence 
of an endotracheal tube, has realized that anything is amiss. 
These cases may be briefly enumerated as follows: 
(a) Respiratory obstruction in curarized patients due to 
kinking of the endotracheal tube in the pharynx,• not 
observed initially because of the inexperience of the 
anaesthetist involved (2 cases). 
(b) Obstruction of the airway by herniation of the tube 
cuff. This form of respiratory obstruction, of which the 
mechanism is well documented,'' is particularly dangerous. 
It may occur some time after the original intubation, or 
may cause initially incomplete, but insidiously increasing, 
respiratory obstruction which is difficult to spot clinically 
until it is too late (3 cases). 
(c) Obstruction of a Carlen double lumen tube in a 
patient with gross bronchiectasis and bronchial distortion 
(I case). 
(d) Endotracheal intubation performed in the absence 
of sufficiently deep general anaesthesia, or complete muscu-
lar relaxation, or adequate topical analgesia of the larynx 
I.I 
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TABLE 111. ANAESTHETIC CONTRfflUTORY DEAT
HS, GROOTE SCHUUR HOSPITAL (195~, 1963-66) 
% (Jf anaa. 
Mechanism C






Respiratory obstruction 16 
27-6 
Vomiting and regurg. 3 
Secrctional bronch. obstruction 2 
Tidal Comp!. of intubation 8 
Anoxic anoxia (*cardiac arrest, 13) 
lnad. postop. supervision 3 (47rJ 
Relaxant-contrib. death 
'} IS·S 
Resp. abnormality I:! 
· ·· Neostig. cardiac arrest I 
LAlveolart Pulmonary oedema 
1·7 
(overtransfusion) 
Prolonged hypotension 13 22-4
 l Circulatory failure '} I lschaemic anoxia (*cardiac arrest, 8) Cerebral damage 4 c26rJ _, Hypertension (UrovertJ ~ 2 J,4 
· :.._., . l~;rect causesJ uncertain aetiology "' ::> ~ 
(J,1 
II. Cardiac arrest (*13) 
8·6 
entnc. tachycardia (postop. death) 2 
3·5 
Ill. Miscellaneous 
Jncompatible blood transfusion I 
1-7 
"No. of cases that suffered cardiac arrest during anaes. a
nd operation. 
tTypes of anoxia - after Saklad." 
or trachea. In these circumstances such intubation may 
be 
followed by bronchospasrn and, more important, spas
m 
of the respiratory muscles in expiration so severe as 
to 
render ventilation of the patient impossible. The effec
ts 
of the gross anoxic anoxia that follows are compound
ed 
by simultaneous profound vagal stimulation. In su
ch 
circumstances, only the rapid administration of a par
a-
lysing dose of muscle relaxant will permit adequate passi
ve 
ventilation of the lungs (2 cases). 
Inhalation of Vomitus 
Deaths due to inhalation of vomitus or regurgitated
 
stomach-content during anaesthesia, feature in most su
r-
veys of deaths due to anaesthesia. In this survey the num
-
ber was small. One of the 3 cases recorded was an examp
le 
of silent gastric regurgitation and aspiration ... ·" 
Secretional Bronchial Obstruction 
The 2 patients who suffered anoxic cardiac arrest from
 
secretional bronchial obstruction were children, a circum
-
stance where the smallness of the bronchial anatomy is
 a 
factor which markedly worsens the degree of obstructi
on 
which may result from secretions. One of these lit
tle 
patients had bronchiectasis, while the other had inhaled
 a 
foreign body. 
Inadequate Postoperative Supervision 
It is fundamental to safe anaesthetic practice that a
 
patienfs emergence from the anaesthetic state be w
ell 
supervised." The number of deaths due to inadequate po
st-
operative supervision still reported is surprising.n ... All
 3 
deaths attributed to inadequate postoperative supervisi
on 
were associated with the use of muscle relaxants. After t
he 
use of muscle relaxants. though respiration may appear 
to 
be adequate in depth following pharmacological rever
sal 
of neuromuscular block, residual muscle weakness m
ay 
remain." ·" This may result in the inability of the patient 
to 
cough strongly to expel bronchial secretions, or in t
he 
inability of the patient to overcome minor degrees 
of 
Total S8 99·9 
respiratory obstruction by an extra respiratory effort. Mil
d 
residual curarization was probably a factor in each o
f 
these cases, together with respiratory obstruction. In each 




One-third of the group of deaths considered to be the 
result of anoxic anoxia (15·5% of all anaesthetic contr
i-
butory deaths) resulted from causes related to the use o
f 
muscle relaxants. I choose to identify 'relaxant-associate
d 
deaths' as deaths which followed the use of a relaxant 
drug with an IPPR technique during anaesthesia: (
i) 
after which anaesthetic the patient failed to respire spon
-
taneously with a normal respiratory pattern and adequa
te 
minute volume of ventilation ; (ii) for which respirator
y 
abnormality there was no other obvious explanation
 ; 
(iii) for which respiratory inadequacy no efficient pulmo
-
nary ventilation was provided postoperatively by the anaes-
thetist; (iv) which may have been associated with neo
-
stigmine, the pharmacological antidote to non-depolarizin
g 
relaxants. 
While all 9 of these cases involved abdominal operations, 
7 were acute abdominal emergencies, suffered marke
d 
abdominal distension and were of poor physical statu
s 
pre-operatively. Seven of the 9 had lesions which woul
d 
produce rather similar patterns of fluid and electroly
te 
depletion. Acute pancreatitis was present in 3. I feel th
at 
this disease warrants separate emphasis, as it features in 
a 
similar context in several recorded cases of anaesthetic 
dilemmas which did not result in death. 
Non-depolarizing relaxants had been used in all these 
patients, and in each case the respiratory inadequacy ap
-
peared to be 'neostigmine resistant'.• Though not invest
i-
gated at the time, it is probable by clinical hindsight that 
7 
of these 9 patients had severe metabolic acidosi~ now
 
well-documented cause of persistent curariz.ation." Now
 
that the means for the rapid diagnosis and treatment o
f 
I.I 
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acidosis are widely available, this cause of persistent 
curarization should be eliminated. It is significant that 
more than half of these cases occurred before 1961 and 
that none occurred in 1966. A point of some clinical im-
portance is that in none of these cases was the volume 
of ventilation adequately monitored postoperatively, the 
anaesthetist contenting himself with clinical assessment of 
its adequacy and the absence of clinical cyanosis before 
return of the patient to the ward. 
Though listed here as occurring in only 1 case, fatal 
cardiac arrest followed, and appeared to be precipitated 
by, the injection of neostigmine in 2 cases. Though an 
adequate dose of atropine had been administered in each 
case, hypoventilation had been permitted for some time 
before the administration of neostigmine, circumstances 
shown by Riding and Robinson"' to render the administra-
tion of neostigmine dangerous. (As hypoventilation in one 
of these cases was due to respiratory obstruction, the 
result of herniation of the endotracheal tube cuff, this case 
is listed under this cause in Table Ill). 
Atmospheric and Alveolar Anoxia 
The remaining 2 deaths in this group, those listed as 
atmospheric anoxia and alveolar anoxia,
16 require little 
comment. The one due to atmospheric anoxia resulted 
from the incorrect coupling of the anaesthetic machine. As 
a result, no fresh gas flow reached the patient, who conse-
quently re-breathed only his own exhalations for several 
minutes. The one listed as alveolar anoxia developed 
pulmonary oedema, resulting from overtransfusion of 
blood by the anaesthetist due to an error of judgement. 
The patient had a ruptured ectopic pregnancy of 48 hours' 
duration. 
DEATHS DUE TO 1SCHAEMIC ANOXIA 
Hypotension During Anaesthesia 
A mode of anaesthetic contributory death that is promi-
nent in my survey is that which follows progressive, pro-
longed and intractable postinduction hypotension, or, less 
commonly, profound intractable hypotension occurring 
during anaesthesia. This was responsible for 22% of the 
anaesthetic contributory deaths. In some cases death 
followed precipitation of cardiac arrest by this phenome-
non. In the remainder, though cardiac arrest did not ensue 
during operation, death followed postoperatively from 
what appeared to be irreversible cerebral damage. 
When hypotension is observed to follow the induction 
of anaesthesia, it is often impossible to identify the cause 
precisely. This is because of the simultaneous or sequential 
use, during anaesthesia, of a number of drugs, any of 
which may itself cause hypotension. In addition, other 
factors such as the effects of IPPR and induced respiratory 
alkalosis must be considered. It is pertinent to draw atten-
tion to some clinical factors that were commonly asso-
ciated with the onset of intractable hypotension : 
l . More than half of these patients were over 65 years 
of age and the majority had evidence of degenerative 
v.ascular disease. 
2. Pre-operative hypovolaemia, a factor strongly 
stressed by Dinnick21 in his survey, was present in one-third 
of the cases. 
3. Inadequate replacement of blood during the opera-
tion was considered an important factor in one-third of 
the cases. 
4. The onset of hypotension followed closely on, and 
appeared to have been precipitated by, the use of thiopen-
tone sodium in 7 of these 13 deaths. In only 1 of these 
was the dose of thiopentone considered excessive. As 
clinical anaesthesia today is induced with the use of an 
intravenous barbiturate almost as a routine, attention must 
be drawn to these deaths. Both the major reports emanat-
ing from the Committee on Deaths Associated with 
Anaesthesia of the Association of Anaesthetists of Great 
Britain and Ireland strongly emphasized this entity of 
circulatory failure following the use of an intravenous 
barbiturate for the induction of anaesthesia."·'" Clifton and 
Hotten," in their survey of deaths associated with anaes-
thesia in Australia, attributed 17 % of anaesthetic contri-
butory deaths to circulatory collapse after the administra-
tion of thiopentone. In South Africa, Kok and Mullan" 
attributed 19·5% of the anaesthetic contributory deaths in 
their survey to this mechanism. 
Hypertension During Anaesthesia 
In this group of deaths due to ischaemic anoxia it is 
convenient to include 2 cases in which death resulted 
from the effects of massive subarachnoid haemorrhage, 
including probable cerebral ischaemia. In each case massive 
subarachnoid haemorrhage was due to rupture of an 
intracranial berry-aneurysm, following an episode of 
hypertension during anaesthesia involving the use of intra-
venous urea (Urovert). The use of intravenous urea as an 
agent to reduce brain bulk and tension has become a 
standard ancillary to anaesthetic techniques for neuro-
surgery. It is known that before the diuresis commences, 
following administration of the urea, the blood pressure 
may rise." It is also recognized that intracranial berry-
aneurysms that have previously leaked, may rupture 
following a rise in blood pressure. While ,:inaesthetizing a 
patient for the operation of ligation of such a berry 
aneurysm, care must be taken to avoid circumstances that 
might provoke a sudden rise in blood pressure. For these 
reasons it is thought that, following the use of intravenous 
urea in the anaesthetic technique for such an operation, a 
rise in blood pressure should be anticipated and prevented 
if necessary. This may be done by the use of drugs such as 
halothane or ganglioplegic agents. One death, listed in 
Table IV, resulted from a pontine haemorrhage which 
followed an episode of severe hypertension occurring at 
the time the aorta was clamped during aortic resection. 
Again the same lesson applies. Such hypertension, if antici-
pated, should be cushioned by some artifice of the 
anaesthetist. 
CARDIAC ARREST DURING ANAESTHESIA 
Of the 58 anaesthetic contributory deaths, 34 were asso-
ciated with the occurrence of cardiac arrest during anaes-
thesia. Twenty-one of these were attributed to anoxia, 
either anoxic or ischaemic. The causes of these have 
already been discussed. In the remaining 13 cases the 
cardiac arrest was due to identifiable direct causes (the 
responsibility of the anaesthetist) in 5, while in 8 the final 
aetiology was not identifiable with any certainty, though 
1.1 
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anoxic and ischaemic anoxia were the most probable 
associated factors. The direct causes identified in 5 cases 
were as follows : 
1. Reflex vagal arrest (plus anoxic anoxia) (1 case). This 
occurred at the time of bronchial clamping during a 
pneumonectomy. 
2. Inadvertent hypothermia (I case). Cardiac arrest 
followed the too rapid transfusion of cold blood in a child. 
3. Drug induced (3 cases): (a) overdosage of ether-I 
case; (b) thiopentone sodium-I case-cardiac arrest 
immediately followed injection of thiopentone down a 
cardiac catheter in a baby with pulmonary stenosis ; (c) 
halothane-1 case-ventricular fibrillation occurred during 
the delirium stage which followed attempted induction of 
anaesthesia with 4% halothane in a fit, healthy adult male. 
The stormy delirium, with struggling and breath-holding, 
doubtless led to hypoxia, hypercarbia and a high level of 
endogenous catecholamines. 
The 2 patients listed as having had ventricular tachy-
.::ardia did not develop cardiac arrest during anaesthesia. 
They are listed here because the ultimately fatal arrhyth-
mia commenced during anaesthesia. In one the arrhythmia 
was precipitated by the intravenous administration of 
Digoxin, while in the other, anoxia and hypercarbia were 
probably precipitating factors in a digitalized patient who 
suffered cardiac failure from gross ischaemic heart disease. 
INCOMPATIBLE BLOOD TRANSFUSION 
During this survey 2 deaths associated with anaesthesia 
occurred as a direct result of the transfusion of incom-
patible blood. One, listed in Table II, was the responsibility 
of the anaesthetist, while the other, listed in Table III, was 
due to an error in the ward in identification of blood 
specimens for cross-matching. 
INEVITABLE DEATHS (GROUP 3) 
Though anaesthesia was not considered contributory, other 
than unavoidably so, to the 95 deaths in group 3 (see 
Table IV). the majority of these occurred during anaes-
TABLE JV. CAUSE OF DEATH. GROUP 3: IMMEDIATE OPERATIVE 
MORTALITY 
Cardioc 
No. o ~~ of arnst 
Cauu of d~ath d~aths group during 
operation 
Massive baemorrhaae .. 44 46·3 41 
(inadvertent hypothermia) . . . . 15 10 
Cardiac suraery (other than hacmorrhaac) 19 20·0 17 
Prolonaed hypoteosion (refractory shock) .. 15 15·8 8 
Coronary thrombosis 3 3-2 2 
Pulmonary embolism 2 2·1 2 
Air embolism I l · I I 
Cerebral embolism (.;,ltral valvoto;,;y) : : 1 1·1 0 
Cerebral ischacmia (carotid stenosis/thromb.) 2 2-1 I 
Pontine haemorrhaae (clampina aorta) .. I l ·I 0 
Brainstcm oedema/neuronal inj. . . s 5·3 2 
Vena caval obst. prone position . . I 1-1 I 
Incompatible blood transfusion I 1-1 1 
Total 95 100·3 76 
thesia and .I therefore wish to comment on aetiological 
aspects of some of them. A little over one-half of these 
cases involved cardiac or major vascular surgery. Neuro-
surgery, the next commonest group, was involved in 11 °~ 
of these cases. 
Occurring in nearly one-half of the cases in this group, 
massive haemorrhage was the factor most commonly 
associated with death. The extent to which cardiac arrest 
and the ultimate death of the patient were due to the 
hypovolaemia, or to the .known deleterious effects of the 
concomitant massive transfusion of stored blood, was 
impossible to assess. One of the more easily monitored 
effects of massive transfusion-inadvertent hypothermia-
was .known to be present in one-third of these cases of 
cardiac arrest associated with gross haemorrhage and 
massive transfusion. It may have been present in more. In 
those in which the oesophageal temperature was moni-
tored, this ranged from 28 • to 32°C at the time of cardiac 
arrest. Unti~ fairly recently, the inadvertent hypothermia 
that followed massive transfusion of stored blood was in 
large measure unavoidable. The means of warming such 
blood with the speed required and the necessary safety 
were not available. However, many devices for this pur-
pose have now been described.• In future, deaths asso-
ciated with gross haemorrhage which appear to have re-
sulted from the hypothermia of massive transfusion, rather 
than from the hypovolaemia of blood loss, should be 
regarded as preventable . 
One other aspect of the deaths I have listed here asso-
ciated with gross haemorrhage concerns those cases which 
occurred during resection and grafting of aortic aneu-
rysms-predominantly ruptured aortic aneurysms. During 
the period of this survey 8 patients died during aortic 
resection. The majority of these were emergency resec-
tions for rupture of the aneurysm. Though all of these 
were associated with gross haemorrhage and massive trans-
fusion, it is significant that 3 of these patients died at the 
time the aortic clamp was released, following completion 
of the aortic graft. It is pertinent to note that at this time 
of maximum aortic run-off, severe hypotension will inevi-
tably result if hypovolaemia, mas.Iced by the previous 
application of the aortic clamp, has been allowed to persist. 
And it must be remembered that this sudden hypotension 
occurs in a patient who suffers from generalized vascular 
disease with a great likelihood of coronary atherosclerosis. 
lschaemic Heart Disease 
Coronary thrombosis as a cause of death during anaes-
thesia-certainly coronary thrombosis with recent myo-
cardial infarction demonstrable at autopsy-is relatively 
rare. During the 9 years of this survey, 3 such cases 
occurred. What is perhaps more important is the profound 
effect ischaemic heart disease has on postoperative morta-
lity. A recent survey by Topkins and Artusio• showed that 
of patients with a pre-operative history of infarction, 6·5% 
sustained a postoperative infarct, whereas the incidence of 
postoperative myocardial infarction in patients with no 
such history was 0·66 % . Of those whose pre-operative 
history of infarction was shorter than 6 months, no less 
than 55% had fresh infarcts postoperatively. Arkins and 
Hicks,• who report a similar incidence of postoperative 
infarction, report a mortality of 69% in those who :suffered 
postoperative re-infarction. In this survey, of the 261 
patients who died postoperatively from causes unrelated 
to the anaesthetic (those in group 2), 23, or approximately 
9 % of the group, died of myocardial infarction. It must · 
be noted that these are deaths occurring in the first 24 
hours postoperatively, and do not include deaths from 
this cause that may have occurred later in the postopera-
tive period. 
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Pulmonary Embolism 
Two patients died during anaesthesia from pulmonary 
embolism. It is perhaps worthy of comment that in both -
cases pulmonary embolism followed movement and mani-
pulation of the patient some days after fractures of the 
leg. 
Air Embolism 
The death due to air embolism, listed here, occurred 
during insufflation of the fallopian tubes, in spite of the 
fact that carbon dioxide gas and not air was used for the 
insufflation. 
Refractory Shock 
Next in size to those involving cardiac and major vascu-
lar surgery is a group of cases where death followed pro-
longed and intractable hypotension, not the immediate 
result of massive haemorrhage. The condition manifested 
by this group of 15 cases can perhaps be best described as 
·refractory shock'. In the majority, this state was ob-
viously present before anaesthesia. Surgical operation was 
undertaken as a measure of desperation. 
It must be realized that in this group as a whole, in-
volving those patients who, if not moribund, were gravely 
ill, the assessment .of the extent to which the anaesthetic 
and its management may have been contributory to the 
patient's death and the extent to which this was possibly 
avoidable, is extremely difficult. 
Cardiac Arrest During Operation 
Finally, it is relevant to summarize the causes of ulti-
mately fatal cardiac arrest during operation and so to 
evaluate the relative importance of anaesthetic factors in 
its causation (see Table V). During the 9 years of this 
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survey, 110 ultimately fatal cardiac arrests occurred during 
anaesthesia (0·93 / 1,000 operations). Factors directly related 
to the anaesthetic and its management were responsible 
for 31 % . The commonest aetiological factors were the 
combined effects of gross haemorrhage and massive trans-
fusion . Together these were responsible for 37% of this 
group. Factors other than haemorrhage related to direct 
cardiac surgery were responsible for the only other indivi-
dual group of cases of any size (15 %). 
CONCLUSION 
The actual incidence of anaesthetic death . is low, yet the 
anaesthetic and its management were considered a signifi-
cant contributory factor to 14% of the 'immediate opera-
tive mortality' associated with 177,928 operations at 
Groote Schuur Hospital. Clinical evaluation revealed that 
almost all of this anaesthetic contributory mortality was 
· either probably or possibly preventable. Though the funda-
mental causes of anaesthetic contributory death remain 
unaltered, continued collection on a wide scale and study 
of clinical data are necessary to reveal their precise mecha-
nisms and the errors and pitfalls from which they result. 
That these change with advancing surgical initiative and 
changing anaesthetic practice necessitates constant review, 
so that when they arise the necessary corrective action 
may be taken, or that, by anticipation, they may be 
avoided altogether. 
Though such continuing reviews of all anaesthetic 
associated mortality are so obviously necessary, they are 
by and large neglected. Yet mortality, the crudest measure, 
is but the tip of the iceberg of clinical anaesthetic mistakes. 
To be of more value in the understanding and elimination 
of anaesthetic contributory deaths, these studies ought to 
include a constant review of all anaesthetic morbidity. 
'The tolerance of the human body is phenomenal and if a 
few die every year, consider how many have been sub-
jected to abusive practices. How many have almost died?.., 
Such surveys, consistently and conscientiously carried 
out, provide the only means by which we may monitor our 
standards of clinical anaesthesia. Further, they provide a 
vital means of measuring and evaluating the safety of 
anaesthesia for the patient and consequently progress in 
anaesthesia. 
SUMMARY 
A survey of the immediate operative mortality, undertaken at 
Groote Schuur Hospital, is described, covenng the 9 years 
1956 -1960 and 1963 - 1966. During this period 177,928 anaes-
thetics were administered. 
Of 2,026 patients who died following surgery, 414 died 
during operation or within the immediate postoperative 
24 hours, or failed to regain consciousness after anaesthesia, 
and constitute the group of 'immediate operative mortality". 
To 58 of these deaths the anaesthetic and its administration 
were considered to have been significantly contributory, result· 
ing in an over-all incidence of anaesthetic contributory death 
of 0·33 deaths/1,000 anaesthetics. Of these anaesthetic contri· 
butory deaths, 93% were probably or possibly preventable. 
Evidence is presented from which we may infer that this 
mortality rate compares more than favourably with other 
world centres, and that in South Africa the incidence of anaes-
thetic contributory death has decreased over the last 30 years. 
Anoxic anoxia was the commonest fundamental cause of 
death, being responsible for 47% of all anaesthetic contnl,u. 
tory deaths. In over half of these, respiratory obstruction was 
the causal mechanism. Special attention is drawn to the acute 
complications of endotracbeal intubation in this context 
Anaesthetic contributory death resulting from progres.,ive, 
prolonged and intractable hypotension following induction of 
anaesthesia-a failure of circulatory homeostasis-is discussed. 
Hypertension resulting from factors in the anaesthetic 
technique is also noted as being responsible for anaesthetic 
contributory deaths. 
The aetiological aspects of some of 95 other deaths, classed 
as inevitable deaths, which occurred during anaesthCSla and 
to which anaesthesia could be considered necessarily and 
unavoidably contributory, arc discussed. In this group, gross 
haemorrhage and massive transfusion were the commonest 
causes of death. 
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EDITORIAL 
MORTALITY IN ANAESTHESIA 
In a remarkably shon period of years a situation has 
been reached in which the number of patients regarded 
as being unfit for general anaesthesia has become a-
tremely small. Prominent amongst possible explana-
tions for this trend is the improved understanding of 
the effects of anaesthesia and surgery in healthy and 
diseased patients; this understanding has led to corres-
ponding improvement in management before, during 
and after surgery. C.Ommon experience confirms that 
a successful outcome may be expected in countless 
patients who might formerly have been considered 
unfit to withstand the proposed procedure and its 
aftermath. 
Nevertheless deaths associated with anaesthesia due 
to causes that might be considered preventable {par-
ticularly with the aid of hindsight) continue to occur 
from time to time. There is no doubt that the series 
of reports on deaths associated with anaesthesia pub-
lished under the auspices of the Association of Anaes-
thetists of Great Britain and Ireland has had a 
profound and beneficial influence in alening anaes-
thetists to the predisposing factors and causes of these 
fatalities. These reports were based on information 
submitted voluntarily and the incidence of deaths 
could not, therefore, be readily related to the total 
numbers of anaesthetics administered in different cir-
cumstances. Reports of the incidence of deaths arc 
uncommon and the survey of 9 years' experience, pub-
lished by Harrison (1968) is accordingly of considerable 
imponancc. The period covered was 1956-60 inclusive 
and 196~ inclusive and was concerned with ap-
proximately 178,000 anaesthetics administered at 
Groote Schuur Hospital, Cape Town. Of the 414 
patients included in the group defined as "immediate 
operative mortality'' 58 were considered by Harrison 
to have died in circumstances in which ". . . the anaes-
thetic and its administration were considered to have 
been significantly contributory". This represents an 
incidcnc: of 0.33 per 1000 anaesthetics, and 14 per 
cent of the deaths at operation and in the 24 hours 
following. He believed that the majority of these deaths 
(54-93 per cent) were probably or pc-ssibly prevent-
able. The author discusses the problems · inherent in 
making comparisons with reports from other medical 
C¢Dtrcs and indicates those fallacies rendering invalid 
superficial direct comparison. 
Examination of the data concerning the group of 
"anaesthetic contributory deaths" prompts reflection 
on the extent of progrcM towards safer anaesthesia. 
Respiratory obstrUCtion aca>unted for 16 deaths, of 
which 8 were related to complications of cndottacbcal 
intubation, and only 3 to the inhalation of vomitus. 
C.Onsidering the probable total number of patients at 
risk the numbers arc not large. They emphasize again 
that the passage of an endotraehcal tube is not of itself 
a guarantee of safety. On the other hand, it would 
appear that repeated stress on the dangers of vomiting 
and regurgitation has not been in vain. 
Harrison found that of deaths occurring as a result 
of anoxic anoxia one-third (9) were "relaxant asso-
ciated" and notes that metabolic acidosis was probably 
a feature in 7 of these. It is heancning to read that 
none of these occurred in 1966 and it may be cxpcctcd 
that the frequency of deaths from this cause is likely 
to decline substantially with intelligent use of facilities 
for acid-base studies and ventilation monitoring. 
Points of significance emerge also from the group 
entitled "Inevitable Deaths" (95 patients), so termed 
because anaesthesia, although apparently clinically 
faultless, could not be excluded as a contributory 
factor. In about one-half gross haemorrhage was the 
factor most commonly associated with death. In several 
inadvenent hypothermia following massive transfusion 
of stored blood was thought responsible for cardiac 
arrest. In Harrison's view this cause of death should 
now be regarded as preventable. 
Ischacmic bean disease is an increasingly common 
pre-operative finding, and in this survey it appears 
that of 261 patients who died postoperatively from 
causes unrelated to the anaesthetic 23 (9 per cent) 
succumbed to myocardial infarction in the first 24 
hours. The risks of surgery and anaesthesia in patients 
with a history of myocardial infarction (especially if 
recent) arc known to be considerable, if perhaPs not 
always appreciated. 
Surveys of this kind repay close study because they 
indicate the changing pattern of factors implicated in 
deaths following surgery and the range of pitfalls to 
be negotiated if "preventable deaths" arc to be pre-
vented. 
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A Classification for Peaths Associated With 
Anaesthesia and 
An Evaluation of Autopsy in Their Assessmer:t* 
Gaisford G. Harrison, M.D., F.F.A.R.C.S. (Eng.). 
SeniM Lecturer, Depgrtment of Anaesthetics, Universit,· of Cape Town, 
Senior Anaesthetist . Groote Schuur Hospital, Cape Town 
Section 86 of Ace 13 of 1928, Union of South Africa, reads : "The death of a 
person whilst under the influence of a general anaesthetic or local anaesthesia, or 
to which the administration of an anaesthetic has been a contributory cause, shall 
not be deemed co be . a death from natural causes within the meaning of the Inquest 
Ace of 1919t or the Births, Marriages and Deaths Regism.cion Act of 1923! or 
any amendment of these Acts'. 
In many countries legislation such as this quoted from South Africa 
ordains the need for autopsy and inquest in all cases of death associated with 
anaesthesia. Its motivation is not the scientific investigation of the cause, 
incidence or prevention of death due to or associated with anaesthesia, 
but the investigation of possible medical negligence, i.e. the protection 
of the public. In such proceedings the forensic pathologist (in smaller 
centres, the district surgeon) is often called on to perform the triple task18 
of : 
i. Performing the autopsy; 
ii. Inferring therefrom the cause of death; and 
ii i. Guiding the Magistrate or, in some countries, the Coroner, in his findings. 
It is important, therefore, that he have a simple and clear classification 
of deaths associated with anaesthesia; criteria for assessing them; and a 
clear concept of the ways in which the anaesthetic and its administration 
may cause or contribute to death. 
Death associated with anaesthesia is the ultimate result of a combination 
of circumstances which may be broadly grouped as : 
1. The Environment of the AtUtesthetic. 
(a) The Patient's Disease. This is often coincidental and not directly associated 
with the lesion necessitating surgery. Even if not itself responsible directly for the 
death of a patient, such disease (by its deleterious effects on the patient's physiologi-
cal, homeostatic mechanisms) will render the administration of an anaesthetic and the 
immediate pre- and post-operative course more critical. 
( b) The Operalion. This includes the effects of the surgical lesion itself, the 
•Based in pare on a Thesis Death d11e to Anaesthesia, submitted to the University 
of Cape Town for the degree of M.D. 
t Nov.• the Inquest Act, Act 58 'of 1959. 
! Nov.· the Births, Marriages and Deaths Registration Ace, Act 81 of 1963. 
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magnitude of the surgical procedure and the effects of possible surgical mishaps and 
errors. 
2. The Conduct of the An11esthetic Itself. These factors and their possible 
binations and permutations have resulted in elaborate cbssifications : 12, as 
I. Death due to the operation. 
2. Death due to the patient's disease. 
3. Death due to the operation and the patient's disease. 
4. Death due to the anaesthesia. 
~- Death due to the anaesthesia and the pacient's disease. 
6. De.::th due to the anaesthesia, the patient's disease and the operation. 
com-
The classification used by many workers is a variation of th:s 
type.2• 8, 9, 16• 19• 21• 30, 31 • 36 An example of a slightly different classification is 
that adopted by a Committee on Deaths Associated with Anaesthesia of 
the Association of Anaesthetists of Great Britain and Ireland.11 , 13 This 
classification is also used by the South African Council of Scientific and 
Industrial Research (CSIR) Anaesthetic Deaths Research Unit,• and a 
similar investigating body in New South Wales, Australia. 25 
I. Those deaths where it is reasonably certain that death was caused by the 
anaesthetic agent, !Ir technique, or in other ways within the iprovince of the 
anaesthetist. · 
2. Similar cases ,in which there is some element of doubt whether agent or 
technique is entirely responsible. 
3. Those deaths due to surgical and anaesthetic factors. 
4. Surgical deaths. 
5. Inevitable, e.g. cases of severe peritonitis but in which the surgical and 
anaesthetic technique is satisfactory. 
6. Fonuitous deaths, e.g. pulmonary embolism. 
7. Cases that could not be assessed. 
8. Cases in which the data presented were inadequate. No opinion. 
As such classifications have gained in detail, so they have lost in 
simplicity and clarity. For the forensic pathologist or, for that matter, the 
anaesthetic statistician, a far simpler classification is necessary. 
1. Dea1h due to Anaesthesia. From their very nature there are few, if 
any, deaths that occur in association with anaesthesia to which it can be 
said that the anaesthetic has made no contribution. The anaesthetic and its 
administration as a cause of death should be identified in a separate 
category only when it can be seen to have been the sole cause of, or a 
significant contributory factor to, a death. In this category the culpability 
of the anaesthetic administration should be considered not only in the 
context of the fit patient, but also equally in that of the more seriously 
ill and aged patient, nowadays an everyday surgical problem. This group 
may also be referred to as Anaesthetic Contributory Dea1h. 
2. Death due to Other Causes. When the conduct of the anaesthetic 
appears faultless, where other circumstances appear to have provided ade-
quate reason for death and a contributory role of the anaesthetic, if present 
at all, is minor, cases are identified in a second group Death due to Other 
Causes, a group of less medico-legal importance. 
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3. Inevitable Deaths. Anaesthesia is necessarily and unavoidably contri-
butory. 
Lastly, there is another group of not uncommon cases which requires 
separate identification. These arc deaths from which the anaesthetic and 
its management, •even though clinically faultless, cannot be excluded as a 
contributory factor. This may be because death has occurred during 
anaesthesia; or it may be that the final collapse of circulatory homeostasis 
in a patient moribund before anaesthesia was induced, appears to have 
been finally precipitated unavoidably by the known effects of anaesthetic 
drugs and anaesthesia, e.g. vasodilation. Such may be regarded as deaths to 
which anaesthesia was 'necessarily and unavoidably contributory' or perhaps 
as 'inevitable' in the terms of the classification of the Association of 
Anaesthetists of Great Britain and Ireland. 
Such deaths are more often than not associated with the surgery of 
desperation. In these circumstances precise assessment of the exact contribu-
tory role of the anaesthetic is impossible and of little clinical importance. 
All cases in which death has occurred following a cardiac arrest during 
anaesthesia, but to which the contributory role of the anaesthetic administra-
tion was minor, should also be classified in this group, even though death 
may have occurred in the post-operative period after the termination of the 
anaesthetic. 
Cases classed as tmaesthetic contribut01''J deaths must now be funhcr 
examined for their more precise cause. 
Anaesthetic Contributory Deaths : The Cause of Death 
The causes of anaesthetic contributory death may be thought of in terms 
of a simple concept on which a simple classification is based (Fig. 1). Death 
is ultimately the result of irreversible, anoxic, cerebral cellular damage. 
This may have resulted directly and finally from a general state of anoxia 
but more commonly follows at the end of the common pathway of 
cardiac arrest. Such cardiac arrest itself may result from a state of anoxia 
or from cenain direct causes (e.g. hypothermia, acidosis, effects of certain 
drugs, changes in the intra- or extra-cellular potassium ratio, autonomic 
reflexes, direct handling of the bean, etc. 
Many of these direct causes have a greater potentiality to cause cardiac: 
arrest in the presence of anoxia. The fundamental state of anoxia which 
arises when the cellular oxygen demand and utilization exceed that avail-
able :G, 27 may arise as a result of a decreased arterial oxygen saturation 
(anoxic anoxia) or from decreased tissue perfusion for one or other reason 
(ischacmic anoxia). Though the state of anoxia is stressed in this 
classification, it must be remembered that acidosis (respiratory in the case 
of anoxic, and metabolic in the case of ischaemic anoxia) is an almost 
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invariable accompaniment and is synergistic with anoxia in the genesis of 
catastrophe. 
The greater proportion of deaths to whlch anaesthesia was a significantly 
contributory factor present as cardiac arrest during an operation. In some 
cases the etiological factors that result in the cardiac arrest are apparent 
before the event occurs. More often these escape notice until the dramatic 
arrest of the heart. In these circumstances the causal factors, though they 
may •be elucidated on occasion in retrospect, are often obscure. Beyond 
the fact that the conduct of the anaesthetic may appear in general to 
be contributory in the absence of more obvious causes, there may be no 
certainty about the precise cause. In this classification cases of cardiac arrest 
are classified in relation to the type of anoxia that was considered causal. 
ANOXIA DIRECT CAUSES 
Anoxic \\ 7 Reflex, Hypothermia lschormic Drugs. . 







Fig 1. The cause of death. 
Where some direct cause other than anoxia is responsible, or where the 
etiology is uncertain, they are classified in a separate category headed 
Cardiac A"est. 
Lastly, a category is provided for those few cases that do not fall into any 
of the foregoing categories, e.g. incompatible blood transfusions. This cate-
gory is headed Miscellaneo11s. 
In summary, the classification of causes of death is as follows: 
1. Anoxu (.r) Anoxic; 
(b) lschaemic. 
2. C.rrditzc Arf'est {.r) Direct causes; 
(b) Uncertain etiology. 
3. Misceluneo,11. 
Within the framework of this classification, anaesthetic contributory 
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deaths must be further examined with regard to the more precise clinical 
fault or 'departure from accepted practicc'.13 
Preventabili ty 
Looked at broadly, deaths due to anaesthesia are a function of 3 factors: :u 
i. The skill of the anaesthetist; 
ii. The condition of the patient; 
iii. The agenc used. 
Of these, the skill of the anaesthetist is the most important-skill which 
is compounded of many parts, e.g. training, clinical experience and ability. 
The condition of the patient, which will respond to some extent to 
skilful pre-operative treatment, may often be something over which the 
anaesthetist will have no .final control. 
As regards the agent used, the anaesthe::st should have sufficient know-
ledge of the drugs he uses clinically, of the actions, side actions and 
methods of combating these, that any death that may be said to result 
from so-called inherent toxicity of the drug used becomes death due to 
lack of skill. If we accept that lack of skill on the part of the anaesthetist 
is the most important factor in the cause of death due to anaesthesia, it 
follows that many, if not most, deaths due solely to anaesthesia arc prevent-
able. This aspect of preventability must be stressed in any consideration of 
a death due to anaesthesia. 
In the assessment of any particular death that is considered due to 
anaesthesia, it is often difficult to say accurately that such a death was 
definitely preventable. Oinical anaesthesia is not an exact science. We sedc 
always to identify 'departures from accepted practice'.13 But this in itself 
must change with the passing of time and accumulation of further know-
ledge and experience. 
On examination of the circumstances of any death in the light of present 
knowledge, we may be able to say that such a death was 'probably prevent-
able'. More frequently the circumstances may allow only the conjecture 
that such a death was 'possibly preventable'. In some circumstances, though 
we may conclude (virtually by exclusion) that a particular death was in 
large measure due to the administration of an anaesthetic, examination of 
the conduct of the anaesthetic may fail to reveal any obviously correctable 
fault. We are then able to give 'no verdict' as to its prcventability. This 
docs not detract from the premise that the majority of deaths actually 
due to anaesthesia are preventable. 
Following from this, those cases classed as anaesthetic contributory deaths 
should be subdivided into the 3 following accessory categories : 
1. Probably preventable. 
2. Pos9ibly preventable. 
3. No verdict. 
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Categories 1 and 2 include those cases described by Morton2' as 'those 
deaths for which a reasonably satisfactory explanation can be provided 
and for which countermeasures are practicable'. While the last category 
includes those cases 'which cannot at present be fully explained and for 
which countermeasures are either lacking or largely empirical'. The 
possibiliry of medical negligence can only be considered in those cases 
regarded as Probabt,, Preventable and, having been considered, it may 
then be very difficult, if r:ot impossible, to distinguish between an error of 
judgement and frank medical negligence. 
In summary, the classification of deaths associated with anaesthesia that 
would be of medico-legal use is as follows : 
1. Anaesthetic Contributory Death. 
Those deaths to which anaesthesia is considered to have been contributory to a 
significant degree. 
Cause of Det1th. 
1. Anoxia 
(a) Anoxic anoxia; 
( b) Ischaemic anoxia. 
2. Cardiac Arrest 
(a) Direct causes other than anoxia; 
(b) Uncertain etiology. 
3. Miscellaneous. 
Preventability. 
1. Probably preventable. {Category of medico-legal importance). 
2. Possibly preventable. 
3. No verdict. 
2. Deaths Due to Other Causes. 
Those deaths occurring in association with anaesthesia which are due to a 
patient's disease or factors relating to the surgical operation and to which the 
anaesthetic was considered either non-contributory or at most a minor contributory 
factor. 
3. Inevitable Deaths. 
Those deaths associated with the surgery of desperation to which the administra-
tion of an anaesthetic, though clinically faultless may be considered to have been 
necessarily and unavoidably contributory. 
The Value of Autopsy in the Assessment of Death Associated 
with Anaesthesia 
The posmve value of autopsy in the assessment of the contributory role 
an anaesthetic and its management may have played in an associated death 
is disappointing. 7 • 10• 17• !!3, H Little has changed since a committee of the 
Bosron Society of Medical Improvement reported in 1861 that 
'No conclusive light can be thrown on the subject by !><>St-mortem examination. 
Ir can only demonstrate a cause exculpating die anaesthetic, there being no 
pathognomonic signs of death from these agents'.' 
Being acute, the factors that may lead to anaesthetic contributory death 
leave no parhognomonic change discernible at autopsy.1• 29 That most basic 
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of mechanisms of death due to anaesthesia, gross anoxic anoxia, may result 
in no histological change if death is rapid.3• ~1 The events that may 
precede a cardiac arrest, e.g. hypotension, cardiac arrhythmias, autonomic 
reflexes, leave no trace.3:! Even as gross a finding as vomirus in the respira-
tory tract may require careful interpretation.13, 17 
Essential to the correct assessment of a death associated with anaesthesia 
is the clinical account of the administration of the anaesthetic with relevant 
records of changes in the vital parameters.lG Consideration must be given 
not only to the ways in which the known actions of anaesthetic drugs 
and errors or misjudgement in their administration may have lethal sequelae, 
but also ro the ways in which errors of commission or omission in the 
wider field of responsibility that has by practice become that of the 
anaesthetist, may cause death, e.g. failure to replace adequately by trans-
fusion blood lost during the operation, or the administration by the 
anaesthetist of incompatible blood. 
Examination of this aspect involves clarification of what may be con-
sidered the enent of the anaesthetist's responsibility. This is something 
that is difficult to define precisely as the compass of the anaesthetist's 
responsibility must vary with time and place, depending on contemporary 
practice. It is submitted that the ambit of the anaesthetist's responsibility 
enends to involve attention to all matters that have a bearing on the 
maintenance of the patient's general physiological homeostasis during and 
immediately after the performance of a surgical operation under any form 
of anaesthesia. 
Though disappointing in a positive sense, autopsy may have value in an 
important negative sense. Occasionally it may reveal the presence of a 
morbid process sufficient of itself to account for death in circumstances 
where an anaesthetic etiology may have been suspected,'· "· 16 e.g. massive 
pulmonary embolus. More often autopsy may reveal a state of general 
systemic disease which may have reduced the general circulatory, respiratory 
and other homeostatic mechanisms of the patient, so rendering him more 
susceptible to the effects of anaesthetic drugs, a state we may regard as 
reducing the margin of clinical error permitted the anaesthetist. Such 
findings will reveal the 'defective soil' on which the 'seed' of anaesthesia 
has been sown. 
A contemporary survey of the mortality associated with 177,928 
anaesthetics administered over a 9-year period at the Groote Schuur 
Hospital, Cape Town, was recently completed.15 Criteria for inclusion of 
cases in this survey were wider than those of Section 86 of the Medical, 
Dental and Pharmacy Act quoted in the introduction to this paper. Clinical 
documentation of cases was completed by the findings at autopsy, where 
possible. When deaths associated with anaesthesia fell within the provisions 
of the Inquests Act of 1919 (and later 1959) or Section 86 of the Medical, 
Dental and Pharmacy Act, autopsy was performed by the State Pathologist. 
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When this was not the case, the necessary legal permission for autopsy was 
sought from the patients' relatives. Where this was obtained autopsy was 
performed by the Department of Pathology of the University of Cape 
Town. 
Of the 414 patients who constituted the group classed as 'immediate 
operative mortality', 293 (71 % ) were submitted to autopsy. The overall 
value of the findings of these autopsies is presented here. 
Immediate operative moralir,, was de.fined as including those patients who 
died : 
I. During operation and anaesthesia; 
2. Within 24 hours of anaesthesia; 
3. W ithout regaining consciousness after an anaesthetic, having been conscious 
before. 
Assessed in terms of the classification described in this paper, the 
.findings are reflected in Table 1. 
Table 1: Operative Mortality Incidence in 177,928 Operations and Anacsctbetics 
Groolt S,bwr Hotpital: 1956-60, 1963-66 (Jn,lusi,t 9 y,ars) 
No-t, 
Dtal 1 D1alb1 p,r 1,000 Aflatslbttiu 
Total operative mortality 2026 11·38 
'mmediate operative mortality 414 2·33 20% of total operative 
mortality 
Group 1 (Anaesthetics) 58 0 ·33 14% of immediate operative 
mortality 
Group 2 261 1·47 
Group 3 95 0 · 53 
The autopsy findings may be grouped in general terms as showing: 
I . Pathological lesions adequate to account for death, including the surgical 
lesion itseli. 
2. No adequate immediate cause for death. 
3. Incidental pathology sufficient to seriously increase the hazard of anaesthesia 
for the patient. In the case of cardiac and vasculat surgery the surgical lesion 
itself was often of a nature that affected the patient's circulatory, physiological 
homeostasis directly. 
4. Pathological lesions sufficient of themselves to account for death where an 
anaesthetic etiology was suspected. 
An evaluation of the autopsy findings in these terms is reflected in Table 
2. 
In very few instances of anaesthetic contributory death (Group 1) were 
the autopsy findings of any positive help in the assessment of the cause of 
death. Whereas pathological lesions of a _severity adequate to account for 
-death were shown in more than two thirds of the deaths to which 
anaesthesia was not regarded as contributory (Groups 2 and 3), such lesions 
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Table 2: General Evaluation of Autopsy Findings Perun/age of indillidlllzl t111topry gro11p in /mu/ult 
GrollJJ No.in No.of Lesitm Noi-ulialt Grat Lesitm Gro11p Alllopsits A.tu4111Ut CflMltfor !Nidmlal ExnJp,,ling lo Auo1111I D,a1b Patbolog .ANuslbtsia for Dtalb 
1 58 52 18 (34%) 34 (65%) 11 (21%) 0 
2 261 154 128 (83%) 26 (17%) 42 (27%) 2 
3 95 87 59 (68%) 28 (32%) 37 (43%) 13 
Tola/ 414 293 202 91 103 15 
could only be demonstrated in one-third of the anaesthetic contributory deaths (Group 1). In only 7 cases was it easy to relate a demonstrable acute cause of death with an incident in the anaesthetic administration (Table 3). 
Table 3: Relacion of Incident in Anaesthesia to Autopsy Finding 
Ca1111 of D1111b Inndmlin Luion D1111onrtra1,d Clini,al Diagnosis .ANuslbeli, Adminislralitm al Alllop,y 
Anoxi, Vomiting and Signs of anoxic anoxia Stomach content soiling Anoxia aspiration bronchi 
Bronchial Open ether anaesthesia Frothy material obstruction without atropine obstructing bronchi prcmedication and trachea 
Pulmonary oedema Ovcrtransfusion Pulmonary oedema 





Patient in sitting 
Areas of cerebral softening 
position 
Cerebral Episode of hypertension Rupture of berry compression and during induction of aneurysm. Subarachnoid ischaemia anaesthesia haemorrhage 
Cerebral Episode of hypertension Ru/iturco=rJaneurysm. compression and during induction of ubarachno ischaemia anaesthesia haemorrhage 
In a further 11 cases of anaesthetic contributory death, gross incidental pathology of the cardiovascular and respiratory systems was demonstrated. But in 34 of the 52 anaesthetic contributory deaths, the autopsy showed no immediate cause of death. In all cases of anaesthetic contributory death, the correct evaluation of the contribut6ry role of the anaesthetic and its 
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administration depended entirely on the clinical account of the conduct 
of the anaesthetic. 
Lest, however, the importance of autopsy be underestimated, attention 
must be drawn to 15 cases in which the findings at autopsy virtually 
exculpated the anaesthetic administration from a contributory role in the 
patient's death, though death had occurred during the anaesthetic adminis-
tration or very shortly afterwards. In each case, though the anaesthetic 
administration appeared in general adequate, aspects of each were open 
to criticism. Little other concrete cause of death was immediately apparent 
at the time it occurred. In each case, autopsy revealed gross lesions which 
quite adequately accounted for death (Table 4). 
Table 4: Autopsy Findings exculpating Anaesthesia as a Cause of Death. 
S11rgi&al Pro"durt A11top,y Finding No.of 
&tlSU 
Craniectomv: Head injurv Brain stem oedema 2 
Excision ofhaemangioma Herniation of uncus 1 
(hypothermia) 
Aonico-rcnal cndarectomy Pontine haemorrhage 1 
Repair post-aortic graft wound Gross ischaemic bean disease 1 
dehisccnce 
Oophorectomy 
Transurethral resection of the Fresh myocardial infarct 3 
prostate 
Laparotomy 
Manipulation of fractured hip Pulmonary embolus 2 
Repair of wound dehisccncc 
Tubal insuffiation Air cmbolus 1 
Laparotomy: Intestinal obstruction Ruptured thoracic aortic aneurysm 1 
Laminectomy: Spinal tumour Secondaries in liver and kidney, 
obstructing· inferior vena cava 1 
Oesophagectomy Trauma to right atrium and 1 
atrio-scptal defect 
Repair of lacerations of neck Right carotid thrombosis 1 
Fresh myocardial infarction, demonstrable at autopsy and occurring 
during anaesthesia, is uncommon. In these 293 autopsies, 3 were demon-
strated. The relationship of various anaesthetic drugs and techniques to 
such infarction is not clear but does not appear at this time to be more 
than coincidental.13 More difficult to interpret and evaluate in relation to 
deaths associated with anaesthesia is the much more common finding of 
gross coronary atherosclerosis. This was noted in 50 of these autopsies. 
Myocardial perfusion depends inter alia on the aortic diastolic pressure and 
the length of diastole. Fluctuations in the blood pressure and heart riit,. 
are common during the course of any anaesthetic. It is easy to envisage 
that in the face of marked narrowing of the coronary ostia, episodes of 
hypotension, even of short duration, may result in poor myocardial per-
fusion severe enough to cause ischaemic arrest of the heart or ventricular 
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fibrillation. Bur how is this ro be assessed ar autopsy in the individual case 
when it is known that patients with equally severe lesions have survived 
unscathed long periods of hyporension during anaesthesia and operation? 
Conclu1ion. 1n view of the limiud positive value autopsy has in the 
assessment of the cause of a death associated with anaesthesia, especially in 
chose cases in which the anaesthetic itself is causal, one may with justice 
question the value of legislation requiring compulsory autopsy and inquest 
in such cases. Where it exists, such legislation has been criticized as 
imposing an unfair burden on the clinical anaesthetist besides being of little 
scientific value.5• 10, 14 • :?O, Z? , 28 • 3c But is dispensing with such medico-legal 
autopies and inquiries the answer? Two factors alone should make us 
hesitate. Throughout the world the demand for anaesthetic services exceeds 
the supply of trained clinical anaesthetists. To fill the demand-supply gap, 
there is often pressure for the less adequately trained person to administer 
anaesthetics. This is a circumstance which surely makes it desirable that 
some form of .review of anaesthetic mortality be retained. One must 
remember, too, the number of cases in which an autopsy is of material 
practical value in the negative sense of excluding the anaesthetic as a 
cause of death. 
What is needed is an increase in the clinical and scientific value of such 
proceedings. It would be of value if independent regional review bodies 
consisting of specialist anaesthetists and surgeons in addition to the forensic 
pathologists were appointed to advise and guide the magistrate or the 
coroner in these cases. More important, such a body of experts could 
evaluate and propagate the clinical and scientific lessons that would emerge 
from a deeper consideration of this mortality associated with anaesthesia. 
In this fashion, from the nec~ssity of providing legal protection of the 
public from possible medical negligence, could be derived the virtue of a 
means towards the promotion of greater safety in anaesthesia. 
Summary 
A simple classification of deaths associated with anaesthesia is described 
and the general etiology of anaesthetic contributory death is briefly 
reviewed. 
From a series of 293 autopsies, the value of this investigation in the 
assessment of the cause of death associated with anaesthesia is evaluated. 
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Anaesthetic-Associated Mortality 
G. G. HARRISON 
SUMMARY 
The mo1t important mea1ure of the eafety of anae1the1la 
for the patient 11 the incidence of anaesthetic-contributory 
death. Evidence is preHnted from an ongoing 1urvey of 
anaesthetic-associated mortality at Groote Schuur Ho1pl-
tal, that the incidence of anae1thetlc-contrlbutory death hH 
decreased from 0,33 to 0,22 per 1 000 anae1thetlc1. 
Reasons for this improvement In the 1afety of anaesthe1la 
and 1ome of the clinical le11on1 that emerge from the aur-
vey are di1cu11ed. The Incidence of cardiac arre1t In the 
operating theatre (0,63°/00 anaeathetica) and the reaulte of 
resu,cltation (19% aurvival) are preHnted. 
S. Afr. Med. J.. 48. 550 (1974). 
Anaesthesia is a highly important adjunct . to the care of 
the patient. Anaesthesia is not therapy which corrects a 
deformity, which restores health, or stays death; it simply 
makes possible the acts which accomplish these things. 
So above all it must be safe. In no field of medical 
practice does the precept 'to do no harm' have more 
cogency than in anaesthesia. Whatever advances are 
claimed for anaesthesia, they can only be regarded as 
real advances if they result in increased safety for the 
patient. However, to measure this safety is difficult. 
Though one may postulate the most fundamental index 
of the safety of anaesthesia to be the incidence with which 
factors related to the administration of an anaesthetic 
cause or are contributory to a patient's death, such a 
postulate immediately poses the problem of apportioning 
blame. Patients who die under anaesthesia do so more 
often from the disease or the surgery undertaken to cure 
it. than from the anaesthesia. To measure this incidence 
we must separate as best we can, anaesthetic-contributory 
deaths from their parent population of anaesthetic-asso-
ciated mortality.' 
At Groote Schuur Hospital I have conducted a con-
temporary survey of mortality associated with anaes-
thesia since 1956. Data on the anaesthetic-associated 
mortality of 15 years in over 300 000 anaesthetics are now 
available. Findings during the first 9 years of this survey 
were reported in 1968.1 The data of the last 6 years 
(1967 - 1972 inclusive) are reported here and compared, 
where relevant, with the former study. 
DEFINITIONS AND METHOD 
For the purposes of this article anaesthetic-associated death 
is defined as a death occurring during or within 24 
Department of Anaesthetics, University of Cape Toffll 
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hours of anaesthesia, or a failure to regain consciousness 
after anaesthesia in a patient conscious before anaesthesia. 
The choice of a period of 24 hours after anaesthesia is 
arbitrary. It embraces a period adequate to permit identi-
fication of anaesthetic-contributory death, without be-
coming unmanageable. Extension of this study to a sur-
veillance of the whole postoperative period, although desir-
able in some respects, would add considerably to its 
difficulties. It is acknowledged that, in these circumstances, 
a small number of deaths to which anaesthesia was a 
major contributory factor, such as some late deaths from 
aspiration pneumonia, might have been missed. 
For each case of anaesthetic-associated mortality the 
clinical records and an account of the conduct of the 
anaesthesia were obtained from the anaesthetist con-
cerned. This information and the autopsy report were 
examined from 3 points of view: 
1. Was the administration of the anaesthetic the cause 
of, or a major contributory factor to, the patient's death? 
Or was the death primarily due to the patient's disease. 
or the surgical procedure being undertaken? 
2. If it was considered to be an anaesthetic-contributory 
death, what was the precise clinical cause-what depar-
ture was there from accepted clinical practice? 
3. Was the death preventable? Was there a clinical 
lesson to be learnt? 
With regard to the fint question, besides the two 
groups of cases implied: (1) anaesthetic-contributory deatbi, 
and (ii) death due to other causes, there emerged a need 
for a third group: deaths associated with the IUllCfY of 
desperation, operations on the moribund, for which, though 
an anaesthetic aetiology may not have seemed directly 
responsible, it could often not be entirely excluded; 
circumstances in which anaesthesia might be regarded as 
being necessarily, but unavoidably, contributory, were 
classified as 'inevitable death'. 
GENERAL INCIDENCE 
This 6-year survey covers about 141 000 anaesthetics. 
This is a crude total and includes all anaesthetics, from 
simple casualty procedures to open-heart surgery. An 
obvious refinement of a study such as this would be an 
analysis of mortality associated with specific operations or 
anaesthetic procedures. This has not been done. For 
comparison, relevant figures from the previous survey 
are included in parentheses in Table I. 
This survey yielded an anaesthetic-associated mortality 
of 253 cases, a rate of 1,8/1 000 anaesthetics. Anacstbeaia 
was considered to be the sole or major contributory 
factor in 12% (31 deaths) of this anaesthetic-associated 
mortality-an anaesthetic-contributory death-rate of 0,22/ 
I 000 anaesthetics. 
lA 
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TABLE I. GROOTE SCHUUR HOSPITAL: ANAESTHETIC-ASSOCIATED MORTALITY IN 140 653 ANAESTHETICS 
(1967 - 1972 (incl.), 1956 - 1966 in parenthesis) 





ACD/ X 100 = 12~-~ 
AAD (14'/ ) 
AAD = Anaesthetic-associated death 
ACD = Anaesthetic-contributory death 
TOM = Tota l operative mortality 
Looked at against the background of the total care of 
the surgical patient. anaesthesia and its mismanagement 
can be said to have been responsible, by means possibly 
preventa ble. for 2.3 u,. of the total surgical mortality. 
In the sense that the rate of anaesthetic-contributory 
death has decreased over the 6 years from the previous 
9-years· report (0.22/1 000 from 0.33/1000) anaesthesia 
may be said to have become a little safer for our patients. 
This increased safety may be a reflection of a fundamental. 
,hough gradual and undramatic, change that has occurred 
in anaesthetic practice during the last decade. This change 
follows the gradual acceptance of the routine use in all 
clinical anaesthesia of the elementary monitoring of vital 
signs. over and above the old-fashioned recording of 
systolic blood pressure. such as ECG. central venous 
prl!ssure and blood gas monitoring. 
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Fii:. I. Anaesthetic-associated mortality and anaesthetic-
contributory death at Groote Schuur Hospital 1956 -1972. 
(Open columns = anaesthetic-associated deaths: black 
columns = anaesthetic-contributory deaths.) 
When anaesthetic-associated and contributory death 
rates are graphically represented on an annual basis 
(Fig. I J. although the initial downward trend in the latter 
is obvious. it appears that in this institution an anaesthetic-
contributory death rate of 0.2.' 1 000 anaesthetics. regret-
tabl y constitutes an irreducible minimum. This is depressing 
No. of 
deaths 










1,04 (1 ,47) 
0,53 (0,53) 
= 2,301 
/ C (2,8 ~~ ) 
ACD/ X 100 
TOM 
when one considers that anaesthetic-contributory death is 
essentially preventable. Perhaps, in mitigation, it may be 
said that this is a teaching institution with a large. 
constantly changing staff, which results in a dilution of 
experience. It seems as though every trainee is educated 
through the same mistakes. Every trainee must be taught 
to acquire the right clinical refl..:xes. Constant and adequate 
supervision of trainees by experienced, specialist staff is 
only part of the answer, for the most enduring lessons for 
the trainee come only from the final acceptance of total 
clinical responsibility. 
MECHANISMS OF ANAESTHETIC· 
CONTRIBUTORY DEATH 
The causes and mechanisms of anaesthetic-contributory 
death were examined in terms of the following simple 
concepts (Fig. 2). The basic requirement for life is per-
fusion of tissue with oxygenated blood. Failure to perfuse 



















' DEATH Fig. l. Mechanisms of anaesthetic-contributory death. 
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supply of oxygenated blood. is the basic cause of death. 
In broad terms, this occurs when there is a failure of either the ventilator or the pump or both. While the former 
may directly cause cerebral death, the final common 
pathway is more usually pump failure and cardiac arrest. 
Cardiac arrest. although often caused by anoxia. has a 
wider aetiology, th~ most prominent factor of which, in a surgical sense, is a failure of the hydraulic system-
hypovolaemia. compounded by the vasodilation of anaes-
thesia and its sequelae of concomitant poor circulatory homeostasis. acidosis. and electrolyt~ changes. It must 
be realised that the greater proportion of anaesthetic-
contributory deaths present as cardiac arrest during ope-
ration. In some cases the reasons may be apparent before 
the event occurs. but more often they may escape notice 
until the dramatic arrest of the heart. At this stage it may 
be difficult to elucidate the cause in retrospect. 
Analysed in these terms. the 31 deaths in this study 
are presented in Table II. This study reveals, like its 
TABLE II. GROOTE SCHUUR HOSPITAL: CAUSES OF 
ANAESTHETIC-CONTRIBUTORY DEATHS IN 
140 653 ANAESTHETICS 
(1967 - 1972 (incl.), 1956 - 1966 in parenthesis) 
No. of Deaths/ 
deaths 1 O' anaesth. 
Ventilator failure 
Sa02L 
F,0 2 technical mishap 0 (1) 0 (0,5) 
Vom. regurg. inhal. 2 (3) 1,4(1 ,7) 
Sec. bronchial obstruct. 2 (2) 1,4 (1 ,1) 
Bronchospaem 1(0) 0,7 (0) 
Comp. Intubation 7 (8) 4,9 (4,4) 
Relax. related 3 (9) 2,1 (5,1) 
Inadequate postop. care 3 (3) 2,1 (1,6) 
Pump failure 
fcirculatory haemostasis) 
Hypovolaemia 8 (12) 5,7 (6,7) 
Hypervolaemia-overhyd. 2 (1) 1,4 (0,5) 
urovert 0 (2) 0 (1) 
Cardiac arrest-direct causes 2 (10) 1,4 (5,6) 
uncertain 1(6) 0,7 (3,3) 
Miscellaneous 
Incompatible blood 0 (1) 0 (0,5) 
31 (58) 22 (33) 
F
1
0 .: = tn:;>i red oxygen concenaa tion . 
Card :ac arre "-d:rect causes = Cardiac arrest due to factors listed 
a, uppc, r 9h1 o: Fig . 2. 
Ove rhyd . = Ove rh ydration . 
predecessor. the same two clinical situations most fre-
quently causally associated with anaesthetic-contributory death. These 2 situations between them are responsible 
for just under one-half of all anaesthetic-contributory deaths. or for the same number of anaesthetic-contributory deaths as all the other listed causes put together. These two situations a,e complications of intubation and hypo-
\'Olaemia. 
Complications of Intubation 
Endotracheal intubation is indeed a necessary technique 
for the anaesthetist. Complications are simple and mecha-
nical, but lethal, unless diagnosed and corrected imme-
diately. The reason for failure is often a false sense of 
security engendered by the very presence of the endo-
tracheal tube, together with, as often as not, a lack of 
experience. A brief look at these 7 cases is instructive, 
as one lesson in particular emerges strongly. Over 
half of these deaths followed the technical failure 
of intubation in the presence of anatomical difficulties. 
All could have been easily anticipated before anaesthesia 
by adequate clinical examination, yet in all instances 
succinylcholine was given before the anaesthetist had 
assured himself that he could intubate or ventilate the 
patient. The anatomical difficulties were caused by carci-
noma of the larynx and oesophagus, cervical tuberculous 
spondylitis, and torticollis. 
One case was an example of that ever-lurking trap-the 
overinflated, herniated cuff-a lesson that needs constant 
repetition, as there often is, as in this case, a period of 
many minutes between the inflation and the herniation of 
the cuff, with subsequent respiratory obstruction. 
One death followed kinking of the endotrachcal tube 
when the patient was turned prone. The last, less culpable 
than the others, followed the obstruction of the right 
side of a Carlen·s tube by distortion caused by an aneurysm 
of the ascending aorta. 
Inadequate Postoperative Supervision 
Disappointing is the appearance in this study of 3 cases 
due entirely to inadequate postoperative supervision. One 
death was caused by the direct attachment of a line 
from an oxygen cylinder to an endotracheal tube left 
in situ by the anaesthetist for postoperative IPPV. A 
second was due to the booby-trap of the endotrachcal 
tube catheter-mount of a nasal endotracheal tube becoming 
detached unobserved inside the nose in a patient requiring 
postoperative IPPV. 
I should like to draw particular attention to the third 
case, for it is an example of a condition to which the 
now widespread use of respiratory-depressant, narcotic, 
analgesic drugs, such as Fentanyl, exposes patients-a con-
dition for which the name 'Ondine's curse' is appropriate. 
As with the nymph, the patient, while recovering from 
anaesthesia, though apparently awake, seems to have 
forgotten how to breathe, unless he is stimulated. This 
particular patient, having initially regained consciousne$ 
after uncomplicated anaesthesia for a hemiorrhaphy, 
relapsed into unconsciousness and apnoea while in the 
care of a nurse in a busy theatre corridor. This event was 
not reacted to until cardiac arrest with some anoxic 
jactitation occurred. Although cardiac massage and resus-
citation were successful, the brain damage sustained was 
irreparable. 
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Vomiting and Regurgitation 
More encouraging is the very low incidence of death due 
to vomiting, regurgitation, and inhalation. Such deaths 
often feature in studies of anaesthetic-associated mortality. 
Relaxant-Related Deaths 
Noteworthy too. is tht: great reduction in relaxant-
related deaths compared with the previous study-deaths 
due to mismanagement of prolonged curarisation. There is 
really little excuse for such deaths today. 
Hypovolaemia 
Under this heading are included those cases in whom 
a frank failure of circulatory homeostasis has followed 
induction of anaesthesia, a failure that appears to have 
resulted from inadequate venous return. These circum-
stances proved to be the most common, .single cause of 
anaesthetic-contributory death. Once circulatory failure 
had ensued. metabolic acidosis and concomitant electrolyte 
disturbance may have been important in the causation 
of the cardiac arrest. But I have chosen to call attention 
in my classification to the initial hypovolaemia, as this 
situation is eminently correctable. Some workers stress 
this by classifying these deaths as due to 'inadequate 
preparation of the patient".' 
These cases, who .,Jso feature prominently in other 
surveys;·•·• present most commonly, as did half of the 8 
listed in Table II, as postinduction hypotension proceeding 
to cardiac arrest. The precipitating factor is often the exhi-
bition of thiopentone to the sick, old. and arteriosclerotic 
who have evidence of ischaemic heart disease, or the ad-
ministration of thiopentone to the shocked. A typical 
example is the old man with diabetic gangrene, presenting 
for amputation of a leg. Whether it be the vasodilatation, 
or the direct depressant effect of thiopentone on the myo-
cardium, the situation is readily preventable by judicious 
hydration to normal CVP levels before induction of 
anaesthesia and avoidance of thiopentone. 
Two of these deaths followed sudden blood loss in the 
presence of vasodilatation, the result of sympathetic para-
lysis: I from an epidural anaesthetic, and l from the 
use of a uterine antispasmodic, isoxuprine. 
I wish to stress that in none of these 8 patients was the 
central venous pressure · monitored, and in 4, the failure 
of circulatory homeostasis was precipitated by thiopentone. 
Hypervolaemia 
The reverse situation is hypervolaemia from over-
hydra tion. This usually results in pulmonary oedema when 
spontaneous respiration commences again at the conclu-
sion of the anaesthesia. Two such cases are recorded here 
of a situation essentially avoidable by the substitution of 
fluid replacement guesswork, with CVP monitoring. 
Cardiac Arrest in the Operating Theatre 
This subject is exhaustively covered in the literature. 
I intend to summarise only the causes and the outcome of 
treatment in the cases occurring in Groote Schuur Hospital 
during the period of this survey. I have excluded from 
consideration all cardiac surgery in which so often cardiac 
arrest and its reversal are almost part of the operative 
technique. I have, however, included 5 cases of cardiac 
trauma from stab and gunshot wounds. The causes and 
results of treatment are set out in Table III. 
TABLE Ill. GROOTE SCHUUR HOSPITAL 1967 -1972: OPERATING ROOM CARDIAC 
ARRESTS IN 
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Cardiac arreat~irect causes 
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Haemorrhage + maaaive transf. 
Toxaemia refract. shock 
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During the period under study, 89 patients suffered 
cardiac arrest during anaesthesia and operation, an inci-
dence of 0.63/1 000 operations. Various anaesthetic prob-
lems were the sole or major contributory factor in the 
causation of 44% of all cardiac arrests. 
As in the causation of anaesthetic-contributory death. 
the two principal faults were failure to maintain normovo-
laemia and complications of endotracheal intubation. 
Worthy of comment in that group of anaesthetic-contri-
butory cardiac arrests thought to be drug-induced, was 
I case in whom the cardiac arrest appeared to follow the 
administration of halothane (with adequate ventilation) 
to a parkinsonian patient being treated with L-dopa. 
Although this combination has i,een suggested as a poten-
tial cause of arrest because of th emobilisation of tissue 
catecholamine stores by L-dopa: we are not aware of its 
having been so recorded. 
Other drug-induced arrests followed the administration 
of succinylcholine, halothane in the presence of under-
ventilation, and the hypotensive drug, trimetaphan, in the 
presence of a recent myocardial infarct-all well-known 
anaesthetic hazards. 
The commonest single cause of cardiac arrest in the 
operating room, and r::sponsible for 30% of cardiac arrests 
in this study, was gross haemorrhage with the deleterious 
effects of the concomitant massive transfusion. While many 
of the problems which follow the latter have been solved 
by monitoring of acid-base and electrolyte status, and 
the warming of transfused blood; the basic problem is 
surgical and circumstantial. 
With the present-day accepted use of vital-function 
monitoring in clinical anaesthesia, and the training of 
anaesthetists in prompt and informed resuscitative proce-
dures, one could hope for a reasonable salvage from 
card;.ac arrest occurring during surgery right under the 
eye of the anaesthetist, but the commonest cause-un-
controllable haemorrhage-precludes this. 
In Table III the results of resuscitation .from cardiac 
arrest are expressed as: 'failed'-death in operating theatre: 
'initially successful'-patient survives to return to ward; 
'ultimately successful'-patient survives to be discharged 
from hospital. 
It can be seen that about one-third of all patients 
suffering from cardiac arrest survived to leave the operat-
ing theatre and one-fifth eventually left hospital. The 
prognosis for those which were the result of anaesthetic 
mismanagement (0,27 / l 000) was slightly better. While 
about one-half survived to return to the ward, resuscita-
tion was wholly successful for about one-third in that 
the patient was ultimately discharged alive from the 
hospital. 
CONCLUSION 
Whatever advances we claim for our speciality, anaesthe-
sia, it must be safe for the patient. Surveys and studies 
such as this are somewhat pedestrian and tedious in the 
extreme to conduct, but if consistently and conscientiously 
carried out, they provide not only the clinical lessons by 
which we can improve our practice, but also the only 
means of measuring and evaluating the safety of 
anaesthesia. 
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DEA TH ATTRIBUTABLE TO ANAESTHESIA 
A 10-year survey (1967-1976) 
G. G. liARRisoN 
SUMMARY 
The mortality associated with 240 483 anaesthetics administered ~ver 10 years . at ~te Schuur 
Hospital, Cape Town, is reported. The frequency of death to which anaesthesia contributed was 
0.22 per 1000 anaesthetics (compared with 0.33 per 1000 in the previous 10 years). These deaths were 
responsible for 2.2% of the total mortality from surgery. ~wo-thirds _of the ~·anaesthetic" dea~ 
were attributable to (in order of frequency) : (a) hypovolaCII11a; (b) rcspll'8tory inadequacy f~llowmg 
myoneural blockade; (c) complications of tracheal intubation; (d) inadequate postoperanve care 
and supervision. 
Although anaesthesia per se does not correct deformity, 
restore health or stay death, it is perhaps the most 
important adjunct to the care of the surgical patient, 
making possible activities which do accomplish these 
things. Of itself non-therapeutic, above all it must be 
safe for the patient. In no field of medical endeavour 
does the precept "to do no harm" have more cogency 
than in clinical anaesthesia. Whatever advances are 
claimed for anaesthesia, they can be regarded as real 
advances only if they result in an increase in safety for 
the patient. A precise measure of this safety is difficult. 
We postulate that the most fundamental index of the 
safety of anaesthesia for the patient is the frequency 
with which factors related to the administration of an 
anaesthetic cause or are contributory to a patient's 
death. This in itself is not something that can be 
estimated with scientific precision, but if we can be 
content with a clinical assessment of the relevant data, 
a useful measure of the "safety of anaesthesia" does 
emerge. Of importance are the clinical lessons yielded 
by such assessment which are essential to the improve-
ment of the service to the patient. 
A prospective survey and assessment of all mortality 
associated with anaesthesia at Groote Schuur Hospital, 
Cape Town, since 1956 has been undertaken. Groote 
Schuur Hospital is the 1300-bedded principal teach-
ing hospital of the University of Cape Town Medical 
School. The data from the past 10 years, 1967-1976 
are reported here, that is the mortality associated with 
240 483 anaesthetics. 
GAISFORD G. HARRISON, M.D.(V,C.T.), F.F.A.R.C.S.(ENG), 
Department of Anaesthetics, University of Cape Town, 




Death associated with anaesthesia is defined as a 
death occurring during or within 24 h of anaesthesia 
or after the failure of a patient, conscious before, to 
regain consciousness after anaesthesia. The choice of 
a period of 24 h after anaesthesia is arbitrary. It 
embraces a period adequate to permit identification of 
death attributed to anaesthesia without the study 
becoming unmanageably large. Extension of this study 
to a surveillance of the whole period after operation, 
although desirable in some respects, would have 
added considerably to its difficulties and complexities. 
It is acknowledged that in these circwnstances a very 
small number of deaths to which anaesthesia was a 
major contributory factor, such as late deaths from 
aspiration and pneumonia, might have been missed. 
For each death associated with anaesthesia, the 
clinical records, together with an account of the 
conduct of the anaesthetic, were obtained from the 
anaesthetist concerned. This information, together 
with the postmortem report, was examined in the light 
of three questions : 
(1) Was the administration of the anaesthetic or other 
factors within the ambit of the anaesthetist's 
responsibility the cause of or a major contributory 
factor in the patient's death? Or was the death 
primarily a result of the patient's disease or the 
surgical procedure being undertaken ? The former 
were classed as "deaths contributed to by anaes-
thesia", the latter "deaths from other causes". 
(2) If it was considered to be death to which anaes-
thesia contributed, what was the precise cause ? 
C> Macmillan Journals Ltd 1978 
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(3) Was the death preventable? What departure was 
there from accepted clinical practice ? Was there 
a clinical lesson to be learned ? 
With regard to question (1), besides the two groups 
defined, deaths to which anaesthesia contributed and 
deaths from other causes, there emerged a need for a 
third group for deaths associated with the surgery of 
desperation, operations on the moribund, deaths for 
which although an anaesthetic aetiology may not have 
seemed directly responsible, often it could not be 
excluded entirely-circumstances in which anaesthesia 
might be regarded as being necessarily but unavoidably 
contributory. Such deaths were classified as a 
separate group, "inevitable deaths". 
In assessing the contributory role of anaesthesia, 
harsh criteria were adopted. This was done in order 
to avoid any bias that might encourage complacency. 
The causes of deaths attributable to anaesthesia 
were classified in terms of the simple concept of 
identification of the mechanism primarily responsible 
for the ultimate failure of perfusion of the brain with 
oxygenated blood which were, fundamentally, a 
failure of (a) respiratory homeostasis, or (b) circula-
tory homeostasis. 
Although there may be a prominent feature in the 
circumstances of a particular death, from the clinical 
aspect the causes of deaths attributable to anaes-
thesia are often multiple, compounded from the 
interaction of many variables. This creates difficulties 
in terms of a precise classification, but in a study of 
this nature it is the aspect of preventability-the 
clinical lesson that may be learnt-that is important. 
This I have endeavoured to accentuate at the expense 
of some overlap and imprecision in the classification 
of causes of death presented. 
GENERAL FREQUENCY 
The general statistical data are presented in table I. 
For comparison relevant data from the first 10 years 
ofthis survey (1957-1966) are included in parentheses 
(Harrison, 1968a, b). 
The figure for the number of anaesthetics adminis-
tered is a crude total which includes all anaesthetics 
administered in the hospital, from those for minor 
surgery to those for cardiopulmonary bypass pro-
cedures. Though this begs the future refinement of 
this study to an analysis of mortality associated with 
anaesthesia in relation to specific surgical operations, 
pilot studies have not shown this to be really valuable 
in the present context. 
During the period of this survey, 531 deaths 
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TABLE I. Deaths associated with anaesthesia (AAD) at 
Groote Schuur Hospital 1967-1976 (number of anaesthetics= 
240 483). Figures for 195~1966 in parentheses (number of 
anaesthetics = 177 928) 
Total surgical monality 
Deaths associated with 
anaesthesia 
Group 
1. Deaths to which 
anaesthesia 
contributed 
2. Other causes 



























occurred in association with anaesthesia (2.2 deaths 
per 1000 anaesthetics) of which 10% (53) were finally 
assessed as those to which anaesthesia contributed. 
This frequency (0.22 per 1000 anaesthetics) is an 
improvement on that reported from the previous IO-
year period surveyed at this hospital, 0.33 per 1000 
anaesthetics. 
As anaesthesia is but an adjunct to the total surgical 
care of the patient, a wider relevance emerges if the 
frequency of those deaths to which anaesthesia 
contributed is viewed against the background of the 
total surgical mortality, that is all deaths following 
operation, before discharge of the patient from 
hospital. Looked at in this way, we may say that, in 
our hospital, anaesthesia and its mismanagement were 
responsible in a preventable manner for 2.2% of the 
total surgical mortality. 
An examination of the frequency of the deaths 
attributable to anaesthesia from 1956 on an annual 
basis (fig. 1) reveals that, following an initial improve-
ment, the frequency decreased to what appears to be 
an irreducible minimum around 0.15 deaths per 1000 
anaesthetics. This is perhaps a reflection of the sad 
fact that despite the prcventability of such deaths and 
the repetitiveness of the errors that cause it, all 
trainees must be educated clinically through the same 
mistakes. While a constant and adequate supervision 
of trainees by experienced specialist staff docs improve 
matters, it is only part of the answer, for the most 
enduring lessons for the trainee come ultimately from 
the final acceptance of total clinical responsibility. 
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FIG. 1. Anaesthetic-associated mortality i95~1976. Clear columns= Mortality associated with anaesthesia; Solid columns 
= Mortality attributable to anaesthesia. 
TABLE II. Causes of death to which anaesthesia contributed (ACD). *Clinical situation responsibkfor more than 





of regional anaesthesia 
Cause of death 
Technical failure 
Vomiting, regurgitation, inhalation 
Bronchial obstruction 
*Complications of tracheal intubation 
*Respiratory inadequacy following myoncural blockade 
*Inadequate postoperative care 
*Hypovolacmia (hypotcnsion after induction) 
Over hydration 
Cardiac arrest 
Drug induced 3 
Heart block 1 
Air embolism 1 
Uncertain 2 
Spinal/cxtradural + haemorrhage 2 














Status of the patient and urgency of operation MECHANISMS OF DEATHS TO WHICH ANAESTHESIA 
Of the 53 patients to whose deaths anaesthesia was 
considered contributory, 27 were in good to fair 
condition (ASA status I and II), while 26 were in 
poor condition (ASA status III and IV). With regards 
to the urgency of operation, 32 were subject to 
emergency operation while 19 underwent elective 
procedures. 
CONTRIBtrrED 
Four clinical situations were responsible for two-
thirds of these deaths (table II). These were (in the 
order of the table): 
(I) C.Omplications of tracheal intubation. 




(3) Inadequate care and obsen•ation after operation. 
(4) Hypovolaemia. 
Complications of trachael intubation (nine patients) 
Over one-half of these deaths (five) followed the 
technical failure of endotracheal intubation in the 
presence of anatomical abnormality. All could have 
been anticipated by adequate clinical examination · 
before anaesthesia, yet, in each instance a neuro-
muscular blocking drug was given by the anaesthetist 
before he had assured himself that he could intubate 
the trachea and ventilate the lungs. 
Other deaths followed the complications of kinking 
of the endotracheal tube (two), respiratory obstruction 
following herniation of the tube cuff (one) and in-
advertent bronchial intubation of a patient undergoing 
an emergency operation while suffering from pneu-
monia. 
Respiratory inadequacy following myoneural blockade 
(10 patients) 
Seven of these deaths involved patients with severe 
chronic obstructive lung disease plus abdominal 
distension as a result of intestinal obstruction. The 
anaesthetist concerned had in each case hesitated in 
providing artificial ventilation in the period after 
operation. 
The deaths of another three patients were in fact a 
result of "over-hydration", although the patients 
presented as respiratory inadequacy following myo-
neural blockade. The patient was in each case an 
overweight, middle-aged female who suffered in-
testinal obstruction as a result of an incarcerated 
para-umbilical hernia, with resultant gross abdominal 
distension, presenting at the hospital at night. In each 
case fluid replacement, both before and during 
operation, had been over-enthusiastic, misjudged and 
unmonitored by measurement of central venous 
pressure. The resultant interstitial pulmonary oedema 
presented as "respiratory inadequacy following myo-
neural blockade" following the establishment of 
spontaneous breathing at the end of operation. 
Inadequate postoperative care (six patients) 
Two further deaths from overhydration resulting 
in frank pulmonary oedema in the period after opera-
tion followed the inadvertent administration of excess 
fluid because of "inadequate postoperative care and 
supervision". 
Other deaths in this category resulted from: 
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(a) direct connection of an oxygen cylinder to an 
endotracheal tube; 
(b) unobserved intra-nasal disconnection of a 
catheter mount from a nasotracheal tube in a 
patient requiring ventilation; 
( c) inhalation in the period after operation of a 
massive post-turbincctomy haemorrhage in a 
patient who was over-sedated with morphine; 
(d) "Ondine's curse"-post-arousal respiratory 
depression following administration of morphine. 
Hypovolaemia (11 patients) 
This group might be sub-titled "post-induction 
hypotcnsion" because this is how the majority 
presented, and it constituted the commonest single 
clinical situation leading to death attributable to 
anaesthesia. I have included under this heading all 
those patients in whom frank failure of circulatory 
homeostasis followed the induction of anaesthesia, a 
failure that appears to have resulted from inadequate 
venous return. 
I have chosen to call attention in this classification 
to the initial hypovolaemia, as this is eminently 
correctable. The precipitating factor was frequently 
the exhibition of thiopentone to the sick, old and 
arteriosclerotic who have evidence of ischacmic heart 
disease. Although some might regard many of these 
deaths as "drug-induced" cardiac arrest because of 
their direct association with thiopentone, I have 
chosen to highlight the functional hypovolacmic state, 
as often this was the basic correctable fault. 
Miscellaneous 
The remaining patients, while not constituting 
such homogenous groups as the above, are worthy of 
brief comment. 
Cardiac arrest (7 patients). Included in this group 
arc: 
(a) Three patients in whom cardiac arrest appeared to 
have been directly precipitated by the anaesthetic or 
adjuvant drugs ( other than thiopentonc ). Two were 
associated with repeat doses of suxamcthonium and 
one followed the administration of halothane to a 
patient with Parkinson's disease who was being 
treated with L-dopa. 
(b) In one patient, suffering from Mobitz Type II 
heart block, anaesthesia and surgery precipitated 
complete heart block, followed by cardiac arrest on 
three occasions, resuscitation failing finally. This was 
deemed to have been preventable by the pre-
anaesthetic insertion of temporary ventricular pacing. 
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(c) A death which resulted from "air embolism" 
following an attempt by the anaesthetist to expedite 
transfusion of blood to a patient bleeding from a 
gastric ulcer by the inflation of air from a sphygmo-
manometer cuff directly into the transfusion bottle. 
( d) In two further instances the cause of cardiac arrest 
could not be established convincingly. 
Ooerhydration (one patient). Although six patients 
died because of "overhydration", only one is listed 
here, the other five having been included above under 
"respiratory inadequacy following myoneural block-
ade" and "inadequate postoperative care". This 
remaining death was from pulmonary oedema 
following inadequately monitored resuscitation of a 
patient, who had a previous myocardial infarction, 
undergoing gastrectomy for haematemesis. 
Deaths from failure of respiratory homeostasis 
other than those already described included: 
Teclmical failure (one patient). Incorrect assembly 
of a self-inflating bellows caused the anoxic death of 
patient during transfer from the operating theatre to 
the intensive care unit. 
Vomiting, regurgitation and inhalation ( two patients). 
These followed (a) C.aesarean section; (b) intestinal 
obstruction. 
Bronchial obstruction (three patients). The follow-
ing circumstances caused fatal bronchial obstruction 
during anaesthesia: 
(a) Blood from oesophageal varices passing an in-
sufficiently inflated endotracheal tube cuff. 
(b) Laclc of adequate bronchial toilette of a patient 
anaesthetized while suffering acute purulent 
bronchitis and undergoing laparotomy for an 
ectopic pregnancy. 
(c) Total bronchospasm following trachael intubation 
in a patient known to have asthma. 
Complications of major local anaesthetic techniques 
(three patients). Three patients died following spinal 
or extradural anaesthesia. In two instances major 
bleeding during operation in the face of sympathetic 
paralysis as a result of the technique caused profound 
and uncontrollable hypotension. In the remaining 
instance the mismanagement of total spinal anaesthesia 
complicating attempted extradural bloclc caused the 
death of the patient. 
INEVITABLE DEATHS 
"Inevitable deaths" constituted 25% of those associ-
ated with anaesthesia (see table HI). Three broad 
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TABLE III. "Inevitable ckaths" 
Circumstances of death 
No.of · % of 
deaths group 3 
Cardiac surgery 45 33.3 
Ruptured abdominal aortic aneurysm 21 15.6 
Other massive haemorrhage 23 17.0 
.Multiple injuries 15 11.1 
Septicaemia/peritonitis 19 14.1 
Ncuro trauma 8 5.9 
Pulmonary cmbolus 1 0. 7 
Myocardial infarction before operation 1 0. 7 
Other 2 1.5 
135 99.9 
groups of surgical procedures and conditions were 
responsible for three-quarters of these deaths. These 
were: 
(a) C.ardiac surgery with cardiopulmonary bypass. 
(b) The surgery of major vascular catastrophes, such 
as a ruptured abdominal aortic aneurysm. 
(c) Multiple injury and other conditions associated 
with massive haemorrhage. 
CONCLUSION 
Because of the great number of variables which in-
fluence various author's estimates of the frequency of 
those deaths to which anaesthesia contribut~ 
differences in the pcri-opcrative period and type of 
surgery, in the assessment criteria and classifications 
adopted and in the computation of the background 
surgical population-no statistical comparisons 
between surveys arc valid. C.Omparison of this survey 
has been confined to that by the same author for the 
previous IO-year period at the same institution. There 
has been improvement. Four fundamental changes 
have occurred pari passu; 
(1) A continuing improvement in routine monitoring 
of vital functions during anaesthesia. 
(2) An increase in the consultant (full time specialist) 
registrar (trainee) ratio, now approximating 1 : 1. 
(3) A decrease in the case load per anaesthetist. 
( 4) The introduction of recovery rooms within the 
theatre area and adjacent intensive care units. 
Although the actual frequency of death attributable 
to anaesthesia was small (0.22 deaths per 1000 
anaesthetics), it is salutory to reflect that the 10% of 
immediate operative mortality for which anaesthesia 
and its mismanagement was responsible was basically 
preventable. It is sad to reflect that the causes of 
anaesthetic deaths are, by and large, simple and usually 
1.5 
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follow the lack of observation of simple precautions, 
and the lack of clinical alertness. What is more, in 
general, these causes recur. It is also sobering to 
reflect that these patients reported here arc probably 
the tip of an iceberg of clinical mismanagement. How 
many more have nearly died? 
Surveys and studies such as this arc somewhat 
pedestrian and arc tedious in the extreme to conduct, 
but if they arc carried out consistently and conscien-
tiously, they will provide us not only with the clinical 
lessons by which we can improve our practice, but 
also the only means by which we may measure and 
evaluate the safety of anaesthesia for the patient. 
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DECES ATI"RIBUABLES A L'ANESTHESIE 
Etude portant sur 10 ans (1967-76) 
RESUME 
La mortalite associec a 240 483 cas d'ancsthesic administrec 
pendant 10 ans a l'h6pital de Groote Schuur a Capetown 
fait l'objct de cc rapport. La frequencc des deces auxqucls 
l'ancsthesic a contribue a etc de 0,22%. (par rapport a 
0,33%. au cours des 10 annees prccedentcs). Ccs dcces ont 
comptc pour 2,2% du total de la mortalitc resultant des 
interventions chirurgicales. Les dcux-ticrs des dcces par 
suite d'anesthesie ont etc attribuables (dans l'ordrc de 
frcquencc): (a) a l'hypovolemic; (b) a l'insuffisancc 
respiratoirc apres blocagc myoncural; (c) aux complications 
BRITISH JOURNAL OF ANAESTHESIA 
resultant de !'intubation trachealc; (d) a des soins ct surveil-
lance postopcratoircs inadequats. 
TOD DURCH ANASTHESIE 
Ein Oberblick auf die lOJaJzre f/on 1967-1976 
ZUSAMMENPASStlNG 
Bcrichtct wurdc die Stcrblichkcitsziffcr in Vcrbindung mit 
240 483 Narkosen, vcrabrcicht wihrcnd 10 Jahrc:n im 
Groote Schuur Hospital in Cape Town. Die Stcrblichkcia-
ratc, die aufNarkosc zuriickzufilhrcn war, war 0,22 pro 1000 
Narkosen (vcrglichen mit 0,33 pro 1000 in den voraus-
gcgangenen 10 Jahren). Dicse Todc machten 2,2% der 
gcsamten Stcrblichkcitsziffcr dcr Chirurgie aua. Zwci 
Drittcl dcr Narkosctode warcn vcrursacht durch (in 
Rcihcnfolge dcr Hiufigkcit): (a) Hypovolimie; (b) Atmungs-
vcrsagen nach neuromuskulii.rcr Blockade; (c) Komplika-
tionen dcr trachcalen Intubation; (d) unzuliingliche, post-
operative Pflcgc und Bcufsichtigung. 
MUERTE ATRIBUIBLE A ANESTESIA 
Un utudio que abarco 10 aifos (1967-1976) 
SUMAJUO 
Sc informa sobre la mortalidad uociada con 240 483 
ancstesicos administrados durantc un pcridodo de 10 liios 
en cl hospital de Groote Schuur, Ciudad dcl Cabo. La 
frccuencia de muertc atnbuida a ancstcsia fue de 0,22 por 
1000 ancstcsias (en comparacion con un 0,33 por 1000 en 1os 
10 anos antcriores). Estas mucrtcs corresponden a un 2,2% 
de la mortalidad total por cirugfa. Dos tcrcios de la muena 
"ancstesicas" fucron imputablcs a (en orden de frccucncia): 
(a) hipovolcmia; (b) insuficiencia respiratoria aiguicndo un· 
bloquco mioncural; (c) complicacioncs de intubacion 
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Anaesthetic deaths 
Death as a result of anaesthesia is rare; but when this does 
occur not uncommonly the patient has been apparently fit, 
and sometimes there seem to have been failures to maintain 
proper anaesthetic practice. We need, therefore, to examine 
the causes of these deaths if we are to avoid similar tragedies 
in the future. 
Surveys over the past 20 years have identified the common 
problems. The Association of Anaesthetists of Great Britain 
and Ireland set up a voluntary reporting system to examine 
deaths resulting from anaesthesia. Two papers, in 19561 and 
1964,2 surveyed 1600 reports. Of these, 989 were thought to 
implicate the anaesthetic. Death was most often attributable to 
failure to maintain the airway, failure to maintain ventilation, 
and circulatory failure. Hypovolaemia was a common cause of 
the circulatory difficulties and was often exacerbated by a 
(relative) overdose of an intravenous injection of thiopentone. 
A few deaths were due to failure of anaesthetic apparatus. 
In South Australia an anaesthetic mortality committee 
surveys all deaths associated with anaesthesia. A report of its 
findings for the years 1969-743 suggests that the incidence of 
death during or after anaesthesia is about 1 in 15 000. One 
problem it highlighted was cardiac arrest, and the suggested 
remedy was that more frequent blood pressure monitoring 
might detect such patients when hypotension preceded the 
arrest. Wylie4 commented on the disastrous consequences of 
delay in recognising cardiac arrest : in those circumstances per-
manent neurological damage may be expected in those who 
survive. 
The report of the confidential inquiries into maternal 
deaths5 found that 37 dooths were due to anaesthesia in 1970-2. 
Obstetrics is known to present special risks, the inhalation of 
stomach contents being the most important. The other causes 
included hypoxic cardiac arrest. The important finding is that 
in three-quarters of the cases there were some avoidable factors. 
The additional risk of anaesthesia in caesarean section seems to 
give a death rate of about 1 in 3000 patients. · 
One of the virtues of the system of reporting maternal deaths 
is that it does not depend solely on voluntary reporting; the 
aim is to assess every maternal death. Harrison6 has recently 
described a similar comprehensive survey of all patients 
anaesthetised in Groote Schuur Hospital, South Africa. In the 
decade studied 240 483 anaesthetics were given and 2442 
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patients died. Of these deaths, 531 were classified as associated 
with anaesthesia in that death occurred during or within 24 
hours of anaesthesia or before full recovery of consciousness. 
But in only 53 of the cases was anaesthesia thought to have 
contributed; the rest were classified as inevitable (135) or a 
result of other causes (343). The death rate from anaesthesia 
was 1 in 4537. The list of causes is depressingly familiar: 
hypovolaemia, ventilatory failure, failure to maintain airway, 
cardiac arrest due to drugs or air embolism, and so on. 
Respiratory failure associated with the use of relaxants was 
common. The usual combination was severe obstructive 
airway disease, intestinal obstruction, and the use of neuro-
muscular blocking drugs. 
The striking features in all these series arc the prepon-
derance of airway, ventilatory, or circulatory problems. 
Jaundice after halothane is absent,7 but the definition of 
death from anaesthesia as used by Harrison• would miss that 
cause: jaundice develops some days after anaesthesia, and the 
patient would be conscious between the anaesthetic and the 
development of liver failure. 
What arc the lessons to be learned? Death due to anaesthesia 
is no respecter of persons-it may happen to any patient and in 
any anaesthetist's practice. Each anaesthetist should determine 
before, during, and after each anaesthetic that there are no 
problems with the airway, that ventilation is adequate, and 
that blood volume and cardiac function arc sufficient for the 
patient's needs. Further training should emphasise fall-back 
procedures. How should the anaesthetist cope if he fails to 
secure endotracheal intubation? Tunstall8 described one such 
drill for obstetric anaesthesia. Better monitoring must give 
earlier warning of cardiac arrest and minimise delay in treating 
it. Is it now time for all anaesthetised patients in Britain to have 
their electrocardiogram or pulse continuously displayed? 
Further surveys should identify what progress is being made 
in reducing the death rate of anaesthesia. The Association of 
Anaesthetists is undertaking a new survey in sclccted areas in 
Britain. All deaths during and after operation will be examined 
to determine the role of anaesthesia. Sadly, the survey will not 
be extended to look at all the causes of death. The close col-
laboration of all concerned in obstetrics has made a major 
contribution to improved maternal care. Was there not a 
possibility of doing the same for surgery? In Harrison's series' 
NO 6165 PAGE 703 
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other causes not considered inevitable led to six :imes as 
many deaths as anaesthesia. 
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SOUTH AFRICAN MEDICAL JOURNAL.Vol.55:192:1979. 
NUUS EN KOMMENT AAR 
STERFl'E TE WYrE AAN NARKOSE 
In 'n 10-jaar oorsig deur professor Harrison (Brit. J. 
Anaesth., 1978, 50, 1041) kom by tot die gevolgtrekking 
dat die insidensie van sterfte na narkose by Groote Schuur-
hospitaal 0,22 per 1 000 was, wat goed vergelyk met ·die 
0,33 per 1 000 van die vorige 10 jaar. Daar is oor die 
10-jaar tydperk 1967. 1976 240 483 narkoses toegedien. 
Die sterftes was verantwoordelik vir 2.Z% van die totale 
chirurgie-mortaliteit. Twee derdes van die narkose-sterf-
tes, in volgorde van frekwensie, is toegeskryf aan hipo-
NEWS AND COMlllENT 
volemie, respiratoriese ontoereilcendbeid na mioneurale 
blokkade, komplikasies wat gepaard gaan met trageale in-
tubasie en onvoldoende na-operatiewe sorg. 
Die fundamentele veranderinge in die 10-jaar tydperk 
was die volgende: (i) verdere verbetering in die roe-
tinebewaking van die pasient onder narkose; (ii) verbete-
ring in die senior/ junior personeelverhouding (tans byna 
1: 1); (iii) minder werk per narkotiseur, en (iv) die daar-
stelling van herstelkamers by die operasiesaal en inten-
siewe sorgeenhede in die nabye omgewing. 
1.6 
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Death due to anaesthesia at Groote Schuur 
Hospital, Cape Town - 1956 - 1987 
Part I. Incidence 
G. G. HARRISON 
Summary 
The data from a 30-year surveillance study ol anaesthetic 
mortality associated with 0,75 million anaesthetics admini-
stered at Groote Schuur Hospital, Cape Town, from 1956 to 
1987 are presented. Behind an overall mortality rate ol 0,19 
deaths per 1 000 anaesthetics attributable to anaesthesia, lies 
a 6-lold decrease in the incidence, computed quinquennially, 
from 0,43 per 1 000 anaesthetics in the first quinquennium to 
0,07 per 1 000 anaesthetics in the last. The latter figure 
portrays a standard ol safety in anaesthesia tor the patient 
equal to anywhere in the world. 
S Air Meet J 1990: 77: 4'12-415. 
I hold that there should be no deaths due to 
anaesthetics. . .' 
- Sir Rohen McIntosh, 19481 
Clinical anaesthesia is an indispensable adjunct to the surgical 
management of disease. Of itself non-therapeutic, above all 
else it must be safe for the patients. An adverse outcome tc, 
anaesthesia, and factors relevant to its administration, results, 
at best, in postoperative morbidity for the patient and at 
worst, in his death (Fig. I). The incidence of the latter event 
provides us with the most fundamental measure of the safety 
of anaesthesia for the patient. 
To audit the performance in this regard of the Department 
of Anaesthetics at Groote Schuur Hospital, an ongoing con-
temporaneous surveillance study of all deaths associated with 
anaesthesia was staned in 1956 and has been continued to 
date. T he surgery for which these anaesthetics were admini-
stered has increased from 16 000 to 40 000 operations annually 
and has included the whole spectrum of modem surgical 
practice from the simplest to the most complex. Although 
most of the anaesthetics were given for standard surgical 
procedures, the advancing edges of surgery were always in 
evidence. The years covered by this survey saw the birth and 
development of cardiopulmonary bypass surgery, major vas-
cular surgery and organ transplantation. It also witnessed the 
increase, to almost epidemic proponions, of major trauma 
requiring management - in panicular the dragon's teeth 
harvest of major multiple injuries spawned by motor vehicle 
accidents. 
While the findings of this Stl,!dy have been reponed over the 
years in various publications/- · the completion of its 30th year 
provides an appropriate moment to repon an overview of the 
study as a whole, with an examination of trends in the 
incidence and aetiological patterns of death attributable to 
anaesthesia. 
Department of Anaesthetics, University of Cape Town and 
Groote Schuur Hospital, Cape Town 
G. G. HARRISON, M .D., F.F.A R.c .s., Emeritus Professor and 
Somerime Fellow 
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Deimitions 
The objectives of this surveillance study have been: (1) to 
establish the incidence of death attributable to anaesthesia; 
·c;,) to identify the mechanisms that caused death and the 
hazard situations from which they result; and (ii,) to formulate 
strategies for prevention. 
The starting point in this process was the examination of 
detailed records of the clinical course, management and autopsy 
of all patients whose death was chronologically closely ~ 
ciated with anaesthesia - anaesthetic-associated death 
(AAD) - in order to identify that approximate 109' subset 
whose deaths were considered due to anaesthesia and its 
mismanagement - anaesthetic contributory death (ACD). 
An AAD was defined as the death of a patient occurring 
during or within 24 hours of anaesthesia or after failure of the 
patient, conscious before, to regain consciousness after anaes-
thesia. 
1.7 
The choice of a 24-hour period after anaesthesia was 
arbitrary. It was considered to embrace a time interval adequate 
to permit identification of those deaths attributable to anaes-
thesia without the study becoming unmanageably large. 
Patients suffering irreversible anoxic or anoxic/ischaemic brain 
damage from anaesthetic-induced crises, yet surviving after 
resuscitation, would be identifiable by their failure to regain 
consciousness. While today, for complete capture of relevant 
data, extension of the surveillance period to the 6th day after 
anaesthetic, is recommended, 8 such demand could not be met 
at the time of this study's inception. In these circumstances, it 
is acknowledged that a very small number of late deaths, 
which may have been attributable to anaesthesia, e.g. aspira-
tion, may have been missed. 
The background population of all anaesthetic administrations 
from which the above arose, was recorded as also the total 
postoperative hospital stay mortality - total operative mor-
tality. 
Identification 
All surveillance studies of anaesthetic-associated mortality 
are bedevilled by difficulties inherent in the assessment of the 
responsibility of anaesthetic drugs and/or techniques for 
adverse outcome. These difficulties arise from the circumstance 
that the conduct of an anaesthetic is inseparable from its 
environment, which is a function of two complex variables: 
(1) the patient's disease, both surgical and intercurrent; and 
(i1) the surgical operation itself and its effects, including 
complications and errors of the surgical technique. 
Interaction of these two variables is responsible for approxi-





8 But in circumstances 
in which this environment of the anaesthetic does not of itself 
provide sufficient explanation for adverse outcome, the conduct 
of the anaesthetic itself must be called in question. In this case 
we are faced primarily with an assessment of that difficult-to-
define quality, the skill of the anaesthetist. 
Preventability 
If it is accepted that lack of skill or human error on the part 
of the anaesthetist is the major factor in causation of death 
attributable to anaesthesia, it follows that such deaths are 
preventable. To say this is not to attribute blame. To quote 
William Osler: 'Errors in judgement must occur in the practice 
of an an which consists largely in balancing probablities.' The 
implication is simply that on review, albeit with the benefit of 
hindsight, a reasonably satisfactory explanation of th~ circum-
stances can be found and countermeasures that could prevent 
the recurrence of the situation are practicable. 
The unavoidable 
Not all deaths attributable to anaesthesia are preventable. 
Besides those for which sufficient information for assessment 
is not available, there will be those which involve mechanisms 
not adequately understood, coven pharm9:cogenetic states or, 
perhaps, unforeseen technical or apparatus failure over which 
the anaesthetist has no control. A difficulty here is that, with 
advances in knowledge and accumulation of experience, com-
plications that may be judged unavoidable today come to be 
regarded tomorrow as due to preventable error. 
The unassessable 
In this type of study it must be noted that it is only the 
more obvious and conventional errors in clinical anaesthetic 
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management that can be identified as being contributory to a 
patient's death. The more subtle role that cenain errors in 
clinical anaesthetic management may play in the genesis of 
postoperative morbid conditions that may lead to death, such 
as myocardial infarction, adult respiratory distress syndrome 
and renal and hepatic failure, is not precisely assessable. And, 
in view of their multifactorial aetiology, is it ever likely to be. 
Classification 
In terms of the above, records of the conduct of the 
anaesthetic and the autopsy repon of each AAD were examined 
in the light of three questions: 
1. Was the administration of the anaesthetic or other factors 
within the ambit of the anaesthetist's responsibility the cause 
of, or a major contributory factor in, the patient's death? Or 
was the death primarily a result of the patient's disease and/or 
the surgical procedure undenaken? The former were classed 
as ACD, the latter as 'death due to other causes'. 
2. If considered an ACD, what was the precise cause? 
3. Was the death preventable? What depanures were there 
from accepted clinical practice? Was there a clinical lesson to 
be learnt? 
Besides the two broad calssificatory classes of death con-
sequent on the first question, viz: (1) ACD; and (i1) death due to 
other causes, a need arose from the circumstances of clinical 
practice for a third category for those deaths associated with 
the surgery of desperation; operations on the moribund - and 
the like - deaths for which, although the anaesthetic aetiology 
was not obvious it could not (from the very nature of the 
process) be entirely excluded. For such deaths a category of 
'inevitable death' was allocated (Table I). 
In assessing the contributory role of anaesthesia, an attitude 
was adopted that is best expressed by Dripps et al. :9 'There is 
nothing to be gained in a monality study by omitting a 
particular death merely to lower a statistical death rate. 
A voiding responsibility or taking refuge in the fact that the 
patient was desperately ill prior to anaesthesia and operation, 
may improve one's mortality figures, but it will not advance 
general knowledge or change one's own practice. On the other 
hand one should not resort to self-flagellation, assuming 
responsibility for a fatality merely because an anaesthetic was 
administered and death occurred.' 
While it must be admitted that there is a considerable 
subjective element in the final assessment of the culpability of 
the three variables that bear on anaesthetic associated mor-
tality - the patient's disease, surgery, and the conduct of the 
anaesthetic - this type of review is the only means by which 
some measure of the safety of anaesthesia and an audit of the 
efficacy of our service to the patient is gained. 
Incidence of ACD 
The general statistical data revealed by this study are pre-
sented in Table I. Of approximately 0,75 million patients 
anaesthetised for surgery, 7 033 died before discharge from 
hospital (total operative monality 8,99 per l 000 operations). 
Of these deaths I 427 ( l ,83 per I 000 anac:;thetics) occurred in 
immediate association with anaesthesia (AAD) and the records 
and clinical treatment of these patients were examined and 
assessed in the manner described. The anaesthetic, or its 
mismanagement, was adjudged the sole cause or a major 
contributory factor to 145 of these deaths, yielding an overall 
incidence of death attributable to anaesthesia (ACD) of 0,19 
per I 000 anaesthetics. In this reveiw, comment is confined to 
the latter. Of these, the deaths of 124 patients (86%) were 
assessed as probably or possibly preventable. 
1.7 
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TABLE I. ANAESTHETIC-ASSOCIATED MORTALITY AT 
GROOTE SCHUUR HOSPITAL 1956 · 1987 
lncidence/1 000 
No. of deaths anaesthetics 
AAD (<24 h) 1427 1,83 
ACD 145 0,19 
Preventable (86%) 
Physical status (ASA 4,5) 
(52%) 
Emergency operations (52%) 
Contribution to surgical 
mortality (2,06%) 
Inevitable 354 0,45 
Other causes 928 1,19 
Total anaesthetics= 782182; total operative mortality= 7033 (8,99 deaths/ 1000 
operabons). 
Over the 30-ycar period of this study, there have been 
considerable changes in clinical anaesthetic practice, stemming · 
from advances in knowledge, a more versatile drug arma-
mcntarium, improvements in training, and the immediacy, 
sophistication, acceptance and availability of monitors of vital 
functions, including the biochemical aspects. That these 
changes have produced a beneficial increase in the safety of 
anaesthesia for the patient becomes readily apparent when the 
incidence of ACD is computed in serial 5-ycar periods (Fig. 
2). This reveals a 6-fold decrease in the incidence of ACD over 
the period of this study, from 0,43 to 0,07 I 1 000 anaesthetics. 
This is accompanied by an approximately 4-fold decrease 
(3,3% - 0,9%) in anaesthetic contribution to total surgical 
mortality, which itself has fallen. 
A major weakness of this type of study is that besides the 
clement of subjectivity, lack of uniformity in the criteria of 
case assessment and classification as well as the peri-operativc 
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Fig. 2. The incidence of ACD and AAD in quinquennla, 1956 -1987. 
the broadest statistical comparisons between studies from dif-
ferent centres meaningless. 
With this caveat, a context for this study is provided by the 
documented incidence of ACD computed at various other 
centres world-wide, as presented in Table II. Citations arc 
TABLE II. ESTIMATES OF INCIDENCE OF ACD FROM AROUND THE WORLD 
Incidence of 
Country. authors, Years studied, Peri-operative ACD (rate/1 000 
year of publication No. of anaesthetics period (d) anaesthetics) 
South Africa 
Kok and Mullan10 (1963) 1956-1962 (1002712) ,;;; 1 0,49 
Kok and Mullan" (1969) 1956-1965 (1760066) ,;;; 1 0,42 
Harriaon21 (1966) 1956-1966 (177 928) ,;;; 1 0,33 
Harrisoni (19~~ 1967-1976 (240483) ,;;; 1 0,22 
Australia 
Clifton and Hotten12 (1963) 1956-1962 (205640) ,;;; 1 0,17 
Bod1ander13 (1975) 1963-1972 (211130) ,;;; 1 0,07 
Anaesthetic Mortality 
Committee S Australia" 
(1975) 1969-1974 (465000) ,;;; 1 0,08 
Anaesthetic Mortality 
Committee S Australia15 
(1985) 1974-1983 (900000) ,;;; 1 0,05 
New Zealand 
Gibbs" (1986) 1979-1984 (1 100 000) ,;;; 1 0,10 
Finland 
Hovi-Vlander17 (1980) 1975 (338934) ,;;;3 0,20 
Canada 
Turnbull et al." (1980) 1973-1977 (195232) ,;;;2 0,18 
UK 
Lunn and Mushin• (1982) 1979-1980 (1147 362) ,,.;;5 0,10 
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confined to those documented over the last 15 years, except 
when serial figures over time arc available from the same 
centre, allowing some validity to inferences from 'within study' 
chronological trends. 
In the above context the incidence at Groote Schuur Hos-
pital of death attributable to anaesthesia per se correlates well 
with that computed at the other centres cited. In spite of the 
statistical caveai:s this allows us to draw two firm conclusions: 
(1) of every 10000 patients undergoing anaesthesia and surgery 
only I dies because of the anaesthetic; and (i1) the incidence. of 
death attributable to anaesthesia has decreased greatly with 
time; our experience of a decrease over the last three decades 
reflects the general trend. 
Some implications 
One implication of such incidence (I ACD per 10 000 
anaesthetics) is that the average anaesthetist would be expected 
to encounter only 1 such death every 5 - 10 years of his 
working life. In terms of human frailty, it must be wondered 
whether it is possible for such a rate to be reduced further. 
On the other hand, although the rate is acceptably low and 
perhaps at an irreducible minimum, it does mean that (based 
on the statistic that every year 1 in every 20 - 25 persons has to 
undergo a procedure which involves anaesthesia) in South 
Africa at least 100 patients die every year because they are 
anaesthetised. Of these 100 or more deaths, 90% would be 
considered preventable. Looked at in this light, death solely 
attributable to anaesthesia must continue to be a matter of 
concern. Furthermore, surveillance studies of death attributable 
to anaesthesia monitor only the extreme endpoint of the 
adverse outcome process - only the tip of the iceberg of 
clinical mismanagement. To quote Davis: 19 'The tolerance of 
the human body is phenomenal and if a few die each year 
consider how many have been subjected to abusive prac-
tices - how many have almost died?' 
It must be remembered, too, that these estimates of death 
attributable to anaesthesia were computed in First-World 
mainstream hospitals, usually teaching institutions. How well 
they represent the situation in the vast rural practice of 
surgery in those countries, and our own, let alone the circum-
stances in Third-World countries, is completely unknown. A 
priori, these are likely to be considerably higher. 
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Prediction of risk 
While these studies audit how we have performed, as a 
predictive measure of the risk of anaesthesia they are of very 
little use . In this regard I can do no better than to quote 
Goldstein and Keats:2° 'The poor predictability of anaesthetic 
mortality should be expected, since a significant proportion of 
this mortality is due to human error, which cannot be pre-
dicted, and to other factors which have never been quantified. 
To a small degree, physical status and the operation contem-
plated provide some predictive basis. To a large degree un-
known factors related to the skill of the personnel and the 
· environment of the therapy contribute to anaesthetic risk. 
Estimates of the anaesthetic risk for individual patients remain, 
therefore, almost entirely intuitive.' 
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Part II. Causes and changes in aetiological pattern of 
anaesthetic-contributory death 
G. G. HARRISON 
Summary 
A general analysis of the clinical failures that were responsible 
for deaths attributable to anaesthesia over a 30-year period, 
1956. 1987, is presented. Four particular general failures in 
clinical management were responsible for 80% of anaes-
thetic-contributory deaths (ACD). These were in descending 
order of frequency: (/) failures in airway management, of 
which the majority were associated with the complications of 
endotracheal intubation (27% of ACD); (//) failures in pul-
monary ventilation management (20% of ACD); (I//) failures In 
blood volume control (19% of ACD); and (iv) failures in 
arrhythmia control (17% of ACD). 
Computation of these groups of causes by the decade 
reveals a distinct and progressive change in the aetiological 
pattern of these deaths with time. While the incidence of ACD 
over the period decreased 6-fold from 0,43 to 0,07 /1 000 
anaesthetics, that proportion due to failures In airway manage-
ment, in general, and complications of intubation, in particular, 
has progressively increased. This has been accompanied by 
a reciprocal decrease in deaths due to circulatory factors. It 
is postulated that this change arises from the fact that the 
physical skills, manual dexterity and clinical Judgement 
demanded by the former have not changed with time, whereas 
the latter depend on intellectual responses to information 
derived from ever-improving vital function monitoring. 
S Air Med J 1990. 77: 416-421 . 
'Experience is the best of school masters, only the school 
fees are hea\'Y .' 
-:- Thomas Carlyle, 1795-1881 
Mechanisms of death 
Death as a complication of anaesthesia is usually an acute 
event, which follows loss of clinical control of the patient's 
physiological homeostasis and the functional failure of those 
interrelated systems - respiratory and circulatory (Fig. 1). In 
assessing these, consideration must be given not only to the 
wavs in which the known actions of anaesthetic drugs or errors 
and misjudgements in their administration may have lethal 
consequences, but also to the ways in which errors of commis-
sion or omissions in the wider field of responsibility, which by 
practice has become that of the anaesthetist, may cause death. 
Based on Fig. 1, the following broad .::lassification of 
mechanisms/ causes of death anributable to anaesthesia was 
adopted : (i) failure to control respiratory homeostasis; 
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Fig. 1. The interrelated system failure of the ACD (CBF = cerebral 
blood flow; ICP = intracranial pressure; Temp = tem-
perature; BMRO = basal metabolic rate for oxygen). 
(i1) failure to control circulatory homeostasis; (iii) complications 
of regional anaesthesia; and (iv) miscellaneous other causes. 
Those causes of. death allocated to failures in control of 
respiratory and circulatory homeostasis, the major groups, 
were in tum subdivided in terms of the mechanisms or clinical 
failures responsible for them as listed in Table I. 
Oassificatory groups arc broad with no allowance for the 
clinical minutiae which distinguish individual cases in order 
that broad practical inferences might emerge clearly. 
The 'process of injury' (Fig. 2), which starts with some 
critical incident and ends in death, is a dynamic process that 
could be avened by correct intervention at any stage. This 
implies that failure to do so usually involves multiple errors, 
which in tum activate the composite mechanisms that ulti-
mately result in death. For example, Holland, 1 in reporting 
findings of the New South Wales Special Commincc on 
Deaths under Anaesthesia, computed an average of 4,3 errors 
per death. To which of the multiple errors the death is finally 
anributed for classificatory purposes, poses a problem. For the 
purposes of this study, the proximate identifiable critical 
incident, error. or mechanism activated was chosen for classifi-
cation. 
General contributory circumstances 
Before proceeding to the particular causes/mechanisms of 
death attributable to anaesthesia, let us briefly consider the 
general impact on anaesthetic-contributory death (ACD) of 
1.7 
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TABLE I. CAUSES OR MECHANISMS OF ANAESTHETIC-CONTRIBUTORY DEATHS 
Causes/mechanisms of ACD 
1. Failurn in control of rHpiralory homeostasis 
Failures in airway management 
Vomtting/regurgilation 5 
Complications, ET Intubation 26 
Bronchial obsl. 8 
Failures in ventilation management 




Deficient post-op. nursing 
Tension pneumolhoru 
Technical/ equipment failure 
2. Failurn in control of circulatory homeostasis 
Failures in blood volume management 
Hypovolaemia/hypolenaion 23 
Hypervolaemia/over-lranatuaion 4 
Failures in arrhythmia control 
Drug related 10 
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the environment in which the anaesthetic is administered. 
Clinical anaesthesia has been described as a state of 'physio-
logical trespass'.2 The more disease has trespassed on the 
body's homeostatic mechanisms, the less anaesthetic trespass, 
per se, can be tolerated. The clinical anaesthetist's margin of 
error shrinks accordingly. The influence of this 'environment 
of the anaesthetic' on ACD is clearly attested by the observa-
tion in this survey that whereas patients in poor or critical 
physical status (American Society of Anesthesiologists 3, 4, 5) 
constitute but 5% of the general surgical population in this 
hospital, 3 such physical status is associated with 52% of the 
deaths attributable to anaesthesia (see Table I, part I). From 
these observations it can be computed that the incidence of 
ACD in patients in poor physical status was 1,19/1000 anaes-
thetics, 13-fold greater than the 0,09/1 000 of those in good/fair 
physical status before anaesthesia. 
The mechanisms/causes of the 145 deaths attributable to 
anaesthesia arc classified in Table I. From the general causes, 
4 particular groups of clinical failures stand out as being 
almost equally responsible for 80% of deaths attributable to 
anaesthesia. These failures were in: (i) airway management -
27%; (i1) pulmonary ventilation management - 20%; (iii) 
blood volume management - 19%; and (iv) arrhythmia control 
(or cardiac arrest due to causes other than anoxia and 
ischaemia) - 17%. 
While the circumstances of each death are individual, a brief 
review of the general clinical failures responsible for them is 
presented as a guide to the formulation of strategics of prcven-
~on and to focus the direction of clinical training. 
Failures in control of respiratory 
homeostasis 
Failures in airway management 
Failures in this most basic of anaesthetic clinical skills were 
the most common general cause of ACD (27% of ACD, 39 
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patients) and of these two-thirds resulted from complications 
of endotracheal intubation (18% of ACD, 26 patients). 
Endotracheal intubation 
Most prominent of the endotracheal tube mishaps 
(8 patients) was the anaesthetist's nightmare - a technical 
failure of incubacion after the administration of a muscle 
relaxant, followed thereafter by an inability to ventilate the 
patient. In all cases, this situation was due to some anatomical 
or pathological abnormality that could have been anticipated 
by adequate pre-anaesthetic examination, but was not. In each 
instance the anaesthetist had failed to assure himself that he 
could intubate and/or ventilate the patient before administering 
a neuromuscular blocking drug. 
Nine patients died as a result of anoxia that arose from 
endocracheal cube obscruccion due to kinking of the tube or cuff 
herniation. The laner complication is panicularly treacherous 
in that it can arise some time after the intubation with few or 
no warning signs. Four patients died from anoxia (plus vagal-
induced cardiac arrest) when acuce massive bronchospasm and 
expiratory muscle spasm - induced by anempts at intubation 
when anaesthesia was too light, laryngeal topical analgesia 
insufficient and muscle relaxation inadequate - rendered 
pulmonary ventilation impossible. Disconneccion and dislodge-
ment of the endotracheal tu~ that was not detected or cor-
rected timeously caused the death of 5 patients. That 4 of 
these occurred postoperatively in patients being treated with 
interminent positive pressure ventilation (IPPV) for various 
indications, reflects inadequacies in nursing care that have 
subsequently been largely corrected. 
Closely related to these endotrachcal tube complications, is 
a group of S deaths, which followed anoxia · consequent on a 
failure to clear obscruccion of the lower aiT'll.la)' (the bronchi) by 
pus, blood or secretions due, in all but 1 case, to pulmonary or 
oesophageal disease. The laner case was a child who, having 
inhaled a foreign body, developed profuse frothy bronchial 
secretions when anaesthesia was induced with open ether (an 
historic remnant! ). Of the remaining cases, 4 involved the 
investigation or surgery of bronchiectasis, a circumstance that 
highlights the grave difficulties inherent m the anaesthetic 
management of this condition, and I patiem had broncho-
pneumonia. 
Vomiting, regurgitation and aspiration 
Anaesthesia in the presence of a 'full stomach', with it~ 
consequent risk of vomiting, regurgitation and aspiration, has 
been recognised traditionally as commonly posing an extremely 
hazardous situation for the patient. However, only 5 deaths 
(3% of ACD) resulted from this situation - 2 each during 
induction of ana~thesia and accompanying extubation, with 1 
featuring silent regurgitation with aspiration. 
Failures in pulmonary ventilation 
management 
The second most common cause of death anributablc to 
anaesthesia was a failure to ensure adequate pulmonary venti-
lation. This was the cause of 29 deaths (20% of ACD ). While 
in the earlv vears of this studY, a few deaths (5\ occurred 
during ope;ation and anaesthcsi~ - the outcome of permitting 
patients with various respiratory impediments to breathe spon-
taneously while anaesthetised with ether or halothanc,instead 
of using IPPV - the majority (24 deaths) occurred at the 
termination of the anaesthetic or in the immediate or shon-
tcrm post-anaesthetic recovery period. Of the laner, 22 cases 
were problems of posr-anaesrheric muscle relaxant reversal with 
consequent hypoventilation that was mismanaged. Most com-
monly contributory to this situation were abdominal distention 
from intestinal obstruction, chronic obstructive airways disease 
or other pulmonary di::case and obesity - often all combined. 
The most common fault in clinical management was the 
adoption for too long after ancmpted reversal of neuromuscular 
block of a 'wait and sec' policy, allowing the patient to breathe 
spontaneously, coupled with a reluctance to recognise or acc:cpt 
the indications for a return to IPPV - as if such action could 
be regarded as a professional failure. The lesson is obvious 
- when in doubt ventilate. Happily, over the course of this 
study the incidence of such deaths has decreased greatly. 
In the remaining 2 incidents, the post-anaesthetic respiratory 
depression was due to narcotic analgesics. One was an example 
of 'Ondine's curse' (post-arousal respiratory depression after 
fcntanyl administration), the other the outcome of a mis-
diagnosis of the postoperative restlessness of anoxia as being 
due to pain, so anracting the administration of more nara,tic. 
In two-thirds of these deaths, deficiencies in postoperative 
nursing care and observation were also a contributory factor. 
Deficient postoperative nursing care 
Attention has been drawn in the above groups of cases to 
the contributory role played in several deaths by deficient 
postoperative nursing care and/or observation. This was _ 
regarded as the sole cause for the death of a funher 7 patients 
(5% of ACD). The panicular errors involved were as follows: 
(1) failure to maintain a clear oropharyngcal airway when 
supervising the recovery to full consciousness of patients after 
anaesthesia (3 cases); (i1) inadvcnent fluid overload due to 
failure to note and react to excessive intravenous infusion drip 
rates in the immediate post-anaesthetic recovery phase, result-
ing in pulmonary oedema (2 cases); (iii) connection of a 
pipeline from oxygen cylinder directly to the endotrachcal 
tube left in situ, leading to tension pncumothorax (I case); and 
(iv) failure to note the emptying of an oxygen cylinder, so 
causing the patient to breathe an anoxic gas mixture (I case). 
Although these tragic errors are laid at the door of the 
nursing ancndants, their occurrence carries the definite impli-
cation of a culpable lack of adequate instruction of the nursi~ 
staff by the attending anaesthetists, for which omission mey 
must bear a grave responsibility. 
Deaths due to tension pneumothorax 
Three deaths followed tension pneumothorax that developed 
during surgery and for which clinical recognition and treatment 
was tardy. Two were associated with pulmonary surgery and I 
- a neurosurgical case - involved the mechanism of alveolar 
rupture with pcribronchial mediastinal air tracking. •.i These 
occurrences arc of an order of rarity that blunts the clinician's 
awareness. 
Death due to equipment misuse or technical 
failure 
Five deaths (3% of ACD) resulted from equipment misuse 
or technical failure . Today modem alarm systems would have 
drawn ancntion to these hazardous situations before they 
became clinically irretrievable. Funher, such events usually 
provoke changes in equipment design, so that these particular 
errors are unlikely to be repeated. They were: (1) an overdose 
of ether due to the mcorporation of an ether vaporiser in the 
design of the now obsolete Coxeter Mushin CO2 absorption unit - the anaesthetist confused the control taps; (i1) total 
rcbrcathing without oxygen due to faulty assembly of a closed 
circuit; (iii) the same due to assembly of a Puritan self-
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inflating bellows without the inclusion of its expiratory valve; 
(iv ) a rotameter fault leading to inhalation of an anoxic gas 
mixture; and (v) disconnection of the inspiratory valve-inflating 
mechanism of a Bear ventilator preventing inspiratory inflation 
of the patient although the ventilator itself appeared to be 
functioning normally. 
Failures in the control of circulatory 
homeostasis 
Responsible, as a group, for 35% of ACD, death due to the 
anaesthetist's failure to control the patient's circulatory homeo-
stasis can be classified into two broad functional groups, 
simplistically perhaps, but in a manner that draws attention to 
the perceived major correctable faults: (1) those that followed 
from failure to maintain normaliry of the patient's circulatory 
blood volume, with resultant hypo- or hypervolaemia - in the 
former case cardiac arrest would have been preceded by, inter 
alia, functional myocardial ischaemia and in the latter cardiac 
overload together with anoxaemia from pulmonary oedema; 
and (i1) cardiac arrest from causes other than anoxia or 
ischaemia - failure of arrhythmia control. 
To this category have been assigned those deaths that have 
followed cardiac arrest seemingly precipitated by circumstances 
such as the administration of a drug, vagal stimulation, gross 
acidosis, hypothermia or other circumstances, the correction of 
which was deemed to be, to a great extent, under the control 
of the anaesthetist. 
Important general contributory factors to most deaths in 
both the above groups were: (1) tardiness in diagnosis; and (i1) 
inefficiencies in the application of cardiopulmonary resusci-
tation (CPR). 
Even when CPR was apparently successful, many patients 
died from irreversible brain damage. 
Failures in blood volume control (27 deaths, 
19% ACD) 
It must be noted that no use was made of central venous 
pressure monitoring in the clinical management of any of these 
cases, although such was readily available for the last two 
decades of this study. Again, the lesson is obvious. 
Hypovolaemia (22 deaths, 15% ACD) 
The feature common to all of .these deaths was cardiac arrest 
preceded by profound and intractable post-induction hypo-
tension of varying duration, the apparent result of inadequate 
cardiac venous return. 
Clinical factors associated with this situation were: (1) in 
more than two-thirds of the cases there was evidence of 
uncorrected pre-operative hypovolaemia, coupled in 11 with 
inadequate blood and/or fluid replacement during operation; 
(ii) 75% of these patients were elderly and showed evidence of 
degenerative vascular disease and ischaemic heart disease; 
(iii) in 50% of cases, the profound hypotension followed closely 
on the administration of thiopentone for the induction of 
anaesthesia; (iv) a subset of 9 patients (6% ACD) warrants 
special mention as it highlights the grave risk anaesthesia poses 
to a common group of surgical patients - the elderly, those 
with arteriosclerosis and diabetes mellitus, possibly suffering 
from ischaemic heart disease, who present for lower limb 
amputation because of diabetic gangrene - an operation so 
often left to the anaesthetic and surgical registrars to deal with 
at the end of the day's operating list; and (v) the special 
circumstances in 4 deaths were: aortic clamp release (2); 
haemorrhage occurring during the technique of induced hypo-
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tension (I); and inferior vena caval compression resulting from 
the turning prone of a paraplegic with a full bladder (I). 
·Of the above patients, 7 were resuscitated only to die post-
operatively from irreversible brain damage, having failed to 
regain consciousness. 
Hypervolaemia (4 deaths, 3% ACD) 
In contrast with the above, 4 patients died after pulmonary 
oedema induced by misjudged over-transfusion of blood and/or 
electrolyte solutions during surgery. In all, the manifestation 
of pulmonary oedema, masked or prevented during operation 
by the use of IPPV, was unmasked by relaxant reversal and 
the re-establishment of spontaneous respiration at the con-
clusion of operation. All of these patients died postoperatively. 
Failures in arrhythmia control - cardiac 
arrest from causes other than anoxia 
and ischaemia 
The combination of clinical circumstances and mechanisms 
other than anoxia and ischaemia that were adjudged to have 
caused cardiac arrest in this group of 24 patients (17% of 
ACD) were many and varied. The most common single asso-
ciated factor (10 patients) was the administration of some drug. 
The drugs concerned and the arrhythmia precipitated were as 
follows: (1) succinylcholine, which was followed by severe 
bradycardia proceeding to asystole (4 patients) - in 2 patients 
this event was preceded by severe acidosis and endotoxacmia, 
I person had a crush injury and I exemplified the 'second dose 
succinylcholine' effect; (i1) halothane, which caused ventricular 
fibrillation in 2 patients - in one death was associated with 
the stormy struggling induction of an unpremcdicatcd out-
patient and the other was a patient with Parkinson's disease 
who was being treated with L-dopa; (iir) ncostigminc, which 
was administered to a marginally anoxic patient causing brady-
cardia going on to asystole; (iv) intravenous digoxin, which led 
to ventricular tachycardia; and (v) isoxsuprine and droperidol, 
which both led to profound hypotension preceding ventricular 
fibrillation. 
In 4 patients the cardiac arrest was directly associated with 
severe vagal stimulation, and in a further 3, all suffering 
ischaemic heart disease, ventricular tachycardia preceded in-
tractable ventricular fibrillation. 
Inadvertent transfusion hypothermia was associated with the 
onset of ventricular fibrillation in 2 patients. 
A patient suffering Mobitz second degree heart block was 
submitted to operation unpaccd and developed a complete 
heart block with later ventricular fibrillation. 
Air embolism from a preventable transfusion mishap caused 
the death of the last patient in this group. 
In addition, no precise cause could be assigned to cardiac 
arrest in 3 other patients, although all were attributed to 
anaesthetic mismanagement. 
Complications of regional anaesthesia 
( 6 deaths, 4% A CD) 
This small group of cases illustrates the difficulties, already 
alluded to, inherent in anaesthetic monality epidemiological 
studies in the formulation of cogent classifications. In terms of 
mechanisms, all could have been classified in the previous 
section. However, I have chosen to class them as a separate 
group to highlight adverse consequences that do occasionally 
follow regional techniques, vii a vii, the more commonly used 
general anaesthesia. It is pertinent here only to list briefly the 
complications that led to the death of these patients. These 
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were: (1) inadvcncnt massive spinal anaesthesia following epi-
dural anaesthesia (2 cases - 1 caudal, I lumbar); (i1) profound 
intractable hypotension following epidural (2 cases) and spinal 
(1) anaesthesia - haemorrhage was the precipitating factor in 
1 patient; and (iii) vagal cardiac arrest complicating the per-
formance of retro-orbital block in a patient suffering very 
severe ischacmic bean disease. 
Miscellaneous (5 deaths, 3% ACD) 
Two patients suffered fatal subarachnoid haemorrhage when a 
rise in blood pressure after the administration of urovcn, 
administered to reduce brain bulk, caused rupture of intra-
cranial aneurysms. Use of this drug is now obsolete. 
Two patients died from acute anaphylaris due to admini-
stration of antibiotic during operation. 
One patient died after an incompatible blood transfusion 
because the anaesthetist failed to apply accepted identity 
checking procedures. 
Significant omissions 
During the three decades covered by this study, 3 new syn-
dromes (2 of which carry extremely high mortality rates), 
which result from exposure to anaesthetic agents, per se, have 
been described. These arc the syndromes of post-anaesthetic 
hepatitis, anaesthetic-induced ncphropathy and malignant 
hypcrthcrmia. 
All could once have been regarded as unavoidable in the 
sense that they were unpredictable and subject to no specific 
treatment. All have been the subject of intense interest and 
research and arc topics of literally thousands of scientific 
communications, yet the incidence of their appearance in 
anaesthetic mortality surveillance studies as causes of death 
seems to be the inverse of this interest. In common with all 
the studies listed in Table II in Pan I, with the exception of 
that of Lunn and Mushin, 6 none of these 3 conditions featured 
as a cause of any of the deaths in our study. 
Changes in aetiological pattern 
The gratifying 6-fold reduction in death attributable to anaes-
thesia was reponcd in pan I of this review. Of interest here is 
the observation that computation of the proportional distri:. 
bution of the general groups of causes of A CDs by the decade 
reveals this reduction in incidence to have been accompanied 
by a change in aetiblogical pattern. This involves a progressive 
increase in the proponion of deaths due to failures in the 
control of respiratory homeostasis accompanied by a reciprocal 
decrease in those due to failures in the control of circulatory 
homeostasis (Fig. 3). More detailed examination by a similar 
computation from the above of the proportional representation 
of subsets of the 4 most common clinical causes of death 
rcponcd, i.e. failures in the management of airway, ventilation, 
blood volume and arrhythmia (Fig. 4), shows clearly that it is 
the failures in airway management - of which the majority 
involved complications of endotracheal intubation - that arc 
responsible for the increased proportion of respiratory deaths. 
Although it may be argued that failures in airway manage-
ment arc the more easily identified, an explanation for this 
state of affairs may lie in the fact that whereas cndotrachcal 
intubation and mismanagement of the airway involves age-old 
physical skills, manual dexterity and a degree of informed 
clinical judgement, control of the circulatory homeostasis 
depends to a large extent on the clinician's intelligent inter-
pretation of, and prompt reaction to, information derived from 
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Fig. 3. Proportional distribution of cauHI of ACD by decade. 
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Fig. 4. Proportional distribution of the most common clinical 
management failures responsible for ACD, by decade. 
the vital function monitoring that has improved so in sophisti-
cation, acceptability and availability in recent years. Such 
reaction requires intellectual rather than manual skills. 
Conclusions 
Thiny years ago The Lancet stated in an editorial that: 'The 
most obvious risks of an operation arc those associated with 
anaesthesia. ' 7 The truth of this statement must now be seriously· 
questioned in the light of observations reponcd here, which 
evidence a decrease in the incidence of death attributable to 
anaesthesia to a level (0,07/1000 anaesthetics) which, having 
regard for the human frailty is perhaps at an irreducible 
minimum. Indeed, the safety of anaesthesia for the patient has 
increased to the point that '. . . the most insidious hazard of 
anaesthesia today is its relative safety',' for this carries the 
inherent risk of generating boredom and in consequence the 
danger of complacency and inattention on the pan of the 
anaesthetist. While the increasing rarity of death attributable 
to anaesthesia may lead one to question the continued value of 
conventional epidemiological studies such as this, in alerting 
the clinician to the above dangers they still serve a purpose. 
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They are of impon, too, in providing the means for 'in-house' 
audit, so necessary for the maintenance of our professional 
standards. However, the fact that 'death' is the criterion for 
entry into the study, limits its focus to the tip of the iceberg of 
anaesthetic clinical mismanagement and information on those 
many 'who have almost died'9 goes abcgging. Yet the causes of 
a near brush with death and of death itself, are no different. 
The funher improvement in the safety of anaesthesia for the 
patient requires that the process of hazard identification and 
prevention be refined by extension of surveillance studies 
antegrade, to the stages of 'morbidity' and 'critical incident' 
(see Fig. I, pan I). In the past the manpower and resource 
needs for monitoring these entities have been prohibitive, but 
with today's computer technology they have become feasible. 
Such refinement of the study would allow also of an evalu-
ation of the more subtle role perceived substandard anaes-
thetic management may play in the genesis of such post-
operative morbid conditions as myocardial infarction, adult 
respiratory distress syndrome, renal and hepatic failure, which 
may result in death. 
Our wider objective is the facilitation of funher improvement 
in the delivery and safety of surgical care. To achieve this, 
anaesthesia - an adjunct only to the whole - should ·no 
longer be viewed in isolation but holistically together with the 
surgeons, in the context of its environment, i.e. the patient's 
disease both specifically surgical and intercurrcnt, together 
with the implications and complications of the surgical pro-
cedure. Quality assurance of the management of all these 
phases jointly, in some manner similar to that pioneered b6 
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must surely lead to further and continued improvement in 
surgical outcome for the patient. 
I acknowledge with gratitude the willing co-operation of my 
many colleagues in the Department of Anaesthetics for providing 
the clinical information upon which this analysis is based. A very 
special word of thanks is due to Mrs Maureen Scholtz, Secretary 
of the Department of Anaesthetics, and her prcdcccssors for 
identifying the relevant cases and thereafter ensuring that the 
. appropriate documentation was obtained. 
This article is published with the permission of the Qlief 
Medical Superintendent of Groote Schuur Hospital, Dr J. Kane-
Berman. 
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'It is the hand that gives the Anaesthetic and the eye that watche
s its effects that matter 
more than the choice of agent, dosage and method.' [Keith Simpson, 1953) 
Anaesthesia per se does not correct deformity, restore health n
or stay death, 
but by making possible procedures which do accomplish these 
things it is an 
indispensable adjunct to the treatment of the surgical patient o
r any patient 
who needs to undergo, as part of the diagnosis and treatment o
f the malady, 
procedures which may be distressful or painful. Anaesthesia d
irectly affects 
the lives of an appreciable section of the population; every year o
ne in every 20 
to 25 people is required to undergo a procedure which necessit
ates his being 
anaesthetized. For each of the millions who submits to a genera
l anaesthetic, 
be it short or long, there is the realization-and in many case
s perhaps the 
fear-that for the duration of the procedure he is surrendering to
tal control of 
his consciousness and his physical well-being to the anaestheti
st. Therefore, 
above all else, anaesthesia must be safe-devoid of accident. 
A MEASURE OF SAFETY 
A precise measure of safety ( or its converse, the risk factor) of 
anaesthesia is 
difficult to establish. Safety means 'absence of danger' and, para
doxically, we 
measure it by establishing its reciprocal, the rate of death. Perh
aps the most 
fundamental index of the safety of anaesthesia is the incidenc
e with which 
factors, relevant to the administration of an anaesthetic, c
ause ( or are 
contributory in a major way to) the death of a patient. This i
n itself is not 
something that can be estimated with precision. In the case of dea
th associated 
with anaesthesia, autopsy is oflittle value in establishing the caus
e of death, let 
alone the manner in which it arose (Harrison, 1968a; Lunn 
and Mushin, 
1982). Essential to the direct assessment of a death associated wit
h anaesthesia 
is the account of the clinical conduct of the anaesthetic with rel
evant records 
of events and changes in vital physiological parameters. In j
udging these, 
consideration must be given not only to the ways in which the k
nown actions 
of anaesthetic drugs or errors and misjudgements in their admin
istration may 
have lethal sequelae but also to the ways in which errors of co
mmission or 
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omission in the wider field of responsibility, that has by practice
 become that 
of the anaesthetist, may cause death. Reversible depression of pa
in perception 
and creation of adequate conditions for surgery must be acc
ompanied by 
control and preservation of the patient's physiological homeo
stasis. While 
this is controlled all is well; when control fails all is lost. 
This control defines the ambit of the anaesthetist 's responsibility
. Published 
as long ago as 1916, Bellamy Gardiner's statement of t
he ambit of 
responsibility of the anaesthetist is still worth repeating. H
e wrote: 'the 
services of a practised administrator should relieve the op
erator of all 
responsibility with regard to the patient's general condition duri
ng operation. 
The anaesthetist therefore has in many instances to underta
ke duties of 
considerable gravity and should be thoroughly equipped 
not only by 
individual qualification but physically by possessing perfect se
nses of sight, 
hearing, keen scent and gentleness of touch. To his share fall the 
provision and 
accurate manipulation of the best drugs and apparatus for the a
dministration 
of the different vapours; the detection of symptoms and phy
sical signs of 
disease which will affect the subsequent anaesthesia; the c
hoice of the 
particular anaesthetic or sequence of anaesthetics most suitable
 to the patient 
and operation in hand; the protection of the body from extern
al harm; the 
regulation of atmospheric temperature; the resort to stimulants
 and methods 
of resuscitation in cases of failing vitality; the safe transference t
o bed and the 
supervision during recovery from insensibility.' (Bellamy Gard
iner, 1916). 
ACCIDENT, HUMAN ERROR AND PREVENT ABILITY 
Death occurring in association with anaesthesia and surgery is 
a function of 
three variables: the patient's pathology for which the operation
 is indicated; 
the surgical operation and its effects: and the conduct of the anae
sthetic. These 
three are inseparable. In judging and assessing the contributio
n to the final 
outcome of the conduct of the anaesthetic it must be borne in m
ind that not 
only the patient's pathology but also surgical errors themselv
es may have 
precipitated the circumstances which subsequently involved th
e conduct of 
the anaesthetic as a contributory cause-even a major one-o
f the patient's 
death. Beecher and Todd (1954) in their classical survey of dea
th associated 
with anaesthesia found that errors in surgical technique, as 
distinct from 
errors in surgical judgement and/or diagnosis, were three times 
as frequent as 
anaesthesia as a primary cause of death and five times as 
frequent as a 
contributory cause. 
Looked at broadly, those in the third category-deaths attributa
ble mainly 
to anaesthesia-are themselves a function of three variables: t
he skill of the 
anaesthetist; the agent used; and the environment of the anaest
hetic (i.e., the 
condition of the patient). Of these, the skill of the anaestheti
st is the most 
important. This skill is composed of many parts: training, releva
nt knowledge, 
experience and ability to deduce the correct inference fr
om a set of 
observations and to react to such inference decisively and expe
ditiously. 
As regards the agents used, the anaesthetist should have
 sufficient 





these so that any death that may result from so-called 'functional toxicity' 
(Bruce, 1980) becomes basically a death due to lack of skill. Clinical 
anaesthesia has been likened to an iatrogenic illness. It behoves the 'iatros' 
therefore to be well versed in the recognition and control of its signs and 
symptoms. Much the same may be said, though perhaps with less cogency, of 
the environment of the anaesthetic-the condition of the patient. Although 
this may respond to and be improved by skilful preoperative treatment, it may 
often be something over which the anaesthetist will have no final control. 
If the lack of skill on the part of the anaesthetist as the major factor in the 
causation of death attributable to anaesthesia is to be accepted, it follows that 
such deaths are preventable. To say this is not to attribute blame, the 
implication being that on review (albeit with the benefit of hindsight) a 
reasonably satisfactory expla.nation of the circumstances can be found and 
countermeasures that could prevent recurrence of the situation are practicable 
(Morton, l 958f 
What then of the 'accidents' of our alliterative title? Accident is defined as 
an event without apparent cause, a chance mishap, the unexpected. Such 
events do happen in clinical anaesthesia but must be regarded as uncommon. 
One of the many difficulties posed in the assessment of death associated with 
anaesthesia is the fact that advance in knowledge and accumulation of 
experience with time often renders what may be judged an anaesthetic 
accident today a preventable error tomorrow. Of these there are many 
examples but one of particular relevance would be the occurrence of 
postanaesthetic kidney failure. Whereas in the light of present knowledge the 
occurrence of this condition after the administration of enfturane may still be 
regarded as an accident (fortunately rare) the same event following adminis-
tration of methoxyflurane to a patient receiving contemporaneous medication 
with dilantin and phenobarbitone ( or any microsomal enzyme inducing drug) 
could no longer be so regarded. 
SOURCES OF ERROR OR ACCIDENT DURING 
INHALATION AN~IA 
If we consider a diagram (Figure 1) of the interactive pattern of the 
anaesthetist, his patient and apparatus, the sources of possible error or 
accident are apparent. Each interactive step in this diagram may be a point of 
failure, a source of error. 
Basic to correct action and reaction on the part of the anaesthetist is the 
availability of accurate information on vital physiological parameters. 
Electronic technology has made these readily available to the clinician. 
Euphemistically referred to in the past as an 'art', anaesthesia has now 
acquired the trappings of a science-the facilities for observation, measure-
ment, inference and reaction. It is no longer necessary, nor should it be 
permissible, to guess. In these circumstances the failure to use adequate 
monitoring when facilities are available should surely be regarded in the same 
light as the driving of a motor vehicle blindfolded (i.e., negligent). Neverthe-
less, it happens (Lunn and Mushin, 1982). 
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Figure I . Pattern of interaction of anaesthetist, patient and apparatus. Modified from Cooper et 
al (1978a). 
The second factor in the process of decision-making and reaction by the 
anaesthetist is clinical experience and relevant knowledge. These should be 
acquired in the vocational training process. Interpretative skills and appro-
priate reactions hopefully improve with experience. It is this aspect of clinical 
anaesthesia which is perhaps the most vulnerable to human error. Man is not a 
machine and there are many factors from day to day which affect his 
performance. 
A third essential factor in the anaesthetist/patient interaction is the 
anaesthetic machine and breathing circuit which can be thought of as 
interfacing with the patient at the endotracheal tube (or face mask). This 
system (Figure 2) embraces: all the components necessary for the storage, 
distribution and measurement of flow of respirable and anaesthetic gases; the 
means of accurate dispensing of anaesthetic vapour to the patient and the 
means of providing and measuring adequate pulmonary ventilation. This is 
the system most subject to technical failure and in which development and 
elaboration have multiplied the chances of accident through machine failure 
and operator error. 
It is not the intention here to review exhaustively the possible malfunctions 
in the system that may result in patient demise. These have been adequately 
reported (Dinnick, 1973; Dorsch and Dorsch, 1975; Feeley and Hedley-
Whyte, 1976; Ward, 1975; Wyant, 1978). Let it suffice here to remind the 
reader that there are at least 12 sites in the total system at which technical 
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Figure 2. Sites of potential technical failure and accident. 
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contaminated gas being delivered to the patient; excessive pressure in the 
breathing system; major leaks in the system; obstruction to the system; 
excessive concentration of anaesthetic vapour; excessive concentration of CO2 
and overheated humidification. The implication of this formidable, yet 
incomplete, list of hazards is clear. If technical failures are to be recogni7.Cd 
and their consequences averted the anaesthetist must not only fully under-
stand the function of the breathing and anaesthetic system he is about to use 
but must also personally check all his apparatus before he uses it (Ward, 1975; 
Dripps, Eckenhoff and Van Darn, 1977). 
HOW SAFE IS ANAESTHESIA? 
While it is to be admitted that there must be a considerable subjective element 
in the final assessment of the culpability of the three variables that bear on 
anaesthesia associated mortality-the patient's disease, surgery and conduct 
of anaesthesia-this type of review is the only means by which some measure 
of the safety of anaesthesia and an audit of the efficacy of our service to the 
patient is gained. However, the lack of uniformity in anaesthesia mortality 
surveillance studies, in classification and assessment criteria used (periopera-
tive period and type of surgery included) renders meaningless any but the very 
broadest statistical comparisons between studies (Harrison, 1968b; Goldstein 
and Keats, 1970). 
For this reason the recent publication of two studies of anaesthesia-asso-
ciated mortality of similar structure, which individually allow some between-
study comparisons over a number of years, is of interest. These are the studies 
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Table 1. Incidence of death attributable to anaesthesia 
Years studied ACD" 
(number of Incidence per 
Study anaesthetics) I 000 anaesthetics 
Sydney 
Clifton and Hotton, 1952-1962 0.17 
1963 (205 640) 
Bodlander, 1963-1972 0.o7 
1975 (211 130) 
Cape Town 
Harrison, 1956-1966 0.33 
1968b (177 928) 
Harrison, 1967-1976 0.22 
1978 (24 0483) 
Harrison 1977-1980 0.14 
unpublished (128 401) 
Studies included deaths occurring during or ~ 24 hours of 
anaesthetic or failure to regain consciousness. 
a ACD = Anaesthetic contributory death-anaesthesia 
sole or major contributory cause. 
of Bodlander (1975) from Sydney, Australia and Harrison (1978) from Cape 
Town, South Africa. Bodlander reviewed the anaesthetic-associated mortality 
at the Prince Alfred Hospital, Sydney, for ten years (1963 to 1972) as a 
follow-up to the study by Clifton and Hotten (1963) at the same hospital of the 
previous ten-year period (1952 to 1962). Harrison reviewed the anaesthetic 
associated mortality at Groote Schuur Hospital, Cape Town, for the ten years 
1967 to 1976 as a follow-up of his own review of the previous ten years at the 
same hospital (Harrison, 1968b ). For further comparison, as yet unpublished 
data from the Groote Schuur Hospital study for the subsequent four-year 
period (1977 to 1980) is also given (Table I). These studies estimated the 
incidence of deaths attributable solely to anaesthesia to range from 0.07 to 
0.22 deaths per 1000 anaesthetics. Not only is the computed rate low but 
encouragingly there is evidence from between-study comparisons that it has 
also fallen with time. 
Four other recently published surveys support a similar conclusion (Table 
2). In a class of its own, not least for size and breadth of coverage, is the 
comprehensive study in England by Lunn and Mushin (1982) sponsored by 
the Association of Anaesthetists of Great Britain and Ireland (AAGBI). 
Deriving from a background surgical population of 1.1 million, this is the 
largest study of anaesthetic-associated mortality ever reported other than that 
by Kok and Mullan (1969) in South Africa which covered 1.7 million 
anaesthetics. The other studies are those in Finland (Hovi-Viander, 1980), 
Canada (Turnbull, Fancourt-Smith and Banting, 1980) and Australia 
1.8 
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Table 2. Jncidence of death attributable to anaesthesia 
Years studied Pcriopcrativc ACD" 
(number of period Incidence per 
Study anaesthetics) included I 000 anaesthetics 
Great Britain 
Lunn and Mushin, 1979-1980 <6 days 0.1 
1982 () 147 362) 
Finland 
Hovi-Viander, 1975 <3 days 0.2 
1980 (338 934) 
Canada 
Turnbull, Fancourt-Smith 197l-1977 <2 days 0.18 
and Banting, 1980 (195 232) 
Australia 
Adelaide Committee, 1969-1974 <I day 0.08 
1976 · (465 000) 
0 ACD = Anaesthetic contributory death-anaesthesia sole or major contribu-
tory cause. 
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(Adelaide Committee, 1976). The incidence of deaths attributable to anaes-
thesia computed from these studies matches that reported by Bodlander and 
Harrison, ranging from 0.08 to 0.2 deaths per 1000 anaesthetics. 
One implication of this sort of rate (one to two deaths attrir.u table ti) 
anaesthesia per IO 000 anaesthetics) is that the average anaesthetis t w~u!d be 
expected to encounter only one such death every fiv.e to tt:n years of his 
working life. In terms of human frailty it may be wondered whether it ts 
possible for this rate to be further reduced. On the other hand, although this 
rate of anaesthetic-contributory death may be considered not only acceptably 
low but also perhaps at an irreducible minimum, it also means that every year 
in a country the size of the United States something of the order of 2000 
patients die because they are anaesthetized (Epstein, 1978). Looked at in this 
light, death attributable solely to anaesthesia and anaesthetic accidents must 
continue to be a matter of concern. 
As anaesthesia is an adjunct to the total care of the surgical patient, a 
relevant context in which to consider deaths attributable to anaesthesia would 
be the total background surgical mortality (i.e. , the operative and postopera-
tive hospital stay mortality). Although not presented in most anaesthesia 
mortality surveillance studies, such data is recorded in the studies from 
Groote Schuur Hospital (Harrison, 1968b; 1978). From 1956 to the present, 
anaesthesia and its mismanagement has been held responsible for 2. 7 reducing 
to 2.0 percent of total surgical mortality. Lunn and Mushin (1982) included in 
their study in Great Britain data and deaths up to six days postoperatively. In 
this study anaesthesia and its mismanagement were considered responsible for 
1.5 per cent of the total surgical mortality and contributory in some way to 
almost one in 20 (4.5 per cent). 
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PAITERNS OF ANAESTHETIC MORTALITY 
The most beneficial spin-off of anaesthetic mortality surveillance studies is 
that they serve to identify patterns of anaesthetic mortality and so provide the 
clinical lessons from which we may improve our practice. The lack of 
comparability between published mortality studies which frustrates attempts 
at establishing, except in very broad terms, a rate of death attributable to 
anaesthesia applies with equal, if not greater. force to attempts to evaluate 
common patterns of anaesthetic related deaths, their clinical environment and 
the risk situations that engender them. 
To illustrate the immense variability that exists in the literature in 
classification of causes of anaesthetic-related deaths, two examples must 
suffice. As a first example, consider this actual case report. 
The patient was an obese female aged 52 years who presented at hospital after 20 hours of 
symptoms with bowel obstruction following incarceration of colon in a paraumbilical hernia. 
Rehydration and electrolyte correction was undenaken and the patient presented for anaesthesia 
after replacement of three litres offluid. Other than for her surgical disease, abdominal distention 
and obesity, the patient was considered generally fit. Following preoxygenation. anaesthesia was 
induced with thiopentone, paralysis obtained with succinylcholine and endotracheal intubation 
performed while cricoid pressure was applied. No regurgitation of gastric content or tracheal 
soiling was observed. Anaesthesia was maintained with an IPPV technique using N20 and 02 
with 0.5 to 1 per cent halothane together with alloferin for muscular relaxation. The ECG and 
blood pressure were monitored but not central venous pressure. Surgery took three hours during 
which the anaesthetist transfused a funher 3.5 litres of balanced salt solution. Anaesthesia was 
otherwise untoward other than that the anaesthetist noticed some decrease in pulmonary 
compliance as surgery progressed. At the conclusion of surgery, neuromuscular blockade was 
reversed with neostigmine and atropine, the patient was allowed to breathe spontaneously and 
extubated. Subsequently, when the patient was waking, some difficulty with respiration appeared 
and the colour of the patient became slightly dusky. The anaesthetist contented himself with 
giving additional neostigmine and sent the patient, breathing spontaneously with a 40 per cent 02 
entrainment mask. to the recovery ward. Shonly thereafter the anaesthetist was called into the 
recovery ward to find the patient in grave respiratory distress, cyanosed and sweating, her pulse 
bounding. While he attempted reintubation of the patient, cardiac arrest followed a brief period 
of extreme bradycardia. Subsequent attempts at CPR failed. Autopsy revealed firm stiff lungs 
with interstitial oedema and some frothy bronchial and tracheal fluid. 
While many would find little difficulty in deciding that sufficient preventable 
errors of management were evident to attribute the patient's death largely to 
mismanagement of the anaesthetic, the cause of death might well be classified 
by different authors as one of: 
I. post relaxant respiratory inadequacy; 
2. inadequate ventilation-hypoxia from abdominal distention and obesity; 
3. premature extubation; 
4. covert regurgitation and inhalation of fluid gastric content; 
5. inadequate monitoring-no central venous pressure; 
6. inadequate postoperative care; 
7. pulmonary oedema; 
8. overhydration; 
9. cardiac arrest: 
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PATTERNS OF ANAESTHETIC MORTALITY 
The most beneficial spin-off of anaesthetic mortality surveillance stu
dies is 
that they serve to identify patterns of anaesthetic mortality and so prov
ide the 
clinical lessons from which we may improve our practice. The 
lack of 
comparability between published mortality studies which frustrates at
tempts 
at establishing, except in very broad terms, a rate of death attribut
able to 
anaesthesia applies with equal, if not greater. force to attempts to e
valuate 
common patterns of anaesthetic related deaths, their clinical environm
ent and 
the risk situations that engender them. 
To illustrate the immense variability that exists in the literatur
e in 
classification of causes of anaesthetic-related deaths, two example
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The patient was an obese female aged 52 years who presented at ho
spital after 20 hours of 
symptoms with bowel obstruction following incarceration of colon i
n a paraumbilical hernia. 
Rehydration and electrolyte correction was undenaken and the patient
 presented for anaesthesia 
after replacement of three litres offluid . Other than for her surgical disease. abdo
minal distention 
and obesity. the patient was considered generally fit. Following preoxy
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induced with thiopentone, paralysis obtained with succinylcholine and
 endotracheal intubation 
performed while cricoid pressure was applied. No regurgitation of g
astric content or tracheal 
soiling was observed. Anaesthesia was maintained with an IPPV tech
nique using N20 and 0 2 
with 0.5 to I per cent halothane together with alloferin for muscular r
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blood pressure were monitored but not central venous pressure. Surger
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with respiration appeared 
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st followed a brief period 
of extreme bradycardia. Subsequent attempts at CPR failed. Autops
y revealed firm stiff lungs 
with interstitial oedema and some frothy bronchial and tracheal fluid
. 
While many would find little difficulty in deciding that sufficient prev
entable 
errors of management were evident to attribute the patient's death lar
gely to 
mismanagement of the anaesthetic, the cause of death might well be cl
assified 
by different authors as one of: 
I. post relaxant respiratory inadequacy; 
2. inadequate ventilation-hypoxia from abdominal distention and ob
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3. premature extubation; 
4. covert regurgitation and inhalation of fluid gastric content; 
5. inadequate monitoring-no central venous pressure; 
6. inadequate postoperative care: 
7. pulmonary oedema; 
8. overhydration: 





11 . cardiac failure . 
As a second example, let us consider the circumstance during an anaesthetic 
when respiratory obstruction develops suddenly because herniation of the 
endotracheal tube cuff totally obstructs its outlet. Death ensues from hypoxic 
cardiac arrest before the anaesthetist diagnoses the situation. In various 
surveys such has appeared under the following categories: technical failure; 
respiratory obstruction; complications of intubation; and cardiac arrest. 
Reporting the findings of the New South Wales Special Committee for 
investigation of death under anaesthesia, Holland ( 1970) noted an average of 
4.3 errors per anaesthetic contributory death. Yet when classified for study 
and publication, most authors will record cases under a single diagnosis or 
error only. In spite of these difficulties, certain common patterns of 
anaesthetic mortality and the risk situations from which they were engendered 
can be discerned in data presented in the mortality surveys quoted, as well as 
others. 
Useful for this purpose, as again some between-study comparison is 
possible, is the AAGBI study in which Dinnick (1964) reviewed 600 
anaesthetic-associated deaths. This report was a follow-up of the original I 000 
case study, published 8 years previously (Edwards et al, 1956). A slightly 
different facet of the problem was shown by Utting, Gray and Shelley (1979) in 
their analysis of anaesthetic mortality patterns operative in cases reported to 
the Medical Defence Union in the United Kingdom (i.e., cases that were the 
subject of litigation or official enquiry). 
A drawback manifest in all these studies is death being the criterion for case 
entry into the study; an endpoint is studied and little information is derived on 
the risk or hazard situation that preceded the crisis. Additionally, only the tip 
of the iceberg of clinical mismanagement is revealed. If these have died; what 
of those who nearly died? Complementary to the more conventional studies of 
death attributable to anaesthesia are two recent reports of what one might call 
the prodrome of anaesthetic-induced fatalities. Cooper et al ( 1978b) and Craig 
and Wilson (1981) analysed information submitted voluntarily by anaesthe-
tists on 'critical incidents' occurring during clinical anaesthesia of which few, 
if any, led to the death of the patient but all of which, uncorrected, had the 
potential so to do. Cooper et al took note of incidents that: 
1. involved a recognizable error by the anaesthetist or a failure of anaesthetic 
equipment; 
2. occurred at a time when the patient was under the care of an anaesthetist; 
3. could be described in clear detail by the person who either observed or was 
involved in the incident; 
4. were clearly preventable. 
These studies-the retrospective, as we may regard mortality studies, and the 
prospective, the 'critical incident' analysis-complement each other well, each 
highlighting a different aspect of the problem of anaesthetic accidents. In spite 
of tremendous variability in the presentation of data certain broad areas and 
1.8 
424 GAISFORD G . HARRISON 
clinical circumstances can be delineated which seem to constitute the major 
hazard or accident situations. 
The endotracheal tube 
Common to both mortality studies and 'critical incident' analyses are 
problems at the anaesthetic equipment/patient interface-the endotracheal 
tube (Figure I). Complications related to placement, misplacement or failure 
to place an endotracheal tube, obstructions due to kinking, cuff hemation, 
dislodgements and disconnections, feature as a very frequent (in many studies 
the most frequent) cause of death and, indeed, critical incident. A technique, 
peculiarly the stock-in-trade of the anaesthetist, has become his unconscious 
patient's Achilles' heel. The persistent reappearance of the endotracheal tube 
hazard in mortality studies must indicate where the major accent in 'education 
for safe practice' must fall (Dripps, Eckenhoff and Van Dam, 1977). 
Relaxants 
The other stock-in-trade of today's anaesthetist, the neuromuscular blocking 
agent, is still held responsible for many deaths attributable to anaesthesia. 
These deaths feature as post relaxant respiratory inadequacy, recurization, 
respiratory insufficiency or inadequate postoperative care. Considering the 
now standard provision of postanaesthesia recovery facilities, not to mention 
intensive care units with the concomitant availability of expertise in prolonged 
ventilation, it is hard to understand why this should still be. This recalls the 
study of Beecher and Todd (1954). In many cases the patient suffers from 
chronic obstructive airway disease and the anaesthetist, who is inexperienced 
and feels that putting the patient 'on a ventilator' postoperatively is a 
confession of failure, persists hopefully in permitting the patient to breathe 
spontaneously to the ultimate detriment of the patient. The lesson is 
obvious-when in doubt 'ventilate'. 
Inadequate postoperative supervision 
That 'inadequate postoperative supervision' is still held accountable for many 
anaesthetic related deaths surely needs little comment. While the provision of 
high intensity nursing care recovery areas within operating room precincts 
with ready access for the anaesthesiologist has now become standard in 
hospital design, the safety of the patient is still entirely dependent upon the 
quality of nursing care and vigilance. 
Vomiting and regurgitation-the full stomach 
The full stomach with its consequent risk of vomiting, regurgitation and 
aspiration has Jong been recognized as posing an extremely hazardous 
situation, especially in anaest~esia for obstetrical surgical procedures. It is 
gratifying to note that, in contrast to so many other causes of death 
attributable to anaesthesia, some recent mortality surveys show a decreased 
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incidence due to this cause (Dinnick, 1964; Harrison, 1978). While this may be 
due to increased awareness of the problem, better training and improved 
techniques, some would attribute it to the increased use of epidural 
anaesthesia and other regional techniques in obstetrics (Bodlander, 1975). 
Circulatory homeostasis 
In the management of the patient's circulatory homeostasis, not the least 
problematical variables for the anaesthetist are the patient's coincidental 
cardiac disease and abnormal circulatory status (i.e., the manner in which 
these conditions affect the reaction to anaesthetic drugs and the conditions 
imposed by surgery). Most important in this regard is ischaemic heart disease. 
Lunn and Mushin's study (I 982) revealed that this was regarded as significant 
in 39 per cent of patients submitted to autopsy. It is not pertinent to detail here 
the many and varied mechanisms and combinations of circumstances by 
which anaesthetic-related factors might precipitate cardiac arrest and possibly 
death, but it is relevant to draw attention to the most common general 
circumstance or hazard situation associated with cardiovascular deaths 
attributable to anaesthesia. This is the state of preanaesthetic hypovolaemia 
which is often covert. Presenting often as profound postinduction hypoten-
sion (a lethal circumstance in the presence of grave ischaemic heart disease) it 
may be listed as 'drug-induced cardiac arrest' for the simple reason that it is so 
often directly associated with the administration of thiopentone. The 
situation may also be regarded as 'inadequate preparation for surgery' 
(Holland, 1970). Under whatever guise this general situation of preanaesthetic 
hypovolaemia presents, it is prominent in all recent mortality surveys as the 
situation with the highest anaesthetic accident potential. Less common, but 
not infrequently featured, is the reverse situation in which liberal fluid 
replacement, unmonitored by central venous pressure measurement, results in 
over-hydration which is manifested as pulmonary oedema with the re-estab-
lishment of spontaneous respiration on termination of anaesthesia. Bearing in 
mind the virtual universality of cardiopulmonary bypass surgery and the 
attendant growth in expertise in circulatory control, a diminution in this risk 
factor would be expected. 
Apparatus/technical failure 
Considering the number of possible sources of hazard and accident in the 
system concerned with the supply of 0 2 and inhalational anaesthetic to the 
patient (see Figure 2) it is perhaps not surprising that in their 'critical incident' 
analyses both Cooper et al (1978b) and Craig and Wilson (1981) reported 
equipment failure and technical mishap as the major threat to the patient's 
safety. The most common failure was the 'disconnect' . The 'slip-on' becomes 
the ·slip-off' easily. When the multiplicity of connections that has evolved in 
the breathing circuit of today's anaesthetic machine is considered (many of 
them being unnecessary), it is obvious that systematic redesign is needed 
(Cooper et al, I 978a). Redesign and incorporation of safety devices can help in 
reducing the hazard, as evidenced by Cooper's (1978b) report; in 4 out of9 
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incidents of failure of 02 supply in which the anaesthetic machine was 
equipped with a pressure fail-safe system, this was known to have been 
activated before the absence of 0 2 flow was noticed by the anaesthetist. Surely 
the time has come when the incorporation of such a fail-safe pressure alarm 
device, together with an 0 2 analyser with low-limit alarm in the patient 
breathing circuit. should be mandatory in anaesthetic machine design (Mazze, 
1972). 
In spite of the above, it is somewhat surprising that equipment and technical 
failures feature so rarely as causes of death in mortality surveillance studies 
(Dinnick, 1973). Of the recently published surveys, only in the British Medical 
Defence Union cases do equipment and technical failures feature prominently 
(Utting, Gray and Shelley, 1979). That the cases submitted to the Medical 
Defence Union were basically the subject of an official enquiry or litigation 
may well have biased their selection. 
Factors affecting performance 
While the title of this chapter is 'Anaesthetic Accidents', the stress has been 
that, on the whole, deaths attributable to anaesthesia do not result from 
accident but from human error. Cooper et al (1978b) and Craig and Wilson 
( 1981 ) have produced information on an important aspect of these errors that 
has been completely lacking in previous conventional mortality studies. This 
concerns their specific enquiry into the factors associated with the error 
situation. Hurry, inattention, carelessness and fatigue were high up on their 
lists. All of these could doubtless lead to the failure to perform normal checks 
and failure to assess the situation preoperatively which were also listed. 
'Inadequate total experience' and 'inadequate familiarity with equipment, 
technique or surgical procedure', which also rated high in the study by Cooper 
et al must carry an admonition for the chairmen of departments and their 
academic programme directors. 
THE REAL ACCIDENTS 
The preoccupation with human error and frailty in the causation of 
anaesthetic related death and mortality should not detract from the fact that, 
over the last two decades, three new syndromes of mortality and morbidity 
that may follow exposure of a patient to inhalation anaesthetics have become 
apparent (i.e., anaesthetic-induced hepatitis, nephropathy and malignant 
hypertherrnia). All of these may be regarded as anaesthetic accidents in that 
they are unpredictable and to a large extent unavoidable and must be treated 
simply on their merits when they arise. These three syndromes have been the 
subject of major anaesthetic research for the last 20 years and indeed two are 
the subject of chapters in this Issue. From these, especially the latter two, 
much of the mystery has now been removed. Yet in spite of all the attention 
paid to these syndromes in the literature they find scant mention in mortality 
surveillance studies. Halothane hepatic failure features only in the Medical 
Defence Union case studies, being held responsible for 3.4 per cent of deaths. 
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Malignant hyperthennia, also reported in this study, is reported in only one 
other, that of Lunn and Mushin (1982), in which three out of 58 deaths are 
attributed to it. 
SUMMARY 
Safe, accident-free anaesthesia is a prerequisite for the application of surgical 
treatment. While it is conceded that accidents do occur in clinical anaesthesia, 
it is arguable that deaths, when attributable to anaesthesia. are usually the 
result of error or lack of skill on the part of the anaesthetist and, as such, are 
basically preventable. 
The sources of accident and error during inhalation anaesthesia are 
examined in terms of the pattern of interaction between anaesthetist, patient 
and apparatus. The latter subset of the system which includes the means of 
storage, distribution and measurement of flow of respirable and anaesthetic 
gases and vapours to the patient, together with the means of providing 
pulmonary ventilation, are highlighted for the number of sites of potential 
technical failure and accident they embrace. 
An answer to the question 'How safe is anaesthesia today?' is sought in a 
brief review of the most recent surveillance studies of anaesthesia associated 
mortality. While differences between studies in structure, case inclusion, 
classification and assessment criteria render invalid any but the very broadest 
comparisons and inferences, evidence from these studies seems to suggest that, 
associated with surgery. there is an incidence of death attributable to 
anaesthesia of between 0.07 to 0.2 per 1000 anaesthetics. This represents a 
primary anaesthetic responsibility for approximately 2 per cent of total 
surgical operative mortality. Examination of the patterns of anaesthetic 
mortality in the studies reviewed reveals much agreement in the identification 
of the commoner accident and risk situations. These are: 
I . complications of endotracheal intubation; 
2. relaxant related postoperative problems; 
3. inadequate postoperative supervision; 
4. the full stomach; 
5. failure to secure circulatory homeostasis; 
6. apparatus and technical accident/failure which is the commonest cause of 
'critical incident' but which seldom causes death; 
7. hurry, inattentiveness, carelessness and fatigue, which are the factors that 
most commonly adversely affect the anaesthetist's performance. 
In short the causes of death attributable to anaesthesia have changed little 
with time. They are basically simple and follow failure to observe elementary 
precautions together with a lack of clinical alertness. 
CONCLUSIONS 
Some evidence that the safety of anaesthesia for patients has increased is 
presented . The actual frequency of death attributable to anaesthesia seems in 
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many places, to have decreased to a level which, having regard for human 
frailty, is perhaps at an irreducible minimum. Indeed the diversity of modem 
surgery itself bears witness to the relative safety of contemporary anaesthetic 
practice. In spite of this, it is sad to reflect that the actual numbers of patients 
who die every year because they were anaesthetized is appreciable. Generally, 
the basic causes have not changed but simply recur. The causes of these deaths 
are mostly simple and usually follow the lack of observation of simple 
precautions and lack of clinical alertness. Because of this, in writing of 
anaesthetic safety one finds oneself uttering repeated trite aphorisms, so trite 
indeed that they are ignored and forgotten until too late. To quote Thompson 
(1981) 'The road to anaesthetic safety is paved with pious platitudes!' 
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G. G. Harrison 
Ji1a. l The outcomes of 
anaesthesia. 
DEATH ATTRIBUTABLE TO 
ANAESTHESIA: ITS 
INCIDENCE AND THE 
COMMONER CAUSES 
'Anaesthesia is a Iatrogenic Illness' (Bruce, 1980). 
The commonest outcome of anaesthesia-the achievement 
of the treatment goal-is a course without complication, per-
mitting surgery, followed by rapid recovery of the patient to the 
pre-anaesthetic state (see Fig. 1). 







Adverse outcome is less common. At worst, some compli-
cation of anaesthesia and/or the accompanying surgery-a 
critical incident-will not have been recognized, recognized 
too late and/or treated inappropriately, resulting in the 
patient's death. As will be discussed, this extreme is fortunately 
rare . 
More commonly, detection, recognition and correct 
management of the complication/critical incident will result in 
re-establishment of control of the patient's physiological 
homeostasis and thereafter the recovery of the patient. Such 
recovery may be in the normal anaesthetic time-course or may 
be delayed by the development of a morbid process consequent 
15 
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on the original complication or critical incident. Usually. the 
patient will recover from this completely, but the delayed 
time-course and increased hospital stay with added consump-
tion of resources imply some failure in goal achievement. 
The final outcome may become less favourable in that the 
patient. though he or she survives. suffers chronic loss of 
function of some major organ such as the brain. lung, liver or 
kidney as a result of the initial critical incident or subsequent 
morbid process. Finally, the morbid process itself may end in 
the death of the patient. 
Prevention of adverse outcome and anaesthesia practice 
audit require evaluation of the role of anaesthesia in each of 
these circumstances-mortality. morbidity and critical 
incident. 
While certain centres are now developing methods of 
data acquisition for the assessment of morbidity and critical 
incident (Cooper et al, 1978a; Flood, 1980), monitoring of 
these entities requires resources beyond the means of many 
anaesthetic services, and therefore only the extreme end-point 
of the adverse outcome process-anaesthesia-associated 
mortality-has been the subject of most surveillance studies to 
date. A drawback that manifests itself in studies of anaesthetic-
associated mortality is that, death being the criterion of entry 
into the study, an end-point is studied; insufficient information 
may be derived on the risk or hazard situation which preceded 
or engendered the crisis. In addition, the event studied is but 
the tip of the iceberg of clinical malpractice. 'The tolerance of 
the human body for abuse is phenomenal and if a few patients 
die every year, consider how.many more have been subjected 
to abusive practices. How many have almost died?' (Davis, 
1957). 
Anaesthesia-associated mortality surveillance studies 
should: 
• identify deaths to which anaesthesia mismanagement or 
untoward reaction is considered to have been contributory 
in a material measure 
• identify. with a view to future prevention, points of break-
down in the anaesthetist 's control of the patient's physio-
logical homeostasis and their cause 
• include surveillance of an adequate time-span post-anaes-
thetic to permit detection of any morbid process induced by 
mismanagement of anaesthetic drugs or by inefficient tech-
nique 
• include acquisition of background population data to allow 
for the rating of phenomena and the use of surveillance 
studies a.s a measure of the safety ( or conversely the risk) of 
anaesthesia or as a practice audit to monitor maintenance of 
professional standards. 
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Fig. 2 Variables inherently 
inseparable from deaths 
associated with anaesthesia. 
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ANAESTHETIC CONTRIBUTORY DEATH 
Identification 
All surveillance studies of anaesthetic-associated mortality are 
bedevilled by difficulties inherent in the assessment of the 
responsibility of anaesthetic drugs or techniques for adverse 
outcome. These difficulties arise because anaesthesia is insep-
arable from: 
• the patient's pathology, both surgical and incidental 
• the surgical operation and its effects including surgical 
complications which may subsequently involve the conduct 
of the anaesthetic as a contributory cause of the patient's 
















In circumstances in which the relation of the anaesthetic to 
the patient's pathology and the surgical operation does not 
provide sufficient explanation for the adverse outcome and the 
conduct of anaesthesia in question, we are faced primarily with 
an assessment of the difficult-to-define quality of skill of the 
anaesthetist. This skill is composed of many parts: training. 
relevant knowledge, experience and the ability to make correct 
deductions from a set of observations and to react decisively 
and timely to the deduction. 
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As regards the agents used. the anaesthetist should have 
sufficient knowledge of these, of their actions, side-effects and 
methods of counteracting these that any death which may 
result from so-called 'functional toxicity' (Bruce, 1980) must be 
judged a death basically due to lack of skill. Much the same 
may be said, though perhaps with less cogency, of the 
environment of the anaesthetic-the condition of the patient. 
· Although this may respond to and be improved by skilful 
preoperative treatment, it may be something over which the 
anaesthetist will often have no final control. 
Preventability 
If it is accepted that lack of skill on the part of the anaesthetist is 
the major cause of death attributable to anaesthesia, it follows 
that such deaths are preventable. To say this is not to attribute 
blame; the implication is simply that on review (albeit with the 
benefit of hindsight) a reasonably satisfactory explanation of 
the circumstances can be found and countermeasures that 
could prevent recurrence of the situation are practicable 
(Morton, 1958). 
The unavoidable 
Not all deaths attributable to anaesthesia are preventable. 
There will always be those which involve mechanisms not 
adequately understood, covert phannacogenetic states or 
perhaps unforscen technical or apparatus failure over which 
the anaesthetist has no control. A difficulty here is that, with 
advance in knowledge and accumulation of experience, 
complications that may be judged unavoidable today come to 
be regarded as due to preventable error tomorrow, e.g. the 
death from fulminant liver failure following anaesthesia with 
fturoxene of a patient on microsomal enzyme inducing 
medication or renal failure following methoxyfturane admin-
istration. 
HOW SAFE IS ANAESTHESIA? 
While it is to be admitted that there must be a considerable 
subjective element in the final assessment of the culpability of 
the three variables that bear on anaesthesia-associated mor-
tality-the patient's disease, surgery and conduct of anaes-
thesia-this type of review is the only means by which some 
measure of the safety of anaesthesia and an audit of the efficacy 
of our service to the patient is gained. Sadly, any but the very 
broadest of statistical comparisons between studies is rendered 
meaningless by the la_ck of uniformity in the classification and 
1.9 
Table 1 Incidence of death 
attributable to anaesthesia 
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assessment criteria used and perioperative period and type of 
surgery included in anaesthesia mortality surveillance studies 
published to date (Harrison. 1968: Goldstein & Keats. 1970). 
It is to be hoped that in the future greater uniformity and 
compatibility between studies will emerge following the work 
of the 1984 Royal Society of Medi.cine Foundation/Harvard 
University Symposium on 'Preventable Anaesthesia Mortality 
and Morbidity' which sought to construct a universal thesaurus 
of definitions and classifications for anaesthetic-associated 
mortality and morbidity. 
Because of the many difficulties involved, relatively few 
epidemiological studies of anaesthetic-associated mortality of 
any magnitude have been published during the last four 
decades and the relevance of any but those of the last decade is 
seriously called into question by the constantly changing 
patterns of practice in response to continued technological 
advance. 
Two recently published studies of anaesthetic-associated 
mortality of similar structure and which individually do allow 
some comparisons within and between studies over a number 
of years are of interest. These are the studies of Bodlander 
(1975) and Harrison (1978). Bodlander reviewed the anaes-
thetic-associated mortality at the Prince Alfred Hospital, 
Sydney for 10 years (1963-1972) as a follow-up to the study by 
Clifton & Hotten (1963) of the previous 10-year period (1952-
1962) at the same hospital. Harrison reviewed the anaesthetic-
associated mortality at Groote Schuur Hospital, Cape Town 
for the 10 years from 1967-1976 as a follow-up of his own 
reivew of the previous 10 years at the same hospital (Harrison, 
1968). For further comparison, as yet unpublished data from 
Place Years studied *ACD 
Author and incidence per 
Year of publication No. of anaesthetics 1000 anaesthetics 
Svdnev 
Clifto~ & Hotton 1952-62 0.17 
(1963) 205640 
Bod lander 1963-72 0.o7 
( 1975) 211130 
Cape Town 
Harrison 1956-66 0.33 
( 1968) 177928 
Harrison 1967-76 0.22 
(1978) 240483 
Harrison 1977-82 0.12 
(unpublished) 195164 
Studies included deaths occurring during or within 24 hours of 
anaesthetic or failure to regain consciousness 
• ACD = Anaesthetic contributory death 
Anaesthesia sole or major contributory cause 
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the Groote Schuur Hospital study for the subsequent 6-year 
period (1977-1982) is also given (Table 1). 
These studies estimated the incidence of death attributable 
solely to anaesthesia to range from 0.07 to 0.22 deaths per 1000 
anaesthetics. Not only is the computed rate low but, encourag-
ingly, there is evidence from comparison between and within 
studies that this rate has fallen with time. 
Four other recently published studies, although they lack the 
uniformity of criteria and classification of the former two. 
support a similar conclusion (Table 2) . Table 2 Incidence of death 
attributable to anaesthesia. 
Place Years studied •ACD Perioperative 
Author and incidence per period 
Year of publication No. of anaesthetics 1000 anaesthetics included 
Great Britain 
Lunn & Mushin 1979-80 0.1 ~ 6days (1982) 1147362 
Finland 
Hovi-Viander 1975 0.2 ~ 3days (1980) 338934 
Canada 
Turnbull et al. 1973-77 0.18 ~ 2days (1980) 195232 
Australia 
Anaesthetic Mortality 
Committee 1969-74 0.08 ~ 1 day (1976) 465000 
• ACD = Anaesthetic contributory death 
anaesthesia sole or major contributory cause 
In a class of its own, not least for size and breadth of cover-
age. is the comprehensive study in England by Lunn & Mushin 
( 1982) sponsored by the Association of Anaesthetists of Great 
Britain and Ireland. Deriving from a background surgical 
population of 1.1 million, this is the largest study of anaes-
thetic-associated mortality ever reported other than that by 
Kok & Mullan (1969) in South Africa which covered 1.7 
million anaesthetics. The other studies are those of the Anac:s-
thetic Mortality Committee (1976) in Australia, Hovi-Viander 
(1980) in Finland and Turnbull et al (1980) in Canada. The 
incidence of death attributable to anaesthesia computed from 
these studies matches that reported by Bodlander (1975) and 
Harrison (1978) (Table 1), ranging from 0.08 to 0.2 deaths per 
1000 anaesthetics. 
It must be remembered that these estimates of the incidence 
of death attributable to anaesthesia were computed in main-
stream first world hospitals. How well they represent the 
situation in the vast rural practice of medicine in those 
countries let alone the circumstances in third world countries is 
completely unknown. A priori, it is probable that the rates 
1.9 
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computed represent what must be the minimum of the global 
range . 
Some implications 
One implication of such a rate (1-2 deaths attributable to 
anaesthesia per 10 000 anaesthetics) is that the average anaes-
thetist would be expected to encounter only one such death 
every 5-10 years of his working life. In terms of human frailty . 
it may be wondered whether it is possible for such a rate to be 
further reduced. On the other hand, although the rate of 
anaesthetic contributory death may be considered not only 
acceptably low but perhaps at an irreducible minimum, it 
means also that every year, in a country the size ofthe 1United 
States, something of the order of2000 patients die because they 
are anaesthetized (Epstein, 1978). (One in every 20-25 
· persons in a population is submitted to anaesthesia every year). 
Looked at in this light, death attributable solely to anaesthesia 
and anaesthetic misadventure must continue to be a matter of 
concern. 
A further implication to be considered is the anaesthetic 
contribution to surgical mortality. As anaesthesia is an adjunct 
to the total care of the surgical patient, a relevant context in 
which to consider deaths attributable to anaesthesia is the total 
background surgical mortality i.e. the operative and post-
operative hospital stay mortality. Although not presented in 
most anaesthesia mortality surveillance studies, such data are 
recorded in the studies from Groote Schuur Hospital 
(Harrison, 1968, 1978). From 1956 to the present, anaesthesia 
and its mismanagement was held responsible for 2. 9 reducing 
to 1.8% of total surgical mortality. Lunn & Mushin (1982) in 
their study in Great Britain included data and deaths up to 6 
days postoperatively. In this study, anaesthesia and its mis-
management were considered responsible for 1.5 per cent of 
the total surgical mortality and contributory in some way to 
almost one in 20 (4.5% ). 
Prediction of risk 
It must be remembered that, while these studies audit how one 
has performed, as a predictive measure of risk they are of little 
use. In this regard one can do no better than to quote Goldstein 
& Keats (1970) that-'The poor predictability of anaesthetic 
mortality should be expected since a significant portion of this 
mortality is due to human error which cannot be predicted and 
to other factors which have qever been quantified. To a small 
degree, physical status and the operation contemplated 
provide some predictive basis. To a large degree unknown 
factors related to the skill of the personnel and the environment 
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of the therapy contribute to anaesthetic risk. Estimates of 
anaesthetic risk for individual patients remain therefore almost 
entirely intuitive and one cannot deny an anaesthetic to any 
patient who requires operation' . 
POINTS OF BREAKDOWN-
IDENTIFICATION AND PREVENTION 
Having identified the deaths attributable to anaesthesia it is 
necessary to establish the point of breakdown in the anaesthe-
tist's control of the patient's physiological homeostasis and its 
pathogenesis and thereafter to assess the aspect of prevent-
ability. In this way patterns of anaesthetic mortality and the 
hazard situations that spawn them come to be recognized. 
Death as a complication of anaesthesia follows functional 
failure of the respiratory and circulatory systems, which are 
interrelated, and against this background (Fig. 3) it is necessary 
I MILIEU INTERIOR I 
Fig. 3 Interrelated systems in 
which anaesthetic effects modify 
control of physiological 
homeostasis. 
CBF (ICP) = cerebral blood 
flow, intracranial pressure 
BMRO = basal metabolic rate 
for oxygen 
IPPV = intermittent positive 
pressure ventilation. 
I CIRCULATION _I __.7_ pH PaO:z P.C02 I RESPIRATION I 
~~Temp. BMAO ~
HEART rate Oemolenty 
contractility Na+ K+ ca+ cone.~ 





reflex protectlOII i IPPV 
PHYSIOLOGICAL 
HOMEOSTASIS 
j e10TRANSFORMATION j 
to view in each case the known ways in which the actions, but 
more often side-actions, of anaesthetic drugs and the 
techniques associated with their use may cause complications 
in the context of the environment of the anaesthetic (Fig. 4). 
The interaction between the anaesthetist, his patient and 
apparatus is complex (Fig. 5) (Harrison, 1983). Each inter-
active step is a possible locus of failure. It cannot be empha-
sized too strongly in anaesthetic training programmes that 
deaths attributable to anaesthesia do not 'just happen'. 
Invariably there are warning signs. While in the past the early 
detection of such signs may have required the skill of the very 
astute clinician, today they are rendered obvious by routinely 
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available vital function monitoring apparatus. No longer is 
there any excuse for guessing. Timely effective reaction to such 
signs will prevent tragedy. 
Having said all this, we come once again to the sticking 
points of nomenclature. The lack of comparability between 
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UR I NE OUTPUT 




CONT ROLL I NG; ,-----, 
I 02 FLOW RATE 
I N2 FLOW RATE 
-----ii ANES, CONC. I 
I VENT. RATE I 
: VENT. VOLU .. E I _____ J 







,.EASURE .. ENT 




24 G . G . HARRISON 
published mortality studies which frustrates attempts at estab-
lishing a rate of death attributable to anaesthesia applies with 
equal , if not greater, force to identification and classification of 
common patterns of anaesthetic related death and the environ-
mental and risk situations that engender them. The following 
two examples illustrate this problem. 
Consider the circumstances when, during anaesthesia, respi-
ratory obstruction develops suddenly because herniation of the 
endotracheal tube cuff totally obstructs its outlet. Death 
ensues from hypoxic cardiac arrest before the anaesthetist 
diagnoses or deals with the situation. In various surveys such an 
incident has been classified under the following categories: 
• technical failure 
• equipment failure 
• respiratory obstruction 
• complication of intubation 
• cardiac arrest. 
What of the circumstances of the demise of a gravely ill. 
dehydrated patient shortly after induction of anaesthesia with 
thiopentone? This will be found classified variously as being 
due to: 
• drug overdose 
• wrong or inappropriate drug 
• cardiac arrest 
• preoperative hypovolaemia or inadequate preparation 
• patient's existing disease. 
Reporting the findings of the New South Wales Special 
Committee for the investigation of death under anaesthesia, 
Holland (1970) noted an average of 4.3 errors per anaesthetic 
contributory death. Yet when classified for study and public-
ation, most authors still record cases under a single diagnosis of 
error-continuing a situation so perceptively complained of by 
Treloar (1956) nearly 30 years ago: 'The causation of a given 
death is always multiple so that the necessity of selecting a 
single cause for the purpose of tabulation has become a distres-
sing problem'. 
I believe much of the confusion evident in the taxonomy and 
classification of events related to and causes of death attribu-
table to anaesthesia would be avoided if such were considered 
in the context of the process of anaesthetic in jury delineated by 
Cooper (1984) (Fig. 6). Occurrences and consequences arc 
then clearly separated. Classification for such should then be 
designed on a broad basis in such a way that immediately 
suggests the strategies that would lead to prevention. A sugges-
ted classification is: 
• Clinical failure-failure in any aspect of patient care 
directly under the control of the anaesthetist. 
(a) Errors of judgement-in matters of diagnosis, assess-
ment of degree of difficulty and risk, clinical manage-
ment. 
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Fig.60ccurrence-aneventthat PROCESS OF ANESTHETIC INJURY 
alone could lead to injury; 
Critical incident-a preventable 
occurrence; 
Associated factor-events or 
circumstances that would not 
alone cause in jury, but could 
cause injury in conjunction with 
an occurrence; 
Immediate consequence-the 
physical or physiologic change 
that results from an 
occurrence(s); 
Complication-the effect of an 
occurrence(s) that must be 
treated or must correct 
spontaneously to avoid injury; 
Action required-
Something that must be done to 
deal with immediate · 
consequences or complications; 
Anaesthetic injury-an 
undesirable result of anaesthetic 
management. 
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(b) Technical failure-factors in the performance of clinical 
techniques. 
( c) Observational failure-lack of adequate monitoring. 
( d) Unavoidable or fortuitous reaction/illcident. 
• ·Organizational failure-allocation of staff inappropriate 
for task 
-lack of specialist/consultant staff 
supervision of trainees 
-lack of adequate support facilities 
such as theatre nursing assistants, 
recovery room service, etc. 
• Equipment failure-failure of any component of the system 
for storage, distribution and measurement of flow of respir-
able and anaesthetic gases, dispensing of anaesthetic 
vapours, the means of providing and measuring adequate 
pulmonary ventilation, etc. 
THE COMMONER CAUSES 
In spite of the tremendous variability in the classification and 
presentation of data in published anaesthetic mortality surveil-
lance studies, certain clinical circumstances which seem to 
constitute the major hazard or accident situations from which 
the deaths attributable to anaesthesia arise can be delineated. 
The endotracbeal tube 
Common to both mortality studies and 'critical indent' analyses 
are problems at the anaesthetic equipment/patient interface-
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the endotracheal tube. Complications related to placement or 
misplacement of an endotracheal tube. or failure to place it. 
and obstructions due to kinking. cuff herniation. dislodge-
ments and disconnections feature as a very frequent (in many 
studies the most freHuent) cause of death and. indeed. critical 
incident. 
A technique. peculiarly the stock-in-trade of the anaesthe-
tist. has become his unconscious patient's Achilles· heel. The 
persistent reappearance in mortality studies of the endo-
tracheal tube hazard emphasizes the priority that must be given 
to ensuring the acquisition of skills and experience-in-depth in 
endotracheal intubation techniques together with meticulous 
respiratory monitoring. Perhaps some attention to an old 
anaesthetic adage may ·also save life on occasion: 'When in 
doubt, pull it out , ventilate by mask'. 
Neuromuscular blocking agents 
Sadly that other stock-in-trade of today's anaesthetist. the 
muscle relaxant, is still held responsible for many deaths 
attributable to anaesthesia. These deaths feature as post-
relaxant respiratory inadequacy, inadequate reversal, recurar-
ization, respiratory insufficiency or inadequate postoperative 
care. Considering the now standard provision of postanaes-
thetic recovery facilities, not to mention intensive care units 
with expertise in prolonged ventilation, it is hard to understand 
why this should still be. In many cases the patient suffers from 
chronic obstructive airways disease, and the anaesthetist. 
inexperienced and feeling that putting the patient 'on a venti-
lator' postoperatively is a confession of failure, persists with the 
hope of permitting the patient to breathe spontaneously to his 
ultimate detriment. The lesson is obvious-when in doubt 
'ventilate'! 
Inadequate postoperative supervmon 
That 'inadequate postoperative supervision' is still held 
accountable for many anaesthetic related deaths surely needs 
little comment. While the provision of high intensity nursing 
care recovery areas within operating room precincts with ready 
access for the anaesthesiologist has now become standard in 
hospital design , the safety of the patient is still dependent 
entirely on the quality of that nursing care and vigilance-the 
human factor. 
Vomiting and regurgitation-the full stomach 
The 'full stomach' , with its consequent risk of vomiting, regur-
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gitation and aspiration. has long been recognized as causing 
extreme danger, especially in anaesthesia for obstetrical surgi-
cal procedures. Though this has not changed, it is gratifying to 
note that in contrast to so many other causes of death attribu-
table to anaesthesia. some recent mortality surveys show a 
decreased incidence due to this cause (Dinnick. 1964: 
Harrison, 1978). While this may be due to increased awareness 
of the problem, better training and improved techniques, some 
would attribute it to the increased use of epidural anaesthesia 
and other regional techniques in obstetrics (Bodlander, 1975). 
Circulatory homeostasis 
In his control of the patient's circulatory homesostasis the 
greatest variable for the anaesthetist is the patient's incidental 
cardiac disease and circulatory status, and the manner in which 
these affect his reaction to anaesthetic drugs and the conditions 
imposed by surgery. Most important in this regard is ischaemic 
heart disease . Lunn & Mushin's study (1982) reveals that this 
was regarded as significant in 39% of patients submitted to 
autopsy. It is not pertinent to detail here the many and varied 
mechanisms and combinations of circumstance by which 
anaesthetic related factors might precipitate cardiac arrest and 
possibly death. But it is relevant to draw attention to the most 
common general circumstance or danger associated with 
cardiovasuclar deaths attributable to anaesthesia. This is the 
state of pre-anaesthetic hypovolaemia-often covert. Present-
ing often as profound 'post-induction hypotension' (a lethal 
circumstance in the presence of grave ischaemic heart disease) 
it may be listed as 'drug-induced cardiac arrest' for the simple 
reason that it is so frequently directly associated with the 
administration of thiopentone. The situation may also be 
regarded as 'inadequate preparation for surgery' (Holland, 
1970). Under whatever guise , it is prominent in all recent 
mortality surveys as the situation with the highest anaesthetic 
accident potential. A less common but not infrequent circum-
stance is the reverse situation in which liberal fluid replacement 
unmonitored by CVP measurement results in overhydration 
which manifests as pulmonary oedema on re-establishment of 
spontaneous respiration at tennination of the anaesthetic. 
Apparatus technical failure 
Considering the number of possible sources of hazard and 
accident in the system concerned with the supply of oxygen and 
inhalational anaesthetic to the patient (Feeley, 1976; Wyant, 
1978) , it is perhaps not surprising that in their 'critical incident' 
analyses both Cooper et al (1978a; 1984) and Craig & Wilson 
(1981) report equipment failure and technical mishap as the 
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major threat to the patient's safety. The most common failure 
was the ·disconnect' . The 'slip-on· so easily becomes the ·sJip-
off. If we consider the multiplicity of connections that have 
evolved in the breathing circuit of today's anaesthetic machine. 
it is obvious that this is an area that cries out for systematic 
redesign (Cooper et al, 1978b). The'redesign and incorporation 
of safety devices can help in reducing hazard. as evidenced by 
Cooper et a/'s {1978a) report that in four of nine incidents of 
failure of oxygen supply in an anaesthetic machine equipped 
with a pressure fail safe system this was known to have been 
activated before the absence of oxygen flow was noticed by the 
anaesthetist. Surely the time has now come when the incor-
poration into the patient breathing circuit of such a fail safe 
pressure alarm device together with an oxygen analyser with 
low limit alarm should be mandatory in anaesthetic machine 
design. 
Though in the past equipment and technical failure has 
rarely featured in mortality surveillance studies as a cause of 
death (Dinnick, 1973) such failure achieves much greater 
prominence in two more recently published surveys. that of 
cases referred to by the British Medical Defence Union (Utting 
et al, 1979) and Holland's study of anaesthesia-related mor-
tality in Australia (1984). In the latter equipment failure, other 
than involving the endotracheal tube, was blamed for 17% of 
anaesthesia-related deaths. 
Factors affecting performance 
I have been at pains to stress that, on the whole, death attribu-
table to anaesthesia does not result from accident but from 
human error and lack of skill. Recently, important contri-
butions towards understanding such errors have been made by 
Cooper et al (1978a. 1984) and Craig & Wilson (1981) through 
their studies of human factors associated with performance 
error. Hurry, inattention, carelessness and fatigue are high up 
on their lists. All of these could doubtless lead to the 'failure to 
perform normal checks' and 'failure to assess the situation 
pre-operatively' also listed. Inadequate or substandard per-
formance of the anaesthetist may reflect not so much his own 
failure but that of the organization. when this is responsible for 
the allocation of staff inappropriate for the task or failure to 
provide adequate specialist/consultant staff supervision of 
trainees . 
The unavoidable 
Our preoccupation with human error and failure in the caus-
ation of anaesthetic related death and morbidity should not 
blind us to the fact that over the last two decades. three new 
syndromes which may lead to mortality and morbidity have 
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been described following exposure to inhalational anaes-
thetics. These are the syndromes of anaesthetic induced malig-
nant hyperthermia, nephropathy and ~epatitis. All could once 
be regarded as anaesthetic accidents in that they were unpre-
dictable, unavoidable and subject. to no specific treatment. 
However, this is no longer so. Intense research has resulted in a 
specific therapy for the first together with a knowledge of its 
genetics; the identification and withdrawal from practice of the 
causative agent of the second; and while the third is still some-
thing of an enigma, volatile agents introduced into practice 
since halothane bid fair to have minimal, if any, hepatotoxic 
potential and may well supercede it in practice. In spite of all 
the attention paid to them, these syndromes find scant mention 
in mortality surveillance studies. 'Halothane hepatic failure' 
features only in the Medical Defence Union case study, being 
held responsible for 3.4% of deaths. Malignant hyperthermia. 
also reported in this study, is reported in two others-those of 
Lunn & Mushin (1982) in which three of 58 deaths are 
attributed to it and Holland's Australian study (1984) which 
includes seven cases in 20 years from five million anaesthetics. 
CONCLUSION 
Twenty-three years ago the Lancet opined in an annotation 
that '. . . the most obvious risks of an operation are those 
associated with anaesthesia' (Anon., 1962). I have presented 
evidence to show that the safety of anaesthesia for the patient 
has indeed increased. In many places the actual incidence of 
death attributable to anaesthesia seems to have decreased to a 
level which, having regard for human frailty, is perhaps an 
irreducible minimum-a circumstance which has provoked 
the warning from Cooper (1984) that 'the most insidious hazard 
of anaesthesia today is its relative safety'. 
In spite of this, it is sobering to reflect that actulll numbers of 
patients who die every year because they are anaesthetized are 
appreciable and that the basic causes in general have not 
changed with time but simply recur. The causes of these deaths, 
and of much morbidity, are by and large simple and usually 
follow the lack of observation of simple precautions and clinical 
alertness. Extension of surveillance studies to the stages of 
morbidity and critical incident (Fig. 1) in the process of break-
down to adverse outcome will not only refine the process of 
hazard identification and the formulation of the strategies of 
prevention, but will also serve to re-emphasize an aspect of 
clinical practice and training that seems in danger of being 
forgotten in our technological age: 'It is the hand that gives the 
anaesthetic and the eye that watches its effect that matter more 
than the choice of agent, dosage and method' (Simpson, 1953). 
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THE PHARMACOGENETIC STATES OF CONCERN TO THE ANAESTHETIST. 
The Malignant Hyperthermia Myopathy. 
The Acute Porphyrias. 
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Hyperpyrexia During Anaesthesia 
S um.mary : Work in pigs has shown that malignant hyperpyrexia during anaesthesia may o:::cur without 
suxamethonium having been given. A virtually constant 
feature in reported cases and in our own observations 
is that all subjects developing hyperpyrexia had received 
nitrous oxide and halothane. 
The baffling and frightening complication of malignant 
hypcrpyrexia ocet.rring during anaesthesia has been described 
in humans by many authors (Cullen, 1966; Davies and Graves, 
1966 ; Hogg and Renwick, 1966; Lavoie, 1966 ; Rclton et al., 
1966 ; Thut and Davenport, 1966 ; Purkis et al., 1967) and 
in anaesthetized pigs by Hall et al. (1966). Most of these 
workers attribute this unpredictable, lethal, and puzzling 
reaction to suxamethonium, genetically determined. We wish 
to report six further instances of hyperpyrexia in the anaes-
thetized pig. No suxamethonium was administered to these 
pigs as part of the anaesthetic technique. Though of the same 
breed and from the same farm, these pigs were not siblings. 
The pigs, healthy 6- to 8-week-old Landrace of 35-40 kg. 
weight, were being used for experimental isolated liver perfusion 
and liver transplantation. The anaesthetic technique, the same 
in each case, was as follows : 
Having been starved for 16 hours preoperatively, the pigs 
were anaesthetized by the inhalation of nitrous oxide, oxygen, 
and hdothane administered by means of a Magill circuit and 
facepiece, the animals breathing spontaneously. No pre-
medication was given. Nitrous oxide and oxygen were 
administered at fl.ow rates of 6 litres and 3 litres per minute 
respectively, while halothane concentration was rapidly 
increased to 3 % during the induction of anaesthesia. As soon 
as the pig lost consciousness (usually within three to five min-
utes, depending on the size of the pig) it was removed from 
the portable pen in which anaesthesia was induced and placed 
on the operating-table. Anaesthesia was deepened for a 
further three to five minutes, oral endotracheal intubation then 
being performed (not an easy task in the pig). A stomach 
tube was now passed. Shortly after this, monitoring of oeso-
phageal temperature was begun. E.C.G. and arterial and 
venous pressure monitoring were instituted. Anaesthesia was 
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maintained by the inhalation of nitrous oxide and oxygen, 
6 litres and 3 litres per minute respectively, with 1-2 % halo-
thane vapour administered by an intermittent positive-pressure 
respiration technique utilizing a non-return system powered 
by an East-Freeman Autovent. The minute-volume of ventila-
tion was 8 to 9 litres. Ambient temperature of the operating-
theatre varied between 15 and 20° C. during the period of 
these experiments. 
The six instances of malignant hyperpyrexia reported here 
occurred in a total of 34 pigs submitted to anaesthesia. Its 
occurrence appeared to be quite unpredictable. In each case 
the rise in temperature began about the time of or shortly 
after the induction of anaesthesia and was heralded by a 
blotchy blueness of the skin. (The skin of the normal 
TABLE I.-T,mperatur, C'hang,s (D1gr11s C1ntigrodl) 
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• Early monitoring of temperature was undertaken only after our fint c:s:periences 
of the condition. 
TABLE II.-Acid-bas, Studies• (FffllDTal Arilrial Blood-AstrMt> 
Technique) 




{ It~· / 
6·85 I Pig 1 130 I 
-16'8 
712 : { 7·37 6·85 Pig 2 ~co, i 40 I 80 i 144 
B.E. I -1'5 I -5·9 · -19-0 
{ t~o, J 7·08 n Pig3 55 67 B.E. j -8·4 _,., 
centw { H ' 
6·65 ' Pig 5. Mised ~co, : 90 venous blood B.E. > -22·0 
Pig 6. Miud centw { i~Os 6·44 6·73 6·79 6-99 >150 > 150 71 136 venous blood B.E. > -22 -4·0 +n -1'5 
• (a) Studies were begun after femoral arterial cannulation. Pig 4 IUCCUlllbed 
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Pig 5. (b) The values shown for Pig 3 rdlect the acid·bae swe after the achninima· 
tion of 200 mEq of sodium bicarbonate. Between the 30-minute and 120-minute 
periods in Pig 6 a total of 375 mEq of sodium bicarbonate was !liven. 
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anaesthetized pig has a uniformly pink appearance.) The rise 
in temperature was rapidly progressive and was associated 
with a marked and ultimately fatal deterioration in the circu-
latory condition of the pig. Pari passu a gross metabolic and 
respiratory acidosis was evident. Whereas the limbs of the 
normal anaesthetized pig arc relaxed during anaesthes~ 
light anaesthesia-the limbs of the hypcrpyrcxial pigs were 
stiffly extended, the muscles in extreme spasm in a way similar 
to that described by Hall et al. (1966) in their pigs and by 
the Canadian workers (Cullen, 1966; Davies and Graves, 
1966 ; Hogg and Renwick, 1966; Lavoie, 1966; Rclton et al., 
1966 ; Thut and Davenport, 1966; Purkis et al., 1967) in the 
hypcrpyrexial humans following the suxamcthonium they 
postulated as being responsible for this condition. We did 
not observe any marked change in pulmonary compliance. 
Cultures of blood taken from the first two pigs which displayed 
this syndrome were negative. In the last two pigs the admini-
stration of nitrous oxide and halothanc was discontinued as 
soon as the condition became evident. From then on oxygen 
alone was administered by intermittent positive-pressure 
respiration. This made no difference whatsoever to the 
inexorable progress of the condition. 
Details of time, temperature, and acid-base state arc pre-
sented in Tables I and II. 
DISCUSSION 
Malignant hypcrpyrexia during anaesthesia has been 
described in both humans and pigs. A new aspect of this 
problem that emerges from our report is that it can occur 
in the absence of the use of suxamcthoniwn, the drug on 
which other workers have focused attention. E:s:arnioation of 
the recently published reports of malignant hypcrpyreDa 
during anaesthesia shows that, with one exception, the common 
factors to all these cases and our own arc the anaesthetic 
agents-a fluorinated hydrocarbon and nitrous oxide. The 
mechanism by which so immense an amount of heat is so 
rapidly produced poses a fascinating physiological problem. 
Docs some disturbance of oxidative phosphorylation play a 
part (Snodgrass and Piras, 1966 ; Wilson et al., 1966)? 
Vigucra and Conn (1967) failed to produce this picture of 
malignant hypcrpyrcxia in chickens, both by the production 
of muscle spasm and by dinitrophenol-induccd uncoupling of 
oxidative phosphorylation. Even more fundamental than the 
problem of the mechanism of heat production is the question 
of the precise identity of the stimulus that initiates this veritable 
metabolic storm. Most important to the solution of this 
2.1 
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problem is the salvaging of one of the pigs that react in this 
way so that we may see if the event is experimentally 
reproducible. 
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ANAESTHETIC-INDUCED MALIGNANT HYPERPYREXIA AND A METHOD 
FOR ITS PREDICTION 
BY 
G. G. HAluusoN, S. J. SAUNDERS, J. F. BIEBUYCK, R HICKMAN, D. M. DENT, 
V. WEAVER AND J. TERBLANCHE 
SUMMARY 
The clinical syndrome of anaesthetic-triggered malignant hypcrpyrcxia occurring in 
pigs is described. This condition in the pig is considered to be the same "explosive 
thermal idiosyncrasy" to general anaesthesia that is manifested by humans. The 
condition has a strong genetic factor occurring in 25 per cent of Landrace pigs used 
by us. Sex has no influence on its appearance. The clinical syndrome consists of: 
(1) tachycardia; (2) muscle rigor; (3) tachypnoca and hyperventilation progressing to 
apnoea; (4) blotchy cyanosis of the skin; (5) rapid, sustained and cmcmc rise in 
temperature; (6) gross acidosis. Prognosis, once the condition is well established, is 
extremely poor. All attempts at treaanent have failed. Histological investigation has 
shown change in muscle only. The significance of this change is unknown. The muscle 
of affected pigs shows, in comparison to normal pigs, an abnormal fall in ATP content 
in response to incubation and to "in vitro" exposure to halothanc. This reaction 
provides a method of predicting the development of the syndrome. Halothanc, 
chloroform and suxamcthonium have been identified as triggering agents. The 
mechanism of heat production is unknown. 
Cases of malignant hypcrpyraia or fubninant 
hypcrthcrmia occurring during the course of 
clinical general anaesthesia have been described 
with disturbingly increasing frequency over the 
last few years (Leading Article, 1968; Hawthorne, 
Richardson and Whitfield, 1968; Marx ct al, 
1968). The most frightening aspects of this con-
dition arc that: 
(1) Mortality is in excess of 70 per cent. 
(2) Occurring most frequently in young healthy 
patients undergoing relatively minor surgical 
procedures, its occurrence appears to be 
completely unpredictable. 
(3) The stimulus, or trigger, appears to be 
directly related to the administtation of a 
general anaesthetic. 
(4) Because of the complete ignorance of patho-
genesis, treatment is empirical, symptomatic 
and, in general, unsuccessful. 
The discovery by Hall and associates (1966) 
and ourselves (1968) of what we have become con-
vinced is exactly the same abnormal response to 
general anaesthesia-malignant hypcrp~-in 
the pig is of interest, for quite fortuitously we 
have been provided with an animal experimental 
model in which to investigate this frightening 
condition. 
The pig is used by us as the experimental 
model in a research programme on liver trans-
plantation and isolated liver perfusion. Three 
breeds of pig have been ·used: Landrac:e, 
Landrace/Large White Cross, and Large White. 
Pigs of each breed come to us from separate 
farms. The pigs arc used between the ages of 
6-10 weeks, weighing between 30 and 45 kg. 
ANAESTHETIC TECHNIQUE 
Two anaesthetic techniques which differed only 
in the drugs used were employed. Certain events 
and manoeuvres were common to both. These 
were: 
G. G. HARRlSON, M.D., F.F.A.R.C.S.; s. J. SAUNDDS, 
M.D., M.lt.c.P., F.C.P.(S.A.); J. F. Bn!BuYCJC, M.B., al.II., 
F.F.A.(S.A.); R. HICKMAN, M.D.; D. M. DEN'r, MJL, 
CH.JI.; V. WEAVER, B.SC.; J. T!!lw.ANam, CH.M., 
F.C.S.(S.A.), F.LC.S., Liver Research Group and 
Dcpanments of Anaesthetics, Medicine and Surgery, 
University of Cape Town, South Africa. 
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(a) Pre-anaesthetic starvation of 16 hours. 
(b) Induction of anaesthesia. 
(c) Orotracheal intubation with cuffed endo-
tracheal tube. 
( d) Maintenance of anaesthesia with nitrous 
oxide and oxygen administered by an IPPR 
non-rebreathing technique utilizing .a Bird 
ventilator (Voss, 1967). 
(c) Passage of oesophageal thermometer lead and 
large-bore stomach tube. 
(f) Establishment of arterial and venous pres-
sure and blood-gas monitoring by means of 
femoral artery and jugular venous catheteri-
zation. 
The two techniques diff ercd in the inclusion or 
omission of halothane. 
Technique 1. 
Halothanc with nitrous oxide and oxygen was 
used both for induction and maintenance of 
anaesthesia. For induction 3 per cent halothane 
vapour was utilized, while for maintenance 0.5-2 
per cent depending upon the demands of the 
surgery. 
Technique 2. 
Anaesthesia was induced with thiopentone 
sodium (5 per cent solution) administered by an 
car vein. During maintenance of anaesthesia with 
nitrous oxide and oxygen supplemental doses of 
thiopcntone, with in some cases the addition of 
3-5 mg doses of tubocurarine, were administered. 
In a group of 7 pigs which survived aborted 
episodes of malignant hypcrpyrcxia and were the 
subject of further specific experiment, e.g. identi-
fication of triggering agents, monitoring was 
first established under thiopcntonc-nitrous oxide-
oxygen anaesthesia. 
Incidence of malignant hyperpyrexi.a. 
With the two anaesthetic techniques used, the 
syndrome of malignant hypcrpyraia occurred 
only in those pigs which were exposed to halo-
thanc. The incidence of occurrence of the syn-
drome in the three breeds of pig when 
anaesthetized with halothane (technique 1) is set 
out in table I. 
Twenty-three pigs (Landrace 20, Landrace/ 
Large White 3) were anaesthetized with thiopcn-
tone, nitrous oxide and oxygen (technique 2). 
None of these pigs developed the syndrome. 
TABLE I 












"An explosive thermal idiosyncrasy" (Wilson 
et al., 1967) is present in response to cxposurc 
to halothane in one quarter of the pure Landrace 
pigs we have used. It is pertinent to note that 
the pigs in which Hall and co-workers (1966) 
found this trait in response to suxamethonium 
were of the Landracc/Wcssex breed (Woolf, N., 
1969, personal communication). The appearance 
of the syndrome in the cross-breed Landrace/ 
Large White pigs we have used has been rare. 
As in reported human cases, the sex of the 
animal had no influence on the appearance of 
the syndrome. 
THE CLINICAL SYNDROME 
The clinical syndrome in pigs develops with 
dramatic speed. The onset, with rare exception, 
occurs within minutes of exposure to halothane. 
The changes in physiological parameters arc grass 
and all the manifestations appear almost simul-
taneously. These arc: 
(1) Tachycardia. 
(2) Stiffness and hardening of the muscles. 
(3) Tachypnoea and hypcrvcntilatioo which 
rapidly progresses to apnoea. 
(4) Blotchy cyanosis of the skin. 
(5) A rapid sustained rise in temperature up to 
as much as 45°C. 
Tachycardia. 
With the onset of this syndrome a sinus tachy-
cardia of 200-300 beats/min develops and is 
maintained until very shortly before the death of 
the animal. Arterial blood pressure is maintained 
for 30--60 minutes, thcrcaftcr declining progres-
sively due to falling cardiac output. Terminally, 
ventricular arrhythmias, coupling, and finally 
gross bradycardia precede asystole. Asystole has 
occurred at varying periods from the commence-
ment of the condition, the shortest being 10 
minutes, the longest 165 minutes. Mean survival 
time was 106 minutes. 
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FIG. 1 
Susceptible pig anaesthetized with thiopentone. Note rclued hind limbs. 
FIG. 2 
Same pig as fig. 1, 4 minutes after administration of halothane. Note extension of hind limbs. 
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Muscle rigor. 
Rigor of the muscles occurs rapidly. Though 
generalized, it is most obvious in the limbs which 
become rigidly extended, as in rigor morris (figs. 
1 and 2). 
The administration of tubocurarine in doses of 
6-10 mg has had no effect on this rigor, which 
is maintained until the death of the animal and 
beyond. Observation of animals up to 18 hours 
postmonem has revealed no softening or autoly-
sis of the muscle rigidity. 
T achypnoea and hyperventilation. 
Tachypnoea commences with the onset of the 
syndrome and is rapidly succeeded by apnoea. 
When attacks of the syndrome have been success-
fully aboned by the discontinuance of halothane 
within minutes of its introduction, before the 
onset of apnoea, the tachypnoea has persisted for 
up to 30-45 minutes. This tachypnoea is extreme 
with respiratory rates up to 125 b.p.m.-panting 
is a better description. In some survivors, if 
apnoea has ensued following discontinuance of 
the halothane, tachypnoea has resumed after a 
period of IPPR with oxygen. In these pigs, though 
exposure to halothane was extremely brief, deep 
coma has persisted until the tachypnoea has 
recommenced. 
Blotchy cyanosis. 
Cyanosis of the skin, described in some human 
cases, is a constant early feature in the pig. As 
measured anerial Po2 at this stage is not reduced 
(vide infra) it indicates skin vasoconstriction, with 
areas of stagnant hypoxia. The skin soon becomes 
hot to the touch. 
Rapid, sustained rise in temperature. 
Rise in temperature is rapid and extreme. An 
example is presented in figure 3. In this experi-
ment a pig which previously survived an aborted 
attack of the syndrome was re-challenged with 
halothane after anaesthesia had been induced 
with thiopentone and monitoring established. The 
first change in oesophageal temperature was 
recorded at 6 minutes, with a subsequent rise at 
a rate of 1 °C every 7 minutes. Other eumples 
are to be seen in figures 4 and 5. In these 
examples, the rate of rise was as fast as 1 • C in 
5 minutes at one stage. When unmodified by 
cooling, oesophageal temperatures reached 45° in 
some pigs before death; 43-44 • was the common 
end point. 
Acid base and blood-gas state. 
Acidosis was profound and invariable with 
both gross metabolic and respiratory compon-
ents; 15-20 minutes from the first signs of the 
syndrome the arterial acid base state ba5 been 
typically: pH 6.8; Pco2> 150 mm Hg; BE<-22 
m.equiv/1. 
No primary respiratory reason for the gross 
hypercapnia-pulmonary, lesion or underventila-
tion-was apparent in any animal. As soon as the 
syndrome commenced IPPR with oxygen was 
instituted with tidal volumes of 500 ml and 
minute ventilatory volumes of the order of 10 
1./min. aear air entry to both lungs was noted in 
all animals. This gross hypercapnia, with its 
probably accompanying high carbon dimide out-
put is paralleled in human cases in which carbon 
dioxide absorbers were observed to become 
rapidly very hot (Cullen, 1966; Davies and 
Grayes, 1966; Hogg and Renwick, .1966). 
Anerial oxygen tension values (Clarke elec-
trode) were above normal in all aoimaJs, ranging 
from 145 mm Hg in pigs breathing 30 per cent 
nitrous oxide and oxygen to 400 mm Hg when 
IPPR with oxygen alone had been instituted. 
These values fell df later when there was evi-
dence of progressive circulatory failure. Mixed 
venous blood always appeared emcmcly desat-
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FIG. 3 
Continuous record of oesophageal temperature during 
a control period of thiopcntone anaesthesia followed 
by administration of halothane. 
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FIG. 4 
Record of oesophageal temperature and other events during administration of suumethonium 
to a susceptible pig anaesthetized with thiopentone. 
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FIG. S 
Record of oesophageal temperature and other events during administration of suumethonium 
and cyclopropane to a susceptible pig. Conttol period anacsthesia-thiopentone. 
Thiop. =thiopcntonc; S.C. =suxamcthoruum; Cyclo. =cyclopropane; Intubn. =intubation. 
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Electrolyte changes. 
Limited investigation of serum sodium and 
potassium changes has shown the development of 
a marked hyperkalaemia. Levels as high as 11-12 
m.equiv /1., which could well have accounted for 
the ultimate cardiac asystole, were observed . in 
some animals. 
PROGNOSIS AND TREATMENT 
As with human cases (Wtlson et al, 1967), the 
prognosis in the pig, once the syndrome is 
established, is extremely poor. Ten minutes after 
exposure to halothane and commencement of the 
syndrome, discontinuance of this agent, !PPR. 
with oxygen, active cooling, treatment of the 
acidosis, and other measures, have had no infl.u-
Blood cultures. ence on the inexorably fatal outcome of the con-
Blood from 2 pigs which died of the syndrome · dition. Cooling has failed to prevent mortality, 
was submitted to bacteriological culture with even on those few occasions when a drop in 
temperature was achieved. Doses of sodium negative results. bicarbonate, sufficient to correct base deficits, of 
Histology. 
Postmortem examination of pigs dying of 
malignant hyperpyrexia showed no macroscopic 
abnormalities. Tissue from 4 such pigs was 
examined histologically (Prof. C. J. Uys); sections 
of brain, liver, kidney and adrenals showed no 
changes of note. Only striated muscle showed 
demonstrable changes (fig. 7). In these sections 
the majority of fibres appeared normal. However, 
isolated fibres were shortened and shrunken. At 
their ends these fibres were separated bun adja-
cent fibres, and in some instances they appeared 
to have ruptured transversely. These shortened 
fibres were more intensely eosinophilic than nor-
mal fibres. Similar fibres were observed in muscle 
sections from normal pigs, but in the affected 
pigs they were more frequent and readily 
observed. 





AG I TAT ION - -
Method of incubation and csposurc of muscle to halo-
thane "in vitro". 
the order of 40-50 m.equiv /L of emacellular 
water administered over 30 minutes have had 
little effect in changing pH. If this has been 
shifted up at all, it has rapidly reverted to less 
than 7. Attempts at hyperventilation have met 
with no success in lowering the raised Pco,, 
boosted as it is, no doubt, by the infusion of 
sodium bicarbonate. Administration of up to 
0.3M of THAM over 20-30 minutes has had as 
little success in terms of survival. 
In the light of some unproven hypotheses of 
the biochemical lesion, we have administered the 
following drugs with complete lack of therapeutic 
effect: 
(1) Adrenergic blocking agents: (a) propranolol; 
(b) propranolol and phentolamine. These 
drugs were given to block any possiole 
adrenaline-induced or mediated rise in calori-
genesis (Havel, 1968; Depocas, 1960; Hsieh, 
Carlson and Gray, 1957). Pretreatment with 
these drugs did not prevent the onset of the 
syndrome, nor did they control it oocc estab-
blished. 
(2) Promethazine. This drug is known to have 
an "in vitro" antoxidant effect (Slater, 1968). 
Pretreatment with the drug did not prevent 
the onset of the syndrome nor did it control 
the condition once established. 
(3) Magnesium sulphate. This drug has an 
inhibitory effect on mitochondrial respiration 
(Chance, 1959) and was used because of 
the suggested role of uncoupling of ozidative 
phosphorylation in this syndrome (Wilson 
et al, 1966). 
( 4) Insulin and glucose. This combination was 
used in an attempt to combat the observed 
hyperkalaemia. 
2.2 
(B) Muscle of susceptible pig under con-
trol thiopentone anaesthesia. 
FIG. 7 
Histological sections of striated muscle. 
H . & E. stain; magnification x 100. 
(A) Normal pig. 
(c) Muscle biopsied during malignant 
hyperpyrexia following halothane anaes-
thesia. 
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(5) ATP. We observed a fall in muscle ATP 
during this syndrome (vide infra) and sought 
to replace it . . 
Prompt discontinuance of the agent at the 
earliest moment either of the three major signs 
appeared (tachypnoea, muscle rigor, tachycardia) 
left us with 7 initial survivors in 23 examples of 
this syndrome. These survivors had no treatment. 
Their survival depended entirely on extremely 
early diagnosis with discontinuance of halothanc 
within a matter of minutes. In that survival only 
occurred in cases in which the triggering stimulus 
-halothanc-was discontinued at so early a stage 
that the syndrome was not properly established, 
identification of the syndrome could be called in 
question. However, all survivors developed the 
full-blown syndrome fatally . on a subsequent 
occasion when re-challenged with halothanc or 
other triggering agent. 
THE TRIGGERING AGENT 
All 23 instances we have experienced of this syn-
drome have followed a first exposure to halothane. 
In the 7 survivors of aborted attacks we have 
tested other possible triggering agents. 
The anaesthetic techniques used in the reported 
human cases have, in each case, involved multiple 
agents. These have included thiopcntonc, halo-
thanc, methoxyfiuranc, cyclopropanc, ether, 
nitrous oxide, and the relaxants suxamcthonium 
and tubocurarinc. 
We have challenged known susceptible pigs 
with all these agents individually. Because of the 
apparent imponancc of the halogenated hydro-
carbon anaesthetic agents, we have tested, in 
addition, trichloroethylenc and chloroform. In the 
case of a negative response, anaesthesia, tempera-
ture and blood-gas monitoring were continued for 
1 hour. 
A negative response followed administration of 
thiopcntonc, nitrous oxide, ether, trichloro-
cthylenc, methoxyfiuranc and tubocurarinc. As 
thiopentonc was shown neither to prevent the 
onset of the syndrome nor to influence its pro-
gress once established, monitoring for subsequent 
specific experiments in survivors was first estab-
lished under anaesthesia with this agent. 
In an experiment complementary to that in 
which adrencrgic blocking agents were adminis-
tered (vidc supra) we challenged a susceptible pig 
with an intravenous infusion of adrenaline 
1 : 100,000. The syndrome was not triggered. 
Positive triggering of malignant hypcrpyrcxia 
followed administration of halothanc ( our stan-
dard triggering agent), chloroform, suxamctho-
nium (sec fig. 4) and possibly cyclopropanc. 
The muscle fasciculations that followed 
administration of suxamcthonium were, as in the 
reported human cases, cxttcmely coarse and tonic, 
causing the legs to be rigidly extended. The 
muscle fasciculations that followed the second 
dose of suxamcthonium were the most intense. 
A question-mark must be left next to cyclo-
propanc. This drug was tested in a known 
susceptible pig only after two test doses of sun-
mcthonium had been given (sec fig. 5). Malignant 
hyperpyrcxia commenced the moment cyclopro-
panc was administered. But subsequently we 
demonstrated that fnlrninant hypcrthermia could 
foUow the administration of suxamethonium alone; 
AN ASPECT OF MUSCLE FUNCTION 
One of the most obvious clinical manifestations 
of this condition is muscle stiffness, rcminiscmt 
of rigor mortis. Szcnt-Gyorgyi (1944) in his 
classical studies on muscle concludes that " .•• 
rigor and insolubility of the actinomyosin arc * 
dlfercnt consequences of one and the same con-
diti~ lack ·of adcnosine-triphosphatc (ATP)". 
This, and the observation that muscle taken from 
one of our pigs during a fatal episode ci malig-
nant hyperpyrcxia showed a low ATP contcn~ 
led us to study the concentration of ATP in the 
muscle of susceptible pigs and its behaviour "in 
vitro" to exposure to halothanc. 
Twelve Landracc pigs were submitted under 
thiopcntonc anaesthesia to muscle biopsy. Two 
biopsies of approximately 2 g each were taken 
of the gluteal muscle. Each piece of muscle wu 
immediately divided into three aliquots which 
were blotted, weighed and then treated as follows. 
(1) One aliquot was immediately fromi in 
liquid nitrogen. · 
(2) A second aliquot was incubated for 30 
minutes at 38°C in 15 ml of Krebs-Ringer 
solution through which carbogcn ( oxygen 95 per 
cent, carbon dioxide 5 per cent) was bubbled (sec 
fig. 6). Thereafter it was frozen in liquid nitrogen. 
(3) A third aliquot was treated cnctly as the 
second except for the addition to the carbogcn of 
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4 per cent halothane vapour. This resulted in 
concentrations of halothane in the solution which 
ranged between 19 and 29 mg/100 ml Concen-
trations of halothanc in the solution were esti-
mated by gas chromatography (Gadsden, Risinger 
and Bagwell, 1965). 
Following extraction of the muscle in TCA, 
the concentration of ATP in mM/ g of muscle 
was now measured in each aliquot using a kit 
supplied by Boehringer (Kit Ref. CAT. No. 
15979TW AC). The aliquot duplicates were then 
averaged to give the cooccntratioo of ATP, (i) in 
fresh muscle, (ii) after incubation without halo-
thanc, (iii) after incubation with halothanc. 
Following muscle biopsy the pig was allowed 
to recover consciousness and was returned to its 
pen. Two days after the muscle biopsy each pig 
was anaesthetized with halothanc, nitrous oxide 
and oxygen, and its reaction was observed. 
RESULTS 
Of 12 pigs used, 7 showed no abnormal response 
to halothanc, whilst 5 developed maJignant 
hypcrpyrcxia. The concentrations of ATP meas-
ured in muscle arc presented in table Il, grouped 
in relation to the pig's subsequent response to 
the exhibition of halothanc. 
The concentration of ATP in fresh muscle was 
the same in both groups of pigs. Incubation of 
the muscle with and without halothanc caused 
a fall-off in ATP concentration. In these circum-
stances, but especially after halothane, fall-uf in 
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ATP concentration was greater in muscle from 
pigs with the hypcrpyrcxia trait. The constancy 
of this reaction permitted prediction of the pig's 
ultimate response to halothanc. 
DISCUSSION 
Anaesthetic-triggered malignant hypcrpyraia 
poses a nightmare situation for the clinical anaes-
thetist. We believe that certain suscepn'ble pigs 
of the Landracc strain suffer precisely the same 
"explosive thermal idiosyncrasy" to anaesthetic 
agents as humans and provide an important, if 
fonuitous, experimental model for the investiga-
tion of this condition. 
From our experience, it would appear that the 
one hope for the patient exhibiting this abnonnal 
response lies in its very early recognition, allow-
ing discontinuance of the triggering stimulus. 
Early signs which presage the onset of the con-
dition arc: 
(1) Tachycardia. 
(2) An abnonnal response to suxamethonium 
such as coarse fasciculations or sustained 
muscular contraction. 
(3) Abnormal muscle tone that docs not respond 
to reasonable doses of tubocurarinc. 
( 4) Tachypnoca and hyperventilation. 
(5) Blotchy general skin cyanosis. 
(6) A rapid rise in temperature. 
Two accompaniments of this syndrome have 
been identified: (a) gross acidosis; (b) a fall in 
muscle ATP. 
TABLE II 
ATP conuntro1ion in muscle. 
ATP cooccnttations in mM/g 
30 min 30 min incub. 
Fresh muscle incubation +halothanc 
Normal pigs 
n=7 
Mean ± SD 3,68±0.30 2.27 ±0.33 2.22±0,43 
"Hot" pigs 
n=5 
Mean±SD 3.29±0,36 1.24±0.41 0.82±0.38 
Signifiamce of 
difference be-
tween similar 0.05<P<0.10 P<0.01 P<0.001 
means (Student's Not 
t test) significant 
% Fall-off in ATP 
coocenttatiom 
Fresb-30 min 






ANAESTHETIC-INDUCED MALIGNA}.i'T HYPERPYREXIA 853 
(a) Acidosis. 
The acidosis which occurs in the presence of 
an above normal anerial Po2 is characterized by 
a rapid fall in base and rise in Pco2• The former 
has recently been shown to be due to a severe 
rapidly developing lactacidosis, and in the absence 
of any obvious respiratory cause, the latter is 
assumed to result from buff cring of this acid load 
(Berman et al., 1969). Whether this is the primary 
result of the heat-producing mechanism, a 
secondary or coincidental occurrence, remains to 
be investigated. The high Pco2 recorded docs 
serve to explain two clinical observations: (1) 
hyperventilation progressing to apnoea with the 
reappearance of hyperventilation should the 
animal survive; (2) persistent unconsciousness of 
the animal long after the anaesthetic agent has 
been discontinued and while the animal is being 
artificially respired with oxygen only. The former 
is the normal respiratory response to hypcrcarbia 
while the latter is probably carbon dioxide 
narcosis. 
Though we have had no success with it in the 
pig, it would appear reasonable, from the above 
observations, to use THAM rather than sodium 
bicarbonate in treating this acidosis. 
(b) The fall in muscle ATP. 
In vitro study of pig muscle showed a greater 
fall-off in ATP concentration in affected pigs after 
simple incubation as well as an even greater 
fall-off after exposure to halothane. This may 
indicate that not only is the response of these pigs 
to halothanc abnormal, but that the muscle cells 
have an even more basic abnormality. The fall in 
ATP may be due to either inhibition of mito-
chondrial respiration (Fink and Kenny, 1968), 
or perhaps to uncoupling of oxidative phosphory-
lation (Snodgrass and Piras, 1966; Wilson ct al., 
1966) or perhaps to the triggering of energy 
formation via a non-phosphorylating pathway 
(Challoner, 1966). Whatever its genesis, the fall 
in ATP content may be an explanation of the 
rigor-mortis-likc rigidity of the muscle (Szcnt-
Gyorgyi, 1944). Though we arc ignorant of its 
theoretical implications this reaction does have a 
useful practical application. It provides us with 
a method of predicting which pig will develop 
malignant hypcrpyrexia when exposed to halo-
thane. 
The identity of the triggering mechanism 
remains an enigma. First, some genetic faaor 
appears necessary to provide the cnviromncnt in 
which the triggering substances can act. In oar 
pigs, and those of Hall and associates (1%6), this 
genetic factor appears to be associated with the 
Landracc breed. A genetic factor has been in-
criminated in reports of human cases involving 
near relatives (Barlow, 1968; Britt, Lochner and 
Kalow, 1969; Dcnborough ct aL, 1962; Pum 
ct al., 1967). Given this genetic enviromncm, 
there appears to be no single triggering agent. 
We have identified halothanc, chloroform and 
suxamethonium. There arc probably others. 
Though a comforting molecular similarity may 
be seen between halothanc and chloroform, the 
intrusion of the chemically dissimilar smamctho-
nium is bewildering. This seems to rule out any 
direct chemical triggering mechanism, leaving us 
the likelihood of some biophysical phcnomcnm 
(Allison and Nunn, 1968). 
One thing is cenain. H by some quirk of fate 
Ravent6s (1956) had used Landracc pigs instead 
rats, mice, dogs, cats and monkeys on which ID 
test his new-found anaesthetic, halothanc, it 
would never have emerged from the laboratory 
to become the most widely used anacstbetic jn 
the world. For who would dare suggest the 
clinical use of an agent that killed a quancr <i 
those animals exposed to it? 
ACKNOWLEDGEMENTS 
This research programme is financially supported by 
the following donon, whom we gratefully aclmow-
ledge : the Anglo-American and De Beers Anaesthetic 
Research Fund; the Univenity of Cape Town Std 
Research Fund; and the South African Council oi 
Scientific and Industrial Research. 
We acknowledge also our indebtedness to Professor 
A. B. Bull, Head of the Department of Anaesthetics, 
for figures 1 and 2 and much helpful, consaucti'f'e 
criticism; the Deparanent of Chemical Pathology for 
serum elecuolyie estimations, and Dr. Berman of this 
department for figure 3; the Department of Pathology 
for histological sections and Professor C. J. Uys of this 
department for figure 7; S. Wicht, L. Frith and A. 
Munroe for technical assistance and the J. S. Marais 
Laboratory for Surgical Research (Director, Professor 
C. N. Barnard) for the facilities placed at our disposal. 
REFERENCES 
Allison, A. L., and Nunn, J. F. (1968). Effects oi 




Barlow, M. (1968). Hypcrpyrexia during anaesthesia : 
3 cases occurring in close relatives. Paper read at 
Biennial C.Ongress of South African Society of 
Anaesthetists, Blo:mfontein. 
Berman, M. C., Harrison, G . G., Bull, A. B., and 
Kench, J . E . (1969). Biochemical changes asso-
ciated with malignant hypcrpyrcxia induced by 
halothane in susceptible pigs. Nature (in press). 
Brin, B. A., Lochner, W. G., and Kalow, W. (1969). 
Hereditary aspects of malignant hyperthermia. 
Canad. Anaesrh. Soc. 1,, 16, 89. 
Oialloncr, D. R. (1966). Hypcrmetabolic states. 
Lanar, 2, 681. 
Owx:c, B. (1959). Quantirati-ve Aspects of the Control 
of Oxygen Utilisation in "Regulalion of Cell 
Metabolism" (Ciba Symposium) (eds. Wolsten-
holme, G. E. W., and O'C.Onnor, C. M.). London : 
Churchill. 
Cullen, W. G. (1966). Malignant hypcrpyrcxia during 
general anaesthesia. Canad. Anaesrh. Soc. 7., 13, 
437. 
Davies, L . E., and Graves, H . B. (1966). Hypcrpyrexia 
and death associated with · general anaesthesia. 
Canad. Anaesrh. Soc. 7., 13, 447. 
Dcnborough, M. A., Foster, J . A., Lovell, R. R. H., 
Maplestone, P. A., and Villiers, J. D . (1962). 
Anaesthetic deaths in a family. Brit. 7. Anaesth., 
34, 395. 
Depocas, F . (1960). Calorigenic response of cold 
acclimatized white rats to infused noradrenaline. 
Canad. 7. Biochem., 38, 107. 
Fink, B. R., and Kenny, G. E. (1968). Metabolic effects 
of volatile anesthetics in cell culture. Anesthesio-
logy, 29, 505. 
Gadsden, R. H ., Risinger, K. B. H., and Bagwell, E. E. 
(1965). Determination of blood halothanc levels 
by gas chromotography. Canad. Anaesth. Soc. 7., 
12, 90. 
Hall, L. W., Woolf, N., Bradley, J. W. P., and Jolly, 
D. W. (1966). An unusual reaction to suxameth-
onium chloride. Brit. med. 1,, 2, 1305. 
Harrison, G . G ., Biebuyd:., J . F., Terblanche, J., Dent, 
D. M., Hickman, R., and Saunders, S. J. (1968). 
Hypcrpyrexia during anaesthesia. Brit. med. 1,, 
3, 594. 
Havel, R. J. (1968). The autonomic nervous system 
and intermediary carbohydrate and fat meta-
bolism. Anesthesiology, 29, 702. 
Hawthorne, A. T ., Richardson, M E., and Whitfield, 
G. T . (1968). Fulminating hypcrthermia and 
general anaesthesia. Brit. med. 1., 4, 705. 
Hogg, J ., and Renwick, W. (1966). Hypcrpyrexia dur-
ing anaesthesia. Canad. Anaesth. Soc. 7., 13, 429. 
Hsieh, A. L., Carlson, L . D ., and Gray, G. (1957). The 
role of the sympathetic nervous system in control 
of the chemical regulation of heat production. 
Amer. 7. Physiol., 190, 247 . 
Leading Article (1968). Malignant hypcrpyrexia. Brit. 
med. 1., 3, 69. 
Marx, G. F., Steen, S. N ., Berenyi, K. J., Erlanger, 
H . L., Foster, E. S., Kepes, E. R., Jardwat, C. M., 
Potash, R. S., and Shapira, M. (1968). Fulminat-
ing hypcrthennia during anesthesia. N .Y. Sr. 1. 
Med., 68, 2566. 
Purkis, I. E., Horrclt, 0., De Young, C. G., Fleming, 
R. A. P., and Langley, G . R. (1967). Hypcrpyrcxia 
in a second member of a family. Canad. Anoesth. 
Soc. 1 .. 14, 183. 
BRITISH JOURNAL OF ANAESTIIESIA 
R~vent6s, J. (1956). The action of Fluothanc: a new 
volatile anaesthetic. Brit. 1- Pharmacol., 11, 394. 
Sleter, T. F. (1968). The inhibitory effects in vitro of 
phenothiazine in other drugs on lipid peroxidatioo 
systems in rat liver microsomes and their relation-
ship to the liver necrosis produced by carbon 
tcuachloride. Biochem. 7., 106, 155. 
Snodgrass, P. J., and Piras, M M (1966). The effccts 
of halothanc on rat liver mitochondria. Bi().. 
chemistry, 5, 1140. 
Szent-Gyorgi, A. (1944). Srudies on muscle. Acta 
physiol. sca,ul., 9. Suppl. XXV. 
Voss, T . J. V. (1967). The adaptation of ventilators 
for anaesthesia. S. Afr. med. 7., 41, 1079. 
Wilson, R D., Dent, T . E., Traber, D . L., McCoy, 
R. R., and Allen, C. R. (1967). Malignant hyper-
pyrexia with anesthesia. 7. Amer. med. A.ss., 2'2, 
183. 
-- Nichols, R. J., Dent, T . E., and Allen, C. R. 
(1966). Disturbances of the oxidative-phosphoryla-
tion mechanism as a possible etiological faaor in 
sudden unexplained hypcrthermia occurring dur-
ing anesthesia. Anesthesiology, 27, 231. 
HYPERPYREXIE MALIGNE INDUITE PAR 
L'ANESTHESIQUE ET UNE METHODE POUR 
LA PREVOIR 
SOMMAIRE 
Le syndrome cliniquc d'unc hyperpyrexie maligne 
dccienchec par l'ancsthcsique Ct SC produidant cbez 
des cochons, est dccriL Cet ctllt chez le coc:bon est 
considcrc comme idcntiquc a "l' idiosyncrasie 
thermique explosive" apres anesthcsie ,cncralc, 
manifestec par l'hommc. n y a un puissant factCUr 
gcnetique dans cct ctllt, qui s'est produit chez 25 
pourccnt des cochons Landrace que nous awns 
utilises. Le sexe n'influence pas son apparition. Le 
syndrome cliniquc consistc en (1) tachyardie, (2) 
rigor de la musculature, (3) tachypnee et hyperventila-
tion, progressant vcrs l'apnec, (4) cyanose en tlCbes 
de la peau, (5) augmentation rapide, SOUtcnUe ct 
CXU'CmC de la temperature Ct (6) acidose gencralisec. 
Le pronostic est trcs negatif, des que l'ctllt s'est bien 
ctllblL Tout essai de traitement a echoue. L'etudc 
histologique n'a montrc que des modifications dam 
les muscles. La signification de ces modific:atiom est 
inamnue. La musculature des ax:hons attcints pn:-
aentc, cx,mparativcment aux cochons Slim, UDC 
reduction anormale du taux d' ATP par reaction i 
l'inrubation et la soumission "in vitro" a l'halothane. 
Cene reaction est une mcthode permenant de pn:voir 
le developpcment du syndrome. L 'halothane, le 
chloroformc et le suxamcthonium ont etc identifies 
comme agents declencheurs. Le mecanisme de pnr 
duction de chaleur est inconnu. 
DURCH NARKOTIKA INDUZIERTE MALIGNE 
HYPERPYREXIE UND EINE METHODE ZU 
IHRER VORAUSSAGE 
zt1SAMMENFASSUNG 
Das klinische bei Schweincn auftretende Syndrom 
einer durch Narkotika ausgclostcn maligncn Hyper-
pyrexie wird beschriebcn. Dieser Zustand bei den 
Schweinen wird als die gleiche "explosive thmnale 
ldiosynkrasie" auf cine allgcmeinc Betiubung ange--
2.2 
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sehcn, wie sic bci Menschen manifest wird. Das 
Krankheitsbild wird durch eincn swken gcnctischen 
Faktor bcstimmt, der bci 25 Prozcnt der van uns 
verwcndetcn Landracc-Schwcine vorhandcn ist. Das 
klinische Syndrom bcsteht aus: (1) Tachykardie, (2) 
Muskclrigor, (3) Tachypnoc und Hyperventilation, die 
in Apnoc iibcrgcben, (4) flcckigc Z}'IDOSc dcr Haut, 
(S) rapider, anhaltcnder und extremer Tcmperatur-
anstieg, (6) swk ausgcpragte Azidose. Wcnn das ' 
Krankheit'Sbild sich ent einmal voll cntwickclt bat, 
ist die Prognosc auficrordcntlich schlccht. Alle 
Bcbandlungsvenuche babcn vcnagt. Eine histologische 
Untcnuchung hat als einzigcn Bcfund cine Veriindcr-
ung im Muske! ergcbcn. Die Bcdeutung dicscr 
Vcriindcrung ist unbckannt. Im Vcrgleich mit gcsundcn 
Schwcincn zeigt sich im Muskclgewebc der bctroJfcncn 
Schwcinc als Rcaktion auf cine Inkubation und 
Halotban-E.xposition "in vitro" cin abnormcs Absinken 
des A TP-Gehaltcs. Dicsc Rcaktion stcllt cine Mctbode 
dar, mit dcren Hilfc man die Entwicklung des Syn-
droms voraussagcn kann. Halotban, Cilorofonn und 
Suxamcthonium aind als auslosendc Agcnticn idcnti-
fizicrt wordcn. Der Mec:banismus dcr Wannc-
produktion ist unbckannt. 
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[Liver Research Group and Dcparunents of Anaesthetics. Medicine, and Surgery, University of 
Cape Town, South Africa] 
The clinical syndrome of anaesthetic-triggered malig-
nant hyperpyrexia (MH) in pigs is described. It is con-
sidered to be the same as MH in humans and is like-
wise genetic in origin. Clinical features are accom-
panied by profound acidosis. Histological change is 
found in muscle only. In vitro, an abnormal deple-
tion of muscle ATP is observed. Halothane, chlorer 
form, and suxamethonium are identified as triggering 
agents. [The SCI® indicates that this paper has been 
cited in over 145 publications.) 
Gaisford G. Harrison 
Department of Anaesthetics 
University of Cape Town 
and 
Groote Schuur Hospital 
Cape Town 7925 
South Africa 
January 8, 1987 
Of all the complications of general anaesthesia, 
perhaps the most dramatic, and indeed frightening, 
is that veritable metabolic storm that characterizes 
the unexpected, and in the past frequently fatal, 
syndrome of anaesthetic-induced malignant hyper-
thermia (MH). first described in 1960,1 and defini-
tively characterized through case reports over the 
next six years,2 this syndrome became the nightmare 
of the anaesthetist. Rare and sporadic, its occurrence 
unpredictable, the syndrome boasted a mortality of 
7D-80 percent. Knowledge of the pathog~is was 
lacking, and no specific therapy was available. 
As on so many other occasions in the long history 
of medicine, serendipity now provided the tkus e:c 
machina that would ultimately help solve this 
dangerous clinical conundrum-in this case, the 
"Hot Pig." The authors of this paper, an interdisci-
plinary group that included surgeons, anaesthetists, 
physicians, and. a laboratory technologist, all mem-
bers of the Liver Research Group of the Univ.enity 
of Cape Town, South Africa, were engaged in a pro-
gram of experimental liver transplantation utilizing 
the pig (Landrace and Landrace X Large White) as 
the experimental model. The anaesthetic protocol 
was based on halothane. 
To the surgeons' annoyance, the physicians' puz-
zlement, and the.anaesthetists' embarrassment, one . 
of the first animals anaesthetized became, for no 
apparent reason, cyanosed and extremely hot, its legs 
rigidly extended, and died before the surgical experi-
mental protocol proper could be started. When, 
frustratingly, a further 5 of the first 34 animals 
anaesthetized displayed the selfsame reaction, we 
realized that the anaesthetist had no cause for .em-
barrassment; we had stumbled on a specific 
syndrome. 
Led through Hall's description (a year previous) of 
the identical reaction in littermate -pigs in response 
to suxamethonium3 to -a consideration of the de-
scribed syndrome of anaesthetic-induced malignant 
hyperpyrexia in human patients,2 we came to the 
exciting conclusion that we had. stumbled.on a fac-
simile in pigs of the human condition. Here, indeed, 
was the animal experimental model of. MH. 
This discovery, reported firit in a preliminary 
cornmunication4 and definitively ·thereafter in this 
paper, was seminal. Today, just less than 20 years 
later, though the minutiae of the pathogenesis of MH 
have yet to be elucidated,knowledge that has come 
from worldwide studies in MH swine has led not only 
to effective pharmacological control of the ~ 
drome,s but.also to valuable ..»in-offs in many bio-
medical areas, in particular those of 111111Cle and 
membrane physiology, calcium transport, and kinet-
ics, and in the meat industry. 
A second reason for this paper's citation is that it 
carried, inter .ua, the first report of:an identifiable 
fundamental functional biochemical lesion in the 
muscle of animals susceplible to M~ i.e., .a marbdly 
increased rate of ATP depletion;,; vitro. We were. 
led to investigate specifically the ATP content of 
musc!e . by the severity of . the . muscle rigor that 
characterizes the syndrome ud that one of us (DD) 
insistently likened to rigor mortis setti'll in-ante-
mortem. Rigor mortis was alrady known to corre-
late with ATP depletion. 
Further, this paper reported for. the first time the 
laboratory in· ~vo identification of agents that trig-
ger MH. 
-Though I e1rned no specific honour or ~ward di-
.rectly through this publiation, it ud the re1e1rch 
that followed from it doubtless contributed to my 
later election as a Life fellow .of my. university. 
It is of some human interest that the authors of 
this paper (excepting the ~tory technologist) 
have .ii subsequently become profeaon and one has 
become a university vice chancellor. [for a recent 
review of the subject, .see. reference 6.J 
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ANAESTHETIC INDUCED MALIGNANT HYPERPYREXIA 
Sir,-In our paper which appeared in your October 
issue (Brit. J. Anaesth., 41, 844) we mentioned the 
possibility that cyclopropane might trigger the onset of 
this syndrome in susceptible pigs. We wish to report 
that we have now had the opportunity on two occasions 
to retest this possibility in known susceptible pigs with 
negative results. Cyclopropane does not trigger malig-
nant hyperpyrcxia in susc!ptible pigs. The triggering 
of the syndrome we observed following exposure of a 
susceptible pig to cyclopropane must be accepted as 
having b:eo due to the previous administration of 
suxamethonium. 
G. G. H.uuu:soN 
s. I. SAUNDERS 
J. F. BIEBUYCK 
R. HICK.'1.\N 





(Reprinted from Nature, Vol. 225, No. 5233, pp. 653-655, 
February 14, 1970) 
Changes underlying Halothane-induced 
Malignant Hyperpyrexia in 
Land race Pigs 
MALIGNANT hyperpyrexia is a rare but often fatal compli-
cation of inhalation anaesthesia in man1• The fluorinated 
hydrocarbon halotha.ne, CF 8CHBrCl, is among the many 
anaesthetic agents which have been implicated\ A 
similar syndrome has been described in a pure Landrace 
strain of pig3 • The onset of this phenomenon is rapid 
(10-15 min after administration of halothane) and there 
is extreme rigidity of skeletal muscles, a rapid rise in 
body temperature to 42°-45° C, severe acidosis and a 
fatal outcome in spite of cooling, muscle relaxants and 
intravenous · alkalis. Once initiated, the process seems 
independent of the tissue -concentration of ha.lothane, 
which appears to act as a trigger. A few animals have 
recovered after brief exposure to halothane. 
Wilson et al. have suggested uncoupling of oxidative 
phosphorylation a.s a possible mechanism•. The process 
is augmented by dinitrophenol and halothane is known to 
uncouple oxidative phosphorylation in normal rat liver 
mitochondria in vitro'. 
All animals studied were of pure Landra.ce or Landra.ce-
Large White cross strains. No untoward effects of thio-
pentone were observed in susceptible pigs over periods of 
up to 150 min. Monitoring was accordingly established · 
under controlled steady state conditions of thiopentone 
anaesthesia with pigs breathing oxygen. Observations 
ma.de during thiopentone anaesthesia were compared with 
those following halothane. Arterial blood samples and 
pressure readings were ta.ken from a femoral catheter. 
Venous blood was withdrawn from an indwelling right 
atrial catheter. Temperatures of the core (oesophagus 
and rectum), liver, muscle and skin were recorded by 
thermistor probes. Oxygen uptake was measured with a 
Benedict-Roth spirometer and respiration was assisted 
during apnoeic periods by manual chest compression. 
Carbon dioxide output was determined gravimetrica.lly 
after absorption in Ca.Cl1/soda-lime. The acid-base status 
of the blood was measured by the Astrup technique6 • 
Tota.I C01 content, serum concentrations of Na.+, K+, 
Ca1+, Mgs+, total protein and inorganic phosphate (P1) 
were determined by standard clinical laboratory tech-
niques. Blood lactate• and pyruvate' were determined 
enzymatically. Blood oxygen tensions were measured 
with a. Clarke electrode. Biopsies of muscle were assayed 
for glycogen• and ATP'. 
Anaesthesia with thiopentone for up to 15,0 min had 
no effect on organ temperatures. Within 10 min (usually 
2.5 
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Fig. 1: Temperature changes in organs of pig 82.A induced by halothane. 
" rhile anaesthetized with thiopentone alone, no significant changes 
took place in those portions of the curves from -150 to -10 min. 
Halothane, S per cent (v/Y) in O,. was commenced at O min. and discon-
tinued at 8 min. A , Liver: 0, rectum; x, oesophagus; A, muscle 
(gluteus); e, abdominal skin. 
3-4 min) of introducing halotha.ne, the temperature of 
all organs rose, except skin (Fig. 1). Cooling of the latter 
and cyanotic blotchiness indicated decreased circulation. 
After discontinuing halothane, the temperature continued 
to rise and maximum core temperature (oesophagus) was 
rea.ched at 30-45 min. 
0 2 consumption and CO 2 output after giving halotha.ne 
were compared with control periods of isothermia on 
thiopentone anaesthesia. The results (Fig. 2) reveal 
augmented uptake of oxygen, but the disproportionate 
rise in CO 2 output resulted in high respiratory quotients 
(l ·69 in one experiment). Oxygen consumption rose 20-40 
per cent per °C rise in core temperature. Between 38° 
and 39° C, passive heating raises 0 1 consumption 18 per 
cent in rats10 and 12-15 per cent in normal human adults11• 
Increased oxygen consumption appeared therefore to be 
slightly greater than that expected from elevated tem-
perature a.lone. 
Table 1 presents some metabolic changes observed 
during the development of malignant hyperpyrexia. These 
changes, initiated by halothane, were: (a) Shift of water 
into the intracellular space; serum Na+ and total protein 
concentrations both increased. (b) Shift of Ca1+ and Mg1+ 
into the extracellular space. 
Concentrations of these two cations rose disproportion-
ately with respect to serum protein concentration assuming 
50 and 30 per cent, respectively, to be protein bound. 
(c) Release of P1 into plasma. (d) Increase in blood 
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Fi:;. ~- A , Pig 39A, weight 80 kg ; B , pig 82A, weight 56·1 kg. Effect 
of halothane on 0 2 consumption and CO, output. 0,/CO, exchange 
was measured over timed 4 min periods. Halothane, 3 per cent (v/v, in 
0,), was given from Oto 8 min. White columns, 0 1 ; hatched columns, 
CO,. •, Oesophageal temperature. 
from values of 60 to 80 to below 50-mg/100 ml. after 2 to 
3 h of anaesthesia. (e) Uncompensated metabolic acidosis 
resulting from a rise in plasma lactate. The base deficit 
was equivalent to the increase in plasma lactate and 
reflected a pure lactic acid acidosis. A respiratory defect, 
denoted by lowered arterial p0 1 in spite of administering 
100 per cent oxygen, could be partly responsible for 
elevated pC0 2 • In spite of diminished respiratory gaseous 
exchange, however, raised CO 2 output, measured gravi-
metrically (Fig. 2), doubtless arose fro:r;n the reaction: 
H++HC03-+H20+C02• Although both plasma lactate 
and pyruvate concentrations increased, "excess lactate", 
calculated according to Huckabee's formula12, indicated 
a net shift in the equilibrium NADH+H++pyruvate~ 
lactate+NAD+, in favour of lactate; presumably the 
result of accumulation of NADH. 
To establish more precisely the interrelation between 



































































































































































































































































































































































































































































































































































































































were carefully timed in a. separate experiment on a. 
susceptible pig (82A) in the first 10 min after ha.lothane 
induction. During this period, oesophageal temperature 
rose from 39·5° to 40·8° C. All the expected changes had 
occurred within 4 min and Ca.1+ and Mgs+ shifts and P1 
and lactate production were apparent a.t 2 min. It was 
therefore clear that biochemical changes preceded the 
onset of pyrexia. and were not secondary to heat injury 
to tissues. The sequence of metabolic changes that we 
have encountered in pigs sensitive to ha.lothane seems to 
be completely different from that associated with heat 
injury13, in which rise in blood lactate is a. late mani-
festation. 
Halcithane, in susceptible pigs, initiates massive and 
uncontrolled glycogenolysis with production of "excess 
lactate" a.nd a. rise in blood glucose. The inecha.nism 
responsible for this is not immediately clear, because the 
usual anaerobic ca.uses of lactate accumulation can be 
excluded. The animals breathed pure oxygen throughout 
the experiment and arterial oxygen tensions . were main-
tained above 100 mm Hg in a.11 cases. Blood pressure was 
over 100 mm systolic, but did fa.11 termina.lly after lact-
a.cidosis had become well established. Cyanotic blotchiness 
a.nd decline in temperature of the skin, however, provided 
evidence of a local perfusion defect, but its contribution 
to the stimulation of glycogenolysis in this and other 
tissues, for example, musc;le, cannot be evaluated. Skin 
a.noxia. is considered unlikely to be responsible for the 
lacta.cidosis, for it appeared after 8-10 min on ha.lothane 
(after serum lactate had risen) and was transient. The 
magnitude of the la.ctacidosis, moreover, continued to 
increase after the skin ha.d returned to a healthy pink 
colour. The possibility remains that muscle rigor resulted 
in occlusion of blood vessels ca.using an a.na.erobic state in 
muse!~. The concentrations of muscle glycogen after 
halothane fell in two animals from 0·56 and 0·35 to 0·28 
and 0·20 g/100 ml., respectively. In one instance muscle 
ATP fell from · 2·7 to 2·2 mg/100 ml., concentrations 
above those at which fully developed rigor mortis is to 
be expected u. In the pigs we studied, the mechanism 
of muscle rigor seemed to be intrinsic, for the :relaxant, 
tubocurarine, was ineffective in dispelling the rigidity. 
Impairment of blood supply to a limb consistently delayed 
onset of rigidity, suggesting that the effect of ha.lothane 
on muscle is humoral rather than neural. 
For the purpose of discussion of the origin of heat, we 
may consider pig 82A (weight 56· l kg). Assuming a 
water content in the body of 67 per cent by weight and 
disregarding body solids (whose specific heat is not easily 
measured), the rise in temperature observed (3·9° C) 
represents extra. heat of 147 kca.lories, which-averaged 
over 40 min-is equivalent to 3·68 kcalories/min. Initia.lly, 
however (5-10 min), the rate was 10·5 kcalories/min. If 
this extra heat were strictly related to increased 0 1 
utilization, 2· 18 l./min additional 0 1 consumption should 
have resulted (assuming that I 1. 0 1 consumed generates 
4·825 kca.lories11) whereas the measured increment at 
5 
2.5 
15 min (T = 41 ·5° C) was 0·38 1./min and by 40 min (T=43·4° C) the increment had fallen to 0·22 1./min. 
Non-oxidative mechanisms seem to be at lea.st partly responsible for the excess heat production. Possibly 
anaerobic sources of heat include: (a) Glycolysis: 
(Glucose)n+H10 - (glucose)n-1 +2 lactate+2H+ 
for which f:1F 0 ' = - 52·4 kcalories/moleu. In pig 82A, heat from this source= 21 · 7 kcalories. (b) N eutra.liza.tion of lactic acid: 
H+ + OH--- H 10; f:1H = -13·6 kca.lories/g equivalent 
In the experimental animal this process provided 11 ·? 
kca.lories. These calculations are based on the rise ii 
serum lactate concentration and are minimal because the 
quantity of lactate oxidized was unkno'WD.. (c) Hydrolysis of high energy phosphate esters. 
During ana.erobiasis, fall of creatine phosphate in frog 
sartorius muscle corresponds to rise in its P 1 content17 • Assuming that the released extra.cellular P1 was derived 
from compounds possessing high phosphate bond energy, for example creatine phosphate, ATP or phosphoenol 
pyruvate, capable . of yielding IO kcalories/mole, the rise 
in serum phosphate from 10 to 30 mg/100 ml. represents 2·4 kcalories in this animal. The sum of accountable 
anaerobic heat sources amounted to 35·4 kcalories or a.bout 25 per cent of that actually evolved. We are 
investigating other potential heat sources which could be activated by ha.lothane. 
The mechanism by which ha.lotha.ne stimulates excess heat production in susceptible pigs is still obscure. Certain 
conclusions can, however, be reached which will influence 
further investigations and possibly management of the similar condition occurring in man. 
(I) Excessive heat production is not accountable in 
terms of oxidative mechanisms a.nd uncoupling of oxida-
tive phosphorylation. Halothane induced an anaerobic 
state favouring breakdown of glycogen and organic phosphate esters. Anaerobic mechanisms have· not 
previously been considered as possible sources of physio-
logical or pathological heat. 
(2) Alterations in the distribution of water a.nd electro-
lytes and lactic acid production preceded significant rise 
in temperature and must be regarded as primary and not secondary to non-specific heat _damage. They were 
apparently closely related to the development of muscle 
rigor. The lactate acidosis was uncompensated and blood 
pC01 rose to levels which could cause narcosis. Immediate 
treatment with intravenous HCOi is contraindicated because dee.th could ensue from C01 poisoning rather than H+ accumulation. 
(3) Known causes of defective tissue oxygenation could not account for the extent of lactate production. Future studies will aim at localizing a. possible defect in 
mitochondrial electron transport. 
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Anaesthetic Induced Malignant Hyperpyrexia-Some 
Observations of the Syndrome in Landrace Pigs 
G. G. H.uuusoN, M. C. BERMAN, R. HICKMAN, A. B. Buu., J. TERBLANCHE 
AND J.E. ICENCH 
DEPARTMENTS OF ANAESTHETICS, CHEMICAL PATHOLOGY AND SURGERY, 
UNIVERSITY OF CAPE TOWN, SOUTH AFRICA 
Malignant hyperpyrexia is a rare and usually fatal complication of general 
anaesthesia. We have found that certain Landrace pigs, when exposed to halo-
thane or succinylcholine, develop a syndrome exactly analogous to that described 
in humans ( Harrison, et al. [ 1] ) . 
As in man, the salient clinical features of the syndrome in these pigs are:-
( 1 ) gross muscle rigor; 
( 2) sinus tachycardia; 
( 3) hyperventilation proceeding to apnoea; 
( 4) blotchy skin cyanosis; 
( 5) an explosive and sustained rise in temperature to end levels of 43 ° -45°C. 
These features appear all but simultaneously and the condition proceeds 
rapidly to fatal termination. Once the syndrome is established, no treatment has 
been of any avail. However, it has proved possible to abort the condition if the 
halothane has been discontinued within three to five minutes of the appearance 
of rigor, tachycardia and hyperventilation. Survivors of aborted attacks have 
all developed this syndrome again when re-exposed to halothane. This circum-
stance has allowed us to make serial biochemical observations on the syndrome 
produced under controlled conditions. 
In summary, such observations showed (Berman, et al. [2]; [3]) a rise in 
serum sodium, potassium, calcium and magnesium, glucose, total protein, lactate, 
pyruvate and excess lactate. Profound acidosis was invariable. 
In this example, blood pH fell within 20 minutes from the control level of 
7.35 to 6.60. Severe lactacidosis was reflected by a base deficit greater than 22 
m.Eq/litre matched by a similar rise in lactate, while PaC02 rose above 150 
mmHg. 
We interpreted these findings as indicating:-
( a) a net shift of water into the cells; 
( b) leakage of potassium, calcium and magnesium out of the cells; and 
( c) massive glycolysis. 
The presence of glycolysis was confirmed by the observation of a simul-
taneous fall in muscle glycogen. Muscle ATP levels also were reduced. Arterial 
P02 levels ( the animal being ventilated with pure oxygen) were maintained 
above 200 mmHg. The high PaC02 recorded was associated with an increase in 
CO2 output and was thought to reflect buffering of the lactacidosis. 
Of importance was the fact that these biochemical changes and the muscle 
rigor preceded the recorded rise in core temperature, and had reached extreme 
values in advance of the temperature. From this we inferred that the changes 
observed were not secondary to the effect of heat on the tissues. Further, the 
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Fig. :!. Temperature changes of malignant hyperpyrexia induced by halothane in Landrace pig. 
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Fig. 3. Biochemical changes associated with halothane induced malignant hyperpyrexia in 
Landrace pig. 
observation that the onset of rigor was delayed in a limb to which the blood 
supply was impaired, led us to conclude that the mechanism by which halothane 
initiated the condition was humoral, and considering its refractoriness to non-
depolarizing muscle relaxants, the disturbance responsible for the rigor was 
probably intrinsic. This led us to investigate whether components of the syndrome 
of malignant hyperpyrexia could be demonstrated in the isolated perfused muscle 
of a susceptible pig as in the intact animal. 
Method 
For this purpose we utilized the isolated hindquarters of a known susceptible 
Landrace pig perfused with oxygenated blood by means of a standard pump 
oxygenator circuit using a Rygg bag with Sams roller pumps. For oxygenation, 
a mixture of 97 per cent oxygen and 3 per cent CO~ was used in a ventilation/ 
perfusion ratio of two to one. The preparation was attained in the following way: 
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Under thiopentone-nitrous oxygen anaesthesia, which we have shown does not 
initiate or influence the syndrome, the aorta was cannulated immediately above 
the bifurcation separately in a cephalad and caudad direction. At the same 
level the inferior vena cava was cannulated in a caudad direction. The distal 
aortic cannula was connected to the arterial outflow from the pump oxygenator, 
and that from the vena cava to the venous well. The animal was heparinized and 
bled out via the proximal aortic cannula into the venous well of the pump 
oxygenator, which had been primed initially with one litre of '.fisUsol. The 
inferior vena cava was ligated above its cannula and perfusion of the hind-
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Fig. 4. Acid base changes associated with halothane induced malignant hyperpyrexia in 
Landrace pig ( arterial ) . 
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quarters was commenced. Following the exsanguination of the pig, PCV of the 
perfusing fluid was 20 per cent. As soon as adequate perfusion of the hindquarters 
was established and the animal had been bled out to the point of cardiac arrest 
into the oxygenator, the body was completely transected immediately above the 
pelvis, the gut was removed and haemostasis was secured. The temperature of 
Fig. 5. Isolated hind limbs of Landrace pig perfused with m.·ygenated blood by means of 
a standard pw11p oxygenator circuit. 
the arterial blood was kept constant at 38°C by a thermostatically controlled 
water jacket on the arterial line. Temperature of the venous return was monitored 
by a thermistor in the venous well. After a short period at 700 ml/ min. arterial 
inflow was maintained constant throughout the e"'"Periment at 500 ml/ min. This 
gave an approximate flow of 5-6 ml/ lOOG of muscle per minute. Arterial P02 
values recorded throughout the perfusion varied between 380-480 mmHg. Follow-
ing a control period of perfusion of 70 minutes, 3 per cent halothane vapour was 
introduced into the oxygenator by means of a Fluotec vaporizer and the response 
of the preparation studied. Biochemical changes were followed in serial blood 
specimens taken from the venous and arterial lines. In addition, the pH of the 
venous outflow was continuously recorded from an electrode in the venous well. 
The experiment was terminated 35 minutes after the introduction of halothane. 
Results 
Five minutes after the introduction of halothane fasciculation was observed 
in the muscle, which had been flaccid up to this time. Sustained rigor of the 
muscle followed and was well developed within a further five minutes. 
Serum Electrolytes 
Monitored in the venous efBuent, biochemical changes exactly similar to those 
previously observed associated with the syndrome induced in the intact animal 
developed with rapidity following the introduction of halothane. Following little 
change during the 70 minute control period of perfusion, changes from control 
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Fig. 6. Biochemical changes in isolated perfused muscle preparation in response to halothane. 
levels were noted in the first specimen taken eight minutes after the introduction 
of halothane. Rises were evident in the serum concentrations of sodium, potassium, 
calcium, magnesium and Pi. 
Acid Base State 
Though a degree of acidosis was present during the control period of per-
fusion, the acid base state remained fairly steady. Introduction of halothane was 
followed immediately by the characteristic profound and progressive lactacidosis 
seen in the intact animal. Thirty-five minutes from the introduction of halothane 
the pH had fallen to 6.575; PaC02 was in excess of 150 mmHg and the base deficit 
matched by the level of lactate was greater than 22 m.Eq/L. 
Perfusion Pressure 
The perfusion pressure remained constant at 30 mmHg throughout the 
control period of the experiment. The introduction of halothane was followed for 
a few moments by a slight fall whereafter the pressure rose steadily to reach 40 
mmHg after 30 minutes. 
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Fig. i. Acid base changes in isolated perfused muscle in response to halothane (venous return). 
Temperature 
No change was observed in the temperature of the venous effiuent. 
Discussion 
We did not observe a rise in temperature in the venous effiuenl This 
excepted, the perfused muscle preparation showed the same muscle rigor and 
biochemical changes that we have previously observed in the syndrome of malig-
nane hyperpyrexia triggered by halothane in the intact animal. From this obser-
vation certain conclusions follow:-
( 1) The mechanism by which this syndrome is initiated by halothane in suscep-
tible pigs is in its simplest form humoral. Disturbances of the normal integrated 
mechanisms of heat homeostasis play no primary part in the production of this 
syndrome. 
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( 2 ) The profound biochemical changes observed are not in any way secondary 
to hyperthermia, but evidence of an underlying biochemical lesion of which the 
ultimate rise in body temperature is an accompaniment. 
( 3 ) Taking into consideration the prominence of muscle rigor in this syndrome 
in pigs as well as in man, the proportion of the body mass that is muscle tissue 
and the e,'idence that all the changes recorded in the syndrome in the intact 
animal were shown by this perfused muscle preparation, one may speculate that 
muscle is the tissue primarily responsible for this syndrome. 
Another observation that invites comment is that related to the blood flow in 
this preparation. In examining the possible reasons for the massive lactacidosis 
obsen,ed, Berman and co-workers [3] questioned the possibility of an anaerobic 
state in the muscle due to obstruction of blood vessels from some physical effect 
of the rigor. In this preparation there is evidence of an increased vascular resis-
tance in that progressive rise was observed in the perfusion pressure in the face of 
a constant blood flow, but the biochemical changes recorded preceded this event. 
Lastly, I wish to draw your attention to our observation that in pigs suscept-
ible to malignant hyperpyrexia, both the intact animal and the muscle preparation 
described here, the muscle rigor that followed exposure to halothane was preceded 
b,· fasciculation. In cases of the syndrome recorded in man, both halothane and 
succinylcholine feature prominently as possible initiators of the condition 
(Daniels, et al. [4] ; Wilson, et al [5] ). We have previously demonstrated that in 
these pigs both halothane and succinylcholine are triggering agents ( Harrison et 
al. [l ]) . In both pigs and humans, the fasciculation that followed administration 
of succin~·lcholine was exaggerated. The elucidation of a common denominator 
2.6 
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in the action of these so different agents in the animal-pig or human-susceptible 
to malignant hyperpyrexia may provide the key to an understanding of this syn-
drome. Is this observation perhaps a beginning? 
Summary 
An experiment is described in which the biochemical changes and muscle 
rigor of the syndrome of anaesthetic induced malignant hyperpyrexia, previously 
described in the intact animal, are demonstrated in a preparation of isolated per-
fused muscle taken from a Landrace pig previously shown to be susceptible to 
this condition. 
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PALE, SOFT, EXUDATIVE PORK, PORCINE STRESS SYNDROME AND MALIGNANT HYPERPYREXIA-AN IDENTITY ? 
G. G. HARRISON* 
SUMMARY 
Pale, soft exudative pork (PSE pork) is 
a stress-related syndrome, resulting in un-
desirable meat quality. Clinical and bioche-
mical features of the porcine stress syndrome 
(PSS) seemed similar to those described in 
the syndrome of anaesthetic-induced malig-
nant hyperpyrexia manifested by swine. An 
investigation is described which seeks to 
establish if swine susceptible to malignant 
hyperpyrexia would manifest · PSE pork. 
Changes occurring post mortem in the muscle 
of swine susceptible to malignant hyper-
pyrexia and killed by exsanguination were 
studied. These demonstrated that the muscle 
of swine susceptible to malignant hyper-
pyrexia shows the same gain in expressible 
water with a similar pattern of pH fall to 
that associated with PSE pork. 
INTRODUCTION 
The condition now called pale soft exuda-
tive pork (PSE pork) has long been recogniz-
ed I and is of economic importance in the pork 
industry. Characterized by rapid post mortem 
glycolysis, accumulation of lactic acid and 
rapid fall in muscle pH which results in un-
desirable meat quality, PSE pork has been 
shown to be a stress related syndrome 2-,. 
The porcine stress syndrome (PSS) is also 
of economic importance: it causes death of 
swine in transport, is characterized by pro-
gressive dyspnoea, increasing body tempera-
ture, death within minutes of onset of symp-
toms and immediate rigor mortis 2• This acute 
death syndrome in stress-susceptible swine 
bears an extremely close clinical similarity to 
the syndrome of malignant hyperpyrexia 
which follows exposure of susceptible swine 
to halothane anaesthesia and succinylcho-
line s..7. and even severe exercise •. 
Such association prompts the hypothesis 
that PSS, PSE pork and malignant hyper-
•Department o! Anaesthetics, University o! Cape Town. 
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pyrexia in swine are indeed manifestations of 
the same myopathy. It was of interest, there-
fore, to establish whether malignant hyper-
pyrexic swine, which, at initiation of the 
syndrome, manifest extremely rapid glycoly-
sis, lactacidosis and rapid pH fall immediately 
ante mortem 9, would develop PSE pork post 
mortem. 
MATERIAL AND METHODS 
The post mortem changes in muscle in 
three groups of swine were studied: 
Group 1 normal swine (controls) (7 pigs) 
Group 2 swine susceptible to malignant 
hyperpyrexia (MHS) (3 pigs) 
Group 3 Swine, susceptible to malignant 
hyperpyrexia, J.n which the syn-
drome was established ante mortem 
(MHAM) (3 pigs) 
The inclusion of Group 3 was motivated 
by a desire to simulate the possible initiation 
in susceptible swine of the syndrome ante 
mortem by the exercise, struggle and stress 
of abattoir slaughter. The swine studied were 
Landrace and Landrace x Large White cross-
breds from the Western Cape region. 
Susceptibility to malignant hyperpyrexia 
was tested by screening all animals with a 
test challenge of halothane anaesthesia 5 one 
week or more before each experiment. 
All pigs were killed by exsanguination 
from the aorta following induction of general 
. anaesthesia. Those in Groups 1 and 2 were 
anaesthetized with thiopentone sodium, oro-
tracheal intubation with nitrous oxide and 
oxygen administered by an intermittent posi-
tive pressure ventilation technique. Those in 
Group 3 were anaesthetized with halothane, 
thus effectively initiating the syndrome of 
malignant hyperpyrexia ante mortem. Where-
as most reported investigations into PSE pork 
were undertaken on pigs slaughtered in abat-
toirs by stunning and exsanguination, our in-
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vestigation was undertaken on animals being 
used in surgical research as blood donors. 
Hence our use of general anaesthesia. We 
regarded the subsequent death of the animal 
by exsanguination as simulating that -of abat-
toir slaughtered pigs. 
Immediately following the death of the 
animal, it was turned prone. A pH electrode 
(Metrohm Herisau compensator E 388) and 
thermistor probe (Ellab Type TE 3) were 
inserted directly into the belly of one longis-
simus dorsi muscle at the level of L 2-3, 
while the opposite longissimus dorsi was 
exposed, and from it serial sections were taken 
for analysis. 
The following observations were made 
at 30 mins., 1 hour, 1! hours, 21 hours, 31 hours, 
51 hours and 24 hours post mortem:-
!. Intramuscular pH. 
2. Muscle temperature. 
3. Estimation of expressible muscle water 1• 
4. Measurement of muscle lactate (Boehr-
inger Mannheim Test Combination-Bio-
chemica, Cat. No. 15972) . This measure-
ment was only performed up to 51 hours 
post mortem. Between 51 and 24 hours 
the carcass was refrigerated to 2--4°C. 
Though other workers had graded meat 
on colour, we found the assessment of various 
grades of "pink" subjective and abandoned 
the use of this observation. 
RESULTS 
Expressible water 
The changes recorded in expressible water 
post mortem are presented diagrammatically 
in Figure l, with the actual amounts and the 
statistical significance of the relevant differ-
ences in Table 1. The groups of animals dis-
played 3 grades of increasing expressible 
water content post mortem in the order-
Control (1) <MHS (2) <MHAM (3) 
Whereas the differences in expressible 
water content between the MHAM and the 
control group are significant over the whole 
time range, that between the MHS group 
and controls achieve significance after 5 hours. 
Though the means of the MHS and MHAM 
groups differ, statistical significance is only 
Table I: CHANGES IN EXPRESSIBLE WATER 
Water content expressed as me/& of muscle 
HOURS POST MORTEM 
GROUP ! 1! 2! 3! st 2-4 
CONTROL (1) 37-4 368 359 35-4 387 368 <ISS 
MHS (2) '400 "405 389 393 -429 '453 533 
MHAM (3) <182 506 '496 5"40 516 557 575 
Statistical Sienificance of Differences 
CONTROL-MHS NS* NS NS NS NS P<0,02 P<O.OOl 
CONTROL-MHAM P<0,01 P<0.002 P<0,01 P<0.01 P<0,05 P<0.001 P<0.001 
MHS-MHAM NS NS NS P<0,05 NS NS 
-, NS 
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achieved at one point. Differences were such, 
however, that it is felt that statistical signifi-
cance would have been achieved had more of 
the MHS animals been available. The express-
ible water content of both the MHS and 
MHAM groups at 24 hours is well within the 
range observed in PSE pork 1, 10• 
pH 
Changes observed in intramuscular pH 
are presented diagrammatically in Figure 2 
with the actual figures and statistical signifi-
cance of the relevant differences in Table 2. 
Though the ultimate pH reached is the same, 
the rate of fall is different in the three groups 
of animals in the order-
MHAM (3)>MHS (2)>Control (1) 
That of the MHAM group is the most 
rapid, virtually reaching its lowest limit by 
the time the first observations were made 
30 minutes post mortem. That of the MHS 
group starts at a level near that of the control 
group but falls rapidly to reach that of the 
59 
MHAM group by 2i hours post mortem. The 
control group only reached similar · levels at 
5l hours post mortem. 
The water-holding property of pork has 
been shown to depend on the rate of pH fall 
post mortem, a reflection of the rate of post 
mortem glycolysis u, 10• Taking the pH values 
recorded at 30 minutes, 60 minutes ~d 90 
minutes after exsanguination as reflecting the 
rate of pH fall, we were able to show a strong 
inverse correlation between these values and 
the expressible water content of pork measur-
ed at both 5 hours and 24 hours post mortem, 
·- i.e.- the more rapid the pH fall, the higher 
the expressible water content. The correla-
tion coefficients with their relevant probabi-
lity values are presented in Table 3. 
Lactate 
Corresponding with the patterns of pH 
fall, three grades in the rise of muscle lactate 
were observed in these groups of animals, in 
the order, for rate and quantity: 
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Table 2: CHANGES IN pH 
HOURS POST MORTEM 
GROUP t 1 It 2t H ! st 2'4 
CONTROL (1) 6,70 MO 6.23 6,02 S,91 i S.S2 S,70 
I 
MHS (2) 6.'42 6,0S S,79 S,61 S.63 I S.56 s.ss 
MHAM (3) S,78 S,S9 s.ss S.S3 I s.so I S,S9 s.n I 
Statistical Sienificance of Differences 
CONTROL-MHS NS P<0,02 P<0.02 P<O.OS NS NS NS 
CONTROL-MHAM P<0,01 P<0,001 P<0.002 P<0,01 P<O,OS NS NS 
MHS-MHAM NS NS I NS NS NS NS NS 
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Table 3: CORRELATION COEFFICIENTS 
EXPRESSIBLE WATER/pH 
pH AT TIME POST MORTEM (P.M. ) 
Expressible 
30111inuus 60 111inuies 90 111inuies 
water r=-0,89 r=-0,87 r=-0,83 at 5 hours p.m. 
P< 0.001 P< 0.001 P< 0,001 
Expressible r=-0,67 r=-0,75 r=-0,7'4 water 
at 2'4 hours p.m. P< 0.05 P< 0,01 P< 0.01 
DISCUSSION 
The criteria by which PSE pork is judged 
are primarily colour and content of express-
ible water 2• 3• It has been shown that 
PSE pork is associated with circumstances 
which result in rapid post mortem glycolysis, 
myolactosis and rapid fall in pH 10• u. Such 
conditions appear to exist in association with 
the porcine stress syndrone (PSS). Response 
of stress-susceptible swine to environmental u, 
anoxic 13 and exercise stress I appears to 
resemble closely the clinical ~ and biochemical 
changes' observed in the syndrome of malig-
nant hyperpyrexia. Our observation of the 
Table '4: CHANGES IN LACTATE 
Lactate expressed i~ µmol/e muscle 
HOURS POST MORTEM 
GROUP t I I l! 2i 3i s 
CONTROL 31 '40 '43 '48 58 70 
MHS '43 '49 so 62 79 100 
MHAM 87 99 108 125 120 123 
Statistical Sienificance of Differen:es 
CONTROL-MHS NS NS 
I 
NS NS NS P<O.OS 
CONTROL-MHAM P<0.01 P<0.002 P<0,0'4 P<0.001 P<0.001 P<0,001 
MHS-MHAM NS 
MHAM (3)>MHS (2)>Conµ-ol (1) 
These values are presented diagrammati-
cally in Figure 3 with the actual values and 
statistical significance of the relevant ,differ-
ences in Table 4. The differences between the 
control group and the MHAM group were 
highly significant over the whole range. That 
apparent between the MHS and MHAM group 
just failed to achieve significance due to the 
small size of the two groups of animals. Start- • ing at the same level as that of the control 
group, the MHS pigs show a higher rate of lactate production, the difference from the 
controls achieving statistical significance at 51 hours post mortem. 
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' 
NS NS NS NS NS 
post mortem changes in muscle of malignant 
hyperpyrexial swine shows that it manifests 
the same reduction in water-holding with a 
similar pattern of rapid pH fall as that asso-
ciated with PSE pork. In those swine, in which 
the syndrome was actually initiated before 
death, the changes were most rapid and 
severe, the pH reaching its minimum very 
shortly after death. When the syndrome was 
not initiated ante mortem, the pattern of 
glycolysis, pH fall and myolactosis was still 
much faster than that of controls, with a similar loss in water-holding property. Though 
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FIGURE 3 
pyre:xia were similar to those described in 
PSS by Wismer-Pedersen & Briskey 10 and 
Toppel 1, we did not observe as low levels, 
nor the even lower levels described by Lawrie 
et al 11• This may possibly be the result of 
our use of anaesthesia before exsanguination, 
with a resultant tranquil death, whereas 
stress and struggling usually preceded the 
stunning and exsanguination at the abattoir 
as observed in these studies. 
Malignant hyperpyrexia swine have been 
shown to have higher levels of serum CPK 11• 
This same enzyme is markedly raised in asso-
ciation wit PSE pork 15• Our demonstration 
of the PSE pattern of expressible water in the 
carcasses of malignant hyperpyrexia-suscept-
ible swine is further evidence that PSS, PSE 
pork and susceptibility to malignant hyper-
62 
pyrexia may well be an identity-all expres-
sions of the same myopathy. 
Should such an hypothesis be valid, cur-
rent concepts of the aetiology of malignant 
hyperpyrexia 1'-18 could help towards an under-
standing of PSE pork and PSS and conversely 
so. 
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Chapter 23 
THE EFFECT OF PROCAINE AND CURARE 
ON THE INITIATION OF ANAESTHETIC-
INDUCED "MALIGNANT HYPERPYREXIA 
G. G. HARRISON 
THERE 1s EVIDE:>,;CE that the lesion or abnormality responsible for 
anaesthetic-induced malignant hyperpyrexia in humans lies with-
in muscle.1-::,3 •4 That this is so in certain Landrace pigs, suscepti-
ble to what I believe is the same syndrome, was clearly demon-
strated by Harrison et az.:. when they showed that the clinical and 
biochemical accompaniments of the syndrome previously identi-
fied in the intact pig challenged with halothane could be repro-
duced in an isolated perfused muscle preparation. 
The predominant clinical features of the syndrome in pigs 
are as follows: 6 
l. Gross muscle rigor, particularly evident in the hind legs 
which become rigidly extended (Fig. 23-1). This rigor is usually 
preceded briefly by fasciculation of the muscles. 
2. An explosive rise in temperature-a rate of 1 °C every five 
to seven minutes with end temperatures of between 43°C and 45°C 
being usual (Fig. 23-2) . 
3. Tachycardia. 
4. Hyperventilation proceeding to apnoea. 
I wish to express my gratitude to Mrs. Carin Verburg and Dr. Colin Beig
hton 
for excellent technic:il assistance and Mr. Brian Sassman for the initia
l screening 
and selection of susceptible pigs, as well as post-anaesthetic recovery care
. I am in-
debted to the Liver Research Group and the Department of Surgery o
f the Uni-
versity of Cape Town for the supply of pigs. Electrolyte estimations 
were per-
formed by the Department of Chemical Pathology of the University
 of Cape 
Town. 
This research programme was financially supported by the Anglo Americ
an and 
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Figure 23-1. Onset of muscle rigor in hind limbs of Landracc pig following 
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Figure !!3-2. Continuous record of oesophageal temperature. Administration 
oI halothane following the control period of Thiopentone anaesthesia. 
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5. Blotchy cyanosis of the skin, most noticeable on the ab-
dominal wall and snout. 
In susceptible animals, the syndrome becomes manifest within 
5 to 15 minutes of exposure to halothane. The onset is generally 
more rapid when anaesthesia is directly induced with halothane, 
especially if this accompanied by struggling, and is usually slower 
if anaesthesia is first induced with thiopemone, halothane being 
exhibited when the animal is quiet. If halothane is discontinued 
at the very first appearance of rigor, the development of the syn-
drome may be aborted. If administration of halothane is continu-
ed for approximately ten minutes after initiation, the syndrome 
becomes irreversible resulting inevitably in the death of the 
animal, usually within 40 to 60 minutes. 
Profound acidosis is an invariable accompaniment of the syn-
drome and develops with bewildering speed, as do also rapid rises 
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ACID BASE CHANGES ASSOCIATED WITH 
HALOTHANE INDUCED MALIGNANT HYPERPYREXIA 
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BIOCHEMICAL CHANGES ASSOCIATED 
WITH HALOTHANE INDUCED MALIGNANT 
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Figure 211-5. 
The observation that muscle fasciculation precedes the rigor is 
important in relation to the agents which initiate or trigger the 
syndrome in these animals. '\Ve have identified halothane and suc-
cinylcholine as such agents0 (Fig. 23-6) . Of the many agents that 
have been associated with the condition in humans, halothane 
and/ or succinylcholine are by far the most prominent, featuring 
2.8 
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Figure 23-6. Initiation of the syndrome by succinyld1olinc. S.C. = injection 
of succinylcholine in dose shown. 
in excess of iO percent of cases.6·~·10 That these two so dissimilar 
drugs could have some common denominator or synergism was 
hinted at many years ago by the work of Sabawalla and Dillon,11 
which showed that halothane caused an increase in the twitch 
response of muscle to both direct and indirect stimulation, and 
more recently by Tammisto and Airaksinen1!! who demonstrated 
an increase in serum CPK level after administration of succinyl-
choline, which was sevenfold greater when this drug was given in 
association with halothane than when given with thiopentone 
alone. 
Caffeine has long been known to cause a persistent contraction 
or rigor of muscle fibre which persists until the caffeine is remov-
ed.13·14 This rigor is due to an enhancement of release and an in-
terference with rebinding of calcium ions by the sarcoplasmic 
reticulum. This allows a net efflux of calcium from the sarco-
plasmic reticulum, a rise in sarcoplasmic calcium concentration, 
which actiYates myofibrillar ATPase, and maintains contrac-
tion.1:;.10 
Procaine is known to block this effect of caffeine on muscle by 
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preventing calcium efflux. This effect is due to an action on the 
reticulum and not to a complexing with the caffeine. Once caf-
feine rigor has become well established, procaine has been said to 
have no effect.17 l\Iore recently it .p.as been shown that procaine 
can reverse early caffeine rigor. 1~ 
In a very significant paper last year, Kalow and co-workers1~ 
reported the following as the three most fundamental_ observa-
tions made on muscle preparations from human survivors of an-
aesthetic-induced malignant hyperpyrexia: 
1. Such muscle was more sensitive to caffeine rigor than that 
of normal controls. 
2. This effect was enhanced by exposure to halothane. 
3. Halothane depressed calcium uptake by the sarcoplasmic 
reticulum of these patients, whereas it had no effect on that of 
normal controls. 
An obvious question that must follow from· these observations 
is that if halothane and caffeine produce similar changes in sar-
coplasmic reticular function and, in fact, enhance each other's 
action, would not procaine block such action of halothane in the 
same manner as it is known to block caffeine rigor? Also, what 
effect would procaine have on succinylcholine initiation of the 
syndrome? 
I thought the answers to these questions would give some clue 
to the trigger mechanism common to halothane and succinylcho-
line in this syndrome and so, perhaps, help towards a better under-
standing of the genesis of the syndrome itself. 
The answers were sought in the following experiments on pigs 
(25-30 kg) known from halothane presceening to be susceptible 
to malignant hyperpyrexia. 
EXPERIMENTAL METHOD 
All experiments were carried out under a standard general 
anaesthetic consisting of induction of anaesthesia with thiopen-
tone, endotracheal intubation and maintenance of anaesthesia 
with nitrous oxide and oxygen with IPPR. 
Under these conditions the influence of pretreatment with 
tubocurarine and procaine on the initiation of the hyperpyrexic 
2.8 
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syndrome by halothane and succinylcholine was studied. The 
drugs were administered in the following combinations and se-
quences-each sequence forming a separate experiment. (The 
number of times each experiment was repeated is given in paren-
theses.) · 
Tubocurarine-halothane (1) 




Tubocurarine and succinylcholine were administered as single 
doses. Procaine was administered as a 0.6% solution by I.V. drip 
infusion, a loading dose of 30 mg/kg preceding maintenance in-
fusion at rates which .varied between 0.2 to I mg/kg/min. (Use 
in vitro of 1 to 3.3 mM concentrations is described18•1li) . ECG 
control was found to be mandatory when using procaine in this 
order of dosage together with halothane. Bradycardia and hypo-
tension were innriable and it was expedient to support the cir-
culation with an infusion of isoprenaline (concentration 
Iµg / ml). 
The onset of the syndrome was identified as follows: 
1. The onset of rigor-monitored crudely by means of a \\Tite-
ou ton a revolving drum attached by a string to the pig's hind leg. 
2. The rapid rise in muscle temperature-monitored by an 
intramuscular thermistor probe. 
These two obsen•ations. rigor and rise of temperature, were 
considered adequate for identification of the syndrome. 
3. Serial biochemical parameters were measured on central 
venous blood of some pigs. 
" 'hen the syndrome did not develop following procaine pre-
treatment, the animal subsequently was reexposed under thiopen-
tone anaesthesia to halothane in the absence of procaine. Such 
animals all developed the hyperpyrexic syndrome. 
In five pigs the effect of procaine infusion on the established 
syndrome "·as studied. 
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RESULTS 
The results of these experiments are set out m Table 23-I. 
TABLE !?3-I 
THIOPEXTONE, A20 10 2 A~AESTHESJ..\ 
Pretreatment _. NIL Curare 
Trigger agent l 





Established Cooling Curare 
syndrom~ alkali etc. 
DEATH IN DEATH IN 
RIGOR RIGOR 
Xote: + =initiation of hyperpyrexic syndrome. 







The administration of tubocurarine did not prevent the initiation 
of the syndrome by halothane, but did prevent its initiation by 
succinylcholine. Procaine blocked the initiation of the syndrome 
both by halothane and succinylcholine when these drugs were 
given separately. When succinylcholine was given in the presence 
of halothane, fasciculation passed on into rigor and a fulminant 
rise in temperature occurred in two of three pigs. The rigor was 
ultimately controlled by continued procaine infusion. The rigor 
softened with concurrent cessation of temperature rise. The bio-
chemical changes recorded as accompaniments of the syndrome 
only appeared in the presence of rigor and temperature rise and 
reverted towards normal when these were overcome. 
I will illustrate some of these results (Figs. 23-i, 23-8 and 23-9). 
In five pigs in which the syndrome was well established with the 
temperature in excess of 42°C, large doses of procaine led to an 
ultimate softening of the rigor. No other method of treatment we 
have used has ever achieved this.c Ancillary treatment of admin-
istration of alkali was used in all with cooling in one. Two pigs 
survived (Fig. 23-10). 
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Figure 23-8. Blod of halothane induced hyperpyrexia and rigor by pretreat-
ment with procaine. 
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Figure 23-10. Temperature record of established syndrome treated by pro-
caine. 
2.8 
282 J11t('rnational Symposium 011 Malignant H)•pe1·thermia 
DISCUSSION' 
These experiments on the initiation of anaesthetic-induced 
malignant hyperpyrexia by halothane in susceptible pigs show the 
follmring : 
1. Halothane can trigger the syndrome in the presence of 
neuromuscular block. 
2. Procaine effectively blocks halothane initiation of the 
syndrome. 
'We may infer from the first observation that the site of action 
of halothane must be at some point in the excitation-contraction 
mechanism distal to the muscle endplate. From the second, con-
sidered in association with what we knoll· of the genesis of caf-
feine rigor. procaine's action thereon, and Kalow's observations on 
the reticular function of human malignant hyperpyrexic surviv-
ors. '"e may infer that this site is probably sarcoplasmic reticu-
lum. But as halothane has such an action only on certain geneti-
cally predisposed pigs,G we must postulate that in these animals 
the sarcoplasmic reticulum itself has some intrinsic functional de-
fect-possibly some defect in the uptake of or binding of calcium 
from the sarcoplasm. The existence of some such defect is sug-
gested by our earlier obsen·ation that the ATP concentration in 
muscle in ·vi 11'0 falls more rapidly in muscle from susceptible pigs 
than in that from controls. Such a fall could be secondary to ex-
cess or more rapid than normal utilisation of ATP, following sar-
cotubular calcium release. K.alow and co-work.ers11 have shown 
that halothane enhances this defect in susceptible humans. We 
may postulate that this would allow the sarcoplasmic level of cal-
cium to rise sufficiently in susceptible animals to initiate the con-
traction process. Once contraction is initiated, the continued pres-
ence of calcium ions sen•es to maintain the rigor and the condi-
tions for the runaway glycolysis, which we regard as a hallmark 
of the syndrome, will be present. Berman's recent obsen•ation!!II 
that in the very early stage of the syndrome, triggered by halo-
thane. ATP levels are maintained and, in fact, rise slightly, 
" ·ould support this postulate. Once the syndrome is initiated the 
intrinsic hypoxia and high temperature would further damage 
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the reticular calcium pump, perpetuating the condition and ex-
plaining our observation that once the syndrome is firmly initiat-
ed, removal of the cause-halothane-leads to no amelioration of 
the condition. Halothane serves verily a trigger role. Doubtless 
the depressant effect of halothane on mitochondrial respiration:!1 
is but another factor in the earlv initiation of this vicious cvcle. 
I ' 
My findings with regard to the initiation of the syndrome by 
succinylcholine also fit well the postulate of a reticular calcium 
binding and/ or release defect. 
1. The observation that succinylcholine initiation of the syn-
drome is effectively blocked by the neuromuscular block of tubo-
curarine indicates that end plate depolarization is necessary to the 
trigger action of succinylcholine in this condition. The diffuse 
muscle depolarization and contraction that follow succinylcholine 
administration doubtless presents the defective sarcotubular 
pump with more calcium than it can rapidly remove, so contrac-
tion persists. It is well documented that the muscle fasciculation 
that follows the administration of succinylcholine in affected an-
imals and humans is gross and sustained, progressing to rigor. The 
observation by Sybesma and Eikelenboom~ that severe exercise 
alone will initiate the hyperpyrexic syndrome in susceptible an-
imals would also support this postulate that it is the presentation 
to the reticular pump of an above-threshold task of calcium re-
moval, rather than some action of succinylcholine per se, which is 
the basic mechanism by which succinylcholine induces the syn-
drome. Again, once contraction is initiated and maintained by the 
contim.ied presence of calcium ions in the sarcoplasm, the con-
ditions for the runaway glycolysis with its built-in vicious cycle 
will be present. 
2. Procaine infusion also prevented succinylcholine initiation 
of the syndrome. It did not prevent the muscle fasciculation in-
duced by succinylcholine, but definitely reduced it in degree. 
This reduction in the degree of muscle fasciculation may well rep-
resent a reduction in the magnitude of calcium ion efflux to a 
level that could still be effectively removed by the "defective" 
reticular pump so that relaxation could supervene. 
3. My last obserYation that though procai~e blocks the initia-
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tion of the syndrome by halothane and succinylcholine indiYid-
ually. it does not when these nm drugs are given together may 
simply represent the result of a summation of effects. Of impor-
tance is the obsen-ation that the syndrome so initiated appears to 
be reversible, in contrast to its inexorable course in the absence 
of procaine. It is relevant that in contrast to the findings of oth-
ers, ,veber and Herz1" recorded the observation that in vitrn pro-
caine, besides blocking. could reverse early caffeine rigor. 
This work is also relevant to my observations on the effect of 
procaine infusion on the established syndrome. In five pigs in 
which the syndrome initiated by halothane was well established 
with profound rigor and temperature in excess of 42°, procaine 
infusion resulted in softening of the rigor and cessation of temper-
ature rise. Two of these pigs sun·ived. I report these last obser-
Yations perhaps prematurely, because to me they provide the first 
glimmer of hope of some specific treatment in a condition which, 
though rare, results in a frightening mortality for those afflicted. 
Investigation into factors which enhance calcium ion uptake by 
the sarcoplasmic reticulum will, I am sure, lead ultimately to a 
pharmacologically rational and successful treatment of this dread 
condition. 
SUMMARY 
The clinical features of anaesthetic malignant hyperpyrexia in 
genetically susceptible Landrace pigs are described. 
In such pigs it is demonstrated that procaine blocks the initia-
tion of the hyperpyrexic syndrome by both halothane and suc-
cinylcholine. Curare pretreatment prevents the trigger action of 
succinylcholine only. 
A preliminary report of the use of procaine in the treatment 
of the established syndrome is given. 
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Anaesthetic-induced Malignant 
Hyperpyrexia: A Suggested 
Method of Treatment 
GAISFORD G. HARRISON 
Summary 
Experiments in susceptible Landrace pigs have shown 
that procaine blocks the initiation of anaesthetic-induced 
malignant hyperpyrexia by both halothane and succinyl-
choline. Pretreatment with curare prevents only the 
trigger action of succinylcholine. In a preliminary study 
procaine was used to treat the established syndrome in 
five pigs, two of which survived. On the basis of these 
findings a treatment regimen can be suggested for 
patients who develop malignant hyperpyrexia. 
Introduction 
Though rare, anaesthetic-induced malignant hypcrpyrcxia 
continues to attract attention because of its unpredictability, 
the frightening mortality in those afflicted (in excess of 70° 11 ), 
the puzzle of its pathogenesis, and the complete lack of rational 
treatment (British Medical Journal, 1968). There is evidence 
that the lesion or abnormality responsible for this syndrome 
lies within muscle (Satnick, 1969; Denborough et al., 1970; 
Harrison et al., 1970; Isaacs and Barlow, 1970). This knowledge 
was greatly extended by Kalow ct al. (1970) when they reported 
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three fundamental observations made on muscle preparations 
from human survivors of malignant hyperpyrexia. These were 
that (1) such muscle was more sensitive to caffeine rigor than 
that of normal controls, (2) this effect was enhanced by exposure 
to halothane, and (3) halothane depressed calcium uptake by the 
sarcoplasmic reticulum of these patients whereas it had no effect 
on that of normal controls. · 
Caffeine rigor in muscle due to an enhanced release and 
depressed rebinding of calcium ions by the sarcoplasmic 
reticulum (Weber and Herz, 1968; Weber, 1968) has long been 
known to be blocked by procaine (Feinstein, 1963), an effect 
due to an action of procaine it~elf on the reticulum and not 
procaine caffeine complexing. 
An obvious question that must follow from these observations 
is that if halothane and caffeine produce similar changes in 
sarcoplasmic reticular function, and in fact enhance each other's 
action, would not procaine block such action of halothane in 
the same manner as it is known to block caffeine rigor? (Strobel, 
1971). Also, what effect would procaine have on succinylcholine 
initiation of the syndrome, succinylcholine being with halothane 
the common initiator of the syndrome ? (Wilson er al., 1967; 
Daniels et al., 1969; Harrison et al., 1969; Britt and Kalow, 
1970). Further, what was the common pathway by which both 
halothane and succinylcholine initiated malignant hyperpyrcxia ? 
The answer to these questions was sought in the following 
experiments on Landrace pigs, known from halothane pre-
screening to be susceptible to malignant hyperpyrexia (Harrison 
et al., 1968, 1969). 
Experimental Method 
All experiments were carried out under a standard general 
anaesthetic consisting of induction of anaesthesia with thiopcn-
tone, endotracheal intubation, and maintenance of anaesthesia 
with nitrous oxide and oxygen with intermittent positive-
pressure respiration. Under these conditions the influence of 
pretreatment with tubocurarine and procaine on the initiation 
of the hyperpyrcxic syndrome by halothane and succinylcholine 
was studied. The drugs were administered in the following 
combinations and scquences--cach sequence forming a separate 
experiment-the number of times each experiment was repeated 
is given in parentheses: tubocurarine-halothane (1), tubo-
curarine-succinylcholine (1), procaine-halothane (6), procaine 
-succinylcholine (2), and procaine-halothane-succinyl-
choline (3). 
Tubocurarine and succinylcholine were administered as 
single dose!- . Procaine was administered as a 0·6% solution by 
2.9 
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intravenous drip infusion, a loading dose of 30 mg/kg preceding 
maintenance infusion at rates which varied between 0·2 to 
I mg/kg/min. (Use in vitro of I to 3·3 mM concentrations is 
described (Weber, 1968; Johnson and lnesi, 1969).) When using 
procaine in this order of dosage together with halothane brady-
cardia and hypotension were invariable and it was expedient to 
support the circulation with an infusion of isoprcnaline 
(concentration 1 "g/ml). 
The onset of the syndrome was identified by ( 1) the onset of 
rigor, monitored crudely by means of a write-out on a revolving 
drum attached by a string to the pig's hind leg, and (2) the 
rapid rise in muscle temperature, monitored by an intra-
muscular probe. These two observations, rigor and rise of 
temperature, were considered adequate for identification of the 
syndrome. Serial biochemical values were measured on central 
venous blood of some pigs. 
When the syndrome did not develop after procaine pre-
treatment, the animal was re-exposed subsequently under 
thiopentone anaesthesia to halothane in the absence of procaine. 
Such animals all developed the hyperpyrc:xic syndrome. 
In five pigs the effect of procaine infusion on the established 
syndrome was studied and the results were compared with 
previously tried methods (Harrison et al., 1969). 
Results 
The results of these experiments arc set out in Tables I and II. 
The administration of tubocurarine did not prevent the initiation 
of the syndrome by halothane, but did prevent its initiation by 
succinylcholine. Procaine blocked initiation of the syndrome 
both by halothane and succinylcholine when these drugs were 
given separately. When succinylcholine was given in the presence 
of halothane fasciculation passed on into rigor and a fulminaot 
rise in temperature occurred in two of the three pigs. This 
rigor was ultimately controlled by continued procainC: infusion, 
TABLE 1-Tlsiopnu,,., N10/01 tb1us11iuia 
Prttratment 
Initiatina A,ent 
Nil Curare Procaine 
Halotbane .. . . + + -Succinylcholine . . . . .. .. + - -Halotbane 1uccinylcholine .. .. + -
+ - Initiation af hyperpyraic ayndroi!)e. 
- - No initiation of hyperpyraic syndrome. 
2.9 
4 
the rigor softening with concurrent cessation of temperature 
rise. The biochemical changes recorded as accompaniments of 
the syndrome appeared only in the presence of rigor and 
temperature rise and reverted towards normal when these were 
overcome. 
In five pigs in which the. syndrome was well established, 
with the temperature in excess of 42°C, large doses of procaine 
led to an ultimate relaxation of the rigor. Acidosis was treated 
with infusion of sodium bicarbonate. One pig was actively 
cooled. Two pigs survived. No other method of treatment we 
have used has ever achieved this (Harrison et al., 1969). 
TABLE n-Ruults of Trearmmt of Established Syndrome 
E1tabliahed Syndrome Treated with 
Active coolina, torrcction of acidoaia, etc:. 
(Harri10n •t al., 1969) . . . . 




Death in riaor 
Death in riaor 
Kisor relased. Temperature riae 
1topped. Survivon 
The findings of these experiments that ( 1) halothane can 
initiate the syndrome in the presence of neuromuscular block, 
and (2) procaine effectively blocks halothane initiation of the 
syndrome add support to the observations of Kalow et al. (1970) 
that a defect in sarcoplasmic reticular calcium release/binding is 
the probable lesion responsible for the syndrome of anaesthetic-
induced malignant hypcrpyrcxia. The observation that curare 
as well as procaine blocks the initiation of the syndrome by 
succinylcholine indicates that endplate depolarization is 
necessary for this drug's initiation of the syndrome-an obscrva-
. tion borne out by Sybcsma and Eikclenboom's (1969) observa-
tion that severe exercise alone will initiate the hypcrpyraic 
syndrome in susceptible pigs. The common pathway by which 
succinylcholine, severe exercise, aud halothanc initiate the 
syndrome can be postulated to be a defective reticular calcium-
binding mechanism which allows persistence of a high 
concentration of calcium ions in the sarcoplasm and so persistent 
rigor. 
In contrast to the findings of others, Weber and Herz (1968) 
recorded the observation that procaine in vitro besides blocking 
could reverse early caffeine rigor. This is relevant to my obscrva-
2.9 
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tion that the syndrome when initiated by succinylcholinc given 
together with halothane in the presence of a procaine infusion 
seems to be reversible, in contrast to its inexorable counc in the 
absence of procaine. It is relevant, also, to the observation that 
in five pigs in which the syndrome initiated by halothane was 
well established with profoUJ;ld rigor and temperature in excess 
of 42°C procaine infusion resulted in softening of the rigor and 
cessation of temperature rise. Two of these pigs survived. 
Bearing in mind the above and what we know of the severe 
biochemical chang~s-thc runaway glycolysis and profound 
acidosis-which accompany the syndrome (Berman et al., 1970), 
I would suggest the following steps in the treatment of this 
syndrome: ( 1) discontinuance of anaesthetic agents; (2) rapid 
correction of acidosis by administration of tromctamol or 
sodium bicarbonate; (3) immediate institution of active and 
aggressive cooling; (4) administration of procaine by intra-
venous infusion-a loading dose of 30-40 mg/kg should be 
followed by infusion at a rate of about 0·2 mg/kg/min until 
muscle rigor relaxes; support of the circulation by an infusion 
of isoprcnalinc will be necessary and E.C.G. monitoring is 
mandatory; and (5) correction of the hypcrkalaemia; if initial 
correction of the acidosis docs not bring the scrum K + to normal 
levels administration of insulin and glucose should be resorted to. 
This investigation is incomplete and requires further refine-
ment. There may well be a time by which the syndrome is 
irreversible by procaine. The present early publication of these 
findings is prompted by the lack of specific treatment for the 
syndrome based on a knowledge of its pathogenesis. For the 
future, investigation of factors which enhance calcium ion 
uptake by the sarcoplasmic reticulum will, I am sure, lead 
ultimately to a pharmacologically rational and successful 
treatment of this dread condition. 
I wish to express my gratitude to Mrs. C'.arin Verburg and Dr. 
Colin Beighton for excellent technical assistance and to Mr. Brian 
Sassman for the initial screening and selection of susceptible pigs, 
as well as post-anaesthetic recovery care. I am indebted to the liver 
research group and the department of !UI'gerv of the University of 
C.apc Town for the supply of pigs. Electrolyte estimations were 
performed by the department of chemical pathology of . the Univer-
sity of C.apc Town. 
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Malignant Hyperpyrexia 
The advent of new syndromes in medicine is often treated 
with scepticism, but though the first case of malignant 
hyperpyrexia was reported only just over five years ago it 
has now become fully established as a condition in its own 
right. Essentially it is characterized by a rapid rise of body 
temperature in patients undergoing general anaesthesia for 
surgery. The two drugs most commonly reported as trigger-
ing agents l!re suxametbonium (muscle-relaxant) and halo-
thane (inhalational anaesthetic). Concomitant with the rise 
in body temperature are the signs of increased muscle 
metabolism, such as tachycardia, tachypnoea, sweating, and 
blotchy cyanosis. 
There would appear to be one distinctive sign-namely, 
rigidity-which is present in the majority of patients.1 In a 
typical case this rigidity follows immediately on the 
administration of suxamethonium or alternatively develops 
insidiously during balotbane anaesthesia. If treatment is 
unsuccessful, it merges into rigor mortis. Indeed the mech-
anism of the latter condition has been sought to explain 
malignant hyperpyrexia. In about one-quaner of the patients 
this rigidity does not appear at any stage until after death, 
so possibly these cases are different both in signs and in 
aetiology. 
W. Kalow and his co-workers2 investigated three patients 
who had suffered malignant byperpyrexia and found changes 
of metabolism in muscle biopsy specimens in those patients 
who bad experienced rigidity. The calcium uptake in the 
sarcoplasmic reticulum was low after exposure of the patient 
to balotbane. They concluded -that the lesion in the rigid 
type of malignant hyperpyrexia was an inability of the 
sarcoplasmic reticulum to store calcium. This meant that 
the concentration of calcium in the cytoplasm remained 
high, the enzyme myosin adenosinetriphosphatase was not 
activated, and the myofibrils remained forever locked 
together as in contraction. 
P. Furniss3 bas pointed out that the age of the patient is 
significant when attempting to differentiate between the 
rigid and non-rigid types of malignant byperpyrcxia. Those 
reacting with hypertonus arc usually young (under 20) and 
the abnormality is probably hereditary, while most of the 
non-rigid cases occurred in patients over 20 years old, and 
the incidence appeared to be sporadic. 
c, BRmSH MEDICAL JOUIINAL 1971. All reproduction righu reserved 
Approaching ·the matter from a different angle, H. Isaacs 
and M. B. Barlow4 investigated 99 · members of a single 
family with a history of malignant byperpyrcxia. They found 
that the resting creatine phosphokinase and aldolasc levels 
were high in many of their patients. They concluded that 
the high level of muscle enzymes in the serum was evidence 
of a subclinical myopathy, and that anaesthetic agents like 
suxamethonium and balotbane arc capable of damaging 
muscle metabolism and triggering off a fulminating byper-
pyrexic reaction. On this basis they have suggested that the 
enzyme levels of susceptible patients should be measured 
prcoperatively, and if they are found to be raised the anaes-
thetic agents that cause the trouble can be avoided. 
R A. Pollock and R L. Watson5 have pointed out that 
the syndrome of malignant hypcrpyrma from anaesthetic 
agents is very similar to that sometimes observed after giving 
a combination of tricyclic antidepressants and the mono-
amine inhibitors. These patients too are usually young 
(2~30), and within a few hours of starting treatment with 
the combined therapy they apericnce sweating and hyper-
pyrexia, leading to rigidity. The mortality is about tiO to 
70%. The authors suggest that these drugs might induce a 
hypermetabolic state by increasing the intracdlular ama::n-
ttation of cyclic adenosine monophosphate (A.M.P.).-This 
would provide an alternative theory to the one based on the 
uncoupling of oxidative phosphorylation.6 · 
In this issue of the BM.J. (page 454) Dr. Gaisford G. 
Harrison approaches the matter from another angle. He 
argues that the rigidity produced by caffeine is known to be 
due to a depressed rebinding of calcium iaos by ~ 
plasmic reticulum and that this process can be blocked by 
procaine. C.Ould . this also be true for malignant hyper-
pyrexia? He was able to show that large doses of procaine 
could abolish the rigidity of ezperimcotally produced 
malignant byperpyrexia in the Landracc pig even at a late 
stage of the condition. This is a most important observation, 
for as well as adding further confirmation to tbc calcium 
theory it offers for the first time a really practial approach 
to the treatment of the patient. In this respect c:zperieoce 
bas shown that intensive cooling is required and that gmcral 
vasodilation is important in reducing the intemal tempcnture 
of the body. The administration of large doses of procaine 
NO. S772 PAGI "1 
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(a well-recognized vasodilator), accompanied by isoprcnalinc 
to support the circulation, is an interesting new approach to 
this problem. . 
1 Brin, B. A., and JCalow, W., Canadian AruusrJ.eri.u' Suci,rv Jt11mlal, 1970 
17,293. 
1 Kalow, W., Britt, B. A., Tcrrau. M . E ., and Haist, C., La,,ur, 1970, z. ffl. 
1 Funiiu, P., Proudings of rlu Royal Soaery of Medit:itu, 1971, 64, 216. 
• Iaacs, H., IDd Barlow, M. B., Brirish Journal of A,aoarhuia., 1970, 42, 
1077. 
1 Pollock, R. A., ad WatlOD, R. I-, Anurhuialao, 1971, 34, 188. 
• '\'IV"alaa, R. D., Nicola, R. J., Dmt, T. E., and Allen, C.R., Anuthuio/oo, 
1966. 27 231. 
' Harril:m, G. G., a al., Bririslt J-1 of Ana~srhuia, 1969, 41, 844. 
2.10 
DRITISH MEDICAL JOURNAL 3 FEBRUARY 1973 
Malignant hyrerpyrexia, a rare but often fatal complication 
of general anaesthesia, was first described .only some . s:x 
years ago, but since then reports of the condition have 
come from many parts of the world. It has been described 
most ·often in patients receiving suxamethonium as a muscle 
relaxant, or halothane, or both. 
A rapid rise of body temperature is usually accompanied 
by signs of increased muscle metabolism such as 
tachycardia, tachypnoea, sweating, and cyanosis.1 Typically 
the rise in temperature is accompanied by increasing muscle 
rigidity. This may follow immediately after the administra-
tion of suxamcthonium but comes on more sfowly during 
halothane anaesthesia. However, P. Furniss2 pointed out that 
rigidity was not seen in all cases. This symptom was found 
to be usual in the common, genetically dominant form of 
the abnormality. It is usualiy then recognized in childhood 
and earlv adult life. A sporadic form is less common, and 
many o{ the patients with it are reported to be much older 
when the condition is first recognized. 
W. Kalo~ and bis co-workcrs3 studied muscle biopsy 
samples obraincd from patients in whom hyocrpyrcxia had 
been accompanied by muscle rigidity and found that the 
calcium uptl!ke in the sarcoplasmic reticulum derived from 
such sampl~s was low after exposure to balothanc. They 
suggested, therefore, that the primary lesion is an inability 
of the sarcoplasmic reticulum to store calcium. Among 
others, H. Isaacs and M. B. Barlow4 noted a high resting 
scrum crcatine phosphckinase activity in affected members 
of a family. They suggested that this indicated the presence 
of a subcliriical myopathy. The extensive studies of J. 0. 
King and co-workers,s based on the information they 
obtained from 18 propositi and their. families, has given some 
support to this suggestion. All six survivors tested had high 
serum creatine phosphokinase levels, and they concluded 
that all patients who develop malignant hyoerpyrcxia ha,·e 
one of a number of specific mvopathic disorders. In the first 
group there is evidence of a dominantly inherited myopathy, 
which they found in 9 of their 18 families, though in 6 of 
these the myooathy was not clinicallv detectable in affected 
individuals, while only 3 showed evidence of overt muscular 
weakness. The second group of susceptible patients showed 
clinical and electromyographic evidence of myot~nia -con-
genita, and a similar case was reported some years ago by 
L. J. Saidman and colleagues.6 In their third group were 
patients who had associated physical abnormalities includi~g 
short stature, cryotorchidism, lumbar lordosis, and thoracic 
kyphosis. as well as evidence of a progressive congenital 
myopathy. 
A disorder similar to the human disease bas been de-
scribed in certain Landrace pigs.7 8 A finding that confirms 
the work of Kalow and collcagucs3 in man is that the pigs' 
muscle is more sensitive to caffeine-induced rigor than is 
that of normal controls, and this effect is enhanced by ex-
posure to halothane. Recently G. G. Harrison9 suggested 
that procaine, given as a 0-6% solution by inrravcnou.s drip 
infusion to susceptible pil;s, could sometimes protect the 
muscle from the effects of ba)otbanc and also appeared to 
have some beneficial effect even after the syndrome had 
developed. So far these protective and therapeutic effects 
of procaine have not been confirmed in man. 
Controversy continues on whether measurements of scrum 
249 
creatine phosphokinase actlVlty alone arc a sufficiently re-
liable screening test for liability to malignant hypcrpyrexia. 
There is also some dispute about the presence or absence of 
histological changes in the muscles of affected patients. In 
a recent study of seven persons from four families F. R 
Ellis and colleagues10 found on muscle biopsy in five of 
them non-specific myopathic changes. These included 
variations in fibre size, 'fibre atrophy with nuclear dumping, 
mitohondrial aggregates, and fibres with a· "moth-
eaten" appearance in sections stained for oxidative enzymes, 
together with variable changes in the motor end-plates. These 
histological changes com:latcd well with abnormal muscle 
contracturcs induced by halothanc or by halolhane and 
suxamethonium in vitro. In one patient, however, in whom 
there was histological evidence both of myopathy and of 
muscle contractures induced by halothanc, the · scrum 
creatine phosphokinasc activity was within normal limits. 
Recently W. G. Bradley and D. Murchison,ll who studied 
four persons at risk in two families, found that all but one 
had a raised serum crcatinc phosphokinasc aaivity, but none 
showed histological evidence of myopathy, and only one 
muscle sample developed contracturc when aposcd to 
halothane in vitro. The patient from whom it amc had the 
highest resting scrum creatinc phosp}:lokinasc aaivity of 
any of those studied. 
The position has been further . complicated by the 
observation of M. A. Denborough and his ~waders, who 
report in a paper in th~ BM.7. this week (page m) that a 
muscle biopsy obtained from a susceptible patient showed 
the characteristic · histochemical · and ultnmiaoscopic 
abnormalities of "central core discasc"-a myopathy with a 
characteristic histological appearance of c.ores in the muscle 
fibrcs.12 13 Abnormal tubular aggregates, probably .represent-
ing s~rcoplasmic reticulum, were also found in the muscle 
fibres from this patient when they were c:mninrd UDder the 
electron-microscope. · 
Evidence is now accumulating to suggest that a number 
of histological abnormalities in voluntary muscle previously 
thought to be specific, including the central core anomaly, 
may have less specificity than was previously thought to be 
the case. Nevertheless it would be interesting ID sec whether 
any further muscle biopsy samples ( obtained DDder local, 
not general; anaesthesia) from persons_ liable ID suffer from 
malignant bypcrpyrcxia · show similar histological changes. 
No cases of malignant hyperpyrexia, so far as is known, have 
yet been reported in patients suff cring from typical 
Duchennc muscular dystrophy, dystrophia myotonica, or 
muscular dystrophy of the facio-scapulo-humcral or limb-
girdle types . . Nevertheless, it is becoming incrasiugly ~ 
that this curious metabolic anomaly of the mnsle ccD. which 
predisposes the affected person to this potemwly fml com-
plication during anaesthesia, may be associated with a variety 
of myopathic disorders which are different clinically and 
histologically. 
1 British Medical Journal, 1971, 3,441. . . . 
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ERYTHROCYTE OSMOTIC FRAGILITY IN HYPERTHERMIA-SUSCEPTIBLE 
SWINE 
G. G. HARRISON AND C. VERBURG 
SUMMARY 
The observation is rcponcd that hypcrthcrmia-susccptiblc swine manifest an increased 
red cell osmotic fragility. The imponancc of this observation is discussed. 
Anaesthetic-induced malignant hypcrpyrcxia in 
humans appears to result from some intrinsic abnor-
mality of muscle (Samick, 1969; Harrison et al., 1970; 
King, Dcnborough and Zapf, 1972). Evidence points 
to this defect being in the sarcoplasmic reticulum 
(Kalow ct al., 1970). A ccnain strain of Landracc pigs 
manifests a similar condition and has . been used as an 
animal experimental model for the investigation of 
various aspects of the disease and trials of therapeutic 
measures (Berman ct al, 1970; Harrison, 1971). 
While taking blood specimens for various investiga-
tions from such hypcrthcrmia-susceptible pigs, we 
observed that more often than not these specimens 
were markedly haemolyscd. This observation 
prompted us to investigate the erythrocyte osmotic 
fragility of these pigs. 
METHODS 
Hypcrthermia-susccptible swine were initially chosen 
by observing the reaction of all pigs acquired for the 
Surgical Research Laboratory to a screening chal-
lenge of halothanc inhalation (Harrison et al., 1969). 
Hypcrthermia-susccptiblc swine react in an obvious 
and highly characteristic fashion by manifesting ex-
treme muscle rigor within about 10 min of exposure 
to halothane and recover if the halothane is im-
mediately discontinued. Susceptibility to hypcr-
thcrmia was confirmed in positive reactors by estima-
tion of serum c.p.k. levels, which in hypcrthermia-
susccptiblc swine remain persistently raised rw ooJf 
Ct al., 1970). 
Type of Pia I.I 0.9S 0.8S 0.75 0.65 
H)'J!Ct'lh.- susceptible 
DilS 0 0 0.2 0.7 7.8 
The red cell fragility of three such pigs, aged 9-14 
weeks, was investigated over a time some wccb after 
the original test exposure to halothane. 'Ibrcc speci-
mens of bl~ week elapsing bewecn successive 
specimens-were taltcn from each pig under brief 
thiopentonc anaesthesia. This blood was drawn from 
one of the large veins in the thoracic inlet through a 
wide-bore needle (15 s.w.g.), care being ta1tcn to 
cxcn the minimum of suction. The fragility of blood 
drawn under similar conditions from nine non-reactor 
pigs, non-reactivity being confirmed by low scrum 
c.p.k. levels, served as a control 
Osmotic fragility was tested by the standard 
method (Dacie and Lewis, 1968) of estimating coloro-
mctrically the degree of hacmolysis achieved in acrial 
dilutions of saline solutions. Differences between 
groups of mean pcrocntagc hacmolysis at each con-
centration of saline were tested statistically by a 
standard Student t-tcst. 
RESULTS 
The results (table I and figs. 1 and 2) reveal that 
these hyperthcrmia-susccpttblc pigs manifest a 
greater erythrocyte osmotic fragility than normal. 
The median corpuscular fragility of the hypcr-
thcrmia-susccptiblc swine lay between 0.55 and 
0.50% saline, while that of the control pigs was 
between 0.50 and 0.45 % saline. (The human value 
G. G. HARRISON, M.D., F.F.A.JLC.S.j C. VERBtJIIG; Depan-
ment of Anaesthetics, Groote Schuur Hospital and Univer-
sity of Cape Town, South Africa. 
0.60 0.5S 0.50 0.45 0.40 0.30 0.10 0.10 
20.7 38.9 68.2 83.2 84.4 94.6 97.1 100 (9 samples) ±0.1 ±0.1 ±1.1 ±2-3 ±2.2 ±2.6 ±1.9 ±1.7 ±1.1 
Control pia, 0 0 0 0.2 S.1 10.0 21.5 37.9 72.0 18.8 94.3 99.3 100 (9wnples) ±0.1 ±I.I ±1.0 ±2.1 ±2.5 ±2.9 ±2.4 ±2.8 
PY&lue P<0.10 P<0.05 P<0.10 P<0.001 P<0.001 P<0.001 P<0.01 
Sianificance of difference n.s. ,. D.S. s. s. s. s. n.s. 11.L D.S. D.S. 
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FIG. 1. Red cell fragility curve (mean values with SE). 
for comparison lies between 0.445 and 0.40% saline; 
Dacie and Lewis, 1968.) The increment haemolysis 
curve (fig. 2) demonstrates a difference of 0.05 % 
saline between peaks of maximal haemolysis. 
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FIG. 2. Increment baemolysis curve. - Hyperthermia-
susc:eptible pigs. - - - - - - Control pigs. 
There is quite marked disparity in the few reported 
estimations of porcine red cell fragility (Schalm, 
1965). As the pig populations on which these reported 
estimations were performed may well have inadvcr-
tently included hypcrthennia-susccpn"blc swine 
(Harrison, 1972), comparisons of fragility in this 
paper arc made only with the screened controls 
described. 
DISCUSSION 
Abnormalities in red cell fragility depend to a large 
extent on the functional state of its surface mem-
brane (Dacie and Lewis, 1968). The marked 
morphological similarity between this cell membrane 
and the membranes of cell organelles such as JDito. 
chondria, endoplasmic reticulum and Golgi apparatus 
led to Robertson's concept of these as "unit" mem-
brane (Robertson, 1959). Though there arc important 
functional differences between membranes which 
doubtless reside in the protein enzymes associated 
with the phospholipid skeleton, there is indeed a 
structural organization that is common to !DOit 
cellular membranes (Fawcett, 1962; Giese, 1968). 
It is this that confers relevance to the finding of 
increased red cell fragility in hypcrthermia-susccpn"blc 
swine rcponed here. There is evidence that anaes-
thetic-induced malignant hypcrpyrcxia results from 
some intrinsic abnormality in muscle, more spec:ifi-
2.12 
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cally of the sarcoplasmic reticulum. Herc is evidence 
that another "unit" membrane in animals susceptible 
to anaesthetic induced malignant hypcrpyrcxia is also 
defective. 
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FRAGllJTE OSMOTIQUE ERYTHROCYI'AIRE CHEZ LE PORC SUSCEPTIBLE A 
L 'HYPERTIIERMIE 
SOMMADE 
Les autcun rapportent awir oblene que des pores ma-ceptibles a l'hypcrthermic . manifestent une fragilite osmo-tique accrue des globules rouaca et disoJteDt l'irnpomnce de cettc observation. 




Es wird Qbcr die Beobachtung berichtet, dafi Hyperthennie-ernpfindliche Schwcine eiDc ges=gene osmotische Fragili-
tit ihrer rotm Zellcn aufwcisCD. Die Bcdeuuma diem Bcobachtung wird diskutiert. 
FRAGILIDAD OSMOTICA ERITROCITARIA BN CERDOS SUSCEPTIBLES A LA HIPERTERMINA 
RBStJMEN . 
Sc informa sobrc la observac:i6n de que Joa ccrdos amcep-tibles a la hipcrten:nia prescntan un incremeuto en la fragilidad osrn6tica de sus gl6bulos roios. Se dilane la irnponancia de esta oblcrvaci6o. 
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Summary. The hypothesis is developed that the lesion 
responsible for anaesthetic-induced malignant hyperpyrexia 
is a functional defect in the calcium release/binding mechanism 
of 118.l'coplasmic reticulum. Besides the uae of pigs susceptible 
to a similar condition, recent work indicates that caffeinized 
frog or rat muscle may also serve as an "in vitro" pharma-
cological model of the myopathy. A regime of treatment is 
l!Uggested based on current concepts of the pathogenesis. 
Jungate Fort&chritte im Veratandni8 der .Anaeatheaie-be-
dingten malignen H yperpyre:cie. 
Zuaammenfa&B1lng. Folgende Hypothese wurde entwickelt: 
die fiir eine durch Anaesthesie hervorgerufene bosartige Hyper-
Though rare, anaesthetic-induced malignant hyper-
pyrexia continues to attract attention because of its 
unpredictability, the frightening mortality in those 
afflicted (in excess of 70% ), the puzzle of its patho-
genesis and the complete la.ck, until recently, of any 
approach to a rational treatment [1-3]. Approxima-
tely 180 cases are recorded in the world medical 
literature. 
Much of the little we today know of the patho-
genesis of the condition has followed the happy chance 
discovery that certain pigs suffer from the same con-
dition, thus providing us with an experimental model 
[4]. The condition, which appears to be related to the 
well known porcine stress syndrome (PSS) which 
results in pale, soft, exuda.tive pork (PSEP) [5], is 
found as an autosoma.l dominant of a varying pene-
trance in 3 heeds of pig - the Landrace in South Africa 
Australia and England, the Pietra.in in Holland and 
the Poland China pig in the United States and Canada 
[4, 6-9]. 
Early Theories 
Initial theories embraced: 
1. Disturbance of central heat homeostasis mech-
anisms. 
2. Some form of stress response involving the 
adrenals. 
3. Uncoupling of oxidative phosphorylation. 
The first two had little to support them. The third, 
propounded by Wilson [10] and backed by experi-
mental work in dogs using the uncoupling a.gent DNP 
with and without halothane anaesthesia, did seem to 
fit some of the facts. However, Wang's [11] argument 
that on purely theoretical grounds uncoupling alone 
could not produce the heat necessary for the rapid 
rise in temperature, wa.s followed by the demonstration 
by Berman [12) in South Africa, Denborough [13] in 
Australia, Bruker [14] in the United States and 
Britt, Kalow and Endreyeni [15) in Canada that the 
mitochondria. from affected animals and man were 
not uncoupled by haJotha.ne but, in fact, respiratory 
27a Der Anaeltheallt, Bd. 22 
pyrexie verantwortliche Liiaion ist ein funktioneller Defekt 
im Calcium auf- und abbauenden Mechanismus des aa.rko-
plasmischen Reticul1llil.6. AuJ3er dem Gebrauch von Schweinen, 
die fur ihnliche Bedingungen anfli.llig sind, haben neuere Er-
gebnisse gezeigt, daB Frosch- oder Rattenmuskeln, die unter 
dem EinfluB von Coffein stehen, auch als ein "in vitro" 
pharmakologisches Modell der Myopathie dienen konnen. Ein 
Behandlungsprotokoll wird auf der Basis gegenwirtiger Kon-
zepte der Pathogenese vorgeschlagen. 
control was depressed. There is still a. possibilitythough 
that uncoupling of oxidative phosphorylation together 
with mitochondrial abnormalities may be a. feature in 
the non-rigid form of the disease, a.bout one-quarter 
of human cases [16]. 
Site of the LMion 
Evidence gradually accumulated that the lesion or 
abnormality responsible for the syndrome lay within 
the muscle. 
Following up the observation that muscle rigor 
wa.s such a. dramatic event in the syndrome, especiaJly 
in the pig, we showed that the fall off in ATP content 
in muscle, when incubated "in vitro" in oxygenated 
Krebs solution was twice as great in muscle from 
reactor pigs, and this fall off was increased by the ex-
posure of the muscle to halothane [4]. This indicated 
some fundamental abnormality in the muscle from 
reactor pigs. Sa.tnick [17] described a. patient who 
developed malignant hyperpyrexia. during the course 
of. an orthopaedic operation, involving the use of a 
tourniquet on an a.rm. The whole patient became rigid 
except the limb in which the circula.tion was occluded. 
Perhaps the clearest demonstration that muscle 
was the site of the lesion was an experiment performed 
in our laboratories which showed that the muscle 
rigor and biochemical accompaniments of the syndrome, 
previously identified in the intact animal challenged 
with halothane, (see Figs. 2 and 3) [18] could be repro-
duced in a. preparation of isolated perfused muscle 
(Fig. 1) [19]. This experiment showed, in addition, that 
the profound biochemical changes that were asso-
ciated with the syndrome were not secondary to the 
hyperthermia., but evidence of an underlying biochem-
ical lesion of which the ultimate rise in body temper-
ature was an accompaniment or result. It also demon-
strated conclusively that central heat . homeostatic 
mechanisms and the adrenals had no pa.rt in the patho-
genesis of this syndrome. 
In quick succession thereafter, Isa.a.cs and Barlow 
[20] found that a. high proportion of the families of 
2.13 
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Fig. 1. Pig transected above pelvis. Legs perflll!OO with stan-
dard pump oxygenator 
victims of the syndrome had above normal serum 
levels of the muscle enzyme CPK; Denborough [21, 22] 
confirmed this and demonstrated that the serum levels 
of the same enzyme (as well as of SGOT and LDH) 
were grossly raised during and immediately following 
the actual attack, and Woolf [6] showed that affected 
pigs had the same raised resting levels of CPK. 
In 1970, Ka.low and co-workers [23) reported 3 
fundamental observations made on muscle preparations 
from human survivors of anaesthetic-induced malig-
nant hyperpyre:ria. These were that: 
1. Such muscle was more sensitive to caffeine rigor 
than that of normal controls. 
2. This effect was enhanced by exposure to halo-
thane. 
3. Halothane depressed calcium uptake by the 
sa.rcoplasmic reticulum of these patients, whereas it 
had no effect on that of normal controls. 
Kalow's finding of the halothane depressed SR 
calcium uptake was confirmed by similar observations 
in pig muscle sarcopla.smic reticulum by Bruker [14] 
and Denborough and co-workers [13). 
Caffeine has long been known to ca.use a persistent 
contraction or rigor of muscle fibre which persists 
until the ca.ffeine is removed. This rigor is due to an 
enhancement of release and an interference with re-
binding of calcium ions by the sarcopla.smic reticulum. 
This allows a net efflux of calcium from the sarco-
pla.smic reticulum, a rise in sa.rcopla.smic calcium con-
centration, which activates myofibrillar ATPa.se and 
maintains contraction [24, 25). Ha.lothane it seemed 
acted in a somewhat similar fashion to ca.ffeine on a 
SR abnormally sensitive to this type of action, so 
leading to rigor in susceptible animals. 
Procaine is known to block this effect of ca.ffeine in 
muscle by preventing calcium efflux. This effect is due 
to an action on the reticulum, and not due to a com-
plexing with the ca.ffeine. Once caffeine rigor has be-
come well established, procaine has been said to have 
no effect [26, 27). 
These observations led us to investigate the effect 
that pretreatment with curare (blocking the neuro-
muscular junction) and procaine (blocking the SR) 
might have on initiation of the syndrome of malignant 
hyperpyre:ria by halothane and succinylcholine in 
susceptible La.ndra.oe pigs [28). The results of these ex-
periments (see Tables 1 and 2) showed that the ad-
ministration of tubocura.rine did not prevent the 
initiation of the syndrome by halothane, but did pre-
vent its initiation by succinylcholine. Procaine blocked 
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initiation of malignant hyperpyrexia by Halothane and a 
susceptible pig 
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Table 1. Thiopentone, N20/02 Anaesthesia 
Initiating agent Pretreatment 
Nil Curare Procaine 
Halothane + + 
Succinylcholine + 
Halothane succinylcholine +-
+ = Initiation of hyperpyrexic syndrome. 
- = No initiation of hyperpyrexic syndrome. 
Table 2. Results of treatment of established syndrome 
Established syndrome treated with Result 
Active cooling, correction of 
acidosis, etc. 
(Harrison et al., 1969) 
Tubocura.rine 
(Harrison et al., 1969) 
Procaine 
Death in rigor 
Death in rigor 
Rigor relaxed. 
Temperature rise stopped. 
Survivors 
succinylcholine when these drugs were given separately 
When succinylcholine was given in the presence of 
halothane fasciculation passed on into rigor and a ful. 
minant rise in temperature occurred in two of the three 
pigs. This rigor was ultimately controlled by continu-
ed procaine infusion, the rigor softening with concurrent 
cessation of temperature rise. The biochemical changes 
recorded as accompaniments of the syndrome appeared 
only in the presence of rigor and temperature rise 
and reverted towards normal w-hen these were over-
come. 
In five pigs in which the syndrome was well 
established, with the temperature in excess of 42°0, 
large doses of procaine led to an ultimate relaxation 
of the rigor. Acidosis was treated with infusion of 
sodium bicarbonate. One pig was actively cooled. Two 
pigs survived. No other method of treatment we have 
used has ever achieved this [4]. 
The findings of these experiments add support 
to the observations of Ka.low et al. [23] that a. defect 
in sarcoplasmic reticular calcium release/binding is the 
probable lesion responsible for the syndrome of anaes-
thetic-induced malignant hyperpyrexia. The obser-
vation that curare as well as procaine blocks the 
initiation of the syndrome by succinylcholine indicates 
that end plate depolarization is necessary for this drug's 
initiation of the syndrome - an observation borne out 
by Sybesma and Eikelenboom's [9] observation that 
severe exercise alone will initiate the hyperpyrexic 
syndrome in susceptible pigs. The common pathway 
by which succinylcholine, severe exercise, and halo-
thane initiate the syndrome can be postulated to be 
a defective reticular calcium-binding mechanism 
which allows persistence of a high concentration of 
calcium ions in the sarcoplasm and so persistent rigor. 
The fact that these reactions to halothane and 
succinylcholine occur only in certain genetically pre-
disposed pigs (and humans) points in a.11 probability 
to some genetically determined functional abnormality 
of the SR membrane. The observation made recently 
in our laboratory of increased red cell fragility in 
malignant hyperthermia susceptible pigs shows that 
other "unit membrane" structures &re also defective 
in these animals [29]. 
In vitro Models 
The susceptible La.ndra.ce pig has proved a good 
animal model for pharmacological and other research 
into the condition. But susceptible pigs &re not always 
e&ey to obtain, their supply is not universal and the 
pig as an experimental animal may prove expensive. 
For research into this condition to be made possible at 
more centres, a. more readily available and cheaper 
animal model is essential. Strobel and Bianchi's [30] 
demonstration that caffeinised frog sartorius muscle 
behaves in a. manner similar to that of susceptible 
pigs and the use in our laboratory of ca.ffeinised. rat 
rectus muscle repeatedly suprama.ximally stimulated 
with similar results [31] promises well for the future 
in this regard. 
Treatment 
Though methods of blocking induction of the syn-
drome contribute to the forming of an hypothesis as 
to its pathogenesis, such prevention has no pr&cticaJ 
value in a clinical situation. However, an observation 
made by Weber and Herz [24] on the effect of pro-
caine on caffeine rigor offers us some hope of finding 
a rational treatment for this lethal condition. In 
contrast to the findings of others, they reoorded the 
observation that procaine, besides blocking, could 
reverse early caffeine rigor. 
Following this up, we showed that procaine in-
fusion resulted in the softening of rigor and cessation 
of temperature rise in pigs in which the syndrome was 
well established [28]. Recent patients who have surviv-
ed the syndrome, or improved on treatment, have 
had procaine infusions included in their treatment [32-
34 ]. In conclusion, therefore, to give some pr&cticaJ 
expression to our growing understanding of malignant 
hyperpyrexia. biochemically (eee Figs. 2 and 3) [18] 
and pharmacologically, I wish to suggest the following 
steps in the treatment of the syndrome. 
Prevention 
Pre-anaesthetic-family history and CPK estimation. · 
Awareness during anaesthesia-adequate monitor-
ing of temperature. 
Note any abnormal reaction to succinylcholine. 
In event of any unexplained rise in temperature 
> 1 °0, abnormal reaction to succinylcholine or sudden 
gross increase in temperature of soda.lime canister, 
ACT lmmffliauly. 
1. Discontinue anaesthetic. 
2. Hyperventilate with oxygen. 
3. Correct acidosis with THAM or sodium bica.r-
bonate. 
4. Cool patient actively and a.ggressively. 
5. Administer procaine by intravenous infusion -
a loading dose of 30-40 mg/kg should be followed by 
infusion at a rate of a.bout 0.2 mg/kg/min until muscle 
rigor relaxes or adequate cooling commences; snpport 
of the circulation by an infusion of isoprenaline may 
be necessary and ECG monitoring is mandatory. 
6. Correct hyperkala.emia. if correction of acidosis 
does not reduce this to reasonable levels. 
7. Look out for and treat on its own merits any 
disseminated intra vascular coa.gulation and snbsequent 
fibrinolytic syndrome [35, 36]. 
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8. Administer mannitol to protect kidney against 
the effect of myoglobinuria. 
9. Do muscle enzyme studies and investigate 
patient's family. 
.Ackncwledg~. I wish to acknowlegde my indebted-
ness to Prof. A. B. Bull, Director of the Department of Anaes-
thetics at the University of Cape Town, for help, advice and 
ideas in our investigation of this condition, and my colleagues 
in the Liver Research Group and the J. S. Marais Surgical 
Research laboratory of this University, for the supply of 
susceptible Landrace pigs. Financial as11istance for our labor-
atory has come from the Anglo American and De Beers 
.Anaesthetic Research Fund and the Joseph L. Stone .Anaes-
thetic Research Foundation. 
References 
1. Britt, B. A., Kalow, W.: Malignant hyperthermia. Sta-
tistical review. Canad. Anaesth. Soc. J. 17,293 (1970) 
2. Britt, B. A., Kalow, W.: Malignant hyperthermia aetiology 
unknown. Canad. Anaesth. Soc. J. 1?, 316 (1970). 
3. Furniss, P.: The etiology of malignant hyperpyrexia. 
Proc. roy. Soc. Med. 64, 216 (1971). 
4. Harrison, G. G., Saunders,S. J.,Biebuyck,J. F.,Hickman, 
R., Dent, D., Weaver, V., Terblanche, J.: Anaesthetic 
induced malignant hyperpyrexia. Brit. J. Anaesth. 41, 
844 (1969). 
5. Harriaon, G. G., Pale, aoft, exudative pork (PSEP), por-
cine stress syndrome (PSS) and malignant hyperpyrexia 
an identy. J. S. Afr. vet. med. Ass. 48, 57 (1972). 
6. Woolf, N., Hall, L., Down, .M., Walker, R.: Serum creatine 
phosphokinase levels in pigs reacting abnormally to halo-
genated anaesthetics. Brit. med. J. 1970, 386. 
7. Jones, E.W., Nelaon, T. E., Anderson, I. L., Kerr, D. D., 
Burnap, T. K.: Malignant hyperthermia of swine. Anes-
thesiology 36, 42 (1972). 
8. Nelson, T. E., Jones, E.W., Venable, J . H., Kerr, D. D.: 
.Malignant hyperthermia of poland china swine. Anes-
thesiology 86, 52 (1972). 
9. Sybesma, W., Eikelenboom, G.: Ma.ligant hyperthermia 
syndrome in pigs. Neth. J. Vet. Sci. 2, 155 (1969). 
10. WilBOn, R. D., Nichols, R. J., Dent, T. E., .Allen, C.R.: 
Disturbances of the oxidative-phosphorylation mechanism 
as a possible etiological factor in the sudden unexplained 
hyperthermia occurring during anaesthesia. Anesthesio-
logy 27,231 (1966). 
11. Wang, J., Moffat, E. A., Roseveer, J. W.: Oxidative 
phosphorylation in acute hyperthermia. Anesthesiology 
30, 439 (1969). 
12. Berman, M. C., Kench, J.E.: Biochemical features of 
malignant hyperthermia in land.race pigs. Prooeedings 
international 1.<ymposium on malignant hyperthermia, 
Toronto 1971. Ed. Gordon R., Britt B. A., Kalow W. 
p. 287 Springfield Ill.: Charles C. Thom&111973. U.S.A. 
13. Denborough, M.A., Hird, F. J. R., King, J. 0., Margin.son, 
M.A., Mitchelaon, K. R., Nayler, W. G., Rex, M.A., Zapf, 
P., Condron, R. J.: Mitochondrial and other studies in 
australian landrace pigs affected with malignant hyper-
thermia. Proceedings international symposium on malig-
nant hyperthermia, Toronto 1971. Ed. Gordon R., Britt 
B. A., Kalow W. p 229. Springfield Ill.: Charles C. Thomas 
1973 U.S.A. 
14. Bruker, R.: Mitochondrial and sarcoplaamic reticulum 
studies in poland china pigs affected with malignant hyper-
thermia. Proceedings international symposium on malig-
nant hyperthermia, Toronto 1971 p. 238. Ed. Gordon 
R., Britt B. A., Kalow. W. Springfield,Ill.: Charles C. 
Thomas 1973 
15. Britt, B. A., Kalow, W., Endrenyi, L.: Electron transport 
and oxidative phosphorylation of skeletal muscle mito-
chondria from patients with malignant hyperthermia. 
Proceedings international symposium on mal~t hyper-
thermia, Toronto 1971 p. 387. Ed. Gordon R., Bntt B. A., 
Kalow W. Springfield, Ill.: Charles C. Thomas 1973. 
16. Thorpe, W., Seeman, P.: Drug induced contracture of 
muscle. Proceedings international symposium on malig-
nant hypertenaion, Toronto 1971 p. 152. F.d. Gordon R., 
Britt B. A., Kalow W. Springfield, DJ.: Charles C. Thomas 
1973. 
17. Satnick, J. H.: Hypert.hermia under anaesthesia with 
muscle flaccidity. Anesthesiology 30,472 (1969). 
18. Berman, M. C., Harrison, G. G., Bull, A. B., Kench, J.E.: 
Changes underlying halothane induced malignant hyper· 
pyrexia in landrace pigs. Nature (Lond.) Hi, 653 (1970) . 
19. Harriaon, G. G., Berman, M. C., Hickman, R., Bull, A. B., 
Terblanche, J., Kench, J.E.: Anaesthetic induoed malig-
nant hyperpyrexia-eome observations of the syndrome in 
landrace pigs. Proceedings 3rd Australaaian and PanA.aian 
Congress of Anaesthesiology, Canberra, Australia, p. 158-
166. London: Butterworths 1970. 
20. Isaacs, H., Barlow, M.: The genetic background to malig-
nant hyperpyrexia revealed by CPK estimations in asymp-
tomatic relatives. Brit. J. Anaesth. 4!, 1077 (1970). 
21. Denborough, M.A., Foster, J. F. A., Hudson, M. C., 
Carter, M. G., Zapf, P.: Biochemical changes in malignant 
hyperpyrexia. Lancet 19701, 1137. 
22. King, J. 0., Denborough, M.A., Zapf, P.: The genetiOB of 
malignant hyperpyrexia. Lancet 197!1, 365. 
23.Kalow, W., Britt, B.A., Terreau, M.E., Ha.ilt, C.: Meta-
bolic error of muscle metabolism after recovery from malig-
nant hyperthermia. Lancet 1970Il, 895. 
24. Weber, A., Herz, R.: The relationship between oa.ffeine 
contracture or int.act muacle and the effect of caffeine on 
reticulum. J. gen. Physiol. H, 750 (1968). 
25. Weber, A.: The mechanism of the action of caffeine on 
sarcoplaamic reticulum. J. gen. Phyaiol. H, 760 (1968). 
26. Feinstein, M.: The inhibition of caffeine rigor and radio-
calcium movement by local anaesthetios in frog u.rtoriua 
muscle. J. gen. Phyaiol. 47, 151 (1063). 
27. Bianchi, C. P.: Pharmacological actions on exoit&tion-
contraction coupling in striated muacle. Fell. Proc. !7, 
126 (1968). 
28. Harriaon, G. G.: Anaesthetic induced malignan:t hyper-
pyrexia a saggested method of treatment. Brit. med. J. 
1971, 454. 
29. Harrison, G. G., Verburg, C.: Red cell~ in malig-
nant hyperprexia IUSOeptible swine Brit. J. Anaeethesia 
4o, 131 (1973) . 
30. Strobel, G. E., Bianchi, C. P.: An in vitro model of anaes-
thetic hypertonic hyperpyrexia, halothane-oaffein&-in-
duced muscle oontracturee. Anesthesiology Ii, 465 (1971). 
31. Harrison, G. G: A pharmacological model of rnaJignant 
hyperpyrexia. Paper given at Annual CongrNa S. A. So-
ciety of Anaesthesists, South African Med. J.47, 774 (1973) 
32. Beldava, J., Small, V., Cooper, D., Britt, B. A.: Canad. 
Ana.est. Boe. J. 18, 202 (1971). 
33. De Wet, J. T., van de Vijoer, A. E., Uys, S. P.: Malignant 
hyperthermiain anaesthesia. S.Afr.med.J.4', 1033 (1972). 
34. Haines, A. P., Shoenberg, P. J.: Hyperpyrexi& and over-
dose. Brit. med. J. 197!1, 632. 
35. Daniels, J.C., Polayes, I. M., Villar, R., Hehre, F. W.: 
Malignant hyperthermia with diiiserninated intravucular 
coagulation. Carr. Res. Anesth. 48, 877 (1969). 
36. Sage, R. E.: Severe fibrinolysis in fatal malignant hyper-
pyrexia. Med. J. Aust. 1, 755 (1972). 
G. G. HarriBOn, M. D., F.F.A.R.C.S. 
Dept. of Anaesthetics 
University of Cape Town 
Cape Town, South Africa 
2.13 
Br. J. Anaesth. (1975), 47, 62 
CONTROL OF THE MALIGNA?\TT HYPERPYREXIC SYNDROME 
IN MHS SWINE BY DANTROLENE SODIUM 
GAISFORD G. HARRISON 
SUMMARY 
Experiments are described which demonstrate that dantrolene sodium effectively 
terminates the syndrome of malignant hyperpyrexia induced in susceptible swine by 
exposure to halothane. Dantrolene is also shown to block initiation of the syndrome 
of malignant hyperpyrexia by halothane in MHS swine. Therapeutic use of this drug 
in patients with anaesthetic-induced malignant hyperpyrexia appears to be indicated. 
Anaesthetic-induced malignant hyperpyrexia is a 
rare, often fatal syndrome affecting man and the 
pig, which results from a genetic intrinsic functional 
defect within the muscle fibre (Relton, Britt and 
Steward, 1973; Harrison, 1973b). Rigor of muscle 
is its predominant clinical feature. 
In 1967, Snyder and associates reported the 
synthesis of a series of hydantoins which proved 
to have muscle relaxant properties. One of these, 
dantrolene sodium* was extensively investigated 
and its pharmacological effects were demonstrated 
to follow an action on the intrinsic mechanism of 
muscle contraction. In addition, it was shown to 
act only on skeletal muscle and to have no effect on 
cardiac muscle or smooth muscle (Ellis ct al., 1973). 
Because of this, the effects of dantrolene sodium 
on the syndrome of malignant hyperpyrexia induced 
by halothane in malignant hypcrpyrexia susceptible 
(MHS) swine were investigated. 
METHOD 
In this investigation, use was made of an experi-
mental protocol previously described (Harrison, 
1973a). In MHS swine selected by reaction to 
halothane prescrecning and estimation of serum 
c.p.k. levels, monitoring of vital parameters was 
established under initial ketamine or ketamine/ 
thiopentone anaesthesia, followed by endotracheal 
intubation and maintenance of anaesthesia with 
nitrous oxide and oxygen. IPPV was provided when 
required by a Blease Pulmoflator. 
Monitoring included : 
(1) E.c.g. 
(2) Observation of rigor (see fig. 1). 
•l-([5-(p-nitrophenyl) furfurylidene] amino) hydantoin 
sodium hvdrate svnthesized by Norwich Pharmacal 
Company Laboratories, New York. 
FIG. 1. MHS pig's hind legs before and after ooset of 
rigor following halothane (note extension). The pheno-
menon may be recorded by attachment of the tmtter by 
string over a pulley to a recording pen on a rnolving 
drum. During rigor the muscle mass is palpably hard. 
(3) Temperature measurement by means of a 
thermistor probe (Ellab, Denmark) inserted deep 
into the muscle mass of the thigh. 
( 4) Repeat sampling of mixed venous blood from 
a right atrial cannula. 
Thereafter, the syndrome of malignant hyper-
pyrcxia was initiated by the administration of 
halothanc by IPPV commenced at a concentration 
of 2.5 % and gradually reduced to 0.5 % thereafter. 
Once the hyperpyrexic syndrome was well estab-
lished with marked muscle rigor, acidosis and an 
increase of temperature of 2°C or more, dantrolene 
sodium (O.S mg/ml) was administered intra-
venously; a dosage of 1 mg/kg in early experiments 
was later increased to as much as 7-10 mg/kg. 
The solubility of dantrolenc is limited. The 
GAISFORD G. HARRISON. M.D. (CAPE TOWN), F.F.A.Jl.C.S. 
(ENG.), Department of Anaesthetics, University of Cape 
Town, South Africa. 
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formulation used in these experiments was that 
described by c.astcllion (1973, personal communi-
cation) : 
dantrolene sodium 300 mg 
mannitol 26.640 g 
sodium hydroxide 48 mg 
water to make 600 ml 
Blood samples for acid-base, c.p.k. and potas-
sium estimations were taken : 
(1) Immediately before exposure to halothanc. 
(2) When the syndrome was established. 
(3) After administration of dantrolenc. 
Eight such experiments were undertaken using 5 
pigs, the experiment being performed three times 
in one pig, twice in another and once each in the 
remaining 3 pigs. 
It must be appreciated that in this somewhat 
crude and empiric (though effective) intact animal 
experiment, judgement of the moment at which to 
commence treatment was difficult, and precise cri-
teria as to the degree of temperature increase could 
not be adhered to. The rate at which reactor pigs 
develop the syndrome diff crs. While it was desired 
that the syndrome be well enough established in 
terms of muscle rigor and increase in temperature, 
to render any response to dantrolcnc unequivocal, 
care had to be taken not to jeopardize the entire 
experiment by risking sudden death of an animal 
from cardiac arrest resulting from the concomitant 
acidosis and hypcrkalacmia. In some experiments, 
not only was the moment of commencing dantro-
lcnc dictated by the onset of cardiac arrhythmia, 
but in two animals ''Isoptin" 5 mg (Iprovcratril, 
Knoll, Germany) (shown in previous experiments 
to have no effect on the syndrome (Harrison, 1972, 
unpublished data)) was used to control this before 
the administration of dantrolenc. Once well 
initiated, the syndrome is independent of the con-
centration of halothanc, which appears to act as a 
trigger (Berman ct al., 1970). In five experiments, 
halothane was discontinued 8-18 min before 
administration of dantrolenc, the syndrome continu-
ing unabated with further increases in temperature 
of from 0.5 to 1.9°C. In three experiments halo-
thane was continued for 2-4 min after commence-
ment of dantrolcnc. In neither event did this appear 
to aff cct the outcome. 
The only ancillary treatment generally applied 
was the administration of sodium bicarbonate 
following the onset of rigor. Ambient temperature 
during these experiments was 21-22°C and with 
one exception active cooling was not used. In the 
exception, ice blocks were applied to an animal 
after the temperature had dccrcascd from 43.8°C 
to 41 "C. Ambient temperature on this day was 
2S°C. 
Complementary to the therapeutic use of dantro-
lcne, its ability to block initiation of the hypcr-
pyrcxic syndrome by halothanc in MHS pigs was 
also investigated in two cxpcrimcnts (a week apart) 
on a single fast reactor pig. In these cxpcrimcnts, 
following establishment of monitoring under initial 
kctaminc / nitrous oxide / oxygen anaesthesia as 
described, and treatment of the animal with dantro-
lcne 3 mg/kg, the animal was exposed to halothanc 
inhalation for 90 min. Commencing at 2.5%, the 
halothane concentration was reduced over 30 min 
to 1 %, at which concentration it was maintained. 
RESULTS 
The results of these experiments with details of the 
duration of the malignant hypctpyrcxic syndrome 
before treatment, the actual increase in body 
temperature, maximum temperature attained, dose 
of dantrolcnc and final outcome in terms of survival, 
arc presented in table I. A temperature and events 
chart of one experiment, typical of all the experi-
ments, is reproduced in figure 2. 
In the established syndrome of malignant hypcr-
pyrcxia in susceptible pigs, the administration of 
dantrolenc caused: 
(1) Rapid loss of muscle rigor commencing 
within 5 min and usually complete within 20 min. 
(2) Immediate cessation of the increase in deep 
muscle temperature followed by a rapid dcaeasc. 
(3) Termination of the progressive, inexorable 
acidosis characteristic of the syndrome (Harrison ct 
al., 1969) rendering easy the buffering of acidosis 
developed until the dantrolcnc administration. 
All pigs, except · the first, used in the 8 apcri-
ments survived. This first pig, after showing a 
dramatic initial response to what, in the light of 
subsequent experience, proved to be too small a 
dose of dantrolcnc, suffered a rccurrcncc of the 
syndrome with subsequent death (sec table I). 
Dantrolcnc pretreatment of an MHS 'pig effec-
tively blocked initiation of the hypcrpy1cxic syn-
drome by halothanc, allowing exposure of the 
animal to inhalation for 90 min with impunity. The 
time period of 90 min was chosen arbitrarily as 
being a period six times in excess of the previously 
tested "reaction" time of the pig used. 
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TABLE I 
Resting c.p.k. MH Temp. 
Pig A units/ml duration Increase decrease 
No. at 25°C before in Max. Dose of in first Final 
and (normal dantrolene temp. temp. dantrolene 20min temp. 
weight 0-50) (min) ("C) ("C) (mg/kg) ("C) ("C) Outcome 
170 364 36 3.2 40.1 1 0.6 42.0 Died 
70kg 
168 720 14 2.1 38.5 1 1.9 36.7 Survived 
120 kg 
168 817 40 2.4 38.8 2.5 2.2 36.4 Survived 
125 kg 
182 4932 38 3.6 42.2 7 2.0 38.4 Survived 
30 kg 
180 1480 18 2.0 40.2 6 1.4 38.2 Survived 
39 kg 
180 1340 21 2.0 40.5 10 1.5 38.4 Survived 
40 kg 
180 1440 36 3.2 40.0 7 2.6 37.3 Survived 
44kg 
74 348 30 3.8 42.8 10 1.8 38.0 Survived 
30 kg Ice packs 
Different weights recorded for the same pig used more than once reflect weight gain with time. 
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FIG. 2. Temperature (deep muscle) and events chan of 
typical experiment on MHS pig weighing 45 kg. Dantro-
lene administered as i.v. drip infusion for duration of 
square so marked. Biochemical values from mixed venous 
blood. 
DISCUSSION 
Untreated, the developed syndrome of malignant 
hypcrpyrcxia in pigs has a mortality rate of 100% 
(Harrison ct al., 1969). While earlier work has 
demonstrated that it was possible to reverse the 
syndrome with procaine, especially if it was admini-
stered early enough (Harrison, 1971), the three out 
of five (60%) mortality for the established syndrome 
in pigs so treated dcscnbcd in this paper, has con-
tinued in our subsequent animal experiments. To 
date, procaine is the only drug that has been shown 
to have any effect on the established syndrome. 
These experiments demonstrate that dantrolene 
has the property of rcluing the muscle rigor which 
characterizes malignant hypcrpyraia in the pig, 
and that concomitantly the accss heat and acid 
production cease. A survival rate of 100% was 
achieved in the last seven of eight apcrimcnts. In 
contrast to procaine, dantrolcnc has no effect ·on 
the myocardium, a factor which permits its use up 
to the limits of therapeutic effectiveness. 
The pharmacology and toxicology of dantrolcne 
have been atcnsivcly investigated : .in bumans 
(Basmajian and Super, 1973; Cbyatte and Bird-
song; 1971; Cliyattc, Birdsong and Bcrgman,-1971;-
Hcrman, Mayer and Newcombe, 1972) ·and it has 
been used extensively in the management of condi-
tions characterized by muscle spasticity. The 
apcrimcnts reported here indicate that dantrolcnc 
should prove to be a most effective therapeutic 
agent in the treatment of malignant hypcrpyraia 
in humans. 
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CONTROLE DU SYNDROME D'HYPERPYREXIE MALIGNE (DANS LES SUIDES MHS) AU MOYEN DU SODIUM DE DANTROLENE 
RESUME 
On dccrit certaines apcrienccs qui dcmontrcnt quc le sodium de dantrolcne met fin dlcctivcmcnt au syndrome . d'hypcrpyrcxie malignc provoquc par !'exposition a l'halothane chcz lcs suides prcdispoecs. On montrc eplc-ment quc le dantrolcnc bloquc la manifestation initialc du syndrome d'hypcrpyrexic malignc par l'halothane dans !cs suidcs MHS. L'usage thcrapcutiquc de cc rcmc:dc scmble indiquc pour lcs patients atteints d'hypcrpyrcxie maligne provoquce par un anesthcsique. 
BEKAMPFUNG DES MALIGNEN HYPERPYREXIESYNDROMS (BEi MHS-SCHWEINEN) MIT DANTROLEN-NATRIUM 
ZUSAMMENFASSUNG 
Es werdcn Untersuchungcn bclchrieben, welchc crpbcn, daB Dantrolcn-Natrium das bci empfiinglichen Schweinen durch Ha!othan-Einwirkung hervorgcrufcnc maligoe Hypcrpyrcxicsyndrom wirksam kupicrt. AuOcrdem konntc gczcigt wcrdcn, daB sich bci MHS-Schwcincn die Auslosung cines maligncn Hypcrpyrcxicsyndroms durch Halothan mit Dantrolcn bloclticrcn Wk Das Mittcl schcint sich also zur Bchandlung von Narkosc-bcdingten malignen Hypcrpyrcxicsyndromcn zu cigncn. 
CONTROL DE LOS SINDROMES DE ffiPERPIREXIA MALIGNA (EN CERDOS CON SHM) POR SODIO DANTROLENICO 
SUMARIO 
Se dcscribcn los expcrimcntos quc demucstran quc cl sodio danttolenico acaba cficazmcnte con cl aiDdrome de hipcrpirexia maligna, inducido en un ccrdo, 1uceptlble a clla, por ccposici6n a halotan<>. Sc mucstra tambicn que el Dantrolcno bloquea la iniciaci6n del aiDdrome de hipcrpircxia maligna por halotano en ccrdos con SHM. Parccc scr apropiado el uso tcrapeutic:o de csta drop en pacicntcs con bipcrpirexia maligna, de indua:i6n ancstcsica. 
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The control and prevention of malignant hyperthermia in 
MHS pigs: Some experimental obseroations• 
GAISFORD HARRISON 
Department of Anaesthetics, University of Cape Town, 
South Africa 
The stress related myopathy prominent in certain breeds of pig (Nelson, 1973 ; Harri· 
son, 1972) provides us with what appears to be a close facsimile of the syndrome of 
anaesthetic induced malignant hyperthermia in man. What differences there are appear 
to be quantitative rather than qualitative - the expression of the syndrome being more 
florid and extreme in the pig, a possible consequence of genetic selection for the heavily 
muscled animal characterized by an extremely rapid rate of growth. 
Though muscle from affected pigs can be shown to behave metabolically in an identi-
fiable manner, for example, the consumption of ATP by muscle biopsies taken from 
malignant hyperthermia susceptible (MHS) pigs and incubated in Krebs-Ringer solution is 
twice as rapid as that from non-reactor control animals, the simplest and most certain 
way of identifying the MH susceptible pig is observation of the response of test animals to 
a challenge exposure to halothane (Harrison et al., 1969). On exposure to halothane MHS 
pigs show the rapid onset of rigor, the development of a fulminant acidosis and a rapid 
rise of core temperature. If the halothane is discontinued the moment the rigor becomes 
evident, the pig will usually survive without treatment. While increased serum CPK levels 
will be evident at the time, the diagnosis of stress susceptibility will be clinched by the 
observation of a great increase in CPK activity in the blood measured 24 hr later. 
Whatever the differences may be between pig and man in the precise, intrinsic muscle 
functional lesion, the ultimate common denominator in the genesis of the syndrome is a 
defect in the control of calcium ion flux in the muscle cell causing a maintained high 
cytoplasmic level of calcium with persistence of contraction and rigor (Britt, 1975). 
Aiming our therapeutic arrow at this point, we were early able to show that pretreat-
ment of MHS swine with procaine (a known inhibitor of SR calcium release) blocked 
initiation of the syndrome in them by halothane (Harrison, 1973a). Procaine pretreat-
ment was less effective in blocking initiation of the hyperpyrexic syndrome in response to 
succinylcholine administered together with halothane inhalation. If given early enough in 
the development of the syndrome, administration of procaine could terminate the rigor. 
But the general experience of the therapeutic use of procaine in pigs has been disappoint-
ing (Hall et al.. 1975; Mitchell and Hefferon, 1975). However, in spite of the fact that the 
effect of procaine in large doses on the myocardium proved a marked drawback, procaine 
has been therapeutically successfully used in many instances in man (Britt, 1975). 
Though its mode of action is unknown, the steroid anaesthetic Althesin, when given 
by continuous intravenous administration has also been demonstrated by us to block the 
initiation of the syndrome in MHS swine by halothane, but not by the consecutive 
administration of succinylcholine. Regrettably, Althesin proved therapeutically useless 
(Harrison, 1973b). · 
Following the demonstration of raised catecholamine levels in Pietrain pigs during 
malignant hyperpyrexia. the Bristol workers demonstrated a similar result with a-adrener-
• This work was financed by the Anglo American and De Beers Anaesthetic Research 
Fund of the Department of Anaesthetics, University of Cape Town. 
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gic blockade - initiation of the syndrome could be blocked but once established the 
syndrome could not be stopped (Hall et al., 1975). 
Though Bianchi's (1973) suggestion at the 1971 Toronto Malignant Hyperpyrexia 
Symposium that diphenylhydantoin be investigated as a therapeutic agent did not bear 
fruit , it is another hydantoin - dantrolene sodium - that now offers the greatest thera-
peutic hope in this condition. Following the demonstration by Elis and Carpenter ( 1972) 
that the muscle relaxant properties of dantrolene followed an effect on the excitation/ 
contraction coupling mechanism in skeletal muscle, we showed that administered intra-
venously to MHS pigs in established hyperthermic rigor, dantrolene controlled and effec-
tively terminated the syndrome (Harrison, 1975). It was also demonstrated at this time 
that intravenous pretreatment of susceptible animals with dantrolene blocked subsequent 
initiation of the syndrome by exposure of test animals to halothane . 
Survivors of episodes of malignant hyperpyrexia and investigation and identification 
of their families have given us an increasing population of patients 'at-risk' from malig-
nant hyperpyrexia should they ever require surgery and need an anaesthetic. We deemed 
it expedient therefore to investigate further the possible prophylactic use of dantrolene in 
such circumstances. For this purpose we investigated the oral use of the presently avail-
able capsules of dantrolene in a litter of 8 specially bred MHS pigs, each of which had 
been shown to react within minutes to a halothane challenge and to display high levels of 
CPK activity. The clinical reaction, including observation of core temperature of each pig 
to exposure to halothane anaesthesia was observed in each of the following circum-
stances: (1) Following pretreatment on day previous and day of anaesthetic (4 hr pre-
anaesthesia) with oral dantrolene 5 mg/kg. ln the absence of reaction anaesthesia was 
arbitrarily maintained for I hr. (2) Without any such pretreatment. Exposure to halo-
thane in these circumstances was discontinued the moment rigor, together with com-
mencing rise in core temperature was observed. This occurred in all un-pretreated animals 
within 5-10 min . 
A period of 2 weeks was allowed to elapse between pretreated and un-pretreated 
exposures to halothane. In each pig this programme was repeated after a further interval 
of 7 days. 
Fig. 1. Pigs undergoing test exposure to halothane. That nearest the camera has been pretreated with dantrolene and is in the 30th min of anaesthesia that was continued for 1 hr. That farthest is an unpretreated control. Within 4 min of exposure to halothane, rigor of hind legs is well marked and rise in the core temperature has commenced. 
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RESULTS 
When pretreated with oral dantrolene, all 8 pigs tolerated anaesthesia with halothane 
for I hr on each of 2 occasions without any abnormal reaction and no rise in core 
temperature . When the same pigs were exposed to halothane in the absence of dantrolene, 
all reacted on each of 2 occasions with a rapid onset of rigor with commencing rise of 
core temperature within 5-10 min (see Fig. l ). 
The complete obtundation by dantrolene of the response of MHS reactor pigs to 
halothane was dramatically illustrated by the measurement of CPK activity during and 
24 hr after exposure. Whereas exposure of animals pretreated with dantrolene to 1 hr 
anaesthesia with halothane resulted in no change in CPK activity, exposure of the same 
animals without dantrolene treatment to halothane until the onset of rigor (5-10 min 
only) resulted in a dramatic mean 56-fold rise in CPK activity . 
We have demonstrated in addition in 4 MHS pigs, that dantrolene pretreatment even 
blocked initiation of the hyperpyrexic syndrome in response to the super added stimulus 
of succinylcholine administered together with halothane - a property that the previously 
demonstrated halothane blocking drugs, procaine and Althesin , did not possess. 
CONCLUSION 
If dantrolene can now be shown to act in man as I have demonstrated it to act in the 
MHS pig, we need no longer fear anaesthetic induced malignant hyperpyrexia. We have 
the means to cure it and, better still, to prevent it. 
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THE PROPHYLAXIS OF MALIGNANT HYPERTHERMIA 
BY ORAL DANTROLENE SODIUM IN SWINE 
G.G.HAiuusoN 
The oral administration of danttolene for the prophylaxis of malignant hyperthennia (MH) in 
susceptible swine has been investigated. Complete protection from MH in pigs aposcd to the 
known MH initiating agents, halothanc and suumcthonium, was demonstrated. 
It is now established that dantrolenc. sodium can 
control and prevent the malignant hypcrthcrmia 
(MH) syndrome induced in malignant hypcrthcrmia 
susceptible (MHS) swine in response to a halothanc 
challenge ,(Harrison, 1975; Anderson and Jones, 
1976; Gronert, Mildc and Thcyc, 1976). Application 
of this knowledge in man has been prevented by the 
lack of an acceptable i.v. formulation of the drug, 
which is available for clinical use as an oral capsule 
only. For patients known to be genetically "at risk" 
from MH (Moulds and Denborough, 1974) there is 
no completely safe method of general anaesthesia 
(Ellis ct al., 1974; Britt, 1975). 
We have investigated the efficacy of dantrolenc 
sodium administered orally as a prophylactic agent 
against the development of the malignant hypcr-
pyrcxic syndrome in susceptible pigs in response to 
the most common initiating agents, halothanc and 
suxamcthonium. 
METHODS 
The experiments were conducted in a litter of speci-
ally bred MHS Landracc pigs. At 6 weeks of age all 
had been screened and shown to react to a halothane 
challenge within minutes, with the onset of muscle 
rigor and a concomitant increase in core (rectal) 
temperature. All had increased scrum concentrations 
of creatine phosphokinase (c.p.k.) at rest. 
The clinical reaction of each pig, including change 
in temperature, to exposure to halothanc anaesthesia 
was observed in each of the following circumstances: 
(1) Following pretreatment on the day before and the 
day of anaesthesia ( 4 h before anaesthesia) with 
dantrolene 5 mg/kg administered orally. In the 
absence of a reaction, anaesthesia was maintained for 
1 h. 
(2) With no pretreatment, exposure to halothane 
was discontinued as soon as muscle rigor, to-
G. G. HARRlsoN, M.D., F.F.A.R.C.S., Dcparanent of Anaesthe-
tics, University of Cape Town, S. Africa. 
gether with an increase in core temperature, was 
observed. 
Rigor and pyrcxia were accepted, in these animals, 
as indicating the onset of MH. The concomitant 
occurrence of acidosis was observed in specimens of 
mixed venous blood from vcnepuncture at the 
thoracic inlet in all animals which displayed rigor. 
Scrum c.p.k. was measured (Worthington Statzym 
c.p.k., c.at. No. 7960) in blood sampled immediately 
before and after anaesthesia and, in some animals, 
24 h later. A period of 14 days was allowed to elapse 
between pretreated and unpretreated aposure to 
halothane. Following · recovery, the animals were 
rested for 7 days and thereafter the protocol was 
repeated. 
Dantrolenc powder was administered to the test 
animals in capsules propelled into the pharynx with 
saline from a syringe by means of a flexible Tygon 
tube while the animal was restrained. The dose 
(5 mg/kg) and time of administration in relation to 
anaesthesia were chosen after consideration of the 
therapeutic doses used previously (Harrison, 1975) 
and observations on the relationship of oral dose to 
blood concentration (Leitman, Haslam and Walcher, 
1974). 
Halothane, vaporized in nitrous oxide in oxygen, 
was administered from a Fluotec vaporizer in a Magill 
circuit by means of a face mask, with the pig breathing 
spontaneously. C'.ommencing at 3% for induction of 
anaesthesia, concentrations ofhalothane were reduced 
progressively after induction to 1 % at appro::&:imatcly 
15 min after induction and maintained at this level 
for the remainder of the anaesthetic. 
In a further experiment four of these pigs, pre-
medicated with dantrolene and exposed to halothane 
anaesthesia for 15 min followed by tracheal intuba-
tion, were challenged with two injections of sma-
methonium 1 mg/kg i.v. at intervals of 10 min and 
the reaction observed. IPPV with nitrous oxide in 
oxygen using a Manley ventilator was instituted until 
the return of spontaneous respiration. 
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~IG. 1. MH~ pigs exposed to halothane anaesthesia. The nearer pig, pretreated with dantrolene, is 
m the 30th minute of planned 1-h exposure. The other pig was not treated. After 4 min of halothane 
the characteristic muscle rigor has commenced causing extension of the hind legs. This is aocom-
panied by an increase in rectal temperature. 
RESULTS 
When pretreated with oral dantrolene all eight pigs 
tolerated anaesthesia with halothane for 1 h on each 
of two occasions with no abnormal reaction and no 
increase in core temperature. When the same pigs 
were exposed to halothane in the absence of dantro-
lcne, all reacted on each of two occasions with the 
rapid onset of rigor together with an increase in core 
temperature within 5-10 min (fig. 1). After dis-
continuing halothane the temperature was observed 
until it had reached the peak value. The mean 
increase of temperature following this short exposure 
to halothane was 1.2 °C. 
C.p.k. activity measured 24 h after exposure to 
halothane was expressed in relation to the value 
measured at commencement of the halothane 
challenge. In four pigs (table I) treatment with 
TABLE I. C.p.k. ratio (24 h after/before anaesthesia) 









halothane 5-10 min 
56.0 
21.7 
dantrolenc, followed by exposure to halothane for 1 h 
resulted in no change in c.p.k. at 24 h; in the absence 
of danttolenc, exposure to halothane until the onset 
of muscle rigor only (5-10 min) caused (on average) 
a 56-fold increase in c.p.k. activity measured at 24 h. 
The challenge of smamcthonium in-four animals 
premcdicated with danttolcne and anaesthetized with 
halothane for 15 min failed to elicit the malignant 
hypcrpyrcxia response. All of the pigs recovered. The 
blocking of initiation of the malignant hypctpytcxic 
syndrome in MHS pigs by this most severe combined 
stimulus has not been documented with any other 
agent to date. 
DISCUSSION 
Investigation of the family of patients suffering from 
MH yields a small but increasing number of patients 
considered to be at risk from MH should they require 
a general anaesthetic. 
It may be argued that the patient's best interests 
can be served by an awareness of the risks and by 
avoiding of the most common triggering agents, 
halothane, methoxyflurane and suxamethonium, 
coupled with meticulous monitoring of temperature 
and other vital functions so that corrective measures 
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may be taken promptly should the syndrome com-
mence. Since there arc no general anaesthetic agents 
that arc completely safe in these circumstances, it is 
frustrating to be denied the use of dantrolenc for lack 
of an acceptable i.v. formulation. The oral use of 
dantrolenc in man is well documented and is safe 
(Sykes, 1975). 
Our experiments demonstrate that dantrolenc 
administered orally in the form presently available 
protects the MHS pig from MH in response to both 
halothanc and the overwhelming stimulus of suxa-
mcthonium administered in addition. We would 
recommend that prcmcdication of the patient known 
to be at risk from MH should include oral dantrolcnc 
administered at the appropriate time interval. 
If dantrolenc can be shown to act in man in the 
same manner as in the pig, we need no longer fear 
MH. We have at our disposal the means to prevent it 
and, when an i.v. formulation is available, to cure it. 
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PROPHYLAXIE DE L'HYPERTHERMIE MALIGNE 
PAR ADMINISTRATION ORALE DE 
DANTROLENE DE SODIUM A DES COCHONS 
RESUMB 
L'administration oralc de dantrolenc pour la prophylaxic de 
l'hypcrthcnnic malignc aur des pores susccptiblca d'attrapcr 
cettc maladic I fait l'objct d'unc etudc. II a etc dcmontre quc 
l'on pouvait obtcnir unc protection complete contrc 
l'hyperthcnnic malignc des cochons apoaca aux agents 
connus dcclcnchant l'hypcrthcnnic malignc, tels quc 
l'halothanc ct le swwncthonium. 
DIE VERHINDERUNG B0SARTIGER 
HYPERTHERMIE DURCH MONDLICHES 
DANTROLEN-NATRIUM IN SCHWEINEN 
ZUSAMMENFASSONG 
Die V crabrcichung per os von Dantrolcn fiir die V crhindcr-
ung dcr bOsartigcn Hypcrthcnnic in dafiir cmpflinglichen 
Schwcincn war untcraucht wordcn. Ea wurdc dcr vOlligc 
Schutz gcgen die bOsartigc Hypcrthcnnic in Schwcincn, die 
den bckannten, die bOaartige Hyperthcnnic cinlcitendcn 
Mittcln Halothan und Swwncthonium auagcaetZt wuen, 
dcmonatricrt. 
LA PROFILAXIS DE HIPBRTERMIA MALIGNA 
PORCINA MEDIANTE DANTROLENO SODICO 
ORAL 
SUMAJUO 
Sc ha invcatipdo la adminiatracilm oral de dantroleno para 
la profilaxia de la hipcrtcrmia maligna (HM) CD los ccrdos 
auaccpnblcs. Sc dcmostr6 la a,mpleta protee:Cilm contra 
HM en los ccrdos apucatoa a loa agemes conocidos mmo 
iniciadores de HM, cl halotano y la IUCcinilcx>lina. 
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EDITORIAL 
DANTROLENE AND THE TREATMENT OF MALIGNANT HYPERTHERMIA 
The availability in the United Kingdom in Autumn 
1980 of a stable i.v. preparation of dantrolcnc for the 
treatment of malignant hypcrthcrmia (MH) is an 
important milestone in the management of this rare, 
but often lethal, complication of anaesthesia. The 
development of a specific therapeutic agent for the 
clinical syndrome has followed from experimental 
studies on the porcine model, although there have 
been several "false starts," of which the most notable 
was procaine or procainamidc. 
Danttolcnc, a hydantoin derivative, was synthe-
sized by Snyder and colleagues (1967) and has been 
used orally to treat muscle spasticity (Dykes, 1975). It 
acts on skeletal muscle by interfering with the excita-
tion-contraction coupling mechanism, so that the 
sarcolcmmal action potential is no longer coupled 
or linked to the normal efflux of calcium ions within 
the muscle cell. Thus, there is a reduction in the 
availability of calcium ions for the contractile process 
(for review sec Pinder ct al., 1977). It is often claimed 
that the effects of damrolenc arc specific for skeletal 
muscle, but recent studies have shown that dantrolcnc 
also depresses smooth muscle (Graves, Drctchcn and 
Kruger, 1978), cardiac muscle (Meyer, Wesscling 
and Agoston, 1976) and catecholamine release from 
the adrenal medulla (Cohen and Gutman, 1979). It 
would be surprising if dantrolcnc had no effects on 
other calcium-coupled systems, although these arc 
unlikely to be important at doses used to relieve 
muscle spasticity. 
Harrison (1975) was the first to demonstrate the 
effectiveness ofi.v. dantrolene in the treatment of MH 
in Landrace pigs. This observation was confirmed in 
Poland China pigs by Gronert, Mildc and Theyc 
(1976) and in Picttain pigs by Hall, Lucke and Lister 
(1977) using danttolenc 7.5 mg kg-1• In addition, 
Gronert, Milde and Thcyc (1976) showed that the 
i.v. administration of danttolcne 5 mg kg-1 afforded 
complete protection against porcine MH if given only 
10 min before halothanc and suxamcthonium. 
Harrison (1977) found that oral dantrolcne was also 
effective in preventing MH if given in two doses of 
5 mg kg-1, 24 and 4 h before anaesthesia. The data 
from the experiments on porcine MH arc conclusive; 
danttolcnc is effective both therapeutically and 
prophylactically. 
The application of the results obtained in porcine 
MH to the clinical syndrome has been delayed by the 
difficulties in producing a stable i.v. preparation of 
dantrolcnc. However, a small pilot study has been 
undertaken with a suitable i.v. preparation at 45 
hospitals in the United StateS and Canada. The 
criteria used for confirming the occurrence of MH in 
this study were very weak (for example, a tachycardia 
of 20 beat min-1 greater than baseline values, arterial 
pH<7.35, Pco1 >42 mm Hg) and consequently 
many of the patients reported were undoubtedly not 
suffering from MH. Nevertheless there were three 
cases of MH in which the adminisuation of dantto-
lenc i.v., at doses ranging from 0.9 to 1.6 mg Itg-1, was 
associated with the rapid and complete resolution of 
the hypcrthcrmic response. It seems likely that not 
only is dantrolenc eff cctivc in the treatment of human 
MH, but also the dose required is considerably less 
than in the porcine syndrome. 
The i.v. preparation of dantrolcnc will be available 
in vials containing sodium dantrolene 20 mg, man-
nitol 3 g and sodium hydroxide to produce a final pH 
of 9.5 on the addition of 60 ml of water. The use of 
alkaline mannitol as the solvent for dantrolcnc is a 
useful bonus as a diuresis is necessary during the 
treatment of MH to prevent the deleterious effects of 
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myoglobin on renal tubular function. It is unfortun-
ate that such a large volume of water is required to 
dissolve the contents of each vial because valuable 
time will be lost in preparing the solution. For 
example, administration of dantrolcnc 2 mg kg-1 to a 
70-kg patient will need 420 ml of sterile water. 
Oral dantrolenc has been used recently as a 
prophylactic measure in a patient who was MH-
susccptiblc (Pandit, Kothary and· Cohen, 1979). Peak 
blood concentrations of dantrolenc occur about 4 h 
after oral administration with a plasma half-life of 
~ h (Herman, Meyer and Mccomber, 1972). 
Various regimes have been advocated for oral 
prophylaxis with dantrolcnc but it is my policy to 
confine pretreaanent to the 24 h before surgery when 
the patient is given about 5 mg kg-1. It is possible 
that a smaller dose of dantrolenc may be equally 
effective, but it is essential to err on the side of 
caution until sufficient information is available on the 
use of oral dantrolenc. 
At present it is a difficult choice between the 
administt:ation of prophylactic dantrolcnc for the 
MR-susceptible patient or reliance on the use of a 
"safe" anaesthetic technique. The effective prophyl-
actic dose of dantrolenc is similar to that at which 
adverse side-effects stan to occur. A patient who is 
given oral · dantrolenc and suffers from any of the 
following symptoms : dizziness, blurred vision, inco-
ordination, abdominal pain, diarrhoea, nausea and 
muscle weakness (Pandit, Kothary and Cohen, 1979; 
author's observations), may question the necessity of 
this life-saving therapy. Furthermore, the possible 
interactions of dantrolenc with neuromuscular block-
ing drugs given during anaesthesia have yet to be 
thoroughly elucidated. A recent study by Flewellen, 
Nelson and Bee (1980) investigated the effects of 
dantrolenc on neuromuscular blockade produced by 
tubocurarinc. They found that ncostigminc did not 
reverse the dantrolenc-induccd depression of muscle 
function and warn that this may contribute to respira-
tory inadequacy in ·the period after operation. On 
balance, the anaesthetist who is meeting the problem 
of anaesthesia for the MR-susceptible patient for the 
first time is advised to use ciral dantrolenc prophylac-
tically. The anaesthetist with experience of such cases 
can probably rely on the avoidance of known trigger-
ing agents. 
It is not the purpose of this editorial to describe in 
detail the treatment of MH (for which, sec Ryan, 
1977), but to indicate when and how i.v. dantrolenc 
should be used. As soon as MH is diagnosed all . 
potent inhalation anaesthetic agents must be dis-
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continued, and the acidosis treated immediately by 
hyperventilation and the i.v. administration of sodium 
bicarbonate. Dantrolenc is then injcacd in aliquots of 
1 mg kg-1 at intervals of 5-10 min until MH is 
resolved, as shown by control of the acidosis, tachy-
cardia, temperature and muscle tone. Danttolenc 
2-3 mg 1cg-1 i.v. is probably sufficient to treat most 
cases of human MH, but up to 10 mg 1cg-1 has been 
used in the porcine syndrome without adverse side-
effects (Groncn, Mildc and Thcyc, 1976). 
Some anaesthetists who have never seen a case of 
MH may question the need for purchasing an expen-
sive drug, approximately £1 per mg, with a limited 
shelf-life of 18 months to 2 years. Dantrolenc should 
be regarded, however, as cheap insurance against a 
possible anaesthetic death and be readily available 
in all hospitals in which anaesthetics arc undertaken. 
Anaesthetists in the United Kingdom who usc i.v. 
dantrolenc in MH will be asked to supply all clinical 
details to Eaton Laboratories, who market the drug, 
so that the data can be collected and analysed. This 
service is essential if the correct use of dantrolenc is 
to be established and all anaesthetists arc urged to co-
operate, even if the diagnosis of MH is not subse-
quently confirmed. 
· Progress in the management of MH-susccptiblc 
patients has been painfully slow since the syndrome 
was first described 20 years ago. The usc of dantrolenc 
both orally and i.v. offers a unique opponunity to 
reduce the monality rate significantly. 
I am indebted to Eaton Laboratories, a Division of 
Morton-Norwhich Laboratories, for details of 19 
patients treated with dantrolenc in the Multiccmrc 
Study in North America. 
G.M.Hall 
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Dantrolene sodium in the treatment of 
malignant hyperthermia 
A case report 
G. G. HARRISON 
Of all the complications of general anaesthesia perhaps the most 
dramatic is the veritable metabolic storm which characterizes the 
frequently fatal syndrome of anaesthetic-induced malignant 
hyperthermia (MH), a pharmacogenctic condition associated 
with a rare myopathy which causes the sufferer little or no 
disability in the normal course of events. 1 Although extremely 
rare, the condition has been identified world-wide, the incidence 
(reported as approximately 1/7 000 to 1/50 000 anaesthetics) 
appearing to vary geographically with the gene · pool. 2 The 
syndrome has been reported in South Africa, 3•4 and to my certain 
knowledge more cases have occurred than have been reported in 
the literature. Because of the extreme rareness of the syndrome, 
fatalities have resulted from delays in diagnosis, often due 
directly to a lack of awareness on the part of the clinician. 
Occurring most commonly after exposure of genetically 
susceptible individuals to the volatile anaesthetic agent 
halothane and the depolarizing relaxant succinylcholinc, the 
syndrome has been associated with all volatile and gaseous 
anaesthetic agents in clinical use. 1 
The S}ndrome manifests as a sudden and sustained rise in the 
patient's core temperature during administration of a general 
anaesthetic; this is associated in the majority of cases with muscle 
hypertonus or rigidity and usually preceded by a myotonic 
response with marked massetcr spasm to the injection of 
succinylcholine. The rise in core temperature is rapid, often 
fulminant, rates of I °C every 5 - 10 minutes having been 
recorded. In the untreated patient, the temperature continues to 
rise inexorably until the death of the patient, with a core 
temperature of 42°C. Pan· passu are observed tachycardia, 
cyanosis, tachypnoca, and excessive heating of the soda lime 
cannister (evidencing high CO2 output), accompanied by gross 
biochemical changes in the blood, the most prominent being 
severe acidosis, both metabolic and respiratory, hypcrkalacmia 
and a markedly increased scrum level of the muscle enzyme 
creatinc phosphokinasc (CPK), which is diagnostic. Tiic 
reported mortality has been of the order of 70%. 
Department of Anaesthetics, University of Cape Town 
G. G. HARRISON, M.D., F.F.A.,Profmor 
Date rc~rved: I May 1981. 
Until recently, treatment has perforce been symptomatic, but 
now specific therapy is possible with dantrolene sodium 
(Dantrium; SKF), an intrinsic relaxant of skeletal muscle with a 
modifying action on the excitation/contraction/coupli~ 
mechanism - the probable site of the functional lesion of MH.1 
The following case report demonstrates the first successful use 
in South Africa of dantrolenc in a patient with MH (Fig. I) . 
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Fig. 1. Temperature and ennt1 chart of patient deacrlbecl. 
. Case report . 
This case arose in a private hospital in which biochcniical 
investigative back-up was not as . readily available or prompt as 
could have been wished. A Coloured.girl aged 10 years, with 
weight 37 kg, presented for intranasal antrostomy. Apart from 
the lesion in her maxillary sinuses - the indication for operation 
- she was clinically normal. Her temperature on admission on 
the morning of the operation_ was .36,5°C. She gave a history of 
having had a general anaesthetic for tonsillectomy 3 years 
previously, with no untoward effects. - · 
After premcdication with oral trimcprazine 84 mg, monitoring 
of heart rate and blood pressure was commenced and anaesthesia 
induced with mcthohcxitonc · sodium .70 mg followed by 
succinylcholine 40 mg. Thereafter, intcrtnincnt positive-
pressure ventilation with 100% oxygen and I% halothanc vapour 
was instituted. Attempted laryngoscopy prior to intubation was 
frustrated by the onset of gross·trismus. Thinking that this might 
be due to deterioration of the succinylcholinc, the anaesthetist 
thereupon administered a further 30 mg. Trismus persisted, 
necessitating the use of force with a wooden gag to open the 
mouth to permit topical analgesia of the larynx and orotrachcal 
intubation, after which the teeth were kept apart with a self-
retaining gag. Anaesthesia was maintained with nitrous oxide 
and oxygen (4 and 21/minrcspectivcly)and with l,5%halothanc 
vapour reduced gradually to 0,5%. When · spontaneous 
respiration recommenced mer the action of succinylcholine had 
worn off, tachypnoca ( 40 breaths per minute) was evident. At the 
same ti~e a sinus tachycardia of 140/min was noticed and the 
surgeon observed cyanosis in the blood at the operative site, in 
spite of adequate ventilation with an inspired oxygen 
concentration (Fio2) of 0,33. These conditions persisted. At the 
conclusion of surgery and anaesthesia, 32 minutes after 
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induction, the patient's limbs, especially the legs, were noted to 
be stiff. She felt hot and failed to regain consciousness . Rectal 
temperature , measured now for the first time, was 38,5°C. 
Malignant hyperthermia was diagnosed and the patient was 
transferred to the recovery ward, where an infusion of sodium 
bicarbonate with furosemide JO mg was commenced, followed 
by an infusion of balanced salt solution. Thirteen minutes after 
the discontinuation of the anaesthetic, active surface cooling was 
initiated, the patient being covered with ice and with wet sheets 
on which fans were directed . 
In spite of this, 35 minutes later, by which time supplies of 
dantrolene had arrived from a teaching hospital (the only 
a,·ailable source of supply at this time), the patient' s rectal 
temperature had risen to 39,2°C and she was still unconscious 
and stiff, with a pulse rate of 140/ min and a respiration rate of 40. 
Dantrolene (I , 7 mg/ kg to a total dose of 60 mg) was 
administered intravenouslv over the next JO minutes . Almost 
immediately, muscle tone.decreased, cooling commenced, the 
Je,·el of consciousness rose, and respiration slowed. Within 30 
minutes of commencing treatment, the patient was wide awake, 
extubated and the rectal temperature had dropped to 38,2°C. 
The rate of cooling, initially I °C in 30 minutes, increased rapidly 
with a further fall of 4°C over the next 30 minutes in spite of 
progressive removal of ice, fan, and wet sheets; finally the patient 
was covered with a bunny blanket (Fig. I ). The patient then 
warmed spontaneously to 36,5°C within the next 105 minutes, at 
which level the temperature stabilized. An arterial blood sample 
taken 35 minutes after administration of dantrolene - . when the 
patient was already awake and cooling and had already had 250 
mmol sodium bicarbonate plus 700 ml Plasmalyte and had 
passed I litre of urine - showed that the metabolic crisis had 
largely passed. The acid-base status at that stage was: pH 7,53; 
Pco, 4,8 kPa, Po, 23 kPa (on 30% 0 2 ) , potassium 3,3 mmol/1, 
sodium 147 mmol/1, but the diagnostic marker of MH was 
e\'ident in a CPK level of 7 600 IU/1. 
On the next day, the patient was well, although complaining of 
marked stiffness in her leg muscles. Serum enzyme levels at this 
time were: CPK 575 IU/ 1 (normal < 50 IU/1) and lactic 
dehydrogenase 384 IU/ 1 (normal 120 - 140 IU/1). The iso-
enzyme-5 level was raised, compatible with a muscle lesion. 
Discussion 
Although not as completely documented in many respects as one 
would have liked, this case warrants reporting, for it highlights 
many important clinical aspects of the rare and so often fatal MH 
syndrome. 
The individual susceptible to MH need not respond on every 
occasion to an appropriate stressor with an attack of MH, i.e. a 
history of previous general anaesthesia with no untoward effects 
(as in this case) does not exclude the possibility of an attack, as 
was once commonly thought. 6 The sensitivity of the 'trigger' 
\'aries in degree, not only between patients but in the same 
patient at different times. The anaesthetic administered to this 
patient 3 years previously for tonsillectomy was halothane, 
inhaled for a relatively short time - ± 30 minutes. The ' trigger', 
not too sensitive at this time, was only 'fingered' and not pulled. 
On the present occasion, two doses of succinylcholine and a 2 
MAC initial concentration of halothane meant that the 'trigger' 
was verily pulled. 
This case also illustrates the danger inherent in the common 
reaction of the anaesthetist when the first dose of succinylcholine 
is ' ineffective ' (as manifested by masseter spasm), which is to 
give another dose from a different ampoule in the belief that the 
first had deteriorated pharmacologically. Caffeine stimulation 
tests on muscle biopsy specimens have shown that 50-100% of 
patients displaying this abnormal masseter spasm reaction in 
response to succinylcholine suffer from MH susceptibility.7 
The importance of the sudden onset of unexplained sinus 
tachycardia during anaesthesia as a warning and early 
diasgnostic sign of MH is also illustrated. It follows the rapid rise 
in circulatory catecholamine levels shown to accompany 
initiation of the svndrome. · 
Cyanosis in the presence of adequate Fio2 and pulmonary 
ventilation should also alert the anaesthetist to the possibility of 
MH. 
The specific therapeutic efficacy of dantrolene sodium in the 
established MH syndrome is also well illustrated. It is as if it 
simply turns off the switch of muscle hypermetabolism that 
halothane/ succinylcholine turns on in the genetically 
susceptible individual. 
Since MH when it occurs is a life-threatening emergency, I 
conclude this case report with a summarized treatment protocol. 
Prevention and early effective treatment depend on an awareness 
of the condition by the clinician, and rapid, appropriate reaction 
to the earliest warning and diagnostic signs, before core 
temperature has risen more than 0,5°C, is often sufficient to 
abort an attack. Such early signs arc: (1) masseter spasm 
following administration of succinylcholine, (i1) unexplained 
sudden sinus tachycardia, (ii,) tachypnoea if the patient is 
breathing spontaneously, (ii,) cyanosis in the presence of 
adequate ventilation and Fio,, (v) heating of the soda lime 
cannister, and (v1) any unexplained rise in the core temperature 
of 0,5°C or more. 
The following treatment protocol should be instituted: (1) 
discontinue anaesthesia, (i1) hyperventilate the patient with 
100% oxygen, (ii,) administer sodium bicarbonate (having first 
taken a blood specimen for diagnostic and baseline biochemical 
parameters) to correct the fulminant acidosis (a dose sufficient to 
correct a base deficit of 10 mmol/1 can safely be given in the first 
instance); (iv) cool the patient aggressively - use ice and wet 
sheets with fans, infuse iced intravenous solutions, irrigate any 
open body cavity with iced saline; (v) infuse dantrolene sodium 
intravenously, I - 2 mg/kg every 10- 15 minutes, until there is 
(a) decrease in muscle tone, (b) fall in core temperature, and (c) 
slowing of the heart rate; (vi) maintain circulatory homeostasis 
with intravenous balanced salt solutions (iced), (vii) look for and 
treat associated complicatioI:1s such as myoglobinuria (treat with 
furosemide or mannitol) · and disseminated intravascular 
coagulation (treat with fresh-frozen plasma). ' 
Once the syndrome is controlled, the patient should be kept in. 
an intensive care unit for 24 hours . in case of possible 
recrudescence of the condition, which has happened. Later, 
first-degree relatives should be screened for susceptibility to the 
MH syndrome. · . · 
A drawback to increasing the general availabiliry of 
dantrolene, is its expense (± R420,00 per treatment pack of 12 x 
20 mg ampoules) and its relatively short shelf-life (2ycars from 
manufacture in the USA). WhilenonationalJ>Olicy has yet been 
agreed to in this regard~ a fairly effective and relatively 
inexpensive scheme can be instituted in cities. For example, in 
Cape Town one treatment pack is held at each of the teaching 
hospitals, Groote Schuur and Tygcrberg ·Hospitals, whence it ·. 
can be transported to any other hospital in the town timcously in 
case of need, as happened in this case. Immediately a dose of the 
drug is used, it is replaced within 24 hours by the pharmaceutical 
firm concerned. However, in view of the wide geographical 
spread of the country hospitals where anaesthetics arc 
administered, and at any of which the syndrome might occur, the 
cost-effectiveness of dantrolcne can be called into question. I do 
not have a ready solution to th~s dilemma. 
I wish to thank Dr Y. Bosman for permission to publish and 
Smith, Kline & French for supplies of dantrolene sodium: 
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Dantrolene sodium in the treatment of 
malignant hyperthermia 
To the Editor: A recent issue of the SAMJ carried a report of the 
first successful use in this country of dantrolene sodium (Dantrium; 
SKF) in the treatment of anaesthetic-induced malignant hypmhermia (MH).1 
This covert genetic myopathy is rare, especially in South Africa. 
To reinforce in our colleagues an awareness that there are individuals 
in our community susceptible to MH (such awareness being 
essential to early, life-saving diagnosis of the developing syndrome), 
we report briefly on a second patient successfully treated with 
dantrolene within 14 months of the case previously reported. The 
patients were not related. 
An 8-year-old Coloured girl weighing 23 kg required general 
anaesthesia for Harrington rod correction of congenital lumbar 
scoliosis. She had been anaesthetized without complications 7 years 
before for incision and drainage of an abscess. Apart from the lumbar 
scoliosis, she was healthv. 
The events during the anaesthetic are displayed in chart form in 
Fig. I. On arrival in the operating theatre after oral premedication 
with trimeprazine tartrate 72 mg and droperidol 3 mg, an oral 
l 
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Fig . 1. Anaesthetic events chart. 
temperature of 35,8°C was recorded. Monitoring of the blood 
pressure and ECG was commenced, and general anaesthesia was 
induced by the intravenous injection of thiopentone 100 mg, 
followed by inhalation with spontaneous respiration of nitrous 
oxide/ oxygen ( 4:2) together with halothane vapour of increasing 
concentration. Commencement of the inhalational anaesthetic was 
accompanied by drawing up of the arms and other muscle 
movements. The anaesthetist, interpreting these as signs of waking, 
rapidly increased the concentration of halothane vapour to 3% in an 
endeavour to achieve smoother induction of anaesthesia. Ten 
minutes from the stan endotracheal intubation was performed 
following lignocaine topical analgesia of the larynx. The halothane 
concentration was thereafter reduced to 1 % and intermittent 
positive-pressure ventilation (IPPV) commenced. The pulse rate 
was noted to have risen to 150/min (sinus tachycardia). Twenty 
minutes after induction difficulty in catheterization of the bladder 
drew anention to generalized muscular rigidity. This and a further 
rise in the pulse rate to 160/min prompted thoughts of MH. A rectal 
probe now inserted showed the temperature to be 37,5°Cand rising. 
Halothane was discontinued and the patient ventilated with oxygen 
alone. At 40 minutes, with the rectal temperature 38°C, the pulse 
f!!te 165/ min and a marked generalized increase in muscle tone, 
active surface cooling with wet sheets, ice and fans was instituted. An 
arterial blood sample taken at this time showed the gross metabolic 
acidosis characteristic of an MH crisis - pH 7,07, partial arterial 
carbon dioxide pressure 61,9 mmHg, base excess·-14 mEq, partial 
arterial oxygen pressure 214 mmHg (oo 100% oxygen). Infusion of 
sodium bicarbonate was commenced, and in all over the next 40 
minutes 200 mEq was administered. In spite of the active surface 
cooling the patient's temperature continued to ri~e inexorably and by 
58 minutes after induction had reached 39,6°C {pulse rate 210/min). 
At this stage dantrolene 2 mg/kg in I mg/kg aliquots was 
administered. The muscle spa~rr;;mmediately relaxed, the pulse rate 
slowed and after a further 0,2°C rise to a peak of 39,8°C (the overall 
temperature rise was 4°C in 60 minutes, l,8°C since the Start of 
cooling) the temperature began to fall . Twenty-five minutes after the 
administration of danttolene the temperature had fallen to 37°C, the 
pulse rate was 140/ min, and active cooling was discontinued. The 
patient was now waking and shortly after was allowed to breathe 
spontaneously and cxtubated. An afterdrop of 2°C followed 
cessation of active cooling, rectal temperature bonoming out at 35° C 
30 minutes later, after which it returned to 37°C over the next 3 
hours. Further dantrolene (0,5 mg/kg) had been given when cooling 
was discontinued. In addition to sodium bicarbonate, 5 g mannitol 
was infused and a good urinary output maintained. Throughout the 
crisis the blood pressure remained stable between 120 and 130 
mmHg systolic. 
As so often happens in such crises the Astrup apparatus broke 
down immediately after the first blood specimen had been analysed 
so that final precise real-time acid-base control was not possible and 
progress was judged on clinical grounds. Other biochemical assays of 
interest and diagnostic import were for 5CrUID powsium, which rose 
to 5 mEq/1 during the crisis, and creatine pbosphokinasc (CJ>K), 
which rose to 92 IU/1 in mid-crisis and to 5 510 IU/1 in 24 houn 
(nortnal value< 50 IU/1); tbcsc were acoompanied by more modest . 
. rises in lactate dehydrogcnasc (LH) (191-1 S40 IU/1) (normal l~ 
350 IU/1) and aspartatc aminotransferase (AST) (19-357 IU/1) 
(nortnal <40 IU/1) values. One week later the CJ>K valuehadfallen 
to 187 IU/1 and LH and AST to virtually normal levels. 
Clinical points worthy of comment arc: (1) the history of previous 
unoomplicated general anaesthesia, although it was« short duration 
· and the patient was only 1 year old at the.time; (i1)misinterpraation 
of the initial muscle contraction as indicating lightming anaesthesia 
rather than the onset of MH; and (ii,) unexplained sudden sinus 
tachycardia as an early diagnostic pointer. 
The operation was safely c:arricd out 10 weeks later under general 
anaesthesia. Intravenous danttolcne was used for pre-induction and 
the use of volatile anaesthetic agents was avoided; instead a 
pancuronium/fentanyl/nittous oxide/oxygen IPPV technique was 
utilized following induction of anaesthesia with thiopentooc. 
Investigation of the family - parents and 2 siblings - has shown I 
sibling to be susceptible to MH. 
G. G. Harrison 
D. C. Chapman 
Depanment of Anaesthetics 
University of Cape Town 
I. Harrison GG. Dantroknc sodiumintbetfflltrDelltaCmaligmntbypmbmnia. S Afr M,dJ 1981; 60: 909. 
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DANTROLENE-DYNAMICS AND KINETICS 
G. G. HARRISON 
Although Bianchi's perceptive suggestion [2] at 
the First International Symposium on Malignant 
Hyperthermia in 1971, that diphenyl hydantoin 
should be investigated as a possible therapeutic 
agent for Malignant Hyperthermia (MH), did not 
bear fruit, it was the introduction of another 
hydantoin--dantrolene sodium-that later revolu-
tionized the treatment and prognosis of MH. 
Dantrolene was synthesized originally by Snyder 
and associates [ 49] during the investigation of a 
series of substituted furans that had muscle 
relaxing properties, and its skeletal muscle re-
laxant properties were shown by Ellis and co-
workers [11-13] to stem from a selective depres-
sive action on the intrinsic mechanisms of excita-
tion-contraction coupling (ECC). This demon-
stration motivated the successful therapeutic trial 
of dantrolene in porcine MH [24, 26], followed 
later by its equally successful use in the MH 
syndrome in man [32]. 
At the time this syndrome first came to world 
notice, during the decade of the 1960s, the 
mortality from MH was of the order of 80 % . 
During the 70s, increasing awareness of the 
syndrome with resultant earlier diganosis and 
treatment, albeit non-specific, led to an improve-
ment in prognosis, recorded mortality decreasing 
to 28 % . This decade, following the introduction 
to practice of dantrolene sodium, the mortality 
recorded following MH is now but 7 % and these 
subjects, on review, all manifested serious avoid-
able errors in therapeutic management. Today, 
with correct management utilizing dantrolcne 
sodium, survival from MH is the expected norm 
[4,23] . 
Chemistry 
Dantrolene sodium, 1-{[5-(p-paraphenyl) fur-
furylidene] amino} hydantoin, is pharmacologi-
cally the most active member of a long series of 1-
GAISFORD G . HARRISON, M.D., F.F.A.R .C.S. , Department of 
Anaesthetics, University of Cape Town, South Africa. (Also 
Groote Schuur Hospital. ) 
[(5 aryl furfurylidene) amino] hydantoins synthe-
sized for their muscle relaxant properties (fig. 1 ). 
Dantrolene is the only analogue in the series to 
achieve clinical usage, although others have been 
tested [51]. 
The molecular structure of dantrolene is planar, 
with the exception of the phenyl ring, which is 
rotated approximately 30° out of the plane of the 
furan ring [13] (fig. 1). 
Highly lipid soluble, but extremely poorly 
soluble in water, the drug was originally dispensed 
in capsular form for administration by mouth-a 
circumstance compatible with its originally envis-
aged use for the pharmacological control of 
chronic states of muscle spasm. Once its efficacy 
in the control of MH had been demonstrated, its 
wide-spread use for this purpose was sadly 
delayed some years by the need to develop an i.v. 
formulation appropriate to the clinical circum-
stances of MH. 
Today, for this purpose, the drug is supplied in 
ampoules containing 20 mg of lyophylizcd dantro-
lene sodium, an orange powder, together with 
mannitol 3 g (which improves the solubility) and 
sufficient sodium hydroxide to yield a pH of 9 .5 
when the contents are dissolved in 60 ml of water. 
The final concentration of dantrolenc in this 
solution is 0.33 mg m1-1• 
Pharmacodynamics 
The primary pharmacological action of dantro-
lene is the relaxation of skeletal muscle, with 
reduction in the force of contraction. This, 
although dose-dependent, reaches a plateau at a 
level well short of total paralysis of muscle, 
regardless of the dose [21]-a circumstance attri-
buted to the limited water solubility of the drug 
[13]. 
The loci at which drug action could have such 
an effect in the complex interactions responsible 
for skeletal muscle contraction arc shown diagram-
matically in figure 2 and provide the background 
against which will be presented findings, from the 
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FIG. 1. Top : Structural formula of derivative aryl amino hydantoins. Below : Ground state conformation 

































FIG. 2. Sequential steps in skeletal muscle excitation-contraction c:ouplin&. 
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been submitted, that are most relevant to our 
present understanding of its mode of action. 
Early work, predominantly that of Ellis and 
associates [11-13] showed the relaxant action of 
dantrolene to be unusual and to result from a 
depressive action within the muscle cell at one or 
more loci in the ECC train, specifically affecting 
the sarcoplasmic reticulum (SR). Briefly, these 
conclusions were based on observations that 
dantrolene : 
(1) did not act on the CNS [13,56]; 
(2) had no effects on spinal polysynaptic reflex 
responses [13]; 
(3) acted directly and specifically on skeletal 
muscle and had no effect on cardiac or smooth 
muscle, nor did it affect respiration ventilation 
[13, 15, 21]; 
( 4) had no effect on the neuromuscular junction 
(5, 13,56] and produced no change in "train-of-
four" ratios [21]; 
(5) had no effect on the electrical properties of 
sarcolemma or T -tubular mechanisms, nor was 
the EMG affected [13, 35]; 
(6) caused dissociation of muscle ECC by 
interfering directly with SR calcium release or the 
preceding "trigger calcium ", or both. These 
deductions, based originally on observation of the 
interactive effects of dantrolene with those of 
caffeine, procaine and EDT A on in !litro induced 
muscle twitch and tetanus (13], were confirmed 
by the direct observation by van Winkel [55] and 
Desmedt and Hainout [7] that dantrolene reduced 

























without completely abolishing it. Ellis and Carpen-
ter [13] postulated that the effect on trigger 
calcium might be the basis for the specificity 
of action of dantrolene on skeletal muscle, as 
opposed to its lack of action on cardiac and smooth 
muscle, in which sarcolemmal calcium transients 
constitute the more important mechanism in 
ECC; 
(7) had no effect on SR calcium uptake [13, 53, 
55]. 
Morgan and Bryant's conclusions [39] based on 
the foregoing and their own observations of the 
effects of dantrolene on rheobasic potential, 
chronaxie and on voltage dependent "charge 
movements ", provided the best concept, at that 
time, of the mode of action of dantrolene. They 
proposed that dantrolene acted to cause skeletal 
muscle relaxation by interference with ECC at no 
fewer than two sites, the SR membrane and the 
voltage-dependent "charge movements" of the 
T-tubular-SR coupling. At the first site the effect 
is to decrease the release of calcium out of the SR, 
possibly by decreasing the mobility of a natural 
calcium ionophore. At the second site the effect is 
produced by an increased rate of movement of 
the "charge movement particles " to the OFF 
position. 
Whatever its mechanism, depression by dantro-
lene of the rate and amount of SR calcium release 
finds its most dramatic expression in the abrupt 
termination of the MH syndrome it engineers-
illustrated in figures 3 and 4 by animal biochemical 
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FIG. 3. Effects of dantrolene administration (D) on the Vo., lactate production and catecholamine 
secretion of MHS swine provoked into malignant hypenhermia by anaesthesia with halothane. • = 
Untreated; II,.= supportive treatment only; e c: supportive treatment and danttolene 7.5 mg q-1• 
(From Gronen, Milde and Theye (24) with permission.) 
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FIG. 4. Malignant hypcrthcrmia: illustrative cvcnu chan from a 9-yr-old female patient admined with congenital kyphoscoliosis (sec associated conditions), for insertion of Harrington Rods. Note: Onset tachycardia ; progression of syndrome despite discontinuation of halothane and institution of CX>OWII; immediate response to dantrolcne (delay in administration occasioned by its being obtained from neighbouring hospital). The operation was successfully performed 6 weeks later, when prophylactic i.v. dantrolcne was given with induction. T -= Thiopcntone; Int. -= intubation. Cool ON - Start of CX>Oling; Cool OFF= discontinuation of c;ooling; Dl, D2 • dantrolcne 1 mg kg-1 ; D3-= dantrolene 0.5 mg kg- 1. 
(From Harrison and Chapman [29), with permission). 
which has been shown by direct measurement by 
Lopez [37) to correlate with a dantrolene-induced 
decrease in myoplasmic free calcium, has the 
attributes of the turning off of a switch and itself 
carries implications for both the pathogenesis of 
MH and the mode of action of dantrolene. 
Considered together with observed lack of effect 
of dantrolene on SR calcium uptake, it implies 
that continued SR calcium release-as against 
decreased SR uptake-is fundamental to the 
genesis of MH. Once this is terminated, the 
function of other calcium modulating mechanisms 
appears adequate to return myoplasmic free 
calcium to resting concentrations, permitting 
relaxation of muscle and termination of the 
syndrome. 
An attractive current hypothesis identifies an 
abnormality in the mechanism of calcium-induced 
calcium release (CaIR) from the SR as the 
causative functional lesion of susceptibility to 
MH [16, 17). This putative third SR calcium 
channel, which has no physiological role in the 
mechanism of skeletal muscle contraction, has 
been shown to have a lower than normal threshold 
and to respond with a faster than normal rate of 
calcium release, in subjects susceptible to MH 
[31). As some similarity had been demonstrated 
between caffeine (and halothane) and CaIR [16), 
it seemed not unreasonable to expect that dantro-
lcne would decrease the latter, as it has been 
shown to inhibit the former [13, 43). 
This, however, has not proved to be the case 
[40). Examining the effects of dantrolcne on SR 
calcium release induced by caffeine, calcium jump 
and depolarization, Danko and colleagues [6] 
showed these to be complex and clearly dis-
tinguishable from those of the conventional SR 
calcium channel blocking drugs such as ametho-
caine and procaine, which inhibit all these mod-
alities equally [l]. While inhibiting caffeine- and 
halothane-induced SR calcium release, dantrolene 
produced no effect on CaIR and exhibited a time-
dependent dual effect on depolarization-induced 
calcium release-an initial inhibition being fol-
lowed by enhancement. Associated with these 
findings was a correlative pattern in the binding of 
dantrolcne to both SR and T -tubular membranes. 
Two kinetically distinguishable binding sites 
were identifiable on the T -tubular membranes, 
the slow binding site being related to the effects of 
the drug on depolarization-induced calcium re-
lease. Of that portion which bound to the SR, little 
competed with caffeine binding sites, suggesting 
that much of the binding of dantrolene was to 
non-specific sites unrelated to calcium release. 
Considering the above in the light of their 
therapeutic activity in the MH syndrome, one 
may speculate that the difference between the 
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uncertain action of the conventional SR calcium-
blocking drugs such as procaine and the comple-
tely reliable action of dantrolene (28] must lie in 
the latter's more complex action involving, as it 
does, a major effect on the T -tubular-SR coupling 
mechanism. Such a postulate carries its own 
implications for the conceived pathogenesis of 
MH. 
In this regard it is important to note that, while 
dantrolene has no effect on normal sarcolemma, 
its action on the sarcolemma of MHS muscle is of 
relevance. Gallant, Godt and Gronert (22] have 
demonstrated that, whereas exposure to halothane 
has no effect on the sarcolemma of normal muscle, 
that of MHS muscle responds to such exposure 
by a depolarization of between 5 and 15 mV-a 
reaction that is antagonized by dantrolene. While 
this degree of depolarization, with its accompany-
ing increase in calcium permeability, would not be 
sufficient of itself to initiate contraction in normal 
muscle, it could so do in the presence of SR that 
displayed a low threshold CaIR mechanism such 
as is postulated to characterize MHS muscle 
(44]. 
All in all, therefore, it seems that, although 
dantrolene provides a specific and life-saving 
treatment for the syndrome of MH, we are still a 
long way from understanding the finer details of 
its mode of action and, correspondingly, those of 
the pathogenesis of MH. 
Effective antagonism of the muscle relaxant 
properties of dantrolene sodium is provided by 
germine monoacetate (GMA) [34).This reversal 
follows no direct pharmacological antagonism, 
but is the result of the property of GMA in 
causing repetitive firing of muscle in response to 
single stimulation and, so, repetitive myoplasmic 
free calciwn release. In essence, it produces the 
effects of a brief tetanus, which is well docu-
mented as being depressed by dantrolene less than 
single twitch (13, 42]. 
Pharmacokinetics 
Following its ingestion by mouth, approxi-
mately 70 % of dantrolene is absorbed, peak 
plasma concentration being reached in 6 h [IO]. 
However, especially in children, there is great 
variation between patients in the plasma concen-
trations achieved relative to the oral dose [36]. 
This fact doubtless accounts for the reported 
failure in prophylactic efficacy for MH of dantro-
lene administered by mouth (19, 47]. 
After i. v. administration of dantrolene to the 
conscious patient, the plateau maximal depression 
of muscle twitch response (75 % depression) and 
the maximal depression of grip strength ( 42 % 
depression) coincides with the administration of 
an accumulative dose of 2.4 mg/kg body weight. 
This achieves a blood dantrolene concentration 
of 4.2 µg m1-1 • Thereafter the elimination half-life 
(T/) is 12 h, although the blood concentration is 
maintained at a steady value within the thera-
peutic range for about 5 h. Residual dantrolene 
concentration in the blood at 24 h after such a 
dose is 1. 7 µg m1-1 and this is reflected sub-
jectively by patients, in a feeling of weakness. 
This may persist for up to 48 h, by which time 
the residual blood concentration of dantrolene 
has decreased to 0.3 µg m1-1 [21). 
Dantrolene is microsomally metabolized in the 
liver, through both oxidative and reductive path-
ways. The former results in hydroxylation of the 
hydantoin ring to form 5-hydroxydantrolene 
(5HD), while reduction of the nitro- moiety of the 
benzene ring results in the formation of aminodan-
trolene, which is then acetylated to form the 
reduced acetylated derivative of dantrolene 
(RAD) (36)-metabolites which themselves mani-
fest some muscle relaxant properties [14). 
Excreted in both the urine and the bile, 
dantrolene is 79 % excreted as 5HD, 17 % as 
RAD, while 4 % of the dose appears unchanged in 
the urine [10, 36). 
Adverse effects and drug interactions 
Although dantrolene is documented as having 
no effect on the CNS, the commonest adverse 
reactions it causes are symptoms of dizziness, light-
headedness and drowsiness. These feelings can 
accompany both acute i. v. and chronic oral 
administration of the drug [21, 36). There is, as 
yet, no suitable explanation for these changes in 
the sensorium. It is suggested that they may 
exemplify similar changes in the sensorium re-
ported to accompany inhibition of neuromuscular 
transmission per se by other drugs [21). While 
these unpleasant side effects may be associated 
with nausea and vomiting, the latter more com-
monly follows oral ingestion of the drug, in which 
case they may be accompanied by diarrhoea 
[10]. 
The major adverse reactions that have been 
documented following administration of dantro-
lene, have all accompanied its chronic administra-
tion by mouth. Perhaps most important have 
been reports of hepatic dysfunction [18,45,54). 
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However, several reports to the contrary lead one 
to question whether the drug alone was respon-
sible for the hepatic dysfunction observed. To cap 
the reports of Dykes [IO] of no change in serum 
biochemistry, urine function or haematological 
indices following prolonged administration by 
mouth, and the failure of Flewellen and col-
leagues [21] to find any change in SGOT and 
SGPT concentrations to accompany acute i.v. 
administration of dantrolene, Durham, Gandolfi 
and Bentley [9] have reported their failure to 
produce any evidence of dantrolene hepatotoxicity 
in mice, even after enhancement of any hepato-
toxic potential by the inhibition of acetylation, 
depletion of glutathione, induction of biotrans-
formation and the promotion of reductive metab-
olism. Further, Sorensen and Acosta [50] have 
failed to produce in hepatocyte cultures any 
evidence of hepatotoxicity from dantrolene. 
Other adverse reactions include reports of the 
relatively common and non-specific drug reaction 
of an acneiform rash associated with prolonged 
oral ingestion of dantrolene [IO]. 
The most important adverse interaction of 
dantrolene with another drug is that with vera-
pamil-a drug which may be considered indicated 
in the management of MH associated-cardiac 
tachyarrhythmias. While dantrolene alone has no 
myocardial effects, Saltzman and others [48] and 
Lynch and colleagues [38] reported marked 
myocardial depression in swine and dogs after 
administration of verapamil in the presence of 
dantrolene, and vice versa. Although this reaction 
has yet to be described in man, simultaneous 
administration ofverapamil and dantrolene should 
be regarded as contraindicated in any event, as the 
cardiac arrhythymias that accompany MH in-
variably respond to the termination of the syn-
drome with dantrolene and correction of the 
associated acidosis and hyperkalacmia. 
As dantrolene causes a decrease in the force of 
muscle contraction, some mechanical synergism 
with drugs which block neuromuscular trans-
mission can be expected. Driessen, Wuis and 
Gielen [8] reported an unexpected interaction of 
dantrolene with the non-depolarizing neuromus-
cular blocking agent, vecuronium, in which the 
presence of dantrolene caused marked prolonga-
tion of the neuromuscular junction recovery time 
as monitored by the evoked EMG-a modality 
not normally affected by dantrolene. They specu-
lated that this effect may result from decreased 
transmitter mobilization at the neuromuscular 
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junction because of impairment of calcium release 
from storage sites within the cholinergic ter-
minals. Little more can be said of this reaction 
until there has been considerably more investi-
gation. 
Therapeutic use of dantrolene 
Dantrolene was originally introduced to thera-
peutics for the long term functional control of 
chronic states of skeletal muscle spasm such as 
follow stroke or characterize cerebral palsy. That 
it may still have some use in this regard is born out 
by the very favourable report from Kctcl and 
Kolb (30) of its successful long term use in the 
treatment of stroke patients with spasticity limi-
ting return of function. 
However, the most important therapeutic use 
of dantrolene today is in the treatment of MH, in 
which circumstance it is indeed life-saving [23). It 
has now proved equally life-saving in the manage-
ment of the functionally related ncuroleptic 
malignant syndrome [25). More recently, its use 
has been suggested as an adjunct in the treatment 
of tetanus, especially at the stage at which the 
patient is weaned from conventional neuro-
muscular blocking and antispasmodic drugs [52). 
For i.v. use, dantrolcnc is supplied as an orange 
powder (together with sodium hydroxide ·and 
mannitol), in a vial containing 20 mg, which is 
dissolved by the addition of 60 ml of water. The 
resulting solution, pH 9-10, is irritant to veins 
and should be injected to a fast-running i.v. 
infusion or large vein. Effective therapeutic concen-
trations of dantrolene for the treatment of MH are 
achieved after the administration of 2.4 mg kg-1• 
If necessary, this dose may be repeated at 15-min 
intervals, until relaxation of muscle rigor, control 
of tachycardia and arrhythmia and cessation of 
temperature increase are achieved, or a total dose 
of 10 mg/kg body weight has been given. It is 
seldom that a dose exceeding 4 mg kg-1 is re-
quired. 
Although patients may complain of muscle 
weakness even up to 48 h after administration, 
this will not be of an order which imperils 
ventilatory capacity, or coughing. 
Once controlled, the MH syndrome may recur 
in the post-anaesthetic period. Dantrolcne admini-
stration should be repeated immediately at the 
first sign of such occurrence. In view of this 
possibility, some advocate a repeat prophylactic 
dose of dantrolene 2.4 mg kg-1 after 10-12 h-thc 
elimination half-life of the drug. 
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In the treatment of MH, it must be emphasized 
that after a timely administration of dantrolene, 
after early diagnosis, little or no supportive 
therapy is necessary. The need for therapy is 
directly, perhaps exponentially, proportional to 
the delay in diagnosis and the institution of 
treatment. Such supportive measures and the 
treatment of MH generally are dealt with else-
where in this issue and will not be discussed 
further here. 
Following control of the syndrome the patient 
must be closely monitored and sedated for 24 h 
after initial recovery, for fear of recurrence of the 
syndrome. 
Pre-anaesthetic prophylactic dantrolene for the 
MHS patient 
The application of simple guidelines will ensure 
safe anaesthesia for the individual known to be 
susceptible to MH. These guidelines are: 
(1 ) Obtundation of the patient's "trigger" sensi-
tivity. 
(2) Utilization of meticulous vital function 
monitoring. 
(3) Avoidance of agents known to trigger MH. 
(4) Immediate availability of i.v. dantrolene. 
While it once seemed obvious that the prophy-
lactic administration of dantrolene was the neces-
sary and most efficacious way of achieving the first 
· of these desiderata [27], this is now subject to 
some controversy. Certainly, the use of oral pre-
anaesthetic prophylactic dantrolene regimens 
[3]-which may involve admission to hospital for a 
2-4 day programme of administration of the drug, 
from which the patient may suffer many un-
pleasant symptoms and which does not guarantee 
prophylactic systemic blood concentrations of 
dantrolene [19, 20, 47]-are no longer to be recom-
mended. Indeed, given the application of correct 
anaesthetic technique with meticulous vital func-
tion monitoring, together with the immediate 
availability of i.v. dantrolene, many would 
question the necessity for the prophylactic ad-
ministration of dantrolene at all, especially if the 
planned surgical procedure is relatively short. 
However, when the surgery contemplated is 
prolonged, there are those who still think the 
patient's best interests are served if dantrolene is 
administered prophylactically. In these circum-
stances, it should be administered i.v. in a dose 
of 2.4 mg kg-1 during the induction of-anaesthesia 
and-to avoid unpleasantness for the patient-
after consciousness has been lost [29]. 
When this regimen is adopted, it must be noted 
that the effect that pre-anaesthetic prophylactic 
dantrolene might have on the outcome of in vitro 
contracture testing of muscle biopsied in these 
circumstances, is controversial. While, a priori, an 
invalidating inhibitory effect on both caffeine-
and halothane-induced contractures is to be 
expected, and indeed has been reported [3, 33], 
the contrary has also been documented [41,46]. 
These reported discrepancies are in all probability 
dose (and tissue concentration) dependent. 
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A Pharmacological in Vitro Model of 
Malignant Hyperpyrexia 
G. G. HARRISON, M.D. UNIV. CAPE TOWN, F.F.A. .R.c.s. ENG., Associate Professor, Department of .-inauthetics, Groote Schuur Hospital and University of Cape Town . . 
SUMMARY 
Caffeine caune contracture In muacle. Drugs which Initiate malignant hyperpyreJda In auaceptlble plga, lo_, the threahold concentration of caffeine at which thl1 con-traction occure. The lmpllcatione of and uHa for thla finding are deac:rlbed. 
S. A.fr. Med. J., 47i 774 (1973), 
Anaesthetic-induced malignant hyperpyrexia has been shown to be a disorder of muscle:·• Certain pigs of the Landrace strain in South Africa• and Australia,' the Poland China strain in America,• and Landrace Wessex in England,' have been shown to suffer from a similar disorder, and have ICl'Ved as useful models of this puzzling lethal condition. But pigs as experimental animals are expensive, and supplies of animals of the specific susceptible strain sporadic. Attempts at direct breeding of this specific strain have not proved very successful in our hands, and so we searched for a more readily obtain-able and cheaper animal experimental model Whatever the precise nature and site of the defect of malignant hyperpyrexia myopathy, Kalow et al.' showed that it prodw:a responses in muscle. rather similar to thoee which follow application of caffeine, a concluaion which gained pharmacological support from my demon-stration that initiation of the syndrome in susceptible pigs could be effectively blocked by procaine.' Strobel and Bianchi' demonstrated that if frog sartorius muscle was exposed to subcontracture-producing doses of caffeine, subsequent administration . of halothane to the prepara-tion led to rigor in a manner analogous to the response of the muscle of hyperpyrexia-susceptible pigs. As the only known subjects of malignant hyperpyrexia are mammals, I chose to investigate rat rectus as an in vitro model. The rat is a readily available and inexpensive laboratory animal, and the rectus is easily cut into strips of parallel fibres. 
METHOD 
The apparatus is shown diagrammatically in Fig. 1. One-gram strips of rat rectus were mounted in a vertical bath of approximately 120 ml volume, containing pharma-cological solution (Table I), to which S mg/100 ml of calcium chloride was added. This solution was oxygenated with carbogcn (3 % CO, and 97 % 0,) bubbled through a dispersion grid. The pH, monitored by a pH probe <Metrohm) was buffered to 7,4 by the addition of tri-
hydroxymethylaminomethane as needed. Temperature was maintained at 22• - 32°C. Muscle strips were mounted vertically between a fixed lower clamp and a platinum wire attached to the cross beam of a Devices displace-ment transducer, counterbalanced by a 1,S g weight, this arrangement permitting isotonic contraction of the muscle. The muscle attachments served as elec:trodes of a stimulator, programmed to stimulate the muscle supra-maximally at 0,25 Hz. Muscle contractions were recorded on a Beckman 10"' recorder. Caffeine stock solutions were made by the acid solution method of Frank et al.• Anaesthetic agents were added by passage of the carbo-gen stream through the appropriate vaporizer, provision being made by a venting side arm to keep gas flows within the performance toleran~ of the vaporizer .. Relaxant drugs used were from commerciaDy available solutions. 
TABLE I. COMPOsmoN OF SOLUTION 
Concentration Concentration Seit (mEq/L) Salt (mEq/l) Sodium 137,6 Potanlum 5,8 Magnealum 1,6 Chloride 142,3 Sulphate 1,6 Phosphate 1,1 
RE.flJLTS 
Caffeine in increasing concentration caliles . eohanc:ed muscle contraction, followed by shortening and ri,or of the muscle (Fig. 2). If a muscle is expoeed to a sub-contracture-producing concentration of c:affeinc,. 1111*-quent exposure to halothane causes . ..&orteniq·.w ... 3). If, on the other hand, the muscle strip· is first expoted to halothane and caffeine is then added, a reciproc::alJy synergistic effect is evident and shortening of the mmc;e occurs at a lower concentration of ca1feine than when caffeine alone is added (Fig. 4). By notiq the concen-tration of caffeine at which shortening occurred after exposure to halothanc-or &QY other anaest.hetic-this effect could be quantitated. I have called this concentra-tion of caffeine at which shortening started to develop the 'caffeine threshold'. As this level differed slightly between rats, I have in each cue used muscle from the same rat as its own control. The normal caffeine threshold was found to be 1 - 1,S mM caffeine. 
The effect of various anaesthetic agents and reJaxants on the caffeine threshold was investigated. Results are given in Table II. From these it will be secri .that aaents which have been shown to initiate the syndrome of malig-nant hyperpyrexia in susceptible pigs•· lower the caffeine 
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threshold of this muscle preparation. There is discrepancy 
between the· agents that have been incriminated as trigger 
agents in humans" and those that have been shown to 
so act in susceptible pigs.• Though many more agents 
have been incriminated in the human disease, the com-
monest agents in humans-halothane and suc:cinylcholine 
-are those which strongly initiate the condition in pigs 
and lower the caffeine threshold in this preparation. 
(Chloroform, which does so in pigs and which lowe:red the 
caffeine threshold preparation in our in vitro experiment 
is no longer used in humans). A notable exception is 
methoxyfturane. Though this ap:nt marbdly lowered 
the caffeine tlueshold in our preparation and has been 
recorded as being a strong inducing agent in susceptible 
human subjects, I have failed to initiate malignant hyper· 
pyrexia with it in susceptible pigs. 
It is also of interest to note that though Chalstry and 
Edwards" have described pancuronium as a trigger agent 
in pigs, I have failed to confirm this. 
CONCLUSIONS 
These observations appear to support K.alow's hypothesis 
that the functional lesion of malignant hyperpyrexia in 
susceptible subjects is a caffeine-like defect in the function 
of the sarcoplasmic reticulum. It seems that certain anaes-
thetics cause a similar alteration in membrane function 
of the sarcoplasmic reticulum. If susceptible human sub-
jects, pigs, or muscle preconditioned by caffeine, are 
exposed to such agents, the defect is acc:entuated by a 
TABLE II. EFFECT OF ANAESTHETICS. AND RELAXANTS ON 
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A practical use for this in vitro rat muscle preparation would be as a screening test for new anaesthetic agents for malignant hyperpyrexia-inducing properties. Further uses of this model are the investigation of the efficiency of agents such as procaine to block initiation of malig-nant hyperpyrexia, or perhaps of even more importance in the therapeutic field, the development from this of a preparation of sustained rigor on which agents which 
might actively relax rigor could be sought Qd tested. 
I should like to thank Mr Jan Korrubel of the Deputment of Bio-enaineerinl, Groote Schuur H~tal. for comtructioo of the muscle stimulator u well u modifications to the traDl-ducer. The project wu supported fiDancially by ,rants from the Anglo American and De Been Anaesthetic R-,cb Funds. 
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AL THESIN AND MALIGNANT HYPERPYREXIA 
G. G. HAllISON 
SUMMilY 
Altbesin is shown to block initiation of rnaJignant hyperpyraia by halothanc in ~ 
tiblc swine. It has no effect on the established syndrome, nor does it prevent the 
initiation of hyperpyrexia by smamethonium. 
The growing number of cases of anaesthetic-induced 
malignant hyperpyrexia with its genetic associations 
bas brought with it a growing number of individuals 
known to be at risk from this condition, should 
they present for anaesthesia and surgery. In this 
context, the observation of Hall, Trim and Woolf 
(1972) that Althesin appears to block initiation of 
malignant hyperpyrcxia by halothane/smarnctho-
nium in suscepn'ble pigs, is of great clinical impor-
tance. As there arc differences in the response of 
diff crcnt strains of maJignant hyperthermia suscep-
n'ble (MHS) pigs (Hall, Trim and Woolf, 1972; 
Harrison et al., 1969; Jones et al., 1972) and because 
the observations of Hall's group were rnade in few 
pigs exposed to halothane for 15 minutes only, it 
seemed important to confirm these observations in 
another strain of MHS pig during a longer aposure 
to halothane and, perhaps of more importance, to 
investigate the effect of Althesin on the established 
syndrome. 
METHOD 
MHS pigs were selected from the general pig in-
take of our Surgical Rescarc:h Laboratory by ex-
posure of all to a chaJJengc dose of halotbane 
(Harrison et al., 1969). Those displaying. the charac-
teristic rigor were chosen, susceptibility to rnaJignant 
hypctpytcxia being confirmed by estimation of the 
serum CPK (Woolf et al., 1970). Of the six pigs 
chosen (8-16 weeks old) all had resting CPK values 
in excess of 4SO i.u./l rising to lS00-2000 i.u./l 
following aposurc to halothanc. The weights of 
pigs selected varied from 18 to 70 kg. 
Anaesthesia was induced in the experimental 
animals by administration of Althesin -400-SOO pl/kg 
intraVeDOUSly via an car vein. Following endotncbell 
intubation, the animals were ventilated with a nit-
rous mide and mygen mmurc by means of a 
Blease Pulmoftator. Thereafter, Althesin was admini-
stered continuously as an intravenous infusion 
(50 pl/ml) via a cannula in the right atrium, which 
was also used for blood sampling when required. 
Initiation of the syndrome of rnaJignam hyper-
pyrcxia in response to halothanc and sunmetho-
nium cballenges was judged by the onset of tell-tale 
rigor in the hind legs and a rise in intramuscular 
temperature recorded by a thermistor probe (Blab) 
inserted deep into the thigh muscles. 
Six MHS pigs so anaesthetized were cbaJJengcd 
with halothane inhalation, 2 % decreasing to 0.5 %, 
for 1 hour. Altbesin was administered throughout 
at rates varying between S-15 pl/kg/min, but in-
creasing to as much as SO pl/kg/min in one pig 
to abort onset of the syndrome which appeared 
irnrnh,em:. Aftt:r 1 hour, halotbaDe and Ald1esin 
were discontinued until the animals showed signs 
of waking. Thereupon halothanc inhalation WIS 
rm,ncnicnccd to confirm the rnaJignant hypctpy1mc 
response to halotbane in the absence of Alrberin 
In a repeat ezpaiment in one sm vivm, after 30 
minutes halotbane amesthcsia the IDimal wa 
challenged with tlli8Dier:bonium 50 mg. 
ltEStJLTS 
Althesin administration succcssfully blocked initia-
tion of maJignant hypapy1aia by halothane in five 
of the m MHS pigs cballeogcd. The susceptibility 
to malignant hn,etpytaia of all pigs used . WIS 
confirmed by the onset of rigor and rise in tempera-
ture in response to re-alu'bition of halothane after 
discontinuance of Altbesin. This CODfiimatory 
initiation of the syndrome proved revem'blc by 
timely discontinuance of the halothane in all but 
one of these five animals (fig. 1). In one animal, 
Althesin administration (S-10 pl/kg/miD-possibly 
too low a dose) failed to block the omct of fml 
malignant hypctpytcxia. 
GAJSPORD G . HAltmsoN, .M.D. (CAPJ! TOWN), F.P.U.C.S. 
(ENG.), Deparmmt of Amesthetia, Univenity of Cape 
Town, South Africa. 
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FIG. L Intramuscular temperature, pulse and muac:le tone ftCOld of MHS pis espoeed CD haJotbme after administration of Althesin. Terminal ezposurea to halotbane c:auaed mnusible m•Jipm hype1py1e:xia. 
Althcsin also failed to prevent the onset of fatal 
hypcxpy,czia in the animal to which sm.amctho-
nium was administered after 30 minutes of halo-
thane inhalation. The use of massive doses of 
Althcsin (30-SO µl/kg/min) in this animal, as also 
in another in which the syndrome was established, 
had DO effect-acept perhaps that the rate of 
temperature rise was slower than usual (Berman et 
al., 1970). This may have resulted from the vuo-
dilatation caused by Althcsin (du c:ailar, 1972) 
pennitting a greater beat loss. 
DISCUSSION 
Althcsin blocb initiation of malignant hypcxpyraia 
by halothane in MHS pigs. The results of our aperi-
ments differ a little from those of Hall, Trim and 
Woolf (1972) in that in ours Althcsin failed to block 
the trigger action of suxamethonium given in the 
presence of halothane. .Further, continuous Althesin 
administration as against a single dose, was necessary 
to protect pigs successfully against the trigger action 
of balothane. But it must be pointed out tbat the 
reactor response of the pip used by· Hall's group 
and of ours differ. Whereas our MHS pip responded 
to a· chaJJenge of halothanc alone (Harrison et al., 
1968) tbo9c med by Hall's group require sma-
mcthonium in addition (Hall et IL, 1966). 
In view of the above, . Altbesin _wouJd appear to 
be the preferred amestbeac induction agent in 
patiems wbo bne amvived cpilodes of nnJigmm; 
hypapyresia, or are mown from family mstmJ ad 
raised CPK levels to be at risk (King, Dcnboroagb 
and Zapf, 1972). Such me of Aldain would, how-
ever, not justify the subscquem me c:i halathane 
in a patient at risk. 
It is disappointing in the e:maue mat Althesia, 
with its lack of effect OD cudiac ompm. (Saftge ct 
IL, 1972), appears 10 be me1es!' in the Ueatmem fi 
the eat1bJisbcd syndxume « D'~":l.3.Jl~ hypapyxaia, 
for the ueatmcnt cuueudy in wgu~ ua fi 
proc:aiDc in large dose (Harmon, 1971}--requha, 
because of its myoc:ardial dcprrmm effec:11, pat 
circumspection. 
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MINAXOLO))."! AND MALIGNANT HYPERTHERMIA 
Sir,-Althesin has been shown to block initiation of the 
malignant byperthermia syndrome by halothane in MHS 
swine (Hall, Trim and Woolf, 1972; Harrison, 1973), and 
recommended for use in human subjects susceptible to the 
condition (Honda et al., 1977). 
It was of intm:St, therefore, to uc:cnam whether 
minaxolone, the water-soluble steroid anaesthetic (Aveling 
et al., 1979; McNeill, Clarke and Dundee, 1979) possessed 
similar properties. 
We report here the results of our investigation in four 
MHS swine of the eff'eets of continuous infusion of 
minaxolone on the initiation of the MH syndrome by 
halothanc. The e:x:perime:ntal programme used was simila-
to that desaibed previously (Harrison, 1973) with modmc:ar 
tion which included: 
(l) Direct arterial pressure monitoring via femoral artery 
c:annulation. 
(2) Use of a cerebral function monitor. 
(3) GLC assay of blood concentrations of minuolone 
during the experiment. 
Dosage of minamlone was as follows: mduction-1.4-2 
mg kg-1 ; maintenance infusion-40-100 Pl q-1 mm-1; 
total dose (45-60 mm~ me tr1• 
Intravenous c:oncmtratiom of rninsxolone varied from 
0.66 to 1.55 µg m1-1 in most, and 2.84 pg m1-1 in one p~ 
where the infusion rate was sreatlY increased .in an mc:mpt 
to abort the onset of MH. 
Although minamlone itself did not pJ:'O\IOkc the onset of 
the syndrome, in all four expetime:na it failed to blod: 
initiation of the MH syndrome .in response to the admini-
stration of halothane, the syndrome being wdl cmbJisbed 
within 20 min of exposure in each case. 
We cannot as yet define the role, if any, of c:remophor 
(the solvent for Althcsin) in these contrutin& actions of 
Althesin and minamlone. 
G. G.HAmsoN 
D. F. MOUBLL 
Cape Toam, Sou:1, A/ri&a 
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RESPONSE OF MHS SWINE TO I.V. INFUSION OF LIGNOCAINE 
AND BUPIV ACAINE 
G. G. H.wusoN· AND D. F. MORRELL 
SUMMARY 
We report the negative response of MHS swine to i.v. infusions of lignocaine and bupivacaine 
yiddina pluma concentrations which equal or ezceed those reported in humans durins emadmal 
analpaia. It is concluded that local anaesthetic techniques 1lling the amide-linked local anaes-
thetics administered in conventional dosage are safe to use in patients known to be aenetically 
rmceptible to rnaiilJJ•Dt hyperthennia. 
While it is aa:cptcd that the anaesthetic technique of 
lowest risk for the patient known to be genetically 
susceptible to malignant hyperthermia is some form 
of regional or local analgesia, strictures against the 
use of the amide-linked group of anaesthetic drugs· 
(lignocaine and bupivacaine) arc still voiced (Britt, 
1973; Britt, Kwong and Endrcnyi, 1977a; Rclton, 
Britt and Steward, 1973; Strobel, 1977). 
Such striaurcs arc based on the work of Bianchi 
and others which demonstrated that lignocaine, in 
contrast to procaine and other ester-linked· tertiary 
amine local anaesthetics, potcntiatcd caffeine and 
caffeinefhalothane induced contracmrcs of muscle in 
flitro, enhancing also the oxygen uptake of such 
preparations (Bianchi and Boulton, 1967; Novotny 
and Bianchi, 1967; Bianchi, 1968; Strobel and 
Bianchi, 1971). 
Clinic:al evidence cited in support of such strictures 
is scant and consists of ''unpublished data" and 
"personal communication" reporting rare incidc:nrs 
of putative initiation of malignant hyperthermia by 
the administration of amide-linked anaesthetics to 
MHS individuals (Kalow ct al., 1970; Britt, Kwong 
and Endrenyi, ct al., 1977b ). 
In many hospitals today, the most readily available 
local anaesthetic drugs arc usually members of the 
amide-linked group-lignocaine, mepivacaine and 
bupivacainc. This circumstance, and the fact that the 
concentration of lignocaine which produced potcntia-
tion of caffeine induced muscle rigor in flitro, WIS 
about 100-fold greater than the convulsive threshold 
in flffJO in man (Foldes ct al., 1960; Sasyniuk and 
Ogilvie, 1975), and WIS so greatly in excess of 
G. G. liADisoN, M.D., P.P.A.LC.S. (ENG.); D. F. MOIIJUILL, 
M.B., CH.B., P.P.A.(s.A.); Depanment of Anaesthetics, 
University of Cape Town, South Africa. 
0007--0912/80/040385--0.3 $01.()() 
concentrations likely to be found systemically after 
conventional clinic:al use, stimulated us to cum.inc 
the validity of these strictmcs against the use of 
such loc:al anaesthetics in the MHS patient. We used 
the MHS Landrace pig as the apcrimental model. 
We report here the response of MHS Landrace 
swine to the i.v. infusion of lignocaine and bupi-
vacaine in doses which produced serum concmtraticms 
equal to and greater than those reported in humans 
following atradural and other major regional blocb 
or topical analgesia of the 1arym. 
ME'IBODS 
Four MHS Landrace swine, screened and identified 
as desaibcd previously (Harrison, 1977), were used 
in this investigation. The reactions of these animals 
were observed in response to the infusion of ligo-
caine on 10 occasions (two pigs three times, two pip 
twice) and bupivacaine on eight occasions (fou! pip 
twice). Subsequently, each pig·WIS subrnittt .. to a 
confirmatory halothane cballcngc. 
The plan for each infusion WIS as follows: 
Anaesthesia WIS induced with thiopcntone admims-
tercd via an car vein, the trachea WIS intubated and 
anaesthesia WIS maintained with nitrous mide in . 
oxygen administered by immnittcnt positive 
pressure ventilation using a Manley vcnti~. Wbm 
necessary, supplementary doses of tbiopcmone were 
administered. Body tcmpc:raturc WIS recorded UQlll 
the probe of an Electric Univenal 'I"herrnometcr 
(TE3, ELLAB, Denmark) placed deep in the medial 
muscle mass of the thigh. A catheter WIS introduced 
into a jugular vein via a cut-down in the ncdt and 
advanced to the level of the right atrium. Tms 
catheter served for blood sampling and for the i.v. 
e Macmillan Joamail Lid 1980 
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administration of drugs. Blood samples (mixed 
venous blood) from this site were analysed for: 
(I) Acid-base studies at 2, 5, IO, 15 and .30 min. after 
loc:al anaesthetic infusion (interpolation tech-
nique). 
(2) Plasma concentrations of lignocaincfbupivacainc 
at 2, 5, 10, 15 and .30 min after infusion. Ligno-
cainc and bupivacainc were assayed by the gas-
liquid chromatographic method of Tucker (1970). 
A calibration curve with standard solutions was 
prepared from a blank specimen for each pig on 
each occasion. Using cyclizinc hydrochloride as 
an internal standard and with quantitation by 
peak height ratios correlation coefficients wa-e 
consistently greater than 0.998. (Pye Unicam 
GCV Chromatograph with dual FID and DP88 
computing integrator using . 2.1-m columns 
packed with 5% OVlOI.) 
The test drugs, lignocainc and bupivacainc, were 
administered as foUows: Lignocaiu--initial dose 
1.5 mg Itg-1 followed by infusion of .30 p.g Itg-1 min.-1 
in initial apcrim.ents, incrcascd in later experiments 
to 2-3 mg Itg-1 and 120 p.g Itg-1 min-1. Bupir,acaine 
-1 mg Itg-1 administcrcd over 5-10 min. 
In view of the importance of the free base form of 
the anaesthetic to its contracturc-producing ability 
(Bianchi, 1968), we deliberately induced severe 
metabolic alkalosis in two test animals by infusions of 
sodium bicarbonate 4.2% in addition to the routine 
use of hyperventilation. 
Criteria of the malignant hypcrthcrmic syndrome 
sought included onset of muscle rigor resulting in 
characteristic atcnsion of hind legs (Harrison, 1975); 
supraventricular tachycardia; rapid progressive 
increase in muscle temperature; and metabolic 
acidosis. 
RESULTS 
No sign of the onset of malignant hypcrthcrmia 
syndrome was observed in any animal in response to 
the i.v. infusion of lignocainc or bupivacainc. 
The plasma concentrations of lignocainc and 
bupivacainc assayed during infusion arc recorded in 
figure 1. Mixed venous pH values during the majority 
of infusions (13) were in the range 7.4-7.5. The 
ranges 7.5-7.6 and 7.6-7.7 were noted in two 
infusions each, and 7 .2-7 .3 in one. 
At the conclusion of the experiment all animals, 
when exposed to halothanc, developed MHS syn-
drome to an cncnt which required treatment with 
dantrolenc i.v. to ensure their survival. 
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FIG. 1. Peak and mean plasma lianc,caine and bupivac:aine 
c:onc:entratiom observed followiq i.v. infusion. 
DISCUSSION 
When loc:al anaesthetic techniques arc used, with 
the notable exception of bilateral intcrcostal nerve 
blocks, the greatest plasma concentrations of local 
anaesthetic drugs arc rca>rded in association with 
emadural anaesthesia. 
In the c:asc of lignocainc, concentrations from 
2.4 i,tg m1-1 (Tuc:kcr and Mather, 1975)to4.5 p.g m1-1 
(C.Ovino and Vassallo, 1976) arc rcponcd. With 
bupivacainc, plasma concentrations reported range 
from the former authors' report of 0. 7 p.g m1-1 to 
1.49 p.g m1-1 reported by Moore and others (1976). 
Exposure of MHS swine to such circulating con-
centrations and greater failed to evoke any untoward 
response. Our findings, considered with the lack of 
well-documented· human cases of malignant hypcr-
thcrmia provoked by lignocainc or bupivacainc, cast 
doubts on the validity of the strictures advocated on 
the use of the amide-linked group of local anacsthctic 
drugs in patients known to be susceptible to malignant 
hypcrthcrmia, and suggest that these drugs may be 
safe when given in conventional clinical dosage. 
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REACTION DE PORCS SUSCEPTIBLES A 
L'HYPERPYREXIE MALIGNE A UNE INFUSION 
INTRAVEINEUSE DE LIGNOCAINE ET DE 
BUPIVACAINE 
JU!SUME 
Nous 1ignalom dam cet article la reaction negative de pores 
ausceptibles l l'hype.py,exie maligne (MHS), •ux infusions 
de lisnoc:aine et de bupiVICline entralnant dee concentra-
tions dam le pluml equivalentes ou auperieures l cellea 
aignalees chez lea humains pendant une IDllabie czua-
durale. On en I conclu que lea· techniques d'anesthbie 
locale buees 1W' lea qmu aneathbiants locaux de la 
c:luse des amidea peuvent etff adminiatres IIDS dan,er et 
aux doses hlbitudlea aux patients que l'on llit ~ 
genmquement auaceptiblei l l'hyperthermie maligne. 
REAKTION VON MHS-SCHWEINEN AUF 
INTRA VENOSE INFUSION VON LIGNOCAIN 
UND BUPIVACAIN 
ZUSAMMENPASSONG 
Wir berichten Uber die negative Reaktion von MHS 
(anfillig auf maligne Hype.prme)-Schweinen auf intn-
venOle Infusionen von I isnoc:ain und Bupivaain in 
Pl•anakonzentrationcn, die diejeniam erreichen oder 
1lberttcffen, die bei Memc:ben wihrmd cztraduraler 
Analsaie aemcldet werden. Ea wird aac:hloaen, dm 
Lobleniatheaiemetboden, bei denen amidhiltige loble 
Beliubunpmittel in konventionellen Dolen verwendet 
werden, aefabrlol bei Patientm an,ewmdet werdell 
kOnnen, die aenetiach auf maligne Hypcrthermie lilfi1lil 
aind. 
RESPUESTA DB CHANCHOS CON HMS A 
INFUSIONBS I.V. DE LIGNOCAINA Y DE 
BUPIVACAINA 
stJMAUO 
Informamos aobre la reapuestl neptiva del chancho am 
HMS a infusionea i.v. de lilDO('lin• y de bupiVIClina que 
tuvieron por reaullado concentt9Ciona en el pluma 
i,ualea o mayores de la reptrada en leftl humanos 
durante la analaaia emadural. Se llep a la conclusi6o de 
que la tecnicu de aneateaia local mediante qema 
anestma>s locales del srupC> de las imidal adminimedol 
ICIU1l dolia convencionales pueden uaane en toda 
aquridad en pacientes conoc:idos por 1er ausceptiblea 
genmcamente a la h.ipertermia ma1isnL 
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THE SCREENING OF ATRACURIUM IN MHS SWINE 
D. F. MORREL~ AND G. G. HARRISON 
The non-depolarizing neuromuscular blocking drugs tubocurarinc (Britt, Webb and Le Due, 1974), gallaminc (Ryan, 1979) and pancuronium (Chalstrey and Edwards, 1972; Waterman, Albin 
and Smith, 1980) have all been incriminated at somctimcastriggcnofthcmalignanthypcrthcrmia syndrome (MH) in susceptible individuals or swine. Although these original claims arc now a matter of contention (Shon ct .al., 1976; Den-borough, 1979; Harrison, 1980) they do provide the raison d'etre for the screening of all newly-developed non-depolarizing neuromuscular blockers for MH triggering potential. 
W c rcpon the outcome of such an assessment of the recently developed non-depolarizing agent, atracurium bcsylatc, in MHS Landrace swine. The design of the study differs from that of a previous study (Lucke, 1983) in that our animals were challenged (a) when atracurium-induced neuromuscular blockade was maximal and neither clinically waning nor reversed, and (b) with halothanc alone, avoiding suxamcthonium with its associated interaction with non-depolarizing agents at the neuromuscular junction (Harrison, 
1973). 
MATERIALS AND METHODS 
Six MHS Landrace swine were selected on a positive MH response to a brief "barnyard" exposure to mask-administered halothanc~ the syndrome being reversed with dantrolenc (Harri-son, 1975). Weights ranged from 22 to 35 kg. 
For all investigations, anaesthesia was induced in the pen with thiopcntonc administered via an 
car vein on the first and via an internal jugular catheter on subsequent occasions. Following cndotrachcal intubation, anaesthesia was main-tained with 70 % nitrous oxide in oxygen administered via a volume preset ventilator set to 
D . F . MoRULL, F.F.A,(S.A.); G . G. ffAJuusoN, M.D., F.F.A.R,C.S.(ENG.) ; Department of Anaesthetics, Univenity of Cape Town and Groote Schuur Hospital, Medical School, Observatory 7925, South Africa. 
SUMMARY 
The potential tole of atracurium besylate as a trigger or attenuator of the malignant hyperthermia syndrome was tested in six MHS Landrace swine. Animals were tested for susceptibility and then exposed to atracurium given as an i. v. bolus both alone and concomitantly with 2 % halothane. In no instance could the syndrome be triggered by atracurium nor did it convincingly attenuate the syndrome when triggered by halothane. 
maintain normocarbia (as usesscd by ancrial gas analysis) supplemented by intermittent thio-
pcntonc. 
Cathctcn were inserted to an internal jugular vein and carotid anery via a cut-down in the neck to provide: a source for samples of blood for the measurement of blood-gas tensions and acid-base balance, a continuous waveform display and digital read-out of ancrial and venous pressures (Statham P23 strain gauges), and a route for the infusion of drugs and fluids. ECG monitoring (Hclligc Scrvomed) was maintained using chest wall electrodes. 
Temperature was recorded from an i.m. thermistor needle probe deep in the thigh muscle mass (ELLAB). 
The atracurium challenge consisted of a 1.0-mg Itg-1 i.v. bolus in all instances except one, when 0.8 mg kg-1 was administered inadvertently. 
Thchalothancchallcngcwas byway of introduction of 2 % halothanc (Fluotcc Mark 2 vaporizer) to the fresh gas supply. 
Established malignant hypctpyrcxia was identi-
fied by 20 % increases in resting heart rate and mean ancrial pressure, a stiffening of the hind quancrs and the development of a combined metabolic and respiratory acidosis. Those animals which were destined for subsequent challenges were salvaged with titrated amounts of i.v. dantrolenc, i. v. sodium bicarbonate and hyper-ventilation with 100 % oxygen. 
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Before the challenge all animals were homco-
statically stable, particular attention being paid to 
indices of cardiovascular function, and acid-base 
balance. 
The design of the study was such that it could 
test the MH triggering potential of atracurium, 
and the modification of the triggering potential of 
halothanc by atracurium. 
Two animals (Nos 1 and 2) were challenged de 
nooo with atracurium and then 1 h later with 
halothanc and a second bolus dose of atracurium. 
The remaining four animals were challenged 
initially with halothanc in order to provide control 
times for the onset of the syndrome, and 2 days 
later were rcchallengcd with atracurium. The last 
two (Nos 5 and 6) were given a third challenge of 
simultaneously-administered halothane and atra-
curium 1 h after the second. 
RESULTS 
The results are set out in table I. 
Animals Nos 1 and 2 were unaffected by the 
initial dose of atracurium, but the syndrome was 
triggered in its full fnlrninant form following 
exposure to halothane, the second dose of 
auacuriumaffordingnoprotection. The syndrome, 
once established, was allowed to run its course 
without being fuelled by further halothanc or 
reversed with dantrolene and was characterized by 
progressive limb stiffness, cyanosis, hypertension, 
tachycardia, muscle temperature increasing to 
above 40 °C, a combined metabolic and respiratory 
acidosis, and eventual death following the develop-
ment of ventricular arrhythmias. 
MH was triggered in 845 min by halothanc in 
animals Nos 3-6. The subsequent exposure to 
TABLE I. Time (mm) u, mgger MH ,yndr-. Hal. • 2% 
halorhane; Arra. - arraanilan; CPK - CreatiNpl,osplloltina.u 
11WJS11Tld befurt and 24 h ajrer initial halorhane diallmtt 
(nonnaJ: 1~7511 /irr,-1) ; N,g. = MH nor rriuerld; -
• lrrwsrigarum nor pnft1r1Md; d • Dtarhfrum a,nrr,aud MH 
CPK (u liue-1) 
Pi& Atta. 
No. Hal. Atta. +Hal. Before After 
1 Nea 25 374 d 
2 Nea 10 78 d 
3 8 Nea 816 1470 
4 45 Nea 2180 
5 15 Neg 20 8090 24900 
6 15 Neg 20 313 10490 
atracurium failed to trigger the syndrome when 
given alone but, despite a slight increase in the 
time required (from 15 to 20 min), the syndrome 
appeared on cue when animals Nos 5 and 6 were 
given their third challenge with halothane (plus 
atracurium) 1 h later. 
Crcatininc phosphokinase concentrations in 
those animals which survived were markedly 
increased on the day following the manifestation 
of MH. No attempt was made to compare the 
increase following halothane alone with that 
following halothanc administered concomitantly 
with atracurium. 
DISCUSSION 
Our study dcmonsuated that atracurium neither 
initiated nor attenuated the MH syndrome in 
. MHS swine in response to the inhalation of 
halothane, an action similar to that of other 
non-depolarizing neuromuscular blockers when 
studied in· the same model (Harrison, 1979). 
Although there is inherent danger in extrapolating 
from animal data, it would seem that the drug is 
safe for use in the human MHS subject. 
Ao aspect of the action of atracurium in the 
circumstances of MH that still needs be addressed 
is whether its action would be prolonged by the 
very severe acidosis or shoncned by the hyper-
thermia of the established MH syndrome. How-
ever, such action per se is unlikely to affect 
prognosis. . 
A side issue perhaps worthy of comment 
concerns thcusclessnessof rcstingscrumcreatininc 
phosphokinase (CPK) concentrations in swine as 
a diagnostic .criterion of MH (Mitchell and 
Heffron, 1975), or as a correlate of rapidity of 
response to halothane aposurc. ni.s is wdl 
exemplified by examination of the resting (before) 
conccnuations of CPK in our animals (table I), in 
particular that of animal No. 2, in which a virtually 
normal CPK conccnuation accompanied one of 
the most rapid reactions to halothanc and actual 
death from halothane-induced MH. 
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The Screening of Propofol in MHS Swine 
Milton Raff, BSc(Rand) MB ChB(Pret) FFA(SA), and 
Gaisford G. Harrison, MD(Cape Town) FFARCS(Eng) DARCP & S(Eng) 
RAFF M. HARRISON GG. The screening of propoiol in 
MHS swine. Anesth Analg 1989;68:T:,0-1. 
Thi,; study im,e;tignted tire 11se of propofol i11 ,;wi111• ~i·m•t-
icnlly s11sce,1til1/r to 111nlig11n11t lry1~rt/rer111in IMHI. T/rir-
tei:11 n11i111n/s wt-re <'X/JOsed to 2% /,a/otlin11r i11 i11,;1'irt•d nir, 
n 11roriofol inj11sio11 of 12 mg,kg- 1./rr-1 for 11p to ~5 111i11 . or 
n co111bi11ntio11 of both. Wir<'II MH t1111s tri,~:~ered t/ri• ,111i111n/,; 
wcrr treated with dnntrol<'lle. Menn 0115<'1 time of 111nl(..:11n11t 
l1y111.·rt/rer111in 011 e:q10S11rr to l,n/otlume nlo11e m1,; 7.1 111i11 
The precipitation of malignant hyperthermia (MH) in 
genetically susceptible (MHS) individuals by expo-
sure to certain anesthetic drugs and adju,·ants ren-
ders essential the screening for such property of all 
newly developed anesthetics (1). We report here on 
the screening in MHS swine of the newly introduced 
intravenous anesthetic propofol (2) to determine its 
potential for eliciting or preventing or attenuating 
halothane induction of MH. 
Methods 
Specially bred MHS Landrace swine (20-65 kg 
weight), initially identified by their positi\'e MH 
response to a brief "barnyard" mask exposure to 
halothane (1), were selected for this study. Under 
thiopental/N20/02 anesthesia with appropriate mon-
itoring, the animals were exposed to propofol and 
halothane in the following protocol in random order 
and evidence of the onset of MH was sought: 1) To 
halothane alone; 2) To propofol alone for 45 min; 3) 
To propofol for 45 min followed by halothane alone; 
and 4) To both propofol and halothane simulta-
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::: 3.0 111i11 n11d 0115<'1 n•it/r 11ro110fol n11d l,n/otlume was 5.0 
::: 2.5 111i11. /11 110 i11,;tn11cr di,1 1iro1iofol n/011r triRSt'r t/rr 
s1111dro111e 110, 11111s then· n stnti,;ticn/ diffi.Te11cr (P < 0.05) i11 
d11set timr 11>/1e11 t/rr drug was 11sei1 i11 co11j111rctio11 with 
/rn/ot/,n11r. 011 t/rr l111sis of lir<'se rt'sults. Wt' co11c/11dr flint 
11ro110jol i,; almost crrtni11ly $11.f<' for 11,.e i11 l111111n11s who nrr 
,;11sce,1til1lt- to MH. 
Kev Words: ANESTHETICS, INTRAVENOU~ 
pr~pofol. HYPERTHERMIA-malignant. 
neously, with propofol given ten min before expo-
sure to halothane. 
In each of the above circumstances except the 
second, halothane was to be continued until trigger-
ing of MH occurred or, failing this; for 60 minutes. 
Exposures were separated by 72 hours to ensure 
adequate recovery of the animals. Individual animals 
were submitted to procedures 1, 2 and 3 or l, 2 and 4. 
All animals were anesthetized with 4 mg/Kg i.v. 
thiopental (ear vein on first occasion, jugular cannula 
subsequently), intubated and mechanically ventilated 
with N20/02 (Fi02 = 0.4) using a non-rebreathing 
circuit. Minute volume was regulated to maintain 
Pacei in the range 40-45 mm Hg. Pao2 ranged from 
180-220 mm Hg while the mean pH during control 
periods was 7.412 (+/-0.05). 
The internal carotid artery and jugular vein were 
cannulated by cut-down in the neck providing access 
to arterial blood samples for serial measurements of 
blood gas tensions and acid/base status (Radiomem), 
arterial and venous pressure monitoring (Hellige), 
and administration of fluids and drugs. The ECG was 
monitored using skin electrodes, the temperature by 
means of a thermistor probe (ELAB) inserted deep 
into the thigh muscle mass, and F~02 by sampling 
of gases at the proximal tracheal tube mount by 
capnography (Morgan). 
Following anesthesia and the establishment of a 
hemodynamic steady state, propofol was adminis-
tered as a continuous intravenous infusion of 12 
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Table 1. MH Omit.'I Times 
MH On~I TimCl; 
Drug Exposure (in minutes) 
Protocol Mean SD 
Halothane 7.2 ::: 3.0 
Propoiol NoMH 
Propoiol-Halothane 8.7 ::: 4.4 







mg-kg- 1-hr- 1 (the upper limit of the recommended human dose) (2). Halothane 2% in inhaled air was administered into the fresh gas flow by means of a Fluotec Mark 2 vaporizer. 
The onset of MH (1) was manifested b,· all of the following: 1. Muscle fasiculation proceeding to rigor, seen in the supine pig most clearly by extension of the hind legs; 2. A gross increase (>2'k) in FEC02 (a manifestation of the development of metabolic and respiratory acidosis); 3. Tachycardia and an increase in blood pressure (manifestations of the svstemic release of cathecolamines); 4. A progressive fulmi-nant increase in body temperature of 1°05-10 min, . terminating halothane exposure after a rise above 400c. 
In these experiments the commencement of a progressive extension of the hind legs was recorded as the time of onset of MH. Increases in FEC02 and core temperature were measured thereafter as confir-matory evidence of the onset of the syndrome. Fur-ther evidence of the initiation of the svndrome was sought in the gross increase in serum ~eatine phos-phokinase (CPK) levels 24 hours later. 
When triggered, MH was allowed to continue until an increase in core temperature at 1-2°C had oc-curred. The animals were then treated, following discontinuance of halothane, bv the administration of dantrolene, 4.2~ sodium bicarbonate, and hyperven-tilation with lOO'k oxygen. 
The statistical significance of differences in mean times to onset of MH was tested by Student's t test (P < 0.05). 
Results 
Results are summarized in Table 1. Exposure to halothane triggered MH in all animals. No animal developed MH when exposed to propofol alone. Administration of propofol failed to prevent or atten-uate halothane triggering of the syndrome (protocols 3 and 4), there being no statistically significant differ-
.. ,:--:1:sn1 .. ,:--: .. , 1.c; 
l"l<" ;n., :7:'-11-1 
i 51 
ence in times tli unset. On each occasion that MH was clinically evident its presence was subsequently con-firmed by many-fold increases in serum CPK levels sampled at 24 hours. 
Discussion 
Despite their heterogeneity, no intravenous anes-thetic agent has been shown to trigger MH in suscep-tible patients (1). Howe\'er, an effect on halothane provocation of MH has been attributed to althesin, thiopental and etomidate. Althesia has been reported to block it (3), thiopental to attenuate (4) and etomi-date to enhance the time of onset of MH (5). 
Our observations show that propofol, does not trigger MH in MHS swine nor has it any modifying effect on halothane pro,·ocation of the syndrome. These data indicate that propofol may be safely used as an anesthetic for individuals known to be suscep-tible to MH. 
Study of propofol in l'"IHS swine for its effects alone and on halothane induction of MH as described indicates that propofol neither elicits nor modifies halothane induction of malignant hyperthermia in MHS swine. We conclude that propofol may be safely used as an anesthetic in patients known to be sus-ceptible to MH. 
We acknowledge with thanks our indebtedness to Brian Suman for the screening. anesthesia of and establishment of monitoring in our experimental animals. 
This research was supported by the South African Medical Re-search Council and the Anglo American and de Beers Research Funds of the University of Cape Town. 
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Propofol in malignant hyperthermia 
Sm,-ln-vitto evidmc:e sugests that propofol may be safe for 
individuals genetically susceptible to malignant hypenhermia 
(MH).1 In-vitro dam support tms belief and I DOW report clinic:al 
data from 19 patients susceptible to MH. 2.J 
Patiems undergoing a biopsy of muscle for diagnostic in-vitro 
cxmraaure testing (IVCT) for susceptibility to MH were 
anaesthetised aa:ordmg to a standard proaxx,I, which included 
propofol for induction and maiott'NDO" of anaesthesia. Patic:ms also 
received diazepam pmnectirarion, alfmrmyl maJgesia, macurium 
neuromuscular block, c:ndoalcheal intubmicn and venriJarim with 
N 20/02 (FI02 0-3), md reversal of neuromuscular block with 
ncostignrine and ~ Of 19 pariems, 9 have satisfied 
IVCT aite:ria for MH susceptibility.' Dumian of maestbesia 
ranged from 60 to 90 min. No Jmimt showed sip of MH. 5 These 
finrlmp sugpst that propofol is safe in t80IC suscepnble to MH. 
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To elucidatt a pathogenesis for the reduction in bone calcium 
con1em ob.sen•ed in MHS individuals, we .studied the acute cal-
cium homeostasis of MHS swine. This was achieved by the serial 
measurement, with a calcium .selective electrode, of calcium 
transiems in Landrace MHS (five) and control Landracellarge 
white cross MH negative (five) swine following W bohu injection 
of calcium gluconate 0.1 mmol·kg- 1 - a dose which induced an 
acute 45 per cent increase in plasma ionised calcium. Eiperi-
mental animals were OJIM.sthet~d with ketamine JO mg·kg- 1 JM, 
thiopentone (intermittent divided doses) JS-25 mg·kg- 1 (total) 
IV and Nz()/01 (Ft01 O.J J by IPPV to maintain a normal blood 
gas, acid/base state. The plasma ionised calcium decay curve 
observed in MHS swine did not differ from that of control 
normal swine. Funher it was noted that the induced acute rise 
in plasma ionised calcium failed to trigger the MH syndrome in 
uny ltlHS swine. It is concluded that the mechanisms of acute 
nudum homeostasis ita MHS swine are normal. An upl/Uuuion 
fur the redu,·tiun in bone calcium content ob.served in MHS 
i1ulfrid""ls must bt sought, the ref ore, through study of the slow 
/u,1g·tenn component of the calcium regulatory procus. In addj. 
tion, the con,•entional strictures placed on the use, in MHS 
patients, of calcium gluconate are called in question. 
Key words 
HYPERTHERMIA: malignant hyperthennia, MHS swine; 
t.lALIGNANT HYPERTHERMIA: calcium homeostasis, bone 
physiology. 
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Acute calcium homeo-
stasis in MHS swine 
Although the primary site of the functional lesion respon-
sible for malignant hyperthermia (MH) resides in the 
skeletal muscle organelles, there is evidence which 
suggests a more widespread and general membrane 
defect. 1 Inter alia, reduction in bone calciwn content and, 
by inference, abnormalities in ostcoc:ytc function have 
been reported in patients susceptible ao MH. 2 Tbcsc 
observations, considered in the light of the central role of 
bone in the homeostasis of plasma calcium concentra-
tion, 3 led us IO investigate the acute calcium homeostasis 
of MHS swine. 
Methods 
The experimental animals, five especially bred Landracc 
MHS swine, weight 30-50 kg, selcc:tcd initially based on 
a positive MH response to brief "barnyard" exposure to 
mask administration of balothanc4 were formally retested 
under anaesthesia in the laboratory before use in the 
definitive experiments and the onset of MH (for criteria 
sec later) in response IO hal<>lhane was timed. 
Five large whitc/Landrace crossbred swine which 
displayed a negative reaction IO similar testing served as 
c:onttols. 
Anaesthesia 
For all experiments, animals were anaesthetised with 
kctaminc 10 mg·kg-t IM followed by IV thiopentonc via 
an car vein and then tracheal intubation. Anaesthesia 
tbcreaftcr was maintained with N20/C}z (F1C}z 0.3) de-
livered by mccbanic:al ventilation via a non-return circuit, 
the volume of ventilation being adjusted IO maintain 
PaCC}z in the range 40-45 mmffg. Intcnniucnt supple-
mental doses of thiopcntonc were administered at any sign 
of lightening anaesthesia; Total doses of thiopcntonc 
ranged from 15-25 mg·kg-t. Mean pH during the control 
period of the experiments was 7 .41 :t 0.05 (n = 30). ~ 
ranged from 180-2lOmmHg. Catheters inserted into the 
carotid artery and internal jugular vein via cut-down in the 
ncc:k provided acc:css to blood samples for calcium, blood 
gas and acid/base assay (Radiometer), arterial and venous 
pressure monitoring (Hellige) and the route for fluid and 
drug administration. 
The ECG was monitored via skin elcc:trodcs and 
temperature was recorded from a thermistor needle probe 
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FIGURE Trnsient response of MHS 111d normal swine to tbe 
bolas injection or calcium gluc:onlte 0.1 nunoHtg· •. Plot is of 
diffemx:c from control values (Mean :t SD). 
Protocol 
Following establishment of steady state conditions under 
anaesthesia and three control blood samples, a bolus of 
calcium gluconate (0.1 mmol·kg-1) was administered via 
the jugular vein infusion. Thereafter blood was sampled 
serially for 60 minutes at the following time intervals: one 
minute for the first ten; five minutes for the next 20, and 
ten minutes for the last 30. 
The dose of calcium gluconate chosen was such as 
would induce an appreciable increase in plasma ionised 
calcium, without invoking cardiac anhythmia. 
Calcium concentration was measured by calcium selec-
tive carrier disc electrodes, 5 all samples being read in 
duplicate and the mean result recorded. Values expressed 
are of ionized calcium. 
Additionally, the possible onset of MH was monitored 
for, the following criteria of the syndrome being sought: 
> 20 per cent increase in heart rate and/or mean arterial 
pressure, development of combined respiratory and meta-
bolic acidosis (>20 per cent increase in PaC02), increase 
in muscle core temperature of >0.5° C and extension of 
the hind legs. 
CANADIAN JOUllNAL OF ANAESTHESIA 
Results 
Data point.,; on the constructed plasma ionised calcium 
concentration decay curve (change from control values) 
(Figure) reflect mean and SD of values at each time 
interval in experimental and control groups. The signifi-
cance of differences observed between MHS and control 
animals at individual data points was tested with Student's 
t test after equivalence of variance had been tested. 
Following bolus injection of 0.1 mmol calcium glu-
conate·kg-1, peak concentration in plasma ionised cal-
cium was reached within the first minute, the mean rise 
above control values being 34 per cent (1.40 mmol·L-1-
1.88 rnmol·L-1) and 45 per cent (l.33mmol·L-1-l.90 
rnmol ·L-1) respectively'in nonnaJ and MHS swine. This 
was followed by a fast transient response which restored 
the ionised calcium concentration to control levels in 25 
and 35 minutes respectively, followed by an overshoot 
below control levels. This decay curve was in every way 
analagous to our previously published observations on 
normal swine. 5 
No difference of statistical significance was demon-
strated between the nonnaJ and MHS pig plasma ionised 
calcium decay curves. 
The acutely induced rise in plasma ionised calcium 
concentration failed to trigger the MH syndrome in any 
animals. 
Discussion 
The mechanisms involved in the control of plasma ionised 
calcium are arranged in a hierarchical fashion from 
the minute-to-minute to long term. 3 Our investigation 
examines the initial calcitonilHlependent fast transient 
response (lt of 15 minutes) of MHS 1winc, a response 
mediated by the cells lining the fluid compartment of 
bone. 
Our observations show this response in MHS swine to 
be no different from nonnaJ controls and to differ in no 
way from our previously published data on the normal 
response.' 
These findings provide no explanation for the reduced 
bone calcium content of MHS patients reported by Britt, 
Harrison and MacNei112 which must be related therefore 
to a possible dysfunction of the slow long-term compo-
nent of the calcium regulatory process. 
Our incidental observation of the failure of an acutely 
induced rise in plasma ionised calcium concentration to 
trigger the onset of MH in susceptible swine, in line with 
similar observations recently reported,6 calls in question 
the strictures placed in the past on the use of calcium 
gluconate in MHS patients. 7 
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Resume 
A.fin d' llllcider pa1hoglnese pour la reduction dans le contenu osstux tn calci11m observe chtz Its persoMts SHM, nous avons l1udil I' homlostase aiglli du calci11m chez It pore SHM. On a ,nesurl de /afon slrilt, a /'aide d'une 1/ectrode sllective de calci11m, Its changements de calclmit chtz cinq pores SHM Landract et chtz cinq pores tlmoins Landracela-crois-blancht-large HM nlga1if, l'effet d'1111t injection de 0.1 mmol·lcg-1 de glllcona1e de calci11m JV - dost qui a prow,qlll MM agtnellla· tion aiglli de 45 pour cent dons le calcium ionisit plasma1iq11t. On a anesthlsil Its animma explrimtlllOIIX avec tk la lcltamine JMJ JOmg·lcg- 1 (total), du thiopental IV (dose inlennilkntt 15-25 mg·lcg-1) ti du N:0101 (F101 0.3) par VPPI afin de maintenir un Ital de gaz sangllin acido-basique normal. La courbt dlcroissantt du calcium plasmalique ionisl que I' on a remarqule chtz le pore SHM ne difflrait pas tk ct/It du porc-tlmoin normal. Dt plus, on a remarqlll que la provoca1ion ti MM agmenta1ion aigui dons le calcium ionise plasmalique n' a pas rlussi d dlclenchtr le syndrome HM chtz acun des porcsSHM. 
On en conclut done que ks mlcanismts d' homlostases aigus de calci11m chtz Its pores SHM sont normaux. On doit done chtrchtr d expliquer la rlduction du contenu osse,a tn calcium remarqlll cha ks personnes SHM tn ltudianl la co,nposante knit ti a long ltnM du proctSSIU rlgulaloirt du calciwn. De plus, on ranet en question Its mises en gardes COIIHlllionntlla conctmanl I' 111ilisa1ion du glllconau tk cakiwn . cha la palitnts SHM. 
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The Effects of Calcium Channel 
Blocking Drugs on Halothane 
Initiation of Malignant Hyperthermia 
in MHS Swine and on the Established 
Syndrome 
G. G. HARRISON,• I. G. WRIGHT't AND D. F. MORRElJ.t 
Department of Anaesthesia, University of Cape Town Medical School. Observatory, South 
Africa 
SUMMARY 
We have investigated in malignant hyperthermia swceptible swine in •ivo the effects on 
halothane initiation of the MH syndrome and on the rstablished syndrome of five calcium 
channel blocking drugs - ni/edipine, nisoldipine, diltiazem. •erapami/ and jlunarazine. 
Nifedipine alone caused attenuation of halothane-initiated malignant hyperthermia to the extent 
of blocking onset of the syndrome in 29% of animals for 'the 60 minute period of exposun. In the 
face of the established malignant hyperthermia syndrome, all the drugs lated wre 
therapeutically completely ineffective. 
Key Words: malignant bypcrthermia, MHS swine; balothane, calcium channel blockers, 
nifedipine, nisoldipine, diltiazem, verapamil, flunarazine 
The pathogenesis of malignant 
hyperthermia (MH) rests on a cycle that 
results in a sustained rise in myoplasmic free 
calcium. 1.2 Of the many factors that may 
contribute to this, studies have identified in 
MH susceptible (MHS) swine and .humans a 
halothane induced or enhanced dysfunction 
of sarcolemma involving increased calcium 
permeability'l-7 associated with sarcolemmal 
depolarisation. 1 Considered in the light of the 
hypothesis that the underlying functional 
lesion responsible for the susceptibility to MH 
is an abnormally low threshold calcium 
induced calcium release from the 
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sarcoplasmic reticulum,'· 11 such 
abnormalities of sarcolemmal calcium 
permeability could constitute the mechanism 
by which the syndrome is triggered. 4 
In these circumstances, should the action of 
calcium channel blocking drugs (CCB) on 
skeletal muscle match their action on cardiac 
and smooth muscle, 12.13 it could be anticipated 
that pretreatment of MHS animals with CCBs 
would block initiation of the MH syndrome in 
response to their exposure to halothane. 
Support for such a postulate comes from in 
vitro studies which demonstrate both 
inhibition and reversal of balothane induced 
contractures in MHS muscle by diltiazcm. i4,u 
To test this hypothesis we have investigated 
in MHS swine in vivo the effects on balothane 
triggering of the MH syndrome of 
pretreatment with CCBs representative of 
each of the four classes of these agents.12.16 In 
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view of the therapeutic implications of the in 
vitro studies, we investigated also the effects 
of these CCBs on the established syndrome. 
The drugs investigated included: 





Animals and experimental protocol 
Specially bred MHS Landrace swine of 
30-50 kg weight, initially identified at the 
post-weaned stage by brief 'barnyard' mask 
exposure to halothane, 17 served as the 
experimental animals. Under general 
anaesthesia and appropriate monitoring (see 
later) these animals were exposed to halothane 
inhalation and the consequent MH reaction 
time was observed in a protocol wherein each 
animal served as its own control as follows: 
I . under general anaesthesia alone, 
2. under general anaesthesia, with CCB 
treatment preceding halothane exposure. 
In these circumstances administration of 
halothane was continued until the onset of 
MH or, failing this, for 60 minutes, 
3. under general anaesthesia alone. 
Steps in this protocol were separated. by an 
interval of three to five days, so as torensure 
complete elimination of prev"iously 
administered drugs, particularly dantrolene 
(elimination half-life 10-12 hours). The 
average of times I and 3 was recorded as the 
halothane/MH reaction control time for 
comparison with 2 - that observed following 
CCB pretreatment. Experiments were 
conducted on groups of 2-3 pigs at a time, 
depending on the availability of the MHS 
strain of swine. Choice of pretreatment drug 
was random. 
To test the effect ofCCBs on the established 
MH syndrome, following establishment of 
anaesthesia and monitoring, MH was induced 
by the exposure of test animals to halothane 
for sufficient length of time to ensure its 
persistance after discontinuance of the 
halothane, 11 whereafter the test CCB was 
administered IV and the effect observed. 
Anaesthesia 
For all experiments animals were 
anaesthetised initially with ketamine I 0 
mg/kg by intramuscular injection (dorsal neck 
muscles), followed shortly by IV thiopentonc 
injection (ear vein), endotracheal intubation 
and N20/02 (F102 - 0.4) administered by 
IPPV with a non-return circuit ventilator, the 
volume of ventilation being regulated to 
maintain Pco2 in the range 40-45 mmHg. Poi 
ranged from 180-220 mmHg, while mean pH 
during the control periods was 7.41 (SD O.OS) 
(n - 60). Intermittent supplemental doses or 
thiopentone were administered at any sign or 
lightening anaesthesia. Total dose or 
thiopentone utilised ranged from 15-25 
mg/kg. 
Monitoring 
Carotid artery and jugular venous 
cannulation via cut-down in the neck 
provided access to blood samples for serial 
blood gas and acid/base assay (Radiometer). 
arterial and venous pressure monitorin& 
(Hellige) and the route for fluid and drus 
administration. Expired CO2 concentration, 
sampled at the endotracheal tube mount, 1''1S 
monitored by capnography (Morgan), ECO 
via skin electrodes and temperature by means 
of a thermistor (Ellab) inserted deep in the 
thigh muscle mass. 
CCB pretreatment 
After establishment of control conditions 
under anaesthesia, the test CCB was 
administered IV. Thereafter ten minutes was 
allowed for haemodynamic changes to 
stabilise. In view of the vasodilating effects of 
most CCBs, fluid loading with balanced salt 
solution was needed to achieve this. 
Thereafter test exposure to halothane 2'111 was 
commenced. After ten minutes halothane 
concentration was reduced to I 'Iii. 
Dosage of drug 
For both preventative pretreatment and 
treatment of the established syndrome, the 
dosage of CCBs utilised was in excess to an 
extent that could be tolerated - of the 
relevant human therapeutic dose. Doses 
utilised were as follows (human dose in 
parenthesis): 
nifedipine I 00 µg/kg (20 µg/kg) 
nisoldipine 6 µg/kg (2-4 µg/kg) 
diltiazem 500 µg/kg ( I SO µg/kg) 
verapamil 400 µg/kg ( 50-100 µg/kg) 
In the case of flunarazine, an oral 
formulation only was availa~le. A dose or 1.2 
... _.._ - ·-c-. I'll. 16, Ne. Z. 11.,, ,_ 
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mg/kg/day (human 0.15-0.3 mg/kg/day) was 
administered for four days before exposure to 
halothane. Because of its oral formulation, the 
testing of Ounarazine in the established 
syndrome was not possible. 
Onstl of halolhant triggtrtd MH - timing 
The onset of the MH syndrome 1s 
manifested by:17 
I. muscle fasciculation proceeding to rigor, 
manifest in the supine pig most clearly by 
extension of the hind legs, 
2. a gross increase in FEC02 (a manifestation 
of the development of metabolic and 
respiratory acidosis), 
3. sudden tachycardia and rise in blood 
pressure as a manifestation of the 
accompanying systemic catecholamine 
surge, 
4. progressive fulminant rise · in body 
temperature. 
In these experiments the commencement of 
a progressive extension of the hind limbs was 
recorded as the 'time of onset' of the 
syndrome. While the rise in FE<X)2 and onset 
of tachycardia arc normally equally early (and 
confirmatory) signs of initiation of MH, their 
use in marking onset of the syndrome in this 
experiment was invalidated by the use of 
CCBs. In the former case hypotension, 
consequent on the combined use of CCB with 
halothane, resulted in an initial fall in FEC02 
before the rise consequent on the syndrome 
became evident, while in the latter, use of 
CCB greatly attenuated any response to the 
catecholamine surge . 
. Time of onset of temperature rise was used 
as some indication of the severity and speed of 
the induced intramuscular reaction, as was 
also the rate of temperature rise. 
Once triggered, the syndrome was allowed 
to continue until a rise in core temperature of 
1-2 degrees C had occurred. Thereafter, 
following discontinuance of halothane, 
salvage of the experimental animals was 
ensured by administration of dantrolene 
sodium. 
The statistical significance of differences 
from the control reaction were tested as 
follows: 
l . proportion of experimental groups in 
which CCB pretreatment blocked MH 
triggering, by the Chi-square technique 
2. compatjson oftimes of onset and the rat~ of 
clinical reaction by Students t test for equal 
and unequal variances as appropriate. 
The number of pigs with the established 
syndrome in which the different drugs were 
tested were: nifedipine 6, nisoldipine 3, 
diltiazem 4, verapamil 4. · 
REsULTS 
These arc summarised in Tables I and 2. 
T.uul 
E.l!ttt of calcium channtl blocki111 d"'fS in modifyin1 tltt rapons, to s,ucqdblt pip ,o aponn ,o ltalolluuw 
Number of pigs 1es1ed 
Number in whom e1posure 
IO balothane failed 













1111,m,/ in which pits dtttloptd M!I ~/Wttn Int commenctmtnl of txposvrr to ltalotJuu,e and onm oflq atmsion and 
1tmpna111rt rut (m1n111n). Mnn 'Nliun with SlOndard dnialions in ~
Pmreaunen1 dnaa 
None Nifedipine Nisoldipine Dilliazcm Vcrapamil Flunaruine 
Lq aaension '4(4) 13(15) S(3) 7(4) 4(2) 12(9) 
T cmperalure rise 7(10) IS(lS) 6(3) 13(2) 4(1) 15(16) 
Numbers of pigs 31 10 4 s 4 3 
in each sroup 
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Of the drugs tested, pretreatment with nifedipine alone blocked halothanc initiation of MH for the 60 minutes of exposure in a statistically significant proportion of test MHS swine (4/14). 
After nifedipine pretreatment administration of halothane commonly caused hypotcnsion. Severe hypotcnsion (MAP< 40 Torr) was manifested by three of the four pigs whose MH response to halothanc was blocked by nifcdipinc - a statistically significant proportion compared with the incidence of a similar degree of hypotcnsion in animals whose MH response to halothanc was not blocked by nifcdipinc (P < 0.05). In reactor pigs no significant attenuation was apparent following pretreatment with any CCB, in the time of onset of MH as judged by commencement of leg extension or commencement of temperature rise, nor in the rate of temperature rise - the latter averaging 1 "C per seven minutes. 
None of the drugs tested displayed any therapeutic efficacy in the presence of established MH. 
DISCUSSION 
The therapeutic role suggested some years ago for the conventional CCBs by Bikhazi, Thomas and Foldcs, 19 a suggcstiop which found support from the in vitro observations of Jwatsuki, Koga and Amaha, 14 and llias ct al.," is clearly refuted by this in vivo demonstration of the therapeutic ineffectiveness of CCBs of all classes in established malignant hypcrthcrmia. While such has been rep0rtcd previously with regard to vcrapami1,20.i1 examples of each class of CCB 12•16 were included in our investigation. Considering current concepts of the pathogenesis of the established MH syndromc, 1.l such findings.arc not surprisinf.i Recent work on sarcolcmmal function,'·'· ·' however, does provide some rationale for the expectation that CCBs would cause some attenuation of halothanc initiation of malignant hyperthcrmia. 
Again, with the exception of nifcdipinc, our observations belie the expectation. Nifedipinc alone showed a statistically significant effect in blocking halothane triggering of MH for 60 minutes but acted thus on a minority of test animals. The single instance of diltiazcm 
blocking initiation of the syndrome, thou,h not statistically significant, should be noted. With so low a rate of response, however, it was thought that proceeding to a greater number of animals would be unlikely to provide further information of phenomenological or clinical import. .., 
Why the action of nifedipine should differ from that of other CCBs tested is open to speculation. In that nifcdipinc is thought to act on the postulated voltage dependant outer calcium channel gate - as against the action of the others on the inner phosphorlyalioa dependent gate - these findings may be construed as supporting the concept of an MH triggering mechanism based on a halothane induced, depolarisation based, increase ia sarcolcmmal calcium permeability. On the other hand, the apparent correlation of blocking of MH onset with extreme hypotension (systolic MAP < 40 Torr) may imply a non-specific reduction of exposure of the effector organ, the muscle, to the trigger, halothanc, consequent on reduced cardiac output. We arc planning to explore this postulate further in the future. 
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HISTORICAL NOTES 
Malignant hyperthermia 
An historical vignette 
G. G. HARRISON AND H. ISAACS 
Summary 
This paper reports previously unpublished accounts of the deaths in 1915 and 1919 of two members of the same family during 
general anaesthesia. The deaths were subsequently ascribed to a 'hereditary susceptibility' to chloroform. Contemporary evidence 





The report by Dcnborough and Lovell, in 1960 [I], of a 
family who manifested a strange predisposition to death 
during general anaesthesia, led ultimately to the identifica-
tion of malignant hypcrthennia (MH) as a clinical phanna-
cogenetic entity [2). Subsequent experience has indicated 
that all volatile anaesthetics, especially the newer halo-
genated agents as well as chloroform. arc capable of 
triggering the MH crisis in genetically susceptible 
individuals (3), and this has begged the question why MH 
had not been noted before 1960 as a genetic entity. Letters 
that have recently come to light do seem to provide 
evidence that, some 40 years before Dcnborough and 
Lovell's classic description, a Dr G.A. Jones of 
Buckinghamshire did observe and record an example of 
such a familial fatal idiosyncrasy to chloroform anaesthesia 
but, sadly, never published his observations. 
In 1987 a 2.5-year-old child died tragically from MH 
while subjected to general anaesthesia for conservative 
dentistry of a minor nature. Subsequent muscle biopsy in 
vitro contracture testing (IVCT) of the proband's close 
family showed the child's father, uncle and cousin (the 
latter's son) all to be susceptible to MH (MHS). A cousin 
of the child's grandfather, (Fig. 1 (6)), had believed that 
members of her family had a strange and dangerous sensi-
tivity to general anaesthetics and a family tree was revealed 
(Fig. I) which showed circumstantial evidence of the MHS 
trait in all four generations. This by itself can no longer be 
regarded as extraordinary (MHS transmission is autosomal 
dominant and many such pedigrees have been reported 
since Dcnborough and Lovell's original description [ID. 
However, letters written in 1919 and earlier about the 
circumstances of the first two deaths during anaesthesia of 
members of this fanµly, those of Figure 1 (1) in 1915 and 
her son, (Fig. I (3)), in 1919, arc of considerable historical 
interest. The first of these deaths occurred in 1915, but the 
letters were written in 1919 following the death of this 
patient's son, when the similar circumstances of the latter's 
death motivated re-examination of those of the former. 
The death of the latter, (Fig. 1 (3)), occurred in February 
1919, at Marlborough during an operation for the explora-
tion of a ruptured kidney. The following is an extract from 
the report submitted by the anaesthetist, Dr E. Penny: 
'The anaesthetic was chloroform and ether given on an 
open Schimmelbusch mask and the amount used during 
the operation was almost exactly one ounce of the 
former and two ounces of the latter, the duration of the 
administration being half an hour. The patient, who did 
not seem at all nervous, passed nonnally and quickly 
under the anaesthetic but when the surgeon was about 
to begin the operation, it was noticed that a curious 
muscular rigidity existed in the arms, legs and 
abdominal muscles, the patient being fully under the 
anaesthetic and breathing quietly and freely. This 
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F11. 1. Genealogical table (abridged). •. died of malignant 
hypcnhennia (MH) or? malignant hypcnhennia; <ii) in "Vitro 
contracture testing (IVCT) MH susceptible; Q, IVCT MH 
negative. 
muscular condition persisted during the operation 
which consisted in the first stage of exploring the perito-
neal cavity in front of the injured kidney and in the 
second stage in cutting down to the kidney from behind. 
Just as the second stage was being completed a violent 
and persistent spasm of all the respiratory muscles of 
the thorax occurred and the movements of the chest 
ceased suddenly and absolutely. Artificial respiration 
was at once resorted to but no re-establishment of 
natural breathing could be obtained, though it was 
evident no impediment existed to the passage of air 
through the larynx. The heart continued to beat for a 
time after the fatal spasm occurred ... '. 
On receipt of this report, Dr G .A. Jones of Little Sccleys, 
Beaconsfield, Buckinghamshire, the anaesthetist concerned 
4 years earlier with the death under anaesthesia of this 
patient's mother. wrote to her husband this letter, from 
which extracts follow: 
· ... Mrs . .. 's operation was a rather long one in two 
stages, the first being abdominal for the fixing of the 
womb to the abdominal wall and the second vaginal for 
still further preventing prolapse ... I began with gas and 
ether but changed to a mixture of chlorofonn and ether 
as is usually done in operations of any length. The first 
stage was done in half-an-hour to three-quarters-of-an-
hour, and there was nothing then in the condition to 
cause the slightest anxiety . . . The second stage took 
about half-an-hour and it was not until near the end 
that any alarming symptoms showed themselves. There 
was a marked tendency to spasm of the muscles of the 
arms and jaw and apparently those of respiration, and 
the breathing stopped fairly quickly. The condition of 
the pupils had indicated a medium rather than deep 
anaesthesia i.e. they were contracted, not dilated as in 
chloroform overdose. When breathing stopped, the 
pulse was present though rather rapid. Stimulants and 
artificial respiration were tried without avail. 
Tracheotomy was tried as a last resort. 
There is a strong similarity in the cases of mother and 
son as regards the curious rigidity and spasm . .. but it is 
very rare indeed for any spasm of the muscles of respira-
tion to occur. It looks as if in both cases there was a 
tendency of abnormal rigidity coupled with a suscept-
ibility to chloroform. 
The sister of the house told me afterwards that Mrs 
. . . had had attaclcs of muscular spasm apparently 
suggesting the condition known as Tetany .... 
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The fact of a fatality occurring to both mother and 
son is very suggestive, but I cannot find any mention of 
hereditary susceptibility definitely ascertained in the 
standard text book on Anaesthetics ... One is inclined 
to advise that the two other children should be 
thoroughly examined by a first-class physician who 
might be able to say whether they had anything of the 
kind, but its a condition very difficult to recognise. I 
think chlorofonn should be absolutely barred if an 
operation were necessary and as little ether given as 
possible on an open mask after an injection of 
morphine. Yours sincerely, etc.' 
Later, Dr Jones wrote to-the 'sister of the house' (Fig. 1 (2)) 
when she had become the guardian of the remaining chil-
dren: 'Dear Miss ... , With reference to your nephews, I 
consider that in view of what occurred in the case of their 
mother and brother, they should never have chloroform for 
an operation in any circumstances, but that with either gas 
and oxygen or ether by the open method prcceeded by an 
injection of Morphia gr 1/6 and atropine gr 1/20 the risks 
should be practically negligible. Yours &J;.' 
In 1925 a third member of the family, (Fig. 1 (4)), died 
while anaesthetised undergoing an appcndiccctomy. 
Oinical details of this fatality have been lost. However, this 
succession of three deaths under anaesthesia in this family 
led them to take the precaution of showing the above 
letters to the matron of the Johannesburg Hospital in 1933 
when another member of generation 2 (Fig. 1 (7)), entered 
the nursing profession. Some years later, yet another 
member of generation 2 (Fig. 1 (5)) (the grandfather of the 
child whose death motivated this report), died while anaes-
thetised. In this case, details of which also are now sadly 
lacking, the patient died immediately postoperatively after 
a gastric operation. 
This family's history begs the question. •was Jones' fatal 
familial susceptibility to chloroform indeed MHT In 
describing the clinical circumstances associated with the 
deaths of 1915 and 1919, neither Jones nor Penny make 
any mention of their patients' body temperature, an omis-
sion that could be regarded as invalidating any retrospec-
tive diagnosis of MH. Yet it must be remembered that at 
that time monitoring of the patient's temperature during 
anaesthesia and surgery was not routine practice, if indeed 
it was ever recorded at all under these circumstances. 
Further, both accounts lay particular stress on the appear-
ance of that other cardinal manifestation of MH, muscle 
rigor, implying that respiration ceased because of the rigi-
dity of the muscles of respiration. Jones also mentions the 
history given by a 'sister of the house' that her sister bad 
complained of bouts of muscle spasm, a feature well-
documented in some subjects of the MHS trait (4). 
When the Jones and Penny accounts arc considered in 
the light of objective contemporary evidence of the death 
from MH of Figure I (11), the IVCT-diagnoscd MH trait 
in her father, (Fig. I (9)), her uncle, (Fig. 1(8)), and her 
cousin, (Fig. 1 (10)), together with the histories of the 
anaesthetic-related deaths of her grandfather, (Fig. 1 (5)), 
and his cousin, (Fig. I (4)), the balance of probability must 
lead us to conclude that these cases of 'hereditary suscept-
ibility' to chloroform, identified by Jones, were none other 
than historically very early examples of MH, indeed among 
the very earliest to be described [2] albeit unpublished till 
now. 
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Table 1. Results of diagnostic tesU. 
Family 
member % halothanc Contracture, g. 












All displayed normal histology and histochemistry. 
Appendix, data relevant to Figure 1 
MH proband, family member Figure I (11), died during 
anaesthesia with halothane and nitrous oxide/oxygen 
approximately 45 min after the onset of a fulminant 
episode of MH, which exhibited the classic features of 
tachycardia, muscle rigidity, cyanosis and hypcrthermia; 
the core temperature reached 42°C antcmortem. To date, 
seven . members of the family have subsequently been 
screened for susceptibility to MH by IVCT of biopsied 
skeletal muscle utilising the methods and diagnostic criteria 
of the European MH Group (5, 6). 
In our laboratories, once the muscle is in the tension 
study apparatus and stimulated to contract utilising a pulse 
of 0.1 amp at 0.25 Hz, the muscle is left for 5 min to 
establish a regular baseline before individual muscle strips 
arc subjected to challenge by halothane and caffeine. At the 
end of the procedure the challenging substances arc 
removed and the muscle, still being stimulated, is allowed 
to return to baseline confirming the contractility and viabi-
lity of the muscle strip. 
Caffeine concentration 













Muscle of three members of the family (sec Fig. 1) bas 
satisfied the diagnostic criteria for susceptibility to MH. 
These results arc in Table 1. 
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Porcine Malignant Hyperthermia· 
GAISFORD G. HARRISON 
Much of what we understand today about the pathogenesis and 
management of the anesthetic-induced malignant hyperthermia 
(MH) syndrome in man has followed the happy chance discovery 
that the well-known stress-related myopathy manifest in certain 
breeds of pig provides a close facsimile of this syndrome in man. The 
possibility that strains of certain breeds of pig might serve as a valid 
animal experimental model of this rare, puzzling, and lethal com-
plication of general anesthesia in man was first suggested by the 
observation by Hall and co-workers [44] and ·Harrison and associates 
[5S] of muscle rigor associated with fulminant hyperthermia oc-
curring in the anesthetized pig. In Hall's report this reaction was a 
response to the administration of succinylcholine (preceded by halo-
thane), while in Harrison's it followed administration of halothane 
alone. The chance nature of these discoveries, reported from centers 
as far apart as Cambridge (U.K.) and Cape Town (S.A.), can be 
judged from the fact that it was an investigation into the patho-
genesis of atherosclerosis in the fint instance and liver transplanta-
tion in the second that motivated the use of pigs as . experimental 
animals and thus their being anesthetized. Similar syndromes have 
since been reported in other species-the dog [SS], the cat [21], and 
the horse [6S]-but so rarely as to constitute scientific curiosities. 
Only in the pig does the condition occur with any regularity, a pos-
sible consequence of the geneyc selection practiced by breeders to 
produce a heavily muscled animal characterized by a rapid rate of 
growth with high feed efficiency [76]. 
• Financial auppon for this work came from The Anglo American and De Been 
Anaesthetic Research Fund and The Joeeph Stone Anaesthetic Research Fund. 
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Though the identity of the syndromes of anesthetic-induced MH 
in the susceptible pig and in man has been questioned [5, 11, 57], the 
pig has proved to be a practical experimental model of the condition 
[69]. What differences there are appear to be quantitative rather 
than qualitative-the expression of the syndrome being more florid 
and extreme in the pig than in man. 
CLINICAL SYNDROME IN THE PIG 
The following predominant clinical features of the hyperthermic 
syndrome in the pig all develop pari passu: 
1. Gross muscle rigor, usually preceded by fasciculation. This 
rigor is particularly evident in the hind legs, which become 
rigidly extended in a few minutes (Fig. 1). 
2. An explosive and sustained rise in core temperature (Fig. 2). 
Though rate of increase varies among pigs, a rate of I °C. every 
5 to 7 minutes is commonplace, with temperatures reaching 
43 to 45°C. antemortem. 
FIGURE I. Progressive rigid extension of MHS Landrace pig hind legs 
produced b)• the onset of muscle rigor provoked by exposure of this animal 
to halothane after a control period of anesthesia with thiopentone and 
nitrous oxide. This phenomenon may be recorded by attaching trotter by 
string over pulley to a recording pen on a revolving drum. 
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FIGURE 2. Record of esophageal temperature in MHS Landrace pig dur-ing the course of an MH syndrome provolted by exposure to halothane after a control period of thiopentone and nitrow oxide anesthesia. Note the "trigger" effect of halothane. (From Harrison et al. [HJ.) 
3. Sinus tachycardia. A rapidly developing sinus tachycardia at a 
rate usually in excess of 200 beats per minute is often the 
earliest detectable harbinger of the syndrome. Tachycardia 
continues until shortly before death in the untreated animal. 
4. Open-mouth breathing and hyperventilation that proceed 
within minutes to apnea necessitating the institution of inter-
mittent positive-pressure ventilation if the animal is to survive 
for more than 10 to 15 minutes. 
5. Blotchy cyanosis of the skin, most noticeable on the abdominal 
wall and snout. 
In susceptible animals the syndrome usually becomes manifest 
within 5 to 15 minutes of exposure to the stressor or triggering agent 
(e.g., halothane). This interval depends to a large extent on the time 
it takes for the tissue tension of the stressor to reach the threshold 
level; hence the onset is faster in small than in large animals. 
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Onset is more rapid when the induction of anesthesia is ac-
companied by struggling and excitement [2, 89), circumstances that 
alone may initiate the syndrome [61, 9S]. On the other hand, onset 
is slower when induction of anesthesia is quiet, such as it may be 
with intravenous agents preceded by suitable sedative premcdication 
(e.g., azeparone or ketamine). 
If exposure to the stressor (e.g., halothane) is stopped within min-
utes of the first appearance of any of the major clinical manifesta-
tions, the syndrome is spontaneously reversible. If, however, ex-
posure to the stressor is continued for more than several minutes 
thereafter, the syndrome rapidly becomes irreversible and will con-
tinue independently of the tissue concentration of the strcssor, which 
can now be said to have acted as a trigger. 
Profound acidosis develops with bewildering speed and is ac-
companied by equally rapid and gross changes in serum biochemistry 
-changes that precede and reach extreme values in advance of the 
recorded rise in core temperature [4). The acidosis is primarily an 
uncompensated metabolic acidosis due to a gross rise in plasma lac-
tate ("excess lactate" in terms of Huckabce's formula [59]) reflected 
by the appropriate base deficit (Fig. S). The phenomenal rise in 
PCOJ, a reftection of the H+ + HC08- -+ HsO + C01 reaction! is 
doubtless responsible for the open-mouth brcathing-hyperventila-
tion-apnca sequence, in effect CDs narcosis. The great speed at 
which these changes occur is graphically illustrated in Figure 4, in 
which a pH probe in pig hind limb muscle records a drop in extra-
cellular fluid pH from 7.2 to 6.6 in a period of 12 minutes, while 
the experiment recording arterial blood acid-base changes illustrated 
in Figure S shows a fall in arterial blood pH from 7.S5 to 6.6 in 20 
minutes. The changes recorded in serum biochemistry values (Fig. 
5) include rises in NA+, K+, ea++, Mg++, total protein, glucose, 
intracellular P (P1), and lactate and indicate: (I) shift of water into 
the cells (with concomitant rise in Na+ and total protein); (2) leak-
age of K +, Ca++, Mg++, and P1 out of the cells; and (S) glycolysis. 
The rise in serum K + is so large that it may well contribute to the 
ultimate death of the animal in hypcrthcrmic rigor. 
Untreated, the syndrome is inevitably fatal; death occurs within 
2.31 
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FIGURE 4. Changes in pH, recorded from an intramuscular pH probe, 
together with .simultaneous record of esophageal temperature during the 
course of an MH syndrome provoked by exposure to halothane in a MHS 
Landrace pig. Note that experimental treatment with a chelating agent 
caused the death of the .animal. (From Harrison [48].) 
15 minutes if the animal has been breathing spontaneously and 
within 40 to 60 minutes if it has been mechanically ventilated. 
THE MALIGNANT-HYPERTHERMIA-SUSCEPTIBLE 
STRAIN 
It was soon apparent that this "explosive thermal idiosyncrasy" 
[97) was a genetic trait displayed only by certain pigs of a few breeds, 
mostly the leaner, heavily muscled, high-growth-rate breeds. Breeds 
in which this trait of malignant hyperthermia susceptibility (MHS) 
has been described include the Danish Landrace, Dutch Pietrain, 
Poland China, and crossbreeds of these strains [76). Its occurrence in 
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Yorkshires has also been recorded [19]. MHS was originally re-
garded as a single autosomal dominant trait [44, 61, 94], but the 
graded phenotype variations produced in recent breeding experi-
ments now indicate the involvement ot more than one gene, or at 
least a complex or strongly modified single dominant gene, in the in-
heritance of porcine MHS [14a, 94a ]. Similarly, it is now proposed 
that the condition in humans manifests a pattern of inheritance that 
is polygenetic and multifactorial [25a ]. 
One of the difficulties facing the researcher intent on breeding 
MHS swine is the fact that stressors that provoke the syndrome in-
clude excitement and severe exertion-a circumstance that often re-
sults in what may be termed "purple porcine passion," with the sub-
sequent demise of a valued MHS boar. 
STRESSORS OR TRIGGERING AGENTS 
Knowing what we do .today of the pathogenesis of MH, it is not 
unreasonable to suspect that any of the conventional volatile anes-
thetics could trigger the syndrome in susceptible animals. Indeed, in 
humans the syndrome has been reported in association with all such 
anesthetics [I 1, 26] though some appear to be more potent as triggers 
than others. 
Investigation and identification of possible stressors, or triggering 
agents, has been one of the first aspects of the condition to be inves-
tigated in MHS swine. The number of agents identified as stressors 
is relatively limited, though perhaps the search has not been suffi-
ciently persistent or exhaustive. 
Of the conventional volatile agents, we have investigated halo-
thane, methoxyflurane, trichlorethylene, chloroform, cydopropane, 
diethyl ether, and nitrous oxide [54, 55]. More recently we have con-
ducted as yet unreported investigations of fluroxeoe and ethrane. 
Prompt initiation of the syndrome follows exposure of MHS pigs to 
halothane, chloroform, and ethrane. Fluroxene has proved to be a 
weak and inconsistent stressor. 
In direct contrast to the volatile agents, not only do none of the 
intravenous agents tested (thiopentone, althesin, and ketamine) act 
2.31 
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as stressors, but one, althesin, when administered by continuous in-
travenous infusion, consistently blocks initiation of the syndrome 
[49]. 
Among the muscle relaxant drugs tested, the only stressor is suc-
cinylcholine. Though in Hall and co-workers' original report the 
stressor action of succinykholine was noted only in an environment 
of halothane anesthesia [44), in pure Landrace strain [54) and Pie-
train pigs [66), succinylcholine alone has proved to be a potent 
single stressor. In these animals the MH stressor action of succinyl-
choline is characteristically preceded by a grossly abnormal myotonic 
reaction to the drug. This myotonic reaction appears to be neces-
sary for the MR-triggering action of succinylcholine, because if it is 
blocked by the preliminary administration of a nondepolarizing re-
laxant, the syndrome fails to develop [40, 48). As can be anticipated 
from this observation, nondepolarizing relaxants do not act as MH 
triggering agents in MHS swine. Not only have we failed to confirm 
the existence of porcine MH in response to the administration of 
pancuronium reported by Chalstrey and Edwards [17), but Hall and 
associates [40) have even demonstrated a degree of protection ex-
erted by pancuronium against the halothane-induced syndrome. 
Short and colleagues [84) go so far as to recommend pancuronium 
for elective use in anesthesia for MH swine. 
In contrast to MHS Landrace and Pietrain swine, MHS Poland 
China pigs fail to develop MH in response to succinylcholine alone 
[78). Succinylcholine, however, may act as an additive stressor in ani-
mals that fail to react initially to a halothane challenge. This differ-
ing response to stressors displayed by the various genotypes probably 
reflects varying degrees of severity of the same basic dysfunction in 
the mechanisms controlling the normal muscle intracellular Ca+ + 
flux (see later discussion). 
While the possibility of catecholamine-mediated effects on thermo-
genesis soon engaged our attention (with negative results) [54), the 
Bristol group has investigated the problem also. Following their 
demonstration that circulating levels of catecholamines increased 
during the MH syndrome in Pietrain swine [66), these workers suc-
cessfully provoked the syndrome by a-adrenergic agonist infusion 
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[41] with the corollory demonstration that initiation of the syndrome 
was blocked in response to other stressors by a-adrenergic blockade 
[67]. 
Though Williams and co-workers [92, 9!1] proposed circulating 
norepinephrine as the key triggering factor for the hyperthermic 
syndrome provoked by psychological or exercise stress, Hall, Lucke, 
and Lister could provoke it in the anesthetized MH Pietrain pig with 
infused norepinephrine only when this was accompanied by the 
,B-adrenergic blockade of propranolol [41]. 
PALE, SOFT EXUDATE OF PORK, PORCINE STRESS 
SYNDROME, AND PORCINE MH-AN IDENTITY? 
The occurrence of pork with unfavorable meat qualities (pale, soft 
exudative pork [PSEP]) has long been the subject of concern and 
research in the meat industry [64]. This condition (judged primarily 
by its color and the amount of expressible water) occurs when condi-
tions are present that lead to rapid postmortem glycolysis with con-
comitant myolactosis and a fall in carcass muscle pH that is more 
rapid than normal [65, 100]. The identification of these conditions in 
association with both the porcine stress syndrome (PSS) [88] and the 
anesthetic-induced syndrome of MH in swine [48] immediately sug-
gested that these separately described syndromes were by manifesta-
tions of the same underlying myopathy. Sybesma and Eikelenboom's 
provocation of MH with halothane in stress-susceptible Pietrain 
swine [87], and our demonstration of the converse (changes in ex-
pressible water of the PSEP type in carcasses of MHS Landrace 
swine [ 4 7)-a finding confirmed in Poland China swine by N clson 
and co-workers [79]), provide perhaps the simplest evidence in sup-
port of this hypothesis. More elegant perhaps is the evidence that the 
response of stress-susceptible swine to environmental [!12], psycho-
logical [9!1], exercise [87], and anoxic stress [68] is identical with the 
clinical and biochemical changes observed in the MH syndrome. 
The association in swine of susceptibility to stress and susceptibil-
ity to MH has been proposed as evidence that the condition in the 
pig and in man are different, for man does not seem to display the 
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former [57]. However, until more is known about the causes of sud-
den death unassociated with general anesthesia in members ·of MHS 
families [98, 99], and about those unfortunate persons who die of 
"heat stroke" with associated muscle necrosis (crushed-muscle syn-
drome) following severe, unaccustomed exercise (e.g., route marching 
of new military recruits), this argument cannot be supported, for 
perhaps these episodes are human manifestations of a stress syndrome 
similar to that observed in swine. 
In this regard, an interesting analogy that invites speculation is 
the condition of capture myopathy of wild game and its relation to 
the hypothermia and stress syndromes in swine and man [58]. Here 
is a condition with many of the features of PSS but one that usually 
occurs in response to a more severe stimulus. The relevance of the 
comparison lies in the possible application to wild game manage-
ment (especially for endangered species) of therapeutic measures use-
ful in the pig and man. Would the addition of dantrolene to the 
sedative and tranquilizing drugs used in darting animals requiring 
culling and transport reduce losses due to this condition? 
SCREENING AND IDENTIFICATION OF MHS SWINE 
Clinical and Biochemical 
The demonstration that muscle from MHS pigs could be shown in 
vitro to behave metabolically in a manner different from that of 
normal nonreactor pigs, i.e., that the rate of adenosine triphosphate 
(ATP) depletion in incubated muscle biopsies was approximately 
double (Fig. 6), provided the basis for the first diagnostic screening 
test for the MHS trait [54]. However, equally reliable identification 
of susceptible animals follows the simple clinical observation of a 
test animal's response to a challenge exposure of halothane. Sus-
ceptible animals usually commence developing muscle rigor with its 
consequent characteristic extension of the hind legs (see Fig. 1) 
within 5 to 15 minutes, whereupon discontinuance of halothane en-
sures spontaneous reversal of the syndrome and recovery of the ani-
mal. When no abnormal response is evident, halothane is continued 
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FIGURE 6. The effect on muscle biopsy ATP content of incubation in 
oxygenaud Krebs-Ringer's solution and exposure to halothane. Hot pig= 
MHSpig. 
ing animals during the immediate postweaning stage at 4 to 6 weeks 
of age. 
Though mean levels of serum creatine phosphokinase (CPK) are 
higher in MHS than in nonreactor pigs [IOI], the variability in val-
ues observed renders the level recorded in any individual pig of little 
diagnostic significance [72). What is of diagnostic value is the ob-
served change in the level of serum CPK measured on induction of 
anesthesia when compared with that measured 24 hours later. In 
MHS swine the increase is truly immense-being of the order of 
20- to 100-fold-even if exposure to the anesthetic is brief [51, 101]. 
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Difficulty arises in pigs such as those originally described by Hall 
and associates [44] in which initiation of the MH syndrome requires 
administration of succinylcholine in addition to halothane, for this 
reaction is uncontrollable and usually results in the death of the 
animal. Such an event may be circumvented by the intraarterial 
(femoral) injection of a small dose of succinylcholine, with resultant 
gross myotonic response in the susceptible animal confined to one 
leg [43, 80). The diagnosis of MHS may then be confirmed on muscle 
biopsy by resorting to the original in vitro ATP depletion test. 
Histological and Histochemical Screening 
Harking back to the hypothesis that the stress syndrome and MH 
in the pig are manifestations of the same myopathy, and the fact that 
conventional light and electron microscopy have demonstrated some 
characteristic features in muscle biopsies from human MHS patients 
[15, 45, 60], we hoped that such investigation would provide a means 
of confirming the diagnosis of MHS trait in the pig. The outcome of 
such investigation, though negative, was interesting. Comparison of 
the histology on conventional light and electron microscopy of mus-
cle from previously screened MHS and nonreactor Landrace pigs re-
vealed no differences (the histologist viewed the material "blind"). 
Muscles from both strains, however, showed features that would be 
considered abnormal in human muscle, e.g., fiber grouping, hetero-
geneity in fiber size, and occasional cell necrosis. Perhaps, like high 
CPK values, these are features of the rapid muscle growth character-
istic of this breed. 
Hematological Screening 
Finally, some help in screening for the MHS trait may come from 
Rasmusen and Christian's recent finding that stress susceptibility ap-
pears to be associated primarily with one porcine blood type-the H 
system [81]. This is a complex system of blood groups in the pig con-
trolled by at least seven alleles with five different blood factors. The 
MHS characteristic is associated with only two genotypes of this sys-
tem, Ha/a (negative for A or 0) and H -/- (positive for A or 0). 
On the other hand, resistance to PSS is associated with three other 
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genotypes of this system, all positive for A or 0, H a/a, H a/c, 
and H c/-. 
PATHOGENESIS 
Site of Lesion 
Some idea of the magnitude of heat production responsible for the 
meteoric rise in core temperature which characterizes the hyper-
thermic syndrome in swine could be derived from the observations 
of Berman and colleagues (4] and Williams and associates [93]. Ber-
man and co-workers recorded the average heat output by a 56-kg. pig 
in hyperthermic rigor as 0.275 J. kg. - 1 min. - 1, this figure being three 
times greater, 0.78 J. kg.-1 min.-1, during the first 10 minutes of the 
syndrome. Williams and colleagues more recently recorded a 17-fold 
increase in heat production from normal resting levels in susceptible 
swine provoked into the syndrome merely by being caged, measuring 
an average heat output in excess of 0.47 J. kg. - 1 min. - 1• 
With rigor of skeletal muscle-the other prominent feature of the 
syndrome-it was not long before the results of various investigations 
pointed to muscle, not only as the site of the lesion responsible for 
MH but also as the primary source of heat production. In our labo-
ratory we showed several years ago that muscle from MHS swine be-
haves metabolically in a manner different from that of normal swine. 
Thus the in vitro ATP consumption of incubated biopsies was twice 
as great as that of normal muscle (54] (see Fig. 6). In similar in vitro 
muscle experiments, Nelson and associates (80] showed that this 
rapid in vitro ATP consumption in muscle biopsies is accompanied 
by an appropriately rapid production of lactate. 
Further evidence of the primary involvement of muscle came from 
our demonstration that the rigor and biochemical changes of the 
syndrome could be reproduced in response to halothane in a prepa-
ration of isolated perfused MHS pig hind limb-in effect, a prepara-
tion of isolated perfused muscle [52] (Fig. 7). These observations, 
later confirmed in vitro by Moulds and Denborough [74], drew 
attention away from the stress-related endocrine aspects of the 
syndrome as a primary event. The disturbances in pituitary and 
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FIGURE 7. Preparation of isolated perfused hind limbs. Following ex-sanguination of the animal from the proximal aorta into a pump oxygena-tor, the hindquarters were perfused through the distal aorta with venous return via the inferior vena cava. The animal was then transected at the lumbar sacral region. Exposure to halothane was achieved by introduction of halothane vaporizer into the oxygen line of the pump oxygenator. (From Harrison et al. [52].) 
adrenal function, which have been the subject of so much research 
into the PSS and PSEP aspects of this syndrome [70], together with 
the reported concomitant increases in circulating catecholamines [66, 
92], would seem to be either associated defects or defects that are 
secondary to the primary lesion in muscle. 
Any doubts that may have lingered on this score have since been 
effectively laid to rest by Gronert and co-workers [SS], who demon-
strated in the MHS pig that total sympathetic denervation fails to 
block initiation of the syndrome in response to a stressor, but does 
block the usual accompanying rise in circulating catecholamines. In 
addition, they demonstrated the corollary that administration of 
dantrolene, which effectively blocks initiation of the syndrome, has 
no effect on stress-provoked increases in circulating catecholamines. 
The fact that muscle is the source of the increased heat output was 
validated by Clarke and colleagues [20] when they showed a differ. 
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ence of 2°C. in the temperature of venous blood outflow compared 
to that of arterial inflow in the hind limbs of hyperthermic pigs. The 
next step after these observations, a demonstration that muscle was 
responsible for the increase in whole-body oxygen uptake measured 
during the syndrome, has now been taken by Gronert and asso-
ciates [35). 
The astounding explosive heat production which characterizes the 
syndrome directed early attention to the possibility that uncoupling 
of oxidative phosphorylation, with the further implication of a de-
fect in mitochondrial function, was the mechanism responsible [96). 
Attractive as this hypothesis was, Wang and colleagues' argument 
[91] that on purely theoretical grounds uncoupling of oxidative 
phosphorylation could not account for all the heat output was fol-
lowed by the demonstration by many workers [5, It 14, 16, 22] that 
mitochondria isolated from muscle of both MHS humans and pigs 
displays normal respiratory control, and the changes in mitochon-
drial function produced by exposure to halothane-a depression of 
nicotinamide-adenine dinucleotide-linked substrate metabolism-
were not different from those produced in normal mitochondria. 
Accelerated Glycolysis 
Evidence of massive muscle glycolysis led Berman and co-workers 
[4, 5) to an in vivo study of the glycolytic intermediates in the hind 
limb muscle of MHS swine together with simultaneous observations 
of oxygen uptake and CO2 production during the course of the 
hyperthermic syndrome provoked by exposure to halothane (Fig. 8). 
They concluded that anaerobic mechanisms are responsible for as 
much as 50 percent of the extra heat production that accompanies 
the syndrome, while less than IO percent of the heat production can 
be accounted for by aerobic mechanisms. These conclusions fitted 
well with observations by workers investigating the PSS and PSEP 
manifestations of the syndrome. They observed that stress-susceptible 
swine have a larger proportion of fast white fibers per unit mass of 
muscle than non-stress-susceptible animals, such muscle having a 
lower capacity for oxidative metabolism and an increased potential 
for anaerobic glycolysis [70]. 
2.31 
Porcine Malignant Hyperthermia 
1500 





















FIGURE 8. Oxygen uptake and carbon dioxide output with simultaneous 
esophageal temperature recorded during the course of an MH syndrome 
provoked by exposure to halothane in a Landrace pig. Control period of 
anesthesia was with thiopentone and nitrous oxide. Note that the increased 
oxygen uptake is accompanied by a far greater output of CO2• (From Ber• 
man et al. [4].) 
Further studies of the phase of accelerated glycolytic flux [S] 
showed that there was a rise in all the glycolytic intermediates mea-
sured. No single enzymatic step appeared to be specifically activated. 
It was postulated that this accelerated glycolysis was due to a "flash 
activation" of glycogen phosphorylase by intracellular Ca++ release 
(see later discussion). 
Other Mechanisms of Heat Production 
Besides glycolysis, other anaerobic mechanisms suggested as con-
tributory to the heat production were neutralization and buffering 
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of excess lactic acid, entropy, change of muscle filament shortening 
[5], and hepatic lactate gluconeogenesis [22). 
The resynthesis of glucose in the Cori cycle is a major route of 
lactate disposal in the body. During exercise (and the conditions of 
rigor with accelerated glycolysis are· very similar to conditions im-
posed by severe exercise), enhanced gluconeogenesis can limit the re-
sultant lactic acidosis. It has been suggested by Exton [29) that the 
"oxygen debt" phenomenon is but a reflection of ATP consumption 
associated with lactate gluconeogenesis. A factor that doubtless con-
tributes to the extreme and rapid lactic acidosis that characterizes 
the MH, PSS, and PSEP syndromes is the finding by Dimarco and 
co-workers [24) that the livers of stress-susceptible swine have a greatly 
reduced rate of lactate gluconeogenesis and oxidation to CO2-a rate 
less than half that of normal animals. A factor in the genesis of PSEP, 
this deficiency in la.ctate gluconeogenesis also surely contributes to 
the rapidity with which the MH syndrome becomes irreversible (see 
later discussion). 
Clarke and co-workers [20] have set forth the challenging hypothe-
sis that accelerated substrate cycling of fructose-6-phosphate is the 
source of the increased heat production and ATP depletion in mus-
cle that characterize the hyperthermic syndrome. Following their 
demonstration that the recycling of fructose-6-phosphate in bumble 
bee flight muscle through reactions catalyzed by phosphofructokinase 
and fructodiphosphatase generates heat to maintain the thoracic 
muscle temperature necessary for flight (Fig. 9), they have produced 
evidence that a similar accelerated rate of fructose-6-phosphate cy-
cling occurs in the hind limb muscle of pigs during the hyperthermic 
syndrome. They accordingly suggest that this is the mechanism of 
heat production and depletion of ATP observed during the hyper-
thermic syndrome. However, the amount of heat released by the 
rates of substrate cycling they observed in hyperthermic pig muscle 
is not sufficient to account for the total heat output observed by them 
during the syndrome. To account for the difference, they propose 
substrate cycling at other sites in the glycolytic pathway as a further 
potential source of heat generation-an interesting hypothesis that 
still awaits proof [92]. 
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FIGURE 9. Substrate cycling in bumblebees and MHS swine. (After Clarke et al. [20].) 
Of import in understanding the genesis of rigor is Berman and 
Kench's observation [5] that ATP levels in muscle are in fact well 
maintained early in the course of the syndrome when muscle rigor is 
already established, and only fall after an appropriate depletion of 
creatine phosphate. This has dispelled the idea developed from our 
earlier in vitro muscle studies [54] and those of Nelson and co-
workers [80] that a decrease in ATP level was the primary cause of 
muscle rigor. 
INTRACELLULAR Ca++ FLUX 
The key to this excess metabolic activity was found initially by 
Kalow and co-workers [62] when they reported the following three 
fundamental observations made on muscle preparations from human 
survivors of anesthetic-induced MH: 
I. Such muscle was more sensitive to caffeine-induced rigor than 
that from normal controls. 
2. This effect was enhanced by exposure to halothane. 
3. The uptake of Ca++ by the sarcoplasmic reticulum (SR) from 
such patients was depressed by exposure to halothane, an 
event that produced no change in SR from normal patients. 
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Their hypothesis that "malignant hyperthermia is caused by an in-
born error in skeletal muscle which renders the muscle susceptible 
to disturbances of intracellular Ca++ distribution" still holds today. 
The attractiveness of this hypothesis is that this one event, an in-
creased myoplasmic Ca++ flux, can explain both of the principal 
manifestations of the syndrome: (1) muscle rigor from Ca++ inhibi-
tion of troponin and activation of myofibrillar adenosine triphos-
phatase; and (2) hyperrnetabolism from flash activation of glycogen 
phosphorylase. These are the two events from which all other ac-
companiments of the syndrome flow. 
Evidence of the release of Ca++ from intracellular binding sites 
was deduced by Berman and Kench [5] from their observation of a 
rise in plasma Ca+ + and a concomitant decrease in total muscle 
Ca++ during progression of the syndrome in MHS swine. That drugs 
known to lower myoplasmic Ca++ or reduce its release-procaine 
[48] and more recently dantrolene sodium [50]-block initiation of 
the syndrome in response to known activators in vivo and halothane-
induced rigor in vitro [74] added not only pharmacological support 
for Kalow's etiological hypothesis but pointed the way toward spe-
cific techniques of therapy and prophylaxis [50, 51). 
Brief consideration of the role of Ca++ in the muscle excitation-
contraction coupling train indicates that membrane dysfunction, 
genetic or drug induced or both, at any or all of three sites, the SR, 
sarcolemma, or mitochondria, could lead to the postulated sustained 
high myoplasmic Ca++ concentration. 
Sarcoplasmic Reticulum 
That no overt rigor has been observed in smooth muscle in associa-
tion with the hyperthermic rigor of skeletal muscle in MH immedi-
ately suggests the pathogenic role of SR dysfunction in this condition. 
In contrast to skeletal muscle, the main flux of excitation-contraction 
coupling Ca++ in smooth muscle is from the extracellular fluid 
(ECF) across the sarcolemma. SR is much less well formed in this 
type of muscle than in skeletal muscle and of much less consequence 
in the excitation-contraction coupling. Such dysfunction could lead 
to sustained levels of Ca+ + in the myoplasm from either increased 
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release or defective resorption, or both. Kalow's observation that 
halothane depresses Ca+ + uptake by SR in MHS humans, supported 
by similar observations of Brucker and associates [16] and Den-
borough and co-workers [22] in MliS pigs, seemed to confirm such a 
hypothesis. Paradoxically, however, SR both from human MH pa-
tients [IO] and from MHS swine [5, 12, 80, 86] has been shown in 
vitro to have an increased capacity for Ca++ resorption, which is 
improved by exposure to halothane. These contradictory findings 
may be due to differences in experimental technique but may also be 
seen as a chronic adaptation of this organelle to a high myoplasmic 
Ca++ level, the result of a defect in some other intracellular Ca++ -
binding organelle, e.g., increased sarcolemmal Ca+ + release or leak, 
or decreased mitochondrial Ca ++ uptake. 
Direct evidence that the SR membranes of MHS swine are indeed 
different from normal has now been reported by Berman and col-
leagues [6], who have shown that they display differences in both 
density and lipid composition. More recently these same workers, in 
describing the phenomenon of proton inactivation of Ca+ + trans-
port by SR membranes [7], have provided one ready explanation for 
the rapid establishment of the vicious circle which characterizes the 
MH syndrome once the initial rise in myoplasmic Ca++ has oc-
curred. This phenomenon is doubtless the explanation for the ob-
servation reported by Britt and associates [12] that, whereas SR prep-
arations from muscle biopsies taken from MHS pigs before exposure 
to halothane displayed enhanced Ca+ + uptake, the Ca+ + uptake of 
similar SR preparations from muscle biopsies from MHS swine taken 
after their exposure to halothane (and initiation of MH) was 
markedly reduced. 
Sa,·colemma 
The well-documented raised serum levels of CPK in MHS sub-
jects, both pig and human, have been proposed as evidence of in-
creased porosity of their sarcolemma [I I] . 
Experimental evidence in support of this hypothesis comes from 
in vitro investigation of responses of muscle of susceptible subjects 
(human [75] and porcine [77]) to halothane in conditions of varying 
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Ca++ concentration. The failure of halothane to provoke contrac-
ture in a Ca+ +.free solution, with restoration of this property by the 
addition of Ca+ + to the muscle-bath solution, implies that sarcolem-
mal Ca+ + transit plays some part in this process. 
Mitochondria 
The considerable investigation that has been made of the primary 
energy-producing function of mitochondria in relation to MH has 
been mentioned already. Much less study has been made of the other 
function of mitochondria relevant to this syndrome-Ca++ accumu-
lation. · 
Britt and colleagues [13] observed that MHS porcine mitochondria 
possess a greatly reduced ability to accumulate Ca++ -on the order of 
8 to IO times less-than mitochondria from the normal pig. This 
Ca ++ accumulation . is not significantly affected by exposure to halo-
thane. Such a reduction of Ca++ -accumulating capacity can be as-
sumed to enhance the effects of any excess intracellular Ca++ re-
lease on appropriate stimulus and should be regarded as contributing 
to the overall pathogenesis. 
More recently, Cheah and Cheah (18] reported their observation 
that the efflux rate of Ca++ from mitochondria of the MHS pig 
in circumstances of anaerobiosis, in this instance immediately post-
mortem, is twice that of stress-resistant animals and that this Ca++ 
efflux rate from the mitochondria is enhanced by their exposure to 
halothane. As the circumstances of the MH syndrome rapidly en-
gender anaerobic conditions in the cell, these observations are no 
doubt pertinent to the pathogenic role in MH syndrome of the high 
level of myoplasmic'Ca + + maintained and the establishment of irre-
versibility. 
Generalized Membrane Defect 
Though there are important functional differences between the 
membranes of intracellular organelles, there is indeed a structural 
organization that is common to most [30, 34, 82]. That the mem-
brane "defect" responsible for MH is not confined to muscle was 
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FIGURE IO. Increment hemolysis curve demonstrating increased fragility of MHS pig erythrocytes. (From Harrison and Verburg [56].) 
suggested by Harrison and Verburg's observation [56] of increased 
osmotic fragility of MHS porcine erythrocytes (Fig. 10). 
Observation of other calcium-mediated reactions becomes relevant 
to the question of a more generalized membrane "defect." Prompted 
by Malaisse's proposal that the regulation of insulin secretion de-
pends on the level of Ca++ in the beta cells of the pancreas, Den-
borough and co-workers [2!] studied insulin secretion in MHS hu-
mans and found that they had an increased insulin response to a 
glucose load, an observation yet to be investigated in the MHS pig. 
The observed increase in circulating catecholamines in porcine MH 
[66] may well have the same implications, judging from the work of 
Douglas and Rubin [25] on the role of Ca+ + in the secretory re-
sponse of the adrenal medulla. 
IRREVERSIBILITY-THE VICIOUS CIRCLE 
The hyperthermic syndrome is described as "malignant" because 
of its rapid progression to irreversibility. Applied for a sufficient 
time, any activating stimulus acts as a trigger; the syndrome there-
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FIGURE 11. The vicious 
circle. 
after continues independent of the stimulus. Consideration of some 
of the observations of muscle cell organelle function and hepatic 
gluconeogenesis already referred to allows us to form a reasonable 
working hypothesis of the evolution of this state (Fig. 11 ). 
The initial stressor acts by causing the release of Ca++ (possibly 
an excess in relation to the magnitude of the stimulus) into the myo-
plasm from a genetic functionally defective SR and possibly sarco-
lemma. This causes muscle contraction and flash activation of gly-
colysis, events which produce heat and lactate. Defective hepatic 
gluconeogenesis [24] results in a reduced rate of lactate clearance by 
the liver, and consequently severe intracellular acidosis, soon caus-
ing the intracellular pH to fall below the critical level of pH 6 at 
which Berman and co-workers [7] showed that irreversible inactiva-
tion of Ca++ transport by the SR occurs. In conjunction with the 
reduced Ca + +-accumulating capacity of the mitochondria [IS], these 
events lead to the maintenance of a high level of Ca++ in the myo-
plasm. Activation of muscle and glycolysis continues, contraction be-
coming rigor. At the same time, the anaerobic conditions engendered 
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by these events in the muscle cell cause an increased rate of Ca++ 
efflux from the mitochondria [18], adding yet another factor con-
tributing to inexorable irreversibility of the syndrome. 
The high level of myoplasmic Ca++ maintained may not be the 
only factor leading to irreversibility of the syndrome. Fuchs [!!] has 
now demonstrated that the Ca+ + control system of human actomyo-
sin is inactivated by temperature increases of the magnitude encoun-
tered in intact muscle during the hyperthermic syndrome. This 
thermal inactivation of the Ca++ -regulating mechanism of actomyo-
sin is potentiated by decline in ATP levels. Thus, two key events in 
the MH syndrome, pyrexia and fall in muscle ATP level, can per-
petuate muscle rigor independently of the intracellular Ca++ con-
centration. 
In addition, attention has been drawn to the stimulating effects on 
muscle and metabolism of the vast increase in circulating catechol-
amines observed in Pietrain pigs with MH and their possible role 
in events leading to irreversibility of the syndrome [41, 7!, 92, 95]. 
THERAPY 
Pharmacological support for Kalow's hypothesis of the central role 
of Ca+ + flux in the genesis of human MH came from the observa-
tion that procaine, a known inhibitor of SR Ca++ release, blocks 
initiation of the syndrome in MHS swine. This pointed the direction 
from which specific therapy for the syndrome might emerge [46] 
(Fig. 12). In spite of initial reservations based on the lack of effect 
of procaine on established rigor in vitro [8, !I] and the negative 
inotropic effect of procaine in large doses on the myocardium, pro-
caine has acquired a history of successful therapeutic use in MH in 
man [11, 15]. However, in porcine hyperthermia the therapeutic use 
of procaine has proved ultimately disappointing [!6, !9, 4!, 71]. 
Though its mode of action is unknown, the steroid anesthetic 
Althesin, when given by continuous intravenous infusion, has a simi-
lar action to that of procaine, blocking initiation of the porcine MH 
syndrome in response to halothane but not to halothane combined 
with succinylcholine. Disappointingly, as with procaine in the por-
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FIGURE 12. The original in vivo demonstration in MHS Landrace pig 
of block of halothane-induced rigor by procaine (continuous intravenous 
infusion). Events recorded (from above downward): procaine infusion, halo-
thane administration, intramuscular temperature, and rigor (recorded as 
extension of hind limb). Note the onset of rigor and rise in temperature 
when procaine was discontinued. (From Harrison [48].) 
cine syndrome, it has proved therapeutically useless once the syn-
drome is established [49]. 
Attention has already been drawn to the interrelated observations 
reported by the Bristol group of high circulating levels of catechol-
amines, a-adrenergic agonist trigger action [41), and prevention of 
that action by a-adrenergic blockade [67) in porcine MHS. As was 
the case with Althesin, a-adrenergic blockade could not be extended 
to offer therapy for the established syndrome. 
Though Bianchi's suggestion [9] in 1971 that diphenylhydantoin 
should be investigated as a therapeutic agent did not bear fruit, it is 
another hydantoin-dantrolene sodium-that now offers the greatest 
therapeutic hope. Interested in drugs that might be of use in relax-
ing spastic muscle states, Snyder and associates [85] reported in 1967 
the synthesis of a series of hydantoins which proved to have muscle 
relaxant properties. One of these, dantrolene sodium, was exten-
sively investigated, and its muscle-relaxant properties were shown to 
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be due to an effect on excitation-contraction coupling. Further, prob-ably as a result of its limited water solubility, dantrolene, no matter what the dose, did not produce complete muscle paralysis in vitro 
or in vivo [27]. Interestingly, its effects were on skeletal muscle only, 
and no effect on cardiac or smooth muscle was apparent [27, 28]. 
These properties immediately excited my curiosity about the pos-sible use of dantrolene sodium in treating MH. My investigation of 
this drug produced results excitingly different from those of other 
drugs previously investigated [50, 51]. Administration of dantrolene sodium blocked initiation of the syndrome in response not only to 
halothane and succinylcholine separately, but also to succinylcholine administered in addition to halothane (Fig. 13). Furthermore, when 
administered to animals in established hyperthermic rigor, dantro-
FIGURE 13. ' Bloc/ting effect of oral dantrolene on halothane-induced rigor in MHS swine. The nearer pig, pretreated with dantrolene, is in the thirtieth minute of a planned one-hour exposure to halothane. The legs are relaxed and temperature is falling. The other pig was not so treated. After 4 minutes of halothane inhalation, muscle rigor has commenced, causing a characteristic extension of the hind legs. This is accompanied by an increase in rectal temperature. (From Harrison [51] .) 
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lene sodium effectively terminated the syndrome (Fig. 14). These 
findings, now confirmed in Poland China swine [l, 37] and Pietrain 
pigs [42], have yet to be applied to humans, such application having 
been prevented by the lack of a suitable intravenous formula for 
clinical use in humans. Development of a lyophilized form of the 
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FIGURE 14. Temperature (deep muscle) and events chart showing in 
vivo termination by intravenous dantrolene of the established MH syn-
drome provoked by exposure to halothane in Landrace swine. Dantrolene 
administration commenced at the 51st minute coincident with the left 
margin of the block so marked. The presence of rigor was recorded as ex-
tension of hind limb. Biochemical values recorded were from mixed venous 
blood. (From Harrison [50].) 
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water solubility, and the results of the first clinical trials may be 
known by the time this issue is published. If dantrolene can be shown 
to act in man in the same manner as in the pig, we need no longer 
fear MH. We will have at our disposal the means to prevent it and 
cure it. 
I want to conclude this chapter with a brief consideration of how 
present knowledge on the action of dantrolene sodium may affect 
our ideas about the pathogenesis of the syndrome of MH. Considera-
tion of the effects of dantrolene in vivo on muscle twitch responses 
and caffeine contracture led Ellis and Carpenter [27] to suggest 
that dantrolene acts on the trigger Ca++ mechanism of excitation-
contraction coupling. This suggestion would conveniently explain 
its apparent specificity of action in skeletal muscle and its lack of 
action on smooth or .cardiac muscle. In skeletal muscle a small sarco-
lemmal Ca+ + flux triggers a large intracellular Ca++ efflux from the 
SR, whereas in cardiac and smooth muscle the sarcolemmal Ca++ 
flux is the large component. Thus a small depression of Ca++ flux 
at this point in the excitation-contraction coupling train would have 
a large functional effect on skeletal muscle, whereas in cardiac and 
smooth muscle a similar small depression would have only an in-
significant effect. If this is so, it implies that an element of sarcolem-
mal defect is at least part of the essential lesion of MH. On the other 
hand, recent work by van Winkel [90] on isolated SR has demon-
strated that dantrolene depresses not only the rate of Ca++ release 
on stimulation but also the total amount of Ca++ released-without 
completely inhibiting such release. In addition, dantrolene had no 
effect on SR Ca++ uptake. These observations not only support the 
central role of abnormal Ca++ flux in the genesis of MH but also 
suggest that the principal defect is situated in the SR. In light of van 
Winkel's findings, the fact that the hyperthermic syndrome is readily 
reversed by dantrolene sodium seems to imply that continued release 
of Ca++ into the myoplasm may be an important factor in the 
genesis of the syndrome. Once this release is effectively stopped, there 
is still sufficient functional ability in the various Ca++ .modulating 
mechanisms to restore the myoplasmic level once more to that which 
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PORCINE MALIGNANT HYPERTHERMIA-THE SAGA OF THE "HOT" PIG 
G.G. HARRISON 
Depal"tment of Anaesthetics, Unlvel"slty of Cape Town and Groote 
Schuul" Hospital Medical School, Obsel"vatol"y 7925, South Africa 
ABSTRACT 
Much of what we undel"stand today of the pathogenesis and 
thel"apeutlc management of the anaesthetic Induced mal lgnant 
hypel"theMnlc syndrome In man fol lowed from the happy chance 
dlscovel"y, approximately twenty years ago, that the well-known 
stl"ess syndrome of swine was a vel"y close facslmlle of this puzzling 
and fatal syndrome In man. In both, the syndrome was genetically 
based, a fact that al lowed fol" the breeding of a val Id animal 
expel"lmental model of human malignant hyperthermla. So extensive 
has been the use of the MHS pig model that today an account of 
pol"Clne hypel"theMnla pel" se would Indeed be the whole story of the 
evolution of oul" present understanding of the human MH syndrome, 
the subject of this book. 
This chapter" confines Itself to 
aspects (If that Is possible) of the 
descl"lptlons and discussions of: 
the more purely porcine 
syndrome. It Includes 
I. The syndr-ome In the pig· including clinical signs, biochemical 
accompaniments and val"latlons In the syndrome. 
2. The Identity of the separately described stress myopathles of 
swine-pol"clne mal lgnant hypel"thermla, pol"Clne stress syndrome and 
pale, soft, exudatlve pol"k. 
3. Modes of lnhel"ltance. 
4. The MHS pig and othel" experimental models of human MH. 
5. Pharmacological trlggerln·g, attenuation, blocking and 
l"evel"sal of pol"Cine malignant hyperthel"fflla. . 
6. Pathogenesis of the vicious cycle of malignant hyperthermla 
in !"elation to the stress syndromes of the pig and man. 
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INTRODUCTION 
"All animals are eQual; only some animals are more eoual 
than others". The pig Napoleon, Animal Farm (George Orwell). 
Of al I the comp I ications of general anaesthesia perhaps the 
most dramatic and indeed frightening is that veritable metabolic 
storm which characterizes the unexpected, in the past frequently 
fatal, syndrome of anaesthetic-induced mal i gnant hyperthermia. 
First described in 1960 in Denborough's et al report (I) (later 
elaborated in 1962 (2)) of a family which displayed an apparent 
hereditary oredisposition to death attributable to general 
anaesthesia, ·this syndrome became definitively characterized over 
the next six years through the reports of Seidman et al (3) and 
those in the Canadian Anaesthetists' Society Journal of September 
1966 (4) which presented the collected experience of six groups of 
authors of eleven cases of this fatal condition. Variously refeM"ed 
to up to this date as "hyperpyrexia", "hyperthermia" or even 
"extreme hyperthermia during anaesthesia", in this publication we 
find this syndrome referred to for the first time as "Malignant 
Hyperpyrexia" (5,6), later changed by common usage to "Malignant 
Hyperthermia" (MH). Since this time little has been added to the 
clinical manifestations we recognize of the syndrome. 
As on so many other occasions In the long history of 
medicine, serendipity now provided the deus ex machine that would 
ultimately help solve this dangerous clinical conundrum-the "hot" 
pig. The possibility that strains of certain breeds of pig might 
serve as a valid animal model of MH was suggested, also In 1966, 
by the observation reported by Hall and co-workers (7) of muscle 
r i gor and hyperthermia in I ittermate pigs, anaesthetized with 
halothane in response to the injection of succinylchollne, followed 
short I y by Harrison and co-workers' (8) report of the same reaction 
but now in response to halothane alone. As with the human cases 
this response appeared to be pharmacogenetic. 
These discoveries were seminal. Today, just less than 
' twenty years later, though the minutiae of the pathogenesis of 
mal i gnant hyperthermia have yet to be elucidated, knowledge that . 
has come from studies worldwide in malignant hyperthermia 
susceptible (MHS) swine has led not only to effective 
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phar-macologlcal contr-ol of the syndr-ome, but also to valuable spin-
offs in many biomedical areas, in par-ticular- those of muscle and 
membr-ane physiology, calcium tr-ansport and kinetics and the meat 
industr-y. 
THE CLINICAL SYNDROME IN PIGS 
The mellgnant hyper-thermia syndr-ome In swine has two 
pr-erequ is i tes: 
1. Possession of the oper-atlve gene or genes. 
2. Exposure to a specific stressor- for an adequate time. 
The specific str-essor-s originally descrlbed-halothane anaesthesia 
alone or succlnylchollne administration during halothane 
anaesthesia-Identified genetically based differing gl"'ades of 
sevel"'lty of lesion and l"'esponse. 
Once established the syndl"'Ome l"'apldly becomes self-sustaining 
and lrr-evel"'slble, continuing Independently of wlthdl"'awal of the 
stl"'essol"' which can be then seen to have acted as a trlggel"' (8, 9) • .. 
Clinical Signs 
The syndr-ome Is manifested by a 
pr-ogr-essive clinical signs togethel"' with a 
changes which Immediately pl"'eCede them ( 10). 
The clinical features Include: 
group of lnexol"'ably 
myriad of biochemical 
I. Cyanosls of the snout and blotchy cyanosls of the skin, most 
marked on the antel"'IOI"' abdominal wall. This blotching dlsappeal"'S 
as the syndl"'Ome becomes established, often "pinking up" befol"'e It 
does so. 
2. Twitching and sporadic fasciculation of muscles, most obvious 
in the thigh, proceeding usually within minutes to pl"'Ogl"'esslve 
extreme rigor of muscle. This rigor causes the limbs, most 
mar-kedly the hind I lmbs, to become rigidly extended. Rarely, rigor 
may hold a limb in flexlon. Trlggel"'ing of the syndl"'Ome by 
succlnylcholine is characterized by extremes of coal"'Se muscle 
fasciculation and myotonia. 
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3. Sinus tachyc:al"dia pl"oceeding often to extr-eme !"ates of the 
ol"del" of 240 beats pel" minute. This is accompanied in the eal"ly 
stages of the syndl"ome by a l"ise in blood pr-essur-e. Cal"diac 
al"l"hythmias, usually of the natul"e of ventl"iculal" tachyal"l"hythmias, 
apoea,. val"iably, sometimes ve!"y eal"ly, at othel"s tel"minally. 
4. An explosive sustained l"ise In COl"e tempel"atul"e. Change in 
tempel"atul"e may be eal"I iest obsel"ved by means of a thel"fflistol" 
pl"obe sited deep in the thigh muscle mass. The rate of temperature 
l"ise val"ies between animals. 
rise of 1°c every five to 
4~S°C ante mol"tem. 
In highly susceptible strains !"ates of 
seven minutes are common, l"eaching 
S. Open-mouthed breathing and hyperventilation. This manifests 
only in pigs allowed to breathe spontaneously. 
within ten to fifteen minutes. 
Biochemical Accompaniments (11) 
Apnoea supel"venes 
The underlying hypercatabolism of the syndl"'Ome and Its 
effects &l"e l"eflected in the conventional indices of ac:id/base, blood 
gas, electrolyte and substl"ate status. Of these, changes obser-ved 
in the first two can be considel"ed diagnostic. These changes In 
biochemical oal"ameters are chal"acterized by a rapid pl"'Ogl"esslon, 
preceding and !"eaching extreme values ahead of the rise In core 
temperatul"e. Profound, l"apidly worsening metabolic acidosis--
lactacidosis-with concomitant rise in PC0
2 
fl"'Om Its buffering, is 
the hal I mark of the synd,.ome. Blood and tissue pH may fall fl"'Om 
7 .4 to 6.8 and lowel" in as I ittle as ten minutes ( 10). The 
hypel"capnia, l"eadily monitor-ed by capnogl"aphy, is the eal"liest and 
most sensitive mal"kel" of initiation of the syndl"'Ome ( 12). 
Capnography, t her-efor-e, should be considered an essential 
monitoring device in the clinical situation in humans. Reduction in 
PaCl
2 
accompanies the acidosis. While this need not be gl"eat, the 
reduction in ?0
2 
of the mixed venous blood is, leading to a gl"eatly 
i ncrea!;ed P(a-V)0
2 
gradient. The A-a gl"adient may also widen 
113), all this in the face of a ma,.ked incr-ease in o
2 
uptake (9,14). 
Rises l"ecorded in al I sel"um electl"olytes, tot a I Pl"'Otei n, 
glucose enc lactate indicate a shift of water into eel Is, a leak of 
+ + 
Na , I( , 
-+ ++ 
Ca , Mg and Pi out, and glycogenolysis ( 11, 14). Of 
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particular- impor-t to the clinical management and prognosis is the ... r-i se in ser-um K . As the syndr-ome pr-ogresses, i ncr-easi ng per-meabi I lty of the ser-colemma is manifest by r-apidly rising ser-um levels of the muscle enzymes cr-eatine kinase (CK) and lactic dehydr-ogenase (LOH) ( 12, 15). Within skeletal muscle the hyper-catabol ic state is mar-ked by· e r-apid fell off in the high energy inter-mediates cr-eatine phosphate (CP) and adenosine tr-iphosphate (ATP) (11,12,15). 
fatal. 
Untr-eated the syndr-ome is inevitably 
Animals per-mitted to breathe spontaneously may die in fifteen minutes. . Ar-tlficially ventilated animals can sur-vive up to forty, even sixty minutes. 
Variations in the Syndrome 
Variations in (I) sensitivity of the trigger-ing mechanism; and (2) r-ate of pr-ogr-ession of the established syndr-ome, occur- In response to envir-onmental, pharmacological and genetic factors. 
Excitement fr-om the stress of manhandling and struggling has e profound effect on both the sensitivity of the tr-lggerlng and the speed of pr-ogr-ession of the hyperthermle crisis and may of Itself spontaneously initiate the syndrome ( 16). Such conditions are the inevitable accompaniment of the conventional barnyard screening procedure for- MH susceptibility viz brief mask anaesthesia with halothane. In these circumstances the syndr-ome may be fired by en exposure to halothane of as short a dur-etion as 30-40 seconds. Skin blotching becomes very marked and muscle r-lgor- occurs almost before the onset of anaesthesia. It ls often difficult to distinguish between the stiff leg of conscious induction str-uggl Ing and the extended leg of muscle rigor---one merges so imperceptibly with the other-. The syndr-ome rapidly becomes Irreversible and dantrolene ( 17) may be needed for- salvage. Highly reactive animals should be carefully observed dur-ing recovery from a halothane challenge for fatal recrudescence of the syndrome can fol low return of consciousness and muscle activity. The same may Indeed occur after initially successful tr-eetment with dantrolene. 
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Sedation with hypnotics, trenquillizing or enxiolytic drugs 
( 18-20) on the other hand, reduces triggering sensitivity end deleys 
l nitietion of the syndrome, though the speed of progression once the 
syndrome Is established, may be uneffected. Varietions in these 
same aspects of the syndrome may also be induced non-speclfical ly 
by other groups of drugs such as non-depolerizing relaxants (21) or 
those which lower blood pressure and perhaps reduce cerdiac output 
and limb blood flow (G.G. Harrison, unpublished). In these 
circumstances triggering of the syndrome by halothane may be 
delayed by as much as 45 minutes or longer or even prevented 
altogether; - - requiring - ultimately the injection of succinylcholine to 
fire the syndrome (vide infra: Triggering agents). 
Genetic fectors are the major determinants of variations In 
the manifested syndrome (22). Though malignant hyperthermia 
susceptibility was originally thought of as something of an 
al I-or-none phenomenon (23), control led breeding experiments have 
since produced phenotypes with graded responses in both the 
sensitivity of the triggering mechanism and thereafter In the rate 
and extent of progression of the established syndrome from what we 
may cal I the hair-triggered "rocket" to the "slow burner" 
(22,24,25). In the case of the former, the syndrome Is fired by 
exposure to halothane alone while In the latter the addition of 
succinylcholine (as was the case with Hall's historic pigs (7)) Is 
necessary. These genetically based variations In resPonse occur In 
all the MH affected breeds-Landrace, Poland China and Pletraln. 
PORCINE STRESS MYOPATHY~PMH. PSS AND PSEP 
Fol lowing its identification It was soon established that this 
Porcine Malignant Hyperthermia (PMH) response to halothane and/or 
succinylcholine, was heritable and could be evoked only In selected 
strains of relatively few breeds of pigs (26). Further, cl lnical and 
biochemicel features of the syndrome were Identical to those of the 
Pm·cine (sudden death) Stress Syndrome (PSS) (27) long recognized 
in the same breeds of pig in resp
1
onse to stress, excitement, severe 
exercise and/or environmental extremes alone (28-30). The breeds, 
worldwide, in which this genetic trait is manifest Include the 
Landrece, Pietrain, Poland Chine and crossbreeds of these strains, 
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all breeds genetically selected for rapid growth, high feed 
efficiency, heavy muscling and high muscle/fat ratios. Ironically, 
the improved profitability of pig husbandry sought through such 
high grade genetic selection has often been reduced by losses 
incurr-ed from the concomitant increased incidence of PSS. For 
example, annual losses of th~ order of 300 million dollars have 
been reoorted in the USA from this condition and PSEP (vide infra) 
(31). 
Also of long time concern to the meat industry and subject of 
much r-esearch is the occurrence of pork with unfavourable meat 
quality in that ·1t is pale, · soft and watery. Studies ·of porl<··meat 
quality in different countries have shown Its presence in as much 
as 20-35% of carcasses (31-33). Variously cal led "wasseriges 
fleisch", "muscle degeneration" or "pale, soft, exudatlve pork" 
(PSEP) (34) It occurs in carcasses which manifest accelerated 
glycolysis with concomitant myolactosis and rapid fall In pH In the 
immediate one to two hours post slaughter (35,36). The pale 
appearance, 
the muscle 
alter-ed textur-e and increased water-holding quality of 
fibre is thought to be due to denaturatlon of the 
sarcoplasmic protein consequent on the low muscle pH while the 
carcass is still warm (37). 
The Identification of these same conditions In association 
with l)oth PSS (27) and the MH syndrome (38) immediately suggests 
that these three separately described syndromes were simply 
manifestations of the same covert myopathy. This hypothesis has 
been amply supported by the demonstration of halothane-provoked 
MH syndrome in stress susceptible swine (28), the PSEP meat 
condition and its biochemical accompaniments post mor-tem in pigs 
dying of malignant hyperthermla (39) and finally the correlation of 
enzyme markers of malignant hyperthermia susceptibility with the 
incidence of PSEP (33,40). 
The inference from this concept that susceptibility to PSS and 
PSEP could now be simply identified, considerably facilitated 
research in the field of pork quality control. By identification of 
susceptible animals at wean I ing stage, progl"'essive pig farmers have 
been enabled to breed out from their herds this undesirable trait. 
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Screening for Malignant HypertheMnia Susceptibility 
The simplest, most practical end reliable screening test for 
MHS remains the cr-ude "barnyarc" halothane challenge, clinical 
observatic.-n of t'"te test animal's response to brief mask halothane 
inhalation-beering in mind the caveat expressed earlier. Animals 
having a degree of susceptibility worth noting for meat Quality 
"breeding out" or laboratory "breeding in" purposes will react with 
skin blotching and muscle rigor within five minutes. 
Of simple blood sampling tests none have proved to be 
specifically diagnostic. Sadly, the variability observed in the 
muscle enzyme markers -of -this_myopathy, even the most specific, 
CK, is such that the level recorded in an individual pig is of little 
diagnostic si gnlficance ( 33, 41). For laboratory purposes 
collaborative diagnostic data may be sought "in vitro" from muscle 
biopsy. These tests (42) are based on identifying and Quantifying 
two abnormalities manifest by MHS muscle: (I) sensitivity to 
caffeine induced contracture; and (2) an increased rate of 
ischaemically induced ATP depletion. They are time consuming and 
not practical for large scale screening of animals. However, 
Ver!:>urg's et al (12) observation of consistently low levels of 
creatine phosphate in MHS muscle may provide the basis for a 
Quicker and more widely applicable screen for animals, especially 
if the method could be miniaturized to assay creatine phosphate in 
needle biopsy specimens. 
Inheritance Patterns 
I nherltance of this readily "in vivo" identifiable myopathic 
trait was thought initially to involve a simple autosomal dominant 
allelic gene, inconsistencies in transmission being explained as 
varying expressivity and incomplete penetrance (7,15,43). 
SubseQuently, planned breeding experiments have produced evidence 
for the existence of two sharply differing modes of inheritance-a 
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Modifice,ions to the concept of a single gene autosomal 
transmission have fol lowed from the nicely graded clinical 
manifestetions of the MH syndrome correlated with "in vitro" muscle 
caffeine and caffeine/halothane responses demonstrated by the five 
MHS ohenotypcs brE"d by Britt and co-workers (24) from Poland 
China (MHS) and Yorkshire (MH resistant) crosses. These 
grade.lions in !'.)henotype response fol lowed from the offspring of 
crosses manifesting response characteristics that were the mean of 
those of the individual parents and not segregating out into groups 
which fol lowed the l"'esponse chal"'acteristics of one or other 
individual parent. The identification of five phenotypes In two 
generations indicated that two gene alleles (et least) must be 
involved and the gradations observed meant that such genes must 
be co-dominant. 
Support for this hypothesis of co-dominance ln porcine MH 
alleles comes from Nelson's et al (25) report of similar graded 
phenotype reactions in first generation MHS (Poland Chine) and MH 
nE"gative mini swine (Pittman-Moore/Hertford) crosses, similarly 
identifiable clinically, with col"'robol"'etlve graded "In vitro" 
halothane and caffeine/halothane contractures. 
Obsel"'ving In addition to graded clinical severity of the 
syndrome, grnded elevations In basal metabolic rate In MHS 
phenotypes, WIiiiams end co-workers (22) also proposed the 
existence of more than one co-dominant gene, but accepted the 
possibility of a strongly modified single dominant gene. Like 
Nelson et al they warn against the validity of accepting the 
barnyal"'d halothane cha I lenge elone in Identifying MHS phenotypes 
in breeding studies end themselves only consider an animal 
completely MH negative when Its response to succlnylcholine 
administl"'ation as wel I es to helothene Is negative and basal 
metabolic rate is not raised. 
The llkellhood of a multlfectorlal Inheritance pattern Is 
further suggested by evidence of cross-linkage of this myopethlc 
trait with other characteristics. Rasmussen and Christian (45) and 
Jorgensen et al (46) l"'eport the association of MH susceptibility with 
only one pol"'cine blood group, the H system. Susceptibility to MH 
occurs in only two of the phenotypes of this complex seven allele 
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system while l"esistance or negative l"esponse is associated with 
three othe,..s. Andersen (47) goes furthe,.. and infers from his data 
a I inkage in Landrace swine of the MHS gene with that for 
phosphohexose i somerase. 
While all the above is compatible with the general thesis of 
autosomal dominant or codominant inheritance, good evidence of the 
antithesis-a recessive pattern of transmission-has also been 
published . 
Eikelenboom and co-workers (48) especially, as well as 
Christian (49) and Ollivier et el (50) have reported from their 
breeding . programs with Dutch Lendrece and Pietra In swine; strong 
evidence of recessive transmission of MH susceptibility, proposing 
the involvement of e single major r-ecessive gene with complete 
penetrence. 
An explanation for the co-existence of two distinct patterns 
of inheritance is not as yet forthcoming. That these differences 
may be associated with breed is obviously not the case-certainly 
in broad terms-for although studies involving the Poland China 
breed have ell evidenced the dominant pattern of Inheritance, both 
dominant and recessive modes have been demonstrated In Landrace, 
Landrace crossbreeds and Pietralns. 
Though intellectually dissatisfying, It seems that for the 
moment we must accept that in swine, as In the human, there are 
two subclinical or covert stress-associated myopathlc states which 
may manifest the malignant hyperthermlc syndrome as the functional 
final common pathway. Considering the subsets of musculoskeletal 
disorder as well as the various overt myopathies and muscular 
dystrophies associated with the susceptlblllty of humans to 
malignant hyperthermia (SI), It is perhaps not surprising that the 
inheritance pattern of MH susceptlblllty in swine has turned out to 
be considerably more complex than appeared at first sight. 
Anaesthetic-induced syndromes . clinically similar to the 
malignant hyperthermia syndrome of swine and humans have been 
described rarely in other species such as the horse (52,53), dog 
(54) and cat (55). In contradistinction to the porcine and human 
syndrome, genetic factor-s do not appear to play an obvious role in 
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the repeatability of the reaction in 
been established ( invariably the 
in other species is discussed by Klein and Rosenberg elsewhere (see Chapter 6), wish to allude briefly here to a common regularly appearing stress-related myopathy in other species which has some superficial resemblance to that of swine though the initiating factors are entirely envir-onmentel and genetic factors appear to play no part. This is the so-called "capture myopethy" of wild animals, in particular-ungulates ( described in nineteen species) and birds (56). Indeed, a similar condition has been observed also in sharks (Thurman, South African Association of Marine Biologists, personal communication). Precipitated by the alarm, stress and extreme muscular- exertion of flight that precedes the darting, sedation, immobilization and capture of wild game, the syndrome presents as shock, prostration, muscle stiffness ("spastic paresis" is another name) with moderate hyper-thermia proceeding to coma and death. 
Sharks, taken I Ive but exhausted from entanglement In beach protection nets and released In aquaria, swim with ever Increasing muscle stiffness until completely Incapacitated. 
The principal biochemical derangement In all these species Is a pr-ofounc lactacidosis which together- with raised serum levels of muscle enzymes, CK, LOH, alanine amino tr-ansfer-ase (ALT) and asoar-tate amino tr-ansfer-ase (AST), point to the initiation of enaer-obic metabolism in muscle and membrane damage (57). 
Skeletal muscle lesions very similar to those of PSEP appear post mortem. Once induced, the mortality from this syndrome, as is that 
from PMH, is exceptionally high-rates of up to 100% of affected animals having been reported. For this reason an under-standing of the syndrome and Its prevention Is now of enormous Importance for 
game conservation as attempts at capture of remaining nuclei of rare species for relocation or restocking can well be, and indeed h!!!ve been, rendered abor-tive by this unacceptably high mor-tallty rate. Fortunately, the steps in the reaction chain lack the extreme run-away character-istics of the por-cine syndr-ome. Adequate sedation by a var-iety of tranquillizer-s or- anxiolytics, if achieved 
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with a min imum of elarm, stress end pursuit, prevents the 
condition. Harthoorn's demonstration (58) that control of the 
acidosis alone with sodium bicarbonate will abort the established 
condition, as wet I as being of great practical importance indicates 
that in all probability the pathogenesis of this condition differs 
fundamentally from the PSS it superficially resembles (vide infra 
Pathogenesis). Further understanding of this condition and its 
relationship, if any, to PSS must surely fol low from observation of 
the effect!' of halothane and succinylcholine on stressed and 
unst.-essed animals, as wet I as from the effects of dantrolene on the 
established condition (doubtless a very expensive exercise). But 
all this is still for the future. 
MODELS OF MALIGNANT HYPERTHERMIA 
Proposed in 1968 as an animal model for the study of the MH 
syndrome in man (8), use of the MHS pig has stood the test of 
time. With few exceptions, all the features of the syndl"'Ome 
observed in man-clinical, biochemical and ultracellular-have been 
documented in susceptible swine and vice versa. Some differences 
there may be but, being largely quantitative rather than 
qualitative, they do not appear to be fundamental~ 
The clear association of the porcine syndl"'Ome with stress, 
both psychological and environmental, was once held to distinguish 
it frorr. human MH. This distinction has since been rendered 
considerably less clear by Winger-d's (59,60) identification of 
instances of unexpected sudden deaths in famll ies of MH probands 
as exemolifying a "Human Stress Syndl"'Ome". 
Another difference that has been postulated twixt MH in pig 
and man stems from differences recorded in levels of serum Ca++ 
observed at various stages of the syndl"'Ome (II, 61). However, as 
levels recorded by various workers have been very variable, a reel 
systematic difference is difficult to sustain (Si). 
Wliiie i n the most reactive, animals the trigger mechanism-
bein9 responsive to environmental as wet I as pharmacoiogic 
act i vation-may be regarded as more sensitive than in man, not al I 
the drugs associated in man with initiation of the syndrome have 
been demonstrated to fire the syndrome in the MHS pig. This may 
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wel I be because the association of pal"tlcular dl"ugs with the tl"iggel"ing of MH In man is lal"gely anecdotal usually involving gl"eatel" or lessel" degrees of the polypharmacy of clinical anaesthesia, whereas in the pig model dl"ugs can be deliberately tested singly. However, as MHS humans have been shown to develop 
the syndrome in response to a 11 the dl"ugs demonstrated to tl"igger MH in susceptible swine, this model does provide a useful positive screen fol" dl"ugs that would be potentially harmful to the MHS 
human. 
In using the MHS pig model, especialfy_ .. for -dl"ug screening, 
it is impol"tant that the caveats previously expressed (vide supra Variations In the syndrome) be observed If misleading, even spurious, l"esults are to be avoided. 
phenothiazine and · · neuroleptlc drugs 
propel"ties ( 19, 20) is an example of 
The conclusion that certain 
deductions wel"e based on animal 
displayed MH 




times of minutes only. Experimental protocols should be so designed that dl"ug induced attenuation or delay in onset of MH can be clearly distinguished from MH blocking or prevention. Uneventful exposure 
to halothane of adequate duration, sixty to ninety minutes, terminated by an MH free succlnylchollne challenge Is necessary 
before true MH blocking properties be attributed to any drug. (vide Infra Triggering, Attenuation, Blocking and Reversal). 
Othel" animal models of MH both "in vivo" and "In vitro", based primar-i I y on two concepts of Its pathogenesis, have been 
proposed. The first of these sought to give experimental expression 
to Wilson and co-worker-s' (62) proposal that "·· .this explosive ther-mal idiosyncracy" was due to "some disturbance of biological oxidation, possibly uncoupling of oxidative phosphorylation". 
Dinltr-o::,henol pretr-eated dogs (63) and rats (64) were utilized to 
study helothane induced or- exacerbated uncoupling of oxidative phosphor-ylation. This mechanism, and thus model, was soon discounted by the demonstration of sever-al wor-kers (10) that mitochondl"ia isolated from ~~HS muscle, both por-clne and human, display nol"mal l"espil"atol"y control and that halothane induced depression of NAO linked substr-ate metabolism is no different in MHS 
OI" nol"mal muscle. 
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The second mor-e r-elevant gr-oup of animal models Is based on 
Kalow and co-wor-ker-s' (65) ear-ly fundamental obser-vations that 
muscle fr-om sur-vivor-s fr-om MH was mor-e sensitive "in vitr-o" to caffeine induced contr-actur-e · than nor-mal muscle, a sensitivity enhanced by exposur-e to halothane; obser-vations that car-r-ied with 
them the infer-ence that the functional lesion of MH was a ++ caffeine-like distur-bance of SR Ca flux. This was given fur-ther 
expr-ession by the demonstration 'in vltr-o' that muscle strips fr-om 
labor-ator-y animals including fr-ogs (66) and r-ats (67) pr-etr-eated 
with subcontr-actur-e pr-oducing concentr-ations of caffeine r-esponded 
to halothane and indeed other MH tr-igger-ing dr-ugs In a manner 
similar to MHS muscle. 
vivo" in the r-abblt (68). 
su i tab I e scr-eens for- the 
These conditions wer-e pr-oduced also "In 
These models wer-e pr-oposed inter- alla as 
MH tr-lger-ing or- blocking potential of 
dr-ugs. The caffeine-like effects of r-yanodine wer-e also used to 
gener-ate models of MH both "In vivo and vitr-o" (69) but these wer-e 
I ess successfu I • 
Lastly, the myotonic/hyper-pyr-exic r-esponse of domestic 
poultr-y to succlnylchol ine which has been shown to be blocked by 
the same dr-ugs that attenuate MH (70) has also been pr-oposed as 
constituting a suitable MH dr-ug scr-een. 
However, none of these models can be said to emulate the r-eactions of human MH as accurately as does the MHS pig. At best 
they may each be said to mirror some fragment, and some fragment 
only, of the MH r-esponses. As such one must question their 
r-elevance. 
Anaesthesia for- the MHS Pig 
The conventional method of Inducing anaesthesia In the pig 
for- laborator-y pr-ocedul"'es, I.e. physical r-estr-aint followed by the 
injection of thiopentone into an ear vein, car-ries with It the risk 
that, in the most sensitive MHS str-ains, the physical manhandling and str-uggle necessar-y to achieve, this may initiate MH. This may 
be avoided by the pr-eliminar-y intr-amuscular- Injection-into the 
dor-sal muscles of the neck--of ketamine 10 mg/kg, a pr-ocedur-e . that r-equir-es a minimum of manhandling or skill. Within five minutes the Rnimal will be l"'eCumbent and unr-esponsive, allowing easy 
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access to ea!" veins. It must be allowed that we have not found 
ketamine to be a particularly suitable anaesthetic in the pig fol" 
genel"el surgical procedures 
Gene,-el enaesthesia is then 
but. fol" this purpose it serves well. 
induced with thiopentone (up to 10 
mg/kg), endotl"acheel intubation is performed and IPPV with nitrous 
oxide/oxygen (Fto
2 
0.3) instituted. Thereafter anaesthesia is 
maintained with nitrous oxide and oxygen supplemented by 
intermittent thiopentone as required. 
temperature monitoring ar-e established. 
ECG and intramuscular-
Ar-ter-ial and venous access 
fol" artel"ial and venous pressure and biochemical monitor-Ing as well 
as drug and fluid administr-ation are achieved by means of jugulal" 
vein and car-otid . ar-tery canulation. If the time taken for-
establishment of the planned exper-imental protocol or- for achieving 
steady state conditions is prolonged, in or-de!" to avoid the MH 
attenuating effects of lar-ge doses of thiopentone (vlde Infra) Its use 
is discontinued to be replaced by continuous infusion of etomidate 
(O.S-1 .0 mg/kg/minute). At the conclusion of the experimental 
procedure the endotracheal tube is left In situ with the pig 
breathing spontaneously until It Is conscious once more. 
THE PHARMACOLOGICAL TRIGGERING. 
REVERSAL OF PMH 
Anaesthet lcs 
ATTENUATION, BLOCK ING AND 
Trigger-ing of anaesthetic Induced MH In susceptible swine Is 
a propel"ty displayed by potent volatile anaesthetics only. 
Intravenous anaesthetics not only fall to initiate the syndl"Ome but 
in many instances modify, even block, Its onset In response to the 
active volatile agents. 
Although the volatile egents most ective in the MHS pig 
include the halogeneted alkanes end ether-s, no con-elation of their-
activity es tr-19gers of MH is evident with eny physical 
charactel"istic-solubilities, verious par-tition coefficients or MAC 
values. Prompt initiation of the syndrome in susceptible swine 
follows theil" exposure to halothane, chloroform, enflurene (10), 
i sofl urane (G.G. Harrison, unpublished), and sevoflurane (71). 
Fluoroxene and cyclopr-opane have been documented as weak and 
inconsistent triggers ( 10). Howeve,-, not all of the conventional 
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inhalational anaesthetics have been shown to act as triggers of MH 
in susceptible swine. Strangely, methoxyflurane (MOF) as well as 
trichloroethylene, diethyl ether and nitrous oxide have failed to 
initiate the syndrome In exposed animals. Each of these, 
r.,articularly MOF, has been documented as triggering MH In man 
(72). 
Triggering of MH in swine has not been ascribed to any of 
the conventional intravenous anaesthetic agents, Including ketamlne. 
On the contrary, one, the steroid, althesln (73), administered as a 
continuous infusion, blocks Initiation of the syndrome In response to 
halothane alone, while another, thlopentone, slows and attenuates 
its onset (18,21). In neither circumstance Is the trigger action of 
succinylchollne affected. Surprisingly, the water soluble analogue 
of althesln, minaxolone (74) has no similar attenuating effect. 
Somewhat out of I ine with other Intravenous agents is 
etomidate (75) which, a recent report alleges, enhances speed of 
onset and progression of the halothane Induced syndrome though 
itself is not a trigger. 
Muscle Relaxants 
Of the relaxant drugs tested In MHS swine, It Is the 
depolarizing dr1:1gs only-succinylchollne and decamethonlum-that 
have been shown to trigger MH. In the most sensitive MHS strains, 
those that respond with MH to halothane alone, succlnylchollne 
alone is also a potent trigger though two pulse doses may be 
necessary (23). In the less sensitive strains that fall to respond 
with MH to halothane alone, succlnylchollne acts as the specific 
additive stressor to trigger MH though alone It, too, falls to fire 
the syndrome ( 10). In these circumstances triggering of the 
syndrome appears to depend on the widespread endplate 
depolarization with resultant Induced muscle contraction, because If 
this is blocked by preliminary administration of a non-depolarizing 
relaxant the syndrome falls to develop (76). 
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A corollary of this action of succinylchollne would appear to 
be the triggering of the syndr-ome in sensitive strains by excitement 
and exercise alone, as is also the exercise-mediated reduction In 
response time and increase in the severity of the syndr-ome in 
response to halothane (16,28). 
Of the non-depolarizing muscle relaxants, none have been 
documented as triggers of MH in swine with the possible exception 
of pancuron i um. There Is one report of the apparent precipi tatlon 
of MH by th;s drug which is Invalidated however by the concomitant 
use of halothane (77). Further It has not been - confirmed by other 
workers ( IO) • 
Atracurium, the non-depolarizing relaxant that dlffer-s 
markedly fr-om others In Its mode of biodegradation, has also now 
been screened In MHS swine (78, 79) and shown to lack any MH 
triggering potential. 
In contrast to their blocking effects on 
succinylcholine-lnduced MH, non-depolarizing r-elaxants do not 
prevent Initiation of the syndr-ome by the potent volatile 
anaesthetics. Some do attenuate or delay onset of the syndr-ome. 
In particular, attenuation of haiothane-lnduced MH by pancur-onlum 
(21, BO) has led to Its being recommended as the muscle relaxant of 
choice In both MHS animals and man (81). 
Attenuation, to the extent of prevention, has been claimed 
for the pre-administration of metocurlne (82) though examination of 
the documented results validates attenuation only. 
Catecholamines 
Induction of MH by stress, fright and severe exercise 
immediately calls in question the part played by catecholamine 
response. The answer-s are still far fr-om clear cut. Early on the 
Bristol group demonstrated that Iner-eased levels of circulating 
catecholamines accompanied induction of MH In swine (83). 
Thereafter they reported initiation of the syndr-ome In response to 
the infusion of alpha adrenergic agonists (84) and the converse, 
the prevention of MH in susceptible animals by alpha adrenerglc 
blockade (BS). Williams and co-workers (29,31) have consistently 
and vigorously proposed circulating nor-epinephrine as the· key 
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triggering agent, yet the Bristol group could Induce MH In 
susceptible Pietralns with Infusion of epinephrine only In the 
presence of beta adrenerglc blockade (84). 
At the same time there is lncontrovertable evidence that the 
biochemical merkers and muscle rigor of MH can be Induced In 
isolated perfused muscle (86) and "In vitro" in muscle strips (87) 
in the absence of any catecholamine intervention. This 
circumstance was nicely II lustrated by Gronert's et al (88) 
demonstration "In vivo" that total sympathetic denervatlon failed to 
block Initiation of the syndrome with no accompanying rise In 
catecholamines and the converse that dantrolene blocked Initiation 
of MH In response to a stressor but not the accompanying rise In 
the circulating catecholamines. 
While It is most likely that the surge of catecholamines that 
accompanies Initiation of MH Is a secondary phenomenon which plays 
an ampllfylng role, a primary triggering role for the catecholamines 
Is possible If their effects on skeletal muscle (89)-,-factlttatlon of 
prejunctlonal acetylchollne release, amplification of glycogenolysls 
energy transduction and 3/5 cycl le AMP mediated change In the rate 
++ of SR Ca uptake-are considered In the I lght of present concepts 
of pathogenesis (vlde Infra). 
Calcium Channel Blocklng Drugs 
Of the many factors Involved In the pathogenesis of MH, 
evidence of sarcolemmal dysfunction Involving halothane-lnduced 
depolarization (90) and increased calcium permeability (91-93) has 
led to the postulate that calcium channel blocking drugs might be 
effective therapeutically or at least prevent or attenuate Initiation 
of the syndrome by halothane. 
Indeed, In the case of verapamfl (92) and dlltiazem (94) 
some in vitro evidence does appear to support this hypothesis. 
However, later studies In vivo In MHS swine fafled to show 
therapeutic effect for any calclum channel blocking drugs. Gallant 
et al (95) clearly demonstrated that verapamll has no therapeutic 
or prophylactic effect. 
study in this author's 
These observations were supported by a 
laboratory (96) which showed that In 
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addition to verapamll, other calcium channel blocking 
drugs-nifedipine, diltiazem, nisoldipine and flunarazine-also 
lacked any therapeutic effect on the established MH syndrome. 
However, in the latter study, nifedipine and diltlazem were 
shown to manifest the property of blocking and attenuating, 
respectively, halothane initiation of the syndrome. While dlltlazem 
merely delayed the time of onset of MH In response to halothane, In 
the case of nlfedlplne attenuation was of an order that prevented 
onset of the syndrome in response to halothane for the planned 
sixty minute period of exposure in 36% of animals and markedly 
delayed the onset in the remainder. 
These effects were achieved only with doses far In excess of 
the human therapeutic dose. 
Negative Responses of Note 
Besides drugs that trigger MH In the MHS pig model, 
relevant to comment on some that unexpectedly do not. 
It Is 
Such 
observations bring in question past strictures placed on the use In 
the MH syndrome or MHS patients of certain drugs-strictures based 
originally on anecdotal clinical association ("personal 
communication" and "unpubll.shed" data) backed by theoretical 
considerations of the effects of such drugs on membrane Ca++ 
fluxes. 
An Important example of such negative response Is that now 
reported to amide-linked local anaesthetic drugs. The use of this 
group of drugs, perhaps the most widely used local anaesthetic 
agents in clinical practice and In many hospitals the only local 
anaesthetic agents available, has long been regarded as 
contra-indicated In the MHS patient. Such strictures are now called 
in question by the demonstration by two groups of workers (97, 98) 
that the intravenous Infusion Into the MHS pig of lldocalne and 
bupivacaine, up to monitored toxic levels failed to trigger the MH 
syndrome. This negative response indicates that this important 
group of drugs, in conventional doses, is safe to use In the MHS 
patient. 
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Digitalis, equally long claimed as deleterious in the MH 
syndrome and contra-indicated In the MHS patient, is another such 
drug. Gronert et al (99) have screened digitalis In the MHS pig 
model supported by cardiopulmonary bypass to obviate its 
cardiotoxic effects. In this model digitalis infused to the 
supratoxic levels of 61 ng/ml failed to stimulate any increase In 
whole body metabolism or by inference that of skeletal muscle. In 
the same preparation calcium chloride too, Infused to serum levels 
in excess of 15 mEq/L, similarly failed to trigger the syndrome. 
Blocking and Reversal 
In considering specific pharmacological r-ever-sal of the 
established syndrome In the MHS pig-the bottom line In terms of 
human ther-apy-two drugs only, procaine and dantrolene war-rant 
consider-ation. The action of each In these clr-cumstances suppor-ts 
Kalow's original broad hypothesis (65) of the centr-al role of 
increased myoplasmic Ca++ Ion flux In the genesis of MH. 
Procaine, the classical Inhibitor "In vltroll of caffeine 
induced muscle contracture, was ear-ly shown "In vivo" to block 
initiation of MH in the MHS pig by halothane (76). For- ~this effect 
I arge doses were necessary. Along with all the other- dr-ugs to 
which attention has been drawn for- demonstrably attenuating onset 
of the syndrome In response to halothane, procaine also failed to 
prevent triggering of MH by the administration of succlnylchollne 
additional to halothane though It did modify this reaction. If 
administered in large doses early in the progress of the established 
syndrome, procaine has been documented as terminating It (100), an 
act i on su;:,oorted by similar "in vitro" action on halothane Induced 
muscle contracture (87). In spite of the disappointing Inconsistency 
of this reaction documented in the MHS pig (101,102) and the fact 
that large doses with gr-ave cardiac negative lnotropic effects were 
required, procaine did acquire a history of successful therapeutic 
use in MH in humans (61). 
Dantrolene, a drug which reduces the rate and total amount ++ of SR Ca release on appropriate stimulus (103) is the only . drug 
to have demonstrated the property of blocking both halothane and 
halothane/succinylcholine induced MH "in vivo" in the MHS pig (17). 
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Moreover- it is the on I y drug to date to reverse the es tab Ii shed MH 
syndrome consistently, . even If administered fairly late in its 
progress. Like the "turn-on" Qua I ity of the triggering mechanism 
of MH, dantrolene's action on the established syndrome and all its 
biochemical accompaniments "in vivo" has all 
attributes of e switch ( 104-107). 
the "turn-off" 
PATHOGENESIS-THE VICIOUS CYCLE 
The physical and biochemical events that characterize MH are 
witness to the induction of a profound hyperc:atabolic -state in 
skeletal muscle which continues inexorably until total substrate 
depletion ( 10). 
The fundamental lesion responsible is functional and in Its 
simplest terms cannot be better described than It was in 1970 by 
Kalow et al (65), "· •• an Inborn error in skeletal muscle which 
renders the muscle susceptible to disturbance in intracellular 
calcium distribution". In short, control of the myoplasmlc flux of 
++ excitation-contraction coupling Ca Is abruptly lost, resulting In 
I . [C• ++] b . I d d I the cytoso rc .. erng susta ne at contracture pro uc ng 
levels. Drugs such as caffeine which serve to raise myoplasmlc 
++ [Ca ] enhance this process, while those such as dantrolene and 
++ procaine which serve to lower cytosollc [Ca J counteract the rigor 
and lead to survival. 
Brief consideration of the role of calcium In muscle 
excitation/contract ion coupling and energy transduct Ion ( 108) 
indicates that membrane dysfunction, genetic or drug induced, at 
any or all three sites-the sarcolemma, 
mitochondria-could cause the postulated rise 
the SR or the 
in myoplasmlc Ca++. 
The extensive investigations that have been undertaken Into these 
functional domains, together with the insight they give into the 
pathoohysiology of malignant hypertherml~ are discussed elsewhere 
in this volume in chapters by Britt ( Chapter 2), Cheah 
( Cha;,ter 3) and Nelson (Chapter 4). 
However, to complete the picture here of PMH, PSS and Its 
reultant PSEP and perhaps to distinguish it from capture myopathy, 
it remains necessary to summarize briefly the MH cascade to 
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i,-,.eve,.sibility and, in pa,-ticular, the r-ecent wo,.k which brings us 
a little closer to an unde,-standing of the t,-igge,. mechanism 
(Figure I). 
Though it has long been established that physiological 
++ 
cont,.action of skeletal muscle is elicited by Ca released from the 
SR and the molecufa,- mechanisms of how the released Ca++ triggers 
off the contractile reaction-the troponin/myosin/actin interaction-
have been fairly well worked out, the mechanism by which calcium 
is r-eleased from the SR is the least understood part of the entire 
se,-ies of events through which spread of an action potential In a 
muscle eel I leads to contraction ( 109). 
Following Bianchl's proposal that the coupling of T tube 
depolarization to SR Ca++ release was by means of "trigger calcium" 
possibly released from sarcolemmal sites, Endo (109) and Ford and 
Podalsky ( 110) independently identified a mechanism of Ca++ induced 
SR Ca++ release. This mechanism was demonstrated In both skeletal 
and cardiac muscle. As the threshold cytosolic [Ca++] for 
-7 -5 contraction in skeletal muscle was 6-9 x 10 M peaking to 10 M at 
peak twitch while the threshold of Ca++ Induced Ca++ release · was 
I0-4M, they concluded that the mechanism did not play a primary 
role In normal physiological contraction of skeletal muscle and 
possibly constituted an independent calcium channel. However, the 
mechanism did appear to be relevant In the excitation/contraction 
coupling of cardiac muscle. 
Consideration of the factors which affect Ca++ induced Ca++ 
release suggested a strong relevance for this mechanism In the 
genesis of MH. Of the physiological variables, Mg++ was 
++ ++ 
paramount-Ca induced Ca release being inversely and Its 
thr-eshold positively correlated ( 111). The action of caffeine-
enhancement of twitch response progressing with Increasing 
concentration to contractur-e-as wel I as halothane-enhancement of 
muscle twitch-wer-e both shown to result from an enhancement of the 
Ca++ induced Ca++ release phenomenon. On the other hand 
inhibition of Ca++ induced Ca++ release with a rise in Its threshold 
was shown to be the basis of the classical caffeine Inhibitory 



















FIGURE 2. Dependence of Ca++ release from SR on free [~++] In 
nOMnal (open symbols) and MH (closed symbols) fibres at ~C. 
Without halothane: circles (n-4-11) ++ 
With 0.011 halothane (v/v) applied during Ca Induced Ca++ 
release (n=22-5) 
Mean and SE shown. 
•p 0.05 
(From Endo et al., reference 112, with pennlsslon). 
Endo's group have now reported from studies of human MH 
muscle (112) corroborative evidence of the Involvement of Ca++ 
induced Ca++ release in the genesis of MH. They have demonstrated 
that muscle of a human MH patient displayed a lower threshold for 
Ca++ induced Ca++ release than normal and In addition, a greater 
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++ ++ max i mum rate of Ca release at optimum [Ca ). Confirmatory 
f i ndings from studies in MHS pig muscle are reported by Do Han Kim 
and co-workers (113). 
The higher sensitivity of the Ca++ induced Ca++ release 
mechanism of MH fibres compared 
greater maximum rate of Ca++ 
with normal, together with the 
I • [Ca++] . re ease at optimum 1s 
illustrated in the Figure from Endo's report (Figure 2). 
was shown to enhance this effect. 
Halothane 
Of great interest in explaining many of the vagaries of the 
triggering of MH by various stressors as wel I as factors that 
provide attenuation of the response, 
calculation of simultaneous SR Ca++ 
are 
uptake 
the results of Endo's 
and release rates In 
r-elation to cytosollc [Ca++]. These showed that even in 
enhanced Ca++ induced Ca++ release, 
circumstances of moderately 
such as in normal fibres under the influence of halothane or even 
MH fibres without halothane, Ca++ uptake rates were substantially 
++ greater than release rates. This ensured that even when [Ca ] 
was increased by release through channels other than those of Ca++ 
induced Ca++ release, eg. by depolarization, the rate of SR Ca++ 
++ uptake was still adequate to return myoplasmlc [Ca ] to resting 
levels. Whereas in MH fibres Influenced by halothane, the rate of 
Ca++ induced Ca++ release exceeded the rate of SR uptake 
throughout most of the [Ca++) range so that net Ca++ release 
++ proceeded spontaneously to levels of [Ca J that produced 
contractul"'e. Ful"'ther, in circumstances of enhanced Ca++ Induced 
Ca++ release It is not difficult to imagine cll"'Cumstanees In which 
the balance between rates 
even unstable, 
of uptake and release are finely 
so that any further- increase in [Ca++] 
balanced, 
produced by other factol"'s such as succlnylchollne induced 
depolarization or even severe exercise, could provide the positive 
feedback loop to tip the balance to contl"'acture (Figure 3). 
The concept that the primary genetic abnol"'fflallty which 
chal"'actel"'izes susceptibility to . MH lies In the domain of SR Ca++ 
release mechanisms, fits well with the obsel"'Ved action of .dantrolene 
viz that it depresses both the rate and total amount of SR Ca++ 
released in response to a stimulus yet has no effect on SR Ca++ 
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[ Ca2• J ( M) [ c.,. J ( .. ) 
++ FIG~ 3. Left - dependence of+r.ate of Ca uptake, U, and that 
of Ca release, R, on free [Ca ] In a model system. (See Ref. 
109 for calculatlons.) 
Right - demonstration of pc,sslble existence . In MH m~ under 
certain clrcum,nances of three crossover points between Ca uptake 
rate and Ca release rate which may explain succlnylchollne 
induced aggravation of MH. 
Lowest and highest points are stable. M~dle point repreeents 
unstable state, from which departure of [Ca ] In either direction 
wll~roceed further untll stable point Is reached. An Increased 
[Ca ] concentration wlll result In sustained contracture. 
(From Endo et al., reference 112, with permission). 
that fol lows administration of this drug Implies continuing SR Ca++ 
release 8$ the kP.y factor in its genesis. Once terminated, the 
function of other Ca++ modulating mechanisms ls adequate to restore 
[c .++) rr.yoplasmic .. to resting levels, permitting muscle relaxation 
and termination of the syndrome. 
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In addition to this primary mechanism other factors of note 
that serve to swell the cascade to lrreverslblllty are (Figure I): 
I. Acid Inhibition of SR Ca++ transport (115), an event 




++ Thermal inactivation of Ca /actomyosln control mechanisms, 
event enhanced by ATP depletion (117); 
Abnormalities manifest by MHS swine: 
++ a) reduced mitochondrial Ca accumulating ability (118); 
b) Increased anaerobically Induced mitochondrial Ca++ 
efflux (119); 
c) decreased hepatic gluconeogenesls rate (120). 
In these terms the variations of the MH syndrome both In the 
sensitivity of triggering and the rate of progression In response to 
genetic, envlronmental and pharmacologlcal factol"'S can be simply 
conceptualized as reflecting Inherent variations In the threshold and 
magnitude of Ca++ induced Ca++ release phenomenon based In Its 
turn possibly on an SR structural abnormality. 
In slaughter animals susceptible to MH, 
myoplasmlc [Ca++] due both to anaerobically 
post mortem rise In 
depressed SR Ca++ 
uptake and Increased mitochondria! efflux (greater than normal In 
MHS animals) exceeds the threshold of the abnormal Ca++ Induced 
Ca++ release mechanism which then provides the milieu for the 
excessive and rapid glycolysls and lactacldosls essential for the 
production of PSEP. 
Attention has been drawn to the superficial resemblance 
capture myopathy bears to this porcine stress myopathy. It was 
noted, however, that whl le an end stage vicious cycle was 
apparent, It could be Interrupted by simple control of the acidosis 
alone. Such observation would not support the presence In this 
case of an abnormal Ca++ lduced Ca++ release mechanism. Acid 
inactivation of SR Ca++ transport In response to the severe 
lactacidosis of excessive muscular activity, together with the effects 
of raised circulating catecholamine levels, appears to provide an 




Since its original i dentificatlon, elucidation of the 
pathogenesis of this frightening, yet fascinating, originally 
irreversible and fatal, hypercatabollc state that Is Malignant 
Hyperthermia, has provided an ongoing stimulus for research by 
investigators from the whole field of biomedical sciences from the 
clinical anaesthetist to the membrane chemist, from the veterinary 
scientist to the geneticist. 
The story recounted In this volume of the development and 
progression of knowledge and ideas in these various areas, from 
identification of muscle as the site of the lesion and abnormal SR 
Ca++ release mechanisms as a basis of the vicious cycle, to calcium 
flux depressant drugs as therapy, Is an exciting history. Much 
indeed has been a gift of "pearls fr-om swine". 
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Gaisford G. Harrison 
Malignant hypertherrnia (MH) is a covert pharrna-
cogenetic myopathy which incommodes the sufferer 
little, if at all, in the normal course of events but, in 
response to exposure to general anaesthesia, manifests 
in the susceptible individual as a life-threatening 
syndrome of muscle hypercatabolism and rigor, accom-
panied by a rapid and inexorably progressive rise in 
body temperature to extremes of the order of 42°C. 
Untreated, this syndrome is invariably fatal. Its rapid 
progression to irreversibility, in spite of withdrawal of 
the original stimulus, characterizes this 'hypertherrnic' 
syndrome as 'malignant'. 
History 
This condition was first recognized in 1960 in Australia 
by Denborough and Lovell (1960) (Denborough et al., 
1962), who described it as a fatal reaction to anaesthetics 
which showed the hereditarv characteristic of autosomal 
dominant transmission. MH was recognized indepen-
dently and contemporaneously in the USA by Locher, 
but the evidence was published only much later 
(Henschel and Locher, 1977). As a clinical entity the 
syndrome gained definite shape from descriptions of 
cases by Ruttle (1962), Saidman, Harvard and Eger 
(1964) and finally by several authors in the September 
1966 issue of the Canadian Anaesthetists' Society Journal 
(Multiple authors, 1966). 
Few, if any, cases of this syndrome, as here defined, 
were reported before 1960. Perhaps the explanation lies 
in the introduction into clinical practice in the late 1950s 
of suxamethonium (succinvlcholine) and halothane, the 
two agents subsequently shown to be the most 
potent-almost specific-agents for triggering MH. 
Much of our knowledge is based on the chance 
discovery of the 'hot pig' (Harrison, 1979). 
The possibility that strains of certain breeds of pig 
might serve as a valid animal model of MH was 
suggested by the observation, in litter mate pigs 
anaesthetized with halothane, of muscle rigor and 
hypertherrnia in response to the injection of suxametho-
nium reported by Hall and co-workers (1966); thereafter, 
Harrison and co-workers (1968) reported the same 
reaction but in response to the administration of 
halothane alone. 
This MH response in pigs, later identified with the 
porcine stress syndrome, was shown to be heritable, 
confined to selected strains of a few breeds (Landrace, 
Pietrain and Poland China) and to mirror the human 
reaction in every way. Syndromes clinically similar to 
the MH svndrome of swine and humans have been 
described -rarely in other species such as the horse 
(Klein, 1975; Waldron-Mease and Rosenberg, 1979), dog 
(Short and Paddleford, 1973) and cat (De Jong, Heavner 
and Amory, 1974). In contradistinction to the porcine 
and human syndrome, genetic factors do not appear to 
play an obvious role in these biological curiosities. 
Epidemiology 
The MH sundrome, though rare, occurs world wide in · 
most broad racial groups, its incidence displaying a 
40-fold range from 1: 5000 to 1 :200000 depending 
demographically on the gene pool (Table 1). However, 
the natural historv of the condition is such as to defeat 
all attempts at establishing the true incidence of MH 
susceptibility (MHS). Thus MH is not an 'every time' 
phenomenon-one-third to one-half of MHS patients 
give a history of previous reaction-free general anaes-
thesia (Halsall, Cain and Ellis, 1979; Kalow, Britt and 
Chan, 1979)-a circumstance that must lead to an 
underestimate of the true incidence, while gene 
isolation in small communities may produce the reverse. 
Whilst no age group can be said to be exempt (Britt, 
1985), the syndrome manifests most commonly in the 
second decade, seemingly coincidental with the period 
of major growth in skeletal muscle bulk. MH is 
exceptionally rare below the age of 3 and over the age of 
655 
2.33 
656 Malignant hypcrtliermia 




Country and re1rrencc 
Canada and USA 
(Britt. 1985) 
Pacific Basin Japan 
Europe 
(Kikuchi et al. , 1978) 
New Zealand 
(Newson, 1972) 
UK (Ellis, 1981) 
Austria (\'\'alter. 1986) 
Switzerland 
(Kalow et al .. 1979) 










50 years . Although few cases of the MH syndrome 
proper have been reported in the newborn, a gro\.\'ing 
body of evidence points to some association between 
'cot deaths' or the sudden infant death syndrome (SIDS) 
and susceptibility to MH. Recent retrospective studies 
have revealed susceptibility to MH in 30 per cent of the 
parents of victims of SIDS (Denborough, Galloway and 
Hopkinson, 1982; Ording, Rankle,· and Fletcher, 1984; 
Peterson and Davis, 1986). 
The clinical syndrome 
During clinical anaesthesia onset of MH is presaged 
usually by a surge of sympathetic activity (Figure 1). This 
manifests clinically as the sudden appearance of 
unexplained tachycardia and possibly tachyarrhyth-
mias . An accompanying cyanosis (in the presence of 
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Figure 1 Events chart of an illustrative case of MH in a 9-year-old 
girl with congenital kyphoscoliosis, for insertion of Harrington 
rods . Note: onset of tachycardia; progression of syndrome despite 
discontinuance of halothane and institution of cooling, immediate 
response to dantrolene (delay in administration occasioned by its 
being obtained from neighbouring hospital) . Operation 
successfully performed 6 weeks later. Prophylactic intravenous 
dantrolene was given with induction . (From Harrison and 
Chapman (1982), with permission.) 
adequate pulmonary ventilation and inspired oxygen 
concentration greater than 0.3) reflects the immediately 
increased oxygen demand triggered by muscle hyperca-
tabolism. This in tum results in a greatly increased 
carbon dioxide output which, monitored most effecti\'e· 
ly by capnography, provides the earliest evidence of this 
svndrome's onset (Baudendistel et al. , 1984; Dunn, 
Mal~· and Eggers, 1985). Failing this, clinical evidence 
of the event would be hyperventilation in the spon-
taneously breathing patient going on to apnoea and an 
excessivelv hot soda-lime cannister. 
Muscle ·hypertonus or rigor appears in a majority of 
cases (over 80 per cent). This is preceded-if the drug 
has been used-by an exaggerated myotonic response 
to suxamethonium. ln these circumstances the myotonic 
response presents characteristically as masseter ·muscle 
spasm (MMS) which may cause difficulty with tracheal 
intubation. Of itself, MMS is now recognized as reliable 
evidence of the presence of MHS. Onset of the 
syndrome can be prevented or aborted at this point by 
discontinuation of the anaesthetic or change to an MH 
safe technique (see later). Of all patients who manifest 
MMS, 60-70 per cent have been shown to be MHS on 
subsequent diagnostic screening (Ellis and Halsall, 1984; 
Flewellyn and Nelson, 1984a; Rosenberg and Fletcher, 
1986). 
Muscle rigor, though a cardinal component of the 
syndrome, may rarely be absent-the so-called 'non-
rigid' variety of MH. As .muscle rigor and fever both 
result from the same underlying mechanism, it is 
probable that this 'non-rigid' variety of MH represents a 
variation in the chronological presentation of the 
syndrome, rather than in the basic disease process as 
proposed by Kalow, Britt and Chan (1979). 
Pari passu the patient develops a progressive, often 
fulminant, pyrexia. Rates of core temperature rise of l°C 
every 5-10 minutes are not unusual (Steward, 1979; 
Ellis, 1981). Once established, this reaction soon 
cascades into a vicious cycle and continues indepen-
dently of the action of the triggering agent (Berman et 
al., 1970). Untreated, the patient's temperature rises 
inexorably until death supervenes at the extreme of 41°C 
and more. Paradoxically, death from MH may occur at 
normothermia, even mild hypothermia. When trigger· 
ing of the syndrome has been delayed (Beldavs et al., 
1971; Murphy et al., 1984) the patient may well have 
cooled during anaesthesia to 34°C or lower before the 
syndrome has fired. Thereafter death may follow 
cardiac arrhythmia due to the catecholamine surge 
and/or hyperkalaemia which accompany the syndrome, 
before the temperature has risen above normal level. 
Likewise, the onset of the syndrome may be masked by 
induced hypothermia; for example, during cardiopul-
monary bypass (MacGillivray et al., 1986). 
Biochemical accompaniments 
The underlying muscle hypercatabolism and its effects 
are reflected in the conventional indices of acid-base, 
2.33 
blood gas. electrolyte and substrate status. The changes 
recorded are characterized by their rapid progression, 
preceding and reaching extreme values ahead of the rise 
in core temperature (Berman et al., 19i0). 
Profound metabolic acidosis-lactic acidosis-with 
concomitant rise in Pco2 from its buffering, is the 
hallmark of the svndrome. A fall in arterial Po, usuallv 
accompanies this· acidosis . This fall need not be great, 
but, because of excessive muscle oxygen utilization, 
reduction in venous Po2 is disproportionately great, 
leading to the prominence of cyanosis as a clinical sign. 
Elevations are recorded in the serum levels of .all 
electrolytes, total protein, glucose and lactate. These 
indicate glycogenolysis, glycolysis, a shift of water into 
the cells and a leakage of sodium, potassium, calcium, 
magnesium and inorganic phosphorus (Berman and 
Kench, 1973; Verburg et al., 1984). Of all the above, 
gross acidosis and hyperkalaemia are of the greatest 
clinical import. 
As the syndrome progresses, increasing permeability 
of the sarcolemma becomes manifest by rapid rise in 
serum levels of the muscle enzymes creatine phosphoki-
nase (CPK) and lactic dehydrogenase (LDH) as well as 
alanine transaminase (ALT) and aspartate transaminase 
(AST) . The rise in serum levels of CPK particularly-
often tenfold at 24 hours-is considered diagnostic 
(Denborough, 1979). 
An ominous consequence of the progressive intrinsic 
muscle damage and sarcolemma permeability is the 
release into the circulation of myoglobin and tissue 
thromboplastins. The myoglobinuria, renal failure and 
disseminated intravascular coagulopathy (DIC) which 
may follow, worsen the prognosis immeasurably 
(Gronert. 1980). 
Differential diagnosis 
With the onset of MH, the rate of progression of 
alarming signs and pyrexia are usually of such a 
dramatic nature that there is little else with which the 
syndrome can be confused. However, some thought 
should be given to possible alternative diagnoses. 
In small children, in particular, the possibility of a 
response to an adverse heat environment should be 
considered. This could be related to operating room 
temperature and humidity, a faulty humidifier in the 
anaesthetic circuit or a warming blanket. Other possible 
pyrexial reactions to consider are those associated with 
surgically induced bacteraemia or septicaemia, the 
infusion of pyrogens or reaction to blood transfusion 
(Crider, .Nightingale and Hill, 1986). Thyroid storm 
(crisis ) is another possible differential diagnosis. 
Clinically the late stage of the neuroleptic malignant 
syndrome (NMS)-a hyperpyrexic syndrome which fol-
lows overdosage with antipsychotic neuroleptic drugs-
virtualh· identifies with MH and responds to the same 
treatment. However, the patient's history and circum-
stances surrounding its onset will distinguish it (Guze 
and Baxter, 1985). 
MH triggering agents 657 
MH triggering agents 
There are three prerequisites for the precipitation of an 
MH crisis: 
1. Possession of the MH gene . 
2. Exposure of the susceptible individual to a specific 
trigger agent for an adequate time. 
3. A 'qualifying' factor which influences the sensitivity 
of the patient trigger. 
The circumstances which enhance sensitivitv of the 
patient trigger increase systemic catecholamine levels. 
Such circumstances are preanaesthetic anxietv and 
stress (Gronert, Thompson and Onofrio, 1980; Fietcher 
et al., 1981), heavy muscular exercise as in the 
injured sportsman (Kalow, Britt and Chan, 1979) and 
environmental heat. stress (Ording, Hald and Sjontoft, 
1985). By contrast, drugs which control or reduce such 
stress-related responses, depress the sensitivity of the 
MHS patient trigger and attenuate the onset of the 
svndrome. 
, MH can be triggered in susceptible patients by all 
volatile anaesthetic agents (Britt and Kalow, 1970). The 
most potent are the newer halogenated agents-
halothane. methoxyflurane, enflurane, isoflurane and 
sevoflurane. Fluroxene, cyclopropane and ether have 
been documented as onlv weak and inconsistent 
triggering agents (Harrison,· 1987). 
Although nitrous oxide has been implicated rarely in 
episodes of MH in humans (Ellis, Clarke and Ap-
pleyard, 1974; Waite, Ballard and Yonfa, 1985), its 
identification as an MH trigger must be questioned. Not 
only has it been used with impunity in countless MHS 
patients, but also it has failed to evoke positive response 
in MHS swine even when administered at hyperbaric 
levels (Gronert and Milde, 1981a). 
None of the commonly used intravenous anaesthetic 
agents has been identified as a trigger of MH, although 
some reservations have been expressed in regard to the 
use of ketamine (Gronert, 1980) and etomidate (Suresh 
and Nelson, 1985). 
Of the neuromuscular blocking agents, the depolariz-
ing relaxant suxamethonium is virtually a specific 
trigger of MH in the susceptible patient, especially when 
administered in the presence of a potent volatile agent. 
However, a single dose of suxamethonium, of itself, will 
not trigger the syndrome. Repeat doses, usually 
administered misguidedly in response to MMS, and/or 
the presence of halothane are necessary for initiation of 
the syndrome (Harrison, 1981; Ellis and Halsall. 1984). 
In the event of an MMS response, suxamethonium must 
not be repeated (see 'The clinical syndrome', above). 
Non-depolarizing relaxants do not trigger MH (Hall, 
Lucke and Lister, 1976; Morrell and Harrison, 1986). The 
triggering of MH attributed to tubocurarine in two 
often-cited cases (Britt, Webb and Le Due, 1974) is 
questionable on many grounds (Harrison, 1973; 
Gronert, 1980), particularly as no further cases have 
been reported. Non-depolarizing relaxants do not 
prevent initiation of the syndrome by the potent volatile 
anaesthetics, but attenuation or delay in onset of the 
syndrome has been attributed to pancuronium, which 
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some regard as the muscle relaxant of choice for the 
known MHS patient (Hall , Lucke and Lister, 1976; 
Gronert and Milde, 1981b). In spite of the association of 
both atropine (Pollock, 19i3) and cholinergic agents 
(Gronert, Milde and Taylor, 1980) with the provocation 
of MH, untoward reactions have not been generally 
reported following standard reversal of non-
depolarizing neuromuscular blockade in the MHS 
patient. 
The identification of drugs with MH-triggering poten-
tial has depended -initially at least-on anecdote a°nd 
often isolated 'personal communication' (Britt and 
Kalow, 1970). Considered in relation to the 'anxiety' 
factor and against the background of the polypharmacy 
inherent in clinical anaesthesia, the identification as 
triggering agents of drugs but rarely associated with MH 
must be questioned . The screening of drugs for 
MH-triggering potential in the · MHS pig model has 
shown that human MHS patients react positively to all 
drugs identified positively in swine, although MHS 
swine do not react positively to all drugs implicated in 
the triggering of MH in humans (Harrison, 1987). MHS 
swine can show exquisite sensitivity of MH triggering 
that is not found in humans. When such animals fail to 
respond to a putative triggering agent, consistently and 
unequivocally, the circumstances of its original iden-
tification should be examined. On these grounds, 
strictures Jong applied to the use of amide-linked local 
anaesthetic drugs, digitalis and calcium gluconate in the 
MHS patient (Britt, 1983) now call for review (Wingard 
and Bobco, 1979; Harrison and Morrell, 1980; Gronert et 
al . . 1986). 
Pathogenesis 
The MH reaction is based on the induction of an abrupt 
and sustained rise in myoplasmic free calcium (Lopez, 
1986; Lopez et al., 1986), an event which initiates muscle 
contracture, activates glycolysis and mitochondrial 
activih', and sets in train a series of events which 
interact to forrn a vicious cycle. The lesion responsible is 
a genetic functional derangement in the excitation/ 
contraction/coupling (ECC) mechanism distal to the 
neuromuscular junction (Gronert, 1980; Cheah and 
Cheah, 1985). 
Heat production 
Rise in myoplasmic free calcium above a threshold value 
activates the troponin/actin/myosin interaction leading 
to muscle contraction-soon to persist as contracture 
when free calcium elevation is sustained. Later, ·with 
rise in temperature, this reaction becomes progressively 
independent of free calcium, an event that may 
ultimately contribute to its irreversibility (Fuchs, 1975). 
Contracture is fuelled by powerful ATPase systems and 
hydrolysis of adenine nucleotides as follows: 
LACTATE GLYCOGEN 
..........___.. Myokinase Adenylate deaminase 
~ AMP IMP+NH3 ATP ADP 
~ 
CRE ATINE CREATINE PHOSPHATE 
No abnormalities have been identified in the contractile 
proteins themselves (Heffron, 1984; \-Valsh et al ., 1986). 
Pari passu, rising cytosolic free calcium flash activates 
glycogen phosphorylase and massive glycolysis ensues, 
muscle glycogen being depleted stoichiometrically with 
the production of lactate which may rise 15- to 20-fold 
(Berman et al ., 1970; Berman and Kench, 1973). At an 
early stage, heat output may increase 15- to 17-fold 
(Williams, Houchins and Shanklin, 1975) to equal 
conditions of very severe exercise in a trained athlete. 
But, in contrast to the tenfold increase in 0 2 uptake 
recorded by the athlete, the patient in MH records· at 
this time only a threefold increase in 0 1 uptake and 
c?nsequently, due to predominantly anaerobic glycoly-
s1s, manifests a severe acid-base disturbance (Gronert 
and Theye, 1976). 
Mitochondria have a high affinity for calcium but its 
sequestration is an energy-consuming, respiration-
dependent process which replaces and takes primacy 
over that of phosphorylation (Stadhouers et al., 1984). 
Exposed to this high calcium load, mitochondria of MHS 
muscle display only 60 per cent of the normal capacity to 
synthesize ATP (Ruitenbeek et al. , 1984). Ab initio, 
increased consumption of ATP exceeds mitochondrial 
capacity for its regeneration. Supported initially at the 
expense of creatine phosphate-resting levels of which 
are reduced in MH (Verburg et al., 1984}-ATP levels 
soon decline rapidly (Berman and Kench, 1973). Once 
these are depleted, various membrane ion pumps (e.g. 
~ mitochondria and sarcoplasmic reticulum) are dep-
nved of substrate, membrane integrity fails and the 
biochemical conditions of rigor mortis ensue. 
Excitation/ contraction/ coupling 
ECC ~nd its related energy transduction are an integral 
function of the sarcolemma, sarcoplasmic reticulum and 
the mitochondria (Sandow, 1965; Endo, 1977). In MHS 
muscle, defects have been identified at all points in this 
cycle (Figure 2). Most relevant to the MHS crisis are 
those of the sarcoplasmic reticulum, the organelle which 
plays the primary role in the regulation of myoplasmic 
free calcium. 
Sarcoplasmic reticulum (SR) 
~xtensive investigations of SR calcium reuptake function 
m . MH (Gronert, 1980) have not revealed convincing 
evidence for a mechanism primarily responsible for 
initiating the surge in myoplasmic free calcium-the 
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MH triggering process. Now, advances in knowledge of 
the mechanisms of SR calcium release rather than 
uptake, and the modifications of these in MHS humans 
and swine, have provided a basis for a rational 
h~1>othesis of the pathogenesis of MH. This concerns 
the mechanism of calcium-induced calcium release 
(CaIR) from the SR, identified independently by Ford 
and Podolsky (1970) and Endo (197i') . In his review of 
SR function, Endo (1977) proposed the hypothesis that 
an abnormalitv of this CaIR mechanism-low threshold 
and increased.rate of calcium release-was the function-
al lesion responsible for MH. This hypothesis has now 
been effectively validated by the reported identification 
of low threshold, enhanced rate CaIR from SR of seven 
MHS patients (Endo et al., 1983; Horiuti et al., 1986), 
backed b,· similar findings in MHS swine and humans 
b,· Kim and co-workers (Kim et al., 1984; Kim, Sreter and 
Ikemoto, 1986). In each case these effects were 
enhanced by exposure of the SR to halothane. The 
results of the calculations of Endo et al. of simultaneous 
SR calcium uptake and release rates in relation to 
C\'tosolic free calcium (Endo et al., 1983), which reveal 
circumstances in which they may be finely balanced, 
even unstable, are of great interest in explaining many 
of the ,·agaries of the triggering of MH. 
Paradoxicallv, a phenomenon of normal (rather than 
MHS) SR calcium uptake may play a contributory role in 
the establishment of the MH vicious cvcle. This is the 
phenomenon of proton or acid inactivation of SR 
calcium transport reported by Berman, McIntosh and 
Kench (1977), which the early fall in myoplasmic pH 
would soon invoke. Additionally, the pH threshold of 
this reaction is raised in the presence of halothane 
(Diamond and Berman, 1980). 
Sarcolcmma 
Abnormalities that have been identified in the SL 
function of MHS muscle manifest as halothane-induced, 
increased permeability to calcium (Moulds and Denbor-




Figure 2 Sequential steps in skeletal muscle/excitation/Contraction ' 
coupling. Ser text for discussion. 
1984). Exposure to halothane induces a 5-15mV 
depolarization of sarcolemma which is both preventable 
and reversible by dantrolene (Gallant, Godt and 
Gronert, 1979). Whilst this degree of sarcolemmal 
depolarization and increase in calcium permeability 
would not be sufficient of itself to initiate contraction in 
normal muscle, it could well do so in the presence of the 
low threshold CaIR of MHS muscle (Okumura, Crocker 
and Denborough, 1980). 
Other membranes 
The functional abnormalities in mitochondrial, SR and 
sarcolemmal membranes suggest the possibility of a 
generalized membrane defect in MHS subjects. The 
increased erythrocyte osmotic fragility of MHS swine 
(Harrison and Verburg, 1973; Heffron and Mitchell, 
1981; O'Brien et al. , 1985), backed by findings of electron 
spin resonance spectroscopy which indicate abnormali-
ties in the bilayer organization of MHS erythrocyte 
ghosts (Louis, 1986), as well as abnormalities in bone 
calcium storage (Britt, Harrison and MacNeil, 1979) and 
increased insulin response to glucose loads-a calcium-
mediated response (Denborough et al., 1974)--are all 
claimed as evidence of such an underlying generalized 
membrane defect,. but final proof is still Jacking. 
Othe~ enzymes 
Th~ Y:fr:ities of several muscle enzymes, other than 
t r- .~ 0 d,eadv considered, have been examined in MH 
1,: '.: . v < (C,1·:,nert, 1986). In general, initial positive 
L :.in~.- i'1ave been shown by subsequent investigation 
to ..aci- sptc.ificity. 
The role of the sympathetic nervous system 
The induction of MH in susceptible swine by stress or 
severe exercise alone, a circumstance very occasionally 
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mirrored in the human (Gronert, · Thompson and 
Onofrio, 1980; Wingard, 1981), and the prominence of 
tachvcardia and other sympathetic phenomena as the 
first ·clinical signs of the syndrome's onset, all point to a 
major role for the sympathetic nervous system and 
endogenous catecholamine secretion in MH. Indeed, 
surging increases in circulating catecholamine levels 
have been shown to accompany the syndrome's onset 
(Lister, Hall and Lucke, 1974; Gronert and Theye, 1976). 
Although a primary role has been proposed for this 
catecholamine surge (Lucke et al., 1978; Williams et al., 
1985), the bulk of evidence favours its being a secondary 
phenomenon (Gronert, Milde and Theye, 1977; Harri-
son, 1979; Gronert, Milde and Taylor, 1980) which plays 
an important amplifying role in the course of this 
svndrome (Bowman and Nott, 1969). 
· In conclusion, the pathogenesis of MH can be 
summarized best (Figure 3) as a vicious cycle based on 
derangements in ECC mechanisms, of which the sud-
den induction of a sustained rise in myoplasmic free 
calcium is the principle . 
Treatment 
If onset of the syndrome is diagnosed early in its course, 
before its vicious cycle is irreversibly established (i.e . up 
to 10 or so minutes from onset), mere discontinuance of 
the triggering anaesthetic may be sufficient to abort the 
syndrome. Failing this, the therapeutic success of 
specific measures is ensured by their early application. 
Treatment consists of (1) specific therapy to arrest the 
primary dysfunction (continued SR free calcium re-
lease), and (2) supportive therapy to treat the secondari-
ly induced phenomena. The complexities and urgency 
of the treatment protocol are such as to require the 
services of more than one person. The anaesthetist will 
need assistance. 
Figure 3 Malignant hyperthermia-the vicious cycle. u 2•Jea2~R 
= calcium-induced calcium release; CrP = creatine phosphate; SR 
= sarcolemma. 
Specific therapy 
The advent of dantrolene sodium, a hvdantoin, has 
revolutionized the treatment and prognosis of MH, and 
in practice its use has completely superseded that of 
agents previously used such as procaine, procainamide 
and steroids. Synthesized originally by Snyder and 
associates (1967) for use in spastic muscle states, Eilis's 
conclusion that dantrolene's muscle relaxant properties 
stemmed from a depressive action on ECC (Ellis and 
Bryant, 1972; Ellis and Carpenter, 1972), motivated its 
successful therapeutic trial in porcine (Harrison, 1975, 
1977; Gronert, Milde and Theye, 1976) and later human 
MH (Kolb, Horne and Martz, 1982). 
Dantrolene binds to and acts on the SR and the 
T-tubular membrane (Figure 2, sites 4 and 3), reducing 
the rate and amount of calcium release from the former 
and altering the T-tubular/SR coupling 'charge move-
ments' of the latter (Morgan and Bryant, 1977; Danko et 
al., 1985; Harrison, 1988). As triggering agents switch 
MH on, so cantrolene, quite literally, switches it off 
(Figures 4 and 1). 
For clinical use dantrolene is presented as an orange 
powder (together with sodium hydroxide and mannitol) 
in vials of 20 mg which require to be dissolved in 60 ml of 
diluent, preferably sterile water. The resulting solution, 
pH 9-10, is irritant to veins and should be injected into a 
fast-running intravenous infusion or large vein. Effec-
tive tr erapeutic levels of dantrolene follow the adminis-
tratior. of 2.4 mg•kg-1 (Flewellyn et al., 1983). If 
necessary, this dose may be repeated at 15-minute 
intervals, until relaxation of muscle rigor, control of 
tachycardia and arrhythmia, and cessation of tem~-
ture rise are achieved or a total dose of lOmg·kg- has 
been given. It is seldom that a dose exceeding 4mg·kg-1 
is required. 
Although patients may complain of muscle weakness 
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Figure 4 Effects of dantrolene ;\dministration (Rx) on oxygen uptake, lactate production
 and catecholamine secretion of MHS swine 
provoked into malignant hyperthermi,1 by anaesthesia with halothane. • untreated; " 
supportive treatment only; • supportive treatment 
and dantrolene. (From Gronert, Milde and Theye (1976), with permission.) 
be of an order which imperils respiratory ventilatory 
capacity or coughing, as dantrolene does not block SR 
calcium release completely and its effects plateau short 
of muscle paralysis. 
Conveniently, dantrolene has no adverse car-
diovascular effects (Ellis et al. , 19i5; Gallant et al., 1985). 
Metabolized by the liver, its subsequent renal excretion 
results in orange urine, an event which might cause 
some alarm if not anticipated. 
Once controlled, the syndrome . may recur in the 
postoperative period. Dantrolene administration should 
be repeated immediately at the first sign of such 
occurrence. In view of this possibility, some advocate a 
repeat prophylactic dose of dantrolene (2.5mg·kg-
1) 
after 10-12 hours (T i,,,jl 12 hours). 
Neither hepatic dysfunction nor any other of the rare 
complications of prolonged high dosage oral administra-
tion of dantrolene follows its acute short-term use 
(Flewellyn et al., 1983; Britt, 1984). 
A therapeutic role has also been suggested for the 
conventional calcium channel blocking agents (Bikhazi, 
Thomas and Foldes, 1979). Despite some 'in vitro' 
support for this suggestion (Iwatsuki, Koga and Amaha, 
1983; Ilias et al., 1985), 'in vivo' these agents have been 
devoid of therapeutic effect (McGrath, Lee and Remple, 
1984; Gallant et al., 1985; Harrison, Wright and Morrell, 
1986), although nifedipine pretreatment did attenuate 
halothane induction of MH in susceptible swine. 
Finally, in terms of specific therapy, should dan-
trolene be unavailable-and only in this event-the use 
of procaine (30-40 mg·kg-1 i.v.) or procainamide should 
be considered, bearing in mind that this may result in a 
consequential need for cardiac inotropic support (Harri-
son, 1971). 
Supportive therapy 
It must be emphasized that after timely administration 
of dantrolene, following early diagnosis, little or no 
supportive therapy is necessary. The need for such 
therapy is directly, perhaps exponentially, proportional 
to the delay in diagnosis and institution of treatment. 
If not already established, ECG and temperature 
monitoring must be instituted immediately, peripheral 
and central venous and arterial lines inserted for 
intravenous fluid replacement, as well as circulatory and 
biochemical monitoring. The bladder needs to be 
catheterized. These sources will provide the information 
appropriate to the control of the supportive therapy, of 
which the most important steps are to: 
1. Discontinue the administration of all anaesthetic 
agents, hyperventilate with oxygen. 
2. Correct metabolic acidosis with sodium bicarbonate 
to pH 7.2-7.3. It is appropriate to assume and to 
correct a base deficit of 6mmol·l-
1 immediately while 
awaiting the first biochemical results. Correction of 
hyperkalaemia usually follows control of acidosis. 
Cardiac arrhythmias usually do not require indi-
vidual treatment but respond to dantrolene control of 
the syndrome. Should this not be the case, procaina-
mide is the drug of choice. Although use of verapamil 
may seem logical, it cannot be recommended 
because, in the presence of dantrolene, it may cause 
profound myocardial depression (Gallant d al., 1985). 
3. Institute aggressive cooling. Whilst application of ice 
is traditional, consideration should be given, rather, 
to the more efficient cooling by fan evaporation of a 
fine spray of tepid water from the body surface 
(paradoxically, warm air is employed because this 
maintains vasodilatation, assisting heat dissipation, 
while the low thermal capacity of air ensures 
negligible heat input) (Lloyd and Scott, 1985). H ice 
has been used, active cooling should be discontinued 
at 38°C. 
4. Induce diuresis by the administration of mannitol in 
the interests of protecting the kidney against the 
effects of myoglobinuria. Should treatment of the 
acidosis have involved heavy sodium loading, the 
use of frusemide (furosemide) is more appropriate. 
5. Infuse fresh frozen plasma if the syndrome has been 
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Jong lasting and there is any hint of the development 
of DIC. 
Once the patient's temperature has reached normal 
levels, the arterial Pco~ is normal and metabolic acidosis 
has been corrected, spontaneous respiration can be 
allowed to recommence and the patient is extubated 
once conscious. 
The patient must be closely monitored and sedated 
for 24 hours after initial recovery, for fear of recurrence 
of the syndrome. 
Mortality and prognosis 
The mortalitv from MH at the time it first came to world 
notice was of the order of 80 per cent. During the 1970s, 
increasing awareness of the syndrome, with resultant 
earlier diagnosis and treatment, Jed to an improvement 
in prognosis, mortality dropping to 28 per cent. This 
decade, following the introduction of dantrolene 
sodium, the mortality recorded from MH is now only 7 
per cent-all such cases on review manifesting serious 
errors of therapeutic management. Today, with correct 
management, survival from MH should be 100 per cent 
(Britt, 1985; Gronert, 1986). 
Inheritance 
Although it was its genetic aspects which first Jed to 
identification of MH, the details of its mode of 
hereditary transmission are still unclear. Whilst early 
evidence supported the concept of autosomal dominant 
transmission involving a single gene allelle-what 
inconsistencies there were being attributed to incom-
plete penetrance and varying expressivity (Kalow and 
Britt, 1973; Denborough, 1979}-all the evidence now 
points to the mode of transmission being multigenic 
(Ellis, Cain and Harriman, 1978; Kalow, Britt and Chan, 
1979; McPherson and Taylor, 1982). Although the 
condition is more common in males, any apparent sex 
linkage has been sholA.'ll to be spurious. 
Associated conditions 
Approximately 30 per cent of MH sufferers manifest one 
of a group of non-specific musculoskeletal disorders 
such as strabismus, congenital ptosis, kyphoscoliosis, 
subluxation of patellae and recurrent joint dislocation. 
Whilst this association allows us to recognize a group of 
patients at risk from MH if anaesthetized, it has 
contributed nothing to characterization of the mode of 
MH transmission. 
Although sufferers from the classic overt organic 
myopathies-myotonia congenita or dystrophica, 
Duchenne muscular dystrophy, central core disease and 
others-are prone to complications when subjected to 
general anaesthesia, it is surprising how rarely such 
complication is MH (Gronert, 1980; Brownell et al., 1983; 
Wang and Stanley, 1986). The Denborough myopathy, 
in which transmission is recessive, and central core 
disease, are the only overt myopathies with which the 
MH syndrome is consistently associated. The Den-
borough rnyopathy is found in boys, small for age who 
display cryptorchidism, kyphosis, Jordosis, pectus cari-
natum, neck webbing, low-set ears and antimongoloid 
obliquity of the palpebral fissure (Denborough, 1979). 
Arthrogryposis multiplex congenita has been anec-
dotally associated with MH. This association is tenuous, 
however, and it remains to be proven that the incidence 
of MHS in this group of patients is any different from 




Preanaesthetic identification of the individual suscepti-
ble to MH is prerequisite for the prevention of the 
syndrome. This involves diagnostic screening of the 
family of the MH proband. Because transmission of MH 
is dominant, those relatives who have a 50 per cent 
probability of possessing the gene-siblings, parents 
and children-should be screened. Thereafter, screen-
ing is extended in a similar manner from any individual 
identified as MHS (Ellis, 1981). 
Invasive diagnostic tests (involving open 
muscle biopsy) 
The original demonstrations that in vitro biopsy muscle 
strips from MHS pigs and humans reacted pharmacolo-
gically differently from normal muscle, in a manner 
which could be quantified, provided the basis not only 
for early insights into the pathogenesis of MH but also 
for diagnostic screening tests. These reactions were: 
1. Excessive rate of ATP hydrolysis (Harrison tt 111., 
1969). 
2. A lower threshold and increased reactivity to 
caffeine-induced contracture (Kalow tt 111., 1970). 
3. Contracture induced by exposure to halothane (Ellis 
et al., 1971; Moulds and Denborough, 1972). 
4. Lower threshold to potassium chloride depolariza-
tion-induced contracture (Moulds and Denborough, 
1974). 
From these, differing test protocols haye been formu-
lated, based on evaluation o'f the isometric contracture 
tension developed in vitro by dissected fascicles of 
muscle, in response to serial increase in concentration of 
caffeine and/or halothane (Moulds and Denborough, 
1974; Ellis et al., 1978; Britt, 1979; Gronert, 1979). 
Although the in vitro contracture test (IVCT) has proved 
the only reliable diagnostic screening procedure for MH, 
the gradations observed between normal and MHS 
muscle in contracture response to caffeine, halothane, 
and halothane and caffeine in combination have led to 
difficulties in the definition of precise diagnostic criteria 
(Nelson, Flewellyn and Gloyna, 1983). 
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Based on the findings of Rosenberg and Reed (1983), 
that IVCT to halothane alone and to caffeine alone 
provided the most discriminant diagnostic procedure, 
the European MH Group (1984, 1985) have advocated a 
standard NCT protocol consisting of (1) static caffeine 
test, (2) static halothane test, and (3) dynamic halothane 
test. Results are reported in terms of the threshold 
caffeine or halothane concentration at which contracture 
first appears (tension increase >0.2 g). Critical values 
are 2mmol·l- 1 caffeine and 2'7c (0.44mmol·l-
1
) 
halothane. Specimens scoring less than both indices are 
classified as MHS, those greater than both as MHN 
(negative). All others are classed as MHE (equivocal), to 
be kept under review. 
Histology 
Muscle is the only tissue in MH subjects in which 
histological abnormalities have been found. About 
two-thirds of patients have abnormal skeletal muscle 
histology indicative of a myopathy (Harriman, 1979). 
These abnormalities, though protean and non-specific 
(Isaacs, Frere and Mitchell, 1973; Isaacs and Heffron, 
1975), may contribute to the definite diagnosis of 
equivocal cases (MHE). 
Non-invasive tests 
For the purpose of this discussion, venous blood 
sampling is not considered invasive. 
Many non-invasive tests have been developed but all 
lack specificity. Assay of serum CPK activity has been 
the most widely used of these. 
CPK activity 
It is ironic ·that the observation of elevated levels of 
serum CPK-the "marker muscle enzyme by which 
Isaacs and Barlow (1970) and Denl:,orough et al. (1970) 
originally identified susceptibility to MH as a subclinical 
hereditary myopathy-should ultimately come to be 
regarded as having little, if any, usefulness as an MHS 
diagnostic screen. 
Raised serum CPK levels may be found in 80 per cent 
of either known MH patients or affected relatives (Britt, 
1979) but also in 10 per cent of normal individuals (Britt, 
1985). Repeat estimations have shown that levels of CPK 
activity vary within the same patient and that 50-60 per 
cent of known MH reactors display normal values at 
some time (Ellis et al., 1975; Britt, 1985). Hopes that 
study of CPK isoenzymes would reveal a diagnostic 
pattern (Zsigmond et al., 1972) were also vain (Addis et 
al. , 1978). Now Paasuke and Brownell (1986) recom-
mend that CPK assay be abandoned in MH diagnostic 
protocols, for fear that misleading results may lead to 
medical mismanagement. 
In one circumstance, however, the observation of 
elevated serum CPK activity does serve a useful 
diagnostic purpose. If a close relative of a known MH 
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reactor has raised serum CPK activity for which there is 
no other cause, that individual should be regarded as 
susceptible to MH-IVCT may be dispensed with. 
Blood 
Attempts at basing MH diagnostic screening tests on 
various abnormalities that have been observed in MHS 
porcine and human blood cells have proved unsuccess-
ful. Not only has the increased osmotic fragility of MHS 
swine erythrocytes (Harrison and Verburg, 1973; Hef-
fron and Mitchell, 1981) not been found in MHS humans 
(Zsigmond, Penner and Kothary, 1977) but also hopes 
that platelets with their A TP/calcium/actin/myosin con-
tractural process would mirror the functional lesion of 
MH muscle and so constitute a diagnostic screen 
(Solomons and Mason, 1984) have been shown to be 
illusory (Giger and Kaplan, 1983; Lee, Adragna and 
Edwards, 1985; Britt and Scott, 1986). 
Anaesthesia for the MHS patient 
The application of three simple guidelines will ensure 
safe anaesthesia for the individual identified as suscepti-
ble to MH: 
1. Obtundation of the patient's 'trigger' sensitivity. 
2. Utilization of meticulous vital function monitoring. 
3. Avoidance of known MH-triggering agents. 
An essential corollary to the above is the immediate 
availability of the drugs and equipment necessary for 
treatment of MH should it be initiated. 
Obtunding the patient trigger 
From previous discussion, it is obvious that anaesthetic 
safety for the MHS patient can be enhanced by 
preanaesthetic control of any apprehension and anxiety 
the patient may evince. For this, personal.reassurance of 
the patient is as important as the use of appropriate 
sedative and anxiolytic drugs. For this latter purpose the 
benzodiazepines, droperidol and opiates are all suitable, 
although the phenothiazines are best avoided (Moyes, 
1973). 
The preanaesthetic prophylactic use of dantrolene is 
the subject of some controversy. Certainly, the use of 
oral dantrolene-a 3-day preanaesthetic protocol from 
which the patient may suffer many unpleasant symp-
toms and which does not guarantee prophylactic 
systemic drug levels-is no longer to be recommended 
(Flewellyn et al.; 1983; Ruhland and Henkle, 1984; 
Flewellyn and Nelson, 1984b). If prophylactic dan-
trolene is desired, it should be administered in-
travenously in a dose of 2.4 mg·kg-1 with the induction 
of anaesthesia (Harrison and Chapman, 1982). Given 
the application of a correct anaesthetic technique with 
meticulous monitoring and immediate availability of 
intravenous dantrolene, many question the necessity of 
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prophylactic administration at all . However, it is 
generally agreed that when prolonged or major surgery 
is contemplated, the MHS patient's interests are best 
served if dantrolene is given prophylactically. 
Utilization of meticulous vital function 
monitoring 
This should include capnography and monitoring of 
ECG, blood pressure and core temperature. If the 
surgery is major or prolonged, provision should also be 
made for serial acid-base and the blood gas monitoring. 
Avoidance of known MR triggering agents 
Local or regional anaesthesia 
Although it has long been taught that anaesthesia with 
the lowest risk for the MH patient is provided by 
regional techniques, the decision to use such should be 
based on the merits of the technique itself. Unfamiliar 
techniques should not be embarked upon simply 
because the patient is susceptible to MH. 
General anaesthesia 
A blanket ban on all potent volatile inhalational agents 
and suxamethonium is the only constraint on general 
anaesthetic techniques for the MHS patient. 
Lastly, the individual who presents for anaesthesia with 
a history of MH in his close family, but whose 
susceptibility status has not yet been decided by JVCT, 
should be treated as susceptible to MH until proved 
othernrise . 
References 
ADDIS, P.B. , BRITT, B.A. , HENDERS01', A.R. d al. (1978) CPK 
isoenzymes in human and porcine subjects susceptible to 
malignant hyperthermia . In Stcond Jntmzational Symposium on 
Malignant Hyperthmnia , edited by J.A. Aldrete and B.A. Britt, 
pp . 227-32. New York: Grune & Stratton 
BANES, D. B. , DOUGLAS, J. D. and OVERTON, J.H. (1986) Anaesthesia for 
patients with arthrogryposis multiplex congenita: what is the 
risk of malignant hypertherrnia? Anaesth . Jntms. Care 14, 370-2 
BAL'DE.'>:DJSTEL, L., GOUDSOUZIAN, N., COTE, c . and STRAFFORD, M. 
(1984) End tidal CO2 monitoring: its use in diagnosis and 
management of malignant hypertherrnia. Anaesthesia 39, 1000-3 
BELDAVS, J. , SMALL, , ·. , COOPER, D. and BRITT, B.A . (1971) Postopera-
tive malignant hypertherrnia. Can . Anacsth. Soc. J. 18, 202-12 
BERMAN, M.C. and KENCH, J.E. (1973) Biochemical features of 
malignant hyperpyrexia . In Jntmzational Symposium on Malignant 
Hyperthmnia, edited by R.A. Gordon, B.A. Britt and W. Kalow, 
pp . 287-97. Springfield, Ill: Charles C Thomas 
BERMAN, M.C., MCNTOSH, D.B. and KENCH, J.E. (1977) Proton 
inactivation of calcium transport by sarcoplasmic reticulum. J. 
biol. Chem. 252, 994-1001 
BERMAN, M. C. , HARRISON, G. G. , BULL, A.B. and KENCH, J.E. (1970) 
Changes underlying halothane induced malignant hyperpyrexia 
in Landrace pigs. Nature 225, 653-5 
BIKH AZI , G.B., THOMAS, c. and FOLDES, F. (1979) Effects of verapamil 
on mammalian muscle in i•itro. Anesthesiology 51, 5275 · 
BOWMA:S:, w.c. and !'JOTI, :,.i .w . (1969) The action of sympatheto-
mimetic amines and their antagonists on skeletal muscle. 
Phnniwc. Rcr. 21, 27-72 
BRITT. B.A. (1979) Preanesthetic diagnosis of malignant hyperther-
mia . In Malignant H!JP"thennia , (International Anesthesiology 
Oinics, vol. 17), edited by B.A. Britt, pp. 63-96. Boston, Mass: 
Little, Brown 
BRITT. II .A. (1983) Malignant hyperthermia. In Complications in 
AneMhesiology, edited by F. Orkin and L.H. Cooperman, pp. 
291-313. Philadelphia: J.B. Lippincott 
BRITT, B.A. (1984) Dantrolene. Can. Anaesth. Soc]. 31, 61-75 
BRITT, B.A. (1985) Malignant hyperthermia. Can . Anaesth. Soc. /. 32, 
666-77 
BRITT, B.A. and KALOW, w. (1970) Malignant hyperthennia: a 
statistical review. Can. Anaesth. Soc. J. 17, 293-3]5 
BRITT, B.A. and SCOTT, E.A . (]986) Failure of platelet halothane 
nucleotide depletion test as a diagnostic or screening test for 
malignant hypertherrnia. Anesth . Analg. 65, 171-5 
BRITT, B.A. , HARRISON, J.E. and MaCNEIL, K.G . (1979) In vivo neutron 
acti,·ation analysis of bone calcium (IVNAA) in malignant 
hyperthermia susceptible subjects. Carr. AlllttSth. Soc. /. 26, 
117-24 
BRITT, B.A. , WEBB, G.E. and LEDUC, c. (1974) Malignant hyperthermia 
induced by curare. Can. Anaesth. Soc. J. 21, 371-5 · 
BROWNELL, A.K: W:, PAASUKE, R.T. , El.ASH, A. d al. (1983) Malign.mt 
hyperthenrua m Duchenne muscular dystrophy. Anesthaialogy 
58, 180-2 
CHEAH, K.S. and CHEAH, A.M. (1985) Malignant hyperthennia-
molecular defects in membrane permeability. Expmt,rtill '1, 
656-61 
CRIDER, B. , NIGtmNGALE, P. and HJLL, A.B: (1986) lntraoperative 
hyperpyrexia-keep an open mind. Not all is gold that glitters. 
Anesthesiology 64, 413 
DANKO, S. , KIM, D. H. , STRETER, F. A. and IKEMOTO, N. (1985) Inhibitors 
of calcium release from SR II: the effects of dantroiene on c.alc:ium 
release induced by caffeine, calcium and depolarisation. Biodrim. 
Biophys. Acta 816, 18-24 . 
DE JONG, R.H. , HEAVNER, J.E. and AMORY, D.W. (1974) Malign.mt 
hypertherrnia in the cat. AntSthtsiology 41, 608-9 
DENBOROUGH, M.A. (1979) Etiology and pathophysiology af malig-
nant hypertherrnia. In Mlllignant Hypmhmnilz (International 
Anesthesiology Oinics, vol. 17), edited by B.A. Britt, pp. 11-23. 
Boston, Mass: Little, Brown · 
DENBOROUGH, M.A. and LOVELL, R. R.H. (1960) Anaesthetic deaths in 
a family. Lanat 2, 45 
DENBOROUGH, M.A., GALLOWAY, C.P. and HOPICINSON, IC.C (1982) 
Malignant hyperpyrexia and sudden infant dsth. umaf l, 1068 
DENBOROUGH, M.A., FORSTER, J.A. , LOVELL, it.R.H., MAPlJiSTONE, P.A. 
and VIWEKS, J.D. (1962) Anaesthetic deaths in a family. Br. J. 
Anaesth. 34, 395-6 
DENBOROUGH, M.A. , EBELING, P. , KINC, J.O. and ZAl'f, P. (1970) 
Myopathy and malignant hyperpyrexia. umaf 1, 1138-40 
DENBOROUGH, M.A. , WARNE, G. L. , MOUU>S, R.F., TSE, P._and MAJmN, 
F.J.R. (1974) Insulin secretion in hyperpyrexia. Br. mtd. J. 3, 493-5 
DIAMOND, E.M. and BERMAN, M.C. (1980) The effect of halothane on 
the stability of calcium transport activity of isolated fragmented 
sarcoplasmic reticulum. Biochem. Pharmac. 29, 375-81 
DUNN, C.M., MALTRY, D.E. and EGCERS, G.W. (1985)Thevalueofmass 
spectrometry in the early diagnosis of malignant hyperthermia. 
Anesthesiology 63, 333 
aus, F. R. (1981) Malignant hyperpyrexia. In 1"hmttd DiSlll5t •nd 
Anaesthesia; edited by F.R. Ellis, pp. 163-99. Amsterdam: 
Elsevier/North Holland, Biomedical Press 
aus, P.R. and HALSAU., P.J. (1984) Suxamethonium spum; a 
differential diagnostic conundrum. Br. J. AnatSth. 56, 381-4 
El.US, F.R. , CAIN, P.A. and HARRIMAN, D.C. (1978) Multifactorial 
inheritance of malignant hypertherrnia susceptibility. In Second 
lntmzational Symposium on Malignant Hypathmnia, edited by J.A. 
Aldrete and B.A. Britt, pp. 329-38. New York: Grune le Stratton 
2.33 
ELLIS, F.R., CLARKE, J.M.C. and APPLEYARD, T.:-1. {19i4) Malignant 
hyperpyrexia induced by nitrous oxide and treatment with 
dexamethasone. Br. med. f. 4, 270-1 
ELLIS. F.R., HARRJMA.'I;, D.G., KEANEY, N.P., KYEJ-MENSAH, K. and 
TYRREU., J.H. (1971) Halothane induced muscle contracture as a 
cause of hyperpyrexia . Br. / . Anaesth . 43, 721-2 
ELLIS, F.R., CLARKE, J.M.C., MODGILL, M., CURRIE, 5. and HARRIMAN, 
D.G. (1975) Evaluation of creatine phosphokinase in screening 
patients for malignant hyperpyrexia . Br. med. /. 3, 511-13 
ELLIS, F.R., HARRIMA.._, D.G., Ct.:RRJE, 5 . and CAIN, P.A. (1978) 
Screening for malignant hyperthermia in susceptible patients. In 
Second International Symposium on Malignant Hyperthermia , edited 
by J.A. Aldrete and B.A. Britt, pp. 273-85. New York: Grune & 
Stratton 
ELLIS, K.o. and BRYA.,'T, s.H. (1972) Excitation-contraction uncou-
pling of skeletal muscle by dantrolene sodium. Naunyn-
Schmiedeberg's Arch. Phamzac. 274, 107-9 
ELLIS, K.o. and CARPENTER, J.F. (1972) Studies on the mechanism of 
action of dantrolene sodium. Naunyn-Schmiedeberg's Arch. Phar-
amac. 275, 83-94 
ELLIS, R.H., SIMl'SON, P., TATt!M, P .. LEIGHTON, M. and WIWAMS, J. 
(1975) The cardiovascular effects of dantrolene sodium in dogs. 
Anaesthesia 33, 318-22 
ENOO, M. (1977) Calcium release from the sarcoplasmic reticulum. 
Physio/. Rev. 57, 71-108 
E!l.'00, M., YAGI, s., ISHIZL'KA, T., HORJUTI, K., KOGA, Y. and AMAHA, K. 
(1983) Changes in calcium induced calcium release mechanism in 
SR of muscle from a patient with malignant hyperthermia. 
Biomed. Res. 4. 83-92 
EUROPEAN MALIGNANT HYPERPYREXIA GROUP (1984) Protocol for 
investigation of malignant hyperpyrexia susceptibility. Br. f. 
Anaesth. 56, 1267-9 
EUROl'EAN MALIGNA1''T HYPERrYREXIA GROUP (1985) Laboratory di-
agnosis of malignant hyperpyrexia susceptibility. Br. / . Anaesth. 
Si, 1038 
FU:TCHER, R., RANKLE\', E., OLSSON, A.K. and LEANDER, s. (1981) 
Malignant hyperthermia in an anxious patient. Br./. Anaesth. 53, 
993-5 
FLEWELLYN, E.H . and !'/ELSO:>i, T.E . (1984a) Halothane-
succinylcholine induced masseter spasm: indication of malig-
nant hyperthermia susceptibility? Anesth. Analg . 63, 693-7 
FLEWELLYN, E.H. and :-.IELSON. T.E. (1984b) Prophylactic and 
therapeutic doses of dantrolene for malignant hyperthermia. 
Anesthesiology 61, 477 
FLEWELLYN, E.H., ~ELSON, T.E .. JONES, w.r., ARENS. J.F. and WAGNER, 
D.L. (1983) Dantrolene dose response in awake man: implications 
for management oi malignant hyperthermia. Anesthesiology 59, 
2T:,-80 
FORD, L.E. and PODOLSKY, R.J . (1970) Regenerative calcium release 
within muscle cells. Science 167, 58-9 
Ft;CHS, F. (1975) Thermal inactivation of calcium regulating 
mechanism of human muscles. Anesthesiology 42, 584-9 
GALLA.'ITT, E.M., GODT, R.E. and GRONERT, G.A. (1979) The role of 
plasma membrane defect of skeletal muscle in malignant 
hyperthermia. Muscle Ner..>e 2. 491-4 
GALLA:-'T, M •• FOLDES, F.F., RE.\IIPLE, W.E. and CRO~"ERT, C.A. (1985) 
Verapamil is not a therapeutic .idjunct to dantrolene in porcine 
malignant hyperthermia. Anesth. Analg. 64, 601-6 
GIGER, L'. and KAPLA.'I, R.F. (1983) Halothane induced ATP depletion 
in platelets from patients susceptible to malignant hyperthermia 
and from controls. Anesthesiology 58, 347-52 
GRONERT, G.A. (1979) Muscle contractures and ATP depletion in 
porcine malignant hyperthermia. Anesth . Analg. 58, 367-71 
GRONERT, c .A. (1980) Malignant hyperthermia. Anesthesiology 53, 
395-423 
GRONERT, G.A. (1986) Malignant hyperthermia. In Anesthesia, edited 
by R.D. Miller, pp. 1971-94. New York, Edinburgh, London, 
Melbourne: Churchill Livingstone 
GRONERT, G.A. and MILDE, J.H. (1981a) Hyperbaric nitrous oxide and 
malignant hyperthermia. Br. / . Anaesth. 53. 1238 
GRONERT, G.A. and MILDE, J.H. (1981b) Variations in the onset of 
porcine malignant hyperthermia. A11esth. Analg. 60, 499-503 
&ferences 665 
GRO:S:ERT, G.A. and THEYE, R.A. (1976) Halothane induced porcine 
malignant hyperthermia: metabolic and hemodynamic changes. 
Anesthesiology 44, 36-43 
CRO:\'ERT, G.A., MILDE, J.H. and TAYLOR, S.R. (1980) Porcine muscle 
responses to carbachol. alpha and beta adrenoreceptor agonists, 
halothane and hyperthermia. /. Physiol. 307, 319-33 
GRO:\'ERT, G.A., MILDE, J.H. and THEYE, R.A. (1976) Dantrolene in 
porcine malignant hyperthermia. Anesthesiology 44, 488-95 
GRO:\'ERT, G.A., MILDE, J.H . and THEYE, R.A. (1977) The role of 
sympathetic activity in porcine malignant hyperthermia. Anes-
thes,ology 47, 411-15 
GRO:S:ERT, G.A., THOMl'SON, R.C. and ONOFRIO, B. M. (1980) Human 
malignant hyperthermia: awake episodes and correction by 
dantrolene. Anesth. Analg. 59, 377-8 
GRO!'l:ERT, G.A., AHER.'li, L.r .• MILDE, J.H. and WHm, R.D. (1986) The 
effect of CO2, calcium, digoxin and potassium on cardiac and 
skeletal muscle metabolism in MHS swine. Anesthesiology 64, 
24-8 
GRL'E.'liER, R. and BLANCK, T. (1980) Volatile anaesthetics and skeletal 
muscle: evidence for sarcolemmal involvement in malignant 
hyperthermia. In Molecular Mechanisms of Anesthesia (Progress in 
Anesthesiology vol. 2), edited by B. Raymond Fink, pp. 423-7. 
New York: Raven Press 
Gt.:ZE. B.H. and BAXTER, L.R. (1985) Neuroleptic malignant svn-
drome. New Engl. f. Med. 13, 163-6 · 
HAL?., C.M., LUCKE, J.N. and LISTER, D. (1976) Porcine malignant 
hyperthermia . IV. Neuromuscular blockade. Br. /. A1111tsth. 48, 
1135-41 
HALL, L.W. , WOOLF, N., BRADLEY, J.W.P. and JOLLY, D.W. (1966) 
lJnusual reaction to succinylcholine. Br. med. / . 2, 1305 
HALSALL, P.J., CAIN, P.J. and EWS, F.R. (1979) Retrospective analysis 
of anaesthetics received by patients before susceptibility to 
malignant hyperthermia was recognised. Br. /. A1111tsth . 51, 
949-54 
HARRJ:.tAN, D.G. (1979) Preanaesthetic investigation of malignant 
hyperthermia: microscopy. In Malignant Hyperthmnia (Interna-
tional Anesthesiology Oinics, vol. 17), edited·by B.A. Britt, pp. 
9i-117. Boston, Mass: Little, Brown 
HARRISON, c.c. (1971) Anaesthetic induced malignant hyperther-
mia: a suggested method of treatment. Br. mat. /. 3, 454-6 
HARRISON, c.G. (1973) The effect of procaine and curare on the 
initiation of anaesthetic induced malignant hyperpyrexia. In 
lnttrnationa/ Symposillm on Malignant Hyperthmnia, edited by 
R.A. Gordon, B.A. Britt and W. Kalow, pp. 271-86. Springfield., 
Ill: Charles C Thomas 
HARRISON, G.G. (1975) Control of the malignant hyperpyrexic 
syndrome in MHS swine by dantrolene sodium. Br. /. Anatsth. 
4i, 62-5 
HARRISON, G.G. (19i7) The prophylaxis of malignant hyperthermia 
bv oral dantrolene sodium in swine. Br. / . Anusth. 49, 315-17 
HARRISON, c.G (1979) Porcine malignant hyperthermia. In Mlllig,umt 
Hyperthermia (International Anesthesiology Clinics, vol. 17), 
edited by B.A. Britt, pp. 25-61. Boston, Mass: Little, Brown 
HARRISON, c .c. (1981) Dantrolene in the treatment of malignant 
hyperthermia. S. Afr. med. / . 60, 909-10 
HARRISON, G.G. (1987) Porcine malignant h}-perthermia. In Malig-
nimt Hypertlremria , edited by B.A. Britt, pp. 103-36. Boston: 
l'viartinus Nijhoff Publishing 
HARRISON, G.c. (1988) Dantrolene--dynamics and kinetics. Br. f. 
A11aesth. 60, in press 
HARRISON, G.G. and CHAPMA~, D.C. (1982) Dantrolene sodium in the 
treatment of malignant hyperthermia. 5. Afr. mat. / . 62. 503-4 
HARl<ISON, G.G. and MORREU, D.F. (1980) Response of MHS swine to 
i.v. infusion oi lignocaine and bupivacaine. Br. J. A.1111esth. 52, 
3S5-7 
HARRISON, G.G. and VERBt..'RG, C. (1973) Erythrocyte osmotic fragility 
in hyperthermia susceptible swine. Br. / . Anaesth. '5, 131-3 
HARRISON, G.G. , WRIGHT, ,.c. and MORJlEU., D.F. (1986) The effect of 
calcium channel blocking drugs on the initiation of malignant 
hyperthermia in MHS swine and its treatmenl In Procmiings of 
the 4th International Malignant H~ Worlcshap (York, 1986), 
Abstracts Poster Presentations no. 3, edited by F.R. Ellis and P.J. 
2.33 
666 Malignant hyperthermia 
Halsall . Leeds: Leeds MH Investigation Unit , St James Universi-
ty Hospital 
HARRIS01', G.G., BJEBUYCK, J.F., TERBLANCHE, J., DE!\'T, D.M., HICKMA~, 
R. and SAUNDERS, s.J. (1968) Hyperpyrexia during anaesthesia. Br. 
med. ]. 3, 594-5 
HARRISO:S, G.G., SAUNDERS, S.J ., BIEBt:YCK, J.F . et al. (1969) Anaesthe-
tic induced malignant hyperpyrexia and a method for its 
prediction. Br. ]. Anaesth . 41, 844-55 
HEFFR01':, J.J. (1984) Mitochondrial and plasma membrane changes 
in skeletal muscle in the MH syndrome . Biochem . Soc . Trans . 12, 
360-2 
HEFFRoi-:, J.J . (1986) Summan· of Biochemistrv Sessions. In 
Proceedings of the 4th lnternatioi111l Mal ignant Hyperpyrexin Workshop 
(York, 1986) . Abstracts Poster Presentations no. 11, edited by 
F.R. Ellis and P.J . Halsall . Leeds: Leeds MH Investigation Unit, 
St James University Hospital 
HEFFRoi-: , J.J. and :.irrcHELL, G. (1981 ) Influence of pH, temperature , 
halothane and its metabolites on osmotic fragility of erythrocytes 
of MHS and resistant pigs. Br. ]. A1111esth . 53 , 499-504 
HE~SCHEL, E.O. and LOCHER, W.G. (1977) The Wausau ston·-
malignant hyperthermia in Wisconsin . In Malig,111nt Hyperther-
mia-Current Concepts, edited by E.O. Henschel. pp. 3-7. New 
York: Appleton-Century-Crofts 
HORIL'TJ, K., MATSUMARA, M. , MATSt:J, R., )LINO, M . and ENDO, M. 
(1986) The calcium induced calcium release mechanism in 
patients suspected of malignant hyperthermia. In Proceedings of 
the 4th International Malignant Hyperpyrexia Workshop (York, 1986), 
edited by F.R. Ellis and P .J. Halsall, Biochemistry session, p . 7. 
Leeds: Leeds MH Investigation Unit, St James University 
Hospital 
)LIAS, l'l". K. , WILLIAMS, C.H., FCLFER, R.T. and DOZIER, S.E. (1985) 
Diltiazem inhibits halothane induced contractions in MH 
muscles in vitro. Br. ]. A1111esth . 57, 994-6 
ISAACS, H. and BARLOW, M. (1970) Malignant hyperpyrexia during 
anaesthesia; possible association ·with a subclinical myopathy. 
Br. med. ]. 1, 275-7 
JSAACS, H. and H£FFR01':, J.J . (1975) Morphological and biochemical 
defect in muscles of human carriers of the MH svndrome. Br. /. 
Anaesth. 47, 475-80 · 
ISAACS, H., FRERE, G. and MITCHELL, J. (1973) Histological, 
histochemical and ultramicroscopic findings in muscle biopsies 
from carriers of the trait for malignant hyperpyrexia. Br. ]. 
Anaesth . 45, 860-8 
JWATSt:KI, 1'., KOGA, Y. and AMAHA, K. (1983) Calcium channel 
blocker for treatment oi malignant hyperthermia. Anesth. A1111lg. 
62, 861-2 
KALOW, w . and BRITT, B.A. (1973) The inheritance of malignant 
hyperthermia . In lntmuztio1111I Symposium on Malig1111nt Hyperther-
mia, edited by R.A. Gordon, B.A. Britt and W . Kalow, pp. 67-77. 
Springfield, Ill: Charles C Thomas 
KALOW, W ., BRITT, B. A. and CHAN, F.Y. (1979) Epidemiology and 
inheritance of malignant hyperthermia. In Malig1111nt Hyperther-
mia (International Anesthesiology Clinics, vol. 17), edited by 
B.A. Britt, pp. 119-39. Boston, Mass: Little, Brown 
KALOW, W., BRITT, B.A., TERREAt:, M.E. and HAIST, c. (1970) Metabolic 
error of muscle metabolism after recovery from malignant 
hyperthermia . LA11cet 2 , 895-8 
KIKUCHI, H., MORIO, M., SHINOZAKJ, M. and JSHIHARA, s . (1978) 
Statistical considerations of malignant hypertheriia in Japan. In 
Second lnternatio1111I Symposium on Malig1111nt Hyperthmnia, edited 
by J.A . Aldrete and B.A. Britt, pp. 483-98. New York: Grune & 
Stratton 
KIM , D.H., SRETER, F.A. and )!,.'EMOTO, " · (1986) Kinetic and 
biochemical studies of calcium release from SR of normal and 
malignant hyperthermia susceptible pig muscles. In Procttdings 
of the 4th International Malignant Hyperpyrexia Workshop (York, 
1986), edited by F.R. Ellis and P.). Halsall , Biochemistry session, 
p . 4 . Leeds: Leeds MH Investigation Unit, St James University 
Hospital 
KIM, D.H., SRETER, F.A. , OHNJSHJ, S.T. et al. (1984) Kinetic studies of 
calcium release from SR of normal and MHS pig muscle. Biochim. 
Biophys. Acta 75, 320-7 
KLEI~. L.V. (1975) Case report-a hot horse. Vet . A1111esth . 2, 41-2 
KOLB, M.E., HOR.'IE, M.L. and MARTZ, R. (1982) Dantrolene in human 
malignant hyperthermia . Anesthesiology 56, 254-62 
LEE, M.B., ADRAGNA, M.G. and EDWARDS, L. (1985) The use of platelet 
nucleotide assay as a possible diagnostic test for malignant 
hyperthermia . Anesthesiology 63, 311-15 
LISTER, D., HALL, G.M. and LUCKE, J.N. (1974) Catecholamines in 
suxamethonium induced malignant hypertherrnia in Pietrain 
pigs. Br. ]. Anaesth . 46, 803-4 
u.ovo, E.L. and scorr, D.H . (1985) Cooling technique for malignant 
hypertherrnia. IAncet 2, 97 
LOPEZ, J.R. (1986) Intracellular free calcium concentration in skeletal 
muscle and malignant hyperthermia . In Proc«dings of tht 4th 
lnter1111tio1111I Malig1UZnt Hyperpyrexia Workshop (York, 1986), edited 
by F.R. Ellis and P.J. Halsall . Biochemistry session, p. 2. Leeds: 
Leeds MH Investigation Unit, St James University Hospital 
LOPEZ, ).R., ALAMO, L.A. , JONES, D.E. et 111. (1986) Calcium 
concentration in muscle of MHS pigs ddmnined in vivo with 
calcium selective microelectrodes. Muscle Nem' 9, 85-6 
LOUIS, C.F. (1986) Red cell abnormalities in porcine malignant 
hyperthermia. In Proceedings of the 4th lnternatio1111/ Malig1111nt 
Hyperpyrexia Workshop (York, 1986), edited by F.R. Ellis and P.J. 
Halsall . Biochemistry session, p . 11 . Leeds: Leeds MH Investiga-
tion Unit, St James University Hospital 
LUCKE, J.N., DENNY, H. , HAU., G.M., LOVELL, R. and LISTER, D. (1978) 
Porcine malignant hypertherrnia. VI. The effects of bilateral 
adrenalectomy and pretreatment with bretylium on the 
halothane induced response. Br. ]. A1111esth. 50, 241-6 
MACGILLIVRAY, R.G., JANN, H., VANKER, E., GEMMEL, L. andMAHOMEDY, 
A.E. (1986) Development of MH obscured by cardiopulmonary 
bypass. Can. A1111esth. Soc. / . 33, 509-14 
MCGRATH, C.T. , LEE, J.C. and REMPLE, W.E. w(1984) No!H!ffectiveness 
of verapamil in preventing halothane induced malignant 
hyperthermia in susceptible swine. Am. /. 'Del. Res. 45, 93S-7 
MCPHERSON, E. and TAYLOR, C.A. (1982) The genetics of malignant 
hypertherrnia: evidence of heterogeneity. Am. /. mtd. Genet. 11, 
273-85 
MORGAN, K.G. and BRYANT, S.H. (1977) The mechanism of action of 
dantrolene sodium. / . Phannac. exp. Ther. 201, 138-47 
MORRELL, D.F. and HARRISON, G.G. (1986) The screening of 
atracurium in MHS swine. Br. ]. Anaesth. 58, 444-6 
MOULDS, R.F. and DENBOROUGH, M.A. (1972) Procaine in malignant 
hyperpyrexia. Br. mtd. J. 4, 526-8 
MOULDS, R.F. and DENBOROUGH, M.A. (1974) Biochemical basis of 
malignant hyperpyrexia. Br. med. /. 2, 241-4 
MOYES, D.G. (1973) Malignant hypertherrnia caused by trimepra-
zine. Br. / . Anaesth. 45, 1163 
MULTIPLE AUTHORS (1966) Malignant hyperpyrexia: editorials and 
case reports. Can. Anaesth. Soc. /. 13, 415-CS 
MURPHY, A.L. , CONLAY, L., RYAN, J.F. and ltOIIERTS, J.T. (1984) 
Malignant hyperthermia during a prolonged anesthetic for 
reattachment of a limb. Anesthesiology 60, 149-50 
NELSON, T.E., FLEWEU.YN, E.H. and GLOYNA, D.F. (1983) Spectrum of 
susceptibility to malignant hypertherrnia: diagnostic dilemma. 
Anesth. Analg. 62, 545-52 
NEWSON, A.J. (1972) Malignant hyperthermia: 3 case reports. NZ 
med. /. 75, 138-43 
O'BRIEN, P.J., ROONEY, M.T., REIK, T.R. et al. (1985) Porcine malignant 
hypertherrnia susceptibility; erythrocyte osmotic fragility. Am./. 
vet . R.ts. 46, 1451-6 
OKUMURA, F., CJIOCKER, B.D. and DENBOROUCH, M.A. (1980) The site 
of the muscle cell abnormality in swine susceptible to malignant 
hyperthermia. Br. / . Anaesth. 52, 377-83 
ORDING, H. (1985) Incidence of malignant hypmhennia in 
Denmark. Anesth. A,uzlg. 64, 700-4 
ORDING, H., RANKLEV, E. and FLETCHER, R. (1984) Investigation of 
susceptibility to malignant hyperthermia in Denmark and 
Sweden. Br. J. AIUlesth. 50, 1181-2 
ORDING, H., HALD, A.G. and SJOl\'TOFT, E. (1985) Malignant 
hyperthermia triggered by heating in anaesthetised pigs. Adil 
a1111esth . scand. 29, 698-701 
2.33 
PAASUKE, R.T. and BROWNELL, A.K. (1986) Serum creatine kinase level 
as a screening test for susceptibility to malignant hyperthermia . 
/. Am. IMl . Ass. 255, 769-71 
rmRSON, D.R. and DAVIS, N. (1986) Malignant hyperthermia 
diathesis and sudden infant death syndrome. Anesth . Analg. 65, 
209 
POLLOCK, R.A. (1973) Prior drug intake in malignant hyperthermia. 
In Intunational ·Symposium on Malignant Hyperthermia, edited by 
R.A. Gordon, B.A. Britt and W. Kalow, pp. 179-84. Springfield, 
Ill: Charles C Thomas 
ROSENBERG, H. and FLETCHER, J.E. (1986) Masseter muscle rigidity 
and malignant hyperthermia. Anesth. Analg. 65, 161-4 
ROSENBERG, H. and REED, s. (1983) In vitro contracture tests for 
susceptibility to malignant hyperthermia. Anesth. A11alg. 62, 
415-20 
RL"HLAND, G. and HENKLE, A.J. (1984) Malignant hyperthermia after 
oral and intravenous pretreatment with dantrolene in a patient 
susceptible to malignant hyperthermia. Anesthesiology 60, 159-60 
RL'ITENBEEK, W. , VERBl.:RG, M.P., JANSSEN, A.J.M., STADHOUERS, A.M. 
and SENGERS, R.C.A. (1984) 'In vivo' induced malignant hyper-
thermia in pigs. ll . Metabolism of skeletal muscle mitochondria. 
Acta anaesth. scand. 28, 9-13 
RLTT!.E, LO. (1962) Case report no. 246. Death following 
hyperthermia. Am. Soc. Antslh. News!. 26, 16 
SAIDMAN, L.J., HARVARD, E.S. and EGER, E.l . (1964) Hyperthermia 
during anesthesia. /. Am. med. Ass. 190, 1029-32 
SANDOW, A. (1965) Excitation-contraction coupling in skeletal 
muscle. Pharma, Rev. 17, 265-320 
SHORT, C.E. and PAL-DLEFORD, R.R. (1973) Malignant hyperthermia in 
the dog. Anesthesiology 39, 462-3 
s:-.'YOER, H.R., DAVIS, L.S., BICKERTO!II , R.K. and HALLIDAY, R.r . (1967) 
1-((5-arrvlfurfurvlidene)amino] hvdantoins. A new class of 
muscle relaxants. J. mednl Chem. io. 807-9 
SOLOMO!IIS, c.c. and MASON, N.C. (1984) Platelet model for 
halothane-induced effects on nucleotide metabolism applied to 
malignant hyperthennia . Acta anatsth. scand. 28, 185-90 
STADHOUERS, A.M., VIERl!l:G, W.A.L., VERBl}RG, M.P., RUITE.',IBEEK, W. 
and SENGERS, R.C.A. (1984) In vivo induced malignant hyperther-
mia in pigs. Ill. Localisation of calcium in skeletal muscle 
mitochondria by means of electron microscopy and microprobe 
analvsis. Acta anaesth . scand. 28, 14-26 
STEWARD, D.J. (1979) Malignant hyperthennia-the acute crisis. In 
Malignant Hyperthen11ia (International Anesthesiology Clinics, 
\'Ol. 17), edited by B.A. Britt. pp. 1-9. Boston, Mass. : Little, 
Brown 
References 667 
SL'RESH, M.S. and !IIELS01', T.E. (1985) Malignant hyperthermia: is 
etomidate safe? Anesth . Analg. 64, 420-4 
VERBURG, M.P., OERLEMANS, F.T., VAN BE!IINEKOM, C.A., GIELEN, M.J., 
DE BRUYN, C.H. and CRL'L, J.F. (1984) In vivo induced malignant 
hyperthennia in pigs. I. Physiological and biochemical changes 
and the influence of dantrolene sodium. Acta anatsth. scand. 28, 
1-8 
WAITE, r.D., BALLARD, J.B. and YONFA, A. (1985) Malignant 
hyperthermia in a patient receiving nitrous oxide. /. oral 
muillofac. Surg. 43, 907-9 
WALDRON-MEASE, E. and ROSENBERG, H. (1979) Post anaesthetic 
myositis in the horse associated with in vitro malignant 
hyperthermia susceptibility. Vet. Sci. Communs 3, 45-50 
WALSH, M.P. , BROWNELL, A.K., LllTMAN, V. and PAASL"JCE, R.T. (1986) 
Electrophoresis of muscle proteins is not a method of diagnosing 
malignant hyperthermia susceptibility. Antsthtsiology 64, 473-9 
WALTER, M. (1986) Epidemiological aspects of malignant hyperther-
mia in Austria. In Proceedings of the 4th International Hyperpyrexia 
Workshop (York, 1986), edited by F.R. Ellis and P.J. Halsall. 
Epidemiology session, p . 12. Leeds: Leeds MH Investigation 
Unit, St James University Hospital 
WANG, J.M. and STANLE¥, T.H. (1986) Duchenne muscular dystrophy 
and malignant hyperthermia-2 case reports. Can . Anatslh. Soc. 
J. 33, 492-7 
WIWAMS, C.H., HOUCHL"1S, c. and SHANKLIN, M.D. (1975) Pigs 
susceptible to energy metabolism in the fulminant hyperthermia 
stress syndrome. Br. med. / . 3, 411-13 
WIWAMS, C.H., DOZIER, S.E., BL"ZELLO, W., GEHRKE, C.W., WONG, J.K. 
and GERHARDT, K.o . (1985) Plasma levels of norepinephrine and 
epinephrine during malignant hyperthermia in susceptible pigs. 
/ . Chromat. 344, 71-80 
WINGARD, D.w. (1981) Familial stress syndrome. In Inherited Disease 
and Anatsthtsill, edited by F.R. Ellis, pp. 201-11. Amsterdam: 
Elsevier/North Holland, Biomedical Press 
WINGARD, D.W. and BOBCO, s. (1979) Failure of lidocaine to trigger 
porcine malignant hyperthennia. Antsth. Analg. 58, 99-103 
ZSIGMOND, E.K., PENNER, J. and KOTHARY, s.r. (1977) Normal 
erythrocyte fragility and abnormal platelet aggregation in MH 
families. In Second International Symposium on Mlllignant Hypu-
thmnia, edited by J.A. Aldrete and B.A. Britt, pp. 213-19. New 
York: Grune & Stratton 
ZSIGMOND, E.K., STARKWEATHER, e.s., DUBOFF, G.S. and FLYNN, A . 
(1972) Abnormal CPK isoenzyme patterns in families with 
malignant hyperpyrexia. Anesth. Analg. 51, 827-40 
2.33 
CRC Series in Membrane-Linked Diseases 
MALIGNANT 
HYPEKTHBRMIA 
A Genetic Membrane Disease 
Edited by 
S. Tsuyoshi Ohnishi, Ph.D. 
Director 
Philadelphia Biomedical Research Institute 
King of Prussia, Pennsylvania 
Tomoko Ohnishi, Ph.D. 
Research Professor 
Department of Biochemistry and Biophysics 
and the Johnson Research foundation 
University of Pennsylvania School of Medicine 
Philadelphia, Pennsylvania 
CRC Press 
Boca Raton Ann Arbor London Tokyo 
2.34 
Chapter 5 
THE DISCOVERY OF MALIGNANT HYPERTHERMIA 
IN PIGS - SOME PERSONAL RECOLLECTIONS 
Gaisford G. Harrison 
TABLE OF CONTENTS 
I. Introduction ............. . .. . ...................................... 30 
II. The Discovery ....................... .... ............. .. ......... . 30 
m. The Genetic Aspect ..................... ... ....................... 35 
IV. Selection and Breeding ........................ . ... ............... 36 
V. Some Early Investigations ........................................ 37 
VI. Conclusion ................... ... .................................. 41 
References ...... .. ............................................. . ... .. ..... 42 
0-849).1()93-6194/SO.OO + S.50 
() 199' by CII.C Pnu. IDc. 29 
2.3..fa 
30 Malignant Hypenhermia 
I. INTRODUCTION 
It is ironic that although shock-like, stress-related syndromes had long 
been recognized in domestic swine and, because of their economic implica-
tions for the meat industry , they had been the subject of much veterinary 
research, 1•2 the identification of their manifestation of anesthetic-induced ma-
lignant hyperthermia (MH) was so entirely fortuitous . This discovery had to 
await the exposure of pigs to general anesthesia with halothane and succi-
ny lcholine occasioned by their use in medical research. Based, as it was, on 
observations by two independent groups of workers in places as far apart as 
Cambridge (Great Britain) and Cape Town (South Africa), the chance nature 
of this discovery that genetic strains of certain breeds of swine could serve 
as a valid experimental animal model of human MH can be judged from the 
fact that in the former instance the pigs were anesthetiud for an investigation 
into atherogenesis, in the latter for experimental liver transplantation. Further 
at this time, about 1966, except for Denborough's original identification of 
this syndrome in a family in Australia, 3·• published reports of MH in humans 
had been confined to the North American continent. 5•6 No cases had yet been 
documented as such in Great Britain or South Africa. Because so much of 
what we understand today of the pathogenesis of this pharmacogenetic, mem-
brane-based myopathy MH, has come from experimental studies of malignant 
hyperthermia-susceptible (MHS) swine, a brief account of the circumstances 
surrounding the discovery of the "hot pig" is of interest and relevance to 
this volume. 
II. THE DISCOVERY 
The establishment of a program of liver transplantation in man was a 
primary objective of the Liver Research Group, an interdisciplinary group 
formed at the medical school of the University of Cape Town, South Africa 
in 1968. * To this end initial experience was sought in an animal experimental 
model. For this purpose we chose the domestic pig instead of the more usual 
surgical experimental animal, the dog. There were several reasons for this 
besides the very practical one that our research group's surgical leader already 
had considerable experience in experimental liver transplantation in swine, 
which he had acquired while working for a period at the medical school of 
the University of Bristol (Great Britain). First, the pig, in marked contrast to 
other animals, shows little evidence of rejection following liver homo-
transplantation, even of liver of nonrelated donors and in the absence of 
• The original members of this group conccmcd with the "bot pig" discovery were J. Ter-
blanchc (surgeon) , S. J. SaUDders (physician), J. F. Biebuyck (anesthesiology resident), 
D. M. Dent (surgical resident), R. Hickman (surgical resident), and the author (anesthe-




immunosuppression. This strange exception applies only to liver; kidneys , 
skin, and other organs being rejected , as usual, in these circumstances. Sec-
ond, on surgical handling, pig liver does not develop venoconstriction with 
resultant venous outflow block as does that of dogs . Last, pigs were readily 
obtainable from local farm breeding lines in almost unlimited quantities and 
were cheap to maintain, and blood for transfusion during experimental surgery 
was readily obtainable from the local slaughterhouse. 
The first animal models to be used in this project were locally bred 
Landrace piglets , 6 to 8 weeks old weighing 30 to 40 kg . These we anes-
thetized in the following manner. Having been starved for 16 h preoperatively 
(for surgical reasons), the unpremedicated pig was anesthetized in its transport 
pen by the inhalation of N20 with 0 2 (flow rates 6 and 3 1 per minute , 
respectively) with halothane (concentration rapidly increased to 3%) delivered 
via a snout mask attached to a semi-open circuit, with the pig breathing 
spontaneously. When the pig lost consciousness, usually within 3 min, it was 
removed from its pen and placed supine on the operating table. Here , after 
anesthesia had been deepened for a further 3 to 5 min, orotracheal intubation 
was performed - a task considerably more difficult in the pig than in man 
- followed by the passage of a stomach tube and an esophageal thermistor 
for temperature monitoring. ECG monitoring was then instituted followed by 
femoral arterial and jugular venous catheterization for the measurement of 
arterial and venous pressure, arterial blood gas, acid/base and electrolyte 
monitoring, and to provide the conduit for blood and fluid replacement during 
surgery. For the surgery, anesthesia was maintained with N20/02 with hal-
othane (1 to 2%) delivered via a nonrcturn circuit by IPPV, powered by a 
standard automatic ventilator. Ventilatory volumes were adjusted to maintain 
normo- to mild hypocapnia and apnea. This method provided satisfactory 
operating conditions in the pig without the use of muscle relaxants. These 
we chose to avoid so as not to compound the difficulties in relaxant reversal 
and postoperative respiratory problems consequent to the inevitable early 
abdominal distension. Ambient temperature in the operating theater varied 
between 15 to 20°C. Thus the scene was set. 
We had anesthetized but a few pigs in this manner without complication, 
when one reacted to anesthesia in the most bizzare and puzzling manner. 7 As 
the animal lost consciousness, instead of the usual quieting of respiration, it 
commenced panting, developing at the same time a blotchy skin cyanosis, 
despite good auscultated air entry and an FI02 of 0.3. Instead of the expected 
flaccidity , its legs became rigidly extended, so much so that once placed on 
the operating table, it had all the appearance of a pig in rigor mortis (Figure 
1). Orotracbeal intubation presented more than its usual difficulty because of 
masseter spasm and was no sooner successfully accomplished than the animal 
ceased breathing. IPPV was commenced and, as a good but fast pulse was 
palpable , we continued with our experimental protocol. 
Commencement of ECG monitoring showed a sinus tachycardia of 200 
beats per minute while the first blood sample from the femoral artery catheterization 
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FIGURE I. The characteristic ante mortem " rigor mortis" that first drew attention to PMH 
as an entity. I a ) MHS pig anesthetized with thiopentone and (b) same pig after IO min of inhalation 
of halothane . 
revealed a metabolic acidosis so gross (pH 6.85) that we thought it had to be 
an anifact and immediately repeated it - with the same result. Afterwards. 
copious amounts of sodium bicarbonate made no impression at all on the 
acidosis . About 55 min had elapsed from the induction of anesthesia before 
the surgeon performed the laparotomy and immediately remarked on the 
extreme heat of the abdominal organs. (He insisted that steam arose from the 
peritoneal cavity.) The esophageal thermistor, just activated, registered the 
core temperature as an unbelievable 44°C Blood pressure and circulation, 
which had been well maintained until this point, now commenced to fail . 
After several bursts of multifocal ventricular premature beats. the pig finally 
demised in ventricular fibrillation after 105 min of anesthesia . 
Sporadically and quite unpredictably this same sequence of events was 
to be repeated exactly in 6 of the first 34 animals anesthetized in this manner. 
Therapeutic interventions proved fruitless and all died with the longest survival 
being 135 min. the shortest a mere 45 min from commencement of anesthesia . 
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At death, core temperatures, which during anesthesia had risen 1 °C/5 to 10 
min, ranged from 42.5 to 45°C (Figure 2) and all suffered severe metabolic 
acidosis - pH oe; 6.85, PC02 ~ 150 mmHg, base excess< -22 mEqn-
an acidosis seemingly uncorrectable by large amounts of sodium bicarbonate 
(Figure 3). We could discern no cause for all of this. Careful review of the 
clinical events of each death together with laboratory checks for such possible 
reasons as septicemia or pyrogens in infused fluids all proved negative. 
Besides the unpredictability of its occurrence, the most ominous and 
frustrating aspect of what we were now coming to recognize as a specific 
syndrome was the fact that, although it was seemingly initiated in some way 
by the induction of anesthesia, once established discontinuance of all anes-
thetic agents and ventilation of the animals with 0 2 alone made no difference 
whatsoever to its inexorably fatal progress. The anesthetic had, in some way, 
triggered a self-sustaining pathological process.• 
The early random introduction of an alternate anesthetic technique omit-
ting halothane and utilizing intermittent thiopentone with small doses of curare 
together with Ni0/02 by IPPV, soon demonstrated that when it did occur, 
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FIGURE z. Multisile iemperature changes recorded following halotbane initiation of MH in 
an MHS pig following a conttol period of lhiopentone anesthesia. Note extreme rapidity of MH 
onset and speed of iemperature rise in intemal organs. Skin vasoconstriction (blotchy cyanosis) 
has prevenled a similar rise in skin swface lemperature. X .. esophagus; o ., rectum; A "' 
liver; t::. = muscle (gluteus); and • = abdominal skin (swface). (From Bennan et al . Nature. 
225 , 653, 1970. With permission.) 
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FIGURE 3. Arterial blood acid/base changes recorded in an MHS Landracc following initiation 
of MH after control period of thiopentooe IDCStbesia. XL = excess Jactare. Note speed and 
extremes of pH and related changes. (From Harrison, G. G., In:. Symp. Malignanl Hypmhermia, 
R. A. Gordon, B. A. Britt, and W. Kalow, F.ds., Charles C Thomas, Springfield, ll., 1971, 
271. With pennission.) 
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Addition of curare to the halothane technique did not prevent the onset, nor 
did it have any therapeutic effect. 8 Besides pointing the finger at halothane 
as the MH trigger in our original anesthetic protocol, this observation also 
identified an anesthetic technique that could be used safely on MHS swine 
- a technique we were to use subsequently for setting up in vivo the mon-
itoring procedures and achieving control period steady states for investigations 
in such swine. 
Clues as to the nature of this syndrome were given to us by two publi-
cations current at the time. The first was the 1966 September issue of the 
Canadian Anaesthetic Society Journal (now Canadian Anaesthetic Journal) . 9 
This carried reports by six groups of anesthesiologists - originally presented 
at a symposium organized by Dr. R. A. Gordon in Toronto - of 11 human 
fatalities following a syndrome induced by anesthesia, called then for the first 
time malignant hyperpyrexia. The second came from a preliminary com-
munication by Hall and co-workers to the British Medical Journal the same 
year, which described an " unusual reaction to suxamethonium chloride" 
observed in three littermate pigs that bad been anesthetized as experimental 
animals. 10 The component features and outcome of the syndromes described 
by these authors, in man and in swine, described exactly what we were 
observing; however, there was an important difference between the two groups 
of pigs. Whereas the "unusual reaction" in Hall's pigs at Cambridge (gross 
myotonia) was precipitated by the administration of suxamethonium chloride 
after a period of uncomplicated halothane anaesthesia, in our pigs balothane 
alone evoked the syndrome. In the human cases which, like Hall's pigs, bad 
a genetic component both balothane and suxamethonium were incriminated. 
These findings led us to the conclusion that this bizzare hypercatabolic state, 
initiated in some swine by exposure to halotbane, could well be a facsimile 
of the newly described lethal syndrome in humans of anesthetic-induced 
malignant hyperpyrexia. If they could be identified and salvaged in some 
way, we thought that such swine would serve as a valid and much needed 
experimental model of the syndrome. 
ID. THE GENETIC ASPECT 
Establishing the genetic basis of this seemingly unpredictable suscepti-
bility of our pigs to MH was made difficult for us by a local farming practice. 
The local pig breeders all corralled their post-weaned piglets in large groups 
according to weekly age. This made it impossible for us, at this stage, to 
identify accurately the pedigrees of the pigs supplied to us. Also, varying 
sources of supply resulted in our using Large White and Large White/Landracc 
Cross swine in addition to the original pure Landrace strain. As the number 
of pigs anesthetized increased, however, the genetic aspects of MH suscep-
tibility become more obvious on a statistical basis . When this number bad 
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reached 160, we found MH had occurred in 25% of the pure Landrace, 3% 
of the Landrace/Large White Cross and not at all in the pure Large White 
breed . 8 This vulnerability of the Landrace was further borne out when an 
inquiry of Dr. Hall ' s group in Cambridge brought the reply that their "stiff'' 
pigs that suffered this unusual reaction to suxamethonium were Landrace/ 
Wessex Cross breeds. (N. Woolf, personal communication). 
Very soon reports of Porcine MH (PMH) from Europe, 11 America, 12•13 
and Australia14 showed that, far from being rare , this condition was wide-
spread. In a genetic context, though, susceptibility to MH was limited, in 
that it was manifested by selected strains of but two major swine breeds other 
than Landrace. These were the Pietrain and Poland China breeds. All three 
are breeds genetically selected for the qualities of rapid growth, heavy mus-
cling with high muscle/fat ratio, and high feed efficiency. These are the very 
breeds that manifest, in high incidence, the recognized stress-related syn-
dromes, porcine stress syndrome (PSS), and pale, soft, exudative pork (PSEP). 
Indeed it was not long before subsequent research produced good evidence 
to support the hypothesis that PSS , PSEP, and PMH were all manifestations 
of the same covert genetic myopathy. 15 
MH-like syndromes have been documented but rarely in species other 
than swine, most notably the dog and the borse. 16 ln these species, in contrast 
to MHS swine, evocation of the syndrome has needed much longer exposure 
of the animal to MR-triggering agents , progression of the syndrome has been 
slower, repeatability of the reaction in individual animals has not been es-
tablished, and the role of genetic factors bas not been as obvious as in swine 
or humans. 
IV. SELECTION AND BREEDING 
The association of PMH with stress syndromes and , once established, its 
rapid progress to a "malignant" irreversibility caused us much frustration in 
our early attempts to establish the MHS pig as the experimental model of the 
human condition. This required prospective diagnosis and thereafter inbreed-
ing of the susceptible strain. Then, as now, observing the pig's response to 
the inhalation of halothane was the only reliable method of identifying MH-
susceptible animals. 15 However, excitement from the stress of struggling while 
being manhandled profoundly enhances the sensitivity of the triggering and 
the speed of progression of the syndrome and may even be sufficient, of 
itself, to evoke it. 
In these circumstances, MH may be fired by an inhalation of balothane 
for as short a time as 30 to 40 s. Muscle rigor with accompanying blotchy 
skin cyanosis occurs almost before the onset of anesthesia, so much so that 
it is often difficult to distinguish between the stiff leg of conscious induction 
struggling and the extended leg ofMH rigor, so imperceptibly does one merge 
with the other. To compound these difficulties, the syndrome, having been 
aborted by very early discontinuation of balothane inhalation, may often 
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recrudesce in highly reactive animals in the early period of recovery from 
anesthesia. Today, piglets that react so severely are salvaged easily and con-
sistently by the i. v. administration of dantrolene, 17 but in those pre-dantrolene 
days we suffered the frustration of losing animals often in the diagnostic 
screening process. 
Our first attempts at breeding the MHS strain were embarrassingly and 
laughably unsuccessful. In all innocence we had fed and pampered two MHS 
Landrace boars for 6 months before we discovered they had been castrated! 
Unbeknown to us, male pigs destined for the meat market are routinely 
castrated shortly after being weaned, in the interests of improving meat pal-
atability and quality and, on superficial examination, signs of castration in 
young pigs are not that obvious to the uninitiated. Thereafter, having acquired 
a noncastrated young MHS boar and nurturing him to reproductive age, our 
next breeding attempt was frustrated by the syndrome of • 'purple porcine 
passion''. Our boar was so highly stress-susceptible, that his excited attempts 
at procreation evoked fulminant MH that led to his becoming stiff, hot, and 
blue and his immediate and premature demise. Our breeding frustrations were 
not confined to boars. Of the first three MHS gilts that we carefully reared 
to reproductive age, one had a vaginal abnormality, one developed sway back, 
and the third refused to mate. 
V. SOME EARLY INVESTIGATIONS 
Fortunately, we were not dependent for our supply of MHS swine on our 
own initially futile attempts at breeding this strain. The random incidence of 
the MHS gene in the Landrace and Landrace/Large White Cross swine we 
acquired for the surgical research program - 25 and 3%, respectively -
ensured a supply of MHS animals sufficient for our early MH investigational 
needs. Later, by efficient screening and elimination of stress-susceptible an-
imals, the local pig breeders were to reduce this incidence greatly but, by 
then, we had established our own MHS breeding line. 
The early investigations of MH using the MHS pig model were especially 
fruitful and cost effective. In this exciting and virgin field, fundamental 
conclusions could be and were made from relatively simple, unsophisticated, 
and inexpensive experiments. In a short time these led to the identifica~on 
of skeletal muscle both as the site of the lesion and the primary source of the 
heat production. 18 In briefly recalling some of these early fundamental in-
vestigations using the MHS pig model to conclude this account, as these are 
personal recollections, I am confining my remarks to our own investigations 
of the ''hot pig.'' Of course, as MHS swine were identified widely geograph-
ically, similar research was being undertaken contemporaneously in Europe, 
England, America, and Australia with results that were confirmatory and/or 
complementary to our own, but I do not have the space here to review these. 
In pigs dying from MH, the only tissue to show histological abnormalities 
(conventional light microscopy) was skeletal muscle. These changes were 
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consistent with fiber damage and destruction from severe rigor. 8 The character 
of this rigor, clinically so like that of rigor mortis (see Figure 1), which was 
then known to correlate with depletion of ATP from muscle , led us initially 
to investigate specifically ATP content of MHS muscle and the effects on 
this of exposure to halothane . This relatively simple investigation revealed 
the presence of a fundamental , identifiable functional lesion in the skeletal 
muscle of the MHS swine . The rate of depletion of ATP from biopsies 
incubated in vitro was double that of muscle from non-MH pigs, and this 
depletion rate was enhanced by exposure to halothane (Figure 4). Ironically, 












F1GURE 4. Toe effect in vitro on ATP content of muscle from normal and MHS swine of 
incubation in Krebs-Ringer solution and exposure to halothane. (From Harrison, G. G., PorciM 
Malignant Hypmhermia in Malignant Hypmhermia . B. A. Britt, Ed., International Anesthe-
siology Clinics, Vol. 17(4), Little. Brown, Boston. 1979, 25. With permission.) 
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of the muscle rigor. ATP levels in MHS muscle in vivo were well maintained 
early in the course of the MH syndrome initiated by halothane , at a time 
when muscle rigor was already well established. The levels of ATP fell only 
after there had been an appropriate depletion of creatine phosphate (Figure 
5), which by itself correlated with a concomitant depletion of glycogen. 19 
This realization came from the subsequent, more sophisticated studies of 
the correlated dynamic in vivo biochemical changes in blood and serial muscle 
biopsies (liquid N2 frozen) that accompanied progression of this syndrome to 
its fatal end. 18·19 The depletion of glycogen, which accompanied the concom-
itant development of gross acidosis (see Figure 3) with a stoichiometric in-
crease in lactate (Figure 6), was the outcome of mass glycolysis that rapidly 
became anaerobic (Figure 7) . Anaerobiasis was calculated as being responsible 
for at least 50% of the increased heat production. Anaerobic mechanisms had 
not previously been considered as a source of physiological or pathological 
heat. At the same time, no evidence was found of the uncoupling of oxidative 
phosphorylation that had been suggested by some as the source of the increased 
heat. 20 
The muscle rigor was fueled by the activation of the powerful myofibrillar 
ATPase and consequent hydrolysis of adenine nucleotides . 
LACTATE GLYCOGEN 
~ Myokinasc AMP Adcnylate Deaminase IMP + NH. ATP CPI( , 
CREATINE CREATINE PHOSPHATE 
The originally observed depletion of ATP was the outcome of its rate of 
consumption in this system far exceeding its regeneration potential by ana-
erobiasis. Deprived of substrate by this reaction, various membrane ion pumps 
- in the sarcoplasmic reticulum (SR), mitochondria, and sarcolemma (SL) 
- progressively failed, leading to the a loss of membrane integrity, with the 
ultimate production of the biochemical conditions that characterize rigor mor-
tis. 
Both of these interrelated events: (1) activation of myofibrillar A TPase 
and rigor and (2) activation of glycolysis, were explainable, it was suggested, 
by the rapid release of calcium from intracellular sites. We provided phar-
macological support for this contention that the release of calcium from in-
tracellular binding sites was the primary event in the onset of the MH syn-
drome, by a demonstration in vivo that the triggering of the MH syndrome 
in MHS swine by halothane and succinylcholine was effectively blocked by 
the administration of procaine.21 This drug was then well known to block 
caffeine-induced SR calcium release and so caffeine-induced muscle rigor in 
vitro, a reaction for which Kalow ct al. 22 had shown the muscle of MH 
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FlGURE 5. In vivo ATP and creatine phosphate content of serial muscle biopsies during 
progress of PMH provoked by inhalation of balothane. (From Berman, M. C. and Kench, ]., 
ln1. Symp. Malignant Hypenhennia, R. A. Gordon, B. A. Britt, and W. Kalow, Eds. , Charles 
C Thomas, Springfield, IL, 1973, 287 . With permission.) 
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FlGURE 6. In vivo glycogen and lactate content of serial muscle biopsies during progress of 
PMH provoked by inhalation of balothane. (From Berman, M. C. and Kencb, J., ln1. Symp. 
Malignant Hypmhermia , R. A. Gordon, B. A. Britt, and W. Kalow, Eds., Charles C Thomas, 















FIGURE 7. Oxygen uptake and CO, output with simultaneous esophageal temperature recorded 
during a course of PMH evoked by inhalation of halothane after a control period of thiopentone 
anesthesia. Note the disproportionate increase in CO, output compared to O, upcake indicating 
onset of anaerobiasis. (From Berman et al., Na1ure. 225, 653, 1970. With permission.) 
rationale for the first and only specific therapy suggested for MH23 before the 
introduction of dantrolene several years later. 17 
VI. CONCLUSION 
Proposed in 1968 as an animal model for the study of the MH syndrome 
in man, the use of MHS swine has stood the test of time. Though the final 
minutiae of the pathogenesis of MH have still to be elucidated, knowledge 
that has come from worldwide extensive studies of PMH has shown it - and 
by inference the human syndrome - to be the functional result of a genetic 
membrane defect/dysfunction in the triadic SR/f-tubular junctional region of 
the myocyte. 24 •25 In certain circumstances, this leads to a failure of the normal 
control of the calcium-release component of the excitation/contraction/coup-
ling mechanism leading to the induction of an abrupt and sustained rise in 
myoplasmic free-calcium. This event initiates muscle contracture, activates 
glycolysis and mitochondrial activity, and sets in action a series of events 
that interact to form a vicious cycle. 26 Using the MHS pig as the pharma-
cological test bed, these insights into the pathogenesis of MH have been 
accompanied by the development of an effective therapy for the syndrome, 
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a drug that reduces the rate and amount of SR calcium release, dantrolene. 17 
This addition to the anesthetists' annarnenterium has potentially eliminated 
MH as the major cause of unavoidable mortality attributable to anesthesia 
that it once was. Today, with correct management, survival from MH should 
be the norm. 
REFERENCES 
I . Lawrie, R. A., Post monem glycolysis in nonnal and exudative longissimus dorsi muscles 
of the Pig in relation to ~ed white muscle disease, J. Comp. Pa1lw/., 70, 273, 1960. 
2. Nellon, T. E., Porcine stress syndromes, in /111. Symp. Malignant Hyperthermia, R. A. 
Gordon, B. A. Britt, and W. Kalow, Eds., Charles C Thomas, Springfield, ll., 1973, 
191. 
3. Denborough, M. A. and Lovell, R. R., Anaesthetic death in a family, uu,cet 2, 45, 
1960. 
4. DenbofOlllh, M. A., Forster, J, A., Lovell, R. R., Mapleston, P. A., and Vlllien, 
J. D., Anaesthetic deaths in a family, Br. J. Anaesth., 34, 395, 1962. 
5. Britt, 8. A., A history of malignant bypenhermia, in Malignant Hyperthermia , B. A. 
Britt, Ed., Martinus Nijhoff, Boston, 1987, xi. 
6. Gronert, G. A., Malignant bypenhermia, Anesthesiology, 53, 395, 1980. 
7. Harrilon, G. G., Blebuyck, J, F., Terblanche, J., Dent, D. M., Hickman, R., and 
Saunders, S. J., Hyperpyrexia during anaesthesia, Br. Med. J., 3, 594, 1968. 
8. Harrilon, G. G., Saunders, S. J., Biebuyck, J, F., llidanan, R., Dent, D. M., 
Weaver, V., and Terblancbe, J., Anaesthetic induced malignant byperpyrexia and a 
method for its prediction, Br. J. Anaesth. , 41, 844, 1969. 
9. Cullen, W. G., Davies, L. E., Gnves, H.B., Gordon, R. A., Hoa, S., Renwick, 
W., Lavoie, G., Relton, J. E. S., Creighton, R. E., Johnson, A. E., Pelton, D. A,, 
Conn, A. W., 1but, W. H., and Davenport, H. T., Malignant hyperpyrexia: editorial 
and case repons, Can. Anaesth. Soc. J., 13 , 415, 1966. 
10. Hall, L. W., Woolf, M., Bndley, J. W., and Jolly, D. W., Unusual reaction to 
suxamethonium chloride, Br. Med. J., 2, 1305, 1966. 
11. Sybesma, W. and Eikelenboom, G., Malignant bypenhermia syndrome in pigs, Neth. 
J. Vet. Sci., 2, 155, 1969. 
12. Jones, E. W., Burnap, T. K., Nellon, T. E., Kerr, D. D., and Andenon, J. A., 
Preliminary Studies of Fulminant Hyperpyrexia in a Family of Swine, Ann. Meeting Am. 
Soc . Anesthesiologists, Abstracts of Scientific Papers, p. 47. 
13. Pollock, R. A., Standefer, J, C., Hildebrandt, P. K., Goodwin, 8., and U, T. K., 
Malignant hyperthcrmia in the American Landrace pig, in Int. Symp. Malignant Hy· 
perthermia, R. A. Gordon, B . A. Britt, and W. Kalow, Eds., Charles C Thomas, Spring· 
field , ll., 1973, 224. 
14. Denborough, M. A., Hird, F. J., King, J, 0., Margimon, M.A. et al., Mitochondrial 
and otbct studies in Australian Landracc pigs affected with malignant bypenbermia, in 
/111. Symp. Malignant Hyperthermia , R. A . Gordon, B. A. Britt, and W. Kalow, Eds., 
Charles C Thomas. Springfield, ll., 1973, 229. 
15. Harrilon, G. G., Porcine malignant hyperthcrmia - the saga of the "bot pig", in 
Malignant Hyperthennia , B. A . Britt, Ed., Maninus Nijboff, Boston, 1987, 101. 
16. Klein, L. and R-lilerg, H., Malignant hypcrthermia in animals other than swine, in 
Malignant Hyperthennia , B. A . Brin, Ed., Martinus Nijhoff, Boston, 1987, 137. 
2.3-4a 
Ha"ison 43 
17. Harrison, G. G., Dantrolenc -dynamics and kinetics, Br. J. Anaesth. , 60, 279, 1988. 
18. Berman, M. C., llarrilon, G. G., Bull, A. B., and Kenc:h, J.E., Changes underlying 
halothane induced malignant hyperpyrexia in pigs, Nature , 225, 653, 1970. 
19. Berman, M. C. and Kenc:h, J., Biochemical features of malignant hyperthermia in 
Landrace pigs, in Inz. Symp. Malignant Hypmhermia, R. A. Gordon, B. A. Britt, and 
W. Kalow, Eds., Charles C Thomas, Springfield, n., 1973, 287. 
20. Wlllon, R. D., Nicols, R. J., Dent, T. E. and Allen, C. R., Disturbances of oxidative 
phosphorylation mechanism as a possible etiological facu>r in sudden unexplained hy-
perthermia occurring during anaesthesia, Anesthesiology, 27, 231 , 1966. 
21. Harrison, G. G., The effect of procaine and curare on the initiation of malignant 
hyperpyrexia, in Inz. Symp. Malignant Hypmhermia, R. A. Gordon, B. A. Britt, and 
W. Kalow, Eds., Charles C Thomas, Springfield, Il., 1971, 271. 
22. Kalow, W., Britt, B. A., Terreau, M. E., and Hlste, C., Metabolic error of muscle 
metabolism after recovery from malignant hyperthermia, Lancet, 2, 895, 1970. 
23. Harrison, G. G., Anaesthetic induced malignant hyperpyrexia: a suggested method of 
treatment, Br. Med. J., 3, 454, 1971. 
24. Kim, D. H., Sreter, F. A., and Ikemoto, M., Involvement of a 60 kDa pbosphoprotcin 
in the regulation of Ca2+ Release from SR of normal and malignant byperthermia sus-
ceptible pig muscle, Biochem. Biophys. Acta, 94S, 246, 1988. 
25. Mickelson, J. R., Gallaat, E. M., Utterer, L.A., Joblllon, K. M., Rempel, W. E., 
and l..ouls, C. F., Abnormal sarcoplasmic reticulum ryanodine receptor in malignant 
hyperthermia, J. Biol. Chem., 263, 9310, 1988. 
26. Harrison, G. G., Malignant hyperthermia, in General Anaesthesia, J. F. Nunn, J . E. 
Utting, and B. R. Brown, Eds., 5th ed., Buttcrworths, London, 1989, 6SS . 
27. Harrison, G. G., Porcine Malignant Hyperthermia in Malignant Hyperthermia, B. A. 




THE PORCINE HYPERTHERMIA 
AND STRESS SYNDROMES 
Gaisford G. Harrison 
TABLE OF CONTENTS 
I. Introduction . .... .. ..... . .......... ...... ...... . . ..... . . ........... 82 
II. Stress Syndromes in Swine ....................................... 82 
m. Inheritance and Identification ..... . ... . .. .... .. ................. .. 82 
IV. The Clinical Syndrome ............. . ....................... ... .. . 84 
A. Modifications of the Syndrome ........................... . 85 
V. The Biochemical Accompaniments ........ .... . . ...... .. ..... .... 86 
VI. Pathogenesis ..... .... ....... . ..... . .. .... . . ........ . ....... ... .... 87 
A. Myoplasmic Free Ca2 + ........ ........ ........ ............ 91 
B. Sarcoplasmic Reticulum ..... ...... ... . ... .. .... . .... . ..... 91 
C. The Vicious Cycle .......................................... 92 
D. The Milieu of Irreversibility ...... ... . . . .............. . .... 93 
E. Mitochondria .. . . ....... .. .......... .... ..... .. ... . ...... .. 94 
F. Sarcolemrna . .... ...... .. ... . .. ........ .... ... ...... ....... 94 
G. Contractile Proteins ........................................ 94 
H. Other Membranes ..... ... . ...... ............ ..... ....... . . 95 
VII. The Role of the Sympathetic Nervous System .................... 95 
vm. Capture Myopathy . ........ ... .... .... ..... . .. . ...... ... . . .. . .. .. . 96 
IX. The Triggering of PMH ... ...... .. .. . ..... ........... ........ .... . 96 
X. Drug Screening in MHS Swine .. .. . ... ...... .. . .. .... ...... . ..... 97 
XI. Future Directions ............. .. . . ... . . . ....... .... .... . ....... . .. 99 
Acknowledgments .. . . . .... . .. . ......... . ............ .... ... .............. 99 
References .. .. .. . . .. ... .. .. ........ .. . .. .......... . .... . .................. 99 
0-8493-8093-o'94/S0.00+ S.50 
e 19!M by CllC Pftu, IDc. 81 
2.34h 
82 Malignant Hypenhermia 
I. INTRODUCTION 
Malignant hypenhermia in swine (PMH) is the specific drug-induced 
syndrome of hypercatabolism and muscle rigor exhibited by swine, the sub-
jects of a coven phannacogenetic myopathy known as malignant hyperthermia 
susceptibility (MHS) or more general)y, stress susceptibility (SS). The dis-
covery of this lethal syndrome in swine was serendipitous and. as with man, 
it had to await the chance exposure of genetically susceptible animals to the 
classic MH-triggering agents, halothane and/or succinylcholine. occasioned 
by their use in medical research (see Chapter 5) . 
Evoked in these swine, the MH syndrome displays all the features of its 
counterpan in man, validating the use of MHS swine as the animal experi-
mental model of this life-threatening syndrome in man. 1•2 There may be some 
differences but, being quantitative rather than qualitative, they do not appear 
to be fundamental. 3 MH-like syndromes have been observed in species other 
than swine and man, but with a rarity that renders them but biological curi-
osities . Only in MHS swine does the syndrome occur predictably and re-
producibly. Most of our knowledge of the acute biochemical changes that 
characterize the human syndrome and hypotheses of its pathogenesis in this 
volume will have been derived by extrapolation from controlled experiments 
conducted on MHS swine. 
II. STRESS SYNDROMES IN SWINE 
Wbereas in man MH has been documented in most broad racial groups, 
in swine affliction with the MHS genes is confined, strangely. to selected 
strains only of five major pig breeds, the Landrace, Pietrain. Poland China, 
Yorkshire, and Duroc." These are the selfsame breeds that are subject to the 
long recognized porcine (sudden death) stress syndrome (PSS) and its resultant 
postslaughter carcass condition of pale, soft, exudative pork (PSEP) - pork 
that exhibits unfavorable meat quality, being pale, soft, and watery. 1 
Documented separately chronologically, PSS, PMH, and PSEP are now 
accepted as manifestations of the same coven myopathy. PSS and PMH both 
present as the florid MH syndrome, in the former instance evoked naturally 
by severe stress such as engendered by social order fighting. exercise, man-
handling, hot environment, etc. and in the latter, artificially by exposure to 
cenain drugs . PSEP follows from the accelerated postmonem glycolysis, 
concomitarit myolactosis, and abnormally rapid postmortem fall in muscle 
pH peculiar to this myopathy . This, it is proposed, alters the muscle water-
holding capacity and texture by denaturation of the sarcoplasmic protein. 5•6 
III. INHERITANCE AND IDENTIFICATION 
Considering the economic losses sustained by pig breeders around· the 
world from the effects of PSS,7 losses preslaughter in transpon and post-
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slaughter from PSEP, it is strange how inconclusive our knowledge is of the 
inheritance patterns of this myopathy . These patterns have turned out to be 
considerably more complex than appeared at first sight. There are good data 
to suppon hypotheses of both autosomal dominant and recessive modes of 
inheritance . 1.s 
A major difficulty that arises in the conduct of breeding experiments is 
the manner in which SS is identified. In many studies, especially in the past. 
animals were identified as SS retrospectively postslaughter by the presence 
of PSEP.Q Since the discovery of PMH, this method has been superseded by 
the more objective in vivo barnyard halothane test; the observance of the 
animal ' s response to brief mask inhalation of halothane. 1 However. the cor-
relation between genotype and phenotype is not absolute . 
4 For this reason 
some investigators only consider an animal completely MHS/SS negative 
when response to succinylcholine in addition to that to halothane is negative. 
10 
To these criteria Williams adds the requirement of an unraised basal metabolic 
rate ." 
Of simple blood sample tests, none have proved to be specifically di-
agnostic . The variability observed in the serum levels of the muscle enzyme 
markers of this myopathy is such that the levels recorded in an individual pig 
are of little diagnostic significance. 12• 1• As in humans, the only diagnostic 
screening test with any pretensions to sensitivity and specificity of a high 
order involves in vitro contracture testing (IVCT) of muscle biopsy material. 
15 




gistic difficulties obviate its widespread use in this sphere. 
In terms of autosomal dominant inheritance. current data of graded gen-
otype response support the view that this is multigenic (at least two gene 
allelles), the genes involved being codominant. The likelihood of a multi-
factorial pattern of inheritance is further suggested by evidence of the cross-
linkage of this myopathic trait with other characteristics, e.g., blood group. 
17 
On the other hand. workers , especially in Europe, repon data from breeding 
programs in the Dutch Landrace and Pietrain breeds that strongly support the 
existence of a recessive inheritance pattern in these swine involving a single 
major recessive gene exhibiting complete penetrance. In these studies, iden-
tification of MHS/SS was not corroborated with IV CT. 1• 18 
Although all the reported studies in Poland China swine have evidenced 
a dominant inheritance pattern, both dominant and recessive patterns have 
been documented in the Landrace, Pietrain, and crossbreeds of these. The 
present data seem to suppon the hypothesis that swine, as do humans, suffer 
coven subclinical myopathic states both dominantly and recessively trans-
mitted that manifest the MH syndrome as the functional final common path-
way. 
The recent localization of the functional defect responsible for the MH 
reaction to the ryanodine receptor calcium release channel of the sarcoplasmic 
reticulum (see Section VI.B.) has afforded us a rational and more accurate 
insight into the transmission of the PMH/SS trait. In the human. the gene for 
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the ryanodine receptor (ryr l ) has been localized to chromosome 19g 13. I 
and susceptibility to MH has been linked to mutations of this gene.40 In the 
pig, the ryr 1 gene and the PMH (ha!) locus have been localized to chromosome 
6pll-q21. Fujii et al• have demonstrated a single point mutation in this gene 
to be correlated with the PMH/SS phenotype in the five major breeds which 
manifest the condition - knowledge which has allowed the development of 
a simple, accurate , and noninvasive diagnostic test that can provide the basis 
for elimination of this mutation if desired or, in view of its association with 
leanness and muscularity , its controlled retention as the Nin genotype . 
IV. THE CLINICAL SYNDROME 
Evoked in highly reactive MHS/SS swine by stress alone , or ab initio by 
the inhalation of halothane alone, the PMH syndrome is manifested by the 
following clinical signs that progress simultaneously and worsen rapidly: 
1. Generalized blotchy cyanosis of the skin with well-marked cyanosis of 
the snout 
2. The onset of sinus tachycardia often to extreme rates of 200 beats/min; 
untreated, this progresses through multifocal ventricular premature sys-
toles to ventricular fibrilation 
3. Distressed open mouth breathing with increasing hyperventilation that 
progresses to apnca in 15 to 20 min 
4 . Tail twitching and sporadic fasciculation of muscle, most obvious in 
the thighs; this progresses inexorably to generalized muscle rigor that 
causes a characteristic rigid extension of the hind legs (see Figure l in 
Chapter 5). So rigid do the legs become that they arc impossible to flex 
passively. In the absence of endotracheal intubation, this generalized 
rigor may be accompanied by laryngospasm. 
5. An explosive sustained rise in muscle and core temperature at rates as 
extreme as l °C per 5 to 10 min, reaching 43 to 45°C antemonem (sec 
Figure 1). 
Left untreated. other than for the provision of IPPV when apnea super-
venes, death usually follows 45 to 100 min from initiation of the syndrome. 
If exposure to halothane is discontinued within minutes of the first ap-
pearance of any of the major clinical signs, the syndrome is spontaneously 
reversible. This maneuver is the basis of the simplest diagnostic screening 
test for MHS already referred to, the so-called "barnyard test" (see Section 
ill). If, however, exposure to the triggering agent is continued for more than 
several minutes thereafter, the syndrome rapidly becomes irreversible and 
will continue independent of the stressor drug. This can now be seen to have 
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FIGURE 1. Esophageal temperature recorded in a Landrace pig during halothane-induced MH 
following a 30-min control period of thiopcntone anesthesia. N,O (60%)10, (40%) was admin-
istered throughout by IPPV. Maximum rate of temperature rise 0.15°C/min or l 0C/6 min, 42 s. 
(From Harrison, G. G .. Saunders, S . J. , Biebuyck, J. F. , Hickman. R., Dent. D. M., Weaver, 
V., and Terblanche, J .. Br. J. Anesth .. 41. 844, 1969. With permission.) 
A. MODIFICATIONSOFTHESYNDROME 
When the unpremedicated MHS pig is anesthetized with halothane in this 
manner, the MH reaction commences within minutes. as soon as halothane 
concentration in the tissues rises. Subjecting the animal to manhandling stress 
or severe exercise sensitizes the triggering reaction and shortens the onset 
time markedly. 19 On the other hand, for reasons that are not yet clearly 
understood (see Section IX), pretreatment of the MHS pig with hypnotic20 or 
anxiolytic dru_gs causes a variable delay in the onset of MH in response to 
the exhibition of halothane and may prevent that by stress. 21 •22 However, once 
triggered, the speed of progression of the syndrome is unaltered. Usually of 
the order of 15 to 20 min, this delay or latent period may extend for 45 min 
or more, and in some circumstances the triggering of MH by halothane alone 
may even be prevented. Such pretreatment does not .affect the triggering of 
the syndrome by the additional administration of succinylcholine. 
The sensitivity of the MR-triggering mechanism is also affected by the 
genetic factors already discussed. Gradations in genotype-determined trig-
gering sensitivity documented range from those that exhibit delay to those 
that fail to be triggered by halothane alone. 16 The latter, like Hall's historic 
pigs , z3 require the superimposition of succinylcholine depolarization to trigger 
the syndrome. 
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V. THE BIOCHEl\.flCAL ACCOMPANIME1'TTS 
Observed in the laboratory in vivo under controlled conditions, "switch 
on'' of the MH syndrome is signaled by an array of interrelated and rapidly 
progressive changes in biochemical parameters that are indicative of the abrupt 
ignition of a hypermetabolic state accompanied by rigorous contracture in 
skeletal muscle. These changes are reflected by the conventional indices of 
acid/base, blood gas, electrolyte, and substrate status in blood as well as by 
changes observed in serial liquid nitrogen frozen muscle biopsies . They pro-
ceed to extreme values ahead of the physical rise in muscle and core tem-
perature. 24.29 
Profound, rapidly worsening lactacidosis together with concomitant hy-
percapnea, the result of its physiological buffering, is the hallmark of this 
syndrome (see Chapter 5). The latter, readily monitored by capnography, is 
perhaps the earliest indication of the syndrome's switch on. A rise in plasma 
lactate and in oxygen uptake are equally early. Blood and tissue pH may fall 
from control levels to 6.8 units and lower in a time as short as IO min (Figure 
2). 
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F1GURE 2. Simultane<>us record of muscle pH (free-lying pH probe deep in thigh muscle) 
and esophageal temperature from Landrace pig during halothanc-induced MH following 30-min 
control period of thiopentonc anesthesia. N20 (60%)/02 (40'h) was administered lbrougbout by 
IPPV. Note vinual "free fall' " of pH that precedes commencement of temperatUrc rise by 5 min. 
Death of this pig followed promptly on administration of ea2• chelating agent. (From Harrison, 
G. G., -/111. Symp. Malignant HypmMrmia, R. A. Gordon, B. A. Britt, and W. Kalow, Eds., 
Charles C Thomas, Springfield, IL, 1973, 271. With pemiission.) 
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That the rise in plasma lactate precedes the rise in muscle and core 
temperature distinguishes MH from heatstroke and heat injury. In these con-
ditions the rise in lactate is a late phenomenon occurring only after core 
temperature exceeds 41 °C and correlates with the breakdown of compensatory 
mechanisms. 
Though Pa01 may not be reduced much. marked increase in tissue oxygen 
utilization results in an early and marked decrease in mixed venous PO~ long 
before the terminal drop in cardiac output and the prominence of central 
cyanosis as a clinical sign. 
Early elevation of plasma protein and Na .. concentration tally with a shift 
of water into the cells . Elevation of plasma K • and Mg2 .. also occurs early. 
the rise in the fonner being clinically imponant in the generation of the cardiac 
arrhythmias that characterize the terminal phases of the syndrome. Plasma 
Ca1 - and inorganic phosphate also rise, though the fonner has been reponed 
variable. 
Commencement of accelerated glycogenolysis and glycolysis is signaled 
by a rise in plasma glucose that correlates with depletion in muscle glycogen, 
itself stoichiometric with the increase in plasma lactate. Examination of serial 
muscle sections shows the whole glycolytic pathway to be accelerated with 
no single enzymatic step being specifically activated. 
30 Pari passu with ex-
cessive glycolysis within skeletal muscle, the level of crcatine phosphate falls 
within minutes. to be followed by that of ATP as both glycogen and creatine 
phosphate become exhausted. While ADP levels remain unaltered, AMP and 
inosine increase as the syndrome progresses, the end result being continuous 
unrequited nucleotide hydrolysis. This is a process that ends in producing the 
ante mortem biochemical conditions that characterize rigor monis. :?5 
Increasing pcnneability of the sarcolemma (SL) becomes evident in the 
rising plasma levels of the muscle enzymes, specifically CPK but also LDH, 
AST. and ALT.26·18 In treatment-salvaged pigs. a severalfold rise in serum 
CPK 24 h after the experimentally induced syndrome serves as confirmation 
of the previous induction of MH. 31 
A surging increase in circulatory catecholamines accompanies onset of 
the syndrome and is doubtlessly responsible for the early tachycardia and later 
cardiac arrhythmias. It must be noted that chronologically this rise in circu-
lating catecholamines follows that of lactate and PC01 • ~, 
VI. PATHOGENESIS 
This progression of biochemical changes is the outcome of a single event 
- the induction of an abrupt and sustained rise in myoplasmic free Ca
1 •. 
The validity of this hypothesis , founded until comparatively recently on ex-
perimental inference. has now been confirmed by direct observation . Utilizing 
ion-specific microelectrode impalement of MHS myocytes, Lopez and co-
workers have demonstrated a rise in myoplasmic free Ca1 • to accompany the 
onset of MH rigor and a fall, induced by dantrolene, to accompany control 











































FIGURE 3. Changes in membrane po1ential, resting myoplasmic free calcium concentration, 
blood pressure (BP), bean rate (HR), and temperature (T) recorded during MH in MHS swine 
and its reversal with danttolcne. Responses were recorded (a) before halodwie exposure during 
conttol anesthesia with thiopentone/fentanyl/N20, 0/pancuronium; (b) after balocbane exposure; 
(c) after reversal of pancuronium effect with muscle contracture well established; and (d) after 
danttolenc (2 mg/kg). Vm = rating membrane pocential (KC microelec:lrode); VCa "' my-
oplasmic resting free calcium cooccnlrllion (VCaE - Vm); and VCaE • pocential measured 
by ea• · -specific microclecttode (Vm + VCa). (From Lopez et al., Muscle Nnw, 11, 82, 1988. 
With permission.) 
The attainment of a threshold concentration in myoplasmic free ea2•, 
approximately 6 to 9 x 10- 1M, activates the ATPase-dependent troponin/ 
actin/myosin interaction leading to muscle contraction, soon to persist as 
contracture when the free Ca2 .. concentration is not only sustained but rises 
even higher to 10-5M. 35 This reaction becomes progressively independent of 
eai. when muscle temperature exceeds 40°C, an event among many that 
results in the syndrome's ultimate irreversibility. 36 
The early rise in plasma lactate (15- to 20-fold) and modest increase in 
oxygen uptake, 2•.27 which accompany the vast increase in heat output (up to 
17-fold),37 signal the early onset of anaerobiasis. That this occurs in the 
absence of hypoxia long constituted an enigma. 38 Now, this too is seen as 
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but one further sequela of the sustained rise in the level of myoplasmic free 
Ca2 •• 
The sequestration of Ca2 -, for which mitochondria have a high affinity, 
is an energy consuming, respiration-dependent process that takes primacy 
over and replaces that of phosphorylation . Exposed to the high Ca~· load, 
the mitochondria of MHS muscle display only 60% of the ATP-generative 
capacity of normal muscle .39 ·40 Ab initio, the increased consumption of ATP 
by skeletal muscle adenine nucleotide hydrolysis exceeds the mitochondrial 
capacity for its regeneration. This situation may be worsened late in the 
syndrome when reduction in muscle blood supply for various reasons may 
actually reduce available oxygen. 41 The rapid depletion of muscle ATP content 
is a major factor in the establishment of the vicious cycle that finally becomes 
irreversible when ATP concentration falls to half the original resting level 
(Figure 4). 38 
Precise identification of the thermogenic reactions involved and their 
respective contributions has not been possible. The reason is that we are 
unable to observe steady-state conditions in metabolism and circulation during 
the acutely progressing MH syndrome as well as because of uncontrolled heat 
losses . Factors that have been identified as contributory to the heat generation 
(equivalent to maximal muscle exertion) are25 •38•42 
1. Hydrolysis of adenine nucleotides 
2. Aerobic and anaerobic glycolysis 
3. Buffering of the resultant H· ion production 
4. Entropy of muscle contraction 
It is relevant here to mention two attractive early hypotheses of the mech-
anisms of heat production in MH that are now discounted. Historically, the 
first serious hypothesis of a pathogenesis for MH43 proposed the induction 
of uncoupling of oxidative phosphorylation, a proposal subsequently exten-
sively investigated. The subsequent demonstration by many investigators of 
normal respiratory control in MHS muscle mitochondria has long since con-
firmed Wang and coworkers' original objections to this hypothesis on purely 
theoretical grounds."" The bulk of evidence now does not support a role for 
abnormalities in mitochondrial respiration in the pathogenesis of MH.45 
The second hypothesis proposed a role for, and produced some evidence 
of, the futile recycling of fructose 6P04 and fructose 1,6-diphosphate, the 
mechanism responsible for the preflight warming to operating temperature of 
bumble t !e flight muscle .46 Sadly, the amount of heat released by the rate 
of cycling observed in MHS pig muscle was insufficient to account for the 
heat output observed in MH. Further, the accelerated substrate cycling of 
glycolysis in MH is not futile but is in response to the additional ATP demands 
of the ca~· pumps.42 
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A. MYOPLASMIC FREE Caz+ 
91 
The abrupt and runaway rise in myoplasmic free Ca2 ... that drives the 
events of the MH crisis appears to be the response to triggering of the ex-
citation/contraction/coupling (ECC) mechanisms of skeletal muscle afflicted 
by genetically induced dysfunctions of one or more of its complex sequential 
reactions. Indeed, dysfunction has been identified in MHS muscle at many 
ECC steps and in the organelles involved. some of primary import, others 
secondarily induced. 
B. SARCOPLASMIC RETICULUM 
Most relevant to the MH crisis is dysfunction of the sarcoplasmic retic-
ulum (SR), the organelle which plays the principal role in the regulation of 
ECC myoplasmic ea2 • fluxes . Though studies of the Ca2 • transport, uptake, 
and binding functions of MHS-SR have failed to yield a convincing expla-
2.3..fb 
92 Malignant Hyperthermia 
nation for the initiation of the MH process. recent characterization of SR 
Ca2 - release mechanisms and their modifications in MHS muscle now seems 
to provide the basis for an acceptable hypothesis of this event. 45 ·47 
The phenomenon of calcium-induced calcium release (CICR) exhibited 
by the triadic tenninal cistemal SR of MHS skeletal muscle has been shown 
to exhibit substantial differences from that of normal muscle . These differ-
ences are described and discussed at length in subsequent chapters in this 
volume and accordingly are briefly summarized here . 
This CICR function of MHS-SR displays a lower than nonnal threshold 
Ca2 • concentration for triggering. together with an enhanced rate of Ca2 • 
release . 35 -43•52 Parallel findings have been documented from studies of the 
ryanodine receptor with which the CI CR function has been identified . 53 
It has been suggested by some workers that the observed faster Ca2• 
release by MHS-SR may be based on a desuppression rather than an actual 
activation mechanism. S4 This suggestion is based on the observation that in 
MHS pig SR, Ca2 -1CaM-dependent phosphorylation of a 60-kDa protein that 
nonnally inhibits CICR release is lower than normal . Responsible for this is 
a reduction in a 55-kDa subunit of the protein kinase that catalyzes phos-
phorylation of the 60-kDa CICR inhibitor. The Ca2 ... permeability of MHS 
SR has also been shown to be higher than normal. 
Associated with these findings , measurements of the SR membrane order 
parameter. utilizing electron paramagnetic resonance spectroscopy. have dem-
onstrated that halothane, in a less than clinical anesthetic concentration. in-
duces disorder in the MHS SR lipid bilayer to an extent greater than normal. 
These abnormalities are all enhanced by exposure of the SR to halothane and 
are uniquely inhibited by dantrolene, the only drug known to control the MH 
phenomenon. 49•5= 
C. THE VICIOUS CYCLE 
The rapid establishment of the vicious cycle which characterizes the PMH 
and SS syndromes can be more readily explained today in the light of recent 
elucidation of the structure, properties, and function of the ryanodine receptor. 
This receptor, a tetrameric protein which spans the sarcotubular gap, serves 
as the principal ea2 • release channel of the SR.'°' It is encoded by a 15.3 
kb gene located in swine on chromosome 6. In all five breeds of swine which 
manifest it, the MHS phenotype is associated with a single point mutation 
(bp 1843) of a TIA for C/G.' The resultant codon encodes cysteine instead 
of arginine - a change which renders the ryanodine receptor channel leaky, 
in degree varying with the homo- or heterozygous expression of the gene. 
The channel also displays a greater sensitivity (of an order of magnitude) to 
the action of channel opening agents such as Ca2 ... , ATP, and caffeine. It is 
postulated that the anesthetic triggers of MH and/or the endocrine responses 
to stress could act either directly on this abnormal channel or indirectly by 
raising the myoplasmsic concentration of physiological channel gating agents. 
Once opened. this MHS channel is unresponsive to Ca2 ... and Mg2 • induced 
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closure, so engendering the sustained rise in myoplasmic [Ca=-1 which drives 
the vicious cycle (Figure 5). 
The abrupt termination of the syndrome by dantrolene . which itself Jacks 
any effect on SR ca= - reuptake , implies that continued ca= T release. as 
against impairment of SR ca2..- uptake. is fundamental to the genesis of MH. 
Once this is terminated by dantrolene, the functions of other Ca1 • -modulating 
mechanisms of the SR and mitochondria. are sufficient to return free Ca1 + 
concentration to resting levels - at least early in the syndrome - permitting 
relaxation of muscle and termination of the syndrome. 
D. THE MILIEU OF IRREVERSIBILITY 
Though dysfunction of SR itself provides a sufficient basis for the es-
tablishment of the MH vicious cycle; other functions (normal) and dysfunc-
tions (peculiar to MHS genotype) of ECC mechanisms and the organelles 
involved also contribute to the milieu of irreversibility. 
A primary role in the initiation of MH is no longer assigned to reduction 
in SR Caz- reuptake function , but, secondarily induced. it may well contribute 
significantly to perpetuation of the syndrome once established. 
Inhibition, with ultimate inactivation, of SR ca= - reuptake occurs in 




ANAEROBIASIS LACTATE HEAT 
TEMP* 
S.L 
FIGURE 5. The vicious cycle of MH (sec text for description): SL = sarcolemma; SR = 
sarcoplasmic reticulum; DP = depolarization; Sux = Succinylcholine; H- = protonation of 
SR; CICR = calcium-induced calcium release; CRP = creatine phosphate; ATP = adcnosinc 
triphosphate; ADP = adcnosine diphosphatc; IMP = inosine monophosphate; and Temp. = 
Temperature. 
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l. Proton or acid inactivation of SR Ca2 - transport induced by the early, 
rapid fall in intracellular pH, the threshold for which is itself raised in 
the presence of halothane:55 •56 while this phenomenon is a function of 
normal muscle. in MHS swine it may well be enhanced by reduced 
lactate clearance consequent on the defective hepatic gluconeogenesis 
they have been shown to manifest57 
2. Substrate depletion consequent on the exhaustion of ATP38 
3. Increase in membrane permeability secondary to the free fatty acid 
(FFA) release engendered by excessive Ca2 ~ -activated membrane as-
sociated phospholipase A2 activity56 
E. MITOCHONDRIA 
Though a primary role in the pathogenesis of MH for enhanced endog-
enous levels of calmodulin-dependent phospholipase A2 , as postulated by 
Cheah58 is not considered likely,42 an increase in membrane ea2 + permeability 
secondary to the FFA engendered by its ea2 + activation (as in 3 above) may 
well promote the irreversibility of the established syndrome. The consequent 
failure of the mitochondria as a major intracellular Ca2 ... sump is then man-
ifested by (l) the reduction (8- to 10-fold) in mitochondrial Ca2 + accumulating 
ability observed in the MHS genotype59 and (2) the increased rate (normal 
x 2) of mitochondrial Ca2 ... efflux induced by anaerobiasis in MHS swine, 
an important event in the production of PSEP in MHS slaughter animals. 60 
F. SARCOLEMMA 
Though perhaps of more relevance to the triggering ofMH, a dysfunction 
identified in MHS sarcolemma (SL) may also make its contribution toward 
the establishment of irreversibility. The earlier findings that nondepolarizing 
neuromuscular blockade prevented succinylcholine triggering of MH and was 
capable of attenuating that by halothane suggested the importance of contin-
uing SL depolarization as a factor in the triggering of the syndrome by 
exercise. 1 Associated with this, MHS-SL has been shown to manifest: (l) a 
lower than normal mechanical threshold, further enhanced by exposure to · 
halothane61 •62 and (2) deficient Ca2 + pump activity.63 
In addition, halothane has been shown to excn a mild depolarizing action 
on MHS-SL (5 to 15 mV) not apparent on normal SL, an effect countered 
by dantrolene.6,1 Though postulated in the past to play a role in "awake" or 
anaesthetic-induced triggering, 42 this action has recently been shown to play 
no pan. per se, in halothane induction of contracture in MHS muscle either 
in vitro or in vivo. 65 
G. CONTRACTILE PROTEINS 
While the above mechanisms may all contribute ab initio to the estab-
lishment of the vicious cycle, another phenomenon demonstrable in normal 
muscle plays a pan later. once muscle temperature has risen to 40"C and 
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above. This is thermal inactivation of the Ca1 - dependence of the actinl 
myosin contractile interaction: a reaction which. under the circumstances of 
MH. is potentiated by the sharp decline in ATP content .·'" 
H. OTHER MEMBRANES 
Demonstrable dysfunction in the membranous elements of all the organ-
elles involved in muscle ECC suggests the possibility that the MHS/PSS state 
may be associated with a generalized genetic membrane defect. To date, 
blood is the only tissue of which studies by many investigators has produced 
consistent evidence for such a hypothesis .~= 
The finding that MHS swine erythrocytes display an increased osmotic 
fragility1><>-68 has been proposed as support for such a hypothesis. However. 
the importance of this finding. in a primary sense, to any general concept of 
the pathogenesis of MH is immediately called in question by the fact that it 
is not mirrored in the human patient susceptible to MH. 69 
Recently more subtle abnormalities have been identified in the plasma-
lemma of MHS swine lymphocytes70·7 1 and erythrocytes' : .,: that are present 
also in those of human MHS subjects . These concern a halothane-induced 
increase in membrane Ca1 + permeability associated with evidence derived 
from electron paramagnetic resonance spectroscopy that halothane induces a 
greater degree of fluidity in MHS membranes than in those of normal animals . 
These changes induced by halothane in MHS plasmalemma are of a similar 
nature to those induced in MHS-SR49-' 1•5: with the difference that, whereas 
in the latter they occur in response to less than clinical anesthetic concentra-
tions of halothane, the former require a concentration of halothane severalfold 
in excess. While this evidence may strengthen the case for the existence in 
the MHS state of a more generalized genetic membrane defect involving 
tissues other than muscle, it is most unlikely - from this evidence - that 
this plays any pan in the pathogenesis of the MH crisis . 
VII. THE ROLE OF THE 
SYMPATHETIC NERVOUS SYSTEM 
The readiness with which MH can be evoked in MHS swine by excite-
ment. stress, and exercise. considered together with the prominence of tachy-
cardia and other sympathetic phenomena as the first clinical signs of its onset 
and the correlated increase observed in circulating catecholamines,27 •7' all 
suggest that activity of the sympathetic nervous system and endogenous cate-
cholamine secretion must play a major role in the genesis of PMH. However, 
the question of whether sympathetic activity plays a primary role or is a 
secondary event has long been the subject of controversy.42 
In spite of the extensive theory developed by Williams and colleagues 
and Lucke and coworkers incriminating norepinephrine as the primary factor 
in MH both as a basic abnormality and as a trigger,75 ·76 the bulk of evidence 
favors a secondary role . 
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This evidence includes the complementary demonstrations that rigor and 
the biochemical markers of MH were induced by halothane in an isolated 
perfused MH muscle preparation,n that the syndrome was provoked by hal-
othane in totally sympathectomized MHS swine with no rise in circulating 
catecholamine ,76 and the corollary that the syndrome was not initiated by the 
infusion into MHS swine of adrenergic agonists . 3: . 79 Further. as already men-
tioned (see Section V), the rise observed in circulating catecholamines is 
documented to chronologically follow the first metabolic changes observed. 27 
Though assigned a secondary role , when viewed in the context of the 
physiological effects catecholamines have on skeletal muscle - amplification 
of glycogenolysis energy transduction and 3,5 cyclic AMP-mediated change 
in the rate of SR Ca2 ... uptake80 - activity of the sympathetic nervous system 
must be accepted as playing an important amplifying role in the development 
ofMH. 
VIll. CAPTURE MYOPATHY 
As it bears a superficial resemblance to PSS/PMH, a brief consideration 
of the life-threatening, stress-related syndrome manifested by wild game, 
particularly ungulates and birds, known as "capture myopathy"81 is relevant 
here. Lacking the genetic constraints of PSS , this syndrome is precipitated 
in normal animals by the alarm, stress, and extreme muscular exertion of the 
flight from pursuit that precedes capture, or the darting and sedation-induced 
immobilization necessary for capture, of wild game. It presents as shock, 
prostration, muscle stiffness , or "spastic paresis", with moderate hyper-
thermia preceding coma and death. The principal biochemical derangement 
is a profound lactacidosis which, together with raised serum levels of muscle 
enzymes, points to the initiation of anaerobic glycolysis in muscle and mem-
brane damage . Posunortem skeletal muscle may have an appearance very 
similar to PSEP. a: 
However, it has been noted that while capture myopathy does manifest 
an MH-like. end-stage vicious cycle, this can be aborted by the simple ex-
pedient of combating the acidosis alone by the administration of NaHC03 •
13 
Further, it can be reliably prevented by adequate precapture sedation with a 
variety of anxiolytic drugs, if such is achieved with minimal alarm and pursuit 
stress . It is suggested that, in the circumstances of capture myopathy, entry 
into the MH-like vicious cycle is by way of proton inactivation of SR Ca2 ... 
reuptake ( see Section IV. D) . The ultimately uncompensated lactacidosis being 
the result of excessive muscular activity , is also amplified by the effects of 
the persistently stress-raised levels of circulating catecholamines. 
IX. THE TRIGGERING OF PMH 
In the description earlier in this chapter of the clinical characteristics of 
PMH.'PSS . attention was drawn to the variations in triggering sensitivity that 
2.3-4b 
Harrison 97 
are produced by certain circumstances. These were. on the one hand, the 
enhancement of triggering sensitivity produced by stress. excitement, and 
exercise and. on the other. its attenuation in response to sedation. anxiolysis. 
and anesthesia. It is likely that these responses are but a reflection of the 
induction or inhibition of the capture myopathy scenario in the milieu of MHS 
muscle with its dysfunctional CICR and other ECC mechanisms. Circum-
stances most relevant to the enhancement of the sensitivity oi triggering would 
follow from prolonged increases in myoplasmic free Ca2 ~ secondary to con-
tinuing multiple depolarizations, accentuated by catecholamine facilitation of 
prejunctional release and amplification oi glycogenolysis . 80 
X. DRUG SCREENING IN MHS SWINE 
The identification of drugs with MH-triggering potential depended - at 
least initially - on anecdote , "personal communication". and unpublished 
data. often uncorroborated. As ethical considerations prohibited any thought 
of prospective controlled clinical trials in humans. it is probable in the context 
of the polypharmacy .inherent in modem anesthesia, that many such identi-
fications were not valid. Once incorrectly identified as exhibiting MR-trig-
gering potential, a drug could remain pennanently so labeled. its identification 
as such being copied uncritically from text to text. Objective, retestable data 
from the pharmacological screening of drugs in MHS swine have ameliorated 
this situation. 
MHS swine can be inbred to display a uniformity of response and sen-
sitivity of the MH-triggering mechanism that is not found in humans. 1•10 
Further, in such a model. drugs can be tested singly in contrast to the envi-
ronment of polypharmacy that pertains in human clinical anesthesia. For the 
clinical anesthetist, it is of importance to note that human MHS patients react 
positively to all drugs that test positive as triggers of MH in the MHS pig 
model , though the converse does not hold. 84 This circumstance is most likely 
explainable by the above circumstances rather than by inherent species dif-
ferences in drug response. 
In the MHS pig model, the most potent triggers of MH are the newer 
volatile halogenated alkanes and ethers: halothane, ethrane, isoflurane, and 
sevoflurane. Of historical interest, so too is chloroform. Fluroxene (now 
withdrawn) and cyclopropane feature as weak and inconsistent triggering 
agents .1 Strangely, methoxyflurane, trichlorethylene , diethyl ether. and 
nitrous oxide - all documented as MH triggers in the human - do not act 
this way in swine. Indeed. in swine nitrous oxide fails to display any MH-
triggering activity even when administered under hyperbaric condi-
tions. 85 . tH11rr11on IUld W111SOn. unpubli&hcd dlltal 
In the pig model, MH triggering has not been ascribed to any of the 
conventional i.v. anesthetic agents , including ketamine which has been ques-
tionably associated with initiation of human MH. 86 Indeed two such agents. 
althesin (now withdrawn) to a greater extent20 and thiopentone to a lesser 
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extent, 87 block or attenuate MH initiation by volatile anesthetics. Propofol , 
the most recent introduction into clinical anesthetic practice. has tested neutral 
to MH. neither stimulating nor attenuating its initiation." 
Of muscle relaxant drugs. depolarizing succinylcholine alone manifests 
the potential to trigger the syndrome. In the most highly reactive strains (those 
that react to halothane alone) succinylcholine alone also initiates the syndrome, 
though this may require two pulse doses . In those less reactive strains in 
which the syndrome is not precipitated by exposure to volatile anesthetics 
alone, succinylcholine acts as the specific added stressor to trigger the syn-
drome. None of the nondepolarizing relaxants trigger the syndrome, and, as 
already mentioned, pretreatment with them effectively blocks succinylcholine 
triggering. 1•14 
The attribution of MH-triggering potential to several drugs by anecdotal 
clinical association backed, perhaps, by some theoretical consideration of 
their effects on membrane ca2-. fluxes , bas been mentioned. Recent MHS 
pig screening of some of these drugs has revealed such inference to be invalid 
in the case of several clinically very useful drugs . 
Perhaps first among these is lignocaine and the amide-linked group of 
local anesthetics (LA). Arguably , the most widely used LA agents in clinical 
practice and in many hospitals the only local anesthetic agents available , 
amide-linked LAs have long been documented as putative MH-triggering 
agents . That this important group of drugs is, in conventional doses, safe to 
use in the MHS patient has now been validated by a failure to trigger MH in 
the pig model with amide-linked LAs infused i. v. to monitored toxic lev-
els. 89,90 
Digitalis is another such drug. In a sophisticated MH pig model utilizing 
cardiopulmonary bypass to obviate the drug's cardiotoxic effects, Gronen 
and coworkers91 have demonstrated that digitalis infused i.v. to supratoxic, 
cardiac arresting levels (61 ng/ml) lacks any effect on whole body metabolism, 
and by inference that of skeletal muscle. 
Similarly, in the same preparation CaCI~ infused to cardiac arresting levels 
(15 mEq/1) was also shown to lack the MH-triggering potential it was long 
assumed to have. 
Last, and perhaps most importantly, the MHS pig model has served as 
the phannacological test bed in which the strange specificity of dantrolene in 
the control and prevention of MH was established. 92 The demonstration in 
rats by Ellis and coworkers93 that the skeletal muscle relaxing properties of 
dantrolene stemmed from a selective depressive action on the ill-understood 
intrinsic mechanisms of ECC motivated his suggesting its therapeutic trial on 
the MH syndrome established in susceptible swine. In these animals, dantro-
lene proved to be the only drug capable of reliably terminating the MH 
syndrome and of completely blocking its inception by volatile anesthetics 
and/or succinylcholine. As triggering agents switched MH on in the suscep-
tible animal. so dantrolene switched it off. These findings were subsequently 
2.34h 
Ha"ison 99 
successfully applied to the treatment of human MH.92 Dantrolene, we now 
know, binds to and acts on the SR and T-tubular membranes, reducing the 
rate and amount of calcium release from the former, altering the T-tubular/ 
SR coupling '' charge movements'' of the latter and reducing at least the 
halothane component of CICR. 53•54 . 
These actions of dantrolene. superficially those of a Ca1 • channel blocker, 
are exceedingly complex and are still poorly understood. They are clearly 
distinguishable from those of the conventional Ca1 • channel blocking drugs, 
e.g. , verapamil, nifedipine, diltiazem, etc., which act at an SL site and have 
no effect on MH,94 and also the classic SR Ca1 • channel blockers, e.g., 
procaine and amethocaine, which do have a blocking but poor therapeutic 
effect on MH. 92 This virtual specificity of the actions of dantrolene in pre-
venting and controlling the MH syndrome carries with it the implication that 
on their elucidation depends our final concept of the pathogenesis of the 
syndrome. 
XI. FUTURE DIRECTIONS 
Since its original identification in 1960, MH has provided a c~ntinuing 
stimulus for research by investigators in many disciplines, from the clinical 
scientist to the membrane chemist. Now that these endeavors have brought 
a worldwide awareness of the condition, a basic broad understanding of its 
pathogenesis, and a proven specific pharmacological cure, one may well 
question the direction of future research relevant to MH. For the clinician, 
priority must surely be given to the development of a diagnostic test for 
susceptibility to MH that is noninvasive and widely available, yet specific 
and sensitive. For the biological scientist, there remains the more intricate 
task of further unraveling the molecular mechanisms of SR calcium release. 
The solution to these problems in the future will doubtlessly come from the 
continued study of MH in swine . 
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SCREENING OF CERTAIN ANAESTHETIC AGENTS FOR THEIR 
ABILITY TO ELICIT ACUTE PORPHYRIC PHASES IN 
SUSCEPTIBLE PATIENTS 
G. H. BLEKKENHORST, G. G. HARRISON, E. S. CooK AND L. EALEs 
SUMMARY 
The activity of ll-aminolaevulinic acid synthetase (E.C. 2.3.1.37) (ALA-S) was measured in rat 
liver after the simultaneous administration of various anaesthetic agents and 3,5-diethoxycarbonyl-
1,4-dihydrocollidine (DDC) in vivo. Flunitrazepam, Althesin and phenobarbitone caused a sig-
nificant increase in the activity of the enzyme which was not observed with propanidid, ctomidate 
and minaxolone. It is suggested tha, DDC-trcated rat, which resembles latent human variegate 
porphyria, may be a more valid method of testing drugs for their ability to elicit acute porphyric 
phases in susceptible individuals. The anaesthetic agents which induced the activity of hepatic 
ALA-S in this model are not recommended in patients with genetic hepatic porphyria. 
The porphyrias are a group of disorders of haem 
metabolism characterized by specific patterns of 
haem precursor overproduction, accumulation and 
excretion, each pattern defining a particular form of 
porphyria. Variegate, or South African genetic 
porphyria, is one of the forms particularly common in 
southern Africa. It has been estimated that there are 
more than 8000 susceptible individuals (Dean, 1971) 
with a frequency of 1 in 250 in one region. The acute 
phase of this condition and of two other forms of the 
hereditary "hepatic" porphyrias, acute intermittent 
porphyria and hereditary coproporphyria, may be 
life-threatening. It is· usually caused by exposure of 
the susceptible individual to drugs, particularly 
barbiturates (Eales, 1971). The frequency of acute 
porphyric attacks in South Africa has been reduced 
dramatically by effective family surveys, when 
asymptomatic but biochemically positive members of 
families have been warned to avoid precipitating 
agents (Eales, 1971). Identification of drugs which are 
porphyrogenic is also necessary to prevent life-
threatening acute porphyric crises. Previously this 
has been largely a process of trial and error or anecdote, 
but it is now possible to identify the porphyrogenicity 
of drugs in the laboratory. 
Rats given a relatively low dose of 3,5-diethoxy-
carbonyl-1,4-dihydrocollidine (DDC) exhibit a condi-
tion which resembles latent human variegate por-
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phyria. The animals become sensitive to drugs which 
can precipitate the metabolic disorder such that, 
biochemically, the reaction is typical of the human 
attack (De Matteis, 1973). We have used the DDC-
primed rat to test the porphyrogenicity of pheno-
barbitone and the i.v. anaesthetic agents Althesin, 
etomidate, flunitrazcpam, propanidid and minaxolone 
by determination of the activity of hepatic ~amino-
laevulinic acid synthetase (E.C. 2.3.1.37) (ALA-S). 
This is the initial and rate-limiting enzyme of haem 
biosynthesis (Granick and Urata, 1963) and is 
increased in the three hereditary "hepatic" por-
phyrias (Elder, Gray and Nicholson, 1972; Meyer 
and Schmid, 1973). 
MATERIALS AND METHODS 
Male Wistar rats (weight 180-220 g) were starved for 
24 h but water was freely allowed. In each experiment 
the five animals in the control group each received 
arachis oil l .ml; the second group offive received the 
drug under study; a third group of five received DDC 
100 mg 1cg-1 suspended in arachis oil and the fourth 
group received DDC 100 mg 1cg-1 simultaneously 
with the drug under study. The drugs were adminis-
tered i.p. in the doses: phenobarbitone (Gardena!, 
May and Baker, Port Elizabeth, South Africa) 
50 mg kg-1 ; propanidid (Fabantol, Bayer, Lcver-
kusen, Germany) 100 mg 1cg-1 ; etomidate (Ethnor, 
Halfway House, South Africa) 5 mg 1cg-1 ; flunitra-
zepam (Rohypnol, Roche, Isando, South Africa) 
0.5 mg 1cg-1 ; Althesin (GlaxerAllenbury, Wadeville, 
South Africa) 12 mg kg-1 and minaxolone (Gluo 
Group Research, Greenford, Middlesex, England) 
© Macmillan Publishers Ltd 1980 
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15 mg kg-1• The volume of the drug injected was 
usually 1 ml and drugs were diluted if necessary in 
sodium chloride solution (0.15 mmol litre; saline). 
After 17 h, the animals were sacrificed by decapita-
tion, exsanguinated and the livers removed, blotted 
free of blood and washed with ice-cold saline. For 
measurement of ALA-S, the liver was weighed, 
chopped into small pieces, washed twice with ice-
cold saline and homogenized in Tris : HQ buffer 
0.01 mol litre-1, pH 7.4 containing sodium chloride 
0.15 mmol litre-1 and EDT A 0.5 mmol litre-1 using 
a motor-driven Teflon pestle in a glass mortar to give 
a IO% (w/v) homogenate. The assays for ALA-S 
were performed as described previously (Pimstone, 
Blekkenhorst and Eales, 1973) using a modification of 
the method of Strand and others (1972b). 
The significance of difference between mean values 
was assessed by Student's t test. 
RESULTS 
A preliminary experiment established that a dose of 
DDC 100 mg kg.-:1 gave a maximal increase in 
ALA-S activity when administered with pheno-
barbitone, a known porphyrogen (Eales, 1971). 
When administered alone, this dose of DDC gave 
only a modest increase in ALA-S activity. 
The activity of hepatic ALA-Sin rats treated with 
the anaesthetic agents together with DDC is shown 
in figure 1. Phenobarbitone and DDC caused an 
increase in the activity of the enzyme but no change 
was observed in the activity when propanidid and 
DDC were administered compared with the activity 
of ALA-S when DDC alone was given. No significant 
difference in hepatic ALA-S activity was observed 
when etomidate and minaxolone were given together 
with DDC, but flunitrazcpam and Althesin given with 
DDC caused an increase in the activity of hepatic 
ALA-S (P<0.05). 
The activities of the enzyme in rats treated with 
only the drug under test were in all cases found to be 
not significantly different from those in rats receiving 
oil only. 
DISCUSSION 
The results of this study demonstrate that pheno-
barbitone and the . anaesthetic agents flunitrazepam 
and Althesin, when given simultaneously with DDC 
to rats cause a significant increase in the activity of 
hepatic ALA-S compared with the activity of the 
cnzyme·when DDC is given alone. On this basis, these 
drugs must be regarded as porphyrogcnic and contra-
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FIG. 1. Hepatic 6-aminolaevulinic acid synthetue (ALA-S) 
activity in male rats treated simultaneously with 3,5-
dictho:icycarbonyl-1,4-dihydrocollidine (DDC) and various 
drugs. Each result represents the mean for five animals; bus 
indicate SD. One hundred per cent of DDC conaol• 
ALA 479 ± SD 58 (n= 10) nmol formed pr.:r hour per lrlD1 
of liver. Hatched bus indicate a significant dift'crence 
(P < 0.05) when compared with DDC controls. 
A similar investigation (Parikh and Moore, 1978) 
showed that repeated doses of various anaesthetic 
agents, including Althesin and ctomidate, inacased 
hepatic ALA-S activity. The experimental approach 
adopted by these workers may not be correct to 
screen drugs for their porphyrogcnicity, since it 
appears that increased activity of hepatic ALA-S 
results from the coexistence of two requirements, 
each of which alone may have little or no effect on 
the enzyme. These arc: first, an effect on haem 
synthesis and, second, exposure to lipid-soluble 
inducers of haemoprotcin synthesis (Maxwell and 
Meyer, 1978). Thus when rats arc primed with small 
doses of DDC which cause a partial block at the 
fcrrochelatase level (De Matteis, 1973), and a lipid-
soluble inducer of hacmoprotcin synthesis such as 
phenobarbitone is administered, a potcntiation of 
ALA-S activity is observed. However, single doses of 
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EXPERIMENT AL STUDY OF PORPHYROGENICITY 761 
the inducing drugs administered to animals with an 
intact haem biosynthetic pathway have little effect on 
hepatic ALA-S activity (De Matteis, 1978; Maxwell 
and Meyer, 1978). 
Similarly, inducing drugs can superimpose their 
effects on ALA-S in the hereditary hepatic porphyrias. 
The basis genetic defects in the haem biosynthetic 
pathway have been shown to be decreased uro-
porphyrinogen synthetasc in acute intermittent 
porphyria (Strand et al., 1972a), decreased copropor-
phyrinogen oxidase in hereditary coproporphyria 
(Elder ct al., 1977) and a decreased ferrochelatase 
activity (Becker et al., 1977) and decreased proto-
porphyrinogen oxidase, or both (Brenner and Bloomer, 
1979)~ in variegate porphyria. When these drugs are 
administered to patients with the metabolic defect, 
the acute porphyric phase becomes manifest, with an 
inappropriate increase in hepatic ALA-S activity 
(Meyer and Schmid, 1973). 
The determination of hepatic ALA-Sin the DDC-
primed rat, which biochemically resembles latent 
variegate porphyria, appears to be a reliable technique 
in screening drugs for their potential porphyrogenicity. 
Phenobarbitone is the classic porphyrogenic agent, 
while propanidid is known from clinical use to be 
free of this disadvantage. The inclusion of these 
drugs among those tested serves to an extent as a 
control of the method. This method appears more 
sensitive than determination ·of hepatic haem pre-
cursors after administration of DDC and drugs 
(Eales and Blekkenhorst, 1978), when large variations 
in the individual responses of rats to the drugs were 
observed. It should be pointed out, however, that 
induction of ALA-S by drugs is a dose-related 
phenomenon, and a large species variation in the 
therapeutic or toxic effects of chemical substances 
exists. Furthermore, there is an interspecies variation 
in drug metabolism and pharmacological response 
especially to liposoluble drugs (Brodie and Reid, 
1971 ), all of which must be considered when extra-
polating these findings to man. In the present 
experiments, large doses were used, but less than the 
known lethal doses of the anaesthetic agents. The 
in vivo screening technique presented here is more 
valid than the exquisitely sensitive chick embryo liver 
cell culture (Granick, 1966) and chick embryo in 
vivo (Anderson, 1978) screening systems, in which 
metabolites which may augment synthesis of ALA-S 
cannot be readily excreted. It is conceivable that 
some drugs classed as porphyrogenic using these 
methods might be safe to use in the hereditary hepatic 
porphyrias. 
In this investigation of the porphyrogenicity of 
newer i.v. anaesthetic agents, we conclude that 
etomidate and minaxolone are probably non-
porphyrogcnic in susceptible patients, whereas 
Althesin and flunitrazcpam are likely to be dangerous. 
Nevertheless, the ultimate test of porphytogenicity of 
these anaesthetics can only be the · response of 
individuals who suffer genetic porphyria to adminis-
tration of these agents. 
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DEPISTAGE DE CERTAINS AGENTS 
ANESTHESIANTS SUSCEPTIBLES DE 
PROVOQUER DES PHASES PORPHYRIQUES 
AIGUES SUR DES MALADES SUJETS A CE 
GENRE DE REACTION 
RESUME 
On a mesure l'activite de l'acide 8-aminolevulinique 
synthetase (E.C. 2.3.1.37) (ALA-S) dans le foie d'un rat 
aprcs ]'administration simultanee de divers agents anes-
thesiants et de 3,5-diethoxycarbonyle-1,4-dihydrocollidine 
(DDC) in vivo. Le fiunitrazepam, l'Althesine et le phcno-
barbitone ont provoquc une augmentation significative de 
l'activitc de ]'enzyme, cc que l'on n'a pas observe avec le 
propanidide, l'ctomidate et le minaxolone. Ceci laisse 
penser que le rat traite au DDC, lequel ressemblc a la 
porphyrie humaine diversicolorc latentc, pcut constituer 
unc mcthodc plus valablc d'essayer Jes medicaments 
susceptibles de provoquer des phases porphyriques aigues 
11ur Jes individus sujets a cc type de reaction. Les agents 
anesthcsiants qui ont provoquc l'activitc de l'ALA-S 
hcpatique dans cc modcle nc sont pas rccommandes pour 
Jes malades souffrant de porphyric hcpatique gcnetique. 
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PROFUNG GEWISSER NARKOSEMI'ITEL AUF 
IHRE EIGENSCHAFT, AKUTE 
PORPHYRIEPHASEN IN ANFALLIGEN 
PATIENTEN HERVORZURUFEN 
ZUSAMMENFASStJNG 
Die Aktivitat von 6-aminoliivulinische Siiure-Synthetasc 
(E.C. 2.3.1.37) (ALA-S) wurde in dcr Rattenleber ge-
messen nach glcichzeitiger Verabrcichung venchicdener 
Narkosemittel und von 3,5-Diethoxycarbonyl-1,4-dihydro-
collidin (DDC) in vivo. Flunitrazepam, Althcsin und 
Phenobarbiton bewirkten einen wesentlichen Aktivitiitsan-
stieg des Enzyms, der bci Propanidid, Etomidat und 
Minaxolon nicht beobachtet wurde. Man nimmt an, dass 
cine mit DDC behandelte Ratte, die cine menschenihnliche 
Porphyrie aufweist, cine gilltigere Methode zur Oberprlifung 
von Drogen auf ihre Eigenschaft hin darstellt, akute 
Porphyriephasen bei anfalligen lndividuen hervorzurufen. 
Die Narkosemittel, die in diesem Model] die Aktivitiit von 
hepatischer ALA-S hervorriefen, werden fiir Patienten mit 
genctischer hepatischer Porphyrie nicht empfohlen. 
SELECCION DE CIERTOS AGENTES 
ANESTESICOS CON ARREGLO A SU 
HABILIDAD PARA ELUCIDAR LAS FASES 
PORFIRICAS EN PACIENTES SUSCEPTIBLES 
SUMARIO 
Sc midi6 la actividad de la sintetasa de acido 6-amino-
levulinico (E.C. 2.3.1.37) (ALA-S) en el hfgado de rata, 
despues de la administraci6n aimultanca de varios agentes 
anestesicos y · de 3,5-dietoxicarbonil-1,4-dihidrocollidina 
(DDC) in vivo. El fiunitrazepam, la Altesina y la feno-
barbitona ocasionaron un incremento significativo en la 
actividad de la enzima, quc no ae observ6 con la pro-
panidida, etomidate ni con la minaxolona. Parece acr que el 
tratamiento de la rata con DDC, que ae aaemeja a la 
varicdad de porfiria latente en el aer humano, es un mctodo 
de mayor validez para la verificaci6n de drogas respccto a su 
habilidad para elucidar las fues porfiricas agudas en 
individuos susceptiblcs. Los agentes anestesicos quc 
indujcron la actividad del ALA-S hepatico en este modelo, · 
no ae rccomiendan para pacientes con porfiria hepatica de 
tipo genetico. 
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PORPHYRINOGENICITY OF ETOMIDATE AND KETAMINE 
AS CONTINUOUS INFUSIONS 
Screening in the DDC-primed Rat Model 
G. G. HARRISON, M. R. MOORE AND P. N. MEISSNER 
The acute porphyrias are a group of inherited 
metabolic diseases, acute attacks of which are often 
triggered by the use of cenain drugs (Moore and 
Disler, 1983). Prevention of life-threatening crises 
of acute porphyria in genetically susceptible indi-
viduals depends on identification of those individu-
als, and identification of porphyrinogenic drugs. In 
the past, information on the latter was largely anec-
dotal, but additional objective evidence can now be 
obtained by observing, in liver homogenates of 
experimental animal models, the effects of the drug 
in question on 5-aminolaevulinate synthase (ALAs) 
activity and the production of the haem biosynthetic 
porphyrin intermediates (Parikh and Moore, 1978; 
Blekkenhorst et al., 1980). 
Prominent among known porphyrinogenic drugs 
are the barbiturates most commonly used for induc-
tion of general anaesthesia. Of the recently intro-
duced i. v. anaesthetic induction agents, two (Althe-
sin and flunitrazepam (Rohypnol)) have now also 
been incriminated, while animal screening of a third 
(etomidate) has produced results that are suggestive 
of porphyrinogenicity (Disler et al ., 1982). Parikh 
and Moore (1978) also had concluded that this drug 
was porphyrinogenic, following their demonstration 
in the rat that repeated i.p. doses of ·etomidate 
caused an increase in hepatic ALAs activity. How-
ever, in the study of Blekkenhorst and colleagues 
(1980), in the 3,5-dicarbethoxy-1,4-dihydrocol-
lidine (DDC)-primed rat model which simulates 
latent variegate porphyria, the mean increase in 
G. G. HARRISOI'- . M.O .. F.F.A.R.C.S.(ENG.), Dcpanmcnt of 
Anaesthetics , University of Cape Town, South Africa. M . R . 
MOORE. PH.D .. MRC Liver Research Group, Depanment of 
Medicine, University of Cape Town and Gardiner Institute, 
Department of Medicine, Western Infirmary, University of 
Glasgow. P. N. MEISSNER, B.SC.(MED.1 (HONS.), MRC Liver 
Research Group, Dcpanment of Medicine , University of Cape 
Town and Groote Schuur Hospital , South Africa. 
SUMMARY 
The porphyrinogenicity of etomidate and ketamine 
administered as continuous i. v. infusions was 
screened in the DOC-primed rat model of latent 
variegate porphyria. Ketamine produced no 
change from control in 5-aminolaevu/inate synth-
ase (ALAs) activity and haem intermediate pro-
duction in either untreated or DOC-primed rats, 
and would appear to be safe for use in the patient 
with genetic porphyria. Etomidate, while produc-
ing no significant changes in these parameters in 
untreated rats, caused a statistically significant 
47% increase in hepatic ALAs activity with a cor-
roborative 85% increase in coproporphyrin and a 
40% increase in protoporphyrin content, in DOC-
primed rats. On these grounds, etomidate must be 
regarded as potentially porphyrinogenic when 
administered as a continuous infusion for total i. v. 
anaesthesia. 
hepatic ALAs activity that followed single dose i.p. 
administration of etomidate just failed to achieve 
statistical significance. In humans, no corroborative 
examples of acute porphyria precipitated by etomi-
date have yet been reponed. 
The short disposal half-life of etomidate makes it 
particularly suitable for use not only for i. v. induc-
tion of general anaesthesia when administered as a 
single dose, but also for total i.v. anaesthesia when 
administered as a continuous i. v. infusion. In view 
of this and the above findings, it seemed to us impor-
tant to extend the screening of etomidate for por-
phyrinogenicity from single dose administration to 
continuous i.v. infusion in the DDC-primed rat 
model. 
Control conditions of total i. v. anaesthesia were 
produced by continuous infusion of ketamine, a 
drug generally regarded as non-porphyrinogenic 
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(Disler et al. , 1982). 
METHODS 
Male Wistar rats (weight 200-300 g) were submitted 
to i. v. anaesthesia for 6 h by continuous infusion of 
the test drug to a cannulated femoral vein by means 
of a mechanically driven syringe pump. 
Twelve rats were anaesthetized with etomidate 
and 12 with ketamine, the dose of anaesthetic having 
been established empirically as that which main-
tained adequate depth of anaesthesia without caus-
ing anaesthetic death. With etomidate, 4 mg i.p. 
was adequate for anaesthesia for femoral vein cannu-
tation, whereafter anaesthesia was maintained by 
continuousi.v. infusionofl0-15 mg kg-1 h-1• With 
ketamine the doses were 100 mg kg-1 i.p. and 10-
15 mg kg-1 h-1, respectively. Both drugs were 
diluted so that the volume of fluid administered 
approximated 2 ml h-1• 
Spontaneous respiration of air was maintained 
throughout anaesthesia. Experiments were con-
ducted using pairs of rats one from each group 
anaesthetized simultaneously. Six animals in each 
group were treated for 3 days before anaesthesia 
with DDC administered orally at a dose of 
50 mg kg-1 dissolved in 1 ml of corn oil. All animals 
were starved for 24 h before anaesthesia, but were 
permitted water ad libitum. 
After 6 h of anaesthesia, animals were sacrificed 
and their livers removed, blotted free of blood and 
washed with ice-cold saline. Hepatic ALAs activity 
was assayed and full porphyrin analysis of hepatic 
homogenates carried out. 
Assays 
ALAs activity was measured by the method of 
Moore and others (1980), in which the production of 14C-labelled ALA from 14C-labelled glycine is 
measured after separation of ALA by high voltage 
electrophoresis. Incubations were carried out using 
liver homogenate at 37 °C for 1 h . 
Porphyrin analysis. Porphyrins were measured, 
using HPLC, by the method of Seubert and Seuben 
(1982). The methyl esters of porphyrins used as 
standards were obtained from Porphyrin Products 
(Logan, Utah) and dissolved in chloroform. The 
separations were performed on a Waters liquid 
chromatograph with a Model 6000-A solvent 
delivery system, a Model 710-B WISP automatic 
injector, a Model RCM-100 module and Radial-
PAK silica cartridges, 10-µm particle size and a 
Model 420-AC fluorescence detector (Waters 
Associates, Milford, Mass.). The chromatograms 
were evaluated with a Waters Model 730 Data Mod-
ule. 
Liver samples for porphyrin analysis were pre-
pared as follows: known weights of liver were 
esterified overnight, in the dark at room tempera-
ture in 10 volumes of 5% sulphuric acid in methanol 
solution. After centrifugation the supernatant was 
neutralized with 5% ammonia solution in a separat-
ing funnel where the porphyrin esters were 
extracted into chloroform, washed with distilled 
water and dried by draining over anhydrous sodium 
sulphate. Before injection to the chromotograph, 
each sample was evaporated to dryness in a Bucchi 
rotary evaporator and redissolved in exactly 1 ml of 
chloroform. 
TABLE I. Un1rea1ed rats anaesthetized for 6 h with kttamine or e11,midate. No value was signiflClllllly diff tren1 from 
conlTOI ( unanaestluliud) 
ALAs Uroporphyrin Coproporphyrin Protoporphyrin 
(mmol h- 1/gprotein) (mmol/g liver)(wet) (mmol/g liver) (wet) (mmol/g liver)(wet) 
U nanacsthetized 
n 12 3 3 3 
Mean 57 .5 0.0075 0.2314 0.8046 
SD 21.0 0.0044 O. lll6 0.0814 
Ketamine 
n 6 5 s 5 
Mean 53 .0 0.02672 0.2193 0.7613 
SD 22.0 0.0450 0.1293 0.1936 
Etomidate 
n 6 5 5 5 
Mean 69.0 0.0487 0.2975 0.9115 
SD 12.0 0.0584 0.1000 0.2936 
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TABLE II . DDC-primed rars anaesrherized for 6 h wirh keramine or eromidare. *Significanr difference from conrrol 
( unanaesrherized) 
ALAs Uroporphyrin Coproporphyrin Protoporphyrin 
(mmol h-1/g protein) (mmollg liver) ( wet) (mmolig liver) (wet ) \mmol,g liver)(wet) 
U nanaesthetized 
6 3 3 3 
Mean 426.1 0.0271 0.679 9.2536 
SD 122.3 0.0238 0.1709 1.0582 
Ketamine 
n 6 5 5 5 
Mean 473 .0 0.0544 0.6950 9.1044 
SD 77.0 0.7123 0.2799 1.0369 
Etomidatc 
n 6 5 5 5 
Mean 625 .0 0.2869 1.2598 12.9715 
SD 105.0 0.2666 0.4452 1.3720 
P* <0.02 ns <0.05 <0.01 
Control data were obtained from similar assays 
undertaken on six unanaesthetized rats, half of 
which were pretreated with DDC. The significance 
of differences between sample means was estab-
lished by means of Student's t test. 
by a corroborative increase in resultant haem pre-
cursors. The failure of the observed increase in 
uroporphyrin to achieve statistical significance 
reflects the large variation in haem precursor 
150 
RESCLTS 
Anaesthesia with ketamine caused no significant 
change when compared with unanaesthetized con-
trols in either untreated (table I) or DOC-primed 
(table II) rats. Hepatic ALAs activity and porphyrin 
content were the same in both groups. 
By contrast, 6 h of etomidate anaesthesia, which 
produced no change from control in untreated 
animals (table I), caused a marked increase in all 
these parameters in DOC-primed rats (table II, fig. 
1). The 47% increase in hepatic ALAs activity and 
corresponding 85% increase in coproporphyrin and 
40% increase in protoporphyrin content were statis-
tically significant. The almost 10-fold increase in 
uroporphyrin failed to achieve statistical signifi-
cance because of the large variance in the values. 
DISCUSSIOK 
The essential criterion for judging the por-
phyrinogenicity of a drug in the DOC-primed rat 
model of latent variegate porphyria is a demonstra-
ble increase in hepatic ALAs activity in response to 
administration of the drug (Blekkenhorst et al., 
1980). On these grounds we must infer from our 
experiments that etomidate is potentially por-
phyrinogenic. The 47% increase in ALAs activity 
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FIG 1. Effect of a 6-h infusion of etomidate on 5-aminolaevulinatc 
synthase (ALAs) activitv and haem intermediates in DOC-
primed rats. 0 = cont~ol. URO = uroporphyrin; COPRO = 
coproporphyrin; PROTO = protoporphyrin. •Significantly 
different from control. V enical bar = standard error of 
difference. 
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response to drug administration, previously 
observed by Eales and Blekkenhorst (1978), and the 
small numbers of animals used in the present trial. 
Identification of a porphyrinogenic drug in an 
animal model is far removed from proof that it is 
potentially dangerous to the human sufferer from 
genetic hepatic porphyria. We identify only that, in 
this particular animal model, the drug in question 
displays a property known to characterize those 
drugs which do precipitate crises in susceptible 
humans. Drug metabolism differs profoundly 
between species, and even animals so apparently 
similar as rats and mice display marked variation in 
the response of their haem biosynthetic pathway to 
.:he effects of various drugs. 
Final proof of the porphyrinogenicity of a drug 
should come from a clinical report of the initiation of 
an acute crisis in a susceptible individual following 
exposure to the drug. Regrettably, even this premise 
may be false-there are well documented inconsis-
tencies. 
Disler and colleagues ( 1982) devised the following 
simple classification of drugs to guide clinicians in 
the assessment of porphyrinogenicity: 
Category A 
Drugs rcponed in terms of clinical 
experience as dangerous or safe by three or 
more authorities . 
Category B 
As above but only two or fewer authorities. 
CategoryC 
Drugs evaluated only in the experimental rat 
model. 
Category D 
Drugs evaluated in chick embryo liver cell 










On the basis of our present observations and those 
of Parikh and Moore ( 1978), etomidate qualifies for 
a "C" rating. From this we infer that, although its 
use in susceptible individuals cannot be definitely 
contraindicated, it should be so used only when no 
convenient alternative is available. Thereafter, the 
patient should be observed and appropriately 
screened for a period, using biochemical tests, in 
order to detect any nascent crisis in good time. 
Although ketamine has been implicated as por-
phyrinogenic in a single case report (Wetterberg, 
1976), it is considered safe by many authorities 
(Rizk, Jacobson and Silvay, 1977; Parikh and Moore 
1978; Silvay, Miller and Tausk, 1979). Our present 
study supports this belief in its safety for use in the 
patient with porphyria. 
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Propofol anaesthesia in pharmacogenetic states 
G Harrison, University of Cape Town, Cape Town, South Africa 
Two of the pharmacogenetic conditions of direct interest to the anaesthetist are of par-
ticular concern because their abnormal drug responses may be immediately life-
threatening. These conditions are malignant hyperthermia susceptibility and the acute 
porphyrias. For each, the policy for the prevention of crises dictates: (1) identification of the 
susceptible individual, and (2) identification of the drugs which provoke an abnormal reac-
tion and, the corollary, identification of the drugs that are safe to use. With this ,·iew, I will 
review the response to propofol of individuals subject to these two conditions. 
Malignant hyperthermia susceptibility (MHS) 
Introduction 
Susceptibility to this covert myopathy, which is autosomally dominant, is identifiable in 
relatives of those who have suffered malignant hyperthermia (MH) syndrome by in vicro 
contracture testing (!\'CT) of biopsied skeletal muscle. The anaesthetic agents and 
adjuvants which trigger the syndrome include all volatile agents - in particular, the 
halogenated compounds - and the non-depolarizing muscle relaxant, succinyl choline or 
suxamethonium. Triggering of MH has not been attributed to any of the intravenous 
anaesthetic drugs, but three have been shown to influence it ri l: (1) etomidate may shorten 
onset time, (2) thiopentone may lengthen it, and (3) 'Althesin' blocks it - a property which 
made this drug the anaesthetic of choice in the MHS patient. The introduction of propofol 
into clinical practice contemporaneously with the withdrawal of'Althesin' due to its vehi-
cle, 'Cremophor', suggested it as an obvious replacement. 
The first objective evidence that propofol was likely to be safe in MHS individuals was 
provided by Denborough and Hopkinson's brief report in 1988 [2] of propofol's Jack of 
effect on IVCT of muscle biopsied from two MHS swine and two MHS humans. Further 
evidence to support this conjecture was added in 1989 by the simultaneous publications of 
Krisovic-Horber er al. [3] and ourselves [4], which reported the negative in vivo response to 
pro po fol of batteries of MHS swine. We concluded from this evidence that it would be safe 
to proceed with a clinical trial of propofol in human MHS patients. 
Methods 
Over the past three years, all patients presenting to our unit for muscle biO?SY fo:: c.i:?.~ost-
ic IVCT for susceptibility to MH, have been anaesthetized according to a standard pro-
tocol which included the use of propofol for the induction and maintenance of anaesthesia 
by continuous infusion. Included also were Valium premedication, alfentanyl analgesia, 
atracurium neuromuscular block (NMB), endotracheal intubation and IPPV with NP.'02 
(Fi0"=0.3) and NMB reversal with neostigmine/glycopyrrolate. Vital function monitor-
ing included ECG and automated non-im·asive blood pressure recording, capnography, 
inspired gas and pulse oximetry, and nasal thermometry. Dantrolene was immediately 
available in the operating room. 
186 
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Vital function signs of MH were specifically looked for, including (1) rise in FECO~; 
(2) fall in Sa01; (3 ) signs of sudden sympathetic excitation (tachycardia and hypertension); 
(4) muscle rigidity; and (5) rise in core temperature. 
Results 
Of21 patients anaesthetized for muscle biopsy for IVCT, 10 displayed the IVCT criteria of 
MHS [5]. The time course of operation and anaesthesia ranged from 60-90 minutes. No 
patient displayed any evidence of MH triggering, nor were any other complications 
noted. 
Conclusions 
These observations, considered together with the cited in vitro and in vivo MHS swine data 
and other recent clinical reports [6,7,8], allow us to conclude that propofol may be used 
safely to anaesthetize individuals genetically susceptible to MH. 
The acute porphyrias 
Introduction 
This group of conditions results from autosomally dominant hereditary dysfunction of 
various enzymes concerned with haem biosynthesis [9] . Three clinical entities are of con-
cern to the anaesthetist, in that drug exposure may precipitate an acute attack. These con-
ditions are (1) acute intermittent (Swedish) porphyria (AIP); (2) \'ariegate (South African) 
porphyria (VP); and (3) hereditary coproporphyria (HCP) - the rarest. 
In these conditions, acute crises occur when stimulation ofhaem synthesis in the pres-
ence of the dysfunctional enzyme causes concentrations of precursors, especially alpha-
amino-lae,-ulinic acid (ALA) and porphobilinogen (PBG), to rise steeply. Drugs which 
precipitate crises, do so by stimulating the activity of ALA synthetase (ALAs) - the rate-
limiting enzvme. This stimulation is usualh• the indirect result of a reduction in the le\'el of 
haem .: th~ negati\'e feed-back repressor
0 
of ALAs - but some drugs do have a direct 
stimulant action on ALAs. 
As was the case with .i\iH, propofol was introduced into practice at about the time 
when propanidid (the only intravenous induction agent safe for porph~Tics) was 
withdrawn from practice due to reactions to its vehicle, Cremophor. 
The demonstration in an animal model that propofol was non-porphyrinogenic [10), 
moti\'ated our assessment ofits potential for safe clinical use in human subjects susceptible 
to the acute porphyrias. A multicentre, prospective clinical trial was conducted using pro-
pofol as the intravenous anaesthetic induction agent in 13 sufferers from VP and 21 non-
porphyric control patients who presented for surgery. The results of this trial have now 
been published [11 J. All patients were monitored clinically and biochemically immediately 
pre- and post-anaesthetic for up to five days. The biochemical parameters monitored 
included the concentrations of urinary porphyrins and their precursors, ALA and PBG, as 
well as the porphyrin content of plasma and stools. A statistical comparison was made of 
the concentrations of these compounds measured pre-anaestheti.: (day 0) and on days 1, 3 
and 5 post-anaesthetic (Fig. 1 ). 
\'\'hile ALA, PBG and porphyrin concentrations in the group of porphyric patients 
were at all times significantly higher than those in t:1e control group, at no stage did they 
exceed the limits established (in our laboratory) for VP patients in remission. Nor was any 
significant increase over baseline levels of porphyrin precursor or porphyrin output found 
r-ost-2:-:2estheti.: in either the ooroh\":-i:: or control groups of '!:'atients. ~o adverse clinical 
~eactions suggestive of acute a"mick were noted post-anaestneti.: in any porpnyri.: 
patient. 
We concluded from these obser\'ations that propofol is safe to use as an anaesthetic 
induction agent in patients suffering \"P and probably, therefore, in patients subject to the 
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Fig.1. Flucruarfrms fr: the mean·( ::. SD) urinary concmrrarions of AL.A, PBG and total 
porphyrins in VP subjects and non-porphyric controls, follO'Wing induction of anaesthesia with 
propof o/. (DeritJed from [8 ]). 
During the course of this trial, eight repons were published of the safe use of propofol 
in single patients subject to the other acute porphyrias - seven with AIP and one with 
HCP [12-19]. To six of these patients, administration was by incremental doseage or con-
tinuous infusion. In addition, one discordant repon appeared [20] which documented an 
188 
2.3 
increase in urinary porphyrins and their precursors following an anaesthetic with propofol 
administered by continuous infusion to a VP patient, the third anaesthetic received by. the 
patient in as many days. However, the increases observed, which we considered moderate 
(21 ], were not associated with any of the clinical signs of acute porphyria. 
While propofol's exceedingly short metabolic half-life makes it ideally suited for con-
tinuous infusion techniques and for total intravenous anaesthesia (TIVA), this aspect ofits 
use had not been directly addressed in Parikh and Moore's animal screening (10] or our 
human trial of the drug [11]. As this property could have a bearing on the expression ofa 
drug's potential porphyrinogenicity, we have studied this aspect in the diethoxycarbonyl 
dihydrocollidine (DDC) pretreated rat model of VP. This investigation, as yet unpubli-
shed, was undertaken in collaboration with my colleagues, Drs. Meissner and Davis. 
Methods 
In this animal model, blockage offerrochelatase activity by pretreatment with DDC prod-
uces conditions in the rat which simulate those in patients subject to VP. \'X1e studied the 
effects on haem biosynthesis ofTIVA with propofol of four hours' duration, and compared 
these with the effects of a similar adtninistration of the classic porphyrinogen, phenobar-
bitone. 
Drugs were administered by automated syringe-pump via a femoral vein catheter. 
Dosages given to groups of12 rats each, were (1) propofol, i.p. loading 133 mg/kg, followed 
by i.v. infusion ofl3-10 mg/kg/h, or (2) phenobarbitone, i.p. loading 133 mg/kg, followed 
by i.v. infusion of 200 µg/kg/h. One hour before this procedure, 15 mg/kg of DDC in 
01.arachis (5 mg/ml) was administered i.p. to half of each group and a similar volume of 
01.arachis alone to the remainder. After the four-hour drug infusion, the animals were 
killed and hepatectomized and the concentrations of uro-, copro- and protoporphyrin in 
liver homogenates were assayed. Normal (control) concentrations of these intermediates 
were derived from a matched group of animals not subject to drug exposure. 
Results 
Results are summarized in Fig. 2. The classical stimulation of haem biosynthesis by 
phenobarbitone is shown by the consistent and marked increases in concentrations of all 
three porphyrins compared with non-drug-exposed controls. In particular, concentrations 
Pnenooa,o,:one Pro:iofol 
3001 
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' Fig. 2. Percentage change from control (non-drug-exposed) levels in the concentrations of uro-, 
copro- and procoporphyrins in liver homogenaces of racs subjected co four-hour TIT'A with 
phenobarbitone and propofol. 
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of the distal porphyrin intermediates, copro- and protoporphyrin, were significantly 
enhanced by DDC pretreatment, rising from 105% and 225%, respectively, in excess of 
those in non-drug-exposed controls in the absence of DDC, to 288% and 285% after 
DDC pretreatment. 
By contrast, the pattern of response to propofol infusion showed no evidence of consist-
ent stimulation of haem biosynthesis, and the small changes that were recorded were un-
affected by pretreatment with DDC. 
Conclusions 
\Y/e conclude that these findings, considered in the light of the human evidence cited above, 
confirm propofol's lack of porphyrinogenicity. \VJe consider it safe to use for the induction 
and maintenance of anaesthesia in patients subject to the acute prophyrias. 
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PROPOFOL AS AN I.V. ANAESTHETIC INDUCTION AGENT 
IN VARIEGATE PORPHYRIA 
P. N. MEISSNER, G. G. HARRISON AND R. J. RIFT 
SUMMARY 
The choice of an i. v. anaesthetic induction poses 
problems for the anaesthetist confronted with a 
patient with one of the acute porphyrias. We 
undertook a prospective clinical trial in 13 
variegate porphyric subjects using propofol as an 
anaesthetic induction agent. Urinary porphyrin 
precursors and porphyrins were measured before 
operation and 1-5 days after operation. Stool 
and plasma porphyrin concentrations were 
measured over the same period. Comparison of 
these data in the porphyric patients and in 21 
control subjects over the trial period revealed no 
significant change in porphyrin or porphyrin 
precursor output after operation. Urinary por-
phyrin precursor concentrations did not exceed 
the limits established for variegate porphyric 
patients in remission. and there were no changes 
in the stool and plasma porphyrin profiles or any 
symptoms of an acute porphyric attack. We 
conclude that propofol did not appear to be 
porphyrinogenic when used for the induction of 
anaesthesia in 13 patients with variegate 
porphyria. 
KEY WORDS 
Anaesthetics. intravenous : propofol. Complications : por-
phyria. 
The porphyrias are a group of disorders in which 
there is disturbance of haem biosynthesis, 
resulting in excessive production of haem pathway 
intermediates, the porphyrins and their 
precursors 6-aminolaevulinic acid (ALA) and 
porphobilinogen (PBG). The underlying abnor-
mality may be hereditary or acquired and reflects 
a defect of any one of the steps of haem formation 
(fig. 1) [ 1]. The clinical features of the porphyrias 
are two-fold: photocutaneous sensitivity, caused 
probably by tissue accumulation of the por-
phyrins, and the acute attack [2, 3]. The latter 
presents with mild to severe abdominal and 
neuropsychiatric symptoms and may be fatal. 
Such an attack is often precipitated by drugs. 
However, patients may develop spontaneous 
attacks in response to stress, infections, fasting 
and endogenous hormonal fluctuations [4, 5]. 
Three types of porphyria may exhibit these acute 
symptoms : acute intermittent porphyria (AIP), 
hereditary coproporphyria (HCP) and variegate 
porphyn·a (VP). The acute attack is always 
associated with increased production and ex-
cretion of ALA and PBG [6]. These compounds 
are strongly implicated, therefore, in the genesis 
of acute symptoms, although a causal relationship 
has not been established unequivocally; increased 
urinary concentrations of ALA and PBG do serve, 
however, as markers of such an attack. 
Although not encountered commonly, the 
porphyrias are of panicular importance to the 
anaesthetist, as anaesthetic agents arc among those 
incriminated most strongly in the precipitation of 
the acute attack. The i. v. induction agents in 
particular pose problems. The barbiturates, thio-
pentone and methohexitone, are extremely 
dangerous in porphyria [7). Propanidid was used 
safely as the standard i. v. induction agent for 
porphyric patients for more than 25 years. One 
author has reported an adverse effect on porphyria 
[8], but propanadid has been withdrawn from use 
because of a high incidence of anaphylactoid 
reactions. Althesin, withdrawn from use for the 
same reason, had been shown in both animal 
experiments and human subjects to be 
poi;phyrinogenic [8, 9). Testing of etomidate in 
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FIG. 1. The haem biosynthctic pathway, showing the enzymatic abnormalities resulting in the various 
types of porphyria. The three porphyrias which may exhibit acute symptoms arc shown within boxes. 
animal experiments also suggests porphyrino-
genicity [10, 11]. Ketamine has shown no evi-
dence of porphyrinogenicity in animal models, 
even after 6 h of infusion in the diethoxycarbonyl-
dihydrocollidine (DDC)-primed rat model [I I], 
but, even though it possesses excellent analgesic 
properties, it has other drawbacks which preclude 
its use as a routine induction agent. 
Propofol, the most recently introduced i. v. 
agent, possesses many of the properties which 
characterize the ideal anaesthetic agent [12] and in 
addition, porphyrinogenicity could not be 
demonstrated in a rat model [13] . We report here 
a prospective controlled trial ofpropofol as an i.v. 
anaesthetic induction agent in porphyric subjects. 
PATIENTS AND METHODS 
We studied porphyric subjects (ASA grades I and 
II ; aged 16-65 yr ; normal renal function) re-
quiring general anaesthesia for elective surgery 
who presented to the participating anaesthetists 
during a period of I year. As far as could be 
ascertained, no patient had been exposed to any 
porphyrinogenic drugs in their recent clinical 
history (past 6 months). Patients excluded from the 
study were those with severe underlying disease, 
an allergy to propofol, previous adverse experi-
ence with general anaesthesia, those under-
going operations on bladder or bowel, and those 
who were pregnant. These exclusion criteria were 
designed to ensure that there were no circum-
stances that could have an influence on the 
measurement of excreted porphyrins or precur-
sors, or on porphyrin metabolism generally. 
The diagnosis was confirmed in each patient by 
the demonstration of diagnostic changes in stool, 
urine and plasma concentrations of porphyrin. A 
control group was recruited consisting of people 
without a history of porphyria and in whom 
porphyrin analysis was normal. All subjects gave 
written, informed consent. 
No restrictions were placed on the anaesthetic 
procedure except that induction should be with 
propofol and that porphyrinogenic drugs should 
be avoided thereafter. The mean induction dose 
of propofol administered to the 13 patients was 
2.45 mg kg-1 (range l.~3.33 mg kg-1). There-
after, IO received halothane and three cnflurane. 
Atracurium or suxamethonium was used for 
muscle relaxation and fentanyl, alfentanil and 
morphine for analgesia. Patients were observed 
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for any clinical symptoms suggestive of the acute 
anack for up to 5 days after anaesthesia and were 
asked to report any untoward developments 
thereafter. 
Random specimens of urine were obtained 
before operation (day 0) and on days 1, 3 and 5 
after operation. Stool and plasma specimens were 
obtained also, wherever possible, on the same 
days. All specimens were protected from light 
to avoid spontaneous interconversion or photo-
degradation of the precursors or porphyrins. 
ALA and PBG were measured by an established 
ion-exchange technique [14] using test kits 
(Biorad, Munich, West Germany). Urinary, stool 
and plasma porphyrins were extracted, esterified, 
separated by thin-layer chromatography and 
measured by fluoroscanning, according to es-
tablished methods [ 15-17]. Urinary concentrations 
of precursor and porphyrin were expressed as 
µmo!/ 10 mrnol creatinine and . nmol/ 10 mrnol 
creatinine, respectively, to take account of vari-
ability in urinary concentration. Changes in 
concentration of precursor or porphyrin excretion 
between days O and 1, 0 and 3, and O and 5 were 
calculated. Data from each individual patient were 
examined to assess whether values remained 
within the range of values for non-acute VP. The 
significance of any variation in porphyrin, ALA or 
PBG concentration from day O to day 1, 3 or 5 was 
assessed with Student's t test (two-tailed). Sim-
ilarly, variations in the VP group were compared 
with those in the control group, as were changes 
in the porphyric subjects' urinary concentrations 
of precursor and porphyrin from day Oto days 1, 
3 and 5 compared with those in the control group. 
Subjects 
Only patients with VP, the most prevalent form 
of porphyria in South Africa, presented for 
surgery during the study period. Thirty-one 
subjects believed by their physicians to have VP 
were enrolled. Twelve were excluded because 
biochemical evidence of porphyria was lacking or 
because data were incomplete. A further six were 
excluded from analysis because, despite an ab-
normal porphyrin profile, the diagnosis was not 
established beyond doubt. In most instances this 
was where the diagnosis rested on a mild increase 
in faecal excretion of protoporphyrin alone. Thus 
data were obtained for 13 subjects with un-
equivocal VP. These were compared with 21 
control subjects. 
TABLE I. Urinary ALA, PBG and total porphyrin (TP) 
concentrations (mean (SD)) 
ALA concn PBG concn TP conai 
(µmol/10 mmol (µmol/10 mmol (nmol/10 mmol 
Group creatinine) creatinine) creatinine) 
Propofol controls (n = 21 ) 
Day 0 9.8 (5.8) 5.0 (3.9) 55.3 (50) 
Day 1 8.9 (5.2) 5.0 (3.8) 63.8 (40) 
Day 3 10.7 (4.6) 3.9 (2.4) 56.8 (39) 
Day 5 11.7 (2.0) 3.5 (2.3) 70.5 (58) 
Propofol VP (n = 13) 
Day O 24.1 (12.9) 9.6 (7.4) 285 (243) 
Day 1 26.8 (15.6) 11.4 (10.1) 371 (424) 
Day 3 21.3 (12.4) 6.6 (3.9) 128 (70) 
Day 5 24.4 (9.6) 9.1 (7.8) 277 (257) 
Nonna] population (n = 97) 
14.0 (12.7) 5.2 (4.4) 112 (110) 
Non-acute VP population (n = 228) 
29.3 (27.6) 8.1 (23.6) 473 (924) 
RESULTS 
It has been held traditionally that subjects with 
VP have normal urinary concentrations of ALA 
and PBG during remission. We have become 
aware that this is not so. We therefore redefined 
our normal ranges (mean, 2 SD) separately for a 
group of 221 subjects with VP known to be free of 
acute symptoms, and 93 non-porphyric subjects. 
These data were drawn from results from our 
laboratory over the past 5 years. The redefined 
normal ALA and PBG upper limits for VP 
subjects free of acute symptoms were 78 and 
55 µmol/10 mmol creatinine, respectively. The 
upper limits for non-porphyric subjects were 40 
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FIG. 2. Fluctuation of the mean (SD) urinary concentration of 
ALA for the control (IS! ) and porphyric (. ) groups. Individ-
ual values fell within the upper limits of "normal" for each 
respective group at all times. 
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FIG. 3 . Fluctuation of the mean (SD) urinary concentration of 
PBG for the control (i:s:I) and porphyric <•) groups. Individ-
ual values fell within the upper limits of "normal" for each 
respective group at all times. 
The mean concentrations of ALA, PBG and 
porphyrin in the porphyric patients were greater 
than those in the control group at all times (table 
I), including day O (P < 0.001), but ALA and 
PBG concentrations did not exceed the limits 
established for VP patients in remission (figs 2, 3). 
No significant increase in output of porphyrin or 
porphyrin precursor over the baseline was found 
after operation (P > 0.1); the porphyric group 
behaved similarly to the control group in this 
respect. The mean urinary concentrations of total 
porphyrin of the porphyric group varied greatly 
and were greater than those of the control group 
(fig. 4). Again, the change from day O to the 
postoperative days was not significant. No change 
in pattern of excretion of urinary porphyrin to 
the earlier haem pathway intermediates was 
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FIG. 4. Fluctuation of the mean (SD) urinary concentration of 
total porphyrin (TP) for the control (i:s:I) and porphyric <•) 
groups. The concentrations in the porphyric group are high, 
indicative of the underlying porphyric status of the VP 
patients. 
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demonstrated by thin-layer chromatography (data 
not shown). Such a shift would be expected if the 
pathway were stressed. There were no changes in 
stool and plasma porphyrin profiles (data not 
shown). 
No symptoms suggestive of an acute attack of 
porphyria were noted in any subject at any stage. 
DISCUSSION 
To be considered safe for use in the acute 
porphyrias, ideally a drug should meet the 
following criteria: first, it should not cause 
increase in production of porphyrin or porphyrin 
precursor, and should not induce ALA synthetase 
or diminish free haem concentrations in lab-
oratory test systems, including various types of 
cell culture [6, 18-20) and laboratory animals 
rendered porphyric by the administration of 
agents such as DDC [6, 9, 21, 22); second, the 
drug should be devoid of porphyrinogenic po-
tential in human subjects-its administration 
should not be followed by symptoms of the acute 
attack or by a significant increase in excretion of 
porphyrin and precursor. Such data are usually 
derived from personal experience, anecdotal evi-
dence or from individual case reports. Few, if any, 
drugs have had porphyrinogenicity tested pro-
spectively in controlled trials in porphyric 
patients. Thus doctors must often base their 
decision to use a particular drug in a porphyric 
subject on incomplete or possibly inaccurate data. 
Also, experience in human subjects and laboratory 
testing sometimes give conflicting results 
[6, 8, 23). 
Propofol has been reported not to induce 
hepatic ALA synthetase in the rat [13) and 
therefore, by implication, to be non-porphyrino-
genic, but it induces hepatic ALA synthetase in 
DDC-primed chick embryos [20 and personal 
communication, Deybach JC). However, this 
system is considered by some to be extremely 
sensitive and may produce seemingly false positive 
results [6). There have also been conflicting 
reports on its safety in humans. In one study, 
propofol was used to induce anaesthesia in a 
patient with AIP with apparent safety [24), 
whereas another case report indicated that urinary 
concentrations of porphyrin and PBG increased 
in a VP patient anaesthetized with propofol [25). 
However, this patient had been exposed to several 
anaesthetics over a few days, including an infusion 
of propofol, and the changes in concentrations of 
2.3 
64 THE BRITISH JOURNAL OF ANAESTHESIA 
porphyrin and PBG were unconvincing (26, 27]. 
The patient did not experience acute symptoms. 
This study represents a clinical trial undertaken 
to assess the safety of propofol for the induction of 
anaesthesia in patients with an acute porphyria. 
The lack of significant increase in concentrations 
of ALA and PBG following administration of 
propofol suggests that the drug has low 
porphyrinogenic potential in porphyric subjects, 
at least when used in the dose and manner 
reported here. This is supported further by failure 
to alter the urinary, stool and plasma profiles of 
porphyrin either quantitatively or qualitatively. 
No symptoms suggestive of the acute attack were 
noted. We conclude, therefore, that propofol, as 
used for the induction of anaesthesia in 13 patients 
with VP, did not appear to be porphyrinogenic. 
However, the number of patients studied was 
small and the disease is unpredictable, so care 
should always be taken when using any drug in 
porphyria. We cannot extrapolate our findings to 
the use of propofol for maintenance of general 
anaesthesia by continuous infusion until further 
clinical experience has been obtained. In the light 
of the case report referred to above (25], we 
suggest that caution be exercised with propofol 
for this purpose. 
Comment is necessary on the choice of 
halothane for maintenance of anaesthesia in this 
study. Two reports and some experimental data 
warn of its risk in porphyric patients [7, 20, 28], 
but this conflicts with other experimental data 
[ IO] and much clinical experience accumulated by 
our and other units, where it has been used safely 
in porphyric patients on numerous occasions. As 
10 of our patients received halothane, this study 
presents substantial evidence that halothane, in 
addition to propofol, may be used safely in the 
acute porphyrias. 
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REVIEW ARTICLE 
Anaesthesia for the porphyric patient 
G. G. HARRISON, P. N. MEISSNER AND R. J. RIFT 
The porphyrias feature prominently among the pharmaco-
genetic conditions of concern to the anaesthetist, in parti-
cular the three so-called 'acute' prophyrias: acute 
intermittent porphyria, variegate porphyria and hereditary 
coproporphyria. The drug-induced acute attack may be 
life-threatening, and some drugs in common use in anaes-
thetic practice are highly dangerous in porphyria. Many of 
the drugs in the anaesthetist's formulary are listed as 
potentially porphyrinogenic, yet in many instances the 
evidence for such listing is tenuous. An awareness of 
porphyria is essential to any anaesthetist, and is parti-
cularly relevant in northern Europe, with its high incidence 
of acute intermittent porphyria, and in South Africa which 
enjoys the highest incidence of variegate porphyria in the 
world. Here variegate porphyria manifests among ethnic 
groups of pure or mixed western European origin with an 
estimated IO 000-20 000 individuals being affected [J-5). 
The acute attack of porphyria may be prevented by 
(i) the identification of individuals at risk and (ii) the iden-
tification of drugs that are porphyrinogenic and their 
subsequent avoidance in porphyric patients. 
The many changes in the anaesthetic drug formulary 
over the last decade. both deletions and additions, provide 
a raison d 'etre for a specific review of the drugs currently 
used in anaesthetic practice. While this review will not 
cover the detailed description, diagnosis and treatment of 
porphyria, the pitfalls in diagnosis require emphasis. 
Laboratory screening may not necessarily exclude 
porphyria unequivocally. Latent carriers may express the 
classic porphyrin excretion patterns extremely subtly or 
demonstrate no sign of altered porphyrin metabolism at all. 
Such carriers are at risk of an acute attack. Included in the 
latent group would be all prepubertal children of porphyric 
families who, though normal on biochemical screening, 
may be precipitated into an acute attack by exposure to 
porphyrinogenic drugs [6]. We would suggest that the only 
clinical defence is for the anaesthetist to treat all patients 
who have a family history of porphyria, or who have signs 
and symptoms suggestive of porphyria. as potentially at 
risk. irrespective of age or biochemical status. 
Porphyrinogenicity of drugs commonly used in anaesthesia 
By combining and comparing data from several published 
drug lists [5, 7-14) with the personal experience of medical 
practitioners managing porphyric patients and information 
derived from the screening of drugs in animal and tissue 
culture models, we have attempted to evaluate for the 
anaesthetist the relative safety of drugs in everyday use for 
the porphyric patient. It is worth mentioning that such an 
exercise is often frustrating because new drug lists very 
often emerge by modification of existing lists. Thus the 
original source of information sometimes appears to have 
been 'lost in the mists of time' and inaccuracies in reporting 
may have been unknowingly perpetuated. 
It must be noted that with the data presently available to 
us, any list classifying drugs as potentially safe or poten-
tially unsafe will be incomplete. There are those drugs 
whose use in porphyric individuals had not been recorded, 
or investigations of their porphyrinogenicity in experi-
mental models not undertaken. The list of 'safe' drugs, in 
particular, may be understated as generally it is unfavour-
able reactions to drugs rather than a lack of reaction that 
are reported in the literature. On the same basis, some 
drugs reported as 'unsafe/dangerous' may be so listed 
because many instances of their safe use in porphyric 
patients have not been reported, whereas a single 
unfavourable reaction may have been. 
A list of drugs in every day use in clinical anaethesia is 
shown in Table I, classified in descending order of safety as 
safe. possibly safe, contentious, probably unsafe and 
unsafe. Some of these are discussed in greater detail below. 
Intravenous induction agents 
It is the induction of anaesthesia that has provided the 
major problems when anaesthetising the porphyric patient. 
Those stock-in-trade intravenous anaesthetic induction 
agents, the barbiturates, have long been clearly 
contraindicated [7, 15-19). 
Propanidid, though recently listed as 'contentious' 
because it was reported as unsafe in one review [8], was 
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Table I. Safety of drugs commonly used in clinical anaesthesia for patients with acute porphyrias. 
Safe (S) 
Drug group Possibly safe (PS) 
Intravenous induction agents Propofol PS 
Midazolam PS 
Inhalation agents Nitrous oxide s 
Cyclopropane s 
Diethyl ether s 
Muscle relaxants Curare s 
Suxamethonium s 
Vecuronium PS 
Neuromuscular blockade Atropine 
reversal Neostigmine s 
Local anaesthetics Procaine s 
Amethocaine PS 










Anti-arrhythmics Procainamide s 
P-blockers s 
Other cardiovascular drugs Adrenaline s 
Phentolamine s 
Bronchodilators Corticosteroids PS 
Salbutamol s 
Gastric-for Caesarean Metoclopramide PS 
section Domperidone s 
generally accepted as the induction agent of 
choice [9, 18,20] and had been safely used in South Africa 
as the standard intravenous induction agent for porphyric 
patients for 25 years. Unfortunately, it was withdrawn 
from practice because of a high incidence of anaphylactoid 
reactions consequent on its Cremophor formulation. The 
withdrawal from practice of Althesin for the same reasons 
was of little consequence, for this drug ~ad been shown to 
be potentially porphyrinogenic in experimental models [20]. 
Etomidate provided the next hope for a safe intravenous 
induction agent. Laboratory studies initially suggested it to 
be nonporphyrinogenic [20] and it has been used in several 
porphyric patients without any apparent clinical harm 
(personal experience, G.G. Harrison). Further evidence 
from experimental models, however, is against it [10,21] 
and one corroborative report of acute human crisis 
following its use has been reported [22]. It is, nevertheless, 
worthwhile to note that the drug has an extremely short 
half-life and that its use as an induction agent only may not 
provide a stimulus of sufficient strength and duration to 
stimulate haem synthesis and evoke an acute attack of 
Contentious (C) Unsafe (U) 
No data (ND) Probably unsafe (PU) 
Ketamine C Barbiturates u 
Etomidate PU 
Halo thane C Enfturane PU Isofturane ND 
Atracurium ND Alcuronium PU Pancuronium C 
Glycopyrronium ND 
Lignocaine C Mcpivacaine PU Prilocaine C 
Bupivacaine C 
Alfentanil ND Pentazocine u Sufentanil ND Tilidine u 
Diazepam C All other 
Triazolam C benzodiazcpincs u Oxazepam C 
Lignocaine C Verapamil u 
Mexilitine ND Nifedipine u 
Bretylium ND Diltiazem u 
Disopyramide C 
P-agonists ND Hydralazine u 
ix-agonists ND Phenoxybenzamine u 
Sodium ND 
nitroprusside 
Hexaprenaline ND Aminophylline u 
Ranitidine C Cimetidine PU 
porphyria. Only if no alternative were readily available 
would we suggest the cautious use ·or etomidate with 
careful monitoring of the patient both clinically and 
biochemically after anaesthesia. 
Ketamine has shown no evidence of porphyrinogenicity 
in rat models [23,24], even after infusions of 6 h in the 3,5-
diethoxycarbonyl- I ,4-dihydrocollidine (DOC) primed rat 
model [21]. It has been used with apparent safety as an 
induction agent in porphyric patients by some 
anaesthetists [8,25-27] and owes its listing here as a 
'contentious' drug to one report from Poland of a 
porphyric crisis following its use [I I], and evidence that it is 
porphyrinogenic in chick embryo experimental 
systems [9,28]. A further report of an adverse reaction in a 
human patient is of doubtful significance since the patient 
was already in an established acute attack of 
porphyria [29]. However, though possessing excellent anal-
gesic properties, some of ketamine's other effects are draw-
backs to its routine use as an induction agent, especially in 
adults, and its 'contentious' listing for use in porphyria is 
thus perhaps appropriate. 
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Propofol, the most recently introduced intravenous 
anaesthetic, possesses many of the properties that 
characterise the ideal anaesthetic agent, in particular, a 
short metabolic half-life (30]. The lack of porphyrinogenic 
potential it demonstrated in a rat model [19] has now been 
confirmed in a prospective controlled clinical trial of its use 
as an induction agent in variegate porphyria (31]. Eight 
other reports have documented the safe use of propofol in 
single patients with porphyria: seven in acute intermittent 
porphyria (32-38] and one in hereditary copro-
porphyria (39]. In six of these patients administration was 
by incremental dosage or continuous intravenous infusion. 
However, propofol appears to be an inducer of hepatic 
aminolaevulinate (ALA) synthase in DOC-primed chick 
embryos [12], and one adverse case report in a variegate 
porphyria patient documented an increase in urinary 
porphyrin concentration and porphyrin precursor concen-
tration following its administration as a continuous intra-
venous infusion (40]. This was, however, the third 
anaesthetic received by this patient in as many days, and 
the increases documented were modest and unaccompanied 
by any clinical signs of an acute attack. Subsequently, the 
question of the porphyrinogenic potential of propofol 
administered as a continuous intravenous infusion, rather 
than as a single induction boius, has been studied by our 
group (41). In a DOC-primed rat model a 4 h infusion of 
propofol failed to evoke porphyrinogenesis. From the 
animal and human data cited above, it would seem that 
propofol can now fill the gap created by the withdrawal of 
propanadid, as a safe intravenous anaesthetic for use in 
patients with porphyria. We would recommend, however, 
that patients should, in any case, be carefully monitored for 
any signs of increased porphyrinogenesis after anaesthesia. 
The benzodiazepines, which include drugs that may be 
used for the intravenous induction of anaesthesia as well as 
for sedation and anxiolysis, display a strange lack of homo-
geneity in their porphyrinogenic potential. Acute attacks 
have been reported to follow the use of diazepam, chlordia-
zepoxide. flunitrazepam and nitrazepam (8, 11.13. 17.42-
44]. While some corroborative data from animal screening 
tests exist in the case of the first three, other experimental 
systems have suggested that they are 
nonporphyrinogenic [9]. Indeed. the safe use of diazepam 
for sedation during porphyric crises has been 
documented [7-9, 17] leading to its listing as 'contentious' 
rather than ·unsafe' . Lorazepam, which is available in an 
intravenous formulation has not demonstrated porphyrino-
genicity on experimental animal screening (45]. Midazolam. 
a drug more suitable as an intravenous induction agent 
because of its kinetic profile, appears to be nonporphyrino-
genic in the DOC-primed chick embryo liver system (9) and 
has been used in porphyric patients without ill-effect (46]. 
Volatile agents 
Some volatile agents once listed. may now be omitted. For 
reasons unrelated to porphyrinogenicity. chloroform. flur-
oxene and methoxyflurane have all been withdrawn from 
use. 
Enflurane has been classed as porphyrinogenic on animal 
data alone (23]. As yet. no acute attacks in humans have 
been ascribed to it, though we do know of its use in 
porphyries (personal experience. G.G. Harrison). However, 
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without good clinical data to the contrary it is likely to 
remain as 'possibly unsafe'. 
Halothane, perhaps still the most widely used inhala-
tional anaesthetic, owes its contentious listing to two 
adverse clinical reports and to some experimental data (11]. 
This conflicts with other experimental data (23] as well as a 
large body of clinical experience accumulated by our unit 
as well as others [24, 25, 47, 48], and also with the 
convincing clinical and biochemical evidence for its safety 
in porphyric patients shown by a recent controlled clinical 
trial (31]. In the absence of any safer inhalational agent, we 
would recommend halothane as the agent of choice in 
porphyria. 
Muscle relaxants 
Suxamethonium and tubocurarine are known to be 
safe (9,43,49] but there is a suggestion that pancuronium 
may be harmful (8,50]. Alcuronium, one of the most widely 
used relaxants, has been classed as unsafe by some 
authorities (9, 10] but we think its continued uncomplicated 
use by many anaesthetists in the porphyric patient warrants 
its classification rather as 'contentious'. No data are avail-
able on any of the other muscle relaxants in current use. 
Most have been administered to porphyric patients without 
report of acute attacks, negative evidence that allows one 
to assume their safety, until data to the contrary are 
published. 
Narcotic analgesic agents 
With the exception of pentazocine and tilidine, which arc 
unsafe, the narcotic analgesics of which the morphine 
analogues are the most relevant to the anaesthetist, arc of 
proven safety. Fentanyl is nonporphyrinogenic in chick 
embryo systems [9] and has been used safely in 
porphyries (11]. Pethidine, though implicated in an acute 
attack in one case [13], has a long record of safe clinical use 
and is the analgesic of choice for the symptomatic relief of 
the acute porphyric crisis. 
Local anaesthetics 
Although lignocaine has been found to be porphyrinogenic 
in chick embryo and rat liver experimental systems [18,23] 
it has nevertheless been used frequently as a local anaes-
thetic by ourselves in the porphyric patient without ill 
effect. Procaine has been recommended as a local anaes-
thetic for porphyries since there have been no adverse 
reports. However, as we are not aware of any local anaes-
thetics, either amide or esters, having induced an acute 
attack of porphyria in humans we do not think the use of 
lignocaine, amethocaine and bupivacaine is contraindicated 
in porphyries. 
Cardiac anti-arrhythmic agents 
There are adequate substitutes for lignocaine when used for 
local anaesthesia but its ability to provide short-term 
control of ventricular arrhythmias is not so easily replaced. 
As stated, the evidence for its porphyrinogenic potential is 
derived from experimental systems, without any corrobora-
tive evidence of human porphyric crises. As ventricular 
arrhythmias during anaesthesia pose an immediate threat 
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to life that far outweighs the likelihood or risk of an 
episode of acute porphyria, we feel that its use is justified in 
these circumstances. 
Drug structures and porphyrinogenicity 
New drugs are constantly being introduced into clinical 
practice, yet screening of their porphyrinogenic potential is 
not compulsory for their registration by any statutory 
authority. As there is little or no homogeneity in the 
molecular structure of drugs which stimulate porphyrino-
genesis, there is no way of predicting which new drugs 
should be regarded with caution when administered to the 
porphyric. This places ethical constraints on the use of new 
and as yet untested drugs in the porphyric patient. 
Although the giving of new drugs may be justified when no 
satisfactory alternative safe drug is available, it would be 
more difficult to justify in the context of modern clinical 
anaesthesia, where safe alternatives are widely available. 
Inadvertent use of a porphyrinogenic drug 
Occasionally a porphyric patient will be inadvertently 
exposed to a potentially dangerous agent.· This may arise, 
for example, when the personal or family history is unavail-
able and when thiopentone has been used for anaesthesia, 
or where the anaesthetist has only noticed a Medic-Alert 
disc after induction of anaesthesia. 
Under such circumstances there is no specific prophy-
lactic therapy. However, since carbohydrate loading is 
known to suppress the synthesis of porphyrins and is 
effective treatment for the established acute attack, we 
would recommend that this be employed in the hope of 
ameliorating a subsequent attack. Large amounts of carbo-
hydrates should be given, aiming at 2000 kcal/24 hours. 
preferably enterally. or, if necessary, intravenously. At the 
very least. a I 0% dextrose infusion should be used. 
Haematin. the most effective therapy for the acute attack, 
has not been assessed as a prophylactic agent under these 
circumstances. 
It is essential that the patient's condition is carefully 
monitored for a period of 5 days following the administra-
tion of the inducing drug. A sample of urine should be 
tested with Ehrlich's aldehyde reagent daily as this will 
detect elevated porphobilinogen, thus signalling the onset 
of the acute attack. Other complaints such as severe 
abdominal pain, or the passage of red urine are suggestive 
of the onset of an attack and should be managed accord-
ingly. A publication [14] and notes from our Centre giving 
further information on porphyria, the acute attack and its 
treatment are available from the authors on request. 
Conclusion 
The very real problem anaesthesia once posed for the 
porphyric patient is reflected in the number of acute 
porphyric attacks admitted to Groote Schuur Hospital, 
Cape Town, between 1950 and 1971 when 31 of 145 
admissions for the acute attack were precipitated by the 
induction of anaesthesia with thiopentone. Two proved 
fatal. Since that time the identification of patients at risk by 
the biochemical testing of all members of proband families 
has lead to a dramatic reduction in the number of acute 
porphyric admissions [4,5). Significantly, for the past 20 
years only one of these has been related to anaesthesia. 
We believe the 'bogey' image that the patient suffering 
from variegate porphyria, acute intermittent porphyria or 
hereditary coproporphyria has long held for the anaesthe-
tist and surgeon is no longer justified. Provided patients at 
risk are clearly identified before anaesthesia by a combina-
tion of family history, clinical and biochemical examina-
tion, anaesthetists today have at their disposal a sufficient 
number of drugs that are safe to use, allowing them to 
approach the task of anaesthetising the porphyric patient 
with equanimity. 
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PART3. 
THE EFFECTS OF ANAESTHETICS ON THE LIVER 
Studies of Hepatic Drug Metabolism ofrelevance to post-Halothane Hepatitis 
and The Hepatotoxicity of Anaesthetic Agents. 
The Treatment of Fulminant Liver Failure. 
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40:15 - 17:1966. 
POSTOPERATIVE JAUNDICE WITH SPECIAL REFERENCE TO HALOTHANE* 
I. BRUK, M.B., CH.B., F.F.A. (S.A.) AND G. G. HARRISON, M.B., CH.B., F.F.A.R.C.S. (ENG.), D
epartment of 
Anaesthetics. Groote Schuur Hospital and University of Cape Town 
Halothane was introduced into anaesthetic practice in 
1956.' Structural similarity to chloroform, a halogenated 
hydrocarbon, with known hepatotoxic propensities,' imme-
diately posed the question of potential hepatotoxicity. 
The early experimental work of Raventos• was soon 
followed by extensive experimental and clinical investiga-
tions by a host of workers.'·" 
Their findings suggested that halothane was a safe non-
hepatotoxic agent, with hepatotoxic propensities no greater 
than that of other general anaesthetic agents, e.g. ether. 
From 1958. however, the above happy reputation fell 
under a cloud, when an increasing number of reports of 
both fatal and non-fatal cases of hepatic necrosis, follow-
ing halothane anaesthesia, appeared in the literature by 
various authors,•·• though in many instances the connec-
tion between administration of halothane and the appear-
ance of postoperative liver damage appeared tenuous. 
Because of these reports we decided to investigate all 
cases of postoperative jaundice in Groote Schuur Hospital. 
METHOD 
All clinical jaundice occurring postoperatively at Groote 
Schuur Hospital over a period of 10 months was investi-
gated. 
A record was kept of the anaesthetic agents administered 
to these patients and other factors known to be capable 
of producing postoperative jaundice." ·• 
The number of anaesthetics administered during this 
period was recorded. As an estimate of the incidence of 
the use of halothane during the period of this survey, we 
used as a sample a census of anaesthetic agents used in 
this hospital for one month. 
Because of the multiplicity of factors that may result in 
jaundice after cardiac surgery with cardio-pulmonary 
*Paper read at the 45th South African Medical Congress 
(M.A.S.A .), held in Port Elizabeth, July I 965. 
bypass, all such patients were omitted from this investiga-
tion, in spite of the fact that halothane is used as the 
routine anaesthetic for the bypass phase of such surgery 
in this hospital." 
Anaesthetics administered for outpatient surgery in the 
Casualty Department were also excluded, because of the 
possibility of inadequate follow-up, although halothane 
was used in 50% of anaesthetics administered in the 
Casualty Department, and no ~ses of postoperative 
jaundice were registered from this source during the time 
of this survey. 
Patients presenting for ophthalmological surgery, where 
halothane was used as a routine, provided a separate 
group in this investigation. 
RESULTS 
A follow-up of 16,500 consecutive inpatients, anaesthetized 
over a period of 10 months, produced 68 cases of clinically 
obvious postoperative jaundice. Biochemical investigation 
wa ~ carried out in 29 cases. 
Halothane had been included in the anaesthetic tech-
nique in only 7 cases. while the remainder had received a 
variety of anaesthetic techniques of which the majority 
were a thiopentone-N.0-0.-relaxant-IPPR with CO, ab-
sorption sequence. with or without the use of minimal 
amounts of ether (fable n. 
The possible factors involved in the causation of jaun-
dice in our cases are summarized in Table II. 
Of the 7 patients who had received halothane, adequate 
cause for the jaundice other than the association of halo-
thane was apparent in each case. A brief case report of 
the salient features of each follows : 
Case Reports 
Case I. Male aged 60 years. Emergency nephrectomy. Trans-
fused with 4 pints of blood, 2 of which were transfused as an 
emergency-they were compatible on Bromelin testing, but 
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because of a rare blood group factor were later found to be incompatible on Coombs test. 




3. Thiopentone-succinylcholine-N.0-0,-ether 4. Thiopentone-succinylcholine-N.0-0,· d.tubocurarine 
5. Thiopentone-succinylcholine-N,0-0,· 
halothane-gallamme ...... ...... . .... 6. Thiopentone-succinylcholine-N,0-0:· 
ha Jothane-d. tubocu rarine 
Total 










TABLE II. FACTORS WHICH WERE CONSIDERED AS IMPORTANT AETIO-
LOOICAL FACTORS 
I. Type of surgery: 
Upper abdominal-
(a) Gallbladder and common bile duct . . 
(b) Liver 
(c) Stomach and oesophagus 
(d) Major vascular . . 
(e) Other abdominal surgery 
All other surgery 
2. Massive blood transfusion 
3. Hypotension occurring during anaesthesia 










Case 2. Male aged 48 years. Ocsophagcctomy performed. The patient was transfused with 6 pints of blood during surgery. Halothane was used for only ± a !-hour and in concentrations of t to I% V /V in the inhaled mixture VOC. Case 3. Male aged 32 years. Thoracoplasty done for a bronchopleural fistula following pneumoncctomy for extensive pulmonary tuberculosis. Seven pints of blood were transfused. The patient had halothane for ± 1S min. to facilitate closure. Case 4. Male aged 50 years. The patient had 3 thoracotomics in 5 weeks for bleeding, following a decortication of the lung. A total of 52 pints of blood was transfused in a period of 5 weeks. There was jaundice after the second thoracotomy which persisted intermittently-pari passu with blood transfusion-till 4 days after the third operation. Halothane bad been used with the first two operations. 
Case 5. Female aged 38 years. Exploration of the c_ommon bile duct. Jaundice appeared on the first postoperative day and lasted for J days. Chemistry suggested an obstructive iaundice. 
Case 6. Female aged 26 years. Oesopbagcctomy performed for a stricture-8 pints of blood transfused. One week later the oesophageal suture line leaked. A gastrostomy was per· formed and the chest drained and oesophageal leak closed. Two pints of blood transfused. A thiopentone-succinylcholine· N,0-0,-halothane-d.tubocurarine sequence was used in both these cases. Clinical jaundice was noticed 4 days after the second operation and persisted for 3 weeks. Sixteen days after the second operation a laparotomy was performed for jejuna] obstruction under thiopcntone-succinylcholine-N,0-0,-d.tubo-curarine anaesthesia. Three pints of blood were transfused. In this patient, halotbane may well appear to have been a factor. but the surgical trauma and blood transfusion would appear to be greater factors. 
Case 7. Female aged 28 years. Ruptured liver repaired under thiopentone-succinylcholine-N,0-0,·halothane-gallamine anaes-thesia. Jaundice appeared on the first postoperative day. At surgery there was excessive manipulation of the liver. In addi-tion, 12 pints of blood were transfused in the peri-surgical period. 
All these patients recovered. 
To test the possible influence the administration of halothane might have on the incidence of postoperative jaundice, we matched the incidence of the use of halo-thane in the background surgical population with the fre-quency of its administration in those cases of postoperative jaundice registered (Table nn. 
TABLE Ill. PATIENTS WITH POSTOPERATIVE JAUNDICE 
Anaesthetics with halothane 














It will be seen that whereas halothane was administered in 24·8% of all anaesthetics, it had been used in 10·3% of the cases which showed postoperative jaundice. (This differ-ence is highly significant - x' = 6·94 P<O·Ol). Halothane was associated with postoperative jaundice in a signifi-cantly lower proportion of cases than is reflected in the general incidence of its use. 
Halothane in Ophthalmological Surgery 
Because of the low incidence of postoperative vomiting after its use, halothane has been used as the anaesthetic of choice for all ophthalmological surgery in this hospital for some years. Following 1,670 consecutive halothane anaesthetics for ophthalmological surgery, no cases of postoperative jaundice were recorded. 
DISCUSSION AND CONCLUSIONS 
From the above, we think that it is fair to infer that the influence of the use of halothane per se, on the occurrence of postoperative jaundice is insignificant. The occurrence of postoperative jaundice appears to be determined by other factors. 
Factors which appeared to be more significant in the production of jaundice were the type of surgery and the quantity of blood transfused. 
It may be argued that halothane and other anaesthetics were not used for comparable cases, e.g. in most major vascular and abdominal surgery, in persons prone to develop postoperative jaundice, a thiopentone-N.0-0.-re-laxant-IPPR-CO, absorption technique was used. This is to some extent true, but many of the published cases of post-operative jaundice attributed to halothane involved rela-tively minor surgery ....... n Our experience, that jaundice 
occurred most frequently associated with major abdominal surgery, and more particularly major upper abdominal surgery, is in keeping with the experience of many authors. e.g. Zamcheck,.. Geller and Tagnon." Sutton,•... and Torrance,• who described marked disturbance of liver function, raised serum bilirubin levels and even histologi-cal changes in the liver following upper abdominal surgery and particularly following gastric and biliary surgery. They ascribed these changes to varying degrees of interference with the blood supply to the liver and to direct trauma to the liver incumbent with surgery in this region. 
Massive blood transfusion was the next most common factor, 42 of lhe 68 jaundiced patients having received more than 2.500 ml. of blood. with a range of up to 30 
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litres. This is in keeping with the findings of Geller and 
Tagnon." In addition to obviously increased bilirubin 
production associated with the transfusion of stored blood, 
there was definite evidence of a hepatic element in those 
patients who became jaundiced. 
H ypotension of more than 10 minutes' duration during 
anaesthesia occurred in 7 patients, and some of these 
patients were exposed to vasopresso: s. both of which have 
been described as factors in the production of liver dam-
age. or predisposing to liver damage by anaesthetic agents 
including halothane. according to such authors as Anlyan 
et al.,"' Sims et al., .. Stephen et al." and others. 
Eleven of the patients were exposed to recurrent sur-
gery. which was associated in several of our cases with 
major abdominal surgery and massive blood transfusion. 
Lastly, it is peninent to mention the 1,670 anaesthetics 
for ophthalmological surgery. These patients all received 
halothane and no cases of postoperative jaundice were 
registered. 
It is interesting to note, in relation to this present con-
troversy, how in 1932 Guthrie and Robertson" questioned 
the use of ether . as an anaesthetic agent for gallbladder 
surgery because of the high incidence of postoperative 
liver necrosis. 
SUMMARY 
I. An investigation into the occurrence of postoperative 
jaundice in a follow-up series of 16,500 anaesthetics is dis-
cussed. 
2. Note was made of the anaesthetics administered, the 
incidence of the use of halothane, both in the cases of 
jaundice and the background surgical po~lation, and the 
occurrence of other factors known to cause Jaundice. 
3. It is concluded that the influence of the use of halothane 
per se, on the occurrence of postoperative jaundice, is not 
significant. 
We wish to thank Prof. J. H. Louw and the Heads of 
departments and firms in the Division of Surgery, and the 
Departments of Obstetrics and Gynaecology for their help and 
cooperation in our obtaining the data on which this paper is 
based. Also, Prof. A. B. Bull, Head of the Department of 
IN DIE VERBYGAAN 
Dr. B. A. Brad/ow, of Johannesburg, has been elected a Fellow 
of the American College of Cardiology, a designation which is 
rarely given to foreign graduates outside North America. 
• • • 
Dr. A . C. G. B. Anderson, formerly full-time consultant in the 
Department of Anaesthesia at Groote Schuur Hospital, Cape 
Town, has now joined Ors. J. K. Beneke and J. le R. Hau-
mann, specialist anaesthetists, in practice at 300 Medfontein, 
St. Andrew's Street, Bloemfontein. 
• • • 
Cape Western Branch (M.A.S.A .), Alan Sichel Cup Golf 
Tournament. The Alan Sichel Cup Golf Tournament was held 
Anaesthetics, for much encouragement and advice, and Dr. 
J. G. Burger, Superintendent, Groote Schuur Hospital, for 
permission to publish this paper. 
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PASSING EVENTS 
at the Rondebosch Golf Course on 9 December 1965. A total 
of 35 players participated in the competition, and the prizes 
were presented by Dr. A. W. Sichel. 
The winner of the Cup was Dr. I. Levine, and the runner-up 
was Dr. R. Gasson. The Prize for the Longest Drive was won 
by Dr. I. Levine. 
The winners of the Stableford Competition (run concur-
rently) were Drs. I. Levine and I. Kirk, and the runners-up 
were Ors. C. Rauch and P. S. Willers. The prize for nearest 
to the pin was won by Dr. J. Mervis. 
The proceeds of R52 were donated to the Benevolent Fund, 
and the organizers wish to thank the Captain of the Ronde-
bosch Golf Club for the courtesy of the use of the course. 
WORLD LIST OF FUTURE INTERNATIONAL MEETINGS 
ALTERATIONS AND ADDITIONS NOTIFIED DURING NOVEMBER 1965 
12th Congress for Laboratory Medicine, Bad Kissengen, Ger-
many (Fed. Rep.), 4. 8 May 1966. Dr. med. W. Albath, 
Katharinengasse 3, 87 Wi.irzburg, Germany (Fed. Rep.). 
2nd lnternaJional Symposium on Plastic and Reconstructive 
Surgery of the Eye and Adnexa, New York, 16 • 20 May 1966. 
Manhattan Eye, Ear and Throat Hospital, 210 East 64th Street, 
New York, NY 10021, USA. 
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Reprinted from the BRITISH MEDICAL JOURNAL, 
14 March 1970, 1, 668-671 
Multiple Halothane Exposure and Hepatic 
Bromsulphthalein Clearance 
Summary: Multiple exposures to halothane have been shown to have delayed effects on bromsulphthalein 
(B.S.P.) clearance. Rats were exposed to repeated halo-
thane anaesthetics, and their livers were subsequently 
isolated and perfused. B.S.P. retention in the perfusate of 
these isolated livers was greatly increased one to three 
weeks after the last halothane exposure. In similarly pre-
treated animals at the same time period the B.S.P.-
glutathione conjugating enzyme activity in homogenates of 
the livers was found to be depressed. These findings did 
not occur after multiple diethyl ether exposures or follow-
ing a single exposure to halothane. 
INTRODUCTION 
The question of multiple exposures has become an extremely 
important one relative to the mechanism by which liver damage 
may be caused following halothane anaesthesia (Little, 1968). 
Attention has again been drawn to this problem by several 
recent reports (Trey et al., 1968; Klatskin and Kimberg, 1969; 
Rodriguez et al., 1969), in addition to many previous individual 
surveys and case reports (Tygstrup, 1963; Sherlock, 1964; 
Morgenstern et al., 1965; Griner, 1966; Subcommittee on 
National Halothane Study, 1966). 
The controversy surrounding the possible role of halothane in 
the causation of postoperative liver dysfunction has centred on; 
among other factors, the inability of clinical and statistical 
surveys to eliminate the numerous potential causes of liver 
dysfunction during this period (viral hepatitis, blood trans-
fusion, intraoperative hypotension and hypoxia, septicaemia, 
and the concurrent administration of potentially hepatotoxic 
drugs). 
The present investigation was designed in an attempt to 
eliminate these other potential causes of liver dysfunction by 
the study of isolated pcrf uscd livers and liver homogenates from 
animals previously exposed to halothane on several occasions. 
Abnormalities of bromsulphthalein (B.S.P.) handling by the 
livers of such animals were observed, and the study was modi-
fied to confirm the findings and to attempt to isolate the 
abnormality present in the liver. 
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MATERIALS AND METHODS 
ANIMALS 
Male albino rats (weight 375-400 g.) of Wistar and Sprague-
Dawley strains, housed in conditions of controlled temperature 
and humidity and fed on a standard laboratory diet, were used 
as liver donors for both the isolated perfusion and liver 
homogenate experiments. The animals were allowed free access 
to wacer and food up to the beginning of the experiments. The 
animals were divided into three groups : 
Group 1.-Control animals. 
Group 2.-Animals exposed to multiple (3 or 5 : sec Results) 
60-minute periods of 1 % halothane vapour v /v (Vapor 
vaporizer, Drager) in oxygen, on alternate days. 
Group 3.-Animals exposed to multiple (3 or 5 : sec Results) 
60-minute periods of 4 % v /v diethyl ether vapour (E.M.O. 
vaporizer) in oxygen, on alternate days. 
To achieve these periods of light surgical anaesthesia (Dun-
can and Ravent6s, 1959) in groups 2 and 3, batches of six 
animals were anaesthetized in an exposure chamber, anaesthe-
tic mixtures being produced at a rate of 8 1./min., which is 
several times greater than the total average minute volumes of 
the rats. During the periods of anaesthesia -there was no evidence 
of hypoxia or hypcrcarbia, as estimated by blood gas deter-
minations on samples obtained by cardiac puncture from 
random animals. The animals regained full consciousness 
within minutes of the termination of the anaesthe,tic. 
These animals showed no obvious ill effects after the 
anaesthetic exposures, continued to gain weight, and behaved 
normally until their use as liver donors at varying periods after 
the exposures. 
ISOLATED LIVER PERFUSIONS 
Isolated liver perfusions were performed according to the 
method of Miller er al. (1951) as modified by Fisher and 
Kcrly (1964). The method, discussed in detail by the latter 
authors, involves the cannulation of the bile duct and ponal 
vein followed by the removal of the liver and its subsequent 
perfusion in a scaled cabinet. The ·interior of the cabinet is 
humidified, and thermostatically controlled at a temperature 
of 38°C. The liver, mounted on a glass platform with the 
diaphragmatic surface down, is perfused via the portal vein. 
The outflow via the hepatic vein runs into a reservoir below 
this platform, from where it is recirculated by a finger pump to 
the glass "thin film" oxygcnator above the liver. A 95 % 
oxygen and 5 % carbon dioxide mixture is passed into the 
oxygenator at a flow rate of 750 ml./min. 
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In the present perfusions the surgical procedure on the donor 
rats (in all groups) was performed under light diethyl ether and 
oxygen anaesthesia. The livers were not exposed to halothane 
or diethyl ether, however, during the perfusions in this series. 
Perfusate volume used was 100 ml., consisting of pooled Wistar 
and Sprague-Dawley albino rat blood obtained by cardiac 
puncture from multiple donors, diluted to a packed cell volume 
of 25 % with a balanced salt-bicarbonate solution.• Perfusate 
pH (7·35-7-42). Pol (150-175 mm. Hg.), and PCC>.? (35-40 mm. 
Hg) were monitored at IS-minute intervals by the Astrup 
technique and kept within the given ranges. The portal vein 
pressure was 18 cm. perfusate, and the measured hepatic vein 
flow was constant (1 ·25-1 ·5 ml./g. liver wet weight/min.) 
during the per:iod of B.S.P. estimation. 
Apan from limited sampling of the perfusate for blood gas 
and acid-base estimations, the perfusa-te volume in these pcr-
fusions- was kept constant. A different series of pcrf usions was 
undenaken to establish criteria of adequate perfusion and assess 
other metabolic effects of the anaesthetic agents ( various 
criteria · reflecting changes in carbohydrate and protein 
metabolism). 
B.S.P. (supplied by Hynson, Westcott and Dunning, Inc., 
Baltimore) was added, at a dosage of l ·25 mg./100 g. donor 
rat weight, to the perf usate reservoir 30 minutes after the 
beginning of the perfusion. At this time steady blood (l ·25-1 '.5 
ml./g. liver wet weight/min.) and bile flow (80-90 microlitrcs/ 
g. liver/hour) were established. Perfusate samples were then 
withdrawn from the reservoir at 1, 3, 5, and 30 minutes after 
the addition of B.S.P. 
B.S.P. concentration in the perfusate was measured spectro-
photometrically, the samples having been subjected to a tech-
nique (Henry et al., 1959) of acetone precipitation of proteins. 
This technique allows accurate B.S.P. estimations in the pre-
sence of hacmolysis. Free plasma haemoglobin levels ranging 
from 50 to 75 mg./100 ml. were present in the perfusate during 
the period of B.S.P. estimations. 
LIVER HOMOGENATES 
In an attempt to establish which of the three mechanisms 
involved in the handling of B.S.P.-that is, hepatic uptake, 
conjugation, or excretion-was responsible for the findings 
from the isolated perfusion experiments, liver homogenates 
from livers of animals previously exposed to halothane and 
diethyl ether were used to estimate levels of hepatic B.S.P.-




glutathione conjugating enzyme activity. The enzyme act1v1ty 
in the soluble supernatant fraction of liver was assayed by the 
method of Combes and Stakelwn (1962), which involves in-
cubating (for five minutes) homogenized aliquots of liver with 
B.S.P. and glutathione, and subsequently identifying the 
proportions of free B.S.P. and B.S.P.-glutathione by paper 
chromatography of the supernatant fluids. 
Quantification of the B.S.P. on the chromatograms is 
performed by elution of ,the relevant bands of paper, the 
concentration of B.S.P. in the eluate being determined spectro-
photometrically. In the present study aliquots of · liver of 
400-600 mg. were used (from freshly decapitated animals), and 
0·5 mg. of B.S.P. and 4 mg. of glutathione were the quantities 
of substrates added for incubation. The data are expressed as 
milligrams of B.S.P. conjugated per gramme of liver wet weight 
per five minutes. 
Duplicate slices of liver were assayed for glutathione con-, 
tent by the method of Grunen and Phillips (1951). 
RESULTS 
ISOLATED LIVER PERFUSIONS 
The figures for B.S.P. percentage retention in the perfusatc 
given in Tables I-IV represent the retention 30 minutes after 
the introduction of the dye to the perfusate reservoir. 
The control figures in each table refer to B.S.P. estimations 
in isolated liver perf usions where ·the donor animal had not 
been previously exposed to an anaesthetic agent. These control 
animals were housed in -the same conditions as the other 
groups, and control perfusions were interspersed at varying 
times among the perfusions of livers previously exposed to 
anaesthetic agents. 
The results of pcrfusions performed at varying times after 
three halothane exposures (as described in Group 2 ahove) arc 
set out in Table I. The statistically highly significant increased 
B.S.P. retention at one and three weeks after the halothane ex-
posures did not occur at the same periods after diethyl ether 
exposure (see Table II). 
The three-week interval following anaesthetic exposure 
was chosen to assess the effect of a single halothanc exposure, 
and Table III shows that B,S.P. retention in this group did not 
differ significantly from the controls. 
The fact that B.S.P. percentage retention values returned to 
the control perfusion range six weeks after the halothanc ex-
posures (sec Table I) prompted the investigation from which 
data arc presented in Table IV. Animals were exposed to halo-
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thane on three occasions, and after an interval of six weeks 
were re-exposed to halothane on three further occasions (using 
the technique described under Group 2). This procedure 
resulted again in an increased B.S.P. percentage retention at the 
one-week and three-week post-exposure periods, but the figures 
do not differ significantly from those in Table I. 
TABLE 1.-M,an Perfusate B.S.P. Percentage Retention ( ± S.D.) after 
Three Halothane Exposur.s 
Percenta1e retention 
















3 ... 2 
3 
N.S. 
•Number of perfusion, performed. tRefen to relevant values tr. control (Student's 
t test). 
TABLE 11.-Mean Perfusate B.S.P. Ptrctntagt Rttention ( ± S.D.) after 
Three Diethyl Ethtr Exposures 
P~rcenta1c retention 
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3 
Percenta1e retention 
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TABLE 1V.-M,an P,rfusatt B.S.P. Ptrctntag, Rettntion ( ± S.D.) after 
Thr,e Halothane Exposures, Follow,d by a six-wttlc Interval, and Thrtt 














B.S.P.-GLUTATHIONE CoNJUGATING ENZYME ASSAY 
Results of estimations B.S.P.-gluthathione conjugating 
enzyme activity in homogenates of livers from groups of 
animals, previously exposed to halothane and to diethyl ether, 
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are presented in Table V. The control data represent similar 
estimations on animals which had 'never been exposed to an 
anaesthetic agent. 
TABLE V .-B.S.P.-Glutathione Conjugating Enzyme Activity (Mean 
± S.D.) afrer Multiple (5 x ) Anamh,ri, Exposures (,,,,.. B .S.P. 
Conjugated/g. Liuir Wtt Weight/5 Minutts) 
Controls 
Interval After &poaure 
2 Weeks 3 Weeks 
After halothane { !nzyme .•~tivit~ . 
2 ·10±0·62 1·49±0·28 1·68±0·40 
26 .. 5 10 
After diethyl ether{ 
Enzyme activity 2 ·10 :±0·62 1·93±0·36 1·70±0·35 
n . . .. 26 7 6 
n • Number of animals invcsti1atcd. 
Statistical analysis of these results shows significant 
differences between the means of controls and those at two 
weeks after multiple halothane exposures (P<0·05) and between 
controls and the three-week sample (P<O·Ol). The control 
levels of enzyme activity and those following multiple diethyl 
ether exposures show no statistical difference. The glutathione 
content of duplicate slices of liver, at the two-week and three-
week post-halothane exposure periods, docs not differ signifi-
cantly from the control levels (Table VI). 
TABLE VI.-Lfoer Glutathione Content (M,an ± S.D.) Folluunng Multiple 
(5 x ) Halothane Exposures (mg. Glutathione/g. Liuer Wet Weight} 
· Controls 
Interval After &posure 
2 Weelts 3 Weeks 
Glutathione levels .. .. .. 3 ·46 ± 0 ·58 3 ·84 ± 0·45 3 ·34±0·20 
n . . . . .. .. . . 6 6 3 
P ( ti. cont~ol) .. .. . . .. - N.S. N .S. 
DISCUSSION 
The present investigation shows what appears to be a delayed 
hepatic effect of multiple halothane exposure. Several studies 
showing increased B.S.P. retention in the early postoperative 
period following single and multiple halothane anaesthetics 
have previously been reponed in man (Brindle et al., 1957; 
Virtue et al., 1958; Burnap et al., 1958; Carson et ·al., 1959; 
Griffiths and Ozguc, 1964; Joseph, 1964; Kecri-Szant6, 1965), 
in dogs (Brindle et al., 1957), in sheep (Hull and Reilly, 1968), 
and in calves (Middleton et al., 1966). During the immediate 
postoperative period raised B.S.P. retention has also been 
shown to occur following other anaesthetics : chloroform 
(Griffiths and Ozguc, 1964), cyclopropane (Prince et al., 1965), 
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and methoxyflurane (Keeri-Szant6, 1965). In these reports, 
however, the observations have been confined to the immediate 
postoperative period (up to seven days), and have not extended 
over the number of weeks reported in this communication. 
The precise mechanism of the increased B.S.P. retention 
during the liver perfusions following previous halothane ex-
posure in this study is not clear. There is considerable evidence 
(Combes and Stakelum, 1962) to support the view that the 
removal of B.S.P. from plasma is dependent on the simul-
taneous operation of two processes : (a) uptake into a hepatic 
storage compartment, and (b) excretion into bile. 
It is now generally agreed (Combes and Stakelum, 1962) that 
the major pathway of B.S.P. metabolism in man, rat, dog, and 
other species involves conjugation with the tripeptide gluta-
thione, composed of glutamic acid, cysteine, and glycine. Never-
theless, despite the observation that most of the B.S.P. excreted 
into bile is conjugated, the finding of f rec B.S.P. in bile leaves 
it uncertain whether conjugation is important for, or merely 
incidental to, hepatic uptake and biliary excretion of · B.S.P. 
Combes and Stakelum (1961) identified in liver an enzyme that 
.catalyses conjugation of glutathione with B.S.P. A depression 
of this enzyme activity has been shown in the present investi-
gation to occur after multiple halothane exposures. This depres- . 
sion parallels the increase in B.S.P. retention seen in the per-
fused livers in similar circumstances. Impairment of B.S.P. 
conjugation may also be a reflection of low hepatic glutathione 
levels. Such levels did not occur in livers of animals reported 
here, where glutathione levels after halothane anaesthesia were 
within the normal range. 
The enzyme shown to be depressed following multiple halo-
thane exposure is not specific for -the conjugation of B.S.P. 
This enzyme also catalyzes ,the conjugation of glutathione with 
other compounds (Combes, 1964), such as bromobutane, bcn-
zyl chloride, and p-fluoronitrobcnzcne. It is thus possible that 
the enzyme may be concerned with the conjugation of -trifluor-
acctic acid, which has been reported as a metabolite occurring 
during the biotransformation of halothane (Stier and Alter, 
1966; Rehder et al., 1967). The inference is that as a result of 
previous exposure to halothane certain enzymes arc depressed, 
permitting accumulation of hepatotoxic metabolites, perhaps 
chlorinated derivatives which have yet to be identified. The 
possibility of enzyme changes of this nature resulting in hepatic 
injury following halothane has been suggested by Zimmerman 
(1968). The present findings, showing biochemical derange-
ment following previous halothane exposure, arc opposed to the 
criteria (Sherlock, 1964) which, in classifying halothane hepa-
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totox1c1ty as a " sensitivity " or, allergic effect, exclude its 
reproducibility in experimental animals. 
Two further mechanisms of interference with B.S.P. 
clearance merit attention. Alterations in the characteristics of 
serum albumin (Crawford and Hooi, 1968) and the relative de-
ficiency of the hepatic cytoplasmic organic -anion acceptor pro-
tein Y (Levi et al., 1969) have been shown to interfere with 
B.S.P. uptake by the liver. The effect of halothane on these 
criteria would be of interest. 
Finally, species variations are naturally a pertinent criticism 
of the type of study presented here. A mixture of Wistar and 
Sprague-Dawley rats (as supplied in these laboratories) have 
been used in this study. Wistar rats have been reported as 
having genetic variations in enzyme patterns Gavitt, 1965), but 
it should be emphasized that in this study the same animals 
were used as controls as were exposed to anaesthetic agents. 
Despite such factors, these findings are regarded as significant 
in that they serve as a pointer to further directions in animal 
studies and possible application to comparable human 
situations . 
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Massive Lethal Hepatic Necrosis in Rats Anes-
thetized with Fluroxene, after Microsomal 
Enzyme Induction 
G. G. Harrison, M.D., F.F.A.R.C.S., • and J. S. Smith, M.B.Ch.B. 
Rats in which the level of cytochrome P450 
is raised by phenobarbital pretreatment die of 
massive hepatic necrosis when exposed to fturoxene 
anesthesia. This observation has great relevance 
to man when consideration is given to the great 
number of commonly used therapeutic agents which 
induce increased levels of cytochrome P450. Flur-
oxene anesthesia should not be used for any patient 
taking such drugs. (Key words: Enzyme induction; 
Fluroxene; Liver, necrosis; Phenobarbital.) 
UNTIL 1964, inhalational anesthetics in com-
mon clinical use, with the exception of 
trichloroethylene, 1 were considered biologi-
cally inert though pharmacologically active. 
In that year the publication by Van Dyke 
and associates2 of their fundamental discovery 
that all inhalational anesthetics in common 
use were biotransformed, immediately al-
lowed the possibility that mechanisms of 
anesthetic toxicity in the liver might have a 
biochemical basis not previously considered. 
Subsequent studies by the same workers3,. 
identified the endoplasmic reticulum of the 
liver cell as the site of, and the nonspecific 
hydroxylating enzyme cytochrome P450 as 
the agent for, these reactions. 
A pilot study in the rat into the effects 
·On liver function and histology of anesthetics 
administered in the presence of enhanced 
activity of this system6 surprised us by re-
vealing fulminant lethal hepatic necrosis in 
rats anesthetized with Buroxene, an anesthetic 
regarded until recently as innocuous to the 
liver.a We confirmed these findings in the 
following experiment. 
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Two groups of ten Wistar rats (female, 
200-300 g) each were exposed to Buroxene 
anesthesia after the levels of cytochrome P450 
in the livers had been increased by pretreat-
ment with phenobarbital, ip. 7 The livers were 
subsequently examined histologically. 
Group I rats were pretreated with pheno-
barbital, 50 mg/kg/day, ip for three days and 
thereafter (on day 4) anesthetized with Bu-
roxene for one hour, this program being re-
peated three times. Survivors were sacri.6ced 
on the third day after the third anesthesia 
(fig. 1). Group II animals were pretreated 
with phenobarbital, 80 mg/kg/day, ip, for three 
davs and thereafter (on day 4) anesthetized 
with Buroxene for three hours (fig. 2). Animals 
in both groups were starved for 24 hours 
before anesthesia (day 3), having been allowed 
food (Epol Balanced Rations) and water ad 
lib. at all other times. 
With each of these primary experimental 
groups, three groups of control animals were 
associated (figs. 1 and 2). In the first control 
group (ten animals each) the two patterns 
of Buroxene anesthesia-! hour x 3 or 3 hours 
x !-with the 24-hour periods of preanes-
thetic starvation, were studied without pheno-
barbital pretreatment In the second control 
group (ten animals each) the two schedules 
of phenobarbital administration (50 mg/kg/day 
and 80 mg/kg/day) were studied without ex-
posure to fluroxene anesthesia. After sacri-
fice at the relevant time, the livers were 
examined histologically. A third group of 
animals (15 and 5) was used for estimation 
of the cytochrome P450 levels achieved by 
the two schedules of phenobarbital admin-
istration. In these animals cytochrome P450 
content of liver homogenates was measured 
after the two schedules of phenobarbital ad-
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ministration by the method of 'Schoene et 
al.• as modified by Blekkenhorst.• For com-
parison, normal hepatic cytochrome P450 con-
tent was estimated in 11 untreated rats (not 
reflected tn tables 1 and 2) on the same diet 
and after 24 hours of starvation. 
The rats were anesthetized in groups of 
five in a dessicator 28 cm in diameter. The 
total volume of the dessicator was · 27.3 
4 --- 15 
F s L 
u A A 
0 C X 
E R N 
E 
I F1G. 1. Group I program. 
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F1G. 2. Group II program. 
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liters, 4 liters of which comprised the volume 
below the grid, which was filled with standard 
anesthetic soda lime. Fluroxene, 3 per cent, 
in oxygen, was passed through the dessicator 
at a flow rate of 51/min. This concentration 
of fluroxene was just sufficient to maintain 
a light plane of anesthesia, control animals 
regaining consciousness 2-3 minutes after 
discontinuance of the anesthesia. 
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TABLE l . Liver Weights in Group II, Expressed as Percentage of Body Weight 
Phenobarbital , 
80 mg/Day x 3 
+ 
Control, Fluroxene, Fluroxene. Phenobarbital, 
No Treatment 3 Hours 3 Hours 80 mg/Day x 3 
Number of rats 5 10 10 5 
Liver weight 
3.94 3.2 MEAN 2.5 5.45 
SD ±0.12 ±0.44 ±0.36 ±0.18 
Results 
All ten rats of Group II died during or 
immediately after their three-hour exposure 
to fluroxene, as did six of Group I, 12-24 
hours after their first one-hour exposure. Their 
livers were enlarged (table 1) and showed 
massive central and midzonal necrosis (figs. 
3, 4, and 5). Four Group I animals, though 
clinically sick after their first exposure to 
fluroxene, recovered and survived two further 
one-hour exposures. 
Liver cytochrome P450 content was in-
creased from control "no-treatment" levels 
by both schedules of phenobarbital pretreat-
ment (table 2). The Group I schedule (50 
mg/kg/day) increased cytochrome P450 levels 
by a factor (on average) _of 1.5. The Group 
II schedule (80 mg/kg/day) increased cyto-
chrome P450 content by a factor of 2.6 (dif-
ference statistically significant). 
No rat in the control groups anesthetized 
with fluroxene without enzyme induction 
died, but the livers all showed demonstrable 
histologic changes (fig. 6), the most charac-
teristic being feathery degeneration of the 
cytoplasm with widespread vacuolation. 
The livers of rats pretreated with pheno-
barbital without exposure to fluroxene showed 
only the changes in liver weight (table 1) 
and histology described previously by Burger 
and Herdson.10 
Discussion 
This study shows that fluroxene anesthesia 
in the rat in the presence of increased levels 
of hepatic cytochrome P450 causes a rapidly 
lethal fulminant hepatic necrosis, and that 
fluroxene anesthesia alone causes histologi-
cally detectable changes in the liver. This 
is indeed a remarkable finding, considering 
that this drug was originally introduced into 
clinical practice as !ong ago as 1953, 11 that 
in subsequent clinical use in man it has ac-
cumulated an impressive record of clinical 
safety, and that, let alone there being any 
suggestion of hepatotoxicity, it has been 
recommended as the anesthetic of choice 
for hepatic12 and renal13 transplantation. Be-
cause of this one might seriously question 
the relevance to man of these findings in the 
rat, were it not for the recently published 
report14 of the death from massive hepatic 
TABLE 2. Cytochrome P450 after Phenobarbital Pretreatment 
Group 1 
Phenobarbital, Phenobarbital Phenobarbital Pbenobatbital, 
50 mg/Day for 50 mg/Day for 50 mg/Day for 80 mg/Day for Control, 3 Days 3 Days 3 Days 3 Days 
No Treatment x l x2 x3 xl 
Number of rats 11 5 5 5 5 
Cytochrome, P450, 
nM/g liver 
MEAN 44 70 62 70 116 SD ±7.9 ±35.0 ±5.9 :!:19.4 :!:28.7 
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F10. 3. Section of the liver of a Group II rat dying after 3 hours of exposure to fluroxene after enzyme induction, central vein at lower righl Note the cloudy swelling and acute early fatty infiltration. Two already-dead cells with darkly staining nuclei and dark cytoplasm are visible to right of center. Hematoxylin and eosin, x400 . 
. , ... 
FIO. 4. Section of the liver of a Group I rat dying 24· hours after one hour of exposure to fturoxene after enzyme induction. Note the central and midzonal necrosis with dilated peripheral sinusoids. Hernatoxylin and eosin, x40. 
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F10. 5. Section of the liver of a Croup I rat surviving a program of 3 x 1 hour exposures to fluroxene 
after enzyme induction. The rat was sacrificed on the third day after the last exposure. Note the 
complete central and midzonal necrosis with survival of peripheral wne cells. Hematoxylin and 
eosin, x40. 
Fm. 6. Section of the liver of a rat from the control group sacrificed after 3 x 1 hour exposures to 
fluroxene without enzyme induction. Note the generalized vacuolation and feathery degeneration, 
giving a "chicken-wire" appearance. Hematoxylin and eosin, x200. 
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TABLE 3. Some Drugs with Enzyme-inducing 
Properties 
Hypnotics and sedatives 
















necrosis following fluroxene anesthesia for 
a gastrectomy of an epileptic patient treated 
with phenobarbital and diphenylhydantoin, 
drugs with potent enzyme-inducing 
properties. 
The more fundamental question posed by 
our observations relates to the mechanism 
of hepatic damage and its relationship, if any, 
to that which follows other drugs such as 
carbon tetrachloride and chloroform, and to 
the whimsical hepatotoxicity of halothane. 
Fluroxene is subject to biotransformation 
in the liver. 1• 18 Evidence from our study that 
massive necrosis of the liver occurred only 
in animals in which fluroxene biotransforma-
tion would have been increased fits well with 
the observations of Cascorbi and Singh-
Amaranath17 that toxicity of fluroxene in mice 
was enhanced by enzyme induction and de-
creased by enzyme depression. All this evi-
dence would seem to point to the probability 
that it is some reaction in or metabolite 
resulting from the biotransformation of flu-
roxene which is the toxic agent. 
What this reaction or metabolite may be is 
a matter of c~njecture. Though Blake and 
co-workers11 have shown that trifluorethanol 
and trifluoroacetic acid, both products of flu-
roxene transformation, are toxic in dogs and 
mice, their aminals did not show any hepatic 
necrosis, although mild cloudy swelling and 
fatty accumulation are described as occurring 
in the dogs. To explain the gross hepatic 
necrosis we observed, we speculate that free 
radical formation18 or epoxidation of the vinyl 
radical20 of fluroxene as a step in its trans-
formation to CO2 may take place and result 
in lipid peroxidation of the cell organelle 
membranes, this leading ultimately to the 
massive cell destruction we saw. 
Speculation aside, the clinical implication 
of our observations is clear. Fluroxene anes-
thesia should not be used for any patient 
who is on a regime of treatment with a drug 
that has enzyme-inducing properties7 ( table 3). 
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logic studies; Mr. S. Abbott, of the Department 
of Surgery, University of Cape Town, for histologic 
sections; Professor L. Eales, Dr. N. Pimstone, and 
Mr. G. Blekkenhorst, of the Department of Medi-
cine, and Dr. G. Bax, of the Department of Anaes-
thetics, University of Cape Town, for cytochrome 
P4SO estimations. · 
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Fluroxene (2, 2, 2-Trifluoroethyl Vinyl Ether) 
Toxicity: A Chemical Aspect 
G. G. HARRISON, MO, FFARCS* 
K. IVANETICH, PhDt 
L. KAMINSKY, PHLDt 
M. J. HALSEY, D PHIL§ 
Fluroxene is highly toxic to several animal 
species. This toxicity is enhanced by induction 
of raised levels of hepatic microsomal en-
zymes. Experiments in rats are described which 
seek to assess the relative contribution to this 
toxicity of the individual component groups of 
the fturoxene molecule. Though results point to 
the triftuoroethyl moiety of fluroxene as that 
THE anesthetic, fluroxene, has recently been demonstrated to be toxic to several 
animal species under certain circumstances.1 
Rats, guinea pigs, and mice have been shown 
to display toxic effects when chronically ex-
posed to concentrations of fluroxene as low 
as 30 parts per million (1/2000 MAC). 
That this toxicity is the result of some 
aspect of fluroxene biotransformation, rather 
than an effect of fluroxene itself, is suggest-
ed by the demonstration of increased mani-
festations of toxicity following hepatic mi-
crosomal enzyme induction, with a decrease 
in these when microsomal enzyme activity 
is suppressed.2•3 
aspect of the molecule most responsible for the 
obsen·ed mortality, reduction of the vinyl 
group modifies the pattern of liver injury. That 
the liver necrosis, manifest following flurox-
ene anesthesia in the presence of microsomal 
induction, is alone the direct cause of the acute 
death of experimental animals is questioned. 
There is some evidence to suggest that 
formation of the highly toxic trifluoroethanol 
from the fluorinated ethyl moiety of flurox-
ene is responsible for these toxic effects. 4.11 
But, whereas fluroxene anesthesia in the 
presence of enhanced hepatic microsomal 
mixed function oxidase levels resulted in 
florid liver necrosis, 6 direct exposure of ani-
mals to trifluoroethanol resulted in the 
death of the animal without similar histo-
logic changes in the liver.5 We questioned, 
therefore, the contribution to the manifest 
toxicity that might result from the catabo-
lism of the vinyl moiety of fluroxene. 
To this end, we exposed groups of rats in 
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FIG 1. Structural formulas of fluroxene and the 
3 related compounds studied. 
which levels of microsomal enzymes had 
been increased ( together with appropriate 
control groups) to fluroxene anesthesia and 
to 3 related compounds, each of which com-
prised some aspect of the fluroxene struc-
ture. We noted thereafter manifestations of 
toxicity as determined by (l ) death or sur-
vival of the animal and (2) examination of 
liver histology. 
The structural formulas of fluroxene and 
the 3 other anesthetic compounds exempli-
fying modifications of aspects of this struc-
ture ( fig I ) are as follows: 
1. Fluroxene: 2,2,2-trifluoroethyl vinyl 
ether.• 
2. Vinamar, or ethyl vinyl ether, the non-
fluorinated analog of fluroxene.t7 
3. Vinesthene, or divinyl ether.:J:8 
4. Trifluoroethyl ethyl ether (TFEE), a 
chemically reduced form of fluroxene in 
which the vinyl moiety is hydrogenated to 
an ethyl group. 
METHODS 
The experimental animals were 200 to 
300-gm male Sprague Dawley rats. Liver 
microsomal enzyme levels were enhanced by 
the daily intraperitoneal administration of 
phenobarbital (80 mg/kg/day) for 3 days 
preanesthetic. The concentration of pheno-
barbital sodium in saline solution used was 
10 mg/ml, giving injection volumes of ap-
proximately 2 ml. Control rats were injected 
with similar volumes of physiologic saline 
solutions. 
Having been allowed food and water ad 
*Ohio Medical Products. 
t Fluka, AG. 
lBritish drug houses. 
lib until then, rats were starved for 24 hours 
after the 3rd phenobarbital injection, at 
which time ( day 4) they were anesthetized. 
In the event of survival, this program was 
repeated. Survivors were then sacrificed by 
cervical dislocation on the 3rd day there-
after. 
Animals were anesthetized in groups of 5 
for periods of 3 hours in a standard dessi-
cator 28 cm in diameter with a volume of 
27.3 L, of which 4 L, the volume below the 
grid, was filled with standard anesthetic soda 
lime. Additional chemical CO~ absorption 
was provided for by the placement of extra 
vertically standing perforated containers of 
soda lime between the animals. 
The anesthetic agents were carried by a 
flow of 0 ~ (5 L/min) passed through a va-
porizer and the anesthetic chamber in se-
ries. In such circumstances, the level of am-
bient CO.. in the anesthetic chamber was 
less than -1 %. In the case of ethyl vinyl 
ether and divinyl ether, because of their 
limited availability, a lower 0 2 flow (2 
L/min ) was used. 
Animals were exposed to anesthetic and 
subanesthetic concentrations of fluroxene (3 
and 0.5%) delivered from a Fluoromartecg 
vaporizer, or to concentrations of the other 
agents sufficient to maintain a very light 
level of anesthesia, in equianesthetic con-
centrations. This level of anesthesia was de-
fined as that at which response to paw-pinch-
ing became obtunded. TFEE, which pro-
duced anesthesia in rats, was synthesized in 
our laboratory by reduction of commercially 
available fluroxene with hydrogen in the 
presence of a palladium catalyst. Reduction 
of the vinyl function was checked by IR 
spectrophotometry, the material being treat-
ed to remove peroxides and redistilled before 
use. 9 All agents were screened to exclude 
the presence of peroxides. · 
After the death or sacrifice of experimen-
tal animals, the livers were immediately ex-
cised and fixed in formalin. Thereafter, sec-
tions of liver were stained with hematoxylin-
eosin (H & E) and submitted to light mi-
croscopy. 
RESULTS 
The tabulated results, in terms of anes-
thetic agent, number of 3-hour exposures, 
mortality, and histology (table) reveal that 
all enzyme-induced rats exposed to flurox-
ene, both in anesthetic and subanesthetic 
concentrations, died after a single 3-hour 
exposure. Similar mortality followed expo-
3A 




...:... :'With Duration 
induct ion of Number 
O= no anesthet ic. of Anesthetic i nduction hours exposures 
Fluroxene 3% + 3 1 
0.5 % + 3 1 
31H 0 3 2 
0.5 % 0 3 2 
TFEE + 3 1 
0 3 1 
Vinamar + 3 2 
0 3 2 
Vinesthene + 3 2 
0 3 2 
sure of enzyme-induced rats to TFEE. This 
mortality, which occurred during or shortly 
after anesthesia, was associated with his-
tologic evidence of severe centrizonal liver 
damage: frank necrosis, chromatolysis, fatty 
infiltration, pyknosis, and cloudy swelling 
( figs 2 and 3 ) . Congestion, especially in the 
periportal areas, was a marked feature, par-
ticularly of those enzyme-induced animals 
Mortality H istology 
20/20 Periportal congestion, gross centrizonal necrosis or marked cell damage in all. 
10/ 10 Periportal congestion, "gross centrizonal necrosis or marked cell damage in all. 
0/ 20 Periportal hydropic changes, 8/20. 
0/ 10 Normal histology. 
12,'12 Frank centrizonal necrosis, 2/ 12. Marked fatty infiltration ± areas of focal 
necrosis and cell damage, 10/12 
0/ 12 No centrizonal necrosis. Miliary fatty infiltration and periportal hydropic 
degeneration, 6/ 12. 
0/ 9 No necrosis. Peri portal hydropic 
degeneration, 2/ 9. 
0/ 10 No necrosis. Peri portal hydropic 
degeneration , 5/ 10. 
0/ 5 No necrosis. Periportal hydropic 
degeneration, 4/ 5. 
0/ 5 No necrosis. Peri portal hydropic 
degeneration, 4/ 5. 
anesthetized by fluroxene. The incidence 
of frank necrosis was much lower in en-
zyme-induced animals after anesthesia with 
TFEE, in which circumstance marked fatty 
infiltration with centrizonal pallor was the 
most consistent finding (fig 4) . The magni-
tude of histologic liver damage in some ani-
mals after TFEE did not appear sufficient 
to account for death. 
FIG 2. Diffuse centrizonal necrosis and congestion in enzyme-induced rat dying 8 hours after 3-hour exposure to 0.5% fturoxene. H & E x 160. 
3A 
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Fie 3. Early centrizonal changes in enzyme-induced rat dying at termination of 3-hour exposure to 3% 
fluroxene. Note chromatolysis, pal,lor, congestion, and occasional pyknotic cells. H & E x -400. 
Fie 4. Centrizonal pallor, chromatolysis. and fatty infiltration in enzyme-induced rat dying 12 hours 
after 3-hour exposure to TFEE. H & E x 800. 
No mortality occurred in the relevant flur-
oxene- or TFEE-anesthetized, uninduced 
controls, nor in any induced or uninduced 
animal exposed to vinamar or vinesthene. 
Nor was there evidence of centrizonal ne-
crosis in any of these animals. However, the 
livers of some showed a nonspecific peri-
portal hydropic change, apparent in both 
enzyme-induced and uninduced control ani-
mals. 
DISCUSSION 
Following phenobarbital induction of mic-
rosomal enzymes--
I. Fluroxene, even in subanesthetic con-
centrations, causes florid liver necrosis and 
death. 
2. Modification of the vinyl group of 
fluroxene to an ethyl moiety does not lessen 
this mortality, though it does produce a dif-
ferent and less extreme pattern of liver dam-
age. 
3. Neither mortality nor histologic liver 
necrosis followed repeated exposures of ani-
mals to ethyl vinyl ether or divinyl ether. 
Considering as the index of toxicity the 
mortality which occurred in the presence of 
enzyme induction following exposure of rats 
3.4 
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to the test agents, it is immediately appar-
ent that the trifluoroethyl moiety is the 
common denominator, no mortality result-
ing in its absence. However, the modifica-
tion of the histologic pattern of liver injury 
following the use of TFEE rather than flur-
oxene suggests that the vinyl group must in 
some way be involved in the induction of 
the liver damage which, in itself therefore, 
may not be the direct cause of death in the 
experimental animals. This is in agreement 
with our earlier report that catabolism of 
the vinyl group of fluroxene, in vivo or in 
vitro, results in the destruction of hepatic 
cytochrome P450.s ,o It is surprising, in view 
of the apparent damage caused to the liver 
by the biotransformation of the vinyl group 
in fluroxene, that neither ethyl vinyl ether 
nor divinyl ether produces similar liver dam-
age. This aspect is presently under investi-
gation. 
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THE ROLE OF CYTOCHROME P-450 IN THE TOXICITY 
OF FLUROXENE (2,2,2-TRIFLUOROETHYL VINYL 
ETHER) ANAESTHESIA IN v1VO* 
K.ArnRY1' M . JVANETICH**. JEAN J. BRADSHAWt. JULIA A. MARSHt, GAISFORD G. HARRISON" 
and LAURENCE s. KAMINSKvt1 
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(Received 22 April 1975; accepted 25 Sepzember 1975) 
Abstract-Induction of type P-450 cytochromes in rats by i.p. injections of phenobarbital potentiated 
the toxicity (I~,~ mortality) of the normally non-toxic anaesthetic fturoxene (2.22-triftuoroethyl vinyl 
ether), The toxic effects were eliminated by administration of 2-allyl-2-isopropylacetamide prior to 
anaesthesia. Hepatic microsomal cytochrome P-450 levels of the dead rats were markedly diminished 
relative to unanaesthetised induced controls, Induction by 3-methylcholanthrene and 3,4-benzpyrene 
did not potentiate toxic effects of fturoxene but anaesthesia after mixed induction with 3-methylcho-
lanthrene and phenobarbital manifested toxicity more rapidly than induction with phenobarbital alone, 
When 2,2,2-triftuoroethyl ethyl ether was used as the anaesthetic similar toxic effects were observed 
except that levels of type P-450 cytochromes were not depressed at the time of death and induction 
with 3-methylcholanthrene did potentiate toxic effects with this anaesthetic. We interpret these results 
to indicate that cytochrome P-450 catalyses an essential step in the production of toxic metabolites 
from fturoxene and that elevated concentrations of the enzyme are required to potentiate the toxicity. 
Apparently, cytochrome P-448 does not metabolize fturoxene and elevated levels of this enzyme there-
fore do not potentiate the toxicity of fturoxene anaesthesia, The ability of fturoxene to destroy cyto-
chrome P-450 resides in its vinyl group while the toxic metabolite arises from the trifluoroethyl moiety. 
Fluroxene (2,2,2-trifluoroethyl vinyl ether) is a vola-
tile anaesthetic agent first introduced into clinical 
practice in 1953 [l]. Although it has accumulated a 
considerable record of safe clinical usage in man with 
no evidence of organ toxicity [2, 3], recent work has 
shown it to be toxic to many animal species [ 4, 5, 6] 
and even to man under certain circumstances 
[7. 8, 9, IO]. This toxicity, which includes hepatotoxi-
city [11], is markedly enhanced by pretreatment of 
the experimental animal with phenobarbitaL The tox-
icity is considered to result from biotransformation 
of fluroxene into toxic metabolites such as trifluoro-
ethanol glucuronide [12.13] or trifluoroacetalde-
hyde [14, 15] rather than to be an effect of fluroxene 
itself [ 4, 16], Since phenobarbital is known to induce 
the proliferation of the hepatic endoplasmic reticulum 
and the biosynthesis of the components of the cyto-
chrome P-450 drug metabolizing pathway [17], it 
appeared possible that hepatic microsomal cyto-
chrome P-450 could be involved in potentiating the 
toxicity of fluroxene anaesthesia [11]. especially in 
view of the localization of fluroxene metabolism in 
the hepatic endc,pla~mic reticulum [12]. We will use 
•• Department of Chemical Pathology 
t Department of Physiology and Medical Biochemistry 
• Department of Anaesthetics 
the terms 'cytochromes P-450' or 'type P-450 cyto-
chromes' to represent both cytochrome P-450 and 
cytochrome P-448 (see later). We have consequently 
investigated the effect of induction of cytochromes 
P-450 on the toxicity of fluroxene and 2,2,2-trifluoro-
ethyl ethyl ether (TFEE) anaesthesia in rats with a 
view to investigating the role of the cytochromes 
P-450 in potentiating these toxic effects, and deter-
mining the mechanisms of production of toxic effects. 
MATERIALS AND METHODS 
Materials. Sodium phenobarbital (PB) and 3-meth-
ylcholanthrene (MC) were obtained from Maybaker, 
SA and Eastman-Kodak, respectively. 3,4-benzpyr-
ene (BP) was from Sigma Chemicals. 2-Allyl-2-isopro-
pylacetamide (AIA) was a generous gift from Hoff-
man-La Roche, Nutley, New Jersey. Ampoules of 
sterile saline (0-9°/o, w/v) were obtained from Petersen, 
Ltd., SA Fluroxene was supplied by Ohio-Medical 
Products, Madison, Wisconsin. 2,2,2-Trifluorocthyl 
ethyl ether (fFEE) was prepared by hydrogenation 
of fluroxene using our previously published method 
[ 18], The TFEE was tested for the presence of 
peroxides with 5% aqueous KI (w/v) immediately 
before use. Cylinders of CO and 0 2 were supplied 
by Afrox Ltd. All other chemicals were analytical 
grade reagents. Water was distilled and deionized • To whom reprint requests should be addressed 
• This research was supported by grants from the South 
African Medical Research Council. the UCT Staff Research 
Fund and the Anglo American and De Beers Anaesthetic 
Research Fund, 
Animals. Male Wistar rats weighing between 175g 
and 300 g were used in all experiments; animals were 
permitted free access to Epol Laboratory Chow (pro-
. Lein min, 20";"' fat 2·5%, fibre max, 6%, calcium 1-4"'°' 
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phosphorus 0·7?~) and water. Induction of cyto-
chrome P-450 was by i.p. injection of sodium pheno-
barbital (80 mg/kg/day in 0-9% sterile saline). 
3.4-benzpyrene (40 mg/kg/day in corn oil) or 3-meth-
ylcholanthrene (40 mg/kg/day in corn oil) for three 
consecutive days. One group of rats received sodium 
phenobarbital (80 mg/kg) for I day only. In the case 
of a simultaneous induction by sodium phenobarbital 
and 3-methylcholanthrene. the animals received the 
above doses in separate i.p. injections for 3 consecu-
tive days. Control animals were injected i.p. with vehi-
cle for 3 days. All animals were fasted overnight after 
the final injection. and where indicated anaesthetised 
the following morning. Animals receiving AIA were 
injected subcutaneously with a dosage of 200 mg/kg 
(20 mg/ml in 0-9~~ sterile saline) in the loose skin 
of the neck 1 hr prior to anaesthesia. Rats were anaes-
thetised in groups of ten or Jess in a special perspex 
anaesthetic chamber (30 x 30 x 60 cm). Animals 
were placed on a fenestrated floor raised 8 cm from 
the base of the chamber. the space below the fenes-
trated floor being occupied by standard anaesthetic 
sodalime. The anaesthetic (fluroxene or TFEE), 
vaporised by a 5 I/min stream of oxygen through a 
Cyprane Fluoromatek vaporiser, was passed as a con-
tinuous stream into the anaesthetic chamber through 
an inlet port sited at one corner beneath the fenes-
trated floor and exhausted through an exhaust port 
sited at the diagonally opposite upper comer. A flow 
rate o( this order was shown to result in CO2 con-
centration of <0-1%. Animals were exposed to a 2 
hr period of anaesthesia of a level approximately 
equivalent to that which would be attained by the 
minimum anaesthetic concentration of the respective 
agent, this being achieved by exposure of animals to 
a 3% concentration of fluroxene or TFEE. Unanaes-
thetised control animals in these experiments were 
exposed to air. In subsequent experiments in which 
unanaesthetised control rats were exposed to 0 2 only, 
no differences in the parameters under consideration 
were noted. Toxicity was judged by death after anaes-
thesia. Animals not dying were sacrificed by cervical 
fracture. Liver weight was determined immediately 
after excision of the liver. 
Preparation of microsomes. Livers were excised 
from animals within minutes of death. A portion of 
the liver was fixed in buffered aqueous fonnaldehyde 
(IO°.-~ v/v) for histological investigation and the 
remainder was utilized for the preparation of micro-
somes by differential ultracentrifugation [19]. Pro-
tein concentration was determined by the method of 
Lowry et al. [20], as modified by Chaykin [21] using 
bovine serum albumin as a standard. 
Spectrophotometry. Microsomal suspensions (pro-
tein concentration 2 mg/ml) were divided between 
two cuvettes of 1-cm optical path length. Difference 
absorbance spectra of microsomal suspensions were 
recorded at room temperature in a Unicam SP1800 
recording spectrophotometer using the cell holder 
adjacent to the photomultiplier. Microsomal cyto-
chrome P-450 content was determined by the CO dif-
ference spectral method of Omura and Sato [22]; it 
should be noted that total type P-450 cytochtomes 
were measured. and that these values include the con-
tributions of both cytochromes P-450 and P-448 to 
the total. 
RESULTS 
Toxicity of jiuroxene anaesthesia. The effects of 
various inducing agents of cytochtomes P-450 on the 
toxicity to rats of fluroxene anaesthesia are reported 
in Table 1. Injection of saline alone or in conjunction 
with exposure to 3% fluroxene anaesthesia for 2 ht 
did not produce toxic effects and did not affect cyto-
chtome P-450 content per mg of microsomal protein 
or the ratio of liver to ·body weight relative to un-
treated control animals. 
Phenobarbital treatment of animals for three days, 
as described in Methods, resulted in a 2·6-fold in-
crease in cytochrome P-450 levels and a slight in-
crease in liver weight but produced no toxic effects. 
All rats induced with phenobarbital and subsequently 
anaesthetised with fluroxene died between 1 and 3 
hr after the termination of anaesthesia (100"/o morta-
lity). Immediately after death, these animals were 
shown to have a 2·8-fold decrease in cytochtomes 
P-450 content and markedly enlarged livers, relative 
to unanaesthetised phenobarbital induced controls. 
The toxic effects of fluroxene anaesthesia observed 
in phenobarbital pretreated animals were prevented 
by treatment of the animals with AIA 1 ht prior to 
anaesthesia. No deaths were observed in this latter 
group. The animals appeared normal at the time of 
sacrifice and up to that time demonstrated none of 
the symptoms of the phenobarbital induced fluroxene 
anaesthetised animals (e.g. crouching, staring coat 
[23], glassy eyes, sluggishness, bleeding eyelids). Fur-
thermore, fluroxene anaesthesia apparently does not 
elicit any marked effect on cytochromes P-450 content 
or liver weight in phenobarbital induced AIA treated 
rats, relative to unanaesthetised phenobarbital in-
duced AIA treated animals. 
Pretreatment of animals with phenobarbital for 1 
day only, elevated cytochromes P-450 levels approxi-
mately 2-fold relative to control animals and was in 
itself non-toxic. Fluroxene anaesthesia of animals in-
duced in this manner was less toxic (40"/o mortality1 
and the animals that did not die subsequent to anaes-
thesia appeared normal prior to sacrifice at 190 ht. 
Injection with com oil, the vehicle for induction 
with polycyclic hydrocarbons, does . not affect the 
hepatic- microsoman:ytochromes P-450 levels but 
does increase liver weight relative to saline~injected 
or untreated controls. The above effects were not 
altered by subsequent fluroxene anaesthesia. 
Injection of 3,4-benzpyrene or 3-methylcholanth-
rene suspended in com oil increased levels of type 
P-450 cytochtomes approximately 2-fold and in-
creased liver weight relative to com oil controls. Sub-
sequent fluroxene anaesthesia was non-toxic and did 
not affect cytochrome levels and liver weight of 
3,4-benzpyrene induced animals but did slightly 
reduce the cytochrome levels of those rats pretreated 
with 3-methylcholanthrene. After five days the cyto-
chtome content and liver weight of the fluroxene 
anaesthetised rats decreased to within the range found 
for control animals. The appearance and behaviour 
of the anaesthetised animals was completely normal 
at the time of sacrifice. 
Mixed induction by injection of 3-methylcholanth-
rene plus phenobarbital elevated levels of both cyto-
. chromes P-448 and P-450 and resulted in increased 
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Table I. Toxicity of fluroxene anaesthesia 
Cyt P-450 
(nmol/mg wt. liver/ 
Pretreatment• Time of deatht microsomal wt. body 
(no. rats) Anaesthetised (hr) Toxicity protein) (%) 
Untreated (2) 1·27 ± (}12 2·76 ± (}22 
Saline (2) K24 1·31 ± (}JO 3-07 ± (}29 
Saline (2) + K24 1·32 ± 0-02 3-47 ± (}63 
PB (4) K4 3·42 ± (}34 3·39 ± 0-05 
PB (9) + 1-3 + 1·23 ± (}J] 4·63 ± (}44 
PB+ AIA (2) K-~ 0-81 ± 0-02 3·83 ± 0-08 
PB+ AIA {2) K24 (}91 ± 0-02 4·82 ± 0-01 
PB+ AIA (2) Kl66 (}99 ± 0-04 no± cm 
PB+ AIA (2) + K24 (}75 ± (}J5 4·70 ± (}JO 
PB+ AIA (2) + Kl41 0-98 ± 0-07 2·69 ± 0-02 
PB (3)! KO 2-33 ± (}J7 4-07 ± 0-16 
PB (2)! + 18 + 1-41 4·26 
PB (3)! + Kl90 (}98 ± (}J4 4·14 ± (}29 
Corn Oil/saline (2) K2 1·28 ± (}12 3-84 ± (}]J 
Corn oil/saline (2) + K2 1·16 ± (}J5 3·72 ± 0-08 
PB+ MC (2) K2 4·87 ± (}32 5·10 ± (}38 
PB+ MC (5) + 2 + 1·92 ± (}J7 6-96 ± (}44 
Corn Oil (2) K24 1·27 ± (}J2 3-75 ± 0-16 
Corn Oil (2) + K24 !·JO± (}20 3-97 ± 0-05 
BP (2) K24 11!6 ± 0-09 4·49 ± 0-02 
BP {6) + K24 I ·57 ± 0-21 4·31 ± (}]! 
BP (2) + K140 1·31 ± 0-03 3-41 ± 0-21 
MC(3) K24 2·47 ± 0-12 4·81 ± 0-08 
MC(2) K190 1·34 ± 0-09 4·88 ± 0-15 
MC(3) + K24 1·52 ± (}29 4·89 ± (}79 
MC(2) + K190 1·51 ± 0-04 4-62 ± (}32 
Anaesthesia for 2 hr at 3~-~ fluroxcne. All values are means ±S.D. For experimental details sec text. 
• Abbreviations used arc : BP. 3,4-bcnzpyrene; MC, 3-methylcholanthrene; PB, phenobarbital; AIA, allyl-iso-propylace-
tamide. The first two compounds are injected in com oil, the remainder in saline. 
t From the end of anaesthesia or, if not anaesthetized. from the equivalent time. K indicates that the animals were 
killed. 
t Injected with only I dose of PB (80 mg/kg) 1 day prior to anaesthesia. 
~ Killed at a time equivalent to the beginning of anaesthesia. 
hepatic weight and cytochromes P-450 content in 
excess of that seen for either type of induction indivi-
dually [24), but was in itself non-toxic (O"/o mortality). 
Fluroxene anaesthesia of these induced animals 
resulted in l(ff,~ mortality within 2 hr of the end 
of anaesthesia. A marked decrease in cytochrome 
levels and an increase in liver weight relative to the 
unanaesthetised but similarly induced animals were 
also noted. 
Toxicity of TFEE anaesthesia. The effects ofTFEE 
anaesthesia on rats with elevated levels of cytochrome 
P-450 and/or P-448 are reported in Table 2. Anaes-
thesia with TFEE did not affect animals injected with 
vehicle except for a slight increase in liver weight in 
the case of saline. 
In phenobarbital-induced rats., anaesthesia with 
TFEE was toxic: 100"1., mortality was observed within 
35 hr after termination of anaesthesia at which time 
a slight decrease in cytochromes P-450 content and 
an increase in liver weight were evident. Treatment 
of phenobarbital-induced rats with AIA prior to an-
aesthesia with TFEE completely protected the ani-
mals from the toxicity of anaesthesia (O"/o mortality). 
Cytochrome levels and liver weights in unanaesthe-
tised and anaesthetised rats receiving phenobarbital 
and AIA were comparable. 
TFEE anaesthesia of 3.4-benzpyrene induced ani-
11 1' ~ ~ i t 
mals was non-toxic (O"/o mortality) and did not alter 
the levels of type P-450 cytochromes but did diminish 
liver weight relative to that found for unanaesthetised 
benzpyrene treated controls. · 3-Methylcbolanthrene 
induction did potentiate·. the toxicity of TFEE anaes-
thesia (80"/o mortality) without markedly affecting 
cytochrome P-450 levels but decreased the liver 
weights in the animals -that died. Increasing the 
duration ofTFEE anaesthesia to l(i() min for 3-meth-
ylcholanthrene induced rats increased mortality to 
100"/o. Administration of AIA after 3-methycholanth-
rene induction did not noticeably diminish levels of 
type P-450 cytochromes but did overcome the toxic 
effects of TFEE anaesthesia. 
Induction with phenobarbital and 3-methylcho-
lanthrene together potentiated the toxicity of TFEE 
anaesthesia more than phenobarbital alone. TFEE 
lowered the levels of type P-450 cytocbromes of these 
induced rats only very slightly. 
DISCU~ION 
Our experiments on the effects of various microso-
mal inducing agents on the toxicity of the anaesthetic 
fluroxene were initiated to explore the role of the 
cytochromes P-450 in potentiating this toxicity and 
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Table 2. Toxicity of 2.2.2-trifluoroethyl ethyl ether (TFEE) anaesthesia 
Cyt P-450 
(nmol/mg wt. liver/ Prctrea tmcnt• Time of deatht microsomal Wt. body (no. rats) Anaesthetised (hr) Toxicity protein) (%) 
Untreated (2) 
1·27 ± (}12 2·76 ± (}22 Saline (2) K24 1·3 1 ± (}10 3-07 ± (}29 Saline (3) + K24 1·25 ± (}05 3·79 ± (}25 PB (4) K24 3-4) ± 1-08 4·82 ± (}42 PB C8l + 0-35 + 2·49 ± (}63 5·33 ± (}58 PB+ AJA (2) K-2§ (}81 ± (}02 3-82 ± (}08 PB+ AJA (2) K46 (}97 ± 0-08 4·13 ± (}22 PB (2) K46 2·13 ± 0-08 3·84 ± (})4 PB+ AJA (3) + K46 1·22 ± 0-14 3·83 ± (}QI Com Oil/Saline (2) + K24 1·32 ± (}08 3-82 ± (}28 Com Oil/Saline (2) K2 1·28 ± 0-12 3·84 ± (}31 PB+ MC (2) K26 4·80 ± (}69 5-69 ± (}39 PB+MC(S) + 17-26 + 4·09 ± 0·29 5·19 ± (}22 Com Oil (2) K24 1·27 ± (}12 3-75 ± (}16 Com Oil (2) + K24 1-31 ± 0-14 3-81 ± (}22 BP (2) K24 2-25 ± (}05 4·75 ± (}OS BP (3) + K24 2·13 ± (}43 3·27 ± (}23 BP (2) + K145 1-38 ± (}]] 4-15 ± (}25 MC(S) K48 1·72 ± (}09 5·55 ± (}35 MC(4) + 27-76 + 1-96 ± 0-44 3·56 ± (}4() MC(I ) + K144 1-03 5-05 MC+AJA (3) K-2§ 1·74 ± (}32 4-85 ± (}33 MC + AJA (3) K164 1·92 ± (}16 5·20 ± (}48 MC+ AJA (3) + K164 1·94 ± (}09 5·53 ± (}37 MC (5)! + 17-24 + 3·24 ± (}34 4·19 ± (}20 
Anaesthesia for 2 hr at 3% TFEE. All values arc means± S.D. For experimental details sec text. 
• Abbreviations used arc: BP, 3,4-bcnzpyrcnc ; MC, 3-mcthylcholanthrcnc; PB, phenobarbital ; AJA, allyl-iso-propylacc-tamidc. (The first two compounds arc injected in com oil, the remainder in saline.) TFEE, 2,2,2-trifluoroethyl ethyl ether. 
t From the end of anaesthesia or if not anaesthetized from the equivalent time. K indicates animals were killed. t Anaesthesia for 2 hr 40 min at 3% TFEE. * Killed at a time equivalent to the beginning of anaesthesia. 
to determine the mechanism whereby the toxicity is 
generated. 
Type P-450 cytochromes are a heterogeneous 
group of enzymes that metabolize an extremely wide 
variety of substrates. In general, this class of enzymes 
catalyses the detoxification of hydrophobic xenobio-
tics by converting them to relatively more hydrophi-
lic water soluble compounds which are more readily 
excreted from the body, although in some instances 
the metabolites are more toxic than the parent com-
pound [25]. A variety of compounds have been 
demonstrated to induce the biosynthesis of cyto-
chromes P-450. These inducing agents are classified 
into two major groups: (1) those which induce cyto-
chrome P-450 and (2) those which induce a similar 
enzyme, cytochrome P-448 (also called cytochrome 
P 1-450) [26). Phenobarbital is an example of the first 
type of agent. This compound also enhances the pro-
liferation of the endoplasmic reticulum and elevates 
the levels of NADPH-cytochrome c reductase and 
cytochrome b5 per mg of microsomal protein [17). 
The second class of inducers includes polycyclic aro-
matic compounds such as 3,4-benzpyrene and 3-meth-
ylcholanthrene which do not increase the prolifer-
ation of the endoplasmic reticulum or the synthesis 
of microsomal NADPH-cytochrome c reductase or 
cytochrome b5• These polycyclic hydrocarbons appar-
ently only induce the synthesis of cytochrome P-448 
which differs from cytochrome P-450 with regard to 
substrate specificity, spectral properties and sensitivity 
to inhibitors [26]. Mixtures of these two (or more) 
type P-450 cytochromes are apparently always _pres-
ent in hepatic microsomcs, regardless of the pretreat-
ment of the source animal. In phenobarbitaljnduced 
and uninduccd animals, cytochrome P-450 predomi-
nates, while in polycyclic hydrocarbon treated ani-
mals, cytochrome P-448 predominates [26]. We will 
use the terminology 'cytochromes P-450' or 'type 
P-450 cytochromes' to refer to both cytochrome 
P-450 and P-448, whereas 'cytochrome P-450' or 
'cytochrome P-448' refers to the specific enzyme men-
tioned. 
The observed effects of the various inducing agents 
in potentiating the toxicity of fturoxene anaesthesia 
can now be considered in relation to the mechanism 
of toxicity. The fact that uninduccd rats, with levels 
of hepatic microsomal cytochromes P-450 of approxi-
mately I nmol/mg microsomal protein, are not sus-
ceptible to the toxic effects of fluroxene anaesthesia, 
while phenobarbital pretreated rats, with approxi-
mately a three fold elevation of cytocbromes P-450 
levels are highly susceptible (100"/o mortality). (Table 
I) implies that the metabolism of fluroxene is 
enhanced as a consequence of the inductive properties 
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of phenobarbital. Since phenobarbital induces a 
number of microsomal proteins, the enzyme(s) caty-
lyzing the rate-limiting step of this metabolism is (are) 
not determined by this experiment. The effect of AIA, 
however. in overcoming the toxic potentiating effects 
of phenobarbital (Table 1) on fluroxene anaesthesia 
unequivocally demonstrated an essential role for cyto-
chrome P-450. since AIA specifically degrades cyto-
chrome P-450 while not affecting other microsomal 
proteins (e.g. cytochrome b5 or NADPH--cytochrome 
c reductase) or reversing other non-microsomal effects 
of phenobarbital [27, 28]. Thus. while other microso-
mal enzymes definitely play a role in the metabolism 
of fluroxene. elevated levels of cytochrome P-450 are 
essential in potentiating the toxicity of fluroxene. 
Apparently, cytochrome P-450 is involved in an 
essential step of the metabolism producing the toxic 
metabolite and mechanisms such as those involving 
the effect of phenobarbital on other subcellular com-
ponents can be excluded. 
The failure of induction by 3-methylcholanthrene 
or 3,4-benzpyrene, which produces elevated levels of 
cytochrome f-448, to potentiate the toxicity of flurox-
ene (Table n is apparently not a consequence of in-
sufficient concentrations of type P-450 cytochromes. 
In these animals the total type P-450 cytochrome 
levels are approximately 2 nmole/mg microsomal 
protein which is similar to the level obtained follow-
ing phenobarbital induction for one day, a treatment 
which does produce toxic effects subsequent to anaes-
thesia (Table 1). There are several possible explana-
tions for the toxicity differences observed between in-
duction by phenobarbital or by 3-methylcholanthrene 
and 3,4-benzpyrene, which are still consistent with an 
essential role for cytochrome P-450: 
(a) Cytochrome P-448, in contrast to cytochrome 
P-450, may be protecting the organism by converting 
fluroxene to non-toxic metabolites. 
(b) In view of the different specificities of cyto-
chromes P-448 and P-450. cytochrome P-448 may 
metabolize fluroxene slowly compared to cytochrome 
P-450. or not at all. 
(c) 3-Methylcholanthrene may produce physiological 
or biochemical changes which are not directly in-
volved with the microsomal system but which prevent 
fluroxene anaesthesia from mediating toxic effects. 
The first possibility involving the production of dif-
ferent and non-toxic metabolites by cytochrome 
P-448 appears to be highly unlikely in view of the 
results of studies with mixed induction by phenobar-
bital and 3-methylcholanthrene (Table 1). The double 
induction potentiates the toxic effects of fluroxene an-
aesthesia even more rapidly than induction by pheno-
barbital alone (time of death subsequent to anaes-
thesia is used as an index of toxicity). In contrast, 
in view of the competition between cytochromes 
P-450 and P-448 for the substrate fluroxene in the 
doubly induced animals. it would be expected that 
a reduction of toxicity would occur if scheme (a) were 
operative. We can suggest no situation, where the 
suggestion outlined in scheme (c) could arise, to 
explain the results observed. Confinnation of scheme 
(b) requires establishing whether cytochrome P-448 
binds to and metabolizes fluroxene. Our studies in 
vitro of the interaction of fluroxene with microsomes 
induced for cytochrome P-448 or P-450 indicate that 
although cytochrome P-450 forms a spectrally detect-
able complex with and metabolizes fluroxene, cyto-
chrome P-448 docs neither [29]. Apparently, then, the 
failure of the induction of rats with 3-methylcholanth-
rene or benzpyrene to potentiate the toxicity of flu.r-
oxene follows from the failure of cytochrome P-448 
to metabolize the fluroxcne. 
The results of preanaesthetic induction of hepatic 
microsomal cytochromes on the toxicity to rats of 
TFEE anaesthesia were compared with the results of 
the investigations of fluroxene anaesthesia. to identify 
the portion of the fluroxcne molecule in which the 
potential toxicity resides (Tables 1 and 2). Since 
TFEE and fluroxcne anaesthesia exhibited similar 
effects under conditions of no induction. benzpyrcne 
induction, phenobarbital induction or mixed induc-
tion with phenobarbital and 3-mcthylcholanthrenc 
{Tables 1 and 2), it is clear that the potential toxicity 
resides in the trifluoroethyl moiety of fluroxene rather 
than in the vinyl group which is not present in TFEE. 
There is ample support for the metabolism of the flur-
oxene molecule to trifluoroethanol g]ucuronide or 
trifluoroacetaldehyde in vivo, and the toxicity of tri-
fluoroethanol and physiological derivatives thereof has 
been demonstrated [13]. However, although our 
results indicate that the toxicity arises from a metabo-
lite of the trifluoroethyl portion of the fluroxcne mol-
ecule. we have no evidence that the toxic effects 
observed in this study arise directly from a particular 
metabolite such as trifluoroethanol or its g]ucuronidc 
or trifluoroacetaldchyde as proposed elsewhere 
[4, 14, 15). 
The unexpected observation that induction with 
3-methylcholanthrcne potcntiates the toxicity of 
TFEE is difficult to explain cspecially in view of the 
failure of 3,4-benzpyrcne to produce a similar effect 
We have concluded from in vitro studies that hepatic 
microsomal cytochrome P-448 does not bind or meta-
bolize TFEE [29]. It could be postulated that the 
cytochrome P-450 component of the type P-450 cyto-
chromes present after induction with 3-mcthylcbo-
Janthrcne in these experiments is of a high enough 
concentration to potentiate the toxicityofTFEE. 'Ibis 
simple explanation is, however, unlikely in view of 
the failure of 3-mcthylcholanthrcnc induction · to 
potentiatc fluroxenc toxicity. 'Ibis aspect · is undergo-
ing further investigation. 
Comparison of the toxicity of fluroxcnc and TFEE 
indicates that since equivalently-pretreated animals 
expire earlier after fiuroxene than after TFEE anaes-
thesia, the former agent is probably metabolised more 
rapidly by cytochrome P-450. In confirmation, we 
have demonstrated that fluroxene is a better substrate 
for hepatic microsomal cytochrome P-450 in vitro 
[29]. Even though fluroxenc is metabolized by micro-
somal enzymes it does not induce elevated levels of 
cytochromes P-450 [12]. 
Although the vinyl group of the fluroxcne molecule 
has no apparent role in the observed toxicity of flur-
oxene anaesthesia, this moiety appears to be ncccs;-
ary for the fluroxcne induced destruction of cyto-
chrome P-450 observed in vivo (c.f. Table 1 and Table 
2), since TFEE, without the vinyl group, does not 
produce any similar destruction. F1uroxcne-mcdiated 
· destruction of cytochrome P-450 is of the greatest 
magnitude in phenobarbital or phenobarbital-plus-3-
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methylcholanthrene-induced animals. It is. however. 
not clear from the in vivo studies whether this des-
truction arises from elevated concentrations of cvto-
chrome P-450 or other microsomal enzymes (e.g. 
NADPH-cytochrome c reductase) in these animals 
prior to anaesthesia. We have. however. duplicated 
this phenomenon in isolated hepatic microsomes and 
have concluded that the destruction results from the 
interaction of fluroxene with ferrocytochrome P-450 
[18]. The levels of other microsomal enzymes (e.g. 
NADPH-cytochrome c reductase and cytochrome b5) are unaffected by fluroxene in virro. 
Previous reports concerning compounds capable of 
destroying cytochrome P-450 in rim and in virro con-
firm the ability of a monounsaturated carbon-carbon 
bond to function in this manner [30, 31]. Similarly, 
the vinyl portion of fluroxene is also essential for the 
destruction of cytochrome P-450 in vitro and in vivo 
since TFEE elicits no effect on cytochrome P-450 
levels [ 18]. Cytochrome P-450 is apparently more 
susceptible to the destructive effects of fluroxene than 
is cytochrome P-448. 
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An investigation into the hepatic cytochrome P-450 catalysed 
metabolism. of the anaesthetic fluroxene 
(2,2,2-trifluoroethyl vinyl ether)* 
Julia A. Marsh, t Kathryn M. lvanetich,t Jean J . Bradshaw, t Gaisford G. Harrison,§ 
Bruce L. Webber ll and Laurence S. K amins~t 
ABSTRACT 
The role of the different cytochromes P-450 in the metabolism of the 
anaesthetic agent fluroxene, and the mechanism of production of toxic 
effects seen after pre-treatment of the animals with phenobarbital prior 
to anaesthesia, have been investigated. 
Male rats were anaesthetized with fluroxene, or with 2,2,2-trifluoroethyl 
ethyl ether, or with ethyl vinyl ether in an attempt to ascertain the in vivo 
toxic effects of the three anaesthetic agents. The resultant hepatic histology 
is reported. A study of the binding and metabolism of fluroxene by 
isolated rat hepatic microsomes was also made. We conclude that it is ele-
vated levels of cytochrome P-450 which potentiate the toxicity offluroxene 
anaesthesia in phenobarbital treated animals and that cytochrome P-448 
does not bind or metabolize fluroxene. The potential toxicity of the 
fluroxene molecule is considered to reside in the trifluoroethyl moiety, 
while the vinyl group of fluroxene appears to play a role in the observed 
liver damage. 
INTRODUCTION 
Enzymes situated in the hepatic endoplasmic reticulum protect the organism against 
an accumulation of lipophilic xenobiotics by converting these compounds to relatively 
more water-soluble metabolites which can readily be conjugated with glucuronic acid 
or sulphuric acid or directly excreted by the kidney. The most common metabolic change 
catalysed by these enzymes is hydroxylation which is the major function of the 
non-specific hepatic microsomal drug metabolizing system in which the heterogeneous 
class of proteins known collectively as cytochrome P-450 acts as the terminal oxidase. 
Molecular oxygen is utilized and NADPH supplies the reducing equivalents for the 
hydroxylation of substrates by cytochrome P-450 (Gillette et al. 1972). 
Induction or inhibition of the activity of these enzymes has a considerable influence 
on the metabolism and possible toxic effects of exogeneous compounds. Inducing agents 
•Preliminary report : First Annual Congress, South African Biochemical Society, Hermanus 1975. This 
research was supported by grants from the South African Medical Research Council, the University of 
Cape Town Staff Research Fund and the Anglo American and De Been Anaesthetic Research Fund. 
tDcparunent of Physiology and Medical Biochemistry, 
tDcparunent of Chemical Pathology, 
§Dcpanment of Anaesthetics, 
IIDcpartment of Pathology, University of Cape Town Medical School, Observatory, Cape Town 8001. 
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for cytochromes P-450 fall into two major groups: those which induce cytochrome P-450, 
e.g., phenobarbital, and those which induce a similar but spectrally distinct enzyme 
known as cytochrome P-448, or cytochrome P1-450, e.g., the aromatic polycyclic 
hydrocarbon, 3-methylcholanthrene (Conney 1967; Gillette et al. 1972). 
While metabolism of drugs and other xenobiotics by cytochrome P-450 often results 
in the detoxification of these substances, on occasion relatively more active and toxic 
metabolites arise which produce liver injury, e.g., in the case of carbon tetrachloride 
(Judah et al. 1970). Fluroxene (2,2,2-trifluoroethyl vinyl ether) is an inhalation anaes-
thetic which is frequently used in clinical practice but which has recently been shown to 
be toxic under certain conditions to laboratory animals (Cascorbi & Singh-Amaranath 
1972; Stevens & Gibbons 1973; Johnston et al. 1973) and to man (Harris & Cromwell 
1972; Reynolds et al. 1972; Tucker et al. 1973; Wollman & Surks 1973). Fluroxene 
anaesthesia, while not normally toxic to rats, causes their death and produces 
hepatotoxic symptoms after pre-treatment of the animals with phenobarbital (Harrison 
& Smith 1973) . Since phenobarbital enhances hepatic cytochrome P-450 levels, this 
toxicity is considered to result from enhanced biotransformation of the anaesthetic by 
the cytochrome P-450 enzyme system to one or more toxic metabolites. 
We have attempted to elucidate the role of the different cytochromes P-450 in the 
metabolism of fluroxene by investigating the effects of induction of cytochromes P-450 
and P-448 on the toxicity of fluroxene in vivo and by investigating the interactions of 
fluroxene with cytochromes P-450 and P-448 in isolated rat hepatic microsomes. In an 
effort to determine the mechanism of production of the toxic effects, investigations with 
2,2,2-trifluoroethyl ethyl ether (TFEE) and ethyl vinyl ether (EVE) were also carried 
out. 
MATERIALS AND METHODS 
2-Allyl-2-isopropylacetamide (AIA) was a gift from Hoffman - La Roche, Nutley, 
New Jersey. 2,2,2-trifluoroethyl ethyl ether (TFEE) was prepared by hydrogenation of 
fluroxene at 206,8 kPa hydrogen using activated palladium on carbon as catalyst. 
Fluroxene was purchased from Ohio-Medical Products, Madison, Wisconsin, and 
ethyl vinyl ether from Fluka, A. G. 
INDUCTION AND ANAESTHESIA 
Male rats weighing between 175-300 g were used in all experiments; animals were 
allowed free access to Epol Laboratory Chow and water. Induction of cytochrome P-450 
was by intraperitoneal injection of sodium phenobarbital (80 mg/kg/day in 0,9 per cent 
sterile saline) and cytochrome P-448 by injection of3-methylcholanthrene (40 mg/kg/day 
in corn oil) for three consecutive days. Control animals were injected siinilarly with 
saline or corn oil only. 
Animals were fasted overnight and anaesthetized or sacrificed 24 hours after the final 
injection. Animals receiving AIA (200 mg/kg in 0,9 per cent sterile saline) were injected 
subcutaneously in the loose skin of the neck one hour prior to anaesthesia. Rats were 
anaesthetized for 2 hours in a perspex anaesthetic chamber. The anaesthetic agent, 
vapourized by a stream of oxygen at 5 I /minute, was in sufficient concentration to 
maintain light surgical anaesthesia. Ambient levels of CO2 were below I per cent. 
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PREPARATION OF MICROSOMES 
Livers were excised from animals within minutes of death or sacrifice and a portion of 
the liver was reserved for histological investigation (fixative, 10 per cent buffered formal 
saline; stain, haematoxylin and eosin). Microsomes from the livers ofrats used for in vivo 
studies were prepared by differential ultracentrifugation (Holtzman & Carr 1972) and 
microsomes for biochemical studies were prepared by gel filtration on Sepharose 2B 
equilibrated with 0,15 M KCl-0,02 M Tris-HCl buffer pH 7,4 (Tangen et al. 1974). 
Protein concentration was determined using bovine serum albumin as a standard (Lowry 
et al. 1951). Microsomal cytochromes P-450 content was determined by the method of 
Omura and Sato (1964). 
BIOCHEMICAL STUDIBS 
All spectrophotometry was carried out using a Unicam SP1800 recording spectrophoto-
meter. Difference absorbance spectra of microsomal suspensions were recorded at room 
Table 1 
Toxi&i9, cytachromes P-450 concenJrations and his/Qlogical changes after induction and a,uusthesia 
Pre-treat- Anaes- Time of Cyt P-450§ 
ment• thetic• dcatht (nmol/mg micro-
(No. rats) agent (hr) soma) protein) Histology 
Saline (17) None, FL, K24 1,27 ± 0,06 Hydropic change in all. Mild fatty infil-
TFEE or tration in livers of TFEE anaesthetized 
EVE rats. 
PB (4) - K4 3,42 ± 0,34 Ccntrizonal hydropic change. 
PB (9) FL 1-3 1,23 ± 0,13 Pcriportal congestion, gross ccntrizonal 
necrosis. Mild fatty infiltration in all 
areas. 
PB+ AIA (2) - K-2! 0,81 ± 0,02 Marked hydropic change, 'punched out' 
vacuoles in cytoplasm. 
PB+ AIA (2) FL K24 0,75 ± 0,15 Marked hydropic change, 'punched out' 
vacuoles in cytoplasm. No additional 
change. 
PB (8) TFEE 0-35 2,49 ± 0,63 Widespread fatty infiltration. Foci of 
frank necrosis l /9 rats. 
PB (9) EVE K24 Not detcnnined No necrosis. Pcriportal hydropic dcgcn-
cration 2/9 rats. 
Com oil (2) - K24 1,27 ± 0,12 Minimal cytoplasmic vacuolation. 
Com oil (2) FL K24 1,10 ± 0,20 Minimal cytoplasmic vacuolation. 
MC (3) - K24 2,47 ± 0,12 Minimal cytoplasmic vacuolation. 
MC (2) FL K24 1,52 ± 0,29 Ccntrizonal chromatolysis. Midzonal hy-
dropic change. 
•Abbreviations used arc: PB, phenobarbital; AIA, 2-allyl-2-isopropylacetamide; MC, 3-methylcholan-
thrcne; FL, fluroxene; TFEE, 2,2,2-trifluorocthyl ethyl ether; EVE, ethyl vinyl ether. 
tFrom tcnnination of anaesthesia, or equivalent time if no anaesthesia. K indicates animals were killed; 
in other cases toxicity caused death. 
!Killed at a time equivalent to commencement of anaesthesia. 
§Total cytochromcs P-450 including cytochromes P-450 and P-448. 
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temperature by equally dividing portions of the suspension between two I cm path 
length cu\'ettes. Varying quantities of fluroxene or TFEE were added to the reference 
cuvette, and the magnitude of the resultant difference spectrum was measured as the 
difference in absorbance between the peak at approximately 390 nm and the trough at 
approximately 420 nm, and designated !:,_ A. 
The rates of metabolism of fluroxene or TFEE by hepatic microsomes were determined 
by monitoring :'.\ADPH consumption. Equal quantities of microsomal suspension were 
divided between two I cm path length cuvettes and equilibrated at 28 °C. Varying 
quantities of fluroxene or TFEE were added to the sample cuvette and the reaction 
initiated by the addition of 50-JOO µI of KADPH solution (0,12-0,24 mM final concen-
tration). ::\'.-\DPH oxidation was monitored spectrally at 340 nm and was corrected for 
background rates of endogenous NADPH oxidation in the presence of fluroxene or 
TFEE in an atmosphere of C0-02 (80: 20; v/v) (Stripp et al. 1972). 
RESULTS 
II\' Vl\"O STL"DIES 
The effects of the inducing agents of cytochromes P-450 in potentiating the toxicity of 
the three anaesthetic agents to rats are shown in Table I. The hepatic microsomal 
cytochromes P-450 content per mg of microsomal protein and the histological changes 
following induction with subsequent anaesthesia are tabulated. 
Figurr J. s ~ction from liver of a rat given an intraperitoneal injection of saline followed by TFEE 
anaesthesia . :\"ate the hydropic change without marked hepatic swelling. (H & E X 250). 
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Treatment with saline alone or in conjunction with anaesthesia by fluroxene, TFEE 
or EVE did not produce toxic effects and did not affect hepatic cytochrome P-450 
content per mg of microsomal protein. In all cases, histological investigation revealed 
minor hydropic changes, (e.g., Figure 1). 
Phenobarbital pre-treatment of animals resulted in an approximately threefold 
increase in cytochrome P-450 levels. All rats induced with phenobarbital and sub-
sequently anaesthetized with fluroxene died within 1-3 hours after the termination of 
anaesthesia. After death, these animals exhibited a large decrease in hepatic cytochrome 
P-450 content , and there was marked histological evidence of liver damage. Severe 
congestion was an outstanding feature especially in the periportal zones where hepato-
cytes appeared atrophied and compressed by grossly dilated sinusoids. Centrizonal 
hepatocytes were swollen with pale pink featureless cytoplasm. Foci of necrosis were 
present and mild fatty infiltration was noted in all areas (Figure 2). 
Figure 2. Srrtion of liver from a rat induced with phenobarbital followed by fluroxene anaesthesia 
showing pl'ripon al rongestion with atrophy of hepatocytes and centrizonal swelling of hepatocytes with 
bomogenl'ou, pak-staining cytoplasm and very mild fatty change. (H & E Y. 250). 
The toxic effects of fluroxene anaesthesia observed in phenobarbital pre-treated animals 
were prn-em ed by treatment of the animals with AIA one hour prior to anaesthesia. No 
deaths ,n·re obsen 'ed in this latter group and animals appeared normal at the time of 
sacrifice. The marked histological changes observed with fluroxene anaesthesia of 
phenobarbi tal pre-treated animals were also prevented, the only features observed being 
those sho\\'n by phenobarbital and AIA treated anaesthetized controls. 
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Anaesthesia of phenobarbital induced rats with TFEE also resulted in the death of the rats : 100 per cent mortality was observed within 35 hours after termination of anaes-thesia at which time a slight decrease in hepatic cytochrome P-450 content was evident. Histologically, frank hepatic necrosis was rare, the most consistently observed change being widespread fatty infiltration, a change not considered adequate to account for the death of the animals. 
In the group of animals pre-treated with phenobarbital and anaesthetized with EVE no mortality occurred and there was no evidence of centrizon.al necrosis in any of the livers. The non-specific periportal hydropic changes which were observed were also apparent in uninduced anaesthetized control animals. 

















Figure 3. Difference spectrum of phenobarbital induced rat hepatic microsomcs (2,0 mg protein/ml) with fluroxene (6,0 x 10- • M), in 0,02 M tris/HCI, pH7,4. Cytochrome P-450 concentration 2,7 nmolcs/mg protein. 
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IN VITRO STUDIES 
Fluroxene binds to cytochrome P-450 of hepatic microsomes from untreated, pheno-
barbital treated and 3-methylcholanthrene treated rats, resulting in the appearance of 
a 'Type I' difference spectrum (e.g., Figure 3), the extent of which increases with 
increasing fluroxene concentration until saturating concentrations of the anaesthetic are 
reached (Figure 4). Induction of cytochrome P-448 with 3-methylcholanthrene does not 
affect the extent of binding of fluroxene to hepatic microsomal cytochromes P-450 
relative to control microsomes whereas induction of cytochromeP-450withphenobarbital 
increases the maximal extent of binding offluroxene approximately twofold (Figure 4). 
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Figure 4. Effect of increasing fluroxene concentration on the extent of its difference spectrum with 
cytochromes P-450 of uninduced (.), phenobarbital induced (e) and 3-methylcholanthrcne induced 
W rat hepatic microsomes, the respective cytochromes P-450 concentrations being 1,08 2,70 and 2,14 
nmoles/mg protein. Microsomal concentration 2,0 mg protein/ml, buffer 0,02 M tris/HCJ, pH 7,4. 
and permit calculation of the spectral dissociation constants (K1) (Schenkman 1970) for 
the binding of fluroxene to hepatic microsomal cytochrome P-450 (Figure 5), the K. 
values being the same from uninduced, phenobarbital induced and 3-methylcholan-
threne induced hepatic microsomes (Table 2). 
Fluroxene stimulates NADPH consumption by hepatic microsomes from uninduced, 
phenobarbital induced and 3-methylcholanthrene induced rats, and this enhancement 
of NADPH consumption is inhibited by an atmosphere of C0-01 (80: 20; v/v) or 
10 mM KCN and is not affected by l mM KCN. Rates of metabolism of fluroxene 
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Figure 5. Lineweaver-Burk plots or data from fluroxene difference spectral studies with uninduced (.}, phenobarbital induced (e) and 3-methylcholanthrene induced (,A} rat hepatic microsomes, the respective cytochromes P-450 concentrations being 1,20 3,34 and 2,12 nmoles/mg protein. Microsomal concentration 2,0 mg protein/ml, buffer 0,02 M tris/HCl, pH 7,4. 
monitored by the disappearance of NADPH are used to calculate the Michaelis 
constants, Km, under different conditions of induction (Figure 6) by means of Lineweaver-Burk plots. The Km values obtained with microsomes induced for 
elevated cytochromes P-450 or P-448 levels do not differ significantly from that obtained 
with control microsomes. Phenobarbital induction elevated V max relative to uninduced controls roughly in proportion to the increase in cytochrome P-450 content. The V max 
value from microsomes induced with 3-methylcholanthrene did not differ from that of 
the uninduced control value (Figure 6 and Table 2). 
Table 2 
Effects of induction of hepatic microsomal cytochromes P-450 on the binding and metabolism of jluroxene (2,2,2-tri-jluoroethyl vinyl ether) 
Cyt P-450t 
(nmol/mg 
microsomal Ks Km Induction• protein) (M) (M) 
NONE 1,1 9,3 X 10-• 7,6 X 10-• 
PB 2,7 9,5 X 10-• 6,3 X 10- • 
MC 2,1 9,4 X 10-• 9,5 X 10-• 
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Figure 6. Lineweaver-Burk plots illustrating the metabolism of fluroxene by uninduced (.), pheno-
barbital induced (e ) and 3-methylcholanthrene induced CA) rat hepatic microsomcs, the respective 
cytochromes P-450 concentrations being 1,02 3,34 and 2,14 nmoles/mg protein. v represents the rate of 
metabolism as monitored by the corrected rates of NADPH oxidation presented as ll.A3.f0nm/min. 
Microsomal concentration 2,0 mg/ml, buffer 0,02 M tris/HCI, pH 7,4 and temperature 28°C. 
DISCUSSION 
Phenobarbital induces the synthesis of hepatic cytochrome P-450, but not cytochrome 
P-448, and also causes the proliferation of the endoplasmic reticulum and elevates the 
levels ofNADPH-cytochrome P-450 reductase and cytochrome b5 per mg of microsomal 
protein (Conney 1967). In contrast, the polycyclic hydrocarbon inducers, of which 
3-methylcholanthrene is an example, enhance the levels of hepatic cytochrome P-448 
but do not cause proliferation of the endoplasmic reticulum or the synthesis of microsomal 
KADPH-cytochrome P-450 reductase or cytochrome b5• Cytochrome P-448 differs from 
cytochrome P-450 with regard to substrate specificity, spectral properties and sensitivity 
to inhibitors (Fujita & Mannering 1971 ). Mixtures of these two (or more) type P-450 
cytochromes are always present in hepatic microsomes, but cytochrome P-450 predomin-
ates in phenobarbital induced and uninduced animals, whilst cytochrome P-448 
predominates in 3-methylcholanthrene treated animals (Fujita & Mannering 1971) . We 
will use the term 'cytochromes P-450' to refer to both cytochrome P-450 and cytochrome 
P-448, and the terms 'cytochrome P-450' or 'cytochrome P-448' to refer to the specific 
type. 
The fact that fluroxene anaesthesia does not lead to mortality in uninduced rats with 
hepatic microsomal cytochromes P-450 levels of approximately 1 n mole/mg microsomal 
protein but always does so in the case of phenobarbital pre-treated rats with approxi-
mately a threefold elevation of cytochromes P-450 implies that it is the cytochrome P-450 
catalysed metabolism offluroxene to one or more toxic products which is responsible for 
the toxic effects observed. Since phenobarbital induces a number of microsomal proteins, 
the enzyme(s) involved in the rate limiting step of this metabolism is (are) not deter-
mined by this experiment. The effect of AJA, however, in overcoming the toxic poten-
tiating effects of phenobarbital on fluroxene anaesthesia ·unequivocally demonstrates an 
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essential role for cytochrome P-450 since AIA specifically degrades cytochrome P-450 
while not affecting other microsomal proteins (e.g. cytochrome b6 and NADPH-
cytochrome P-450 reductase) or reversing other non-microsomal effects of phenobarbital 
(De Matteis 1970; Levin et al. 1972). Thus elevated levels of cytochromes P-450 are 
essential in potentiating the toxicity offluroxene, probably because an increased rate of 
production of a toxic metabolite(s) results when cytochrome P-450 levels are elevated. 
Other microsomal enzymes undoubtedly play a role in the metabolism of fluroxene but 
are apparently ineffective in potentiating the toxicity offluroxene in the absence of high 
cytochrome P-450 concentrations. The in vitro studies in which uninduced and 
phenobarbital induced isolated hepatic microsomes were demonstrated to bind and 
metabolize fluroxene proportionately to their cytochrome P-450 concentration provide 
confirmatory evidence for the increased in vivo rate of metabolism of fluroxene when 
cytochromes P-450 levels are elevated by phenobarbital (Table 2). 
In uninduced rats anaesthetized with fluroxene, toxic levels of the active metabolite(s) 
are apparently not reached, perhaps because further metabolism or excretion is 
able to balance the relatively slow rate of production of the metabolite(s) . This would 
explain the histological evidence that fluroxene causes minimal damage to livers of un-
induced rats whereas the damage to livers of phenobarbital treated animals is marked. 
In animals pre-treated with 3-methylcholanthrene to induce cytochrome P-448, the 
cytochromes P-450 levels of2,4 nmol/mg micrpsomal protein obtained are similar to the 
levels following phenobarbital induction for one day, a treatment which does produce 
toxic effects subsequent to fluroxene anaesthesia (observation in our laboratory). 
Failure of pre-treatment by 3-methylcholanthrene to potentiate fluroxene toxicity is 
thus not then a consequence of insufficient cytochromes P-450 but must follow from the 
inability of cytochrome P-448 to metabolize fluroxene. 
The studies of the binding offluroxene to hepatic microsomal cytochromes P-450 from 
uninduced, and 3-methylcholanthrene induced animals clearly demonstrate that there is 
no binding offluroxene to hepatic microsomal cytochrome P-448 in vitro, since 3-methyl-
cholanthrene induced microsomes with markedly enhanced cytochrome P-448 levels do 
not exhibit enhanced difference spectra relative to uninduced controls (Figure 4 and 
Table 2). The constancy of the spectrally determined binding constant, K., (Table 2) 
for fluroxene binding to untreated and induced microsomcs provides evidence that the 
same cytochrome P-450 type is binding the fluroxene in all the microsomal preparations 
but in the case of 3-methylcholanthrene induced microsomes this is only the minor com-
ponent of the overall microsomal cytochromes P-450. 
In utilizing the rate of oxidation of NADPH as a monitor of the metabolism of 
fluroxene, correction was made for CO insensitive endogenous NADPH oxidation in 
accordance with the method of Stripp et al. ( 1972) who have investigated the relationship 
between the rates of cytochrome P-450 mediated metabolism of drugs and the rates of 
oxidation of NADPH. The results of inhibition studies with KCN indicate that the 
hepatic dcsaturase system is not involved in the metabolism of fluroxene (Shimakata 
et al. 1971). 
Since phenobarbital induced microsomcs show markedly enhanced maximum rates 
of metabolism of fluroxene relative to uninduced controls while 3-methylcholanthrene 
induced microsomcs show no change in maximum rates relative to control microsomes 
(Table 2), it can be concluded that cytochrome P-448 docs not catalyse the metabolism 
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of fluroxene. The failure of 3-methylcholanthrene induction to potentiate the toxicity 
offluroxene anaesthesia in vivo can be explained, then, by the inability, observed in vitro, 
of cytochrome P-448 to bind and metabolize fluroxene .. 
The close agreement between the average values of Km (0,8 mM) and K1 (0,9 mM) 
for the interaction of fluroxene with all microsomes investigated indicates that the 
'Type I' difference spectrum observed is probably indicative of substrate-cytochrome 
P-450 complex formation. 
The histological investigation reveals that hepatic damage following fluroxene 
anaesthesia of 3-methylcholanthrene treated animals was in the form of a mild version 
of the damage seen following similar anaesthesia of phenobarbital treated animals. This 
demonstrates that the damaging metabolite(s) was (were) not present in toxic concen-
trations and this confirms that the elevated levels of cytochrome P-448 could not 
potentiate the toxicity of fluroxene. 
In attempting to determine the mechanism of production of the toxic effects of 
fluroxene mediated by elevated cytochrome P-450 levels, use was made of two other 
anaesthetic agents structurally related to fluroxcnc. 2,2,2-trifluorocthyl ethyl ether 
is the reduced form offluroxene in which the vinyl moiety of fluroxcne has been hydro-
genated to an ethyl group. Ethyl vinyl ether is the non-fluorinated analogue of fluroxcne. 
Exposure of rats to TFEE anaesthesia following phenobarbital induction resulted in 
the death of the animals but after a longer period than in the case of fluroxcne 
anaesthesia. There was evidence of liver damage in both groups (Table I). The patterns 
of this liver damage differed, however, in that those exposed to fluroxcnc, exhibited 
centrizonal necrosis and congestion, as described previously (Harrison & Smith 1973) 
whereas with those exposed to TFEE, fatty change was the consistent pattern. From a 
comparison of the investigations of fluroxenc and TFEE it is evident that the potential 
for mortality resides in the trifluoroethyl moiety rather than in the vinyl ether moiety 
which is absent in TFEE. This is confirmed by the inability of ethyl vinyl ether (which 
has no trifluoroethyl group) to cause mortality or liver damage in rats which have been 
induced to elevated cytochrome P-450 levels. There is ample evidence for the metabolism 
of the fluroxene molecule to trifluoroethanol glucuronide in vivo, and the toxicity of 
trifluoroethanol and its physiological derivatives has been established (Blake et al.. 1969). 
There is however no unambiguous proof at present that the toxic effects observed in this 
study arise directly from the toxicity of trifluorocthanol. · 
The difference in the histological pattern of liver injury following the use of TFEE 
rather than fluroxene suggests that the vinyl group of fluroxcne must be involved in 
some way in the production of this liver damage which, in itself, isJ>robably not the 
direct cause of death in the experimental animals. In Table I, it can be seen that 
anaesthesia with fluroxene causes a large decrease in hepatic cytochromes P-450 levels 
within 3 hours post anaesthesia, whereas the same is not observed within 35 hours after 
TFEE anaesthesia. The apparent destruction of cytochromes P-450 mediated by the 
vinyl group offluroxene is therefore probably related to the observed liver damage. That 
EVE, possessing a vinyl group, does not produce similar liver damage is surprising but this 
phenomenon is under investigation at present. 
The fatty changes observed in the livers of phenobarbital pre-treated animals anaes-
thetized with TFEE are not considered adequate to account for the deaths of the animals. 
\%ether the actual mode of death following fluroxene or TFEE anaesthesia is hepatic 
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failure, or a more widespread acute toxic effect on other organs cannot be ascertained from these ·studies, although the liver is the site of production of the toxic metabolite(s) and therefore of crucial importance. 
In conclusion, these studies demonstrate that the toxicity of fluroxene anaesthesia potentiated by phenobarbital induction results from the enhanced rates of metabolism of the anaesthetic due to elevated cytochrome P-450 levels. The type P-450 cytochrome involved in the metabolism of fluroxene is cytochrome P-450 in contrast to cytochrome P-448 which neither binds nor metabolizes the anaesthetic. The potential cause of mortality in the fluroxene molecule resides in the trifluoroethyl portion and the causative agent in the observed liver damage is probably the vinyl moiety. 
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Some Aspects of the Hepatic Metabolism of Ethrane 
G. G. HARRISON, J. A. MARSH, J. J. BRADSHAW, I. ZIETSMAN, K. M. IVANETICH 
SUMMARY 
From our studies of the rat we report observation, on 
three Hpect, of the interaction of ethrane and liver. 
1. Interaction of ethrane with cytochrome P4SO in 
vitro. 
2. The effect of ethrane administration on glutathione 
level, in vivo. 
3. The effects of repeated ethrane administration in 
the absence and presence of microsomal enzymic in-
duction on liver morphology. 
We conclude that ethrane has little or no propensity for 
damaging the liver. 
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In the evaluation of any new anaesthetic agent, investiga-
tion of its interaction with the liver is of prime clinical 
relevance. Three aspects of ethrane and liver interaction 
were of special interest to us : 
The interaction of ethrane with hepatic cytochrome P450 
in vitro. As with other lipophilic xenobiotics, the biotrans-
formation of volatile anaesthetics is a function of the hepa-
tic microsomal cytochrome P450. In addition to establish-
ing the equilibrium constants K, and Km for the binding and 
metabolism of ethrane by cytochrome P450, we were in-
terested to establish whether or not this reaction was accom-
panied by any destruction of cytochrome P i50. Our recent 
observations of fluroxene-mediated destn.ction of cyto-
chrome P450' and the similar observation of Brown tt al: 
in the case of chloroform, suggest that destruction of 
cytochrome P450 in this reaction may in some way be 
related to the drug's hepatotoxic potential. 
The effect of ethrane administration on liver g]utatbione 
levels in vivo. Reduced glutathione is the free radical 
scavenger that protects the structural lipid of the hepa-
tocyte from interaction with reactive intermediates that 
might result from microsomal drug metabolism. Such 
reaction, which has been shown to follow exposure of 
animals to bromobenzine, paracetamol, chloroform, carbon 
3.7 
4 Desember 1976 SA MEDIESE TYDSKRIF 2081 
tetrachloride,' and fluroxene . all of which produce liver 
necrosis, results in a fall in the level of hepatic gluta-
thione. We regard the response of liver glutathione levels 
to exposure to a drug, and the further effect on this of 
enhancement of the drug·s metabolism by microsomal 
enzymic induction, as an index of the potential of the 
drug to produce reactive and possibly hepatocyte-damaging 
metabolites. 
The effects on liver histology of ethrane anaesthesia 
in both the absence and the presence of phenobarbitone-
induced enhanced levels of microsomal activity. Though 
somewhat crude, we regard the histological examination 
of the liver as an essential correlate of the investigation of 
any drug and liver interaction, with the further postulate 
that, should any harmful reaction be possible, 1t would, 
as in the case of chloroform, paracetamol , and fluroxene, 
be worsened and made more obvious by artificial enhance-
ment of the metabolism of the drug. 
METHODS 
Interaction of Ethrane with Cytochrome P450 
The interaction of ethrane with cytochrome P450 was 
monitored by methods previously described.'·· 
Calculations: Binding constants and Michaelis constant 
were calculated from plots of [SJ versus [SJ /V or [SJ / 
absorbance change. 
Effect of Ethrane on Liver Glutathione and 
Histology 
The effects of ethrane anaesthesia on liver glutathione 
levels in rfro and liver histology were studied in male 
LE rats weighing 200 - 250 g. both in the presence and 
absence of microsomal enzymic induction. Liver micro-
somal enzymes were enhanced by the daily intraperitoneal 
injections of phenobarbitone (80 mg / kg / d) for 3 days 
before anaesthesia. The concentration of phenobarbitone 
in saline was JO mg / ml. which resulted in volumes for 
injection of approximately 2 ml. Control rats (which 
had received no pretreatment) were injected with similar 
volumes of physiological saline. Having been allowed food 
and water ad lib. until then, the rats were starved for 
24 hours after the third injection of phenobarbitone, at 
which time (day 4 ) they were anaesthetised with ethrane 
1.5 ~~-
The anaesthetic chamber was a rectangular perspex 
box, length 60 cm x breadth 30 cm, depth 30 cm, within 
which a fenestrated floor was raised 8 cm from the base. 
The space below the floor was filled with standard anaes-
thetic soda lime. A further fenestrated metal box of dimen-
sions 12 cm' containing soda lime stood on the floor be-
tween the experimental animals. Ethrane was vaporised 
from a Cyprane vaporiser by a stream of oxygen at the 
ra te of 5 litres per minute. which was introduced into the 
chamber through a port below the floor at one comer and 
exhausted from the chamber via the top corner diagonally 
opposite. Ambient carbon dioxide was monitored and 
was always Jess than l 0 : • • 
In the glutathione studies, groups of 3 rats each which 
had been pretreated, and controls which had received no 
pretreatment, were removed from the anaesthetic chamber 
at 30, 90, and 180 minutes, and were immediately killed 
by cervical dislocation, after which they were hepatecto-
mised. Glutathione levels were then measured in the liver 
by the method of Cohn and Lyle: The level of gluta-
thione for each period of time was taken as the mean 
value for 6 animals. 
In the histological study, animals were subjected to 3-
hour periods of anaesthesia with 1,5 % ethrane at weekly 
intervals for 3 weeks, i.e. three 3-hour periods of anaesthe-
sia in 3 weeks. All rats were killed by cervical dislocation 
on the third day after the third anaesthetic exposure. There-
after the livers were removed, fixed in 10% formol saline, 
sectioned, stained with haematoxylin and eosin and exam-
ined histologically. The 60 rats (30 control, 30 enzyme-
induced) used in the histological study were anaesthetised 
in groups of JO. 
RESULTS 
Interaction of Ethrane with Cytochrome P450 
(Table I) 
Ethrane binds to and is metabolised by hepatic microso-
mal cytochrome P450. The binding is a typical 'type I' 
with a >. .... equal 385 nm, >-... . equal 418 nm (Fig. 1). 
TABLE I. INTERACTION OF ETHRANE WITH HEPATIC 
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The K, for this interaction is 1,3 mM. Ethrane is meta-
bolised by the cytochrome P450-dependent enzymic system 
as judged by ethrane enhancement of CO-inhibitable 
NADPH consumption. The K., for this process is 0,6 mM, 
V .... is IO nmol NADPH/min/mg microsomal protein. 
In vitro, this interaction with ethrane was unaccompanied 
by any change in the levels of any of the microsomal 
proteins measured. 
Effect of Ethrane on Hepatic Glutathione Levels 
In contradistinction to chloroform and fluroxene, ethrane 
administration, even in the presence of microsomal enzyme 
induction. caused no fall in the hepatic glutathione level 
(Fig. 2). 
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Fi&, 1. Difference spectrum of induced mic_rosomes with 
ethrane. 
Effect of Ethrane Administration on Liver 
Morphology 
Of 60 rats (30 enzyme-induced, 30 control, no pretreat-
ment) exposed to three 3-hour periods of anaesthesia with 
ethrane 1,5~~. none died. At sacrifice on the third day 
after the last anaesthetic exposure, there was no histologi-
cal evidence of liver damage in any section of liver from 
either the enzyme-induced or the control group of rats. 
DISCUSSION 
Ethrane has been shown to interact with and be metabo-
lised by the hepatic microsomal cytochrome P450-depen-
dent pathway in vitro. The type and extent of binding, 
K., u.Amu. and the metabolic measurements Km, V ... 
are similar to those found for the interaction of other 
volatile halogenated hydrocarbon anaesthetics with cyto-
chrome P450 in vitno. This interaction of ethrane with 
cytochrome P450 is unaccompanied by any destruction of 
the microsomal electron transfer components measured. 
This metabolism, even when it is enhanced by microsomal 
enzyme induction, is not accompanied by any fall in liver 
glutathione levels. These observations are consistent with 
the conclusion that the hepatic metabolism of ethrane 








Fi&, 2. Liver slutathione levels measured in phenobarbi-
tone-induced and uninduced rats after exposure to eduane/ 
0, anaesthesia. 
possibly organelle-damaging intermediates, such as result 
from the metabolism of the anaesthetics chloroform and 
fluroxene and other agents such as bromobenzine, para-
cetamol, and carbon tetrachloride. 
Such a conclusion correlates with the normal hepatic 
histology observed after repeated exposure to ethrane, even 
in circumstances of enhanced biotransfonnation of ethrane. 
In conjunction with the low rate of biotransformation ob-
served for ethrane• - lower than that of other volatile 
agents except for its isomer, isoflurane - our observa-
tions are consistent with ethrane's possessing little or no 
direct hepatotoxic potential. 
This work was financially supported by the Anglo American 
and De Beers Anaesthetic Research Fund, the Universitv of 
Cape Town Staff Research Fund and the South African 
Medical Research Council. 
Ethrane was supplied gratis by Abbott Laboratories, South 
Africa (Pty) Limited. 
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The Effect of Exposure to Halogenated Anaesthetics on 
Liver Glutathione Levels in Rats 
An Index of Hepatotoxicity 
G. G. HARRISON, V. MANCA 
SUMMARY 
Having studied anaesthetic drug interactions in rats, we 
report the effects of halogenated anaesthetics on the 
liver glutathione levels and histology, as well as the 
results of the enhancement of these effects by microso-
mal enzyme induction. The anaesthetic agents studied 
included methoxyflurane, halothane, ethrane, chloroform 
and fluroxene. While exposure of raa to methoxyflurane, 
halothane and ethrane produced no significant changes 
in hepatic glutathione levels, or in liver histology, expo-
sure to chloroform and fluroxene produced marked de-
pression of liver glutathione, especially after microsomal 
enzyme induction. Furthermore, rats exposed to these 
agents after enzyme induction developed gross centrilo-
bular necrosis and died. It is suggested that the study 
of the effects of any new anaesthetic agent on liver glu-
tathione levels could be a valuable screening test of its 
hepatotoxic potential, before its clinical trial. 
S. Afr. med. J., SS, SSS (1979). 
Reduced glutathione is a free radical scavenger that pro-
tects the structural lipid of the hepatocyte from inter-
action with highly reactive intermediates that might result 
from microsomal drug metabolism. This reaction, which 
is accompanied by a fall in the level of liver glutathione, 
has been shown to follow exposure of animals to many 
drugs which are known to produce liver damage and 
necrosis, e.g. bromobenzene, paracetamol, carbon tetra-
chloride and chloroform.' The effect of exposure to a 
drug on the level of liver glutathione and the further 
effect on this of enhancement of the drug's metabolism 
by microsomal enzyme induction, may be regarded as an 
index of the potential of biotransformation of that drug 
to produce reactive and possibly hepatocyte-damaging 
metabolites, i.e. a measure of its hepatotoxic potential. 
We studied in vivo the effects of exposure to haloge-
nated anaesthetics on the levels of liver glutathione and on 
liver histology in rats, as well as the results of enhance-
ment of such effects by microsom~I enzyme induction. 
The correlation of these findings with the reported effects 
of the same drugs on hepatic cytochrome P-450 content 
is discussed in relation to preliminary screening tests for 
new anaesthetic drugs. · 
Department of Anaesthetics, University of Cape Town 
G. G. HARRISON, M .D., F .F.A. 
\' . MANCA, B.SC. HONS 
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MATERI~ AND METHODS 
Male Long-Evans rats weighing 200 - 250 g were exposed 
to the anaesthetics methoxyfturane, halothane, ethrane, 
chloroform and fluroxene. 
Animals were anaesthetized in a rectangular Perspex 
anaesthetic chamber measuring 60 x 30 cm, with a raised 
fenestrated floor 8 cm from the base. The space below 
this floor was filled with standard soda lime. The anaes-
thetics tested were vaporized in standard clinical vapor-
izers to 1 MAC by a stream of oxygen (5 I/min), which 
was passed into the chamber through a port below the 
floor at one comer and exhausted from the chamber via 
the top diagonal comer. Ambient carbon dioxide was 
monitored and was always less than 1'%. 
Microsomal enzyme induction was achieved by the 
intraperitoneal injection of phenobarbitone 80 mg/kg 
in a 1'% solution administered daily for 3 days before 
anaesthesia. Control animals were injected with similar 
volumes of saline. Pretreated and control animals were 
treated simultaneously in duplicate chambers. 
To study the effects of the anaesthetics on liver gluta-
thione, groups of 5 rats each, pretreated with phenobar-
bitone and not pretreated, were subjected to periods of 
anaesthesia of 30, 90 and 180 minutes. At the conclusion 
of these periods of anaesthesia they were immediately 
killed by decapitation. The livers were removed and 
glutathione levels were assayed in liver homogenates by 
the method of Cohn and Lyle.• A group of 5 rats sacri-
ficed at commencement of the period of anaesthesia 
served as controls for each experiment. In · the case 
of ethrane, hepatic glutathione was assayed in .two groups 
of 5 rats each for each time period. A further control 
adopted was the estimation of liver glutathione in groups 
of 2 rats each confined in the anaesthetic chamber venti-
lated with oxygen alone at a flow rate of 5 I/min for 0, 
30, 90 and 180 minutes. The values from 5 such experi-
ments (10 values at each time period) were pooled. 
In the histological study, 2 groups of 10 animals each, 
with and without phenobarbitone pretreatment, were sub-
jected to 3-hour periods of anaesthesia with 1 MAC of 
the test anaesthetic at weekly intervals for 3 weeks, i.e. 
3 x 3-hour 1 MAC anaesthetics. Animals were sacrificed 
24 hours after the last exposure, the livers were then 
removed and fixed in 10% formal saline, sectioned and 
stained with haematoxylin and eosin and subjected to 
standard light microscopy. In the case of pretreated ani-
mals subjected to fluroxene and chloroform anaesthesia, 
this protocol could not be completed, because all these 
animals died after one exposure. 
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RESULTS 
The effects on the levels of hepatic glutathione of the 
anaesthetics tested are presented in Table I, and are ex-
pressed graphically as the percentage change from control 
levels in Figs I and 2. 
In rats confined to the anaesthetic chamber and 
breathing oxygen alone a statistically significant fall in 
hepatic glutathione levels occurred - a mean of 25 ~~ from 
control values (95 ~~ confidence limits 7 - 43'%). Statisti-
cally significant falls of the same order in hepatic gluta-
thione levels were observed after a 90-minute exposure of-
untreated rats to halothane, and in both untreated and 
treated rats exposed to ethrane. In each instance the mean 
fall in glutathione levels was less after 180 minutes' expo-
sure, and was no longer statistically significantly different 
from the control value (Fig. 1 ). 
Hepatic glutathione levels are subject to diurnal varia-
tion. so it is important to note that we performed 
our experiments at approximately the same time each 
day - the 90-minute period occurring at about midday. 
Three of the anaesthetics tested - methoxyflurane, 
halothane and ethrane - therefore produced changes that 
were statistically no different from those which followed 
exposure of rats to oxygen alone, owing perhaps to 
diurnal variation. Likewise, 3 x 3-hour 1 MAC anaesthetic 
exposure to the same anaesthetic agents produced no histo-
logical changes in the liver, not even in rats which had 
undergone microsomal enzyme induction. 
Exposure of rats to chloroform and fturoxene, how-
ever, produced marked systematic depression of hepatic 
glutathione levels (see Table I and Fig. 2). The reduction 
in glutathione levels produced by chloroform was signifi-
cant only when biotransformation of the drug was en-
hanced by microsomal enzyme induction, while that pro-
duced by fluroxene, gross after em·yme induction, was 
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Fi1. 1. Hepatic a)utatbione levels after uponre to 
methoxyflurane, halotbane, etbrane and oxygen npreaed 
as percenta1e chan&e from control nlue (• difference from 
control value P<O,OS, ,t, 95% confidence limits 7 •43'X,). 
TABLE I. HEPATIC GLUTATHIONE LEVELS (µ.g/100 mg WET WEIGHT) 
No enzyme induction Enzyme induction 
Anaesthetic time (min) Anaesthetic time (min) 
Anaesthetic 0 30 90 180 0 30 90 180 
{ Mean 215 189 202 177 186 186 193 180 
Methoxyflurane ~EM 26 10 30 12 24 20 29 32 
5 5 5 5 5 5 5 5 
J Mean 264 207 199• 221 167 189 20&· 218 
Halothane SEM 17 23 11 15 9 13 10 28 
[ N 5 5 5 5 5 5 5 5 
{ Mean 160 138 104• 158 181 154 132* 152• 
Ethrane SEM 20 13 11 26 8 12 9 10 
N 10 10 10 10 10 10 10 10 
{ Mean 223 235 201 208 197 12&· 59• 27• 
Chloroform SEM 21 11 7 15 16 19 23 4 
t N 5 5 5 5 5 5 5 5 
{ Mean 311 278 180* 199 144 30• 21· 23• 
Fluroxene SEM 36 89 40 48 16 3 6 2 
N 5 5 5 5 5 5 5 5 
J Mean 212 174 1eo• 198 
Oxygen SEM 17 18 8 22 
[ N 10 10 10 10 
• Difference from con trol value P<0.05. 
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Fig. 2. Hepatic glutathione levels after exposure to chloroform and fturoxene expressed as percentage change from control value (• difference from control value 
P<0,05). 
significant even in the absence of such enhancement. 
Exposure of animals to fluroxene after enzyme induction 
resulted in all but total depletion of hepatic glutathione. 
Exposure of rats to the same anaesthetics, in the pro· 
tocol described, produced widespread hydropic degene-
ration in the absence of enzyme induction and gross cen-
trilobular necrosis when microsomal activity was en-
hanced. Furthermore, in these latter circumstances, all rats 
died after only one exposure to the anaesthetic. 
DISCUSSION 
From these experiments, a clear correlation emerges 
between the potential hepatotoxicity of an anaesthetic as 
a result of its biotransformation and its ability to destroy 
liver glutathione. 
Two anaesthetics that were found in these experiments 
to have these properties - chloroform and fluroxene -
have been shown in addition to cause destruction of 
cytochrome P-450 both in vivo and in vitro.'·<.• In the 
clinical field, the association of both these anaesthetics 
with liver necrosis is well documented.' ·' 
The association hetween halothane and clinical post-
anaesthetic hepatitis and liver necrosis, although rare, 
sporadic and unpredictable, is now accepted by most 
authorities.• 
In contrast to chloroform and fluroxene, it has not 
proved possible to reproduce this lesion in a laboratory 
animal until recently. Certainly, in this study, halothane 
produced neither histological liver necrosis, death of ex-
perimental animals, nor destruction of liver glutathione. 
However, Ivanetich et al. •s• in vitro demonstration that 
halothane destroys cytochrome P-450 by an action on 
its haem moiety does seem to provide evidence that bio-
transformation can result in reactive metabolites. Their 
activity appears to be quenched by its reaction with cyto-
chrome P-450, the first protein with which it comes in 
contact, and liver glutathione levels are not affected, nor 
is any liver necrosis evident. 
Biotransformation of fluroxene and chloroform, on the 
other hand, especially in the presence of enzyme induction, 
seems to produce an overwhelming flood of reactive meta-
bolites which, having destroyed cytochrome P-450, require 
further quenching by glutathione. Once glutathione is de-
pleted, other cell structures are attacked and cell death 
and necrosis follow. 
Recently, Nastaincyk et al.tt showed in vitro that in the 
presence of low oxygen tensions, cytochrome P-450 caused 
the reductive synthesis of a highly reactive trifluorocar-
bene complex from halothane, which in tum has been 
shown to cause liver necrosis in rats in vivou - two dis-
coveries which could .add much to our understanding of 
halothane hepatitis. 
In the past, screening of an anaesthetic agent's hepato-
toxic potential bas usually involved in vivo animal and 
subsequently human exposure to the agent, followed by 
serial observations of various measurements of liver func-
tion, most of which reflect only gross change. The experi-
mental evidence presented here suggests that investigation 
of the interaction of the anaesthetic agent with hepatic 
glutathione and cytochrome P-450, both in vivo and in 
vitro in the laboratory animal, would provide a valuable 
and relevant screening test for any hepatotoxic potential 
the drug might have relative to its microsomal biotrans-
formation. 
Of the anaesthetics tested here, only halotbane and 
ethrane are still widely used. While halothane is now under 
suspicion of being a potential cause of hepatitis, ethrane 
has still to prove itself in prolonged and widespread clini-
cal we. 
This work was financially supported by the Anglo-American and De Beers Anaesthetic Research Fund and the Joseph Stone Anaesthetic Research Fund. Technical assistance was provided by Mr Brian Sasman of the Department of Anaes-thetics. 
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Do Methoxyflurane and Enflurane Induce Hepatic 
Drug-Metabolizing Enzymes? 
J . A. MARSH. S. A. LUCAS. G. G. HARRISON. K. M. JVANETICH 
SUMMARY 
The effect of acute anaHthetic (1,0 MAC) and chronic 
1ubanaHthetlc (0, 1 MAC) exposure to methoxyflurane and 
enflurane on the levels of several liver enzymH 11 re-
ported. Methoxyflurane appears to be an enzyme-inducing 
agent similar to aplronolactone. whereas enflurane doea not 
appear to be an inducing agent for any of the enzymes 
studied. 
5. Afr. med. J .. SS. R71 (1979). 
A wide variety of drugs and xenobiotics are known to 
be capable of elevating in vivo the levels of hepatic en-
zymes involved in the metabolism of xenobiotics.'·' The 
enhanced levels of these enzymes in vivo result from an 
induction of enzyme synthesis rather than from a decrease 
in the rate of enzyme degradation.' ·' Inducing agents 
can elevate the levels of the hepatic microsomal enzymes 
cytochrome P-450, NADPH-cytochrome c (P-450) reductase 
and cytochrome b,: as well as microsomal and super-
natant transferases and other enzymes. Some inducible 
hepatic enzymes, such as cytochrome P-450 and UDPGA 
transferase (UDP-glucuronyl transferase), exist in multiple 
forms. with different forms being induced by different 
agents, whereas other inducible enzymes such as epoxide 
hydratase and cytochrome b, appear to comprise only 
a single form.'·" Some inducing agents (e.g. phenobarbitone) 
enhance the proliferation of the endoplasmic reticulum 
and increase the levels of several hepatic enzymes.' ·' 
Other inducing agents (e.g. 3-methylcholanthrene, benzpy-
rene. P-naphthoflavone) do not enhance the proliferation 
of the endoplasmic reticulum and elevate the levels of 
relati~ely few enzymes, such as aryl hydrocarbon hydroxyl-
ase (cytochrome P-448) and UDPGA transferase.'·'·' ·' 
A number of investigations of the ability of methoxy-
flurane (CCbHCF,OCH,) and enflurane (CClFHCF,OCF:H) 
to induce hepatic microsomal drug-metabolizing enzymes 
have been reported:·•• Although mice or rats were utilized 
in most of these investigations, there is lack of agreement 
between these studies as to whether methoxyflurane and 
enflurane are inducing agents for hepatic enzymes in-
volved in the metabolism of xenobiotics. The contrasting 
conclusions drawn from these studies might be explained 
Departments of Medical Biocbemi!itry and Anaesthetics, Uni-
versity of Cape Town 
J. A. :MARSH. PH.O. 
S. A. LUCAS. DIP. CHEM . PATH . . DIP. cus. PATH .. Tecl111ician 
G. G. HARRISON, M .D .. F .F .A. R.c.s .. A.~.wciate Prnfe.~snr 
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Date received : 4 December 1978. 
Reprint request< lo : Dr K. M. Jvanc1ich , Dept of Medical Biochemistry . 
University of Cape Town Medical School. Observatory, 79~~ RSA. 
by differences in the characteristics and inducibility of 
drug-metabolizing enzymes between species and between 
age groups of one species.' Alternatively, the differing 
conclusions may be attributed to the diverse and often 
indirect methods which were utilized by different labora-
tories to assess induction by methoxyflurane and en-
flurane:· "·"· 1· In particular. it would appear that indirect 
methods such as measurement of hexobarbital sleeping 
time, or measurement of the ratios of urinary corti-
costeroids and cortisols, might not provide an accurate 
estimation of the extent of induction of hepatic drug-
metabolizing enzymes.' We have therefore attempted to 
assess the potential of methoxyflurane and enflurane as 
inducing agents by investigating the effect of these com-
pounds on the levels of several hepatic enzymes which 
are involved in the metabolism of xenobiotics. Measure-
ment of the levels of several hepatic enzymes was thought 
to be advantageous because it would provide a more de-
tailed picture of the abilities of methoxyflurane and en-
flurane to induce hepatic drug metabolism, and might 
facilitate identification of these compounds as inducing 
agents in the event that they only slightly elevate the levels 
of relatively few drug-metabolizing enzymes. 
MATERIALS AND METHODS 
Methoxyflurane (2,2-dichloro-1,1-difluoro-ethyl methyl 
ether) and enflurane (2-chloro-1,1,2-trifluoro-ethyl difluo-
romethyl ether) were obtained from Abbott Laboratories. 
Male Wistar rats weighing between 165 and 195 g 
were used. Control and anaesthetized rats were paired 
by weight to within ± 5 g. Except when in the anaes-
thetic chamber, animals were allowed free access 
to Epol Laboratory Chow (protein min. 20~~ . fat 2,5%, 
fibre max. 6 ~~ , calcium 1,4%, phosphorus 0, 7 % ) and 
water, and were bedded on shredded paper. The tempera-
ture of the animal room was maintained at 22° - 24°C, 
and lighting was controlled to give 12 continuous hours 
of light per day. 
Animals were exposed to methoxyflurane or enflurane 
at anaesthetic concentrations (1,0 MAC) for 3 hours per 
day for 1 · 4 days and at subanaesthetic concentrations 
(0,1 MAC) for 6 hours per day 5 days a week for a 
period of 4 - 16 days. The animals were anaesthetized 
in groups of 12 or less in a plexiglass anaesthetic chamber 
(30 x 30 X 60 cm). Animals were placed on a fenestrated 
floor raised 8 cm from the base of the chamber, the 
space below the floor being filled with standard anaesthetic 
soda lime. The anaesthetic agent was vaporized by a 5 
I/ min stream of oxygen through a Cyprane temperature 
flow-compensated Pentec or Enfluratek vaporizer and 
passed as a continuous stream into the anaesthetic chamber 
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through an inlet port sited at one corner beneath the 
fenestrated floor and exhausted through a port sited at 
the diagonally opposite upper corner. Concentrations of 
anaesthetic agents in gas samples taken from the exhaust 
port of the anaesthetic chamber were determined by gas 
liquid chromatography on a Pye Unicam GCV chromato-
graph with a 6-mm x 150-cm column of 10% di-iso-
decylphthalate on chromosorb P. The column temperatures 
were 60° and 40°C for methoxyflurane and enflurane 
determinations respectively. Control animals were ex-
posed to oxygen alone. Animals were fasted overnight 
after the final anaesthesia or exposure to oxygen and were 
sacrificed the following morning ( I 6 - 22 hours after anaes-
thesia or oxygen exposure) . Livers were excised imme-
diately and a portion (50 - 100 mg) removed for determi -
nation of glutathione; the remainder of the liver was 
utilized immediately for the preparation of microsomes 
and postmicrosomal supernatant. 
Preparation of Microsomes 
Microsomes were prepared from fresh liver homogenates 
in 0.02M tris-HCl - 0,15M KCI, pH 7,4, by differential 
high-speed centrifugation." The final microsomal pellet 
was resuspended at the required protein concentration in 
0.02M tris-HCl, pH 7,4. Protein concentration was deter-
mined by the method of Lowry et al." as modified by 
Chaykin," using bovine serum albumin as standard. Micro-
somal suspensions were prepared separately from each 
liver. 
Assays on Microsomes 
Cytochrome b:. and cytochrome P-450 were determined 
on microsomal suspensions (2 mg protein per ml) by the 
method of Omura and Sato."" NADPH-cytochrome c 
reductase was determined as described by Omura and 
Takesue," the concentration of microsomal protein 
in the assay mixture being 0.08 mg / ml. The 0-demethy-
lation of p-nitroanisole was determined by the method of 
Netter and Seidel" using 1,3 mg microsomal protein per 
ml and 1,0 mM p-nitroanisole. The conversion of 3,4-
benzpyrene to 3-hydroxy-3,4-benzpyrene was determined 
spectrophotometrically by the method of Prough et al. 20 
at 2,0 mg microsomal protein per ml and 80 µM benz-
pyrene. UDPGA transferase activity was measured using 
microsomal suspension (0.8 mg protein per ml). 0,4 mM 
p-nitrophenol and 0,04 <;:, Triton X-100, essentially as 
described by Lueders and K uff."' The activity of glucose-
6-phosphatase was determined using a modification of 
the method of Nordie and Arion .=- Microsomal suspension 
(1,3 mg protein per ml) was incubated with glucose-6-
phosphate (20 mM l for 20 minutes at 30°C. The mixture 
was deproteinized by the addition of I 0% trichloroacetic 
acid and subsequent centrifugation. The supernatant was 
assayed for inorganic phosphorus by the method of King ... 
· All assays except the assay for benzpyrene hydroxylase 
were performed on a series of microsomal suspensions, 
with each suspension prepared separately from the liver 
of a single animal. Standard deviations for these assays 
therefore reflect differences between identically treated 
animals. Because of the large volume of microsomal sus-
pension required for the measurement of benzpyrene 
hydroxylase activity. this assay was performed on a mixture 
of equal volumes of all anaesthetized or all control animals 
on a given day. The standard deviations reported for 
this assay do not therefore reflect variations between 
identically treated animals. 
Assays for Glutathione and Glutathione-S-Tram,· 
ferase 
The levels of glutathione in rat liver homogenates were 
assayed fluorometrically by the method of Cohn and Lyle." 
The glutathione-S-transferase activity of rat liver post-
microsomal supernatant was assayed using I -chloro-2.4-
dinitrobenzene as substrate according to the method of 
Habig et al. '' The reaction mixture comprised postmicro-
somal supernatant (0.06 - 0.09 mg protein per ml). 1,3 mM 
l-chloro-2,4-dinitrobenzene and 2.5 mM glutathione in 
0,1 M potassium phosphate buffer, pH 6,5. 
Statistical Analysis 
Statistical analysis of the data was performed using 
Student's t test. Significance was taken as P<0,01, probable 
significance as P<0.05 . 
RESULTS 
The effects on the levels of liver components of exposure 
of animals to methoxyfturane and enfturane at anaesthetic 
and subanaesthetic concentrations are shown in Tables 
J - JV. After exposure to methoxyflurane at anaesthetic 
doses (1,0 MAC, 3 h / d) for 1 - 4 or 8 days, there are 
in general no changes in the levels of liver enzymes or 
glutathione relative to unanaesthetized controls (Table l). 
The only exceptions are the increases in the levels of 
NADPH-cytochrome c reductase relative to controls on 
days 3 and 8, and the slight decrease in the levels of cyto-
chrome P-450 relative to controls on days 4 and 8. 
Exposure of animals to subanaesthetic concentrations 
of methoxyflurane (0,1 MAC, 6 h/d) for 4 - 16 days does 
not affect the levels or activities of any of the hepatic 
enzymes investigated relative to values for unanaesthetized 
controls (Table II). 
The effects of anaesthesia with enflurane (1,0 MAC, 
3 h / d l on hepatic components are shown in Table Ill. 
After I - 4 days of anaesthesia, the levels of all hepatic 
enzymes and of glutathione were unchanged relative to 
controls. Exposure to enflurane (0,1 MAC, 6 h /d) for 
4 · 16 days did not in general affect the levels or activities 
of the hepatic components investigated relative to control 
animals (Table IV). On day 12, however, the slight in-
.creases · in the levels of cytochrome b, and glutathione 
transferase relative to controls are probably significant. 
There are no significant differences in the ratios of liver 
weight to body weight after acute or chronic exposure 
of animals to methoxyflurane or enflurane (Tables V and 
VI). In addition, there are no significant differences in the 
yield of microsomal protein per gram of liver under these 
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The results indicate that methoxyflurane and enflurane at 
anaesthetic or subanaesthetic dosages do not in general 
increase the levels or activities of hepatic drug-metabolizing 
en~ymes, and that these anaesthetic agents are therefore 
not inducing agents for most of the hepatic enzymes 
investigated. Methoxyflurane and enflurane are thus de-
finitel y not in the same category of inducing agent as 
phenobarbitone, which induces several hepatic drug-meta-
bolizing enzymes including microsomal cytochrome P-450, 
flavoprotein reductases. cytochrome b,, UDPGA transferase 
and cytosol glutathione-S-transferase.,.. These compounds 
are also not similar to polycyclic hydrocarbons such as 
3-methylcholanthrene'· "' because they do not elevate aryl 
hydrocarbon hydroxylase (Tables I and II). 
Anaesthesia with methoxyflurane does significantly 
elevate the levels of NADPH-cytochrome c reductase 
(Table J) , suggesting that methoxyflurane may induce the 
synthesis or decrease the rate of degradation of this en-
zyme. This confirms a report by Brown and Sagalyn11 
which demonstrated increased levels of this reductase after 
exposure to O,Q3 ~~ (0,15 MAC) or 0,1'% (0,5 MAC) 
methoxyflurane. It is possible that methoxyflurane may be 
acting in a manner similar to the steroid hormone, spirono-
lactone, which induces in male rats the synthesis of 
NADPH-cytochrome c reductase but not other hepatic 
microsomal drug-metabolizing enzymes such as cytochrome 
P-450, cytochrome b. or NADH-cytochrome c reductase."'· .. 
The induction of NADPH-cytochrome P-450 reductase in 
male rats by spironolactone does not enhance the hepatic 
microsomal metabolism of hexobarbital and 3,4-benzpy-
rene, presumably because the transfer of reducing equiva-
lents via this reductase is not a rate-limiting step in the 
cytochrome P-450-dependent metabolism of these drugs.n 
One might therefore anticipate that the increased levels 
of this reductase brought about by methoxyflurane also 
would not greatly stimulate hepatic microsomal drug meta-
bolism . 
The only other significant consequence of methoxy-
flurane anaesthesia observed was a decrease in the levels 
of cytochrome P-450 (Table I) which also occurs with 
spironolactone and confirms an earlier observation by 
Brown and Sagalyn.u This slight alteration in the levels of 
cytochrome P-450 was not accompanied by significant 
alterations in p-nitroanisole demethylation, benzpyrene-3 
hydroxylation (Table I) or aniline hydroxylation, while 
hexobarbital oxidation was reportedly decreased.u Conse-
quently, it would appear that prior exposure to methoxy-
flurane at anaesthetic or subanaesthetic doses should not 
greatly alter the hepatic microsomal metabolism of many 
xenobiotics. There are reports, however, by Van Dyke' 
and by Berman and Bochantin," that exposure of animals 
to methoxyflurane induces hepatic microsomal drug meta-
bolism. This conclusion does not rely on direct measure-
ment of the levels of hepatic microsomal enzymes but 
rests on the observation that exposure to methoxyflurane 
enhances the defluorination of methoxyflurane and the 
demethylation of aminopyrene by postmitochondrial super-
natant in vitro. The discrepancies between the conclusions 
drawn from the different studies may result from differences 
in the parameters that were measured, from the different 
experimental conditions (e.g. postmitochondrial supernatant 
versus microsomes), or possibly from metabolism of 
methoxyflurane and aminopyrene by cytosol enzymes." 
In any case, the direct measurement of hepatic micro-
3.9 
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soma! enzyme levels, as reported here and by Brown and 
Sagalyn," would be expected to provide the definitive 
experiments. 
Methoxyflurane has also been reported to induce 
hepatic drug metabolism following the observation that 
the production of urinary metabolites from methoxy-
flurane in vivo was stimulated by prior exposure to 
methoxyflurane.• However, when both bone and urinary 
fluoride levels were measured, as deemed necessary by 
Fiserova-Bergerova,•• prior exposure to methoxyflurane did 
not alter the extent of metabolism of a subsequent dose 
of methoxyflurane in vivo. 
The sole remaining evidence that methoxyflurane is an 
inducing agent for hepatic microsomal enzymes rests on 
in vivo studies where enzyme induction was assessed in-
directly by hexobarbital sleeping time.J3 Historically, the 
measurement of hexobarbital sleeping time was proposed as 
being useful because inducing agents decreased hexobarbital 
sleeping time (although decreased sleeping time did not 
always indicate enzyme induction), and because this assay 
provided an easy screening method for identifying com-
pounds as possible inducing agents. However, many re-
searchers and reviewers in the field of anaesthesiology have 
accepted decreased hexobarbital sleeping time as un-
equivocal evidence for enzyme induction." ·• In the lite-
rature, however, one finds an extremely poor correlation 
between the ability of an anaesthetic agent to decrease 
barbiturate sleeping time and its ability to induce hepatic 
microsomal drug-metabolizing enzymes. Decreased hexo-
barbital sleeping time has been reported to occur after 
exposure to diethyl ether, halothane, fluroxene, ethyl 
vinyl ether, chloroform, enflurane, methoxyflurane and 
other anaesthetic agents."·'" Of these compounds, diethyl 
ether is an established enzyme inducer similar to pheno-
barbitone." Halothane, according to some reports, induces 
only hepatic microsomal NADPH oxidase and does not 
elevate the levels of other drug-metabolizing enzymes or 
stimulate hepatic microsomal drug metabolism."'·" Flurox-
ene, halothane and chloroform degrade hepatic cyto-
chrome P-450 in vitro and / or in vivo, which would result 
in decreased rather than increased levels of this drug-
metabolizing enzyme_ ... ., The use of hexobarbital sleeping 
time as the sole experimental evidence to support the 
ability of a compound to induce hepatic microsomal drug-
metabolizing enzymes therefore appears to be invalid, and 
as Conney' stated as early as 1967 : 'In order to find 
out whether a compound induces drug-metabolizing en-
zymes, it is ultimately necessary to prepare the liver 
or its fractions from treated animals and assay enzyme 
activity . . .'. 
The results presented here indicate that enflurane does 
not significantly elevate the levels of any of the hepatic 
drug-metabolizing enzymes investigated (Tables III and 
IV) and therefore does not induce the synthesis of these 
enzymes. This observation is consistent with the data 
of Rietbrock" which demonstrated that enflurane anaes-
thesia (5 x 1 h or 5 x 3 h, 2,5 %) does not result in elevated 
levels of hepatic cytochrome P-450 per gram of rat liver. 
Enflurane has, however, been reported to induce hepatic 
drug-metabolizing enzymes. In some reports, in vitro para-
meters were monitored to assess induction by enflurane. 
In one case the enzyme levels wen: reported per 100 
grams of rat, but if enzyme levels are instead considered 
per gram of rat liver, the data do not appear to support 
the claim that enflurane induces hepatic microsomal en-
zymes." In another case, where Hitt et al." report that 
enflurane anaesthesia results in a 2 . 3-fold increase in 
cytochrome P-450 levels, which is comparable to that 
observed after phenobarbitone induction, no values for 
unanaesthetized, oxygen-exposed control animals are re-
ported. The increasing levels of serum inorganic fluoride 
observed during I · 8 days of enfturane anaesthesia by 
these workers" may be attributed to the additive effect 
on scrum fluoride levels of the repeated doses of en-
flurane rather than to enzyme induction. 
Other reports which suggested that enfturane was an 
inducing agent relied on indirect methods for assessing 
enzyme induction, e.g. hexobarbital sleeping time (see 
above) and measurement of the ratio of urinary 6-
hydroxycortisol to 17-corticosteroids."' The ratio of urinary 
6-hydroxycortisol to 17-hydroxycorticosteroids has been 
shown to vary with a wide variety of factors, including 
physiological factors" which were uncontrolled during 
attempts to utilize this assay to establish enzyme induction 
by enflurane."" 
We conclude that there is no unequivocal evidence which 
demonstrates that enflurane induces hepatic microsomal 
drug-metabolizing enzymes and, in view of our own results, 
sugge5t that enflurane may in fact not be an inducing 
agent for the hepatic enzymes investigated in this study. 
Methoxyflurane, while shown to increase NADPH-cyto-
chrome _c reductase slightly and to decrease cytochrome 
P-450 slightly, may be an inducing agent similar to spiro-
nolactone, but by virtue of its inducing capabilities would 
appear to have little effect on hepatic microsomal drug 
metabolism in vitro. 
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ENFLURANE AND METHOXYFLURANE: THEIR 
INTERACTION WITH HEPATIC MICROSOMAL STEARA TE 
DESATURASE* 
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and MERVYN BERMAN:j: 
Departments of Medical Biochemistry. tAnesthetics and tChemical Pathology, University of Cape 
Town Medical School. Observatory. Cape 7925 , South Africa 
(Received 27 March 1979: accepted 26 June 1979) 
Abstract-The effects of the volatile anesthetic agents enflurane (CCJFHCF20CF:zH) and methoxy-
flurane (CCbHCF20CH3) on hepatic microsomal electron transfer components and stearate desaturase 
are reported. Both enflurane and methoxyfturane stimulated electron flow from NADH and NADPH 
through hepatic microsomal cytochrome bs. The stimulation of electron flow from cytochrome bs by 
the anesthetic agents was not inhibited by metyrapone or CO, but was inhibited by 0.5 mM KCN. The 
effects of enflurane and methoxyfturane were influenced by the diet and pretreatment of the rat prior 
to death. A high-carbohydrate diet enhanced the effects, while fasting with or without phenobarbitone 
treatment diminished them. The anesthetic agents did not affect the rate constant for the autoxidation 
of purified trypsin-cleaved cytochrome bs or the activity of hepatic microsomal NADH- and NADPH-
cytochrome c reductase, except that enflurane slightly increased the activity of NADH-cytochrome c 
reductase. The values of the equilibrium constants (Kcq) for the stimulation of the oxidation of hepatic 
microsomal cytochrome bs by enflurane and methoxyfturane were determined to be 1.2 and 0.5 mM, 
respectively. The Kcq for enflurane differed from the Ks and K,,, values for .the interaction of this 
anesthetic agent with cytochrome P-450. whereas the Kcq for methoxyfturane differed from the K,,, for 
NADPH oxidation by cytochrome P-450, but not from the Ks for binding to cytochrome P-450 or the 
K,,, for fluoride ion production from this anesthetic agent by cytochrome P-450. The K; values of 0.08 
and 0.11 mM obtained for cyanide inhibition of the enhancement of the oxidation of cytochrome bs by 
enflurane and methoxyfturane , respectively, are within experimental error of the K;for cyanide inhi-
bition of stearate desaturase. Enflurane and methoxyfturane, however, did not inhibit the conversion 
of stearoyl CoA to oleate by hepatic microsomal stearate desaturase. It is concluded that enflurane and 
methoxyfturane stimulate hepatic microsomal electron flow from NADH and NADPH through cyto-
chrome bs in vitro , apparently by interacting with stearate desaturase. · 
The cytochrome P-450 mixed function oxidase of the 
hepatic endoplasmic reticulum catalyzes the primary 
step in the metabolism of many xenobiotics [l] . The 
first steps in the metabolism of the volatile anesthetic 
agents enflurane (CCIFHCF20CF2H) and methoxy-
flurane (CChHCF20CIL) involve dehalogenation 
and ether cleavage reactions mediated by hepatic 
microsomal cytochrome P-450 [2-4]. Detailed path-
ways for metabolism of these anesthetic agents in 
vivo have been proposed. but the pathways have 
not, as yet, been fully established. particularly for 
enflurane which is not metabolized extensively in 
vivo [2-6]. 
Stearate desaturase participates in another major 
electron transfer pathway of hepatic endoplasmic 
reticulum membranes. The physiological role of 
stearate desaturase appears to be to convert stearoyl 
CoA to oleate. This reaction can be supported by 
either NADH or NADPH and requires flavoprotein 
reductases and cytochrome bs as obligate inter-
mediate electron carriers [7-11] as shown in Scheme 
1. 
• This research was ~pported by grants from the Medical 
Research Council. the Nellie Atkinson Bequest. the 
Atomic Energy Board, and Anglo-American/De Beers. 
27 
NADH - NADH-cy10Chrome b5 ( c l -Cytochrome b 5 
reduc1ase /.. ! 
NADPH-NADPH-cy1oclrome S1eorote deso1urose -02 P-450 ( c l reducrose ~
Steoroyl Oteote 
CoA 
Scheme 1. Electron transfer to stearate desaturase . Straight 
arrows indicate electron flow. 
Stearate desaturase also exhibits mixed function 
oxidase activity in the oxidation of methyl sterols r12, 13]. Both the oxidase and desaturase activities 
are inhibited by cyanide (K; = 0.1 mM) [10, 12]. 
Stearate desaturase has not been widely investigated 
with regard to its ability to interact with xenobiotics. 
It has, however, been reported to interact with phe-
nolic xenobiotics [11] and with the volatile anesthetic 
agent halothane (CF1CHBrCI) [14] . In an attempt 
to clarify further the metabolism and the physio-
logical effects of the volatile anesthetic agents , 
enflurane and methoxyflurane, we have investigated 
their interaction with hepatic microsomal electron 
transfer proteins and with stearate desaturase. In the 
following investigation, in order to alter the levels 
of stearate desaturase , advantage was taken of the 
3.10 
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fact that the enzvme is under dietarv control. The 
levels of stearate· desaturase are negligible in fasted 
rats , measurable in fed rats , and elevated by feeding 
semi-purified high-carbonate diets [8 . 15. 16) . 
The data indicate that enflurane and methoxv-
flurane enhance hepatic microsomal electron flo·w 
through cytochrome bs at clinically achievable 
anesthetic concentrations. The observed stimulation 
of electron transfer appears to arise from the inter-
action of enflurane and methoxyflurane with hepatic 
microsomal stearate desaturase . 
EXPERIMENT AL 
Materials . NADH and NADPH were obtained 
from Miles Laboratories . Cape Town , South Africa . 
Stearoyl CoA and [l- 14C)stearoyl CoA were 
obtained from Sigma Chemicals. Poole, England, 
and from New England Nuclear. Boston. MA , 
U.S.A .. respectively . Dextrin was supplied by Merck 
Chemicals , Darmstadt , Germany, and by Sigma 
Chemicals. 
The vitamin mixture used in the diet was consti-
tuted from vitamins received as a gift from Roche 
Pty. Ltd., Isando, Transvaal , South Africa . Choline 
chloride, sodium dithionite and · cellulose were 
obtained from B. D. H. Chemicals Ltd .. Poole, 
England. Casein was obtained from Merck Chemi-
cals. Sodium phenobarbitone was supplied by May-
baker, Port Elizabeth, E. P., South Africa. Halo-
thane (fluothane) was obtained from Halocarbon 
Laboratories Inc. , Hackensack, NJ, U.S.A. Enflur-
ane ( ethrane) and methoxyflurane (penthrane) were 
obtained from Abbott Laboratories , Aeroton , 
Transvaal, South Africa . Trypsin-cleaved cyto-
chrome bs was purified from rat liver microsomes by 
the method of Omura and Takesue [17) . 
Treatment of animals. In all experiments. male 
Long Evans rats weighing 25~300 g were used. Rats 
were fed on a normal laboratory diet of Epol Lab-
oratory Chow. manufactured by Epol Ltd .. Good-
wood. Cape Town. This diet is referred to through-
out as the normal diet , and is composed of protein 
(min. 20%), fat (2.5%), fibre (max. 6%). calcium 
(1.4%), and phosphorus (0.7%). Hepatic micro-
somal stearate desaturase was routinely ·induced by 
feeding rats a high-carbohydrate semi-purified diet 
of the following composition : dextrin. 126 g: sucrose , 
30 g; cellulose . 4 g: casein, 30 g; NaCl , 4 g: KC!. 2 g: 
vitamin mixture, 6 g; and choline chloride, 0.2 g [8) . 
The vitamin mixture comprised the following: vit-
amin A, 2.5 g (325 .000 LU.lg): vitamin D. 2.0 g 
(200,000 I. U./g); vitamin B2 (Riboflavin). 500 mg: 
niacin , 7 .5 g; and pantothenic acid. 1 g, made up to 
a total of 500 g with dextrin . This diet is referred to 
throughout as the high-carbohydrate diet. Rats were 
fed this diet for 2 days , fasted on day 3 and were re-
fed the diet for 2 days (16) . The rats were killed and 
experiments were performed on day 6. 
Isolation of hepatic microsomes. Rat hepatic 
microsomes were isolated by differential centrifu-
gation, as described earlier [4) . The protein concen-
tration of the microsomes was determined by the 
method of Lowry et al. (18]. as modified by Chaykin 
(19] . Hepatic microsomes from rats fed a high-carbo-
hydrate diet, suspended at a protein concentration 
of 1.5 mg/ml in 0.05 M Tris-HCI , pH 7.4. were used 
for all experiments unless indicated otherwise. 
Cytochrome P-450 determination . Cytochrome P-
450 concentrations were determined from measure-
ments of the difference spectrum of CO-ferrocyto-
chrome P-450 versus ferrocvtochrome P-450. accord-
ing to the method of Omura and Sato (20) . An 
extinction coefficient of 91 cm- 1 mM- 1 for the dif-
ference in absorbance between 450 nm and 490 nm 
was utilized [20]. 
Re-oxidation of /1.'ADH-reduced cytochrome bs. 
Hepatic microsomal cytochrome b~ was reduced with 
a slight excess of NADH. and the first order re-
oxidation of ferrocytochrome bs. which occurs on 
exhaustion of the NADH, was monitored spectrally 
at 424 nm and 409 nm . using the method of Oshino 
et al. (8]. 
Redox steady-stare of cytochrome bs in the presence 
of NADPH. The steady-state redox status of 
NADPH-reduced hepatic microsomal cytochrome 
bs was determined from the change in absorbance 
between 424 nm and 409 nm by the method of Oshino 
et al. (8] . The results are expressed as the percentage 
reduction of hepatic microsomal cytochrome bs by 
NADPH relative to dithionite. For both the reoxi-
dation of NADH-reduced cvtochrome bs and the 
NADPH steady state assays: the anesthetics, when 
present, were added to 3 ml of microsomal suspen-
sion and vortex mixed prior to the addition of 
NAD(P)H and cyanide. 
NAD(P)H-cytochrome c reductase assays. The 
activities of NADPH-cytochrome c reductase and 
NADH-cytochrome c reductase were determined by 
the method of Omura and Takesue [17]. The anesth-
etic agent was suspended in 2.10 ml of Tris-Ha, pH 
7.4, by vortex mixing, prior to the addition of the 
NAD(P)H, cytochrome c and hepatic microsomes. 
The increase in the absorbance of ferrocytochrome 
c at 550 nm (e = 21.1 cm-1mM-1) was recorded. 
Oxidation of purified trypsin-cleaved fe"ocyto-
chrome bs. Purified trypsin-cleaved cytochrome bs 
was reduced by a modification of the method of 
Smith (21] . Purified ferricytochrome bs was bubbled 
with N2 for 20 min, and 5% Palladium on asbestos 
(2% w/v, final concentration) was added to the 
cytochrome solution. The suspension was then bub-
bled with H2 for 1-2 hr to convert the cytochrome 
bs to the ferrous form. Aliquots of ferrocytochrome 
bs were then removed from the reducing suspension, 
filtered through an 8 µ. millipore filter. and 30 µ.I of 
the resultant solution (ca. 25 µ.M cytochrome bs) 
were added to 1.25 ml of air equilibrated 0.1 M Tris-
HCl, pH 7.4, in the presence or absence of the 
anesthetic agents . The oxidation of purified trypsin-
cleaved ferrocytochrome bs was monitored spectrally 
at 424 nm. 
Stearate desaturase assay. The activity of stearate 
desaturase was assayed via the conversion of 
(14C)stearoyl CoA to [14C)oleate, essentially by the 
method of Oshino er al. [10] . Incubation mi.·iures 
contained hepatic microsomes (1.0 mg p rot~:11). 1 
mM NADH. and 40 mM [14C)stearoyl Co , ~-: i:.Ci ) 
in 0.5 ml of 0.1 M Tris-HCI, pH 7.25 . J.. ,_ l·G.:os 
were for 4 min with shaking at 37°. A r 11 , , J .>f 
the incubation period. 2 mg each of ca1 ;· r , lP..:>.te 
and stearate were added to the reaction m1~_r1,; P. .iut 
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prior to methylation. The fatty acids were methylated 
with BF, · CHJOH by the method of McIntosh et al. 
(22], and the methyl esters were separated by argen-
tation thin-layer chromatography on silica gel plates 
(25 cm x 25 cm x 0.25 mm). according to Berman 
et al. [14] . Scrapings from the thin-layer chromato-
grams were assayed for radioactivity in 7 ml of 
Instafluor scintillation mixture (Packard), using a 
Beckman model LS 8100 liquid scintillation counter. 
The results of the assay were expressed as the per-
centage of radioactivity in oleate/radioactivity in 
oleate + stearate [10] . 
Spectrophotometry. All spectral measurements 
were performed at 25° in a Uni cam SP 1800 recording 
spectrophotometer using the thermostatically con-
trolled compartment which is designed to accom-
modate turbid samples. 
Calculations and statistical analvses. The observed 
first order rate constants (k1) for ·the re-oxidation of 
NADH-reduced hepatic microsomal cytochrome bs 
in air saturated buffer were calculated from the 
slopes of pJots of In (A, - Aoo) versus time, where 
A, and A"' are the absorbance changes between 
424 nm and 409 nm at time t and at infinity, 
respectively. 
The observed first order rate constants (k1) for the 
oxidation of purified trypsin-cleaved cytochrome bs 
were calculated from plots of In (Am, - A424-J versus 
time. In all cases, the absorbance at infinite time was 
determined after approximately ten half-Jives. Stu-
dent's t-test for unpaired data was utilized to assess 
statistical significance, with P < 0.05 being probably 
significant, P < 0.01 being significant, and P < 0.001 
being highly significant. 
RFSULTS 
NADPH steady-state of hepatic microsomal cyto-
chrome bs. In the presence of enflurane. halothane 
and methoxyflurane. the redox status of NADPH-
reduced cytochrome bs of hepatic microsomes from 
rats with elevated levels of stearate desaturase was 
shifted toward the ferric form of the hemoprotein 
(Table 1) . 
Table 1. Effects of anesthetic agents on the NADPH steady-







( "k. reduction) 
56.1 ::t 13.5 
26.0 ::t 4.5t 
26.9 ::t 5.5+ 
37.1 ::t ).6t 
• Values reponed are means ::t S.D. for assays in dupli-
cate for three to seven separate preparations of hepatic 
microsomes from rats fed a high-carbohydrate diet. The 
reaction mixture contained 3 ml of hepatic microsomes 
(1.5 mg protein/ml) , 15 µM NADPH, and additions as 
indicated, at 25°. , 
t Differs significantly from no additions, P < 0.01 . 
Effects of anesthetic agents and inhibitors on the 
re-oxidation of hepatic microsomal ferrocytochrome 
bs. For all studies of the re-oxidation of hepatic 
microsomal ferrocytochrome bs, unless indicated 
otherwise, hepatic microsomes were from rats in 
which the levels of stearate desaturase were elevated 
by feeding a high-carbohydrate diet (see Experi-
mental). That the levels of stearate desaturase in 
these microsomal preparations were elevated was 
demonstrated by the ability of stearoyl CoA to 
enhance the rate constant for the re-oxidation of 
cytochrome bs [8] (Tables 2-4). 
The anesthetic agents, halothane, enflurane and 
methoxyflurane, stimulated tpe re-oxidation of 
microsomal cytochrome bs (Table 2), as was reported 
earlier for halothane [14] . The rate constants for the 
re-oxidation of cytochrome bs in the presence of 
stearoyl CoA or the anesthetic agents were decreased 
by 0.5 mM KCN (P < 0.01) (Table 2). The inhibitors 
of cytochrome P-450, namely metyrapone and car-
bon monoxide , had no effect on the re-oxidation of 
cytochrome bs in the presence or absence of stearoyl 
CoAor any of the anesthetic agents (P > 0.1) (Tables 
3 and 4). 
NAD(P)H-cytochrome c reductase activities. The 
effects of enflurane and methoxyflurane on the 
Table 2. Effect of cyanide on the enhancement of the rate constants for the re-




Stearoyl CoA (0.012) 
Stearovl CoA (0.012) + KCN (0.5) 
Halottiane (18) 
Halothane (18) + KC~ (0.5) 
Enflurane (14) 
Enfluranc (14) + KCN (0.5) 
Methoxyflurane (I) 
Methoxyflurane (1) + KCN (0.5) 
First order rate constant for 
oxidation of ferrocvtochrome bs 
JO: kt (sec- 1) 
1.24 ::t 0.35 
1.28 ::t 0.20 
2.76 ::t 0.73t 
1.55 ::t 0.37 
1.73 ::t 0.29t 
1.23 ::t 0.30 
2.44 ::t 0.63t 
1.67 ::t 0.54 
1.98 ::t 0.28t 
1.68 ::t 0.08 
• Values reponed are means ::t S.D . for assays in duplicate on each of three 
separate preparations of hepatic microsomes from rats fed a high-carbohydrate 
diet. Reaction mixtures contained 3 ml of hepatic microsomcs (1.5 mg pro-
tein/ml). 1-5 µM NADH, and additions as indicated . at 25°. 
t Differs significantly from no additions, P < 0.01. 
3.10 
30 K. M . IVANETICH. V . MANCA. G . G. HARRISON and M . BERMAN 
Table 3. Effect of metyrapone on the enhancement of the rate constants for the re-




Stearoyl CoA (0.012) 
Stearoyl CoA (0.012) + metyrapone (2.3) 
Halothane (18) 
Halothane (18) + metyrapone (2.3) 
Enfturane (14) 
Enfturane (14) + metyrapone (2.3) 
Methoxyfturane ( 1) 
Methoxyfturane (1) + metyrapone (2.3) 
First order rate constant for the 
oxidation of ferrocytochrome bs 
102 k1 (sec- 1) 
1.09 ::t 0.22 
1.17 ::t 0.18 
4.19 ::t 0.59t 
4.15 ::t 0 .33+ 
1.68 ::t 0.15+ 
2.03 ::t 0.48t 
2.23 ::t 0.36t 
2.13 ::t 0.49+ 
1.78 ::t 0.18t 
1.70 ::t 0.1::?t 
• Values reponed are means ::t S.D. for assays in duplicate on each of three 
separate preparations of hepatic microsomes from rats fed a high-carbohydrate diet. Reaction mixtures contained 3 ml of hepatic microsomes ( 1.5 mg protein/ml). 1-5 µM NADH, and additions as indicated, at 25°. 
t Differs significantly from no additions, P < 0.01 . 
Table 4. Effect of carbon monoxide on the enhancement of the rate constants for the re-
oxidation of cytochrome bs by stearoyl CoA <ind anesthetic agents• 
Additions 
None 
C0-02 (80:20, v/v) 
Stearoyl CoA (0.012 mM) 
Stearoyl CoA (0.012 mM) + C0-02 (80: 20, v/v) 
Halothane (18 mM) 
Halothane (18 mM) + C0-02 (80:20, v/v) 
Enfturane (14 mM) 
Enfturane (14 mM) + C0-02 (80:20, v/v) 
Methoxyfturane (1 mM) 
Methoxyfturane (1 mM) + C0-02 (80:20, v/v) 
First order rate constant for the 
oxidation of ferrocvtochrome bs 
la2 kt (sec-1) 
0.97 ::!: 0 .15 
1.04 ::t 0.22 
3.26 ::t 1.05t 
3.31 ::t 0.38t 
1.35 ::t 0.28; 
1.10 ::t 0.30 
1.49 ::!: 0.08t 
1.62 ± 0.20t 
1.69 ::!: 0.31t 
1.56 ::!: 0 .42t 
• Values reponed are means::!: S.D . for assays in duplicate on each of three separate preparations of hepatic microsomes from rats fed a high-carbohydrate diet. Reaction mixtures contained 3 ml of hepatic microsomes (1.5 mg protein/ml) , 1-5 µM NADH, and 
additions as indicated, at 25°. 
t Differs significantly from no additions, P < 0.01. 
; Probably differs from no additions, P < 0.05. 




Methoxyfturane ( 1) 
Autoxidation of purified 
ferrocytochrome bs 
la2 k1 (sec- 1) 
0.85 ::t 0.15 
0.89 ::t 0.16 
0.97 ::!: 0 .05 
NADPH-cytochrome c 
reductase 
( units/mg protein) 
0.051 ::t 0.005 
0.053 ::t 0.005 




0.95 ::t 0.10 
1.34 ::t 0.14t 
1.09 ::t 0.14 
• For the N ADPH- and NADH-cytochrome c reductase assays, 100 µ.I and 20 µl of hepatic microsomes (1.5 mg protein/ml) from rats fed a high-carbohydrate diet were added to 2.10 ml of 0.1 M Tris-HCI, pH 7.4 , containing 20 µM cytochrome c. 0.1 mM of either NADPH or NADH, and additions as indicated. For the oxidation of purified, trypsin-cleaved ferrocytochrome bs, the reaction mixtures contained 1.25 ml of 0.1 M Tris-HCI. pH 7.4, 30 µ.I of purified ferrocytochrome bs , and additions as indicated. Reponed values are means ::t S.D. 
t Differs significantly from no additions, P < O.ot . 
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Table 6. Effect of anesthetic agents and KCN on the rate constants for the re-oxidation of NADH-reduced hepatic 




Stearoyl CoA (0.012) 
Stearoyl CoA (0.012) + KCN (0.5) 
Enfturane (14) 
Enfturane (14) + KCN (0.5) 
Methoxyfturane (1) 






1.56 :t 0.17 
1.48 :t 0.20 
2.09 :t 0.12t 
1.73 :t 0.30 
2.28 :t 0.26t 
2.08 :t 0.15 
1.90 :t 0.27:j: 
1.73 :t 0.28 
0.98 :t 0.05 
H>2 k1 (sec- 1) 
Fasted, 
Fasted phenobarbitone-induced 
1.63 :t 0.41 2.65 :t 0.07 
1.34 :t 0.13 2.03 :t 0.43 
1.83 :t 0.27 2.78 :t 0.17 
1.55 :t 0.18 2.17 :t 0.25 
2.23 :t 0.38:j: 3.61 :t 0.94:j: 
2.02 :t 0.39 3.50 :t 0.78 
1.86 :t 0.09 3.00 :t 0.27:j: 
1.75 :t 0.18 2.82 :t 0.47 
1.24 :t 0.33 2.49 :t 0.12 
• Values reponed are means :t S.D. for assays in duplicate with each of three separate preparations of hepatic 
microsomes. Experimental details are as in Table 2. 
t Differs significantly from no additions for similarly pretreated rats, P < 0.001. 
:j: Probably differs from no additions for similarly pretreated rats, P < 0.05 . 
Table 7. Effect of anesthetic agents and KCN on the re-oxidation of NADH-reduced hepatic microsomal cytochrome 
b5 from differently pretreated rats• 
Per cent increase in first order rate constant (kt) 
High-carbohydrate diet Normal diet Fasted Phenobarbitone-
induced and fasted 
Additions 
-KCN +KCN -KCN +KCN -KCN +KCN -KCN +KCN 
Stearoyl CoA 100-800 50-200 34 16 12 17 5 7 
Halothane 40 0 58t lOt 19t 22t 22t 30 
Enfturane 97 30 46 40 37 24 36 32 
Methoxyfturane 60 31 22 11 14 7 13 6 
• Per~ntage increases were calculated from the values presented in Tables 2 and 4. Percentages are relative to the 
corresponding value for NADH alone 
t Calculated from data in Ref. 14. 
2 .5 
k , 
1.0 2.0 3 .0 
Anesthetic, mM 
Fig. 1. Effects of enfturane (e) and methoxyfturane (+) 
on the rate constants (kt) for the re-oxidation of NADH-
reduced hepatic microsomal cytochrome b5. The first order 
rate constant kt is in units of 10-2 sec- 1• Experimental 
conditions are as given in Table 2. 
activities of NADPH- and NADH-cytochrome c 
reductase are shown in Table 5. Neither enflurane 
nor methoxyflurane had a statistically significant 
effect on NADPH-cytochrome c reductase. Enflur-
ane slightly enhanced the activity of NADH-cyto-
chrome c reductase , whereas methoxyflurane did 
not. 
Autoxidation of trypsin-cleaved fe"ocytochrome 
b5. The rate constants for the autoxidation of purified 
trypsin-cleaved ferrocytochrome b5 in the presence 
of enflurane and methoxyflurane are given in Table 
5. As can be seen, the rate constant for the autox-
idation of purified ferrocytochrome b5 is not altered 
in the presence of enflurane or methoxyflurane 
(P > 0.1) . 
Re-oxidation of hepatic microsomal f e"ocyto-
chrome b5 from fasted, fed or phenobarbitone-pre-
treated rats. The rate constants for the re-oxidation 
of NADH-reduced cytochrome bs in microsomes 
from fasted, fed or phenobarbitone-induced rats are 
shown in Table 6, and the data are summarized in 
Table 7. Stearoyl CoA and enflurane increased the 
k1 in fed rats, but not significantly in fasted rats 
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Table 8. Equilibrium constants for the interaction of anesthetic agents with hepatic microsomal enzymes 
;..,• (mMJ 





for binding to 
cytochrome P-450 
for oxidatio·n of NADPH 
hy cytochrome P-450 





1.18 ::!: 0. )6 
0.48 ::!: 0.14 
0.46 = 0.15 
U.48 = 0.13 
0. 15 = O. IO 
0.10 ± 0.01 
0.36 := 0.117 
0.40 ::t 0.12t 
4.9 ::t 0.9 
• Data for hepatic microsomes from fasted. uninduced male rats from Ref. 4. 
t Two Km values were calculated from biphasic Eadie-Hofstee plots for this process. 
pretreated or not with phenobarbitone . Cyanide 
inhibited the ability of stearoyl CoA to enhance the 
re-oxidation of cytochrome bs in microsomes from 
rats fed a normal diet (P < 0.001), but not in micro-
somes from fasted or phenobarbitone-treated rats 
(P > 0.1) . Cyanide had no significant effect on the 
oxidation of cytochrome bs in the presence of enflur-
ane or methoxyflurane in hepatic microsomes from 
fed , fasted or phenobarbitone-treated rats. The 
activity of stearate desaturase (as assessed by the 
stimulation of the re-oxidation of cytochrome bs by 
stearoyl CoA [8]) and the abilities of enflurane and 
methoxyflurane to stimulate the cyanide sensitive re-
oxidation of NADH-reduced cytochrome b5 
decreased in the order of rats fed a high-carbotiy-
drate diet > rats fed a normal diet > fasted rat~ ~ 
fasted, phenobarbitone-treated rats (Table 7). 
Determination of the equilibrium constants (Kcq} 
for the stimulation of hepatic microsomal electron 
transfer by enfiurane and methoxyfiurane. The effects 
of increasing concentrations of enflurane and 
methoxyflurane on the rate constants for the re-
,,I 
k , 
2.0·~ • • 
• 
1. 5 ~ ·~ . ----• 
0.2 0.4 0 .6 
KCN, mM 
Fig. 2. Effect of cyanide on the rate constants (k1) for the 
reoxidation of NADH-reduced hepatic microsomal cyto-
chrome bs in the presence of (e) 1.4 mM enflurane and 
( +) 0.6 mM methoxyflurane. Experimental cond1uons are 
as given in Table 2. 
oxidation of NADH-reduced cytochrome bs were 
utilized to calculate the equilibrium constants (Kcq) 
for the stimulation of microsomal electron transfer 
by these anesthetic agents (Fig. 1, Table 8). The 
value of Kcq for enflurane differed from the K, and 
Km values for the binding and metabolism of enflur-
ane by hepatic microsomal cytochrome P-450 (Table 
8) (P < 0.01). The Kcq calculated for methoxyflurane 
differed (P < 0.01) from the Km for NADPH oxi-
dation and the high K,,, for fluoride production by 
cytochrome P-450, but did not differ significantly 
from the K, for binding to cytochrome P-450 or the 
low Km for the production of fluoride ion from 
methoxyflurane by cytochrome P-450 (P > 0.1). 
Inhibition of the re-oxidation of hepatic micro-
somal cytochrome bs by KCN-Determination ofK;. 
The effects of increasing concentrations of cyanide 
on the stimulation of the rate constants for the re-
oxidation of NADH-reduced microsomal cyto-
chrome bs by enflurane and methoxyfluranc are 
shown in Fig. 2. The K; values for cyanide were 
found to be 0.08 ± 0.01 mM for enflurane and 0.11 
± 0.02 mM for methoxyflurane. These constants 
compare well with the K; of O .14 mM determined for 
the cyanide inhibition of the stimulation of re-oxi-
dation of hepatic microsomal cytochrome bs by hal-
othane reported by Berman et al. [14] and with the 
value of K;of 0.1 mM for cyanide inhibition of the 
conversion of stearoyl CoA to oleate by stearate 
desaturase reported by Oshino et al. [10] . 
Stearate desaturase assay. The effects of halothane, 
methoxyflurane and enflurane on the activity of 
stearate desaturase, as assayed via the conversion 
Table 9. Effect of anesthetic agents on the stearate desa-





Methoxyflurane ( 1) 
Oleate 
( oleate + stearate) 
0.34 ::!: 0.16 
0.3g ± 0.14 
0.36 ± 0.12 
0.35 ± 0.16 
• Values are means± S.D. for three separate assays 
using microsomes from rats fed a high-carbohydrate diet. 
See Experimental Section for details. 
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of [14C]stearoyl CoA to (1'C]oleate. are shown in 
Table 9. None of the anesthetic agents had any effect 
on this reaction (P > 0.1) . 
DISCUSSION 
Enflurane and methoxyflurane appear to stimulate 
microsomal electron transfer from NADPH and 
NADH via cvtochrome bs, as shown by the ability 
of these anesthetic agents to shift the redox status 
of NADPH-reduced cytochrome bs toward the ferric· 
form of the protein and to increase the rate constants 
for the reoxidation of NADH-reduced cytochrome 
bs (Tables 1 and 2) . Since enflurane and methoxy-
flurane did not decrease tlie activity of microsomal 
NADH- and NADPH-cytochrome c reductase 
{Table 5) , it would appear that these anesthetic 
agents probably do not decrease the rate of reduction 
of cytochrome bs but rather enhance the rate of 
oxidation of this heme protein. 
The oxidation of ferrocytochrome bs can proceed 
via an autoxidation reaction or via the transfer of 
electrons to other microsomal proteins such as cyto- 1 
chrome P-450 or stearate desaturase . In the absence 
of added substrates for cvtochrome P-450, stearate 
desaturase. or other mi"crosomal enzymes which 
accept reducing equivalents from ferrocytochrome 
bs, the oxidation of microsomal cytochrom1: bs in 
vitro is thought to arise in large part from the autox-
idation of this hemoprotein [14, 23-26] . The autox-
idation reaction involves the transfer of reducing 
equivalents from ferrocytochrome bs directly to 
oxygen to produce ferricytochrome bs and super-
oxide [23, 26]. 
Purified trypsin-cleaved cytochrome bs, a heme 
peptide of approximately ninety residues which dif-
fers from the intact hemoprotein only in that the 
hydrophobic tail which attaches the protein to the 
membrane is Jacking, was used as a model to assess 
the effects of enflurane and methoxyflurane on the 
autoxidation of ferrocytochrome bs . Trypsin-cleaved 
cytochrome bs was chosen as a model system because 
it does not aggregate in water, as does cytochrome 
bs prepared by detergent solubilization, and the 
structure of the heme crevice and the rate of autox-
idation of the hemoprotein are not altered following 
tryptic digestion of cytochrome bs [14 , 27] . The first 
order rate constant for the autoxidation of purified 
trypsin-cleaved cytochrome bs reported herein 
{Table 5) is identical to values reported elsewhere 
[14] and is similar to the first order rate constant for 
the oxidation of membrane-bound hepatic micro-
somal ferrocvtochrome bs in the absence of sub-
strates for cvtochrome P-450 and stearate desaturase 
[14. 23] (Tables 2 and 5) . Since the rate constants 
for the autoxidation of trypsin-cleaved ferrocyto-
chrome bs were not affected by enflurane and 
methoxyflurane . it would appear that these com-
pounds probably do not affect the autoxidation of 
ferrocytochrome bs. This conclusion is supported 
further by the obsen·ation that the autoxidation of 
cytochrome b; is not inhibited by KCN [14] (Table 
2), while the effects of enflurane and methoxyflurane 
on hepatic microsomal electron transfer are . It would 
11r19 :l-c 
be anticipated, therefore , that enflurane and 
methoxyflurane may stimulate electron transfer from 
ferrocytochrome bs to another microsomal protein . 
From several lines of evidence. it would appear 
that the microsomal electron acceptor in question 
is not cytochrome P-450. NADH. which does not 
effectively support cytochrome P-450-dependent 
reactions. supported the phenomenon as effectively 
as did NADPH (Tables 1 and 2). Neither prior 
induction of cytochrome P-450 with phenobarbital 
nor the presence of the inhibitors of cytochrome P-
450-metyrapone and CO (see e.g. Refs. [28] and 
[29])-in the reaction mixture had any effect on the 
enhanced oxidation of cytochrome bs seen in the 
presence of enflurane and methoxyflurane (Tables 
3, 4 and 6) . In contrast, cyanide, which is not an 
effective inhibitor of cytochrome P-450, inhibited 
the process with a K;which was well below the range 
of K; values of 2.5 to 10 mM reported for the inhi-
bition of cytochrome P-450 by cyanide (30, 31]. 
Finally, the KCG. for the stimulation of the re-oxida-
tion of cytochrome bs by enflurane differed signifi-
cantly from the Ks and Km values for the interaction 
of enflurane with cytochrome P-450 [4] {Table 8). 
It would appear that the microsomal 6-desaturase 
is not involved in the stimulation of microsomal 
electron transfer by enflurane and methoxyflurane, 
since its levels are not elevated by the feeding of a 
high-carbohydrate diet [15] which enhances the 
effects of the anesthetic agents {Tables 6 and 7) . It 
is also possible to exclude catalase-a microsomal 
contaminant-as having an important role in mediat-
ing the effects of enflurane and methoxyflurane, 
because, although this enzyme is cyanide-sensitive, 
the K;for cyanide inhibition of this enzyme (approx-
imately 8 µ.M (32]) is 10-fold lower than the K; cal-
culated for cyanide inhibition of the re-oxidation of 
cytochrome bs. 
The results presented herein are consistent with 
the proposal that the transfer of electrons to stearate 
desaturase is responsible for the enflurane- and 
methoxyflurane-mediated enhancement of micro-
somal electron transfer through cytochrome bs. The 
magnitude of the observed effect parallels the dietary 
induction of stearate desaturase; for example. the 
feeding of a high-carbohydrate diet, which induces 
stearate desaturase, results in maximal enhancement 
of electron transfer , while fasting, which reduces 
stearate desaturase to negligible levels [8. 15. 16]. 
eliminates the effects of the anesthetic agents (Tables 
6 and 7). In addition. the enhanced re-oxidation of 
cytochrome bs is inhibited by cyanide (Table 2), as 
is stearate desaturase . The K; values calculated for 
cyanide inhibition of the stimulation of electron 
transfer by enflurane and methoxyflurane are within 
experimental error of the K; of 0.1 mM reported for 
cyanide inhibition of the conversion of stearoyl CoA 
to oleate by stearate desaturase [10] . 
The Jack of effect of enflurane and methoxvflurane 
on the conversion of stearovl CoA to oleate is not 
inconsistent with the above proposal since the 
anesthetic agents may not bind to the substrate bind-
ing site of the enzyme. Other compounds which have 
been reported to interact with stearate desaturase. 
namely halothane and p-cresol , also do not inhibit 
the conversion of stearoyl CoA to oleate [11. 14] . 
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In conclusion, it would appear that enflurane and 
methoxyflurane , at concentrations achieved in 
physiological fluids [33. 34] , stimulate hepatic micro-
somal electron flow from NADH or NADPH by 
enhancing the oxidation of cytochrome bs. The 
autoxidation of cytochrome bs and the transfer of 
electrons from cytochrome bs to catalase, to the 6-
desaturase or to cytochrome P-450 appear not to be 
involved in the stimulation by these agents of micro-
somal electron transfer. That the enhancement of 
microsomal electron transfer by enflurane and 
methoxyflurane parallels the dietary induction of 
stearate des!turase and that the K; for cyanide inhi-
bition of the effect of enflurane and methoxyflurane 
equals the K; for inhibition of stearate desaturation 
strongly suggest that the effects of enflurane and 
methoxyflurane are mediated via stearate desatu-
rase. The nature of the interaction of enflurane and 
methoxflurane with stearate desaturase and the 
physiological and pathological effects thereof are 
under investigation. 
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INFLUENCE OF TWO HALOALKANES ON THE REDOX BEHAVIO~ OF HEPATIC 
MICROSOMAL CYTOCHROME ~5 AND ITS POSSIBLE RELATIONSHIP TO 
STEARATE DESATURASE 
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ABSTRACT 
The possible interaction of two haloalkanes - bromotrichloromethane and 
l,2-dibromo-1,2-dichloroethane - with stearate desaturase was assessed 
in hepatic microsomes from rats fed a high carbohydrate diet which ele-
vates the levels of stearate desaturase. Both compounds shifted the 
redox steady state of NADPH reduced hepatic microsomal cytochrome b5 
towards ferricytochrome b5 and enhanced the re-oxidation of NADH reduced 
hepatic microsomal cytoc'Firome b5. The equilibrium constants for the 
enhancement of microsomal electron transfer by the haloalkanes in these 
preparations were 2.2 + 0.3 mM and 0.46 + 0.1 mM for bromotrichloro-
methane and 1,2-dibromo-l ,2-dichloroethane, respectively. The halo-
alkane mediated enhancement of the oxidation of cytochrome ,e_s in hepatic 
microsomes from rats fed a high carbohydrate diet was diminished by KCN 
and the inhibitors of cytochrome P-450, CO and/or metyrapone, as well as 
by fasting of the experimental animals. The I50 values for KCN inhi-
bition of the effects of the haloalkanes on the re-oxidation of cyto-
chrome ~5 (0.1 mM) were identical to the I50 for KCN inhibition of 
stearate desaturase (Oshino et al., 1966). The haloalkanes did not 
affect the activity of hepatTciiiTcrosomal NADH- or NADPH-cytochrome c 
reductase, the autoxidation of purified trypsin-cleaved ferrocytochrome 
£5 or the conversion of stearoyl CoA to oleate. It is concluded that 
bromotrichlorornethane and l,2-dibromo-1,2-dichloroethane stimulate 
hepatic microsomal electron transfer from NADH via cytochrome b5 by in-
teracting with cytochrome P-450 and with stearate desaturase. -
INTRODUCTION 
The stearoyl CoA desaturase enzyme system catalyzes the cyanide inhi- · 
bitable conversion of stearoyl CoA and palmitoyl CoA to their 69-10 un-
saturated analogues (Berman et!}_., 1975; Ivanetich !!_!}_., 19BO). This 
enzyme system comprises the electron carriers - the NADH- and NADPH-
dependent flavoprotein reductases and cytochrome ~5 - and a terminal oxi-
dase which is known as stearate desaturase or the cyanide sensitive fac-
tor (Scheme l) (Oshino et!}_., 1966, 1971; Oshino and Sato, 1971; Jones 
et al. 1969 ; Shimikata et!}_., 1972). 
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NADH- NADH-cytochrome ~5 reductase- cytochrome ~5 
NADPH-+- NADPH-cytochrome P-450 ~ steara\e desaturase - o2 reductase ...----......,_ 
stearoyl CoA oleate 
Scheme l: Electron transfer to stearate desaturase 
(Straight arrows indicate electron flow) 
Stearate desaturase has been reported to interact with a small num-
ber of xenobiotics, including phenols and the volatile anaesthetic 
agents halothane (CF3CHBrCl), enflurane (CFClHCF2ocF2H) and m
ethoxy-
flurane (CC1 2HcF2ocH3) (Oshino and Sato, 1971; Berman et.!!_.,
 1975; 
Ivanetich et.!!_., 1980). In as much as none of these compounds affect 
the conversion of stearoyl CoA to oleate by the hepatic microsomal 
stearoyl CoA desaturase enzyme system, the evidence for their interac-
tion with stearate desaturase is indirect: These compounds stimulated 
the cyanide inhibitable re-oxidation of NADH reduced cytochrome ~5 in 
hepatic microsomes, with the I50 for KCN inhibition of this process 
being identical to that for KCN inhibition of stearate desaturation 
(0.1 mM), and the magnitude of the enhancement of the re-oxidation of 
microsomal cytochrome ~5 by these compounds paralleled the dietary in-
duction of stearate desaturase (Oshino and Sato, 1971; Berman et.!!_ •• 
1975; Ivaneti ch et.!!_., 1980). 
We have attempted to establish whether the halogenated alkanes, 
bromotrichloromethane and l,2-dibromo-1,2-dichloroethane, are capable 
of interacting with hepatic microsomal stearate desaturase. The inter-
action of these compounds with stearate desaturase was of necessity 
assessed indirectly, viz., by measuring their effects on the oxidation 
state of cytochrome E_s in the presence and absence of cyanide (Oshino 
et .!!_. , 1971). In these investigations, advantage was taken of the . 
dietary control of stearate desaturase: The levels of this enzyme were 
decreased by fasting and were routinely elevated by re-feeding a high 
carbohydrate diet (Oshino et.!!_., 1971; Shimikata et.!!_., 1971; Oshino 
and Sato, 1972; Lee and Sprecher, 1971). 
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MATERIALS AND METHODS 
Bromotrichloromethane and l,2-dibromo-1,2-dichloroethane were from 
Aldrich Chemical Co., Milwaukee, Wis., and ICN Pharmaceuticals, Plainview 
N.Y., respectively. The treatment of Long Evans rats (250-300 g) and 
other experimental details are as reported earlier (Ivanetich et~-, 
1980). 
Experiments were routinely conducted with hepatic microsomes (1.5 mg 
protein/ml 0.05 M Tris-HCl, pH 7.4) at 25°. Reported values are means 
.: S.D. for determinations in duplicate to quadruplicate on two to four 
separate preparations of hepatic microsomes. Final concentrations of 
compounds added to incubation mixtures were as follows: KCN (0.5 mM), 
stearoyl CoA (12 µM), NADH (15-45 µM), NADPH (0.15 mM), bromotrichloro-
methane (3.4 mM), l ,2-dibromo-l ,2-dichloroethane (0.6 mM), unless other-
wise indicated. 
RESULTS 
Effects of haloalkanes on the oxidation state of hepatic microsomal cyto-
chrome E_5. In the presence of NADPH and oxygen, microsomal cytochrome 
E.s exists in a redox steady state (Oshino et~ •• 1971). The ability of 
stearoyl CoA to shift the redox steady state of cytochrome ~5 towards 
the ferric form confirms that the hepatic microsomes from rats fed a 
high carbohydrate diet contained appreciable stearate desaturase acti-
vity (Data not shown) (Oshino et~ .• 1971). Both bromotrichloromethane 
and l,2-dibromo-1,2-dichloroethane shifted the redox steady state of 
cytochrome ~5 towards the ferric form. KCN diminished the effect of 
both compounds on the redox steady state of cytochrome E.s (Table 1). 
For assessing the re-oxidation of hepatic microsomal cytochrome £5, 
microsomal suspensions were reduced with limiting amounts of NADH, and 
the re-oxidation of ferrocytochrome £5 which occurs on exhaustion of the 
NADH was monitored. Since NADH reduces ferricytochrome ~5 rapidly, once 
the NADH is exhausted, the oxidation of ferrocytochrome £5 follows 
pseudo first order kinetics (Oshino et~ .• 1971; Berman et!!_., 1975). 
Any increase in the pseudo first order rate constant for the re-oxida-
tion of microsomal ferrocytochrome ~ above this basal value thus pro-




















































































































































































































































































































































































































































































































































































































































































































































VOL. 34, NO. 3 
DECEMBER 1981 
Research Communications in 
Chemical Pathology and Pharmacology 
provides a measure of microsomal electron transfer from ferrocytochrome 
E.5 (Oshino et~-, 1971; Berman et 21·, 1975) . 
The effects of the two haloalkanes on the pseudo first order rate 
constant (kobs ) for the re-oxidation of NADH-reduced cytochrome E.5 in 
hepatic microsomes from rats fed a high carbohydrate diet and from fast-
ed rats are shown in Table 1. Bromotrichloromethane and 1,2-dibromo-
1,2-dichloroethane increased the rate constant for the re-oxidation of 
cytochrome E.5 in hepatic microsomes from rats fed a high carbohydrate 
diet, and the magnitude of this increase was diminished by KCN. With 
hepatic microsomes from fasted rats, the effect of bromotrichloromethane 
on the re-oxidati.on of cytochrome E.5 was diminished (p < 0.01) and the 
cyanide sensiti vity of the effect was eliminated. Fasting eliminated 
the ability of l,2-dibromo-1,2-dichloroethane to enhance the re-oxida-
tion of microsomal cytochrome E.5 (Table 1). CO and metyrapone, which 
are effective inhibitors of cytochrome P-450 (De Bruin, 1976), did not 
significantly affect the re-oxidation of ferrocytochrome E_s in micro-
somes from rats fed a high carbohydrate diet in the absence of added 
haloalkane (p > 0.1) . CO did not significantly (p > 0.1) affect and 
metyrapone slightly (by 20%) diminished (p < 0.01) the effects of bromo-
trichloromethane on the re-oxidation of microsomal ferrocytochrome E_5. 
Both inhibitors decreased the effect of l,2-dibromo-1,2-dichloroethane 
on the re-oxidation of microsomal ferrocytochrome £5 to negligible levels 
( p < 0. 01) . 
The effects of varying concentrations of the two haloalkanes on the 
rate constants for the re-oxidation of NADH reduced cytochrome E.5 in 
microsomes from rats with elevated levels of stearate desaturase are 
shown in Figures 1 and 2. The concentrations of these compounds for 
half maximal effect on the re-oxidation of cytochrome £5 were calculated 
from Figure 2 to be 2.2 + 0.3 nt1 and 0.46 + 0.1 nt1 for bromotrichloro-
methane and 1,2-dibromo-1,2-dichloroethane, respectively. 
The effects of variable amounts of KCN on the rate constant for the 
re-oxidation of NADH reduced hepatic microsomal cytochrome £5 in the 
presence of bromotrichloromethane and l,2-dibromo-1,2-dichloroethane are 
shown in Figure 3. The 150 values were calculated to be 0. 12 ~ 0.03 
and 0.07 + 0.02 mM KCN for the inhibition of the stimulated microsomal 
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Figure 1. Pseudo first order rate constants for the re-oxidation of 
cytochrome~ in hepatic microsomes from rats fed a high carbo-
hydrate diet in the presence of bromotrichloromethane (A) and 
1,2-dibromo-1,2-dichloroethane (B). Experimental details are 
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Figure 2. Hanes plots of the enhancement by bromotrichloromethane (A) 
and 1,2-dibromo-1,2-dichloroethane (B) of the re-oxidation of cyto-
chrome b5 in hepatic microsomes from rats fed a high carbohydrate 
diet. -Experimental details are described in Table 1. v repre-
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Figure 3. Effect of KCN on the stimulation of the re-oxidation of 
cytochrome b5 in hepatic microsomes from rats fed a high carbo-
hydrate diet by 3.4 l!t-1 bromotrichloromethane (A) and by 0.6 mM 
l,2-dibromo-1,2-dichloroethane (B). Experimental details are 
described in Table 1. 
Effects of compounds on microsomal electron transfer proteins and 
stearate desaturase. Neither haloalkane had a significant effect on 
the activity of microsomal NADH- or NADPH-cytochrome ..£ reductase or 
stearate desaturase or on the rate constant for the autoxidation of 
purified trypsin cleaved ferrocytochrome E.5 (p> 0.1) (Data not shown). 
DISCUSSION 
Since bromotrichloromethane and l,2-dibromo-1,2-dichloroethane shifted 
the redox steady state of cytochrome~ towards the ferric form (Table 1) 
and stimulated the re-oxidation of NADH reduced hepatic microsomal cyto-
chrome E_5, which is a measure of the rate of oxidation of this hemoprotein 
(Oshino et !!_., 1971; Berman et !!_., 1975), but did not affect the acti-
vity of the microsomal NADH- and NADPH-cytochrome ..£ reductase1 (Table 1, 
See Results), it would appear that they are increasing the rate of oxida-
tion and not affecting the rate of reduction of microsomal cytochrome E.s· 
The observed increase in the rate of oxidation of microsomal ferro-
cytochrome E.5 for the two haloalkanes could reflect an increased rate of 
1 Since electron transfer from ferrocytochrome b5 to ferricytochrome c is 
rapid, the cytochrome c reductase activities provide a measure of tne 
rate of reduction of ferricytochrome b5 (see e.g. Strittmatter and 
Ve lick, 1956). -
479 
3.11 
VOL. 34, NO. 3 
DECEMBER 1981 
Research Communications in 
Chemical Pathology and Pharmacology 
autoxidation 2 of this hemoprotein or an increased rate of electron trans-
fer from ferrocytochrome £_5 to one or more of the tenninal microsomal 
oxidases. 
The effects of bromotrichloromethane and l,2-dibromo-1,2-dichloro-
ethane on the re-oxidation of hepatic microsomal ferrocytochrome E.5 
would not appear to result from an effect on the autoxidation reaction 
since the stimulation of the re-oxidation of microsomal ferrocytochrome 
E.5 by these compounds was inhibited by cyanide to nearly background 
levels (Figure 3), while the autoxidation of purified trypsin cleaved 
ferrocytochrome £.5 is cyanide insensitive (Berman et !l_., 1975). In 
addition, the autoxidation of purified trypsin cleaved ferrocytochrome 
£_5 was unaffected by these two halogenated hydrocarbons (See Results). 
The enhanced oxidation of hepatic microsomal ferrocytochrome £_5 by 
bromotrichloromethane and l,2-dibromo-1,2-dichloroethane would thus 
appear to be a consequence of the stimulation by these compounds of 
electron transfer to one or more of the tenninal microsomal oxidases, 
such as N-hydroxylamine oxidase, the phospholipid desaturase, the acyl 
CoA 65-, 66- and 69-desaturases or cytochrome P-450 (Oshino, 1978). 
Microsomal N-hydroxylamine oxidase would not appear to be involved 
in the effects of bromotrichloromethane and l,2-dibromo-1,2-dichloro-
ethane on the re-oxidation of cytochrome £s inasmuch as this oxidase is 
insensitive to KCN and CO (Kadlubar et!.!_., 1973), while the effects of 
these compounds on the re-oxidation of microsomal ferrocytochrome £.5 were 
sensitive to KCN and in the case of l,2-dibromo-1,2-dichloroethane also 
to CO (Table l, Figure 3, See Results). 
The phospholipid desaturase and acyl CoA 65- and 66-desaturases would 
appear to play no role in the enhancement of oxidation of microsomal 
ferrocytochrome £.s by the two haloalkanes. The acyl CoA 65-desaturase 
and phospholipid desaturase are less sensitive to KCN [I 50 of 1-5 mM KCN 
(Inkpen et !l_., 1969)] than was the enhancement of microsomal electron 
flow by the two haloalkanes ( 150 of 0.1 mr1 KCN). The activity of the acyl 
CoA 66-desaturase is not enhanced by re-feeding a high carbohydrate diet 
(lnkpen et !l_., 1969) which enhanced the effects of bromotrichloromethane 
and l,2-dibromo-1,2-dichloroethane on microsomal electron transfer (Table 1). 
2 Autoxidation refers to the direct transfer of an electron from ferro-
cytochrome £.s to molecular oxygen (See e.g. Berman et!.!_., 1976). 
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It is also possible to exclude the microsomal contaminant catalase as 
mediating the effects of the halo compounds on the oxidation of microsom-
al ferrocytochrome ~S inasmuch as the_ Ki for KCN inhibition of cat'alase 
(approximately 8 µM) (Chance, 1952) is ten fold lower than the I50 for 
the KCN inhibition of the enhancement of the re-oxidation of cytochrome 
E.s in the presence of the haloalkanes (see Results). 
The abilities of bromotrichloromethane and 1,2-dibromo-1,2-dichloro-
ethane to enhance the oxidation of cytochrome ~Smay be a consequence of 
the interaction of these compounds with cytochrome P-450. Both com-
pounds appear to be substrates for cytochrome P-4503 (Sipes et!]_., 1977). 
Furthermore, CO and/or metyrapone which are effective inhibitors of cyto-
chrome P-450 (Boveris et~ .• 1972), but not of stearate desaturase 
(Ivanetich et~ .• 1980), inhibited the re-oxidation of microsomal ferro-
cytochrome ~Sin the presence of these compounds, and neither KCN nor 
fasting eliminated the enhancement by bromotrichloromethane of the re-
oxidation of microsomal cytochrome ~S (see Results, Table 1). 
It would appear, however, that bromotrichloromethane and 1,2-dibromo-
1,2-dichloroethane may, at least in part, stimulate the oxidation of hepa-
tic microsomal ferrocytochrome ~S by interacting with stearate desaturase. 
The magnitude of the enhancement of the oxidation of microsomal ferrocyto-
chrome ~S by bromotrichloromethane and 1,2-dibromo-1,2-dichloroethane and 
the ability of cyanide to inhibit their effects, paralleled the dietary 
induction of stearate desaturase: The effect ~,as measurable in rats fed a 
high carbohydrate diet which elevates the levels of stearate desaturase 
and the effect or its cyanide sensitivity was decreased or eliminated by 
fasting the experimental animals which drastically decreases the levels of 
stearate desaturase (Table 1 )(Oshino et~-, 1971; Shimikata et!]_., 1971; 
Oshino and Sato, 1972; Lee and Sprecher, 1971). Furthermore, the effects 
of these compounds on the re-oxidation of microsomal ferrocytochrome £s 
were inhibited by cyanide which is an inhibitor of stearate desaturase 
(Table 1, Figure 3). The I50 values for KCN inhibition of the enhanced 
re-oxidation of hepatic microsomal ferrocytochrome ~S by bromotrichloro-
methane and 1,2-dibromo-1,2-dichloroethane (see Results) are equivalent to 
the I50 value (ca. 0.1 mM) for KCN inhibition of h
epatic microsomal stearate 
3 Both compounds produce type I difference spectra with hepatic mi crosoma 1 
cytochrome P-450. V. Manca, Ph.D. Thesis, University of Cape Town, 1980. · 
481 
3.11 
VOL. 34, NO. 3 
DECEMBER 1981 
Research Communications in 
Chemical Pathology and Pharmacology 
desaturase (Oshino et~., 1966; Berman et tl·, 1975), but are signifi-
cantly lower than the Ki values (2.5 - 8 mM) reported for the inhibition 
of cytochrome P-450 by cyanide (Jefcoate et~., 1969; Correia and Man-
nering, 1973). 
The inability of bromotrichloromethane and 1,2-dibromo-1,2-dichloro-
ethane to inhibit the metabolism of stearoyl CoA by stearate desaturase 
(see Results) would not appear to mitigate against the proposal that 
these compounds stimulate the oxidation of ferrocytochrome £5, at least 
in part, by interacting with stearate desaturase. Other compounds, 
including phenols, a haloalkane and haloethers, which appear to stimu-
late microsomal electron transfer by interacting with stearate desatu-
rase, also have no effect on the hepatic microsomal metabolism of 
stearoyl CoA, possibly because stearoyl CoA binds extremely tightly to 
the enzyme or perhaps because the binding site for stearoyl CoA may be 
distinct from that for the xenobiotics (Oshino and Sato, 1971; Berman 
et~ .• 1975; Ivanetich et~ .• 1980). 
The latter proposal is supported by the following consideration: 
Under the experimental conditions used herein 4 , if the haloalkanes and 
stearoyl CoA were binding at the same site on stearate desaturase, a 35% 
to 40% decrease in the metabolism of stearoyl CoA would be expected, 
based on a comparison of the ratios of the experimental concentration to 
the K (or concentration required for half maximal effect) for stearoyl 
CoA and the haloalkane. Since no inhibition was observed (S.D . .:!:_ 2% for 
bromotrichloromethane, S.D . .:!:_ 9% for 1 ,2-dibromo-1,2-dichloroethane), it 
would appear that these compounds bind to a site distinct from the bind- . 
ing site for stearoyl CoA. 
The apparent abilities of bromotrichloromethane and l,2-dibromo-1,2-
dichloroethane to stimulate microsomal electron transfer via stearate de-
saturase may reflect the metabolism of these compounds by the stearate 
desaturase enzyme system. Alternatively, these haloalkanes may be un-
couplers of this enzyme system, and stimulate electron transfer without 
being metabolized. No uncouplers of the stearate desaturase enzyme system 
4 The concentrations of haloalkanes were the highest which would not dis-
rupt the microsomal suspension (assessed visibly) or convert cytochrome 
P-450 to cytochrome P-420 (Shimikata ~ .al,, 1972). Therefore, it was 
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are known, but .!!_-perfluorohexane has been reported to uncouple the hepa-
tic microsomal cytochrome P-450 enzyme system (Ullrich and Diehl, 1971). 
In view of the growing list of xenobiotics which stimulate microso-
mal electron flow apparently by interacting with stearate desaturase, it 
would appear that the possible interaction of xenobiotics with this 
enzyme should be considered in experiments conducted with hepatic micro-
somes, particularly those isolated from fed rats. 
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Metabolism and Toxicity 
of Volatile Anaesthetic Agents 
Kathryn M. lvanetich, Veronica Manca 
and Gaisford G. Harrison 
In 1924 the American physiologist, 
Howard W. Haggard, concluded inter a/ia 
from his classical investigation of the 'ab-
sorption, distribution and elimination of 
diethyl ether' that 'ether is not destroyed nor 
utilised in the body. It is all excreted un-
changed. ' 1 This statement went unchalleng-
ed for 40 years. The same was believed of 
other volatile anaesthetic agents. This was in 
spite of the implications of a demonstration 
by Barrett and Johnson,2 Powell3 and 
Thomas Butler' that trichloracetic acid and 
trichloroethanol were detectable in blood 
and urine of both dogs and man after ex-
posure to trichlorethylene . From this com-
The authors are in the Departments of Medical 
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placent belief in the inertness of the volatile 
anaesthetics, we have been rudely awakened 
in the last 20 years or so, by an explosion of 
interest in the hepatic biotransformation of 
anaesthetic drugs, to the realization that all 
volatile anaesthetics are metabolized in the 
body, the only difference between these 
compounds being one of extent. An incen-
tive for this interest in the metabolism of 
anaesthetic agents was provided by the 
emergence of the rare syndrome of 'unex-
plained post-anaesthetic hepatitis' . Though 
mainly the consequence of anaesthesia from 
halothane, the syndrome has also been 
displayed in patients exposed to other 
volatile anaesthetics. Most worrying to clini-
cians was, and still is, the apparent unpredic-
tability of the syndrome and the serious 
threat it poses to the life of an afflicted pa-
55 
tient.5 
The main thrust of investigations into 
hepatic anaesthetic and other xenobiotic 
metabolism and its relevance to anaesthetic-
induced liver dysfunction has centred on in-
teractions of these agents with the 
microsomal cytochrome P-450 enzyme 
system (sec e.g. refs 6-11). The oxidative 
metabolism of a variety of anaesthetic 
agents, including fluroxene, methoxy-
flurane and chloroform, by this enzyme 
system has proved to result in the metabolic 
activation of these agents into reactive 
and/or toxic species.&-1.io.u The oxidative 
metabolism of halothane by hepatic 
microsomal cytochrome P-450 did not, 
however, produce toxic results, in spite of an 
early, unconfirmed report that 
trifluorocthanol produced from halothane 
by this enzyme system was responsible for 
the deleterious effects of halothane 
anaesthesia. 12 
With the recent discovery that 
cytochrome P-450 can reductively* 
metabolize some xenobiotics, including 
halothane, n .H considerable interest has 
focused on this pathway. The reductive and 
*The term reductive is used in an unusual sense, 
and refers to the ability of the reaction to proceed 
in the absence of oxygen. 
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oxidative pathways compete with each 
other, as it were, at the active site of 
cytochrome P-450. Surprisingly, Ahr et al. 14 
have shown that the reductive metabolism 
of halothane and other haloethanes can 
predominate at the oxygen tensions normal-
ly found within the hepatocyte. The pro-
ducts of the reductive metabolism of 
halothane include CF3CH2Cl, CF2=CHC1 
and CF2 =CBrCl as well as reactive species 
which degrade the cytochrome P-450 and 
bind to cellular constituents. 13 · 17 The 
stimulation of the reductive metabolism of 
halothane by hepatic cytochrome P-450 has 
been shown by Burnell Brown and co-
workers to provide a reproducible ex-
perimental animal model for halothane 
hepatitis.11.19 
One aspect of our investigations into the 
mechanisms of toxicity of anaesthetic 
agents, has centred on their interaction with 
other microsomal enzymes. The emphasis 
of our approach was to ascertain whether 
these microsomal enzymes might mediate or 
influence in any way the toxic effects of the 
anaesthetic agents. 
Our initial interest in this regard centred 
on microsomal stearate desaturase, after the 
demonstration by Berman et al. 20 that ex-
posure of microsomes to halothane enhanc-
ed electron transfer to this enzyme. It was 
thought that this interaction might con-
tribute to halothane hepatitis, since the 
levels of stearate desaturase are controlled 
by diet, which might in part relate to the 
unexplained nature of this form of hepatitis. 
We therefore assessed the effect in vivo of 
alterations in the levels of stearate 
desaturase on halothane hepatitis. The in-
itial experimental model of Sipes and Brown 
- halothane anaesthesia of rats exposed to 
phenobarbital under anoxic conditions19 -
reproducibly and effectively produced 
halothane-mediated hepatoxicity. How-
ever, the induction of stearate desaturase by 
diet interfered with the induction · of 
cytochrome P-450 by phenobarbital. Con-
sequently, we developed a different ex-
perimental model, omitting phenobarbital 
induction, but retaining halothane 
anaesthesia under anoxic conditions. This 
produced toxicity in .about half of the ex-
perimental animals . The induction of 
stearate desaturase with a high carbohydrate 
diet, prior to anaesthesia, fully protected the 
animals against the toxic effects of 
halothane21 as assessed by mortality and by 
serum enzyme levels (SGOT). These obser-
vations suggest the exciting possibility of 
South African Journal of Science Vol. 79 February 1983 
protecting patients against halothane 
hepatoxicity by providing them with a high 
carbohydrate diet for several days before an 
operation involving anaesthesia . 
Another aspect of our investigations cen-
tred on elucidating which halogenated 
anaesthetic agents interact with stearate 
desaturase, and the mechanism by which 
these compounds stimulate microsomal 
electron transfer via this enzyme system. In 
addition to halothane, enflurane and 
methoxyflurane appeared to interact with 
stearate desaturase, whereas fluroxene, 
trichloroethylene and chloroform did 
not.20-22 
The nature and mechanism of the inter-
action of these anaesthetic agents with 
stearate desaturase have yet not been fully 
elucidated. At present, it appears that 
halothane, enflurane and methoxyflurane 
stimulate microsomal electron transfer in 
part by enhancing the rate of reduction of 
oxygen by the enzyme. The evidence from 
our laboratory indicates that these agents 
are not measurably biotransformed by the 
stearate desaturase enzyme system, but 
stimulate the uncoupling of this system, in 
· particular the transfer of reducing 
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These observations raise a number of 
points which motivate current research in 
our laboratories. First, could any 
deleterious effects arise in vivo from the ac-
tive oxygen species produced? Free radicals 
are known to cause cellular damage and to 
produce certain types of tumours. There-
fore, is it not possible that the anaesthetic 
agents could cause deleterious effects 
without undergoing biotransformation, by 
a process such as the stimulation of the un-
coupling of an enzyme system? Finally, 
should not these possibilities be considered 
before a new drug is released for human use? 
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HALOTHANE: INHIBITION AND ACTIVATION OF RAT 
HEPATIC GLUTATHIONE S-TRANSFERASES 
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Abstract-Multiple halothane anesthesias (1.25 MAC for 1 hr on 3 alternate days) of male Long-Evans 
rats initially decreased by up to 30% and subsequently increased to up to 185% liver cytosolic glutathione 
S-transferase activity toward 1-chloro-2,4-dinitrobenzene , 3,4-dichloro-1-nitrobenzene and trans-4-
phenyl-3-buten-2-one and glutathione peroxidase activity. Halothane rapidly and reversibly activated 
hepatic cytosolic glutathione S-transferases and purified isoenzyme 1-2 but not isoenzymes 1-1 and 3-3. 
At high concentrations of halothane (ca. 22 mM), maximal activation was ca . 25 %. Halothane, enflurane, 
isoflurane and methoxyflurane , but not the halothane metabolite 1-chloro-2,2-difluoroethylene, inhibited 
a mixture of liver cytosolic glutathione S-transferases with time (ca . 30% inhibition/ IS min) . The 
inhibition exhibited pseudo-first order kinetics (kobs = 0.13 min- 1) and an 150 for halothane of .-15 mM. 
Halothane inhibited glutathione S-transferases 3-3, 3-4, and 4-4 by SO-«l% , but did not affect isoenzymes 
1-1 and 1-2. The ability of halothane to diminish hepatic glutatione S-transferase activity in vivo may 
in pan reflect the time-dependent inhibition of glutathione S-transferase isoenzymes containing the 3. 
and 4-subunits. 
The GSH· S-transferases (EC 2.5.1.18) are a family 
of ubiquitous , multi-functional proteins found pri-
marily in mammalian liver. The GSH S-transferases 
catalyze the conjugation of a wide range of hydro-
phobic electrophiles with GSH. CDNB is a universal 
substrate for all GSH S-transferase isoenzymes 
whereas the activity of isoenzymes toward other 
substrates is more limited. In rat liver, GSH S-
transferase activity toward DCNB and BSP is charac-
teristic of the 3-subunit, while activity toward trans-
4-phenyl-3-buten-2-one is limited to the 4-subunit 
[1] . Several isoenzymes also function as non-sel-
enium-dependent GSH peroxidases [1, 2]. The GSH 
S-transferases can bind covalently to strong elec-
trophiles and non-covalently to a number of non-
substrate ligands, such as BSP and bilirubin [l, 3, 4). 
The cytosolic GSH S-transferases are dimers, with 
rat liver containing the 1-1 , 1-2, 2-2, 3-3, 3-4, 4-4 and 
5-5 isoenzymes [l] . 
Halothane (CF3CHBrO) is a widely used volatile 
anesthetic agent. The oxidative and/or reductive 
metabolism of halothane by cytochrome P-450 may 
mediate the hepatic damage occasionally observed 
following halothane anesthesia [5 , 6] . 
Neither halothane nor the majority of its metab-
olites appear to be metabolized by the GSH S-trans-
ferases ; one exception is the reductive metabolite 1-
chloro-2,2-difluorothylene which may undergo GSH 
conjugation in vivo [7 , 8] . However, repeated 
exposure of rats to halothane vapor reduced the 
clearance of BSP by isolated perfused liver, GSH 
dependent conjugation of BSP in liver homogenates , 
and cytosolic GSH S-transferase activity toward 
• Abbreviations used: CDNB, J-chloro-2,4-dinitroben-
zcne: DCNB , 3,4-dichloro-1-nitrobenzene; GSH , reduced 
glutathione : BSP, bromsulfophthalein . 
CDNB [9, 10]. The structural analogue 1,2-dibro-
moethane also diminished hepatic GSH S-trans-
ferase activity in vivo perhaps in part via the time-
dependent, irreversible inhibition of selected GSH 
S-transferase isoenzymes [11, 12]. 
The effects of halothane anesthesia of rats on 
hepatic GSH S-transferase activities in vivo are 
reported, as are reversible and irreversible inter-
actions of halothane with rat hepatic GSH S-trans-
ferases in vitro. 
EXPERIMENTAL 
Materials and animals. Materials were obtained as 
follows : halothane, Maybaker, R.S.A.; isoflurane, 
enflurane and methoxyflurane, Abbott Laboratories, 
Kent, U.K.; GSH, Sigma Chemicals, St Louis, MO; 
trans-4-phenyl-3-buten-2-one, Aldrich Chemicals, 
Gillingham, Dorset, U.K. ; cumene hydropcroxide 
(70% in cumene), Fluka AG, Buchs, Switzerland; 
bovine serum albumin, Miles Research Products, 
Cape Town, R.S.A. 1-Chloro-2,2-difluorocthylene 
was from PCR Research Chemicals, Gainsville, FL. 
All experiments utilized male Long-Evans rats 
(200 ± 10 g) or preparations derived therefrom. 
Hepatic cytosol was prepared by differential cen-
trifugation, the mixture of rat liver cytosolic GSH S-
transferases essentially free of other proteins was 
isolated by S-hexyl GSH affinity chromatography, 
and rat liver GSH S-transferase isoenzymes were 
purified by chromotofocusing and characterized, as 
described earlier [12]. 
Halothane anesthesia. Rats (groups of 9-18) were 
anesthetized with halothane (1.25 MAC in medical 
air) or exposed to medical air alone , once for 3 hr or 
thrice for 1 hr on three alternate days , in a manner 
previously detailed [13] . Rats were fasted for 24 hr 
1903 
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prior to each exposure to halothane or medical air. 
GSH S-transferase and GSH peroxidase activities 
were measured with liver cytosol from anesthetized 
or control rats. 
Assays. Protein concentration was determined by 
the method of Lowry et al. [14) as modified by 
Chaykin [15) using bovine serum albumin as stand-
ard . The purified isoenzymes were precipitated with 
ammonium sulfate (90% saturation), centrifuged at 
2000 g for 10 min, and redissolved in water prior to 
assay. 
Initial rates of GSH S-transferase activity toward 
CDNB, DCNB and trans-4-phenyl-3-buten-2-one 
and of GSH peroxidase toward cumene hydro-
peroxide activity were measured spectrally for one 
minute at 25° [16-19] on a Beckman 5230 or Unicam 
SP1800 spectrophotometer. All other experimental 
details are as given earlier [12, 13]. 
Metabolism of halothane by GSH S-transferases. 
The metabolism of halothane by hepatic cytosolic 
GSH S-transferases was assessed by GSH depletion 
in reaction mixtures containing an ethanolic solution 
of halothane or 1,2-dibromoethane (20 mM) vortex 
mixed into Tris-HCI (35 mM), pH 8.2, dialyzed cyto-
sol* (0.5 unit/ml) and GSH (0.2 mM). Incubations 
were at 25° with shaking at 60 cycles per min. At the 
end of the incubation period, 50 µ1 of the reaction 
mixture was diluted with 10 ml of 10 mM HCI. Two 
ml thereof was lyophilized, reconstituted with 2 ml 
of 10 mM HCl, and heated at 60° for 30 min. GSH 
concentration was analyzed spectrophotometrically 
with Ellman's reagent by the method of Brehe and 
Burch [20] . 
Reversible activation of GSH S-transferases by 
halothane. Halothane (50 µl of an 0.6-1.3 M solution 
in ethanol , initial concentration) or ethanol (50 µI) 
was vortex mixed into 2.60 to 2.85 ml of phosphate 
buffer , pH 6.5 (0.1 M) . GSH (0.13-1.45 mM) and 
CDNB (0.028--0.27 mM) were added. The reaction 
was initiated with the addition of 50 µ1 of enzyme 
preparation (ca . 0.5 unit/ ml) . 
Time-dependent inhibition of the GSH S-trans-
ferases. The effect of xenobiotics on the activity of 
rat liver GSH S-transferases in vitro was assessed as 
a function of time in reaction mixtures (total volume 
500 µl) constituted as follows: Forty µl of an ethanolic 
solution of the anesthetic (5--40 mM) or haloethylene 
(16-57 mM) or an equivalent volume of ethanol was 
vortex mixed into Tris-HCI buffer (35 mM), pH 8.2, 
followed by the addition of EDT A ( 4 mM) and GSH 
S-transferase preparation (normally ca . 0.3 unit/ml). 
Reaction mixtures were incubated at 25°with shaking 
at 60 cycles per min . The reaction was terminated by 
chilling to 0°. GSH S-transferase activity toward 
CDNB was assessed with reaction mixtures diluted 
60 fold in phosphate buffer (0.1 M). pH 6.5. Slight 
losses of activity (viz. 10:::: 5%) were noted on incu-
bation of enzyme in buffer for 15 min. Ethanol 
(3.3%) was without effect on enzyme activity. 
Statistical analysis and calculations. Results are 
given as means ::t SD. For in vivo studies. N rep-
resents the number of determinations each on the 
pooled cytosols from control or anesthetized rats. 
• Dialvzed versus 10 mM Tris-HCI. pH 7.8. for 16 hr at 
4•_ . 
Reported N values for in vitro experiments asse 
GSH S-transferase activity as a function of 
reflect the number of determinations each at 
time or following 15 min incubation . For kinetic 
ies of GSH S-transferase activity in the presence or 
absence of halothane. curves were generated by non-
linear regression analysis of the Henri-Michaelis-
Menten equation . The apparent Km and Vmax values 
generated by non-linear regression analysis for the 
rat hepatic cytosolic GSH S-transferases and purified 
isoenzymes in the absence of halothane were can-
sistent with previously reported values [3). Staris1ic,, l 
analyses were performed using Student's t· t·: ,t. I' 
significant difference between means was tak::::1 ar 
P < 0.01. 
RESULTS 
Effect of halothane anesthesia on ic GSH S-
transferase activity in vivo 
A single halothane anesthesia( ] for 3 hr) 
did not significantly affect the s• ~tivity of 
hepatic cytosolic GSH S-transfera d CDNB 
at 1. 5, 10, 15, 25 or 30 days after anes ldata not 
shown). In contrast, repeated halotha. anesthesia 
initially decreased and subsequently in:::1eased the 
specific activity of rat hepatic cytosolic GSH S-trans-
ferase and of GSH peroxidase {Table 1). The specific 
activity of hepatic GSH S-transferase toward CDNB 
and DCNB and GSH peroxidase toward cumene 
hydroperoxide reached a nadir on day 10 and a 
maximum on day 25 or 30 {Table 1). The specific 
activity of GSH S-transferase toward trans-4-phenyl-
3-buten-2-one was not strikingly affected by multiple 
halothane anesthesias. The effect of multiple hal-
othane anesthesias on the GSH S-transferase activi-
ties per gram of wet weight liver showed patterns 
similar to the specific activities per mg protein, except 
for trans-4-phenyl-3-buten-2-one {Table 1). 
Halothane metabolism by GSH S-transferases in vitro 
Halothane was not measurably metabolized 
{E.0.2 nmol/mg protein/min) by hepatic cytosolic 
GSH S-transferases. Under identical reaction con-
ditions, 1.2-dibromoethane exhibited significant 
GSH S-transferase dependent conjugation (3 .8 
nmol/min/mg protein) . 
Reversible activation of hepatic GSH S-transferase by 
halothane in vitro 
Halothane produced a rapid activation of mod-
erate magnitude of certain GSH S-transferase prep-
arations under standard assay conditions (1 mM 
CDNB, 1 mM GSH). The activation was apparent 
with liver cytosolic GSH S-transferases and one pure 
isoenzyme, and was complete before spectral tra-
cings were begun (i.e. t1 E. 5 sec). The rapid acti-
vation of the cytosolic GSH S-transferases by 
halothane was readily reversible. Dilution of halo-
thane in reaction mixtures from 22.4 mM to 11.2 mM 
and 7 .8 mM, reduced the percentage activity in the 
presence of halothane relative to controls from 
117 ::t 1 %* to 112 ::t 1 % • and 104 ::!: 1 % . respectively 
(N = 4-8). 
The activation of the cytosolic GSH S-transferases 
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0 .7 1.4 
[GSH] (mM) 
Fig. 1. Reversible activation by halothane of cytosolic GSH 
5-transferases as a function of the concentration of (A) 
CDNB and (B) GSH. vis given as the change.in absorbance 
at 340 nm per min. For (A) , GSH concentration was 1 mM; 
for (B), CDNB concentration was 0.27 mM. 0, ethanol; 
D, 11.2 mM halothane; "il , 22.4 mM halothane. 
shown in Fig. 1. Halothane significantly activated 
purified isoenzyme 1-2 (Fig: 2)~ but d.id not produce 
significant , reproducible act1vat1on of1soe~mes 1-1 
and 3-3 as a function of CDNB concentrabon (data 
not shown). 
Time-dependent inhibition of hepatic GSH S-trans-
f erases in vitro 
Four volatile anesthetic agents produced a signifi-
cant, time-dependent inhibition of th7 activity toward CDNB of the mixture of rat hepabc GSH S-
transferases in the absence of GSH (Table 2). The 
metabolite of halothane 1-chloro-2,2-difluoro-
ethylene (16 mM-57 mM), did not produ~ sig-
nificant, dose-dependent inhibition of the m!~~re 
of rat liver isoenzymes with time; percent act1vtt.1es 
remaining at 15 min varied from 80 to 104% relative 
to controls {data not shown). 
The inhibition of the partially purified mixture of 
rat liver cytosolic GSH S-transferase isoenzymes by 
halothane in the absence of GSH followed pseudo-
first order kinetics (Fig. 3). The inhibition was char-
acterized by a pseudo-first order rate constant of 
• Differs significantly from activity in the absence of 
halothane , P < 0.001. 
t These assays were not performed under conditions 
where the loss of enzyme activity was directly proportional 
to time (Fig. 3) . 
:t This level of cytosolic protein contributed less than 
10% of the total GSH 5-transferase activity in the incu-





Fig. 2. Reversible activation by halothane of GSH 5-trans-
ferase 1-2. v is given as the change in absorbance at 340 nm 
per min . The concentration of GSH was 1 mM. 0, Ethanol ; 
'v, 22.4 mM halothane . 
0.13 min- 1 {half-life of 5.4 min) . Half-maximal inhi-
bition of the activity of the mixture of isoenzymes 
occurred at concentrations of halothane greater than 
or equal to 15 mM (Fig. 4). t The addition of albumin 
(400 mg/ml) or liver cytosol (0.04 mg protein/ml)t 
· to incubations containing halothane and the mixture 
of GSH S-transferase isoenzymes eliminated the 
halothane dependent inhibition (data not shown). 
With rat liver cytosol as the source of GSH S-trans-
ferase activity, halothane failed to produce stat-
istically significant time-dependent inhibition. 
Neither the in situ perfusion of the rat liver to blanch-
ing with ice cold 10 mM Tris-HCI, pH 7 .8, prior to 
the isolation of cytosol , nor the dialysis of the liver 
cytosol against the same buffer for 1 to 24 hr at 4° 
subsequent to isolation altered this result ( data not 
shown). 
Halothane produced significant time-dependent 
inhibition of purified rat liver GSH S-transferase 
isoenzymes 3-3, 3-4 and 4-4 but not of isoenzymes 
1-1 and 1-2 as a function of time (Table 3). 
DISCUSSION 
Multiple halothane anesthesias decreased GSH 
S-transferase activity as reported earlier (9] , and 
produced a previously unreported, subsequent 
rebound in activity (Table 1). The rebound of GSH 
S-transferase activity may be analogous to the super-
induction phenomenon seen following suicide inhi-
bition (21 , 22] or may represent enzyme activation. 
In our study and elsewhere [9] , a single halothane 
anesthesia did not affect the binding or catalytic 
function of the hepatic GSH S-transferases. 
Information on the hepatic GSH S-transferase iso-
enzymes affected by multiple halothane anesthesias 
is available from a comparison of the data in Table 
1 with the substrate specificities of GSH S-transferase 
isoenzymes. The loss of DCNB activity indicates that 
isoenzymes containing the 3-subunit were affected by 
halothane. Consistent with this observation, multiple 
halothane anesthesias have been reported to 
decrease hepatic BSP metabolism [9] , a process 
which is characteristic of GSH S-transferases con-
taining the 3-subunit [l]. 
The slight loss of trans-4-phenyl-3-buten-2-one 
activity following multiple halothane anesthesias 
3.13 
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Table 2 . The time-dependent inhibition of GSH S-transferases by anesthetic agents 
in vitro 
% CDNB Activity after 15 min (N) 
Anesthetic (mM) - Anesthetic + Anesthetic 
Halothane ( 40) 
Isofturane ( 40) 
Enfturane ( 40) 
Methoxyflurane (40) 
91 ::t: 5 (18) 
93 ::t: 7 (12) 
93 ::t: 7 (12) 
93 ::t: 7 (12) 
70:: l (18)* 
76:: 4 (12)* 
70:: 10 (12)* 
65 ::t: 5 (12)* 
Incubation mixtures contained the mixture of rat liver GSH S-transferases (ca. 
0.3 Unit/ ml), and an ethanolic solution of anesthetic or ethanol in 35 mM Tris-
HCI, pH 8.2, at 25°. Percentage activity is relative to zero time samples constituted 
exactly as were those incubated for 15 min. 
• Differs significantly from value for ethanol, P < 0.001. 
{Table 1), suggests that GSH S-transferases con-
taining the 4-subunit were affected, but to a lesser 
extent than isoenzymes containing the 3-subunit. 
The loss of cumene hydroperoxide activity following 
multiple halothane anesthesias may indicate 
decreased activity of the 1-, 2- or 5-subunit containing 
GSH S-transferase and/or decreased selenium-
dependent GSH peroxidase activity. 
Halothane does not appear to be _a GSH S-trans-
ferase substrate: The anesthetic was not appreciably 
metabolized by hepatic cytosol plus GSH (see 
Results) while the positive control, 1,2-dibromo-
ethane, was [23]. However, halothane bound to one 
or more hepatic GSH S-transferases as evidenced by 
the rapid, reversible activation of enzyme prep-
arations by this drug. Halothane produced a net 
activation of hepatic cytosolic GSH S-transferases 
and purified isoenzyme 1-2, but not isoenzymes 1-1 
and 3-3 (Figs 1 and 2 and Results). The physiological 
relevance of the reversible activation of hepatic GSH 
S-transferases by halothane appears questionable 
since the process was readily reversible, and 
exhibited low extents of activation {:E.125% of con-
trols) even at concentrations of halothane 20-fold 
greater than the blood level of halothane (ca. 1 mM) 














Fig. 3. Time-dependence of halothane inhibition of GSH 
S-transferase activity. Inset: Ln (A, - A&) vs time . The 
mixture of rat liver isoenzymes (0.44 units/ml) was incu-
bated at 25° with EDTA (4 mM). Tris-HCI (40 mM) , pH 
8.2, in the presence (0) and absence (0) of halothane 
(40 mM) . Differs from zero time sample. • P < 0.01, 
t P < 0.05 . 
The time-dependent inhibition of GSH S-trans-
ferases by halothane in vitro occurred on the minute 
time scale , and exhibited an 150 approximately one 
order of magnitude greater than halothane blood 
levels [24] (Figs. 3 and 4) . The reaction exhibited 
pseudo first-order kinetics and incomplete inhibition 
of purified isoenzymes at infinity (Table 3). The 
incomplete inhibition may reflect that only half the 
sites are reactive, incomplete reaction, or competing 
pathways (partitioning) [25] . It appears that the hal-
ogenated anesthetics isoflurane, enflurane and 
methoxyflurane inhibit the GSH S-transferases in a 
manner similar to halothane (Table 2), although the 
effects of these anesthetic agents were not studied 
further . 
The isoenzyme specificity of halothane inhibition 
of the GSH S-transferases in vitro correlated with 
the effects of halothane anesthesias in vivo. Notably, 
the 3- and 4-subunit containing isoenzymes were 
affected in both systems. Although both forms 
appeared to be equally susceptible to inhibition in 
vitro , the activity associated with the 3-subunit was 
inhibited more effectively by halothane in vivo 
(Tables 1 and 3). A direct correlation of magnitudes 
of halothane inhibition of GSH S-transferase activity 
in vitro and in vivo is not possible since GSH, protein 
and possibly other high molecular weight cytosolic 
components protected against halothane inhibition 
in vitro (see Results), and the magnitude of these 
potential effects in vivo is unknown. 
Table 3. Time-dependent inhibition of GSH S-transferase 

















62 ::t: 4• 
45 :!: 12• 
Incubation mixtures contained pure isoenzymes (ca. 
0.3 Units/ ml) . halothane (40 mM) or ethanol in 35 mM 
Tris-HCI , pH 8.2 at 25° and 10 mM GSH. (N = 3-4 for 
each analysis). N.D . Not determined . 
• Differs significantly from activity in the presence of 
ethanol. P < 0.01. 
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Fig. 4. Effect of halothane concentration on the time-
dependent inhibition of GSH S-transferase activity. The 
mixture of rat liver isoenzymes (2.0 units/ ml) was incubated 
with EDTA (4mM), GSH (lOmM). Tris-HCl (40mM) 
and variable concentrations of halothane at 25° for 15 min. 
Residual activity is given as percentage of the zero time 
activity of corresponding samples. • Differs significantly 
from controls, P < 0.01. 
Several xenobiotics have been shown to inhibit 
analogous hepatic GSH S-transferase isoenzymes in 
vitro and in vivo. 1,2-Dibromoethane inhibited iso-
enzymes 3-3 and 3-4 in vitro and in vivo [11 , 12], and 
chloroform diminished the activity of isoenzymes 
1-2, 2-2, 3-3 and 3-4, but not 4-4 and 5-5 in vitro and 
in vivo [26). 
The correlation between the selectivity of inhi-
bition of GSH S-transferase isoenzymes by halothane 
and other xenobiotics in vitro and in vivo suggests 
that GSH S-transferase inhibition may provide one 
mechanism for the loss of transferase activity in vivo. 
An alternate mechanism may involve the release of 
hepatic GSH S-transferase activity into the serum 
which is stimulated by several xenobiotics 
[11. 26, 27) . The effect of halothane on serum GSH 
S-transferase activity was not investigated. 
Since halothane did not require metabolic acti-
vation in vitro to produce time-dependent inhibition, 
the capability for transferase inactivation appears to 
reside in the parent molecule, in contrast to chloro-
form which requires metabolic activation by cyto-
chrome P-450 to inhibit GSH S-transferases [26). 
This proposal is supported by the relative inef-
fectiveness of 1-chloro-2,2-difluoroethylene to pro-
duce time-dependent inhibition of GSH S-
transferase activity in vitro (see Results) . This cyto-
chrome P-450 metabolite of halothane is the only 
halothane metabolite thought to undergo GSH con-
jugation in vivo [7, 8). The relative unreactivity of 
the haloethylene compared to the parent molecule 
is consistent with the reactivity toward nucleophilic 
addition to protein side chains. Identical order of 
reactivity was found for 1,1,2-trichloroethane versus 
trichloroethylene ( unpublished results). 
It is concluded that halothane rapidly and rever-
sibly activated one or more GSH S-transferase iso-
enzvmes, and by a different mechanism produced a 
slO\\' inhibition of the 3- and 4-subunit containing 
GSH S-transferase isoenzymes in vitro. The latter 
effect may underlie the loss of hepatic GSH S-trans-
ferase activity in vivo following halothane 
anesthesias. 
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Halothane Decreases Albumin and Transferrin Synthesis: Studies 
in the Isolated, Perfused Rat Liver and in the Intact Rat 
J. J. Franks, M.D., * J. B. Kruskal, M.B., Ch.B., Ph.D., t R. E. Kirsch, M.D.,t. A. P. G. Beechey, M.B., Ch.B.,§ 
D. F. Morrell, M.B., Ch.B., 1! G. G. Harrison, M.D. •• 
llolated perfmed rat liven expoaed to 1.5~ halothane (equivalent 
to l.S5 MAC) in <>t,ICC>t or to Oz/001 alone produced urea, u well 
u albumin and tramferrin (both measured by immunocliffusion), at 
c:omtant rates during a 4.2S-h pemuion. Urea production did not 
differ in the two treatment groupc, but halothane clepreued albu-
min and tramferrin synthesia 45~ and 45~, respectively. Intact 
rats were aho expoKd to halothane, after which albumin synthesis 
wu measured by the (1'C)c:arbonate technique. The minimum halo-
thane concentration required to inllDff nflicient relaxation for 
ventilation wu aelec:ted and ranged from 1.0 to 1.5~. Measure-
ments were made in control rats not expoaed to halothane (group I) 
and in halothaae expoKd rats immediately after I h of anesthesia 
(group II), H h after the start of I h of anesthesia (group III), and 
immediately after 1/1 h of anesthesia preceded by a 1-h exposure H h 
earlier (group IV). Single exposures to halothane (groups II and III) 
resulted in a decreue in albumin synthesis immediately or H h 
later that did not differ aigni&cantly from c,ontrols (group I). How· 
ever, halothaae given twice to rats at H-h inter:vals (group IV) re-
duced their mean albumin synthesia rate to half that of controls. 
The early omet and constancy of halothane depression of export 
protein synthesis by uolatecl, perfmed liven may re8ect a rapome 
to halothane itaelf, rather than an el'ec:t resulting from the accu-
mulation of halothaae metabolites. Similarly, reduction of albumin 
synthesis in intact rats immediately after a aec,ond halothane expo-
sure may indicate a rapome to halothane, rather than to halothaae 
metabolites. (Key words: Anesthetics, volatile: halothane. Liver: al-
bumin synthesis; tramferrin synthesis; urea production. Toxicity: 
halothane.) 
HEPATIC DYSFUNCTION of varying degree has been at-
tributed to exposure to most volatile anesthetics, espe-
cially halothane, 1 ..... but the only abnormality reported 
to occur regularly after halothane anesthesia is delayed 
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BSP excretion. 5 Histologic and functional derange-
ments can be produced by hormonal and/or pharmaco-: 
logic manipulation of intact experimental animals anes-
thetized with halothane,6-8 and changes in carbohy-
drate and protein metabolism in perfused rat liversg..11 
and in isolated rat hepatocytes12 have been observed 
when these preparations were exposed to halothane. 
One major function of the liver is synthesis of pro-
teins for use in the liver itself or elsewhere in the organ-
ism. We have, therefore, examined the effect of a clini-
cally relevant level of halothane (equivalent to 1.35 
MAC) on albumin and transferrin synthesis by the iso-
lated, perfused rat liver. We also examined the effect of 
halothane on the synthesis of albumin in the intact rat. 
Materials and Methods 
ANIMALS 
Animal use was approved by the Ethics and Research 
Committee of the Faculty of Medicine of the University 
of Cape Town. Male Black-hooded rats of the Long 
Evans strain weighing 296-305 g, housed under con-
trolled conditions of temperature and humidity and al-
lowed free access to food and water at all times, were 
used as liver and red cell donors. Male rabbits of the 
New Zealand White strain, maintained under the same 
conditions, were used as plasma donors. Rats used for 
(1 4C)carbonate studies were, in addition, given drinking 
water containing 0.008M Nal for at least 24 h before 
injection. Animals in this group weighed between 275 
and 325 g. 
LIVER PERFUSIONS 
Considerations and techniques for perfusing isolated 
rat livers have been reviewed recently .15 For our exper-
iments, livers were perfusecJ14-l& with a heterologous 
mixture17 consisting of heparinized rabbit plasma and 
rat erythrocytes washed twice with 0.9% saline. Perfus-
ate volumes ranged from 113 to 144 ml, with hemato-
crits of 25-29%. The perfusate was exposed to 0 2/C01 
(95/5) by circulation in a warmed (37° C), humidified 
perfusion cabinet for 0.5 h before insertion of the liver 
and throughout a 4.25-h period of liver perfusion. Be-
fore placement in the perfusion chamber, the liver was 
flushed with isotonic crystalloid (Plasmalyte A, Tra-
3.14 
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TABLE I. Schematic of Protocol 
Time or Halothane Expooun: 
Time or Measurement 
Croup Fint(l.0 h) Second (O.S h) or Albumin Synthais 
I - - 0 h 
II Oh - l h 
III Oh - 24 h 
IV Oh 24 h 24.5 h 
venol, Deerfield, IL) for 2 min at a pressure of no more 
than 15 cm of H20. The perfusion mixture was then 
pumped through the portal vein in an antegrade direc-
tion, with pressure maintained at 12-13 cm of H20. In 
control perfusions, plasma donor rabbits and red cell 
and li~er donor rats were anesthetized briefly with 
ether m 02/C02, whereas, in halothane experiments, 
1.5%, i.e., 1.35 MAC18 halothane, was used. In addi-
tion, in halothane experiments, the perfusate was ex-
posed to 1.5% halothane in 0 2/C02 throughout the 
0.5-h preparatory and 4.25-h study periods. Perfusate 
flow and bile production were monitored continuously. 
Perfusate blood gases were sampled distal to the liver in 
the perfusate circuit, i.e., on the "venous" side, at 0.5-h 
intervals. P0t was maintained at >90 mmHg, Pc<>z be-
tween 34 and 38 mmHg, and pH between 7 .35 and 
7.44, the last by addition, when needed, of 1.0-3.0 ml 
of 0.5M NaHC05 • Perfusate hematocrit was measured 
before and at the end of liver perfusion, whereas sam-
ples for the measurement of albumin, transferrin, and 
urea19 were taken before insertion of the liver and 0.25, 
0. 75, 1.25, 1. 75, 2.25, 3.25, and 4.25 h after the start 
of hepatic perfusion. Estimates of total albumin, trans-
ferrin, and urea production were adjusted for loss due 
to sampling. The concentrations of albumin and trans-
~errin pr~duc~d by the liver were measured by radial 
1mm_unod1ffus1on.20 The antisera used (Cooper Diag-
nosucs, Malvern, PA) reacted with rat but not rabbit 
albumin or transferrin. Urea production and albumin 
and transferrin synthesis rates were estimated by linear 
regression21 of accumulated values, with rates taken as 
equal to the slopes of the fitted lines. Rates for the 
4.25-h perfusion period were expressed as mg· h-1 per 
300 g rat. Results in the control and halothane treated 
groups were compared by Student's t test. 
INTACT RATS 
Many of the methods have been described be-
fore.22-2• Usually, two rats were brought from the ani-
mal quarters each experimental day at 0700. Table 1 
shows a schematic of the experimental protocol, indi-
cating each treatment group, the hour that the rats in 
each group were anesthetized, · and the hour that albu-
min synthesis was measured in rats in each treatment 
group. The control animal (group I) was lightly anesthe-
~ized with diethyl ether in 0 2/C02 (95/5) and injected 
intravenously at the base of the tail with a mixture of 
200 µCi of sodium (14C) carbonate25 and 10 µCi of 1251-
a_lbumi?. Ether anesthesia was stopped after this injec-
u~n, with total ether exposure time lasting less than 5 
mm. The rat was returned to a cage with free access to 
food and water. Blood samples were collected from the 
tip of the tail at 0.25, 4, 4.5, 5, and 5.5 h after injection. 
At 6_ h, the rat was anesthetized with ether and bled by 
cardiac puncture. The experimental rat (group II, III, 
or IV) was anesthetized with halothane in warmed hu-
midified air/oxygen (FI0t = 0.4). Body tempera,ture 
was maintained with the aid of a heat lamp. EKG moni-
tori~g revealed no detectable changes or abnormalities 
dunng t~e anesthetic period. The oxygen/air mixture 
was obtained from compressed gas sources and deliv-
~red via a rotamet~r ~nk to a halothane plenum vapor-
izer. The anestheuc mixture was delivered at 4 1 • min-1 
via a T-piece circuit to a Tygon cylinder (d = 2.5 cm, h 
= 5 cm) stoppered at one end. The gases entered 
through a lateral opening in the cylinder and exited 
throug~ an openirg at the stoppered (distal) end. With 
the rat m a prone (physiologic) position, the cylinder fit 
snugly over the muzzle and, when held in place with 
both hands, thumbs thrusting the mandible down and 
forward, delivered, under careful observation, an ade-
quate tidal volume at 55-60 b/min. Intermittent posi-
tive pressure ~n the syste~ was developed by occluding 
gas outflow with a solenoid valve. Occlusion was carried 
out manually by an assistant or with a foot switch. Be-
tween 1.0 and 1.5% halothane was used; the minimum 
concentration necessary to insure sufficient relaxation 
for ventilation was selected. (Ventilation was assessed in 
a pilot experiment in three animals anesthetized with 
hal~thane, but ?therwise excluded from the study. 
Thirty and 60 mm after the start of anesthesia, femoral 
arterial blood samples revealed pH, Pa0i, and Pace>z in 
the normal range.) After I h of halothane anesthesia, 
the experimental rat was injected and samples taken 
(group 11) as described for the control rat, with cessa-
tion of an~sthesia after isotope injection. Alternatively, 
the expenmental rat was anesthetized with halothane 
for I h without injection and sampling, and returned to 
a cage with access to food and water. Twenty-three 
h~urs later, the animal was either anesthetized briefly 
wnh ether (group 111) and otherwise treated like groups 
I and II, or anesthetized for 0.5 h with halothane 
(group IV) and otherwise treated like groups I and II. 
In all rats, 1251-albumin activities were measured in the 
0.25- and 6-h plasma samples for determination of 
plasma volume and to provide a correction factor for 
loss of labeled plasma albumin by catabolism and 
transfer to interstitial fluids. Urea carbon specific activ-
ity was measured in the 4-5.5-h samples. The values for 
each animal were plotted against time, fitted by a single 
3.14 
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FIG. 1. Urea production by an isolated perfused rat liver exposed to 
1.5% (equivalent to l.!15 MAC) halothane. Each data point reprcscnu 
the total amount of perfusate urea less the pre-perfusion value. Urea 
production rate is derived from the slope of the regression line and 
expressed per !100 g rat. 
exponential function, and corrected by extrapolation to 
zero time (to). Albumin and urea concentrations and 
arginine-6-carbon specific activity in albumin were 
measured in the 6-h sample,24 and the latter was cor-
rected to to by multiplying by the albumin loss-correc-
tion factor. From these data, the albumin synthesis rate 
at to, in mg· h-1 per 300 g rat, was calculated for each 
animal.2s 
Control and treatment groups were compared by 
one-way analysis of variance, and by the Student-New-
man-Keuls multiple comparison procedure. 21 Statistical 
significance was inferred if P < 0.05. 
Results 
PERFUSION STUDIES 
Perfusate flow, in ml· m-1 per g liver, ranged from 
1.7 to 3.9 in control livers and from 1.6 to 3.5 in halo-
thane-treated livers. Bile flow, in µl • m-1 per g liver, 
ranged from 1.5 to 1.9 in control livers and from 1.1 to 
2.2 in halothane-treated livers. Halothane perfusate 
and bile flow rates did not differ significantly from cor-
responding control values. 
Urea production (mean ± SEM) was 11.36 ± 1.1 7 
and 13.26 ± 1.01 mg·h-1 per 300 g rat in control and 
halothane livers, respectively. These means do not 
differ significantly. Figure 1 shows a plot of urea pro-
duction from a typical halothane liver perfusion. A con-
stant rate of urea production over 4.25 h was a charac-
teristic finding in all experiments, with and without 
halothane exposure. 
Figure 2 shows plots of albumin synthesis by repre-
sentative control and halothane-treated livers. Again, a 
constant rate of production was found throughout the 
.... 60 
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FIG. 2. Albumin synthesis rates per !100 g rat (ASR) by isolated 
perfused rat livers with and without exposure to 1.5% halothane. Data 
poinu and synthesis rates were derived as described in figure 1. 
course of each liver perfusion. Similarly, transferrin was 
synthesized at a constant rate during each perfusion. 
However, the overall rate of synthesis of each of these 
export proteins was significantly depressed by halo-
thane exposure. Table 2 shows the mean and standard 
error for albumin and transferrin synthesis by isolated, 
perfused rat livers exposed to 0 2/C02 (control) and to 
0 2/C02 plus 1.5% halothane for 4.25 h. Halothane 
reduced albumin synthesis by 43% and transferrin syn-
thesis by 45%. Albumin synthesis in control livers ap-
proximated that observed in intact rats as measured by 
the (1 4C)carbonate method and by extrapolation from 
catabolic data. 22- 24 The transferrin synthesis rate, mea-
sured in rats by isotopic techniques, has been reponed 
to be about one-fifth that of albumin,26-27 but rates 
measured in our control liver preparations averaged 
closer to one-third the albumin synthesis rate. 
INT ACT RAT STUDIES 
Table 3 shows the mean and standard error for the 
albumin synthesis rate in each treatment group. A sin-
gle halothane exposure did not significantly decrease 
albumin production either immediately or 24 h later 
(groups II and III). However; halothane given twice to 
rats in a 24-h interval (group IV) reduced their mean 
TABLE 2. Effect of Halothanc on Albumin and Transfcrrin 
Synthesis by the Isolated, Perfused Rat Liver 





12.42 ± 1.15• 
7.10 ~ 0.7!1t 
t Diffen from control (P < 0.01). 
:I: Diffen from control (P < 0.02). 
4.55 ± 0.75 
2.40 ± 0.17:j: 
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TABLE !I. Effect of Halothane on Albumin Synthesis in the Int.let Rat 
Group Time of 
(n) Traanent Measurement• 
I (14) No halothane -
II (6) Halothane X 1 1 h 
III (6) Halothane X 1 24 h 
IV (8) Halothane X 2 24.5 h 
* After st.irt of initial 1-h anesthesia. 
t Per 300 mg rat. 
:j: Differs from group IV, P < 0.01 . 
§ Differs from group IV, P < 0.05. 
Synthesis Raie 
(mgh-'}t 
I 4.07 ± 0. 76:j: 
11.00 ± 1.29§ 
11.81 ± 1.42§ 
7.07 ± 1.06 
rate of albumin synthesis to half that of controls 
(group I). 
Discussion 
Our data from the isolated, perfused rat liver show 
that 1.5% halothane, equivalent to 1.35 MAC, de-
pressed albumin synthesis and transferrin synthesis 43 
and 45%. Nearly equivalent suppression of production 
of these two proteins may be fortuitous or may reflect 
action on a common pathway of protein synthesis, 
though at what level is difficuit to say. Aune et al., 12 
exposing isolated rat hepatocytes to presumably compa-
rable concentrations (2mM) of halothane, found a 65% 
reduction in uptake of radiocarbon-labeled valine into 
medium proteins after 2 h. Flaim et al. reported a 40% 
decrease in the rate of incorporation of radiolabeled 
leucine into albumin by rat livers perfused in situ and 
exposed to 4%, but not to 2%, halothane. 11 A possible 
explanation for this discrepancy between perfusion 
studies may be a difference in methodology. In our 
study, albumin and transferrin production were mea-
sured by radial immunodiffusion in a heterologous per-
fusate. In this way, we avoided the use of radiolabeled 
amino acids, a technique which may underestimate al-
bumin synthesis in the perfused liver,1 7 and possibly 
obscure· differences. Indeed, albumin synthetic rates 
obtained by us in control perfusions were equivalent to 
rates accepted for the intact rat. Other reasons for this 
close approximation to the in vivo rate of synthesis may 
include careful monitoring of perfusate pH and oxygen 
and carbon dioxide partial pressures and the use of per-
fusates with hematocrits less than 30%. These measures 
allow for perfusion over a prolonged period without 
increases in organ vascular resistance and decreases in 
bile flow, common monitors of functional integrity of 
perfused livers. 15 Further evidence for functional integ-
rity of the liver during the perfusion period is provided 
by the steadily maintained rates of urea, albumin, and 
transferrin production that were observed. Synthetic 
rates after more than 4 h of perfusion differed little 
from those during the first hour. Similarly, Flaim et al. 
noted a steady rate of incorporation of tritiated leucine 
into secreted albumin during a 2-h perfusion. 11 These 
observations may be particularly noteworthy in halo-
thane-treated livers, because they indicate an early ef-
fect that is not cumulative. 
Our measurements in intact rats by the (14C)carbon-
ate technique25 confirmed the inhibition of albumin 
synthesis by halothane, but it is interesting that two ex-
posures were required to produce a significant effect in 
this experimental setting. The (14C)carbonate method is 
based on the concept that "flash" labeling of hepatic 
protein takes place via arginine-6-carbon as albumin is 
being assembled within the hepatocyte.25 Incorporation 
of (1"C)carbon occurs during the first few minutes after 
the injection of sodium (1 4C)carbonate, which first 
enters the arginine-ornithine cycle, labeling both urea 
and the guanidine (six) carbon of arginine. Albumin 
synthesis is thus measured "instantaneously" and does 
not reflect an average estimate over a period of hours. 
This feature of the method is important in evaluating 
the effect of halothane exposure, because estimates of 
the rate of synthesis of export proteins are little affected 
by changes in concentration of halothane or halothane 
metabolites that occur after isotope injection, while the 
14C-urea slope is being determined. 
Instantaneous measurement in intact animals may 
help resolve the issue of whether decreased albumin 
synthesis is due to halothane metabolite accumulation, 
and it may allow some speculation regarding the double 
exposure phenomenon. While fluorinated hydrocar-
bons may be retained to a significant degree for more 
than 24 h following a single 1-h halothane anesthetic28 
(though this observation has been questioned19), albu-
min synthesis was not significantly depressed 24 h later 
(group III). Yet, a substantial (nearly 50%) decrease in 
the rate of synthesis was observed after two exposures 
to halothane (group IV). It seems unlikely that a second 
exposure lasting only 30 min could generate enough 
halothane derivative(s) to play an important role in re-
ducing albumin synthesis, as measured at the end of 
that 30-min period. A more tenable hypothesis is en-
hancement by halothane, itself, during a second anes-
thetic of a previous effect of halothane or possibly of its 
metabolites on the protein synthesis apparatus. Thus, 
although a single exposure to halothane was not suffi-
cient in itself to decrease albumin synthesis significantly, 
this first anesthetic predisposed the synthetic apparatus 
to marked inhibition immediately following re-expo-
sure. (In fact, a single exposure may decrease albumin 
synthesis; if groups II and III are combined, multiple 
comparison testing shows their mean of 11.40 mgh-1 
does differ significantly from the coritrol mean of 
14.07, P < 0.05). 
The mechanism of halothane-induced depression of 
hepatic export protein synthesis is unknown. Reduced 
splanchnic blood flow during anesthesia has been pro-
posed as a cause of hepatic dysfunction, but, in our 
3.14 
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isolated liver preparations, perfusion flow rates did not 
differ in control and halothane-treated livers. General 
metabolic depression by halothane also seems unlikely, 
since bile flow by the perfused livers was maintained 
during halothane exposure and since urea production, a 
measure of the activity of the arginine-omithine cycle, 
occurred at similar rates in control and halothane-
treated livers, perhaps reflecting the presence of suffi-
cient amounts of fatty acids50 and amino acids 17 in the 
perfusate plasma. In addition, careful ventilation of in-
tact animals during anesthesia appears to have ruled out 
hypoxia and hypercarbia as contributing causes. 
By whatever mechanism halothane caused decreased 
albumin and transferrin synthesis, its effect appeared 
early and remained constant during more than 4 h of 
perfusion. Further, albumin synthesis in the intact rat 
was swiftly decreased by a short, second exposure to 
halothane. This speed and constancy of effect may re-
flect a direct or indirect action of halothane, itself, on 
the protein synthesis apparatus, rather than a response 
due to halothane metabolites accumulating during the 
course of perfusion. Whether this effect .is limited to 
halothane or is associated with other potent inhalational 
agents remains to be determined. 
Our finding that exposure to clinically relevant par-
tial pressures of halothane depresses albumin (and 
transferrin) synthesis supports the view that prolonged 
or repeated exposure to halothane should be employed 
cautiously, if at all, in patients with compromised pro-
tein metabolism. 
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The liver and anaesthesia 
G. G. HARRISON 
Historically, when considering the 
effects of anaesthesia on the liver, 
attention has usually been focused 
on the pos&blc harmful effects, often 
unpredictable, of specific anaesthetic 
agents. Never was this more the 
case than with halothanc when, soon 
after its introduction, sporadic 
reports of fulminant post-anaesthetic 
hepatitis compromised the clini-
cian's confidence in the safety of 
what seemed to be the most accept- . 
able inhalational anaesthetic agent 
yet introduced. Today 'the enigma 
of halothanc hepatitis continues to 
enslave the enlightened and con-
found the foolish'. 1 The drug and 
this condition have probably been 
the subject of more research and 
consequent literature than has any 
other single drug. Y ct the incidence 
of post-halothanc hepatitis is such 
that the average clinical anaesthetist 
may expect to sec but one case in a 
professional lifetime. 2 Because of its 
potential for causing harm to the 
otherwise fit patient for reasons 
unrelated to a surgical illness, con-
centration of attention on this aspect 
of the liver and anaesthesia has been, 
to a large extent, at the expense of 
that given to the more relevant and 
common clinical problem of the 
anaesthetic management of the · 
patient with liver di.scasc. This prob-
lem, by contrast, concerns the non-
specific effects of anaesthesia and 
its associated techniques - whatever 
the drugs used - on the patient's 
already compromised liver function 
and the obverse of that coin, the 
constraints imposed by the patient's 
deranged liver function on the 
anaesthetist's ability to control the 
physiological homeostasis of the 
patient during the operative and 
pen-operative period. 
It is this latter aspect of the 'liver 
and anaesthesia' that will form the 
major burden of this short review. 
In exploring briefly the importance 
for the clinical anaesthetist of the 
pathophysiological disturbances 
which accompany liver disease, the 
subject is treated in a general, all-
embracing sense rather than in the 
more conventional manner of 
devoting separate discussion to 
hepatocellular disease/ cirrhosis, 
obstructive jaundice and liver &ilurc. 
The patient with parcnchymal liver 
disease may present to the anaesthe-
tist for surgery related either to bis 
di.scasc or to some incidental condi-
tion. In either cvcnt the problems 
presented to the anaesthetist arc 
basically the same, varying only in 
degree. The many features of 
deranged liver function and the con-
sequent problems posed for the 
anaesthetist arc dynamically inter-
related, but in the interests of clarity 
these will be presented as separate 
entities. 
Liver blood flow (LBF) 
A most important determinant of liver 
function that is greatly affected by 
all the circumstances of surgical 
operation, embracing the effects of 
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anaesthetic drugs and techniques 
together with surgical manipulation, 
is I.BF. 
The bulk of the liver's 25% share 
of the cardiac output reaches it indi-
rectly via the portal vein, only 30% 
coming directly via the hepatic artery 
although each source is responsible 
for 50% of the organ's oxygen flux. 
Since vasomotor control in the liver 
itself is mioimal , variatiom in I.BF 
follow cbaogcs in the three variables 
on which its perfusion pressure 
depends: 
• systemic arterial pressure (hepatic 
artery) 
• splanchnic vascular resistance 
(portal venous prcaurc) 
• central venous prcaurc (hepatic 
venous prcMUre) 
From their cfl'ccts on these three 
variables, it seems that all the cir-
cumstances of anaesthesia and sur-
gery conspire to reduce I.BF and 
the best we anaesthetists can do is 
. seek to lessen the dcgrcc by careful 
clinical managcmcnL In the case of 
the volatile anaesthetic agents in 
· current use in South Africa - halo-
thane and enflurane (Ethrane; 
Abbott) as well as the soon-to-bc-
introduccd forane - reduction io 
I.BF follows the dose-related &11 in 
systemic arterial prcsmrc. 3 
The anaesthetic-associated 
technique of intermittent positive 
pressure ventilation (IPPV) may 
cause reduction of LBF for mccbani· 
cal rcasons4 while the associated 
blood gas complications of hypoxia, 
hypcrcarbia or hypocapnia all cause 
increases in splanchnic vascular 
resistance from sympathetic stimula-
tion and thus reduction in I.BF/ an 
effect that is neutralized by balo-
thanc.4 (The c:fl'ccts of cnfluranc and 
forane in these drcwmtanccs arc 
not yet documented). 
41 
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While all the above conditions 
are under the control of the anaes-
thetist, the factor causing the major 
depression in LBF during surgery 
and anaesthesia is not. Gelman's6 
demonstration of the depression in 
IBF during perfonnance of an intra· 
abdominal operation to less than 
50% of that during controlled condi-
tions of general anaesthesia, clearly 
identified surgical manipulation and 
trauma as the major determinant of 
IBF during anaesthesia and surgery. 
A concomitant of general anaes-
thesia is a reduction in ~e oxygen 
utilization so that the potential for 
harm of any reduction in organ 
blood flow and thus oxygen delivery 
can only be measured when delivery 
and demand are correlated. Llbonati 
et al. 7 have done this by estimating 
the ratio of change in IBF to change 
in liver oxygen utili7.ation for various 
agents and cirCWDSWlces (Table I). 
Although their work reports inter 
aJia on drugs and techniques no 
longer in clinical use, it is of interest 
to see how halothane emerges as 
the agent to cause least disturbance 
of the oxygen supply: demand ratio. 
While the reductions in LBF 
demonstrated to accompany anaes-
thesia and surgery have not been 
shown to be associated with evi-
dence of liver hypoxia, anaerobiasis 
or long-term effects on liver function 
in the fit and healthy, it is likely that 
further iatrogenic reduction may well 
be detrimental to the cirrhotic 
patient with an already compromised 
IBF. Certainly, reduction in IBF 
appears to explain adequately the 
disastrous fulminant liver necrosis 
that may follow the inadvertent or · 
unavoidable administration of a 
general anaesthetic to a patient incu-
bating or suffering from viral hepa-
titis. 8 Inadvertent administration of 
a general anaesthetic may be due to 
misdiagnosis of jaundice as obstruc-
tive rather than viral hepatocellular. 
It appears that the anaesthetist 
may best shepherd homeostasis of 
IBF by seeking to maintain adequate 
cardiac output and systemic arterial 
pressure while maintaining normo-
carbia with correctly patterned IPPV. 
Circulatory homeostasis -
haemorrhage and other 
factors 
Successful control by the anaesthetist 
of the circulatory homeostasis of the 
patient with hepatocellular disease 
during anaesthesia and operation is 
severely compromised by scquelae 
of the disease that promote blood 
loss as well as certain other factors. 
Those that promote blood loss are: 
• mechanical 
• deficient haemostasis 
Mechanical factors promoting 
blood loss 
Va.scularlty of tbe Hver 
The extreme vascularity of the 
normal liver is evidenced by its 25% 
share of the cardiac output In addi- · 
tion, the anatomy of the vascular 
bed is such that control of surgical 
bleeding may be difficult to achieve. 
This is of particular relCV2J1ce to the 
anaesthetist in the anticipation of 
blood loss in the resection of liver 
tumours, drainage of the humdrum 
liver abscess ( when infuunmatory 
hyperaemia will compound the 
problem) as well as in the anaes-
thetic management of the increas-
ingly common ruptured liver from 
blunt abdominal trauma. often the 
result of motor vehicle accidents. 
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Hepatic venous obstruction 
resulting from the loss of vascular 
bed in the cirrhotic process leads to 
the venous hypertension in the portal 
circulation which opens up a multi-
tude of ponosystemic venous shunts 
round the gastrointestinal tract. 
During surgery these are the source 
of much of the increased bleeding 
in these patients. As much of this blood 
is lost in undramatic oozing, largely 
hidden from view under swabs, 
assistants' hands, etc., 'look/see' 
judgement of the volume of loss is 
very inaccurate. 
Correct volume replacement is of 
particular importance in these cir· 
cumstances, since the patient with 
severe ponal hypertension may be 
particularly sensitive to hypo-
volaemia; the latter will have 
occurred in the high-output circula-
tory state secondary to the enhanced 
venous runoff of the multiplicity of 
ponosystemic collaterals. 
At worst, ponal hypertensi9n may 
cause life-threatening haemorrhage 
from oesophageal variceal rupture 
that is of itself the indication for 
surgery. Happily for the anaesthetist 
today, control of this bleeding is 
now usually achieved by tamponade 
of the variccal region of the oeso-
phagus with the Sensci:akcn-Blake-
more tube together with initial 
resuscitation followed by peroeso-
phageal sclerotherapy. 9 Prolonged 
anaesthesia of these often moribund 
patients for emergency variceal liga-
tion, gastric transection or shunt 
procedures is a thing of.the-past. 
These procedures, especially the 
modern distal ponosystemic shunts, 
are now usually reserved for the 
long-term prevention of rebleeding. 
Deficient haemostasis 
In the patient with hepatocellular 
disease the above circumstances may 
be compounded by defective hae-
mostasis. This ddect results from 
lower~ levels of fibrinogen, pro-
thrombin and factors V, VII, IX and 
X secondary to depression of protein 
synthesis. In the patient with severe 
ponal hypertension with spleno-
megaly, this deficiency in haemos-
tosis may be compounded further 
by thrombocytopenia. Fibrinogen 
levels are usually depressed only 
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when hepatocellular disease is very 
severe. Obstructive jaundice alone 
may result in prothrombin deficiency 
because of malabsorption of vitamin 
K. This is easily corrected by intra-
venous administration of the vitamin 
pre-operatively. However, when 
associated hcpatocellular disease is 
severe, vitamin K replacement may 
be rendered ineffective by deficient 
protein synthesis. 
gated pre-operatively and corrected 
whenever possible. When thrombo-
. cytopenia is apparent, platelet packs 
for transfusion should be ordered 
well in advance. Provision must 
always be made for rapid large-
volume transfusion; at least one infu. 
sion line should ~ a 14 gauge 
cannula in situ. Equipment for pres-
surized augmentation of infusion 
rate should be available. Fresh blood 
( less than 48 hours old) should be 
available for loss replacement and 
Ascites should be warmed. In general blood 
Of other factors influencing the should be replaced early, bearing in 
management of circulatory homeo- mind the defective liver's reduced 
stasis ascitcs may be of importance ability to metabolize the citrate anti-
primarily for mechanical reasons. H coagulant When massive uansfusion 
the ascitcs is so gross as to cause a is indicated, calcium gluconate 1 
tense abdomen, raised central g/5 units of replaced blood will pre-
venous pressure (CVP), raised intra· vent the effects of citrate intoxica-
pleural pressure with volume tion. Fresh-frozen plasma supple-
restriction of respiration, and dis- mentation will correct coagulation 
tress and discomfort for the patient, factor deficiencies that will have 
it should be tapped some hours pre- been worsened by loss/replacement 
operatively. When cirCl!JDStanccs are · . \VaShout. 
not extreme enough to indicate There must be high-grade cardio-
pre-opcrative drainage but ascitcs is vascular monitoring. always including 
gross, the anaesthetist must be aw.ire that of CVP. It should be noted that 
that sudden release of ascitic fluid portal vein obstruction during sur-
by the surgeon on commencement gery will result in sequestration of 
of a laparotomy with a consequent splanchnic blood flow in the gut so 
rapid drop in the raised intra-abdo- that part of the replaced losses may 
minal pressure will cause a sudden not reach the general systemic cir-
- usually transient - fall in venous culation or reflect correspondingly 
return with a concomitant profound on the CVP level. 
drop in cardiac output and blood 
pressure, a circumstance that may 
well endanger the well-being of the 
seriously ill patient. 
Obstructive jaundice and 
bradycardia 
Lastly, in circulatory homeostasis 
management a factor to be con-
sidered in that common anaesthetic 
problem, the patient with obstructive 
jaundice, is the accompanying brady· 
cardia thought to be induced by 
bile salts. H not appropriately con-
trolled with atropine, this brady-
cardia and its consequences may be 
worsened by visceral traction during 
operation. 
Management 
To manage the patient's circula-
tory homeostasis successfully in all 
these circumstances, certain precau-
tions are necessary. The possibility 
of coagulopathy should ·be investi-
Blood gas and acid-base 
state in liver-disease 
For the anaesthetist, correlated with 
control of circulatory homeostasis 
is the maintenance of a normal acid-
base state in the blood and ultimately 
in the tissues. As with the former, 
portal hypertension, particularly if 
severe, has also an important 
influence on the latter. Some of the 
portosystemic shunts in the medias-
tinum ( lower oesophageal area) 
contrive to drain through bronchial 
veins via pulmonary veins into the 
left atrium, constituting ultimately a 
veno-arterial shunt which manifests 
as arterial hypoxaemia. The hypcr-
ventilatory response to this hypox-
aemia often causes hypocapnic res-
piratory alkalosis in these patients. 
The portal diversion/hepatic by-
passing of ammonia and certain gut-
generated amines and kinins which 
may directly stimulate the respira-
Continuing Medical Education Volume 3 February 1985 
tory centre is proposed as a further 
contributory cause of this hyperven-
tilation To the anaesthetist accus-
tomed to associate respiratory and 
metabolic acidosis with the seriously 
ill patient, the respiratory alkalosis 
in these seriously ill patients must 
seem paradoxical. Because of its car-
diac arrhythmogencsis, the anaes-
thetist should also be aware that 
this alkalosis may contribute to or 
worsen the hypokalacmia that results 
from the secondary aldostcronism 
of liver failure, especially in the 
presence of ascitcs. 
Blood glucose 
As blood gas and acid-base state 
reflect metabolism and perfusion, it 
is relevant to note here that among 
its manifold functions the liver is 
the body's glucosw. Although this 
function usually fails late and only 
in the presence of very SCYCrC parcn-
chymal disease, the anaesthetist 
should always monitor blood glucose 
levels and correct appropriately. 
Renal function and 
obstructive jaundice 
In the past a particularly high inci-
dence of postoperative renal failure 
was noted to be as.,ocwcd with 
operations for obstructive jaundice, 
especially when the bilirubin lCYCI 
exceeded 20 mmol/1. Dawson 
demonstrated that a mannitol-in· 
duced diuresis prcYClltcd this com-
plication. 10 Two factors were pro-
posed in the pathogcncsis:"{I) renal 
pigment load, and ( ff) anaesthetic/ 
surgery-induced reduction in renal 
blood flow - and thus glomcrular 
filtration rate - parallclling reduc-
tion in IBF. 
While induction of diuresis during 
operation has certainly reduced the 
incidence of postoperative renal 
failure, the proposed pathogenesis 
has not been confirmed. Endotox-
acmia secondary to bile-acid dcple· 
tion in the gut is the hypothesis 
most favoured today. 11 Whatever the 
pathogenesis, it is accepted that 
induction of diuresis before and 
during surgery docs prevent post· 
operative renal shutdown. A protocol 
for the induction of diuresis is shown 
in Table II. Still to be decided is 
45 
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TABLE 11. PROTOCOL FOR DIURESIS IN CASES OF OBSTRUCTIVE JAUNDICE Serum bilirubin mmoi-• Management > 20 Urinary catheter: monitor urine output If urine output> 50 ml/h- 1 no action If urine output< 50 ml/h-1 IV fluid load plus mannltol 5~ or 10% until diuresis established > 140 Pre-operative 
Antlbiotlca 




Fluid load · 
1 
Mannltol 5-10% to keep urine flow> 50 ml/h-Poatoperatlve 
Continue mannltol 24-36 h to maintain diuresis IV = intravenous. 
whether mannitol is necessary or if fluid-loading induced diuresis alone is not preferable. 
Pharmacokinetics in liver 
disease 
So far what may be considered the anaesthetic environment created by liver. disease has been discussed. Per-haps more fundamental for the anaesthetist is the manner in which liver disease modifies the disposition and excretion of the drugs used. When a drug enters the circulation: • A variable fraction becomes pro-tein bound and is no longer diffus-ible but is in dynamic· equilibrium with 
• an unbound free fraction which attaches either to specific drug receptors which mediate its effects or 
• to other tissues which play no part in specific drug effects. All ?f these constitute the volume of dis-tribution of the drug at steady state. The free fraction of the drug is also immediately exposed to various mechanisms of disposal: 
• it mav be metabolized by hepa-tocyte endoplasmic reticulum and/or it or its metabolites secreted into the bile 
• the drug or its metabolites may be excreted by the kidney, or 
• it may be acted on by liver-synthesized plasma esterases With the exception of unchanged drug renal excretion, the liver plays 
the major role in these mechanisms so that disease of this organ can materially affect drug clearance by circumstances that lead to: 
1. Altered hepatic blood flow 
• altered total hepatic perlusion • altered degree of intrahepatic shunt 
2. altered intrinsic hepatic drug clearance 
• altered number of hepatocytes • altered hepatocyte function 3. altered plasma protein composi-tion and drug binding with conse-quent alteration in drug volume of distribution. 
In the situation under discussion there will be, in addition, the effects on these mechanisms of general anaesthesia. 
Intrinsic hepatic clearance for every drug is different but this com-bined with hepatic blood flow and plasma protein binding defines the independent biological variables that determine the rate of drug elimina-tion. If the drug concerned is one of high intrinsic clearance and extrac-tion ratio, the hepatic clearance will reflect the volume of I.BF and will be sensitive to its reduction, whereas if the drug is one of low intrinsic clearance and extraction ratio, excess drug is generally available to the elimination process which will then be little affected by changes in blood flow. The reverse applies for alterations in microsomal enzyme activitv, the elimination of a drug with l~w intrinsic hepatic clearance being most sensitive to change. A 
common alteration of which the anaesthetist should be aW2re is mi-crosomal enzyme induction in the alcoholic patient, manifesting as a cross-tolerance to other hypnotic and narcotic drugs. 13 
Protein binding 
In the patient with parenchymal liver disease, reduction in plasma albumin levels is perhaps the m2jor determinant of the associated altered ph.arrnacokinetics. Olanges in drug disposition and dynamics follow: ( i) decreased/altered protein drug binding, and ( ii) an increased volume of distribution. 
With regard to drug binding, increase in the free drug fraction depends on whether the drug is an acid or a base. In the former, inten-sity of drug action will be increased in the presence of hypo-albumin-acrnia, since such drugs bind predo-minantly to albumin. Hypo-albumin-acmia becomes particularly impor-tant when high doses of drugs which exceed the binding capacity of avail-able albumin are given. This pheno-menon can occur after bolus intra-venous injection when free drug concentration in plasma- and vessel-rich tissues such as heart and brain is high before the drug has been distributed to less well perluscd tis-sues. The result will be a greater pharrnacodynamic effect and possible toxicity. In the patient with hepato-cellular disease the behaviour of thiopentone (lntraval-sodium; May-baker) exemplifies this situation. 
Basic drugs on the other hand are bound to gammaglobulins and lipo-proteins. As the former, being pro-duced extrahepatically, arc not reduced in liver disease - and may even be increased - the action of these drugs will not be changed and may even be decreased. The resist-ance of the patient with liver disease to the action of the relaxant d-tubo-curarine (dTc) reponed so many 
14 years ago by Dundee and Gray was once thought to be caused by garnmaglobulin binding of dTc but is now known to be the result of an increase in the volume of distribu-tion of the drug. 
Volumes of distribution 
Increase in a drug's volume of distribution poses very difficult cir-
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cumstances for the anaesthetist. 
Because of the increase a lower free 
drug fraction and thus reduced phar-
macodynamic effect is achieved from 
a conventional dose of the drug; 
hence the patient appears resistant 
and more drug must be administered 
to achieve the desired result. How-
ever, retention of the drug in the 
increased volume of distribution 
slows elimination and thus prolongs 
its effect. With some non-depolar-
izing relaxants this may render 
reversal of their action difficult. The 
behaviour of pancuronium ( Pavulon; 
Organon) in the patient with liver 
disease typifies this reaction. 15 
Interestingly, in the patient with . 
obstructive jaundice the elimination 
half-life of pancuronium is also 
increased because of the reduction 
of biliary excretion of the drug.16 A 
conventional dose of the drug will 
suffice initially and the patient will 
not appear resistant, but prolonga-
tion of its action may then occur 
with consequent reversal difficulties.· 
Narcotics and benzodiazepines 
Other drugs to which the altered 
drug kinetics of liver disease render 
the patient unduly sensitive include 
the narcotics morphine and pethi-
dine because of increased elimina-
tion half-lives due to decreased 
Test 
Albumin 
intrinsic hepatic clearance, fentanyl 
for the same reasons together with 
an increased volume of distribution, 
and the benzodiazepines for all these 
reasons in addition to decreased 
protein binding. With some mem-
bers of this group of drugs the phase 
I metabolites are pharmacologically 
active. There appears to be a theo-
retical advantage to the use of those 
drugs in this group which require 
conjugation only (phase 2) for 
excretion, such as lorazepam and 
oxazepam. 
Plasma cholinesterase and 
succinylcholine 
Another casualty of the reduced 
protein synthesis of liver disease is 
butyryl or plasma cholinesterase 
(BuChE). This nonspecific esterase 
hydrolyses the depolarizing relaxant 
succinylcholine ( Scoline: Glaxo ); the 
normal adult exhibits BuOlE activity 
sufficient to hydrolyse 80 mg suc-
cinylcholine/minute. A fall in the 
plasma level of this enzyme may be 
an early sign of cirrhosis, and there-
after a fall in plasma level parallels 
the clinical severity of the disease. 
Foldes 17 found patients with mode-
rately severe liver disease to have 
depression of BuOlE activity of about 
50% with a resultant twofold in-
crease in the duration of apnoea 
•• 4 ... 
after a standard dose of succinylcho-
line, and patients with severe liver 
disease had 20% of normal BuChE 
activity, resulting in a three-fold 
increase in apnoea time. However, 
as this amounts to a time of only 
30 -45 minutes, it is not of great 
clinical import and the use of suc-
cinylcholine in moderate doses is in 
general safe in patients with liver 
disease - even liver failure. 
Pre-operative assessment 
In assessing the patient with liver 
disease for anaesthesia, the same 
principles apply as for any other 
diseases. The aim is to detect depar-
tures from normal and to correct 
them before anaesthesia as far as is 
possible within the constraints of 
the disease state and the urgency of 
surgery. In the context of liver 
disease, the pathophysiological 
changes discussed in this paper must 
be given special attention. For the 
convenience of the reader, the nor-
mal values of biochemical tests rele-
vant to liver disease and inferences 
from abnormalities are listed in Table 
III. 
With a composite problem such 
as this, it is useful if we can quanti-
tate 'hepatic reserve' and h2VC some 
indication of prognosis. For this pur-
-Alpha-l~feloproteln · -- --- - ·· ·-· · ·-·· · _:?~-:: 
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Continuing Medical Education Volume 3 February 1985 49 
' 
3.15 
TABLE IV. PATIENT STATUS/HEPATIC RESERVE" 
Points scored for increasing 
abnormalities 
Serum bllirubln (µmol r') 
Serum albumin (g 1-1) 
Prothrombln time (•) 
(Increase over control) 
Encephalopathy (grade) 


















5 • 6 points = good oper1bw, rilk (equivllenl IO Child Grade A) 
7 - 8 points = rnoelerlte operatiw, Mk (equivalent to Child Grade B) 
10- 15 points= poor operatiw, nok (aquivalen1 to Child Grlde C) 
pose, Pugh's modifications of Child's 
original criteria are perhaps the most 
useful 19 (Table N). These criteria 
are helpful too in assessing pre-
anaesthetic response to treatment 
aimed at improving the patient's 
condition and prognosis before sur-
gery. 
The HBsAg patient 
After the consideration we have 
given to what the anaesthetist may 
do to the patient, it is in our own 
interests to think of what the patient 
may do to the anaesthetist. Patients 
who have suffered an attack of viral 
hepatitis B - identified by HBsAg 
in the blood - may have become 
carriers of the virus and pose the 
hazard of infection to the health-
care workers who deal with them.20 
There is an increased incidence of 
viral hepatitis B among people such 
as anaesthetists, surgeons, patholo-
gists and renal-dialysis workers. It is 
important therefore to identify 
HBsAg positive patients by screening 
all sufferers from chronic liver 
disease and to adopt sensible pre-
cautions to prevent infection of ope-
rating-room personnel. Such precau-
tions include wearing disposable 
gloves and protective clothing, 
restricting injections and blood 
sampling to the absolute minimum, 
and using disposable anaesthetic 
equipment. Non-disposable equip-
ment must be sterilized with heat 
( 60°C x 12 hours), ethylene oxide, 




Olanges in liver function as detected 
by raised serum enzyme levels are 
relatively common after surgery/ 
anaesthesia and appear to correlate 
with the site and magnitude of the 
procedure, being absent or negligible 
after short surface operations and 
greater after long abdominal, especi-
ally upper abdominal, operations. 
These changes have little more signi-
ficance than fluctuations' recorded 
in blood sugar level with or without 
food intake. Patients with pre-
existing liver disease may undergo 
further deterioration in liver function 
postoperatively, but in patients with-
out pre-existing liver disease serious 
liver dysfunction that manifests 
clinically as jaundice as well as bio-
chemically is not common. While 
we can identify the major functional 
defects engendered biochemically, 
aetiological diagnosis is usually by 
the unsatisfactory process of exclu-
sion. The usual ca~ are related to 
blood transfusion/pigment load, 
tissue injury and liver blood supply, 
infection and various drugs. While 
an anaesthetic contribution to most 
of these complications may not be 
identifiable, the effects of anaesthetic 
drugs and techniques on hepatic 
blood flow must be borne in mind. 
Just as surgical manipulation pro-
vides the environment for anaes-
thetic problems, so the coincidental 
anaesthetic sector problems of 
hypoxia, hypercarbia, hypocapnia and 
hypotension mutually provide the 
environment for the factors that 
cause postoperative liver dysfunc-
tion. 
Very, very rarely cases of profound, 
even life-threatening, liver dysfunc-
tion for which no identifiable causes 
are apparent occur after anaesthesia. 
In these circumstances, suspicion 
must fall on the anaesthetic agent 
involved. We are then faced with 
the whimsical, unpredictable 'halo-
thane hepatitis'. But that is another 
story. 
Summary and conclusion 
To safely anaesthetize the patient 
suffering from liver disease, the 
anaesthetist must have a knowledge 
of the complex pathophysiology 
associated with liver dysfunction in 
order to understand and deal with 
the constraints this imposes on his 
ability to control the patient's phy-
siological homeostasis during sur-
gery. In general, patients with 
chronic liver disease who on pre-
operative assessment score six points 
or less on the Pugh criteria have 
compensated liver function and do 
not constitute a major anaesthetic 
risk, whatever the surgery contem-
plated. By contrast, those who score 
seven or more constitute a serious 
anaesthetic and operative risk, the 
outcome being conditioned to a 
large extent by the magnitude of 
the surgical procedure undertaken. 
There is no clear evidence that 
any of the currently used anaesthetic 
agents or techniques has any definite 
advantage or detrimental effect, pro-
vided the constraints of disturbed 
liver function are recognized and 
adapted to appropriately. 
1n the conduct of anaesthesia, the 
anaesthetist should pay particular 
attention to: 
• Reducing the dose of prcmedi-
cant drugs or avoiding their use alto-
gether in patients with chronic liver 
disease who score seven or more 
points on Pugh's criteria. 
• Cautiously titrating the intra-
venous induction agent used since 
there is great variation in the dose 
required because of changes in pro-
tein binding, drug volumes of distri-
bution and, in the alcoholic patient, 
perhaps microsomal enzyme induc-
tion. 
• limiting the dose of narcotics 
administered in proportion to the 
degree of liver derangement. 
• Minimizing the dose of volatile 
agent so as not to affect the LBF 
adversely. Halothane may be safely 
used in these patients provided there 
is no history of halothane admini-
stration with adverse reaction or, 
many would add, recent ( 2 months) 
administration of the drug. 
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• Maintaining normal Paco, in the 
interests of minimizing changes in 
splanchnic vascular rcsiswice and 
LBF. 
• Monitoring the degree of neu-
romuscular blockade in order to 
minimize the dose of muscle 
relaxant drug used. 
• Inducing diuresis during surgery 
(perhaps even before) when the 
patient's pre-operative bilirubin level 
exceeds 20 mmol/1. 
Lastly, the anaesthetist must 
beware of the twO problems posed 
for him by viral hepatitis: 
• The fuhninant liver failure that 
may follo:w general anaesthesia of 
the sufferer from active viral hepatitis 
identifies the latter as an absolute 
contraindication to anaesthesia 
except for immediate life-threatening 
surgical emergency. 
• The risk of infection to the 
anaesthetist and other operating-
room personnel posed by HBsAg 
carriers. 
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S The circulating blood-volume of a baboon 
ummary (Papio ursinus ursinus) was washed out with 
Ringer's lactate solution under hypothermia. When all 
the baboon's blood was judged to have been removed the 
Ringer's lactate was replaced with human blood. The 
animal was then used for a successful and uncomplicated 
cross-circulation with a patient in terminal hepatic coma. 
Introduction 
PRELIMINARY (unpublished) work in our laboratory has 
shown that the baboon (Papio ursinus ursinus; Roberts 
1951) can tolerate complete exchange transfusion with 
human blood. Although hzmolysis docs develop, it is 
delayed, and immediate transfusion or other reactions 
have not occurred. Accordingly we decided to cross-
circulate a patient in terminal hepatic failure with a 
baboon, after its blood had been replaced with human 
blood compatible with that of the patient. 
Method 
PREPARATION OF THE BABOON 
Aruesthesia 
Anathcsia was induced in a healthy male baboon weighing 
26 kg. with phencyclidine 40 mg. by intramuscular injection 
3.16 
2 
at 10.15 P.M., and diazepam 10 mg. intramuscularly at 10.45 P.M. 
Before the operation the animal was carefully shaved and 
washed with cetrim.ide 2° 0 and chlorhcxidine 2 '}0 • At 
11.45 P.M., · after endotrachcal intubation, ana:sthcsia was 
commenced with oxygen and nitrous oxide, with intermittent 
halothane using an intermittent positive-pressure respiration 
(I.P.P.R.) technique with a non-return circuit. At midnight, 
atropine 0·4 mg. was given intramuscularly. 
Cardiopulmonary Bypass and Hypothermia 
The femoral artery and vein were exposed in the right groin. 
The left femoral vein was cannulated and a polyvinyl catheter 
inserted for central-venous-pressure recordings and infusion 
therapy as required. 
The chest was opened through a left thoracotomy in the fifth 
intcrcostal space and the heart was exposed. After systemic 
hcparinisation (60 mg.) the femoral artery and right atrium 
were cannulated. The cxtracorporcal circulation was so 
arranged to allow for: induction of profound hypothermia, 
complete washout of the animal's circulating blood-volume 
with Ringer's lactate solution, and subsequent replacement of 
the baboon's circulating fluid volume with human blood (fig. 1). 
The Rygg bag in circuit 1 (fig. 1) was primed with two 
litres of ' Plasmalyte B ', and cxtracorporcal circulation 
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heat exchanger in the circuit (Sam's 2 litre). At 1 A.M., with the 
<:esophageal and rectal temperatures at 26·0°C and 31 ·0··c, 
respectively, ventricular fibrillation commenced. The left 
ventricle was immediately vented. At 1.10 A.M. with the 
temperatures, cesophageal 13·5°C, rectal 22·0°C, the bypass 
was changed to circuit 2 (fig. 1). With the protection of 
hypothermia, the animal's blood was effectively washed out. 
Ringer's lactate, precooled to 4 °C, was run into the helix in 
circuit 2 which acted as a reservoir, and with a flow-rate of 
l ·2 litrcs per minute, the animal was washed out, the cardiotomy 
return running to waste where it was accurately measured. To 
ensure complete emptying of the pulmonary circulation of baboon 
blood, the lungs were ventilated and the heart gently massaged. 
The left ventricular vent ran to waste. At 1.21 A.M. the 
cardiotomy return from both the right atrium and left ventricle 
was macroscopically free of red blood-cells. This fluid con-
tained no protein on electrophoresis and very few red blood-cells 
on microscopy. The third circuit was primed with human 
blood, prewarmed to 37°C, oxygenated, and returned to the 
animal (fig. 1 ). · The cardiotomy return was allowed to run to 
waste for a further 1 litre, at which stage the venous return did 
not appear to be ha:modiluted macroscopically. At 1.25 A.M. 
the animal was on routine cardiopulmonary bypass with only 
human blood in the circuit, with a:sophageal and rectal 
temperatures at 20·4°C and 20·2"C, respectively, and a central 
venous pressure (c.v.P.) of 2 cm. of water. At 1.27 A.M. the 
heart defibrillated spontaneously to sinus rhythm with an 
<:esophageal temperature of 27·0''C and a rectal temperature of 
21 ·0"C. The circulation was supported with cardiopulmonary 
bypass and the baboon was rewarmed. 
The left ventricular vent was now removed and the ven-
triculotomy was repaired with 3/0 black silk. At <:esophageal 
and rectal temperatures of 37;C and 29·8;C, respectively, 
and a c.v.P. of 11 cm. water, cardiopulmonary bypass was dis-
continued. The arterial pressure was 120 mm. Hg, packed cell 
volume (P.c.v.) 25 °0 , arterial blood pH 7·431, Po1 310·0 mm. 
Hg, Pco2 25· l mm. Hg, and base-excess - 7·3 meq. per litre. 
The base deficit was corrected with intravenous sodium 
bicarbonate. 
After removal of the right atrial catheter, the atriotomy was 
repaired and the pericardium closed with interrupted sutures. 
The chest wall was closed in layers over a size 28 Argyle 
catheter with underwater drainage. The right-femoral-artery 
cannula was replaced with a size 14 •Teflon' tipped' Silastic' 
catheter and the right femoral vein was then cannulated with 
a size 13 teflon-tipped silastic catheter. The arteriovcnous 
shunt was allowed to circulate while the patient was prepared 
in an adjoining theatre. At 2.45 A.M. surgery of the animal was 
completed and 15 mg. of heparin were given intravenously in 
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Fir. 2-Chanrea in the packed-cell volume, temperature, blood-
preaaurc, and central venous preHurc dllrins the preparation of 
the baboon. 
Amesthesia was maintained in the animal via an I.P.P.R. 
non-return circuit with nitrous oxide, oxygen, and intermittent 
ether. lsoprenaline ten 0·05 ml. drops per min. (1/450,000 
solution) was used to support the animal's circulation. 
Fig. 2 shows the changes in the P.c.v., temperature, blood-
pressurc, and c.v.P. during the preparation of the baboon. 
The baboon tolerated cardiopulmonary bypass with hzmo-
dilution and profound hypothermia well, and appeared 
unaffected by replacement of its blood with fresh human blood. 
PREPARATION OF THE PATIENT 
A White married female, aged 29 years, was admitted to 
Groote Schuur Hospital in hepatic coma: details of her case 
are described by Saunders ct al. (1968). To facilitate exchange 
transfusion a Quinton-Scribner aneriovenous shunt was 
inserted into the right arm under local anesthesia. 'Teflon' 
tips, sizes 14 and 13, were inserted into the radial artery and 





At 2.40 A.M. on the morning of the cross-circulation a 
polyvinal catheter was inserted into the inferior vcna cava 
through a branch of the saphcnous vein to measure c. v .P. The 
patient was on I.P.P.R. (Bird's respirator, 40°{, oxygen). 
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Fig. 3-Blood-preHure, pulae-rate, temperature, central venoua preaaure, plaama-hll:mo-
1Jlobin, packed-cell volume, and plaama-potaaaium durms crou-circ:ulation. 
Continuous line is for the patient, broken line for the baboon. 
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Repeated interruption of the I.P.P.R. did not result in spon-
taneous breathing. She was in a terminal stage of hepatic 
coma. 
CROSS-CIRCULATION 
At 3.10 A.M. (zero hour, fig. 3) the cross-circulation was 
established by connecting the patient's radial arterial flow to 
the femoral vein of the baboon and the baboon's femoral artery 
to the right cephalic vein of the patient. The clamps were 
released simultaneously. 
Direct cross-circulation was maintained between the animal 
and the patient from 3.10 A.M. to 5 A.M. During this period it 
was obvious that the patient was bleeding into the baboon as 
shown by a fall in the c.v.r . and blood-pressure of the patient 
and a rise in c.v.r. and blood-pressure of the animal (fig. 3). 
A screw clamp was then applied to the arterial line from the 
patient to reduce blood-flow. It was felt that although the 
cross-circulation was adequate, the hazard of exsanguinating 
the patient had not been eliminated. 
A! 5.25 A.M. two Sam's modulator pumps were introduced 
into the circuit. The arterial blood from both patient and 
animal was allowed to run into a venous well (2111 in. Mayon tubing) and then returned to the appropriate venous end to 
effect cross-circulation. The levels in the venous wells were 
matched, and the pumps set to run at the same speed. It was 
now easy to adjust the screw clamp on the patient's arterial 
line to effect even cross-circulation. 
After introduction of the pumps there was again an episode 
of blood-loss from the patient into the baboon as judged by a 
rise in the c.v.P. of the animal and a corresponding drop in the 
patient's c.v.P. Flow-rate at this stage was 114 ml. per minute. 
By increasing the flow-rate to 544 ml. per minute and controlling 
the radial arterial flow from the patient with a screw clamp, an 
even cross-circulation was maintained for the remaining 
4 hours. The rate of cross-circulation must, of necessity, 
depend on the lesser volume of arterial flow-in our case the 
arterial flow from the animal. The arterial flow of a larger 
volume per unit of time has to be controlled to maintain 
uneventful cross-circulation. Cross-over flow volume remained 
at 500 ml. or more per minute for the rest of the cross-
circulation-time (4 hours). 
Changes in the patient and baboon with regard to hzmo-
globin, P.c.v., and plasma-potassium are shown in fig. 3. 
There was no evidence of hzmolysis. 
After l hour of cross-circulation, spontaneous respiration 
was noted for the first time, but the tidal volume was inadequate 
and I.P.P.R. was recommenced. After 3 hours and 50 minutes 
of cross-circulation I.P.P.R. was discontinued and she breathed 
spontaneously thereafter (tidal volume 500-600 ml.). After 
4 hours and 45 minutes of cross-circulation she was breathing 
without assistance and her minute-volume was 11 litres, Pco1 
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27 mm. Hg, and Po1 79 mm. Hg. Cross-circulation was 
continued for 6 hours, by which time the patient had a sinus 
tachycardia of 150 per minute, possibly the result of 
isoprcnaline given to the baboon. 
Within 60 hours of the cross-circulation the patient showed 
obvious improvement and within another 12 hours was lucid, 
orientated and fully conscious. 
Conclusion 
We have pref erred not to use cross-circulation between 
patients in hepatic coma and human volunteers and feel 
that the use of the baboon, prepared as described here, 
avoids exposing human volunteers to a number of hazards. 
Our preliminary experience suggests that cross-circulation 
between man and a subhuman primate is feasible and safe, 
and we believe that this technique may be of value in liver 
assistance in hepatic failure, not only in massive liver-cell 
necrosis due to hepatitis but also after liver transplantation. 
This work was supported in the University of Cape Town by the 
Council for Scientific and Industrial Research of South Africa and 
by the C. L. Herman Bequest. We thank the ~ ·estcrn Province 
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S A patient in terminal hepatic coma with 
umma"' high-brain-stem dysfunction was treated 
by multiple exchange blood-transfusions and by aoss-
circulation with a baboon (Papio ursinus ursinus) after the 
animal's blood had been replaced with human blood com-
patible with that of the patient. Spontaneous respiration 
was restored by the cross-circulation which was free from 
complications and the patient subsequently became fully 
conscious and lost all her abnormal neurological signs. 
Introduction 
HEPATIC coma due to massive liver-cell necrosis compli-
cating viral hepatitis has been treated by means of 
exchange blood-transfusion (Trey, Bums, and Saundcri. 
1966, Saunders 1967), hctcrologous liver perfusion (Eisr-
man 1967), and by human cross-circulation (Burnell ct al. 
1967, Swift ct al. 1967). These procedures represent 
attempts to tide the patient over the critical period while 
3.17 
4 
liver cells regenerate. These patients arc also treated by 
the more conventional method of a protein-free, high-
carbohydrate diet, neomycin or kanamycin by mouth, and 
large doses of corticosteroids (Saunders 1967). 
We repon here the treatment of a patient in severe 
hepatic coma, due to massive liver-cell necrosis as a result 
of viral hepatitis, by means of repeated exchange blood-
transfusions and cross-circulation through the intact living 
baboon (Papio ursinus ursinus). 
Case-report 
BEFORE CROSS-CIRCULATION 
A White female aged 29 was noted to be jaundiced at a 
medical examination when she was about 2 months pregnant. 
She had been feeling ill for about a week, with nausea, high 
temperature, and dark urine, and she was treated with bed rest. 
1 week later she was more deeply jaundiced and her stools were 
pale, but after 5 weeks she was much better, was no longer 
jaundiced, and the urine contained a trace of bilirubin. Plasma-
bilirubin did not rise above 3 mg. per 100 ml. On July 14, 
1968, 4 days before her admission to Groote Schuur Hospital 
she again became ill, started vomiting, and her jaundice 
reappeared. A pustular rash developed all over her body, 
especially on the chest and upper arms, and she was admitted 
to the Frere Hospital, East London. She had the early signs of 
hepatic failure, with a flapping tremor, and the liver was small 
on percussion. On July 15 she aborted and thereafter was very 
ill and in the afternoon became stuporose, the tendon reflexes 
becoming brisker. Treatment with a protein-free diet, oral 
neomycin, and corticosteroids was commenced. Her scrum-
total-bilirubin was 15 mg. per 100 ml. (conjugated 8·7 mg. per 
100 ml.); scrum-glutamic-oxaloacetic-transaminase (s.G.o.T.) 
400 units; serum-electrolytes (meq. per litre): sodium 130, 
chloride 100, potassium 3·5; blood-urea 27 mg. per 100 ml.; 
hzmoglobin 13·6 g. per 100 ml., packed-ccll volume (P.c.v.) 
45 <! 0 ; white-blood-cell (W.B.C.) count 24,700 per c.mm., with 
85% polymorPhonuclear cells and 15% lymphocytes. An 
exchange tranSfusion of 10 pints of fresh heparinised blood was 
performed, and she was thought to be slightly improved on 
July 18 when she was flown to Groote Schuur Hospital. There 
was no history of previous administration of blood or blood 
products and she had been taking no drugs, but there was an 
epidemic of infective hepatitis in East London at the time. 
On admission to Groote Schuur Hospital the patient was 
comatose, and responded very slightly to painful stimuli. She 
had repeated myoclonic movements of the limbs; pupils equal 
and reacted well to light; tendon reflexes all very brisk; she had 
bilateral Hoffmann's signs and bilateral extensor plantar res-
ponses. She was deeply jaundiced, and the liver could not be 
felt or percussed. There was a striking fa:tor hepaticus, but no 
elicitable flapping tremor. Blood-pressure 100/60 mm. Hg; 
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cardiovascular system and chest normal. Urine contained 
protein + + + and a large amount of bile, but no urobilin and 
no formed clements on microscopy. She was given 1 g. 
neomycin through a stomach tube 6-hourly and 600 mg. of 
hydrocortisone, 2 g. ampicillin, and 4 g. cloxacillin intravenously 
daily. On admission she was given an enema with 2 g. of 
neomycin and this was retained for as long as possible. She 
received vitamin K 1 10 mg. intramuscularly daily. An artcrio-
venous shunt was inserted between the radial artery and vein 
in the forearm and an exchange uansfusion of 5 litres of fresh 
hcparinised blood was carried out. The cerebrospinal-fiuid 
glutamine before the exchange transfusion was 33 mg. per 
100 ml., serum-total-bilirubin 12· 1 mg. per 100 ml. (conjugated 
9·7 mg. per 100 ml.), cholesterol 323 mg. per 100 ml., alkaline 
phosphatase 6·2 units, thymol turbidity 0, zinc turbidity 4, 
S.G.O.T. 23 units, lactic dchydrogcnase (L.D.H.) 245 units, 
albumin 2·9 g. per 100 ml., and globulin 1·3 g. per 100 ml. 
The blood pH was 7·2, with a Pco1 of 49 mm. Hg, standard 
bicarbonate of 16·5 mcq. per litre, base excess -10·2 mcq. 
per litre, actual bicarbonate 18·5 meq. per litre, and a total 
carbon-dioxide of 20 mcq. per litre. She was given sodium 
bicarbonate intravenously to correct the metabolic acidosis. 
Protaminc sulphate was given intravenously in the usual way 
at the end of this and all subsequent exchange transfusions. 
After the exchange transfusion the serum-total-bilirubin was 
4·9 mg. per 100 ml. (conjugated 4·1 mg. per 100 ml.) (fig. 1). 
A trachcostomy was performed and she was given ' Trasylol • 
(aprotinin) 250,000 units intravenously 4-hourly for three doses. 
At 9.30 the next morning Quly 19) the scrum-electrolytes 
(mcq. per litre) were "sodiwn 133, potassium 2·7, and chloride 
92, and she was given additional potassium. At 2.30 p .M. a 
second exchange transfusion was performed and completed at 
4.15 P.M., 4·5 litres being exchanged (fig. 1). Before the 
exchange the patient was deeply unconscious, responding only 
sluggishly to painful stimuli, and during the procedure she 
became restless and moved about scmipurposivcly. She became 
cyanoscd and coughed quite a great deal and the exchange was 
therefore stopped. Her pulse-rate increased and suctioning 
yielded copious yellowish secretions. Before and during the 
exchange she had dcccrcbratc movements. Vigorous physio-
therapy resulted in a great improvement in the chest signs. 
There was no acidosis after the cxchanec and her scrum-elcc-
trolycs were normal. Culture of the pus in the pustules of the 
skin grew a coagulasc-positive staphyococcus, sensitive to 
most antibiotics except penicillin. Blood-cultures were con-
sistently negative throughout her illness. By 6 P.M. on July 19 
there were no physical signs in the chest and she was more 
responsive than she had been in the morning. Her tempera-
ture was I 00·8°F (38· l °C), and the electrocardiograph was 
normal. She still had notable hypcrrcficxia and bilateral 
extensor plantar responses. 
At 9 A.M . on July 20 the scrum-electrolytes (mcq. per litre) 
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were sodium 121, potassium 4·3, and chloride 98. The blood pH 
was 7·51, Pco1 36·5 mm. Hg, standard bicarbonate 29·5 meq. 
per litre, and base excess + 6·6 mcq. per litre. There was 
considerable bronchospasm and X-ray of the chest showed 
diffuse opacities which were again greatly improved by physio-
therapy. Her eyelids were very ~cmatous. At 2.30 P.M. she 
had athctoid movements of the arms and the tendon reflexes 
were brisk. Her liver was now just palpable under the costal 
margin. Another exchange transfusion of 5 litres of blood was 
performed at 3.40 P.M. (fig. 1). She had bilateral cxtemor 
spasms with forceful pronation before the exchange, and after 
the procedure there was no obvious clinical improvement. She 
was given gentamicin, 80 mg. intramuscularly 12-hourly and 
a single 60 mg. dose of testosterone proprionate for engorge-
ment of the breasts. After the exchange transfusion she had a 
respiratory al.kalosis (pH 7·5). At 1.30 A.M. on July 21 she res-
ponded to minimal painful stimuli, but the cncnsor spasms 
were still present. She had bilateral, brisk tendon reflexes and 
extensor plantars. She was breathing quietly, her chest was 
clear and her temperature was then normal. 
On July 21 she had a 5th exchange transfusion of 5 litres of 
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On July 22 she was in deep coma, reacting very slightly to 
painful stimuli. She still had abnormal movements, her plan-
tars were both extensor, but her pupils were equal and reacting 
well to light. There was clinical evidence of chest infection. 
At 4 P .M. the 6th exchange transfusion of 5 litres of blood was 
performed (fig. 1) without any evidence of improvement. Her 
blood-count at this stage showed a hzmoglobin of 16· l g. per 
100 ml., P.C.V. 45 ~,~. platelets 109,000 per c.mm., W.B.C. 9360 
per c.mm., with 82~~ polymorphs, 16% lymphocytes, and 2 ~~ 
monocytes and an occasional polychromatic cell in the peri-
pheral smear, with a slight shift to the left for the neutrophils 
and some toxic granulation. A number of atypical lymphocytes 
were present. 
On July 23 she responded slightly better to painful stimuli, 
but the neurological signs were otherwise unchanged. No 
exchange transfusion was performed on that day. Apart from 
mild jaundice (fig. 1) there was no detectable biochemical 
abnormality. Vaginal examination showed the cervix was 
dilated to one finger and the uterus was about the size of a 
6-week pregnancy. 
On July 24 her. level of consciousness remained about the 
same, but the bilirubin had risen. Decerebrate spasms of the 
limbs were present. 
On the morning of July 25 she responded to light painful 
stimuli, the pupils were reacting to light, the tendon reflexes 
were abnormally brisk, and both plantars were extensor. The 
chest showed right-upper-lobe consolidation. The liver was 
just palpable below the costal margin. At lG.45 A.M. blood pH 
was 7·455, Pco1 35·5 mm. Hg, standard bicarbonate 26 meq. 
per litre, base-excess + 2·6 meq. per litre, buffer base 63 meq. 
per litre, actual bicarbonate 23·4 meq. per litre, total carbon-
dioxide 24· l meq. per litre. At 12.30 P.M. the patient's respira-
tion became depressed and she started breathing at a rate of 
7 per minute. There were no other changes in her clinical 
condition, she was not cyanosed and her pupils reacted briskly 
to light. She was put on intermittent partial-pressure respira-
tion, using a Bird respirator. At 3.30 P.M. the electrolytes and 
enzymes were normal. The cerebrospinal-fluid glutamine was 
43 mg. per 100 ml.; the cerebrospinal-ftuid glucose 100 mg. 
per 100 ml. and it contained 3 lymphocytes and 560 red blood-
cells per high-power field. An exchange transfusion was per-
formed and after the exchange of 5 litres of blood the patient 
breathed spontaneously and normally for about 10 minutes. 
She then again started breathing at 7 respirations per minute 
and intermittent positive-pressue respiration was recom-
menced. The pupils reacted to light and an eyelash reflex was 
present. She had had a diuresis, with disappearance of much 
of the periorbital ~ema, and she was noted to have doll's-eye 
movements. She was unconscious and responded to no sen-
sory stimuli except for non-purposive limb movements when 
she was touched. She had decerebrate movements of the 
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ment used up to that stage, and we decided to cross-circulate 
the patient with a baboon. 
The details of the preparation of the animal and the cross-
circulation itself are described by Bosman, Terblanche, 
Saunders, Harrison, and Barnard (1968). 
AFTER CROSS-CIRCULATION 
She did not breathe spontaneously after 4.45 P.M. The blood 
pH just before cross-circulation was 7·599 and the Pco1 21 ·8 
mm. Hg. The cross-circulation was done between 3.10 and 
9.15 A.M. on July 26. At 4.10 A.M. (after 60 minutes of cross-
circulation) spontaneous respiration recommenced and the 
respirator was no longer used after 7.00 A.M. During the 111/1 
hours before spontaneous respiration was seen, the respirator 
was stopped for up to 60 seconds on a large number of occasions 
and at no time was any spontaneous respiration observed. 
Throughout this period, and when spontaneous respiration 
returned and was established, the Pco1 remained about the 
same. She was still deeply unconscious and doll's-eye move-
ments persisted. Sinus tachycardia developed and she was 
given digitalis. · It is possible that isoprcnalinc given to the 
baboon may have caused the tachycardia. Elcctrocncephalo-
eram (E.E.G.) before the procedure showed diffuse, modcrate-
to-scvcre, Jencraliaed a1owinJ compatible with hepatic cncc-
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phalopathy, and after the cross-circulation the E.E.G. showed 
some improvement, with changes suggestive of brain-stem 
damage. The changes in blood pH, Pco1, Po1, and bilirubin 
are shown in fig. 2. At 10.45 A.M. on July 26 the cerebrospinal-
fluid glutamine was 35 mg. per 100 ml. That afternoon a final 
exchange of 5 litres of blood was performed in an attempt 
to remove any antigenic material which may have entered the 
patient from the baboon. The patient's neurological state 
remained unchanged throughout that day. It seemed that she 
had irreversible high-brain-stem dysfunction. At 9 P.M. the 
patient bled from the site of the femoral cut-down and her 
coagulation-time was 22 minutes. 250,000 units trasylol were 
given intravenously 6-hourly for three doses, and vitamin Ku 
10 mg. per day intramuscularly, was continued. At 4.30 P .M. 
on July 26 her total bilirubin was 4·7 mg. per 100 ml. serum 
(conjugated 2·8 mg. per 100 ml.). There was no disturbance of 
acid/base status and her serum-electrolytes were normal. 
On July 27 she reacted more readily to mild painful stimuli, 
but was still deeply unconscious. Her pupils reacted to light, 
respiratory-rate was 16 per minute and respiratory excursions 
were normal in depth. Her prothrombin-time was 60% of 
normal, coagulation-time 12 minutes, blood pH 7·52, Pco. 
23·5 mm. Hg, standard bicarbonate 24·9 meq. per litre, base 
excess + l meq. per litre, buffer base 56 meq. per litre, actual 
bicarbonate 18·2 meq. per litre, total carbon-dioxide 13·8 meq. 
per litre, Pa01 117 mm. Hg; serum-electrolytes (meq. per litre): 
sodium 135, potassium 4·7, chloride 103; serum-total-bilirubin 
11 ·6 mg. per 100 ml. (conjugated 7·5 mg. pe1 100 ml.), serum-
fibrinogen 83 mg. per 100 ml. At 6 P.M. she was given 6 g. 
fibrinogen and, over the next 16 hours, 625,000 units of trasylol. 
At 7 P.M. on July 27 her blood-pressure suddenly became 
unrecordable and her pulse fell to 40 per minute. Deep sighing 
respirations developed. Her blood-pressure returned again as 
the foot of the bed was elevated, the respirations and pulse 
became normal. She was given l pint of blood. There was no 
disturbance of her acid/base status or electrolytes. Subsequent 
administration of fibrinogen also caused hypotension and this 
protein may have accounted for this episode as well. 
On July 28 she was unconscious, responding to painful 
stimulation by limb withdrawal, and showed facial grimacing. 
Doll's-eye movements were still present. A ciliospinal and 
comeomandibular reflex were elicited. The eyes moved to the 
right in response to caloric stimulation of the right ear. She 
had a cogwheel type of rigidity, poorly elicited tendon reflexes, 
and extensor plantar responses. Pupillary response to light was 
normal. 
She then made a dramatic recovery. By the evening of 
July 28 she recognised her husband and by the next morning 
she was fully conscious and responded purposefully to com-
mands. In retrospect we interpreted the abnormal neurological 
signs as being due to a metabolic subcortical lesion with 
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resultant functional decortication or due to direct metabolic 
depression of high brain stem activity. 
Apart from a mild aruemia and a platelet-count of 54,000 per 
c.mm., the blood-count was normal on July 29. Plasma-
fibrinogcn was 101 mg. per 100 ml. and she was given 500 ml. 
of platelet-rich fresh plasma. She bled from the artcriovcnous 
shunt in the forearm and was given 1 litre of blood. There-
after, she remained alert, lucid and fully orientated, and within 
a few days no abnormal neurological signs could be detected. 
FOLLOW-UP 
On Aug. 29 she was still fully conscious and had no 
abnormal neurological signs. She was on a normal diet 
and no longer had ascites nor a bleeding tendency, both 
of which had been present during her recovery. She was 
still deeply jaundiced and the scrum-albumin was 2·8 g. 
per 100 ml. It is probable that she had two pulmonary 
cmboli during August. 
Discussion 
This patient had severe hepatic failure as a complication 
of hepatitis, presumably viral in origin. For 7 days she 
was in deep coma and at times she responded to varying 
grades of painful stimuli. During this period six exchange 
blood-transfusions were performed with, at times, slight 
improvement. On the eighth day high-brain-stem dys-
function became apparent and "doll's-eye movements" 
developed in addition to the extensor dcccrcbratc spasms 
she had shown during most of her illness. Respiratory 
failure developed and it is of interest that the exchange 
transfusion done at that time restored normal respiration, 
albeit for a shon while. This is in keeping with our 
impression that exchange transfusion is of value in hepatic 
coma due to massive liver-cell necrosis (Trey, Burns, and 
Saunders 1966, Saunders 1967). She again breathed very 
slowly and finally stopped breathing spontaneously, and 
we thought that irreversible upper-brain-stem and mcdul-
lary lesions were present. All observers agreed that there 
was no hope for the patient and, as a desperate measure, 
cross-circulation through a baboon was performed, after 
its blood had been replaced with human blood compatible 
with that of the patient. After 60 minutes of cross-
circulation, spontaneous breathing recommenced and after 
3 hours 50 minutes of cross-circulation intermittent posi-
tive-pressure respiration was finally stopped. W c were 
very aware at the time of the possibility of apn~ following 
on mechanical forced ventilation and analysis of her blood 
Pco1 levels confirmed our clinical impression that the 
recommencement of spontaneous respiration was due to 
the cross-circulation and not to any change in ventilation. 
3.17 
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The cross-circulation was performed without mishap 
and there was no immediate or subsequent evidence of 
harm to the patient. In panicular there has been no 
evidence of any abnormal immunological response to date. 
After the procedure, the signs of upper-brain-stem damage 
persisted and she remained unconscious but breathing 
well. At this stage we felt that recovery from " irrevers-
ible " brain damage was unlikely. She then made a steady 
dramatic recovery and became fully conscious, and 
normally orientated, with no abnormal neurological 
signs. Although Davis et al. (1968) have pointed out that 
patients in severe hepatic coma can recover with more 
conventional treatment, we do not think that our patient 
would have · done so. 
It would seem from this case-repon that cross-circula-
tion between man and the baboon is a safe procedure, and 
may provide an additional method of treatment of liver 
failure. I ts advantages over human cross-circulation arc 
self-evident. We believe that it will have application not 
only in the management of massivt- liver-cell ncaosis, but 
also in the treatment of hepatic failure after liver trans-
plantation. 
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This paper describes 4 patients with hepatic coma ,resulting from presumed 
viral hepatitis with massive liver cell necrosis, who were treated with pig 
liver perfusion alternating with exchange transfusion. None of the patients 
survived, but two showed a response to the program of treatment employed. 
in that there was an improvement in the level of consciousness. All patients 
died of haemorrhagic complications. The contribution of the oxygenator used 
in the circuit to the development of thrombocytopoenia is discussed, with 
reference to other circuits with and without oxygenators. Thrombocytopoenia 
may also result from disseminated intravascular coagulation in the patient, 
and from sequestration of platelets in the liver perfused with heterologous 
blood. 
Key-words: Fulminant hepatic necrosis; porcine liver perfusion; thrombo-
cytopo:nia 
R. Hickman, M . D., Groore Schuur Hospira/, Cape Town, Sourh Africa 
Between June, 1963, and February, 1970, 77 
patients with fulminant hepatic necrosis were 
seen at Groote Schuur Hospital and the Red 
Cross War Memorial Children's Hospital, Cape 
Town. The majority of these patients were 
presumed to have viral hepatitis. The overall 
mortal1ty irrespective of the form of treatment 
was 80 per c~nt (10). This paper describes the 
use of pig liver perfusion 'in the treatment of 
four of these patients in terminal hepatic coma. 
PERFUSION TECHNIQUE 
The circuit utilized for patient perfusion has 
been described previously (6). It ·is identical to 
that used for perfusion of the isolated liver. 
The circuit -is connected to the patient through 
a Quentin-Sc1"ibner shunt, which is routinely 
inserted ,jnto all patients who receive exchange 
transfusion, an additional procedure used in 
our patients (10). The arterial end of the shunt 
is connected by Silastic tubing to a reservoir 
sited above, and draining ~nto, the oxygenator, 
thus permitting measurement of flow from the 
patient. Blood is returned to the cephalic vein 
from the vena caval reservoir via a bubble 
trap and roller pump where inflow can be 
monitored (Fig. I). 
The circuit is primed with TisUsol (Saphar 
Laboratories, Ophirton, Johannesburg) phys-
iological perfusion solution, and fresh hepari-
nized human blood is added to a haematocrit 
of 30 to 35 per cent. The perfusate is mixed, 
warmed, and corrected to normal acid base 
balance. 
Simultaneously, dissection of the pig liver 
occurs in our laboratory half a mile away, 
according to previously described techniques 
(6) . After removal, the liver ois flushed with 
3 litres of chilled TisUsol, (4-6° C) and is 
transferred to the operating theatre submerged 
in this solution in a basin covered with a 
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sterile cloth. The organ is ·immediately inserted 
into the circuit and rewarming commences. 
Half- to three-quarters of an hour of circula-
tion is allowed for total stabilization of the 
flow and correction of the acid base status 
before connection with the patient. Once con-
nected to the circuit, the patient's circulation 
and homeostasis were monitored by observa-
tion of the arterial and venous pressures, the 
electrocardiogram, and the acid-base and elec-
trolyte status. 
It was intended that perfusion would con-
tinue for at least 4 hours, but in all cases 
circulation had to be discontinued because of 
the appearance of bleeding from venepuncture 
and other sites. This complicatfon will be 
discussed later. 
CASE HISTORIES 
General. All patients were isola,ted and nursed 
in an intensive care area. The conservative 
management included administration of systemic 
hydrocortisone 100 mg 6-hourly, and neomycin 
I g 4-hourly through a naso-gastric tube, which 
was also used for feeding a protein-free, high 
calorie diet. Dextrose infusion was given to 
maintain blood glucose, which was estimated 
at least 6-hourly, and frequent biochemical 
analyses were made of the electrolyte and acid-





Fig. I . A diagram of the circuit 
used to treat patients in hepatic 
coma by extracorporeal assist 
with a pig liver. 
the plasma potassium level. A urinary catheter 
was inserted to assess urinary output. Anti-
biotics were given if infection supervened. The 
volume of blood used for exchange transfusion 
in all cases was five litres, as had been found 
effective previously (11 ). It is our policy to 
perform tracheostomy after the first exchange 
transfusion has temporarily and at least par-
tially, corrected coagulation deficits. Three of 
these patients had this procedure. All personnel 
in contact with the patient donned gowns, 
gloves, and masks before entering the room. 
Case 1 
M . K., an African male of 11 years, with 
a history of two weeks' mild jaundice, became 
deeply jaundiced, drowsy, dizzy, and ataxic, 
and exchange transfusion was commenced. 
Despite a total of eight exchange transfusions, 
there was no improvement, and the patient 
was transferred 800 km to Cape Town for 
further treatment. On admission, he was as-
sessed to be in deep hepatic coma with doll's eye 
movements and decerebrate response to pa:inful 
stimuli. A 2.5 cm liver could be percussed. 
Before perfusion could be commenced, the 
patient suffered a respiratory arrest and after 
tracheostomy, was maintained on intermittent 
positive pressure respiration. Perfusion was 
commenced six hours after admission and was 
3.18 
continued for three and a half hours. No 
haemodynamic difficulties were encountered. 
Spontaneous respiration resumed ,one hour 
after perfusion commenced. Perfusion was 
discontinued because of oozing of fresh blood 
from the shunt site and buccal mucosa. 
Despite two further exchange transfusions, 
the patient became hypothcrmic, then hypoten-
sive, and died following gastrointestinal haem-
orrhage. 
Autopsy revealed gross collapse of most of 
the liver with only one small regenerative 
nodule. The remainder of the liver was bile-
stained. The general necrosis with minimal 
regeneration was confirmed histologically. 
Case 2 
M. A., a Coloured female of. 34 years, with 
a three-week history of malaise and jaundice, 
became confused two days prior to admission. 
On admission, she responded to her name and 
to painful stimuli, but subsequently deteriorated. 
and twelve hours later, despite one exchange 
transfusion, was hyper tonic and deeply comatose, 
with no percussible liver dullness. Twenty-four 
hours later, a liver perfusion was commenced 
and after thirty minutes, the patient recovered 
consciousness completely and remained lucid 
and orientated for twenty minutes. Thereafter, 
she lapsed back into coma. Perfusion was dis-
continued after one and a half hours, owing 
to oozing of fresh blood from puncture sites. 
Three further exchange transfusions were per-
formed at twenty-four hour intervals, but she 
developed a syndrome of consumptive coagu-
lopathy which was treated with platelet-rich 
plasma. She remained unconscious except for 
two further periods of lucidity. the final one 
lasting three days. Haematemesis and malaena 
developed, and the patient died following in-
halation. Hertotal stay in hospital was 19 days. 
Autopsy showed brightly jaundiced regene-
rating liver alternating with deep red areas of 
necrosis. Histology confirmed centri-lobular 
necrosis. There were two sub-acute ulcers at 
the cardio-oesophageal junction of the stomach, 
and a chromophobe adenoma of the pituitary 
was noted. 
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In retrospect, a tracheostomy might have 
prevented the complication of inhalation which 
contributed to death. 
Case 3 
V. M., an African female of 26 years, with 
a five-day hi5tory of anorexia and vomiting 
was admitted jaundiced and uncooperative. 
Extensor plantar reflexes and confusion were 
the only neurological features noted. Six hours 
later she was deeply comatose, and an exchange 
transfusion was performed. Pig liver perfusion 
was advocated twelve hours later when a 
decorticate-type of response to painful stimuli 
was noted. Perfusion was continued for two 
hours and was discontinued because of bleed-
ing. Despite another exchange transfusion, she 
became opisthotonic and another perfusion was 
performed, also for two hours and was simi-
larly discontiinued because of bleeding. This 
was followed by a further exchange trans-
fusion, and within two days she was conscious 
although the liver remained impalpable. Ascites 
and mclaena developed. 
Another exchange transfusion was performed 
when the patient lapsed into coma once again; 
this was perhaps related to gastrointestinal 
haemorrhage which persisted. The liver edge 
became just palpable, but the patient developed 
menorrhagia and massive haematemesis and 
died. 
Autopsy showed inhalation and a lung ab-
scess from which K.lcbsiella pncumoniae was 
cultured. Most of the liver showed total 
necrosis, but in the left lobe, there were three 
areas of regeneration. The clinical bleeding 
tendency was confirmed by a massive haemor-
rhage into the broad ligaments, a subarachnoid 
haemorrhage, and multiple petcchial haemor-
rhages. 
Some biochemical and haematological fea-
tures of this case arc shown in Figure 2. 
Similar features were seen in the other cases 
described. 
Case 4 
J. v. d. M., a Caucasian female of 17 years, 
suffered jaundice for five weeks, and while 
being treated at bed-rest, became comatose. 
3.18 
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Fig. 2. The biochemical and haematological find-
ings in Case 3. xt refers to exchange transfusion 
and pip to pig liver perfusion. 
Decorticate movements were noted on admis-
sion to hospital. After two exchange transfu: 
sions, there was no improvement in the level 
of consciousness, the EEG was iso-electric, 
and she suffered two generalized convulsions 
and a respiratory arrest complicated by two 
cardiac arrests from which she was resuscitated. 
Pig liver perfusion was performed for two 
hours and was discontinued because of bleed-
ing from the shunt site. There was no altera-
tion in the level of consciousness or the general 
condition of the patient, and she died 48 hours 
later. 
Autopsy showed coarse nodularity of the 
liver representing regeneration, but pale, dead 
liver stroma predominated. The pituitary 
showed recent infarction and a chromophobe 
adenoma. 
Pig liver perfusions 
During perfusion, the livers functioned the 
same as the isolated perfused preparation in 
the laboratory (5). Bile production tended to 
fall over the course of the perfusion, but bili-
rubin was seen to be excreted iin the ascitic 
fluid exuding from the liver surface. Owing to 
the complexity of the procedure, little moni-
toring of the liver was performed except for 
the flow rates and pressure recordings, and 
the maintenance of the acid base balance. 
Biochemical analyses of the effluent from the 
liver showed equilibration of the prime with 
the patient's blood in all cases within the first 
half-hour of link up. No transhcpatic studies 
were performed. 
1 





Fig. 3. The levels of fibrinogen 
and fibrinogen degradation prod-
ucts as obtained from nine ex-
periments. 
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Figure 3 shows the results in two cases 
(2 and 3) of heparinization of the patient in 
addition to the circuit as compared with case 
1 where only the circuit was heparinized. In 
cases 2 and 3, fibrinogen was also given during 
perfusion. For comparison, the mean results 
of 9 isolated perfusions of the pig liver with 
human blood in the laboratory are shown. 
There is no apparent fall in fibrinogen levels, 
nor do split products of fibrinogen appear as 
they do in the clinical situation . 
DISCUSSION 
The clinical course of the patients presented 
exemplifies the majority of patients with acute 
hepatic failure currently being encountered at 
this hospital. In all four patients, the overall 
clinical course was one of a steady decline, 
which appeared to be materially unaffected 
by intensive care and exchange transfusion. 
Under such circumstances, pig liver perfusion 
was offered as an additional therapeutic 
measure. 
In the cases described, only in patient M. A. 
did there seem to be a direct relationship . 
between the use of pig liver perfusion and a 
striking temporary improvement in the level 
of consciousness. Nonetheless, the theoretical 
advantage of the use of the liver remains -
whether the function of ,the organ be to remove 
whatever toxins result in hepatic coma, or to 
provide substrate not manufactured by the 
necrotic liver. 
It should be noted that three of our patients 
had normal levels of aspartate transaminase at 
death. This may reflect the severity of necrotic 
damage, suggesting that no further cells could 
be destroyed to result in elevation of this 
enzyme. 
It is also of interest that two of the four 
patients showed a chromophobe adenoma on 
sectioning of the pituitary, and in one there 
was evidence of ·infarction of the gland. 
Coagulation disturbances 
In the circuit described, an oxygenator acts 
additonally as a reservoir and ensures adequate 
blood flow to the liver. Patients treated in this 
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way are often in a terminal state with poor 
cardiac output. which could result in a poor 
blood supply to the liver if ,the circulation 
were unassisted . However. the oxygenator may 
cause thrombocytopoenia which results from 
direct bloodlgas contact. This complication is 
of particular significance in a patient whose 
levels of prothrombin and fibrinogen are 
already low. Thrombocytopoenia and low 
plasma fibrinogen were observed in all four 
patients. In the longest survivor, V . M., this 
thrombocytopoenia was striking and progres-
sive. It is possible that fo the course of the 
multiple transfusions w-ith platelet-rich plasma, 
this patient developed anti-platelet antibodies 
which would have aggravated the tendency to 
thrombocytopoenia. It has recently been shown 
that H-LA compatibility is of great value in 
ensuring survival of platelets under such con-
ditions (4). 
Thrombocytopoenia is a recognized com-
plication of the use of this form of oxygenator 
in cardiopulmonary bypass (3). However, the 
duration of such a bypass is shorter than that 
of perfusion and in addition, the cardiac 
patient does not usually have other coagula-
tion defects. 
Rake et al. (8) describe spontaneous throm-
bocytopoenia developing in patients with mas-
sive liver cell necrosis before any form of 
therapy is undertaken. This :is thought to result 
from consumptive coagulopathy and fibrino-
lysis following the liver necrosis. The results 
of additional heparinization as shown in Figure 
3 tend to confirm this hypothesis. 
An ·immunological factor may also be in-
criminated (7). In any form of rejection phe-
nomenon, platelet deposition may occur on 
endothelial surfaces, and this form of xenograft 
of human blood into pig liver in the experi-
mental model might well result in sequestra-
tion of platelets in the liver. This could be the 
explanation of the thrombocytopoenia in the 
cases of the circuits used by Abouna et al. 
(I), where no oxygenator was used, and Ro 
& Flatmark (9). where the level of platelets 
still dectined . 
However, the trauma of the oxygenator still 
remains a challenge for solution of the circuit 
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described above !is to be used. At present we 
have stopped offering pig liver perfusion for 
treatment of patients in hepatic coma while 
studies are under way in the labora-t0ry to 
attempt to reduce the trauma created by the 
oxygenator. In addition, the sequestration of 
platelets in the heterologous liver is under 
review. 
In a recent paper, Abouna et al. (2) have 
demonstrated conclusively that whilst exchange 
transfusion may improve the coagulation dis-
turbances, only pig liver perfusion materially 
influenced the neurological states in their 
patient, so that the latter may be the preferred 
treatment in some cases. Once the problems 
posed ·by thrombocytopoenia are overcome, 
we feel it desirable to persist with th·is form 
of treatment to evaluate fully its use in acute 
hepatic failure, a syndrome with a very high 
mortality. 
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BABOON INTO PIG UVER AND KIDNEY XENOTRANSPLANTATION* 
J. TERBLANCHE, CH.M. (CAPE ToWN), F.R.C.S., F.C.S. (S.A.); D. M. DENT, F.R.C.S., F.C.S. (S.A.); C. J. UYS, MD., 
D. Cl.IN.PATIi. (RAND), F.C.PATH.; R. HICKMAN, M.D. (CAPE TOWN); J. R . W. ACKERMANN, M.0. (CAPE TOWN), 
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The possibility of using animal organs in human trans-
plantation has great appeal, as suitable cadaver donors are 
surprisingly rare despite the analyses of Couch,' and 
Terblanche and Riddell' indicating a potentially adequate 
supply. The need to study xenotransplantation is particu-
larly urgent in organs such as the liver which tolerate 
poorly the ischaemia that accompanies the procurement 
of human cadaver organs. To date minimal success has 
been attained in humans, with the exception of renal 
xenografts .from primate to man.•.• There are as yet few 
published reports on experimental transplantation across 
a major species barrier, although such studies are essential 
as it is unlikely that sufficient primates will be available to 
meet the demand for human organ transplantation. 
The pig has been widely used in experimental liver 
transplantation. It has been• demonstrated that a pig can 
tolerate a liver alJograft from an unrelated donor without 
•Date received : 23 March 1970. 
919 
immunosuppression for as long as 2 years, while untreated 
pigs frequently demonstrate little clinical or histological 
evidence of rejection,1 •14 although they reject skinu and 
renal allografts normally." The pig therefore appears to 
be an important and as yet unevaluated model in which to 
study liver xenotransplantation. Liver xenotransplantation 
has been studied by Caine et al.u who demonstrated that 
immunosuppressed baboons with pig liver xenografts can 
survive for up to 3-! days without gross evidence of liver 
damage, and by Gliedman et al... who showed almost 
immediate cessation of function in heterotopic pig liver 
xenotransplants in dogs, although immunosuppressed dog.~ 
tolerated heterotopic fox liver xenotransplants for up to 
22 days. The present study was undertaken to assess the 
fate of pigs with baboon liver xenografts. No immuno-
suppression was employed as baseline information on un-
modified liver xenografts was not · available in the litera-
ture. Baboon kidney xenografts in pigs were also studied 
for comparison. 
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MATERIAL AND METHODS 
Orthotopic Liver Xenografts 
The donors were adult baboons (Papio ursinus ursinus) 
weighing between 10 and 32 kg with an average of 18 kg. 
The recipients , were either Landrace or crossed Large 
White/ Landrace pigs weighing between 16 and 28 kg 
with an average of 22 kg. 
Seven out of a total of 11 experiments were carried 
to completion with detailed liistological and biochemical 
studies, and only these experiments will be discussed. The 
donor baboon liver was transplanted orthotopically into 
a pig using a technique essentially similar to that de-
scribed for pig liver allografts," with two differences, viz. : 
it was found to be unnecessary to bypass the vena cava 
in a pig, and long lengths of vena cava and portal vein 
were retained below the donor baboon liver, as a baboon's 
liver is significantly smaller than that of a pig of the 
same weight. The donor baboon liver was washed out 
with 4 - 6 litres of chilled balanced salt solution (Plasma-
lyte-B, Baxter Laboratories). Various hepatic arterial anas-
tomoses were used including direct anastomosis, Carrel 
patch to aorta, an aortic segment and anastomosis to the 
right renal artery. In all cases the liver was observed for 
varying periods of time aiter revascularization before 
closing the animal's abdomen. This allowed the macro-
scopic changes in the liver to be assessed, and adequate 
biopsies to be performed at regular intervals. Both the 
donor and the recipient were heparinized and in the reci-
pient this was usually not neutralized at the end of the 
operation. In an attempt to prevent an anticipated bleed-
ing tendency Trasylol (Bayer) in doses varying between 
50 000 and 250 000 units was administered intravenously 
to the recipients at the time of revascularization except 
in experiments 6 and 7. No immunosupprcssive agents 
were employed. During the operation the animals received 
blood replacement with freshly obtained heparinized 
abattoir pig blood, and when necessary in the postope-
rative period they were given fresh citrated abattoir blood 
which was not cross-matched. Plasmalyte-B was adminis-
tered intravenously during the operative procedure and 
in small volumes postoperatively. Glucose was given as 
indicated by blood sugar determinations with Dextrostix 
(Ames). Regular blood samples were taken for acid-base 
studies and sodium bicarbonate was administered as re-
quiretl (see Table I). 
Liver-function tests were performed pre-operatively and 
at 2, 10 and 30 minutes and hourly after revasculariza-
tion. Biopsy specimens of the donor liver were taken before 
removal from the baboon, after wash-out during the period 
of cold ischaemia, and at 2, 10, 20 and 30 minutes and 
where possible hourly after revascularization. In addition 
a further specimen was taken as soon after death as 
possible. Full autopsies were performed with minimal de-
lay and tissues from the donor liver, the donor and reci-
pient lymph ·nodes, the lungs, the heart and other organs 
were fixed in 10 % formol saline. Paraffin-wax embedded 
4-µm tissue sections were stained as a routine with haema-
toxylin and eosin. Where indicated, special stains for 
reticulin, fibrin, lipid and haemosiderin were performed. 
H eterotopic Kidney X enografts 
Kidney grafts were taken simultaneously from 6 of the 
baboon donors and were washed out with 100 ml of 
chilled balanced salt solution (Plasmalyte-B) to simulate 
the situation in the liver transplants. These were trans-
planted into other Landrace or Large White/Landracc 
recipient pigs and placed in the right iliac fossa, using 
a plug-in technique with polythene tubes. These kidneys 
were observed for colour change, urine flow and blood 
flow until no longer functioning. One kidney was left 
in situ for 4 days. Biopsy specimens for light microscopy 
were taken from the kidney before removal from the 
baboon, after wash-out during the cold ischaemic period 
and at 2, 10 and 30 minutes and at 1, It, 2, 3 and 3t 
hours after vascularization, as the cases permitted. The 
biopsies were performed in a similar manner to the liver 
biopsies. 
RESULTS 
Orthotopic Liver Xenografts 
Survival times are best assessed from the time of rcvas-
cularization, as many of the animals had their abdomens 
left open for several hours to determine the macroscopic 
changes in the liver and to enable the removal of speci-
mens for biopsy. The postvascularization survival time 
varied from 2 to 10 hours (Table I). 
One of the most striking findings was that the liver 
usually regained its normal colour immediately after vas-
cularization, and remained normal during the period of 
observation. The only exceptions were -in the first two 
experiments, where excessive handling led to traumatic 
subcapsular haematomata. Even at postmortem examina-
tion 4 livers still retained a normal appearance. However, 
biopsy specimens of these livers tended to disintegrate 
when placed in formol saline, probably indicating severe 
damage. 
The changes occurring in the serial liver-function tests 
were similar to the early changes noted in pigs with 
autotransplanted and allotransplanted livers (unpublished 
data). A slight rise occurred in SGOT and alkaline phos-
phatase, and bilirubin remained unchanged. No haemo-
lysis occurred. A striking feature was persisting and in-
creasing metabolic acidosis after vascularization, despite 
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regular correction with sodium bicarbonate, as can be 
seen by the amounts of sodium bicarbonate required. This 
was quite unlike our experience in the other groups of pigs 
already mentioned, where postvascularization acidosis was 
minimal and not progressive and sodium bicarbonate was 
not required. 
Clinically the xenotransplanted animals developed a 
shock-like syndrome with blotchy cyanosed skin , poor 
peripheral circulation and tachycardia which progressed 
until death. Unlike allografted pigs which wake up prompt-
ly and move around in the early postoperative phase, these 
animals remained inactive and lethargic. Even hepatec-
tomized pigs (unpublished data) and dogs" get up and 
walk around soon after the operative procedure. 
Histology provided dramatic evidence of early liver 
cell death. The pretransplant biopsy specimens and those 
taken during the period of cold ischaemia showed no 
significant histological differences (Fig. l ). During the 
first 20 minutes after vascularization the histological 
Fi,: . J. Centrilobular region of normal baboon donor liver 
before transplantation (H & E x 670). Experiment 4. 
changes were minimal and consisted of prominence of 
Kupffer cells due to acquisition of cytoplasm and a slight 
increase of polymorphonuclear leucocytes in the intralo-
bular sinusoidal capillaries. These changes were noted in 
pigs with autotransplanted livers as well (unpublished 
data). and no specific significance can be attached to 
them. However. during the following 10 minutes sinusoi-
dal congestion became evident, and intrasinusoidal poly-
morphonuclears were more frequent though they could not 
be regarded as numerous. Signs of liver cell damage also 
became manifest at this stage, presenting as fine non-lipid 
vacuolation of the cytoplasm of some liver cells. and as 
hyaline intracytoplasmic inclusions. Occasionally liver cells 
also showed nuclear pyknosis and cytoplasmic shrinkage 
which characterizes death of parenchymal cells <Fig. 2). 
Whereas cells showing cytological features of necrosis 
were barely present after 30 minutes, they were easily 
demonstrable after I hour. From l to 2 hours after vas-
cularization. a definite pattern emerged which did not vary 
in nature but increased in intensity with the prolongation 
of survival time, being most noticeable in the pigs that 
died between 5 and 10 hours after vascularization. The 
ultimate picture consisted of: (a) a notable degree of 
sinusoidal congestion and associated disintegration of 
capillary walls; (b) mild to moderate polymorphonuclcar 
Jeucocyte response confined to the sinusoidal lumina; 
(c) liver cell damage in its mildest form manifesting as 
cytoplasmic vacuolation and in its severest form as the 
nuclear pyknosis and cytoplasmic shrinkage of cellular 
death ; (d) dissociation of liver cells which became free. 
lying and no longer confined to the columns and trabccu-
lae of the normal lobule; and (e) disintegration of liver 
cells appearing as faintly stained cytoplasmic remnants 
lying within disrupted sinusoids or between degenerate and 
dead liver cells (Figs. 3 and 4). None of these changes 
affected the liver uniformly, but they were patchy in 
distribution with no constant lobular relationship, and 
varied in intensity from one area to another. While altered 
liver cells were easily recognizable in the final stages, it 
was also clear that the majority of cells showed no mor-
phological abnormalities. In two livers there was a mini-
mal degree of liver and Kupffer cell siderosis which had 
obviously anteceded the operation. Notably platelet or 
fibrin thrombi were not evident in the vascular channels. 
Classical signs of cellular rejection were not seen in any 
of the sections. 
Detailed postmortem examinations (see Table I) reveal-
ed little of note with the exception of the liver findings al-
ready mentioned. Moderate haemorrhage occurred in ex-
periments 1 and 5 only, and in the former it arose from 
i;ubcapsular haematomata in the traumatized liver. Even 
when Trasylol was omitted in the last two experiments 
no haemorrhage occurred. Additional factors contributing 
t0 death were collapse of the right lung in experiment 3, 
and thrombosis of the inferior vena cava in experiment 4. 
'.The regional lymph nodes all showed histological evidence 
of haemorrhage into the peripheral subcapsular sinuses; 
activation of the sinusoidal lining cells; intense polymor-
phonuclear leucocyte response in the sinuses; and evidence 
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Fig. 3. Baboon donor liver biopsy 3 hours after trans-
plantation. Advanced changes arc present which arc 
characterized by nuclear pyknosis and disintegration of 
liver cells, sinusoidal disruption and polymorphonuclear 
lcucocyte infiltration (H & E x 670). Experiment 4. 
Fig. 4. Baboon donor liver at autopsy 10 hours after 
transplantation. Signs of liver cell death are more obtrusive 
than in Fig. 3. In addition there is complete disruption of 
liver cell trabcculae with necrotic and degenerate liver 
cells lying free among red blood cells and polymor-
phonuclear Jeucocytes (H & E x 670). Experiment 4. 
of necrosis of lymphoid and reticular cells. Histological 
changes in other organs. such as the heart. lungs, kidneys 
and skeletal muscles were insignificant. 
Heterotopic Kidney Xenografts 
Five of the 6 kidney xenografts were observed for 
prolonged periods after vascularization and the sixth was 
left in situ and the pig's abdomen closed. On the fourth 
post-transplant day the kidney was removed for histology 
and was found to be autolysed. 
Unlike the liver. which remained macroscopically nor-
mal in most instances until the animars death, the kidneys 
became dark and blotchy in 8 - I:! minutes. and all the 
kidneys became pitch-black between 30 and 60 minutes. 
In only 1 of the 6 was there any urine flow, which was 
short-lived and contained a large amount of protein. Blood ' 
flow continued for about 30 minutes and stopped there-
after. 
As with the liver xenografts, the regular biopsies provi-
ded a clear picture of the morphological changes that 
occur in this kidney xenograft model. The pre-transplant 
biopsy specimen and that taken during the period of cold 
ischaemia showed no significant histological differences. 
After revascularization little change was noted for the 
first 10 minutes. At the end of this time amorphous, eosi-
nophilic, protein material became noticeable in the tubu-
lar Iumina. After 30 minutes this material became more 
abundant and small numbers of polymorphonuclear leuco-
cytes were noted in the peritubular capillaries and in those 
of the glomerular tufts. After 1 hour capillary congestion 
was pronounced, moderate numbers of polymorphonu-
clears occurred in the capillary lumina, proteinaceo~ 
material was abundant in the tubular lumina and the 
tubular epithelial cells showed commencing evidence of 
nuclear pyknosis indicative of cell death (Fig. S). Ter-
Fig. 5. Baboon donor kidney 1 hour after tr1msplantation. 
The glomcrular and pcritubular capillaries arc engorged 
with blood and the tubular lumina are filled with protein 
(H & E x 160). Experiment 5. 
minally these changes became more severe. While evi-
dence of tubular epithelial necrosis was observed, the most 
obtrusive and dominant changes were glomerular and 
peritubular capillary engorgement and protein precipita-
tion into the tubular lumina. No platelet or fibrin thrombi 
were noted in the vessels. As in liver xenografts, classical 
signs of cellular rejection were not seen in any of the 
sections. 
DISCUSSION 
Evidence is accumulating that early acute rejection occurs 
in kidneys transplanted across a major species barrier, and 
that this rejection is probably due to the presence of 
naturally-occurring heterospecific antibodies in the reci-
pient,"·" and that both humoral antibodies and comple-
ment are required as immunological effectors." Thus it is 
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not surprising that standard immunosuppression appears 
to be ineffective in preventing this acute rejection," but 
some prolongation of survival bas been obtained by re-
peated kidney grafts and by antigen pretreatment."·" The 
present study provides a clear picture of the morphologi-
cal changes that occur in the xenograft model of a baboon 
kidney transplanted into an unmodified pig, and will serve 
as a baseline for our future studies. 
Liver xenotransplantation, on the other hand, is a 
virtually unstudied field and the main aim of the kidney 
xenografts was to provide a control for the liver xeno-
graft experiments. Pig livers used for extracorporeal bepa-· 
tic assist in humans with liver failure have been demon-
strated to function satisfactorily for several hours in this 
xenograft model.•·" Calne et al.1' reported on 7 baboons 
with ortbotopic pig liver xenografts, some of which were 
on immunosuppressive regimens. These baboons survived 
for surprisingly long periods of time with pig liver xeno-
grafts and did not show the gross evidence of early organ 
death that would have been expected in a xenograft across 
a major species barrier. Three of these baboons survived 
for 30 hours or longer and one for 3t days. The main 
histological finding was centrilobular necrosis of hepato-
cytes, but in the long-term survivor the hepatocytcs were 
well preserved and there was mononuclear ·cell infiltration 
of the portal tracts. Gliedman et al." have demonstrated 
that blood flow through heterotopic pig liver xenografts 
in dogs rapidly ceases, whereas when the liver xenograft is 
obtained from the closely related fox, it functions for 
periods of up to 22 days. 
In the present study survival varied between 2 and 10 
hours after revascularization of the liver graft. The normal 
appearance of the livers was in marked contrast to the 
kidneys which became dull and blotchy after 8 - 12 minutes 
and pitch-black between 30 and 60 minutes. Histological 
changes in the liver bore little relation to the macroscopic 
appearance. Early signs of liver cell damage were manifest 
by 30 minutes. By 1 hour cytological evidence of liver 
cell necrosis was easily demonstrable, and increased in 
intensity with prolongation of survival. Classical signs of 
cellular rejection were not seen. 
Thus early acute rejection occurred in unmodified pigs 
with orthotopic baboon liver xenografts. The nature of 
this rejection suggests that it might be mediated by natur-
ally occurring heterospecific antibodies, although this as-
pect still remains to be investigated. The lack of early acute 
rejection in Caine's baboons with pig liver xenografts is 
somewhat surprising and one wonders whether the pig 
liver, which is so well tolerated as an allograft in the 
pig°·'·" ·" and as an extracorporeal xenograft hepatic assist 
in man,"'·" has some peculiar properties. This should pro-
vide a fruitful line for future research. 
All the animals in the present study were inactive and 
lethargic until death and demonstrated a progressive and 
marked metabolic acidosis, unlike the baboons reported 
by Caine et al." which woke up rapidly after the proce-
dure, and 4 of which were active and alert the day after 
operation. This inactivity and acidosis probably reflected 
liver cell death, rather than a non-functioning liver per se, 
as hepatectomized pigs wake up and walk around soon 
after the operative procedure (unpublished data). 
Trasylol was administered in the first 5 experiments 
because of the fear of a bleeding tendency in animals 
that were likely to have early acute rejection of their 
livers. However, bleeding was not a major problem, and 
so Trasylol was omitted in the last 2 experiments without 
a bleeding tendency developing. It is interesting that hae-
morrhage was a problem in the xenografts performed by 
Caine except where human fibrinogen was a~ministered.11 
Once again, this discrepancy is difficult to explain. 
The universal lack of sufficient suitable human liver 
donors to meet the increasing demand for liver transplanta-
tion makes a study of xenotransplantation imperative. The 
present study indicates the magnitude of the problem, and 
provides baseline information on liver xenotransplantation 
across a major species barrier. In this model it will be 
necessary to study means of overcoming early acute xeno-
graft rejection to determine if long-term xenograft function 
is feasible. 
SUMMARY 
Liver xenotransplantation is a virtually unstudied field, despite 
its potential importance, as there appear to be insufficient 
human liver donors to meet the demand for liver transplan-
tation. A detailed study of 7 unmodified pigs with orthotopic 
baboon liver xenotransplants is presented. The animals all 
died within hours and this has been attributed to acute xeno-
graft rejection. Although most of the livers appeared normal 
macroscopically, repeated biopsies revealed commencina 
morphological evidence of liver cell death within 30 minutes 
after revascularization. This increased in intensity in the en· 
suing hours and was associated with a progressive metabolic 
acidosis and failing circulation until death. A simultaneous 
study of unmodified pigs with baboon kidney xenografts which 
showed acute xenograft rejection is presented for comparison. 
This work was supported in the University of Cape Town 
by the Council for Scientific and Industrial Research of South 
Africa, the C. L Herman Bequest, the Barn Theatre Fund 
Raising Committee, and the Cape Provincial Administration. 
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HEAT HOMEOSTASIS DURING ANAESTHESIA. 
Inadvertent Hypothermia during Anaesthesia. 
Induced Hypothennia during Anaesthesia. 
' 
Brit. 1, Anaesth. (1960), 31, 60 
TEMPERATURE CHANGES IN CHil.DREN DURING GENERAL 
ANAESTHESIA 
BY 
G. G. HARRISON, A. B. BULL AND H. J. SCHMIDT 
The Department of Anaesthesia, University of Cape Town and the Red Cross War 
Memorial Children's Hospital, Cape Town 
THE state of anaesthesia depresses and renders 
inefficient the temperature regulating mechanisms 
of the body. Placed in conditions of high 
ambient temperature with which its deranged 
compensatory mechanisms cannot adequately 
cope, the body temperature of the anaesthetized 
patient has been shown to rise. This is especi-
ally so in children in whom· there arc the 
additional factors of small body mass, high 
internal heat production and immature heat 
regulatory mechanisms. The foregoing and the 
evil effects of hypcrpyrc:xia in the anaesthetic 
state-notably convulsions and death-arc well 
documented (Knight, 1942; Bigler and McQuis-
ton, 1951; Scarles and Lenahan, 1952; Clarke, 
Orkin and Rovcnstinc, 1954): 
The air-conditioning of operating theatres, as 
originally recommended bv Huntington in 1920 
(Scarles and Lenahan, 1952), is a logical solution 
to the problem of heat accumulation during 
anaesthesia and is now widely accepted in the 
normal design of operating theatres. There arc, 
however, no published observations on the body 
temperatures of subjects anaesthetized in such 
surroundings. 
The advent of halothane which appears to 
cause a more profound disturbance of the body 
beat regulatory mechanism than does ether, the 
agent most commonly used in the papers referred 
to, provided a further stimulus to this study. 
We report here on a statistical analysis of 
observations of body temperature made on 248 
infants and children undergoing general anaes-
thesia and surgery. The rectal temperature, 
which was recorded with a low reading mercury 
thermometer, was taken as the most reliable 
indication of body temperature (Machle and 
Hatch, 1947) and is used exclusively in this study. 
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CONDffiONS AND METHODS 
The operating theatre. 
The operating theatre in which these observa-
tions were made is air-conditioned. Air is 
passed into the theatre from central overhead 
louvres at a rate of 900 cubic feet per minute, 
passing out through louvres in the wall of the 
theatre. Humidity is controlled by "dcwpoint" 
control. The conditioning was set at 75 °F with 
relative humidity of 75 per cent. The actual 
theatre temperature was recorded in every case 
with a mercury dry bulb thermometer fixed to 
the theatre wall. Relative humidity was calcu-
lated from this and that recorded by a mercury 
wet bulb thermometer. The actual temperature 
and humidity did not vary widely from the limits 
of setting of the air condition automatic control 
Observations extended over both winter and 
summer. 
The drapes. 
The standard draping 
tions was as follows: 
of patients for opera-
Lower part 
of body 
Chest and arm 
Neonates: 
1 macintosh, 1 sheet. 
2 sheets. 
In addition to the above, 
neonates were insulated with 
rolls of cotton wool placed 
along their sides. 
The obseroations made. 
The following observations were made on each 
patient: 
Weight and length: 
From these the surface area was calculated, 
using the tables of Du Bois and Hannon 
(Du Bois, 1936). 
Age. 
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Pre-operative and postoperative temperatures : 
From these the change in temperature was 
calculated. 
Nature of the operation. 
Duration of operation and anaesthesia. 
Volume of blood replaced. 
Anaesthesia. 
(1) Halothanc group: 166 cases were anaes-
thetized with halothanc, nitrous oxide 
and oxygen. 
(2) Miscellaneous group : 82 cases were anaes-
thetized with nitrous oxide and oxygen 
and ether and/ or cyclopropane or tricblo-
rocthylenc. Of these the majority were 
given ether. In this group 17 cases had 
anaesthesia induced with halothane, 
administered for up to S minutes. 
The agents were administered by means of a 
modified T-piccc system with mask or endo-
tracheal tube, utilizing a high flow of fresh 
gases, 6 litres per minute. For thoracic and 
abdominal operations an I.P.P.R. technique was 
used; the adjuvant use of relaxant drugs, though 
necessary in the miscellaneous group, was seldom 
necessary in the halothane group. Thiopcntonc 
sodium was used for induction of anaesthesia in 
very few cases. 
Premedication. 
All cases with the exception of half of those in 
the miscellaneous group, who were given scopo-
lamine, were given atropine sulphate on a dose/ 
weight basis. In addition to this some of the 
patients were given pethidine or papaverctum 
also on a dose/weight basis. 
RESULTS 
The observations of change in the body tempera-
ture were submitted to statistical analysis in 
relation to the various factors recorded that 
would influence the body temperature. The 
results of such analysis arc submitted as 
histograms. 
General results. 
The range of age in our cases was from pre-
mature newborn to 11 years. The weight range 
in these cases was from 3 lb. 12 oz. to 96 lb. The 
range of duration of anaesthesia was from 20 
minutes to 360 minutes. 
Temperature. 
There was a mean fall of temperature in all 
cases as follows (sec figure I and table I). 
Halothanc group: Mean fall 2.1 °F (range : 
- 8.4°F to +2°F). 
. Miscellaneous group: Mca:i fall l 0F (range: 
- I0°F. to + 3 °F). 
The difference is statistically highly significant. 
Detailed Analysis of Temperature Change with 
Rela:ion to Various Influential Factors. 
Theatre temperature. 
The theatre temperature and humidity are the 
most important factors in causing a rise or fall 
of the temperature of the anaesthetized patient. 
We stress again that our theatre was air-con-
ditioned and, though the temperature recorded 
ranged from 63°F to 81 "F, the temperature in 
the majority of cases was between 71 "F and 
75°F. This is well within the range of ambient 












Mean fall in body temperature in 166 patients 
anaesthetized with halothane, compared with 82 
patients anaesthetized by other methods. 
TABU I (A) 
Mean change 
in temp. 
Anaesthetic degrees Fah. S.D. 
Halothane 
'Miscellaneous 
-2 · 1 1·90 
-1 · 1 2 ·58 
S.E. 








62 BRITISH JOURNAL OF ANAESTHESIA 







S.D. S.E. Number of cases 
Halo- Halo- Halo-









temperature at which loss of heat by radiation is 
highly efficient-Le. loss of heat by evaporation 
is of less importance to the body, and is well 
below the temperatures recorded by other obser-
vers at which heat accumulation with all its 
unpleasant scquelae occurs (Knight, 1942; Bigler 
and McQuiston, 1951; Scarles and Lenahan, 
1952; Clarke ct al., 1954). The results of an 
analysis of temperature change in . the patient in 
relation to theatre temperature are reflected in 
figure 2 and table IL There is an increased fall 
in patient temperature the lower the theatre 
temperature. The differences are significant only 
in the halothane group in our observations. 
A histogram is submitted for this group only. 
C.alculation of the correlation coefficient (0.4) 












Mean change in temperature with relation to theatre 
temperature. 
1."34 0·15 0·18 107 
3·65 0·30 0·68 59 
TABLE II 
Theatre Mean change 



















Because of the air conditioning, the range of 
humidity recorded in this series was relatively 
narrow, 65-87 per cent, with the majority falling 
in the range 71-75 per cent. In no case was the 
aaual wet bulb temperature above 75 "F, the 
temperature stressed by Clarke ct al. (1954) 
above which they most consistently observed 
heat accumulation. Bearing in mind the theatre 
temperatures recorded in our cases it is hardly 
surpr~sing that analysis of our cases revealed no 
relation between the temperature change in the 
patient and the relative humidity. 
Duration of anaesthesia. 
Analysis of temperature change in the patient 
in relation to duration of anaesthesia is illus-
trated in figures 1 and 3 and tables I and III. 
There is an increasing fall in temperature with 
the passage of time. This correlation is not linear, 
correlation coefficient - 0.4. With halothane 
especially there is a rapid initial drop in tem-
perature whereupon the temperature achieves a 
plat~u level, there being no statistical diff crcnce 
between the mean temperature change in the 
three arbitrary time groups up to 120 minutes. 
In operations extending beyond 120 minutes a 
further s:gnificant drop · in temperature is 
evident. This latter group, however, consists 
largely of "smaller" babies to which reference 
is made in the sections following. The diff erencc 
in fall in temperature between the halothane 
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group and that of the miscellaneous group is 
significant only for the period up to 60 minutes. 
Weight. 
Analysis of the change in temperature with 
relation to the weight of the patients (fig. 4 and 
table IV) reveals that there is a significantly 
greater fall in temperature in the infants and 
children who weigh less than 20 lb. than in those 
1·66 0•27 0·5 32 11 1·29 0· 18 0·20 15 42 1·53 0-26 1·8 41 23 4·2 0·64 0·28 18 6 
who exceed this weight. Whereas with these 
latter, the fall in temperature is signific:am:ly 
greater with halothane than in the miKel]aocous 
group, there is no significant differenc:c in the fall 
in temperature between the two groups in the 
infants who weigh less than 20 lb.' Calculation 
of the correlation coefficient (0.4) reveals no linear 
rclatlonsbip between fall in temperature and 
weight; 
4.1 
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Weight degrees Fah. S.D. S.E. Number of cases 
in lbs. 
Halo- Halo-
thane Misc. thane 
<10 -4·3 -5·6 2·19 
10-20 -2 ·2 -1·9 1•72 
20-30 -1 ·4 +0·2 1·50 
30-SO -1 ·2 -0·3 1·28 
>SO -1 ·6 -0·1 0·81 
Surface area. 
The greater cooling of the smaller infants is 
again bome out by calculation of the mean fall 
in temperature in relation to surface area ( see 
fig. 5 and table V). In this case the infants with 
a surface area of less than 0.3 sq.m cool to a 
significantly greater extent than those with a 
larger surface area. Again, in these latter, a 
plateau effect is evident. This lack of linear 
correlation is confirmed by a correlation coeffi-
cient of 0.4. 
As it is thought that the degree of temperature 
change is influenced more by the ratio the mass 
Halo- Halo-
Misc. thane Misc. thane Misc. 
3· 18 0·39 1·13 32 8 
3.50 0·30 1·0S 32 11 
2•27 0·25 O·S8 38 15 
1•17 0·20 0·21 42 29 
1·12 0•17 0·25 22 19 
of the child bears to its surface area than to 
these two factors separately, the cases were 
analyzed for temperature change in relation to 
the ratio surface area/weight. This analysis, 
however, revealed nothing not apparent in the 
foregoing analysis and is consequently not 
submitted. 
Duration of anaesthesia and weight of inf ant. 
The relation of the temperature change to the 
duration of the anaesthetic and to the size of the 
infant elicited in the foregoing analyses is further 
amplified when the observations of change in 
4.1 












Mean change in temperature with relation to surface 
area. 
TABLE V 
Surface Mean change Number 
area in in temp. of 
sq. metres degrees Fah. S.D. S.E. cases 
0·15-0·3 -4-0 2·09 0·32 43 
0·3 -0·6 -1 ·5 1·60 0·22 54 
0,6 -1·2 -1·4 l •14 0·16 69 
temperature are broken down to reflect both 
these factors simultaneously (see fig. 6 and 
table VI). In this analysis the cases are divided 
as follows: 
(1) Children weighing less than 20 lb. 
(2) Children weighing more than 20 lb. 
These groups are then subdivided on the basis 
of the duration of anaesthesia: (a) anaesthesia of 
·a duration less than 60 minutes; (b) anaesthesia 
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6'a ( 20 LBS 
-6·0 
FIG. 6 
Mean change in temperature with relation to time 
and weight 
TABLE VI 
Mean change in 
temp. degrees Fah. S.D. S.E. Number of cases Time in minutes 
<20 lbs. >20 lbs. <20 lbs. >20 lbs. <20 lbs. >20 lbs. <20 lbs. >20 lbs. 
Halothane -2·5 -1·2 1·9 1·30 0-27 0 ·16 39 68 
<60 
Misc. -1·5 +0·1 1·7 0-98 0-SO 0,15 12 42 
Halothane -4·3 -1·8 2·6 1·24 0-49 0·22 28 31 
>60 
Misc. -6·8 -0·9 4· 12 __ 2·04 1·6'0 0·45 7 21 
.of.I 
66 
apparent that, regardless of the anaesthetic, not 
only do the smaller infants have a greater fall in 
temperature than the larger, but this fall is 
progressively greater with increased duration of 
anaesthesia. The use of halothane produces a 
significantly greater fall in temperature in the 
larger children than occurs in these children in 
the misccllancous group. 
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Site of operation. 
On the site of operation depends the encnt to 
which the patient is exposed. Analysis of our 
observations of change of temperature with re-
lation to the site of operation reveals an increased 
fall in temperature with increased exposure of the 
child particularly of viscera as occurs in abdo-
































degrees Fah. S.D. S.E. Number of cases 
-0·8 1·13 0·18 38 
-2·0 1•17 0·18 42 
Thoracic and 
abdominal -2·7 1 ·97 0·21 8S 
Extra 
abdominal -0·4 2·29 0·37 38 
Abdominal -1·5 2·69 0·40 44 
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Pre-operative temperature. 
Bearing in mind the possible part pre-operative 
pyrcxia plays in the production of hyperthcrmia 
and "ether convulsions" we analyzed our 
observations of change in temperature during 
operation in relation to the patient's pre-opcra-
tivc temperature. This latter we arbittarily 
divided into three groups as follows : 
(1) Less than 98°F-hypothcrmic. 
(2) 98° and 99°F-normothermic. 
(3) l00°F and ovcr-pyrcxial. 
Figure 8 and table VIII show that, under the 
conditions of theatre temperature and humidity 
described, the pre-operative temperature of the 
patient had no effect on the mean change in 
temperature which was nevertheless a fall. 
(Though there is a difference of l 0F between 
the hypothcrmic group and the others, this is 
not quite statistically significant.) . 
Blood replacement. 
The transfusion i:ito the patient of cold blood 
can be expected to lower the patient's body 
temperature. Analysis of our cases on this basis 
confirms this (see fig. 9 and table IX). The mean 














operation Mean change Number temp. in temp. of degrees Fah. degrees Fah. S.D. S.E. cases 
<98 -2·9 2·78 O·SO 31 
98 & 99 -1·9 l •76 0-17 103 




Nil -1·5 1•70 0 ·17 10S 
Blood 
replaced -3·1 2 ·18 0·29 S6 
fall in temperature is l.6°F greater in those cases 
that had a blood transfusion than in those that 
did not. It must be pointed out, however, that 
those patients who received blood were, by and 
· 1argc, the smaller babies having prolonged 
operations-two factors which of themselves 
cause a fall in temperature in our cases. 
Neonates. 
In this series there were 16 neonates. All except 
one were anaesthetized with halothanc, nitrous 
oxide and oxygen. Duration of anaesthesia in 11 
of these cases was longer than 120 minutes, and 
in the remaining 5 duration of anaesthesia was 
from 60 to 120 minutes. 
In addition to the standard draping desaibcd, 
5 of these little patients were placed OD the 
operating table on hot-water bottles containing 
water at 101°F. Whereas in the 11 not so treated 
the mean fall in temperature was 5.9°F (S.D. 2.3, 
S.E. 0.69), that in the 5 placed OD hot-water 
bottles was 3.2°F (S.D. 2.9, S.E. 1.6). The mean 
end anaesthetic temperature of the two groups 
was 89.6°F and 93.S"F respectively. We are of 
the opinion that though some fall in temperature 
is in all probability beneficial during anaesthesia, 
neonatal temperatures ought to be monitored as 
the fall is often precipitous and falls of 6°F to 
8 °F arc not uncommon. The temperature should 
not be permitted to fall below 90°F. One of our 
cases in whom the temperature dropped to 
84 °F developed hypothcrmic apnoea, respiration 
only being resumed on warming. A further danger 
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of extreme falls in temperature 1s the possible 
onset of sclerema (Re:s, 1958). 
SUMMARY 
We report here on a statistical analysis of 
observations of body temperature made on 248 
infants and children undergoing general anaes-
thesia and surgery. These observations were made 
in an air-conditioned operating theatre. 
There was a mean fall in temperature during 
general anaesthesia. This was 2.1 °F in the 
group of cases anaesthetized with halothane and 
1 °F in a group anaesthetized with other anaes-
thetics. 
The benefit of the air conditioning of the 
operating theatre is stressed. Over the observed 
range of theatre temperatures there was a posi-
tive relation between this and the patient's 
change in temperature. In this. r.angc of theatre 
temperature the comparatively narrow range of 
relative humidity observed had no bearing on 
the change in temperature of the patient. 
Small infants (less than 20 lb.) cool to a signi-
ficantly greater extent than the larger and this 
fall is progressive with time. The larger infants 
(more than 20 lb.) after an initial rapid fall in 
temperature (especially with the use of halothane), 
attain a relatively static temperature. Similar 
conclusions follow an analysis of the fall in 
temperature in relation to the patient's surface 
area. 
The fall in temperature is related to the site 
of operation : the greater the exposure, especi-
ally of viscera, the greater the fall in temperature. 
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The presence of pyrexia before operation had 
no bearing on the change in temperature during 
anaesthesia. 
The transfusion of blood led to an increased 
fall in temperature. 
The mean fall in temperature in neonates was 
5.9°F. When hot-water bottles at 101 °F were 
placed under the patient, the mean fall was 
3.2°F. 
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Method for the Safe and Rapid Pretransfusion 
Warming of Stored Blood: 
An In Vitro and In Vivo Evaluation of a 
Radiofrequency (RF) Instrument 
G.G. Harrison, A.R. Bird, P. Jacobs, P. Coghlan, M.J. Byrne, J. Ozlnsky, 
and J.L. Bessellng 
Departments of Anaesthesia (G.G.H., J.0.), Haematology (P.J., A.R.B.), Nuclear Medicine 
(M.J.B.), and Electrics/ Engineering (J.L.B.), University of Cape Town and Groote Schuur 
Hospital, and Western Province Blood Transfusion Service (P.C.), Cape Town, South Africa 
Inadvenent hypothermia due to massive infusion of stored blood can be prevented by pretransfusion wanning. One 
approach is the heating of individual packs by means of electromagnetic conduction, which is a method safely 
used over the last 25 years. The prototype instrument, which has now been re-engineered, can effectively raise the 
temperature of a unit of blood to approximately 33°C in less than 3 minutes. Using this new model, we found, in 
vitto, a modest increase in free plasma haemoglobin, but this was not accompanied by any change in potaSsium 
or lactic dehydrogenase levels and the mean red cell fragility was unaltered. In vivo, the survival of autologous 
red cells that had been stored for 33 days and then infused as a concentrate, having a mean baematocrit of 0.60, 
was measured at 24 hours and 21 days. Each donor acted as his own conttol. In paired studies, pretransfusion 
radiofrequency heating was shown to have no deleterious effect when compared to measurements using the un-
wanned blood pack. It is concluded that this method can be recommended as safe. Cl 1992 Wiley-Liss, Inc. 
Key words: hypothermia, large volumes, red cell survival, tramfusion 
INTRODUCTION 
Inadvertent hypothermia, a major hazard of rapid or 
massive transfusion defined as greater than 1.5 mL/kg/ 
minute, can be prevented by pretransfusion warming of 
the blood (1,2). This can be achieved by direct heat 
exchange systems applied to the transfusion line or, al-
ternatively, by warming the unit using electromagnetic 
radiation in both the radio (RF) and microwave frequen-
cies [3,4) . The original Taurus 300 (Plessey, Cape 
Town, South Africa) utilised a 27 MHz RF energy 
source (5). Initially designed to heat blood that was 
stored in bottles, subsequent modifications accommo-
dated polyvinylchloride (PVC) bags (6,7] and these in-
struments have been used safely for a quarter of a century 
in South African hospitals. Advancing technology and 
employment of red cell concentrates rather than whole 
blood, on which the safety of RF heating and its influ-
ence on erythrocyte integrity had originally been tested 
(5, 7,8), have led to the introduction of a re-engineered 
system designated the Taurus 301 (CMEI, Cape Town, 
South Africa). Concern has been expressed that when 
individual units of blood are warmed by energy transfer-
ence from an electromagnetic beam, erythrocyte damage 
may result from either radiation or hot spot formation 
due to uneven heating of the PVC containers, resulting 
© 1992 Wiley-Liss, Inc. 
in haemolysis (9-11). or less obvious lesions, demon-
strable only by shortening of erythrocyte survival follow-
ing transfusion [8,12). 
We report details of the new design and operation 
of this instrument, together with in vitro and in vivo 
comparisons between RF heated and unwarmed autolo-
gous red cells in paired studies and where each donor 
acts as his own control in the in vivo part of the study. 
INSTRUMENT DESIGN AND OPERATION 
The individual PVC bags of blood are heated by 350 
watts generated by a 27 MHz current from a power oscil-
lator in a tuned circuit. The resistance of the PVC bagged 
blood, evenly compressed between heavy copper plates, 
is 2-3 ohms. With approximately 80 watts dielectric loss 
in the PVC bag wall, a uniform temperature of 33°C is 
reached in less than 3 minutes. 
Technically, the bag of blood is suspended on the 
inside of the door (Fig. 1) which, when closed, simulta-
Received for publication July 3, 1990; accepted February 3, 1992. 
Address reprint requests to Peter Jacobs, Department of Haematology, 
University of Cape Town Medical School, Anzio Road, Observatory 
7925, Cape, South Africa. 
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Fig . I . Diagram of blood wanner. The instrument weighs 30 kg . 
has external dimensions of 360 x 360 x 460 mm. and requires 800 
wans power for operation. 
neously compresses the contents between two copper 
plates and activates the heating cycle. Hot spot formation 
during heating is prevented by a rocking action of the 
copper plates at 0.5 Hz, so that the compressed blood 
unit rotates slowly in the forward direction but rapidly 
on return . Studies using a floccular suspension in 0.5% 
saline have shown that this mode of agitation ensures 
unidirectional flow of the contents within the bag rather 
than simple oscillation. 
A thermistor. which indents the bag, is set in the 
middle of the doorside plate (Fig. 1) and monitors the 
temperature of the contents , while a transverse ridge 
which is raised on the same plate indents the bag, thereby 
ensuring that the centre of particulate rotation is not on 
the same axis as the thermistor. 
A comparator detects a bridge circuit point, set at 
33°C, and terminates heating simultaneously with activa-
tion of auditory and visual alarms, which are cancelled 
only when the door is opened to remove the warmed unit 
of blood. Fail-safe devices (see Appendix A) inactivate 
the warmer if agitation ceases , the thermistor breaks , or 
the temperature exceeds 40°C. In addition, LEDs are 
mounted on the outside aspect of the door, showing 
green at 25°C. green at 33°C, and red at 40°C. 
BLOOD COLLECTION AND INSTRUMENT 
PERFORMANCE 
Thirty-nine units of whole blood anticoagulated with 
citrate phosphate dextrose (CPD), each having a vol-
ume between 475 and 550 mL, and 21 units of red cells 
suspended in ADSQLI! (Baxter Travenol Laboratories , 
A Safe Electromagnetic Blood Warmer 13 
Deerfield, IL), having a volume of 360 mL, a haemato-
crit of 0.6 LIL. and stored in PVC bags under standard 
blood bank conditions [ 13] for varying periods, were 
allocated to this study and not subsequently transfused 
into patients . These conditions accurately reflected stan-
dard practice, thereby permitting extrapolation of all 
measurements to the clinical situation. 
Characterisation of the physical performance of the 
blood warmer included, first, a manual check on the 
speed of warming, which was recorded from the time of 
door closure to electronic switch-off and, second, the 
temperature of the contents using a mercury-in-glass 
thermometer enfolded in the unit for I minute imme-
diately after its removal from the warmer [8] . It was 
established that this technique exactly matched direct 
measurement of the temperature by immersion in the 
contents over a relevant range . 
In Vitro Assessment of Red Cell Damage 
A series of tests was selected to reflect possible RF 
damage to cells . Thus , erythrocytic integrity was deter-
mined by comparing pre- and post-warming changes in 
free plasma haemoglobin [ 14] , plasma lactic dehydroge-
nase [15], plasma potassium (Beckman Astra TM So-
dium Potassium Chemistry Module), and saline osmotic 
corpuscular fragility , including a measurement 24 hours 
after incubation at 37°C [16] . 
In Vivo Red Cell Survival Studies 
The effect of radiofrequency heating was determined 
in 12 healthy male volunteers, with a mean age of 36 
years (range 29-54). In a randomised design, each sub-
ject acted as his own control for comparison of red cell 
survival at 24 hours and 21 days , using 51 Cr as the label. 
In expressing the results the 100% survival value was 
calculated from a simultaneous estimate of red cell vol-
ume, using 99ffl-J'c . The comparison was made between 
unwarmed and heated red cells which had been stored 
under identical conditions. 
Participants fulfilled the donor standards of the Ameri-
can Association of Blood Banks [13], and had normal 
full blood count and body iron stores, as defined by 
serum iron, percentage saturation of transferrin and ferri-
tin levels [ 17]. The protocol was approved by the Uni-
versity of Cape Town and Groote Schuur Hospital Ethics 
and Research Committee and informed consent was a 
prerequisite . 
In phase I of the study 480 mL of blood was collected 
into a triple PVC bag system (Baxter Travenol Labora-
tories , Deerfield, IL). The collection bag contained 70 
mL citrate-phosphate-dextrose anticoagulant and the first 
satellite bag contained 111 mL of an adenine-containing 
red blood cell preservative solution (ADSOL®; Baxter 
Travenol Laboratories , Deerfield, IL). Each unit was 
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processed within 6 hours into a red blood cell concen-
trate, with a mean final haematocrit of 0.6L/L = 5% , 
which was then stored at 4°C ± 2°C for 31 to 35 days 
without mixing. These storage times were selected to lie 
near the end of the permissible limits so that any degree 
of damage , however small, would be evident. 
In phase 2 of the study half of the stored units were 
randomly assigned to warming in the Taurus 301 unit 
and the remaining 6 were not warmed. A IO mL aliquot 
of blood was carefully removed from each unit, labeled 
with I.I MBq (30 µCi) 51 Cr, and then injected into the 
donor to determine red cell survival. Simultaneously, 5 
mL of fresh blood was taken from the donor and labeled 
with 11 .1 MBq (300 µCi) 9'hn-J'c, using a pretinning 
method (18) (Cadema Medical Products, Inc., New 
York) . The cells were washed twice in saline to ensure 
that free radiolabel was Jess than 1 % and then reinjected 
to establish red cell mass. 
Four samples were drawn from an indwelling catheter 
in the contralateral arm at elapsed times of 5, 8, 12, and 
.15 minutes; further specimens were collected at 24 
hours, 7, 14, and 21 days . 
Radioactivity was detected in a gamma spectrometer 
(Minaxi Autogamma®5000 Series Gamma Counter; 
Packard Instruments Co. , Downers Grove, IL). There 
was automatic correction for 9'hn-J'c decay during count-
ing. based on a physical half-life of 6.03 hours . Since 
the spill-over from the Compton peak of the 51Cr into 
the 99mTc window was less than 0.3%, this was ignored. 
Technetium blood activity , expressed in counts/minute/ 
mL, was corrected to a reference haematocrit derived 
from the mean of the original four samples collected in 
the 5 to 15 minute interval after re-injection, and red cell 
mass was determined according to recommendations of 
the International Committee for Standardization in He-
matology (19) . The whole blood zero-time activity was 
obtained by linear extrapolation of a semi-log plot of this 
blood radioactivity against time in minutes , using a least 
squares regression method. 
Red cell survi.val at 24 hours and 21 days was calcu-
lated according to the International Committee for Stan-
dardization in Hematology (20), using a similar extrapo-
lation of radiochromium activity in whole blood to zero 
time . Elution correction factors were applied to both the 
24-hour and 21-dav survival studies [21). Immediate loss 
was estimated by :stablishing apparent 51Cr red cell mass 
and comparing this with the 9'hn-J'c as follows: 




= I - s1crRCV x 100. 
In phase 3 of the study the donors were retested 
shortly after 90 days following the first infusion; those 
whose units were prewarrned now received unheated au-
tologous blood, and vice versa. 
STATISTICAL ANALYSIS 
The statistical significance of differences between 
control and experimental observations was tested by Stu-
dent's t test-that for unpaired variables for the in vitro 
tests and for paired variables for the in vivo tests . For 
the latter, because of the small numbers, differences 
were also tested by the Wilcoxon matched-pairs signed-
ranks test. 
RESULTS 
No electronic or mechanical malfunction occurred 
during these studies . The physical response to RF heat-
ing of whole blood and red cell concentrates differed. 
The mean switch-off temperatures of 31.5°C ( = SEM 
0.29°C) and 30.5°C (= SEM 0.39°C) (P < .05) were 
associated with corresponding wanning times of 2 min-
utes 32 seconds ( = SEM 31" as opposed to I minute 44 
seconds (= SEM 4") (P < .001). No attempt was made 
to readjust the set comparator end-point once the trial 
had commenced. 
In Vitro Indices of Red Blood Cell Damage 
(Table I) 
For both whole blood and ADSOL® red cell concen-
trates the only significant abnormality following warm-
ing was an increase in plasma free haemoglobin of I 7 .5 
mg/dL and 44.8 mg/dL, respectively. Proportionate to 
their prewanned levels, these increases in free haemo-
globin-whole blood 40%, RBC concentrate 44%-are 
similar (P = . 7 4). There was no correlation between the 
length of storage and the degree of haemolysis induced 
by RF warming, either in whole blood (r = -0.15; 
P> .l)orRBCconcentrate(r = -0.18;P> .1) . 
These changes were not accompanied by increase in 
plasma potassium, LDH. or mean red cell fragility . 
In Vivo Post-Transfusion Red Blood Cell Survival 
(Table II) 
Two donors were excluded from the 24-hour in vivo 
study; in one there was an incomplete re-injection and 
in the other a 24-hour sample was inadvertently not col-
lected . Two exclusions also occurred in the 21-day study 
for similar reasons . No adverse reactions to the transfu-
sions were experienced. The mean storage time of 32 
days for unwarmed blood was not significantly different 
from the 33 days for the bags that were subsequently 
heated (P > .05). Following autologous transfusion 
there was no statistically significant difference in red cell 
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TABLE I. In Vitro Indices of Red Blood Cell Damage• 
Storage times = SEM (days) 
Whole blood (n = 39); JO = 0.96 Red cell concentrate (ADSOL~) (n = 21); 
(range 1-19) 15 = 3.26 (range 1-30) 
Before After 
Index of red cell damage warming warming 
Free plasma haemoglobin (mg'k) 53 .8 71.4 
= SEM 3.27 4.97 
K+ (mmol/L) 11.7 11.7 
= SEM 0.75 0.75 
Lactic dehydrogenase (IU/L) 497 518 
:= SEM 36 39 
MCF % saline 
immediate 0.52 0.52 
= SEM 0.007 0.007 
Post 24-hour storage 0.55 0.55 
:= SEM 0.004 0.004 
*MCF = mean corpuscular fragility; NS = nonsignificant. 
survival after 24 hours or at 21 days between the RF 
heated units and their unwanned controls. 
DISCUSSION 
No mechanical or electronic malfunction of the re-
engineered RF blood wanner was observed during these 
studies. The marginally shorter warming time displayed 
by the RBC concentrate compared to whole blood in 
response to RF wanning has been documented previ-
ously and is considered to reflect differences in haemato-
crit [7] and electrical conductivity [22] between whole 
blood and RBC suspensions rather than any differences 
in bag volume. The discrepancy observed between the 
end-warming temperature and that set for termination of 
the machine cycle resulted from the temperature sensing 
thermistor being influenced by heat retention in the cop-
per plates, which is an effect exacerbated by serial use. 
Subsequent to the conclusion of the trial this deficiency 
was corrected by modifying the design to include an 
additional thermistor dedicated to sensing and then acti-
TABLE II. In Vivo Post-Transfusion Red Blood Cell Survivalt 
Red blood cell survival Unwarmed. % Warmed. 'k Change 
Immediate loss (n = 12) 4 .3 5.5 NS• 
= SEM 0.9 1.0 
24 hour (n = !O l 75.7 71. I NS• 
= SEM 2.5 3.5 
21 day (n = 10) 62 .2 58 .8 NS* 
= SEM 2.6 2.7 
t Crossover trial : 12 volunteers . Storage time: 30-33 days . 
• Student's ·f and Wilcoxon matched-pairs signed-ranks tests. NS = 
nonsignificant. 
Before After 
Change warming warming Change 
P < .01 103 .3 148.8 P < .05 
IO.I 18.9 
NS 24.4 24.8 NS 
2.9 2.9 




vating mechanisms to compensate for the ambient plate 
temperature. 
Comparison of in vitro indices for red cell damage in 
these two products showed no difference. In both, the 
modest rise in supernatant free haemoglobin was the only 
evidence of in vitro red cell damage that followed warm-
ing. Surprisingly, this was not accompanied by increase 
in serum potassium or lactic dehydrogenase nor by 
changes in the mean corpuscular fragility, and no expla-
nation is evident for these discrepancies . In the context 
of rapid and massive blood transfusion, the magnitude 
of this increase in free haemoglobin was no greater than 
that observed following pressurised infusion [23] or in 
association with cardiopulmonary bypass [24,25]. 
In addition, the radiofrequency heating of red cell 
concentrate caused no significant change in red cell sur-
vival following autologous transfusion at 24 hours or 21 
days (Table II) . As pretransfusion warming of blood is 
essentially undertaken in an emergency situation, the 
mean red cell recovery of greater than 70% at 24 hours 
is acceptable since this is the level above which red cells 
are conventionally regarded as fit for transfusion [26] . 
The validity of these studies depends upon reliable 
methodology for determining in vivo red cell survival 
[27-30] . Although the use of double radiolabeling with 
indirect calculation of red cell mass has been proposed 
[30-31), direct quantitation of red cell mass using 99rrrfc 
is probably preferable since it eliminates inaccuracies 
inherent in making this estimation indirectly from calcu-
lations on the plasma volume [29]. Our experience is 
that the direct quantitation method is only slightly more 
technically complex than the indirect approach. 
The temperature setting of the wanner's switchoff at 
33°C resulted in mean and ranges of temperature within 
.t.2 
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individual blood packs well below the known heat toler-
ance for blood [32,33] , yet achieved a level which would 
be compatible with the maintenance of safe body temper-
ature [3] . 
It is concluded that this re-engineered radiofrequency 
blood warmer is an efficient and safe means of raising 
the temperature of stored blood to levels where massive 
or rapid transfusion can be safely undertaken. The avail-
ability of this instrument provides a practical alternative 
to in-line warmers. most of which are recognised as be-
ing inadequate for the type of rapid transfusion systems 
available , although counter-current warmers can be em-
ployed in a rather more complex system for rapid mas-
sive transfusions [34] . 
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APPENDIX A 
Safeguards and Failsafe Devices 
1 . A damaged thermistor temperature sensor can be 
an open circuit or a short circuit. These extremes are 
detected and the unit is automatically switched off. 
..f.2 
2. Apart from the detection of the 33°C end-point, a 
back-up detection will be activated at 40°C, terminate 
the heating, and bring on a red LED and an alarm. 
3. The presence of an acceptable bag is detected me-
chanically by a microswitch which turns on the heater 
supply of the oscillator valve, the detection electronics, 
and agitation motor power supply. 
4. The final door closure is detected by a second mi-
A Safe Electromagnetic Blood Warmer 17 
croswitch, which allows the high voltage supply to be 
applied to the oscillator valve provided the temperature 
detection circuits and shake detector agree. 
5 . The "shake detector" is a magnetic recd switch 
activated by the magnet swinging up to it if the agitation 
is normal. If more than three successive pulses are 
missed, the heating is switching off and the alarm is 
activated. 
4.2 
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Single-dose relative biological effectiveness and toxicity 
studies under conditions of hypothermia and hyperbaric 
oxygen 
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ABSTRACT 
An approach to using hyperbaric oxygen with radiation in a 
chnical sit~ation has . been described in the preceding paper in 
this ~ssue. !' o ascertain whether there might be a change in the 
relative b1olog1cal effectiveness of radiation on normal 
mammalian tissue treated under conditions of hypothermia 
an_d hyperbari~ oxygen .. the acute reaction to radiation of pig 
skin was studied. A single dose enhancement ratio at the 
erythema reaction level of 1.4±0.0R was obtained when 
compared with irradiation at normal body temperature in air. 
We studied also a series of antioxidant enzymes in rat liver and 
lung after exposure to hypothermia and hyperbaric oxygen. 
Enzyme changes were such as to combat oxygen toxicity which 
might develop as a result of the pre-treatment. 
In order to ascertain whether there is a change in the 
radiobiological effectiveness of radiation on normal 
mammalian tissue treated under hypothermia and 
hyperbaric oxygen (Sealy et al, I 986), we studied the 
acute radiation reaction on pig skin. This was chosen as 
our biological test system since it has been extensively 
used .in RBE determinations (e.g. Fowler, 1981) and 
results can be extrapolated to the human with a high 
degree of confidence (Hall, 1978). In addition, drug 
administration regimes similar to those that were 
envisaged to be used on humans could be put into effect 
(Sealy et al. 1986). 
Secondly. concern for the possibility of oxygen 
toxicity developing in patients as a result of the 
hypothermic hyperbaric oxygenation (Sealy et al, 1986) 
prompted a search for biochemical evidence of oxygen 
toxicitv . 
The· biochemical probes chosen were the activities of 
rat lung and rat liver superoxide dismutase, catalase, 
glutathione reductase. glutathione peroxidase, and also 
glucose-6-phosphate dehydrogenase. since the activity 
of this enzyme has been shown to be increased on 
exposure to hyperoxia (Tierney et al, 1973). 
Glutathione levels were also investigated. 
Address for correspondence: E. R. Hering. Department of 
Medical Physics. Groote Schuur Hospital, 7925 Observatory, 
Cape Town. South Africa. 
METHODS 
Pigs 
Pigs of the Large White/Landrace cross variety were 
u~ed, weighing between 50 kg and 60 kg. In total, 
nme pigs (three sets of three litter mates) were used in 
the investigation. Every pig. was irradiated to one or 
more dose levels under each of the following conditions: 
(a) in air at normal body temperature (range 
34.5-36.5°C); 
(b) in hyperbaric oxygen (3 atmospheres absolute) at 
_norn:ial body temperature (range 34.5-36.5°C); 
(c) m air at hypothermic body temperature (range 
28-31°C); 
(d) in hyperbaric oxygen at a hypothermic body 
temperature (range 28-31 °C). 
Anaesthesia, cooling and profound vasodilatation in 
the pigs was achieved in essentially the same manner as 
that described by Sealy et al (1986) for patients. 
Experimental animals, to which balanced salt solution 
and drugs were administered via jugular venous 
cannulation, were anaesthetised by Alfathesin 
(alphazalone and alphadalone compound, Glaxo) or 
Hypnomidate (etomidate, Janssen) by continuous 
infusion, curarised with Alloferin (alcuronium chloride, 
Roche) and intubated, ventilated by means of a Vickers 
fluid logic ventilator and subjected to alpha-adrenergic 
blockade with Regitine (phentolomine, Ciba-Geigy). 
Hypothermia was induced by surface cooling with ice 
packs, care being taken not to cover the areas to be 
irradiated. Rewarming was achieved by immersion of 
the animal in water at approximately 40°C. The 
temperature of the animal was measured on the skin 
near the irradiated area and in the oesophagus using 
thermistor probes with a Vickers thermometer. 
Irradiation of pig skin. Irradiations were carried out 
inside a single-patient hyperbaric oxygen chamber 
(Vickers Mark IV). Eight fields, each 5 cm x 5 cm, were 
marked by tattooing, four on the right hindquarter and 
four on the right forequarter of each pig with at least 
3 cm between each field . Each field was treated to a 
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Moist desquamation of less than half of the 
irradiated area 
Moist dcsquamation of more than half of the 
irradiated area 
Eight-megavolt X rays from a Philips SL 75120 linear 
accelerator were used with 2 cm tissue-equivalent 
polystyrene build-up. In order to prevent any hypoxia 
occurring due to pressure, the polystyrene plate was 
suspended immediately above the surface of the skin. 
The animals were irradiated with a vertical beam whilst 
lying on the left side inside the hyperbaric oxygen 
cylinder. The doses were measured using a Baldwin-
F armer ionisation chamber and LiF thermoluminescent 
dosemeters. The dose rate at the ·skin surface was 
1.736 Gy/min. 
Skin scoring. The method of estimating the skin 
reactions was that of visual observations carried out on 
Mondays. Wednesdays and Fridays by three to five 
observers who were unaware of how each area had been 
irradiated. An arbitrary scale was adopted based on 
that used by Fowler et al (1963) (Table I). 
Rats 
Male Long-Evans rats, weighing between 250 g and 
270 g. were used. Rats were maintained on a standard 
laboratory diet and allowed food and water ad libitum. 
Animals were divided randomly into four groups of six 
rats. One group of rats served as controls and received 
no treatment. The second group of rats (the "hyper-
baric" group) was exposed for 4 h to 100% oxygen at 
303 kPa. The third group was treated intraperitoneally 
with 70 mg/kg sodium pentobarbital (Sagatal, May and 
----« IN AIR Normal body temperature 005£• 23Gy 
Baker) to induce hypothermia (Pallavicini & Hill, 1983). 
The fourth group of rats (the hypothermic hypcrbaric 
oxygen group) received 70 mg/kg sodium pentobarbital 
intraperitoneally, immediately following which they 
were placed in 100% oxygen at 303 kPa for 4 h. 
Exposures to hyperbaric oxygen were conducted in a 
Vickers Mark IV single-patient hyperbaric oxygen 
chamber. Temperature was measured in both the 
hypothermic group and the hypothermic hypcrbaric 
oxygen group with an Electrolaboratoriet monitor by 
means of thermocouples placed under the skin in the 
abdominal area. The animals in the hypothermic group 
and in the hypothermic hyperbaric oxygen group were 
plac~ i~ cages positioned on plastic bags containing 
meltmg ice immediately after injection of the sodium 
pentobarbital. It was found that the temperature in 
both groups treated with sodium pentobarbital 
decreased from 36°C to a minimum of 29°C. 
Tissue preparation and measurement of biochemical 
parameters. Rats were sacrificed by cervical dislocation 
24 h after commencement of the treatments above. the 
lungs and livers being removed and used immcdiatelv. 
Cytosol Cu/Zn superoxide dismutase was extracted by 
the method of McCord and Fridovich (1969) as 
modified by Sykes et al (1978), and assayed by 
followmg the auto-oxidation of epinephrine to adreno-
chrome (Misra & Fridovich, 1972). Determination of 
glucose-6-phosphate dehydrogenase was by the method 
of Lohr and Waller (1963). Catalase was determined bv 
the method of Holmes and Masters (1970), glutathion~ 
by the method of Saville (1958), glutathione peroxidase 
by th~ method of Lawrence and Burk ( 1976). 
glutath1one reductase by the method of Worthington 
and Rosemeyer (1974) and protein as described by 
Lowry et al (1951). 
The significance of differences between mean values 
for the groups was assessed by Student's t-test. 
REsULTS 
Figure I shows the variation of the average skin 
reaction with time for a single pig irradiated to 23 Gy 
- IN HB02 Normal body temperature 
-- IN AIR HYPOTHEAMIC 
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FtG. I. 
Acute radiation responses for pig skin 
under the four conditions. End-point 
represents the average score for all scorers 
for two fields. Note the increased reaction 
for those areas irradiated in oxygen and 
the curve suggesting a triphasic response. 
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FIG. 2. 
The mean early skin reaction for various doses in nine pigs. 
Data points are given together with standard errors of the 
means. Not all error bars are shown in order to preserve 
clarity . 
under the various conditions. In general, an early wave 
of reaction reaching a peak at about 25 days after 
irradiation was observed. followed by a slight decrease 
in reaction to a more or less constant, slightly lower 
level. At about 50 days after irradiation the reaction 
increased again in intensity. This reaction pattern is 
similar to that observed by Fowler et al (1963). 
The dose-response curves (Fig. 2) were obtained by 
determining the average skin reaction between the time 
when the reaction first became apparent (lower limit) 
and when it started to increase to the second peak 
(upper limit). This is the early reaction stage referred to 
TABLE II 
STUDY OF PIG SKIN REACTION USING HYPOTHERMIA IN 
CONJUNCTION WITH HYPERBARIC OXYGEN 
Anaesthetising Conditions at Enhancement ratio 
agent irradiation at 1.5 reaction 
level 
Alfathesin In Air Wann Standard 
In HB02 Wann 1.4 
In HB02 Cold 1.5 
Hypnomidate In Air Wann Standard 
In HBO, Wann 1.4 
In HBo; Cold 1.4 
HBOi hyperbaric oxygen. 
An error estimate of about ±0.08 on the values for the 
enhancement ratio was obtained by a simple "envelope of 
errors .. analysis on the dose-response curves. 
by Hall (1978). The size of the animals and maintenance 
limited us to this region. 
The shape of the dose-response curves obtained 
(Fig. 2) resemble those of Fowler et al (1963). From 
these curves the values for the radiobiological effective-
ness relative to the treatment at normal bodv 
temperature in air (RBE) were determined, and ar~ 
listed in Table II. The radiobiological effectiveness was 
determined at the 1.5 reaction level because patients 
would not be treated to skin doses resulting in a greater 
level of damage. 
It was noted that the skin damage is increased only 
slightly under hypothermic conditions in air compared 
with normal body temperature in air, whereas there was 
a significant increase in effect for hypothermic/ 
normothermic treatments in hyperbaric oxygen (Fig. 2) 
compared with irradiation in air. 
Results of the hepatic and pulmonary measurements 
in rats are given in Tables III and IV. 
TABLE Ill 
THE EFFECT OF HYPERBARIA. HYPOTHERMIA AND HYPERBARIC HYPOTHERMIA ON BIOCHEMICAL PARAMETERS CHOSEN AS PROBES FOR 
OXYGEN TOXICITY IN RAT LIVER. THE MEAN RESULTS ±SEM FOR DETERMINATIONS IN SIX ANIMALS ARE GIVEN 
Parameter 
Superoxide dismutase (units/mg protein) 
Catalase (µmol H 20 2 degraded/min/mg protein) 
Glutathione (nmol glutathione/mg protein) 
Glutathione peroxidase (nmol NADPH oxidised/min /mg 
protein) 
Glutathione reductase (nmol NADPH oxidised/min/mg 
protein) 









100% 0 2 at 







Significantly different from control: •p < 0.05; tp < 0.01 ; !P < 0.002; §p < 0.001. 
1101 
70 mg/kg 70 mg/kg sodium 
sodium pento- pentobarbital. 
barbital 100% 0 2 at 
303 kPa for 4 h 
1674±505 5000±879§ 
119.6±29.9 178.2± 13.4* 
161.0±25.8 244.5 ± 28.8* 
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TABLE IV 
THE EFFECT OF HYPERBAlllA, HYPOTHERMIA AND HYPERBARJC HYPOTHERMIA ON BIOCHEMICAL PARAMETERS CHOSEN AS PROBFS FOR 
OXYGEN TOXICITY IN RAT LUNG . THE MEAN RESULTS ±SEM FOR DETERMINATIONS IN SIX ANIMALS ARE GIVEN 
Parameter Controls 100% 0 2 at 70 mg/kg 70 mgikg sodium 
303 kPa for 4 h sodium pcnto- pcntobarbital. 
barbital 100% 0 2 at 
303 kPa for 4 h 
Supcroxide dismutase (units/mg protein) 
Catalase lµmol H 20 2 degraded/min/mg protein) 
Glutathione (nmol glutathione/mg protein) 










381 ± 111.5! 474±220· 
17.5±4.9 39.9±5.0! 
105.1 ± 15.4§ 165.8 ± 11.4§ 
12.2±2.6· 11.3 ± l.9t 
Glutathione reductase (nmol NADPH oxidised1min /mg 
protein) 






12.1 ± 1.4• 9.1±1.6 
17.9±2.2· 14.6±2.5 
Significantly different from control: •p < 0.05: tp < 0.02; !P < 0.01 ; §p < 0.001. 
DISCUSSION 
The pig skin studies have shown that, when irradiated 
in hyperbaric oxygen, the skin reaction was always 
greater than when treated in air. irrespective of body 
temperature. The RBE values listed in Table II indicate 
that, while there is an increased effect in those areas 
irradiated under conditions of hypothermic hyperbaric 
oxygenation compared with normal temperature in air, 
the differences were not statistically significant when 
compared with those irradiated at normal temperature 
in hyperbaric oxygen. 
It has been demonstrated by Stewart et al (1982) that 
normal rodent skin is mildly hypoxic. Our findings 
indicate that, even under the influence of alpha-
adrenergic blockade in air, there are some hypoxic cells 
in normal pig skin and that the protective effect of the 
hypoxia is partially reversed by hypothermia alone, but 
more efficiently by hyperbaric oxygenation. The modest 
effect of hypothermic hyperbaric oxygenation compared 
with hyperbaric oxygenation at normal temperatures 
could be explained by the latter overcoming the 
protective effect of nearly all the hypoxic cells. If our 
"hypothesis is correct, a much greater margin might be 
expected if large tumours were irradiated, since the 
proportion of hypoxic cells would be expected to be 
much greater than in normal skin or smaller tumours. 
The lung and liver play major roles in the defence of 
the body against oxygen toxicity. In the clinical 
situation, where patients are treated radiotherapeutically 
under conditions of hyperbaric oxygenation and 
hypothermia, the duration of the hyperbaric oxygen is 
about 40 min (Sealy et al, 1986). The antioxidant 
enzymes are inducible (Tierney ct al, 1973; Crapo and 
Tierney, 1974; Kimball et al, 1976; Rister & Bachner, 
1976; Frank et al, 1978) and can provide protection 
against hyperoxic challenges. In support of this, Deneke 
and Fanburg (1982) reported that significant increases 
in the activities of superoxide dismutase, glucose-6-
phosphate dehydrogenase, glutathione peroxidase and 
reductase and, in some instances, catalase occur within 
24-48 h in young animals exposed to I 00% oxygen. 
This enabled the animals to resist the toxic effects of 
100% oxygen (Frank et al, 1978). It can, thus, be 
expected that if acute oxygen toxicity in rats was to 
develop as a result of hypothermia or hypothermic 
hyperbaric oxygenation, the activities of these enzymes 
would, in fact, not be increased. 
Superoxide dismutase was not induced in the lung by 
hyperbaric oxygen alone, but was increased almost 
twofold after sodium pentobarbital and threefold after 
the combination of pentobarbital and hypcrbaric 
oxygen. We noted also a more than threefold increase 
in hepatic superoxide dismutase activity following 
sodium pentobarbital-induced hypothermia and hypcr-
baric oxygen. These increases in superoxidc dismutase 
activity may afford protection against the increase in 
free superoxide radicals that might be produced under 
these conditions. 
Glutathionc reductase in the lung was induced in 
response to hyperbaric oxygenation, thus implying a 
continued supply of reduced g)utathione which protects 
cells under oxidative stress by scavenging free radicals 
and peroxides (Meister & Tate, 1976). The observed 
depiction of pulmonary glutathione after sodium 
pentobarbital or hypcrbaric oxygen together with 
sodium pentobarbital may be partly due to the increase 
in the activity of glutathione peroxidase in both of these 
ili~ti~L • 
Increases in activity of antioxidant enzymes have 
generally only been shown to occur following several 
days of exposure to hypcroxia (Crapo & Tierney, 1974; 
Kimball et al, 1976: Rister & Bachner, 1976; Frank 
et al, 1978). The observed changes in this study after a 
4 h exposure to hypothermia and hyperbaric oxygen 
were, in general, of such a nature that potential hepatic 
and pulmonary oxygen toxicity or the effects thereof 
would be combated. Our biochemical evidence is such 
that oxygen toxicity will probably not develop during 
1102 
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SinKle-dose RBE and toxicity studies with hypothermia and hyperbaric oxygen 
the course of or during hypothennic hyperbaric oxygen 
irradiation of patients. 
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ABSTRACT 
It is proposed that hyperbaric oxygen fails in the clinical 
situation due to a high proponion (greater than 33%) of 
hypoxic cells in human tumours. The means of overcoming 
this problem are reviewed. Additional to hyperbaric oxygena-
tion. moderate hypothermia (30°C) to allow redistribution of 
oxygen in the tumour is proposed. A system of externally 
controlled intravenous anaesthesia has been developed for the 
single-subject hyperbaric cylinder. Pharmacological vasodilata-
tion is induced in the anaesthetised patient who is then fluid 
loaded and cooled. Initial single-sensitising treatments are 
advocated. Twenty-nine patients with advanced mouth cancer 
have completed a course of this treatment, of whom five of 
nine were free of disease after 2 years and 10 of 21 at I year, 
with three intcrcurrent deaths. Fifteen have experienced local 
failure . This approach would appear to be practical, safe and 
promising. 
Hyperbaric oxygen in clinical radiotherapy has not 
fulfilled its early promise (Churchill-Davidson et al, 
1957). It would appear that large tumour size adversely 
influences response (Van den Brenk, 1968; Chang ct al. 
1973: Henk et al, 1977: Henk & Smith, 1977; Sealy, 
1979). even when subject to prior shrinkage with 
chemotherapy (Sealy et al, 1982). Similar results are 
seen in animal tumours (Suit & Maeda, 1967). 
We postulate, therefore, that the poor response to 
irradiation in hyperbaric oxygen is a function of 
incomplete radiosensitisation due to an increased 
percentage of hypoxic cells present in tumours of a 
more advanced sta2e. Even small human tumour 
nodules may have 2o'=-40% hypoxic cells (Denekamp et 
al. 1977). M urine tumours may have size-dependent 
hypoxic fractions (for a review, see Moulder & 
Rockwell, 1984), while Mueller-Klieser et al (1984) have 
shown that oxyhaemoglobin saturation by hyperbaric 
oxygen in tumour capillaries also depends upon tumour 
size. Our hypothesis is supported by the view of Adams 
(1978) in that a highly significant gain factor for a 
hypoxic radiation sensitiser treatment will only be seen 
Address for correspondence: R. Sealy. Department of 
Radiotherapy. Groote Schuur Hospital, 7925 Observatory, 
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when less than 0.001 % of the tumour cells remain 
biologically hypoxic when so exposed. Hyperbaric 
oxygen at 3 atmospheres absolute increased the oxygen-
carrying capacity of the blood by about 33% over that 
in air; thus, it would not be possible, under the most 
favourable conditions, to oxygenate completely 
tumours with a very high proportion of hypoxic cells by 
this means alone. Morgan (1967) has calculated, for a 
large tumour, that even 1 % of hypoxic cells would 
increase the necessary radiation dose for cure to 
impossibly high levels for clinical tolerance. It is, 
therefore, appropriate to explore methods of achieving 
a several-fold improvement in the oxygen supply of 
tumours over that which is obtained in conventional 
hyperbaric oxygen at 3 atmospheres absolute. Increas-
ing oxygen pressure of from 3 to 4 atmospheres raises 
the oxygen-carrying capacity of the blood by a further 
12%. This would not be adequate if more than 45% of 
the cells were to be hypoxic in even a small area of a 
tumour. 
Peripheral vasoconstriction (Whalen ct al, 1965; 
Bachofen et al, 1971; Johnson, 1971; Johnson ct al, 
1972) may be an important unwanted side-effect of 
oxygen therapy which should be avoided in the clinical 
situation (Sealy, 1979) since it may be protective (Milne 
et al, 1973; Pallavicini & Hill, 1983). However, its 
abolition would not improve the supply of oxygen to 
the tumour more than about 33% above that seen in air 
(Whalen et al, 1965) and, thus, as a sole additional 
measure would not be expected to increase the radiation 
sensitivity of a cell population with greater than 33% 
hypoxic cells. 
Another option is the use of hyperbaric oxygen 
together with a concomitant reduction in the oxygen 
utilisation rate of the tumour. This could lead to a 
centrifugal redistribution of oxygen within the tumour 
cord (Thomlinson & Gray, 1955) or layers (Scott, 
1957). This condition can be achieved pharmacologic-
ally (Crabtree & Cramer, 1934; Hall ct al, 1952; Durand 
& Biaglow, 1974; Haynes & Inch, 1976), but systemic 
doses of drugs in excess of those which can be given 
under ordinary clinical conditions would probably be 
required (Durand et al, 1976). · 
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Induced hypothermia provides an alternative 
approach. Crabtree and Cramer (1934) and Hall et al 
( 1952) suggested that the radiation sensitivity of mouse 
tumours might be increased at 0°C. In an attempt to 
improve radiation sensitivity by causing a reduction in 
oxygen utilisation and, hence, a redistribution of 
available oxygen, Bloch et al ( 1961) irradiated 
moderately hypothermic patients for glioblastoma 
multiforme, but found radiation-induced brain oedema. 
In less critical anatomical situations this might not be a 
limiting factor. Surface physico-pharmacological 
cooling to about 30°C is well known in anaesthetic 
practice and cardio-pulmonary bypass cooling to about 
14°C is frequently undertaken in cardiac surgery. As an 
initial study, we decided to investigate the former. 
Two widely differing rates of change of oxygen 
utilisation with change in temperature are quoted in the 
literature (Bigelow et al, 1950; Ross, 1954; Horvath & 
Spurr, 1956; Wright, 1971; Ganong, 1983). Utilising the 
lower rate quoted (7%/1 °C), it can be calculated that 
the whole-body oxygen consumption at 30°C will be of 
the order of 50% of what it is at 37°C. This figure seems 
to have fairly wide acceptance (Bigelow, 1958; Nunn. 
1980). 
Cardiac output falls with drop in temperature and 
figures of 50% of normal at 28°C are quoted (Ross, 
1954), but even were this to be so and peripheral 
perfusion decreased proportionately, 3 atmospheres 
absolute oxygen at 30°C would still effectively provide 
an excess of additional available oxygen. 
If a tumour was fully oxygenated, and the dose for 
37% cell survival was about 1.40 Gy, then a single dose 
of 6.00 Gy would leave a surviving fraction of less than 
2% . It would be expected that the redistribution of 
oxygen following such massive cell death would allow 
effective reoxygenation of the surviving tumour cells, 
provided that the significant factor was not destruction 
of critical elements of the tumour vasculature. 
We describe here our experience in 31 patients in 
whom radiosensitisation was achieved by hypothermia 
and hyperbaric oxygen (3 atmospheres absolute) in 
combination with pharmacological vasodilatation. 
THE LOGISTICS OF PROVIDING ANAESTHESIA 
The provision of an environment for radiotherapy of 
hyperbaric oxygenation and hypothermia poses patho-
physiological and logistic problems, of which the 
former are the most serious. Of all the pathophysio-
Jogical accompaniments of induced hypothermia, the 
most dangerous is cardiac arrhythmia, especially 
ventricular fibrillation, the threshold for which is 
usually below 30°C, the target temperature accordingly 
chosen. 
Before treatment, all patients have myringotomy 
needles inserted. For the induction of hypothermia a 
standard technique of surface cooling under general 
anaesthesia is used. Because of the constraints of the 
hyperbaric cylinder. we have opted for total intravenous 
anaesthesia with a continuous infusion of etomidate 
(1-2 mg/kg/h) combined with fentanyl (300-400 µg 
during the period of cooling), paralysis with d-
tubocurarine (approximately 45 mg during total period 
of anaesthesia) and ventilation with nitrous oxide with 
40% oxygen during cooling and oxygen alone during 
the hyperbaric phase. 
After induction of anaesthesia and immediately 
before commencement of cooling. vasodilatation and 
control of shivering is achieved by the administration of 
20-50 mg of Largactil (May & Baker Ltd) administered 
with appropriate fluid loading (balanced salt solution 
and plasma). The patient's physiological homeostasis is 
controlled by appropriate reactions to monitoring of 
multiple vital functions. These include electrocardio-
graphy and arterial and venous pressure transduced 
from percutaneous radial arterial and right atrial 
cannulation. These allow also for serial monitoring of 
acid-base, blood-gas and electrolyte status. A separate 
intravenous line is established for fluid and drug 
infusion. End-tidal CO2 concentration is continuously 
monitored by capnography, the volume of ventilation 
being adjusted to maintain end-tidal CO2 concentration 
between 4% and 5% during the fall in temperature and 
metabolic rate. If necessary, 2-4% CO2 is added to the 
inspired gas mixture during cooling to prevent alkalosis. 
Temperature is monitored in the middle third of the 
oesophagus and in the rectum with thermistor probes. 
A cooling rate of l°C/15 min has been found to be 
optimal in terms of accurate control of afterdrop. Once 
the temperature has reached its nadir following 
afterdrop-which approximates 2°C-and oesophageal 
and rectal temperature have equilibrated, core tempera-
ture remains stable for a prolonged period. 
Hyperbaric phase 
Major logistical problems follow from the spatial 
constraints of our single-patient pressure vessel (Vickers 
Mark IV), the spark and explosion danger inherent in 
the hyperbaric oxygen environment and the enforced 
remoteness of the anaesthetist from the patient for the 
period of pressurisation and irradiation. Modifications 
of the cylinder door were made to permit airtight 
passage of intravenous lines for the administration of 
intravenous anaesthetics and other drugs from without 
by means of constant infusion pumps (IVAC), and 
cables from all the monitoring devices to appropriate 
external displays to allow continuous monitoring. 
The period for which the patient is remote from the 
anaesthetist is of the order of 50 min. 
Ventilation 
Ventilation with pure oxygen in the tank is provided 
by a compact Vickers fluid logic ventilator. It bas no 
moving parts and so obviates any danger of spark 
generation. Airway pressure generated during the 
inspiratory phase is registered on a pressure gauge 
inside the tank visible through the perspex wall and, 
together with the capnograph oscillation, provides a 
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Depressurisation, rewarming and reversal of 
neuromuscular block 
At the conclusion of therapy, the patient is 
depressurised. removed from the tank and rewarmed in 
a bath of warm water. 
Once rectal and oesophageal temperatures exceed 
34°C, the action of muscle relaxant is reversed with 
glycopyrrolate/neostigrnine, spontaneous respiration is 
re-established, anaesthesia discontinued and the patient 
allowed to awaken. 
Complications 
We have applied this technique on 42 occasions to 34 
patients, the number of treatments per patient being 
dictated by radiotherapeutic criteria. All patients have 
regained consciousness rapidly after treatment and have 
been fit for discharge from hospital the next morning. 
The most dangerous complication associated with 
induced hypothermia is the onset of various cold-
induced cardiac arrhythmias, the incidence increasing 
sharply at temperatures below 30°C. Fifteen of the 42 
treatments have been so complicated. These were, in 
order of frequency: atrial fibrillation (12), ventricular 
tachycardia (one}, multiple ventricular premature 
systoles (one), ventricular fibrillation (one). Initially, 
aggressive attempts at increasing cooling rates resulted 
in poor control of afterdrop with a high incidence of 
arrhythmia, but with better control of cooling rates; 
only four instances of atrial fibrillation have occurred in 
the last 21 patients treated. Atrial fibrillation has 
reverted to sinus rhythm in all cases on rewarming, 
combined with Verapamil (Knoll. Ltd) 5 mg in all but 
three. The episodes of ventricular tachycardia and 
multiple ventricular premature systoles were controlled 
with lignocaine. 
Cold-induced hypertension 
A consistent reaction has been a hypertensive 
response of varying degree to the movement and 
handling of the cooled. vasodilated and fluid-loaded 
patient and his insertion into, and pressurisation in, the 
pressure vessel. We have found the continuous infusion 
of sodium nitroprusside of use in controlling this 
reaction. The subsequent warming hypotension 
secondary to vasodilatation is then relatively easily 
handled by discontinuing the drug and volume loading 
of the patient. 
Cardiac output 
The relative cardiac output was determined in six 
patients, using a radionuclide technique as previously 
described (Novitsky et al. 1984). Technetium-99m label-
ling of red blood cells was carried out in vitro using the 
Brookhaven National Laboratory Kit according to the 
method of Smith and Richards (1976). Activities of 
about 1500 MBq were used because of the necessity of 
accumulating a sufficient number of counts in as short a 
time as possible. A high-resolution, low-energy col-
limator on a Siemens gamma camera linked to a 
Medical Data Systems computer was employed, 
scanning in the anterior and left anterior oblique views. 
The mean cardiac output in the conscious patient was 
4.11/min (range 2.6-5.31/min) and in the anaesthetised, 
cooled, vasodilated, fluid-loaded patient was 4. 7 I/min 
(range 3.5-6.2 I/min). These findings indicate that, 
under these conditions, decrease in the cardiac output 
did not occur. 
Acid-base and fluid balance 
No difficulties have resulted in relation to blood-gas 
and acid-base homeostasis, but the cold-induced 
diuresis. usually commencing at a core temperature of 
31 - 32°C and which commonly leads to the passage of 
2- 3 I of dilute urine during the procedure, does require 
catheterisation and careful management, especially with 
regard to its effect on serum K + level and control of 
circulatory volume homeostasis. 
CLINICAL RAoJOTHERAPEUTJC EXPERIENCE 
Patient selection 
Since August 1982 the treatment has been offered to 
patients with Cape Town T 3 ( 4-6 cm), T, (in excess of 
6 cm diameter) or N 3 (fixed nodes) histologically 
confirmed inoperable squamous carcinoma of the 
mouth. Such tumours thus tend to be larger than those 
staged as T 3 or T, in the International Union against 
Cancer (UICC, 1978) classification, since invasion of 
muscle or bone does not advance the Cape Town stage, 
which is calculated purely on siz.e. It is our experience 
that about 25% of such patients are free of disease I 
year after conventional radiation treatment. Whilst 
being prepared for treatment, most patients received 
methotrexate intravenously (80 mg/m2 body surface per 
week) to prevent extension of the tumour. It is our 
experience that such chemotherapy administered until 
about I week before irradiation does not affect 
subsequent radiotherapeutic control of the disease 
(Sealy et al, 1982). 
The protocol was passed by our local ethical review 
committee and informed patient consent obtained. 
Irradiation technique 
An individual perspex cast was made for each patient 
and the known tumour and spinal cord localised within 
it. Individually drawn conventional multifield treat-
ment plans were prepared and special attention given to 
avoidance of the spinal cord. The cast was made to 
fasten in a known position on the table top within the 
hyperbaric cylinder. To allow for refraction of the light 
beam, the set-up was rehearsed with the cast only, with 
a simulator of the hyperbaric cylinder on the treatment 
couch. This enabled the beam entry points and angles 
and the source-skin distances to be marked on the cast. 
Ellis-type compensators and a I cm build-up where the 
peak dose was required to be on the skin surface were 
made. Eight MeV X rays and the Vickers Mark IV 
hyperbaric cylinder at 3 atmospheres absolute on a 
modified hand-operated commercial hydraulic ram were 
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used. The time taken to place the patient into the 
chamber averaged about 30 min; thus. patient place-
ment took place when the core temperature was about 
32°C. Afterdrop cooling continued during this place-
ment period, as well as the compression and the soaking 
times (15 min). The intratumour treatment levels, as 
measured by interstitial thermistor probes, closely 
followed those of the core and were about 30°C in all 
cases. before and after irradiation. All patients, except 
the first, also received prophylactic neck nodal 
irradiation given in air at ambient temperature. The 
usual nodal dose was about 42 Gy in 14 fractions 
given three times per week. 
Radiation fractionation 
Large-fraction hypothermic hyperbaric radiotherapy 
to the known disease only was given at the beginning of 
the treatment course. Anaesthetic considerations 
prevented more than one such treatment per week and 
the original aim was, therefore, to deliver two fractions 
of 6.00 Gy tumour dose to produce a large cell kill on 
Treatment Days I and 7, with two fractions of 2.00 Gy 
on Days 3 and 4. However, it became clear that two 
hypothermic treatments were difficult to schedule and 
later only one initial treatment was given. Thereafter, 
five times weekly treatments in air at ambient 
temperature were given to clinical tolerance, usually 
20 x 2.00 Gy with two hypothermic fractions (total dose 
56.00 Gy in 37 days) and 26 x 2.00 Gy with one (total 
dose 58.00 Gy in 38 days). With a single hypothcrmic 
treatment. two booster daily doses of 3.00 Gy were 
usually given to any residual mass at the end of 
treatment. The respective TDF values were estimated to 
be about 95 and 100. and corrected for the hypothcrmic 
RBE to about 114 and 119. using the data obtained in 
the accompanying paper (Hering et al, 1986). Two 
patients, because of machine breakdown or the 
necessity to control hypertension. received hypo-
thermic irradiation at the end of their course of 
radiation. 
Radiation reactions 
Our experience of acute post-irradiation oedema was 
similar to that of Bloch ct al (1961). This appeared 
some 2-4 h after treatment and in the first patient was 
of such a degree that tracheotomy was performed as a 
prophylactic measure before the second treatment. All 
other patients were then controlled by a single dose of 
100 mg of dexamethasone given intravenously at the 
time the anaesthetic was discontinued. The acute 
radiation reactions developing during the course of 
treatment were scored for crythcma and membrane 
formation (Scaly et al, 1982) and did not differ from 
those experienced during conventional courses of 
treatment. 
With the exception of one patient with mandibular 
necrosis. marked late effects have not so far been seen. 
The large tumours treated have necessitated large fields 
which have resulted in mild to moderate xerostomia. 
Mild subcutaneous oedema has been seen in four 
patients but this has regressed in two. One patient has 
subcutaneous fibrosis at 28 months and another at 24 
months. 
In five patients who received two initial hypothcrmic 
treatments, the mean time to clinical tumour regression 
was 14.6 (range 7- 21) days. whereas in 19 patients who 
received one such treatment the mean time was 39.3 
(range 11-60) days. 
Results of treatment 
Thirty-one patients have accepted and completed a 
course of treatment. In two early cases hypothcrmic 
treatment was abandoned. Twenty-seven of 29 patients 
treated hypothermically experienced complete initial 
regression of the tumour. Five of nine hypothcrmically 
treated patients were free of disease after 2 years, whilst 
10 of 21 patients at risk at I year remain free of disease. 
In addition, a further three patients have died free of 
disease in the treated area, of a cercbrovascular 
accident, lung metastases or pneumonia, possibly 
associated with lung metastases, less than 12 months 
after completing treatment. Eight patients completed 
hypothermic irradiation less than I year ago. Compared 
with a series of 64 consecutive patients with T 3 or T 4 
oral cancer treated about the same time with 
conventional fractions in air (63.00 Gy ID in 30 
fractions in 38 days) where only 18 had locally 
controlled disease at I year, the results for control of 
the disease are significant at the 10% level (x2 = 2.7) at 
I year. When the results are compared at 2 years (5/9 
and 5/58), although the numbers are very small, the 
results are significant at less than the I% level 
(r.2 = 13.5). A similar trend is seen when the results arc 
compared with a retrospective series of 47 patients with 
T 3 mouth cancer (Scaly ct al, I 982) treated with large 
fractions (36.00 Gy TD in six twice-weekly fractions in 
18 days) where I I patients were free of disease at I year 
(r.2 = 3.9 and 6% level of significance). The results also 
compare favourably with our past experience of 
irradiating patients with squamous carcinoma of the 
mouth in hyperbaric oxygen (45.00 Gy TD in nine twice-
weekly fractions in 29 days) with T 3 (4-6 cm diameter), 
T4 (greater than 6 cm diameter) or N3 (fixed nodes) 
stage disease where one out of I 3 patients was free of 
disease at I year. The difference is significant at less 
than the 5% level (x2 = 5.8). ' 
Nodal recurrence caused death in two patients in this 
series where the individual nodes were very large with 
diffuse disease in the neck and with estimated volumes 
of 39 cm3 and 48 cm3, respectively, whereas smaller 
nodes usually seem to have been controlled. In another 
two, nodal and primary recurrent disease was observed. 
Two of four patients who had disease involving bone, 
one with extensive destruction of the anterior 
mandibular arch, remain well with the primary growth 
area healed. 
One remarkable feature of this method of treatment 
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hypothermic anaesthetic, which makes post-treatment 
care very easy. 
DISCUSSION 
We have formulated a theory for the clinical failure 
of hyperbaric oxygen radiotherapy and laid the 
groundwork for its application . 
The clinical course of events so far supports the 
original thesis in that 27 of 29 patients in whom 
treatment was successfully completed, had complete . 
regression of disease. These findings suggest that large 
primary growths in the mouth ·may have over 33% 
hypoxic cells and that large nodal metastases may have 
even more. 
The very rapid regression rate seen with two 
hypothermic treatments, which seems to involve the 
whole tumour at once, is of interest since it does not 
have the same pattern as the classical centripetal 
regression of Coutard (1932). On the contrary, this is 
more in keeping with a large random and widespread 
tumour cell death at the initial treatment rather than 
that which might be seen with gradual reoxygenation. 
The slower rate of regression seen after one hypo-
thermic treatment suggests that massive cell kill takes 
place with a second treatment and that a pattern of 
regression is induced with a single treatment more akin 
to that found with successful irradiation in air. Thus, it 
is possible that, even under the circumstances reported 
here, oxygen does not easily gain access to the tumour 
cells because of a poor and perhaps partially destroyed 
vasculature. as in a large, partially necrotic lymph node. 
This need only happen in one small area involving no 
more than about 107 cells for local recurrence to take 
place. It is known that human tumour oxygen supply 
can vary greatly between regions of only a few 
millimetres in volume (Mueller-Klieser et al, 1981). 
Jung et al ( 1984) have recently shown that haemodilu-
tion increases tumour blood flow and the availabilitv 
of oxygen to a rat tumour. After induction of the alpha 
adrenergic blockade, our patients received 2-3 I of fluid 
to maintain blood pressure which, thus, led to a fall in 
the haematocrit to about 30%. Moreover, our cardiac 
output studies show that a decrease did not occur due 
to the hypothermia, presumably due to a high cardiac 
output state induced by the fluid loading and alpha 
adrenergic blockade. 
Others have found supporting evidence in a mouse 
tumour for the theory proposed here. Tozer et al 
(1984), in a search for anaesthetic agents to improve the 
results of irradiation in hyperbaric oxygen, found that a 
combination of ketamine and diazepam lowered the 
body temperature and improved the TCD371 for a 
mouse mammary tumour in hyperbaric oxygen4'ut not 
in air. It is possible that the anaesthesia used in the 
early clinical experiences with irradiation. under 
hyperbaric oxygen. chlorpromazine and pentobarbitone 
sodium (Churchill-Davidson et al, 1957), acted in a 
similar manner. 
The spinal cord has been rigorously avoided for those 
treatments given in hypothermic hyperbaric oxygen. but 
we are at present examining the late effects of single 
doses on pig spinal cord. 
Although this approach is far from trivial and is 
labour intensive, it is no more so than major head and 
neck surgery. If a high success rate is maintained, it 
would be more cost effective than conventional methods 
of treatment with higher failure and all the attendant 
late care problems, quite apart from the overriding 
consideration of failure to cure. 
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Correspondence 
(The Editors do not hold themselves responsible for opinions expressed by correspondents) 
Hypothermic hyperbaric irradiation 
Tur EnnoK StK. 
Last year you were kind enough lo puhlish ;111 aeeounl of our 
cxp.·riences with hyp,,th•·rmic hypcrhari•· irradiation of 
ad\'anccd head :tnd neck cancer (Seal\· cl :ti, 1986h). 
Since we lrnvc had :1 number of cnq.uirics about our previous 
report . we would now like hriefly 10 provide further results. 
Thirty-nine patients were lo have had hypothennic hypcrharic 
irr:1dia1ion. hut in two early patients. treatment was 
abandoned because of reversible hypotension or cardiac 
arrhythmia. Thirty-seven patients. therefore, received this 
treatment. The initial aim was to give two hypothermic 
treatments at weekly intervals at the beginning of treatment 
(seven patients) but this proved to be imprncticable. The 
second group (21 patients), therefore, received one initial 
hypothcrmic irradiation and. lastly, a third group (nine 
patients) received :1 single hypothermic irr.tdiation after four 
frac1ions in :1ir and then completed their irrndi:ttion in air. The 
results ;1rc shown in Table I. 
Although the results with an initial sin_gle hypothermic 
1rc:1tmcnt arc perhaps less satisfactory than with the other two 
regimes. the disease-free results at I year ( I X/37 patients or 
4~ 0 "l of lhe group as a wl!lllc appear In hl· signilicantly better 
1ha11 rhos•· of a similar s•·ries ,,r p;ttients treated with 
conven1i1lllal fra•·tionalinn (6.,.00 (iv in JO fractions). where 
::!8 % (IS :o4) of pa1ients were fr~c of disease :11 I ve:1r v~ = 4.3) (Se:1ly et ,ti. 1986:1). The whole group has not yet 
!!One to ::! years. hut :11 the present time the disease-free 
sun·ival rate al ::! y··ars of the lirsl tw11 groups is not 
si!!nitkantly h•·tla lhan tlllls•· paticnls 1r.·a1cd hy convcntion:11 
means (Scaly cl al, 1986a). There has lx"Cn another major 
toxicity with one patient h:1ving :1 cardim: :1rrest at 27.2 ·c 
following loo-rapid cooling. This p;1ticnt is. however. fn .. -c of 
disease and working 14 months after completing hypothermic 
hypcrb:1ric irrndiation . Because of these complications. we :ire 
invcstig:tting the alternative method of cxlracorporc:11 cooling 
lo 16-t!!·'C through a fcmornl-to-femoral bypuss. This is a 
lesser procedure. is far better controlled and lends itself to 





Departments of Radiotherapy and • Anaesthetics. 
Groote Schuur Hospital and 
University of Cape Town Medical School. 
South Africa 
( R<•cC'ived Oct11her /987) 
References 
SEALY. R .. C'RIULANU. s .. BARRY. L. & NORRIS, R .. 1986a. 
lrrddiatiun with misonidazole and hypcrbaric oxygen: final 
report on a randomized trial in advanced head and neck 
canl'l:r. /111,•r,1111im111/ Jm1mal 11/' Rt1tfiati1111 011m/11gr. llio/11,:,1·. 
/'/,1·.vil'.I'. I:!. IJ4J L\46. -
SEAt.Y. R .• IIARRtSoN. Ci . Ci .. MoRRt,1.1 .. I> .. KoRRlllll:I., J., 
GRE(;ORY, A.. BARRY, L.. BLEKKENIIOR~'T. G.. HERING, 
E. R.. FATAAR. A. ll . & llONIASZ( 'ZllK, J.. 19!!6b. A 
fc:tsibility study of :1 new apprn:1ch to clini1.,1l rndioscnsiti1.a-
tiun: hypothermia ;111d hypcrh:1ric oxygen in comhin:ttiun 
with pharm.1eological vasodil:ttiun . /Jriti.,I, JtJurnu/ 11/ 
Rat!io/11,:,1·. 59. I 093-1 ()IJ!!. 
Tahll' I. Hypothermi•· hypcrharie oxygen in advanced head ;md 111..-ck cancer 
Trcatmcnl Fraelions Total nu. of Alive and Later local Total local Cause of . 
regime tumour per week patients well at recurrences failures intercurrcnt 
dose (Gy) I year deaths (months) 
(i.()(J* 5 7 5 2 4 
2.00 X 2 
6.oo• 
::! .00 x ::!O 
6.oo• 5 21 8 4 14 Metastasis 7 2.0{) X ::!6 Stroke I 
Pneumonia 7 ::!,4() X 4 
6.oo• 4 9 5 3 ?Cause 3 
::!.40 X 18-19 Pneumonia 6 
Totals 14 37 I!! 7 21 5 
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THE HYPERTENSIVE RESPONSE TO HYPERBARIA HYPEROXIA & HYPERTHERMIA 
THE PROBLEM 
Exposure of the conscious individual to an environment ofhyperbaric oxygen (3 ATA, Fi 02 l)causes 
no observable changes, other than trivial and transient, in his cardiovascular dynamics. 
However, when in the interests of increasing tumour radiosensitivity, patients first rendered hypothermic 
( core temperature 30" C)-the achievement of which necessitates the induction of anaesthesia, neuromuscular 
blockade and vasodilatation ( a-adrenergic blockade) with fluid loading and surface cooling - were exposed 
to the self same environment, elevations in mean arterial pressure were observed in virtually all patients1. 
This rise in blood pressure which usually commenced towards the end of the period of cooling and was 
sometimes associated with manhandling of the patient into the pressure vessel, was always enhanced by 
pressurization. In some patients the degree of induced hypertension was severe. Further active 
pharmacologicallyinducedvasodilatatfonwithSNPwasfoundnecessaryineverycase(thesenumbered45)to 
limit this rise in blood pressure to clinically safe limits. Thereafter, fall in blood pressure occurred 
pari passu with depressurization of the patient at the termination of the radiotherapy. Observations of 
cardiac output (measured by means of a Technetium/MUGA sam teclmique) made dwing the period of cooling, 
have shown that the rise in cardiac output that follows induction of vasodilatation and fluid loading, is 
maintained throughout the period of cooling down to a core temperature of30"C. Othecthan for ECG monitoring 
and observations of blood pressure, it has not been possible to continue observation of cardiovascular 
dynamics under the conditions of hyperbaria within the pressure vessel. 
HYPOTHESIS 
As a working hypothesis to explain this reaction it was proposed that the gross vasodilatation and 
fluid loading induced in the patient effectively rendered the vascular bed non complaint. Increase in 
ambient pressure would then result in an effective increase in peripheral vascular resistance, as has been 
described in scuba divers2• This, in the face of the nonnal or raised cardiac output previously measured, 
would lead to the rise in blood pressure observed. 
Alternative hypotheses and/or contributory factors that need to be considered include:-
1) Hyperoxic vasoconstriction. 
2) A response to an increase in circulating endogenous catecholamines as a reaction to 
i) Hypothermia 
ii) Hyperbaria 
iii) Inadequate depth of anaesthesia/inappropriate anaesthethic agent. 
It was proposed to investigate this reaction in swine, utilising the CRC HPNS • pressure facility 
at Northwick Park Hospital. 
• High Pressure Nervous Syndrome 
4.6 
OBJECTIVES 
1) To validate the pig as a suitable animal model. 
2) To characterise the components of the reaction through measurement of the appropriate parameters of 
circulatory dynamics. 
These would include:-
Systolic and diastolic arterial pressure, rt. atrial, pulmonary artery and pulmonary capillary 
wedge pressure, together with estimation of cardiac output by a thermodilution technique. From these 
parameters estimates of pulmonary and peripheral vascular resistance would be derived. These latter 
parameters would all be measured utilising Swan-Ganz rt. heart catheterisation. 
3) To investigate the effect on these components of the reaction to identified variables. 
METHODS 
Initially objectives 1) and 2) were to be addressed simultaneously. Regrettably, logistic 
difficulties were experienced with Swan-Ganz catheterisation in the pig and it became rapidly apparent that 
appropriate adaption of the technique for use in the pressure vessel would prove difficult and time 
consuming. Accordingly, as all the objectives of the investigation were dependent on the validity of the 
proposed animal model, subsequently this aspect alone was addressed. 
The investigation was conducted on25kg large white pigs. These were anaesthetised withi.m. ketalar 
lOmglkg, thiopentone Na i.v. followed by oral intubation and maintenance ofanaethesia with N20/02 (300/o)+ 
Halothane administered by IPPV utilising a Harvard animal ventilator for the period of preparation and 
cooling. Thereafter for the time the animal was in the pressure vessel, halothane and nitrous oxide were 
discontinued and anaesthesia was maintained by means of a continuous infusion of etomidate 1-2 mg/kg per 
hour, the animal being ventilated with oxygen alone by means of a Vickers fluid logic ventilator. 
Jugular venous and caritod arterial cannulation, which allowed venous access for fluid and drug 
administration and for arterial and venous pressure recording, was established surgically. 
Experiment 1: Effects of vasodilatation, fluid loading and cooling ( core temperature 29°c ). 
V asodilatation was achieved by administration ofLargactil 50mg followed by a fluid load of2 1. of 
Hartmanns solution. The animal was then surface cooled to a temperature of29°C-anaesthesiabeingchanged 
at this stage to continuous etomidate infusion and ventilation with oxygen (Fl 02 1) at 1 ATA Thereafter, 
the animal was rewarmed in a bath of warm water, spontaneous respiration re-established, anaesthesia 
discontinued and the animal allowed to recover. 
Experiment 2: Effects ofvasodilation, fluid loading, hyperbaria (5 ATA) and hyperoxia (Fl 02 1) at 
normothermia. Following anaesthesia, establishment of monitoring, vasodilatation and fluid loading (2 1. 
Hartmanns solution) the pig, having been placed in a pressure vessel, was:-
1) Exposed to a pressure of 5 AT A (Fl 02 1) 
2) Depressurised to normal ambient pressure (1 ATA) 
3) Fluid loading with a further 1 L. ofHartmanns solution 
4) Re-pressurised to 5 ATA with FI 02 1. 
5) Depressurized to normal ambient pressure (1 ATA). 
As both major vessels on each size of the neck had been utilised, this pig was sacrificed. 
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Experiment 3 
Effects ofvasodilatation, fluid loading, hypothennia, (29°C) hyperbaria (5 ATA} and hyperoxia (Fl 
02 1). Following anaesthesia, establishment of monitoring, vasodilatation and fluid loading ofa degree that 
raised the central venous pressure (CVP) from 4-12cm H20 (3 1. Hartmanns solution) the test animal was 
surface cooled to 29°C. Therafter, it was subjected to a pressure of5 ATA at an FI 02 of 1 for 15 minutes. 
This was followed by depressurization over 5 minutes. 
RESULTS 
Experiment 1 
Effect of hypothermia. 
Cooling caused a steady and gradual 200/o fall in blood pressure from a steady state condition following 
vasodilatation and fluid loading, falling from 100/60 to 80/55 mgHg. 
Experiment 2 
Effect of hyperbaria and hyperoxia - repeated. 
Other than for a transient 5 mmHg rise in systolic and diastolic pressure at commencement of pressurisation 
on the first occasion, the blood pressure remained stable at a level ofl 00/90 mmHgthroughout both episodes 
of presurisation, depressurisation and extra fluid loading. 
Experiment 3 
Combined effects of hypothermia, hyperbaria and hyperoxia. 
V asodilatation, fluid loading (CVP 4-12 cm H20) and cooling caused a gradual decline in blood pressure from 
110/95 to 75/50 mmHg. Thereafter, other than for a transient 5 mmHg rise in systolic and diastolic pressure 
at the start of pressurisation, no change was observed in blood pressure. It remained stable at 70-75/50-55 
mmHg throughout the pressurisation to 5 ATA Decompression over 5 minutes at tennination of the e,cperiment 
was accompanied by an abrupt rise in blood pressure to 100/70 mmK.g. 
SUMMARY OF RESULTS. 
Cooling of the vasodilated, fluid loaded experimental animal to a core temperature of29°C caused 
only the well documented 10-300/o fall in systolic and diastolic blood pressure. There was no hint at all of 
the whimsical rise in blood pressure that we have observed sometimes to accompany cooling of the similarly 
treated human1. 
Exposure of the test animal to hyperl>aria (5 ATA) and hyperoxia (Fl Oz 1) at both nonnothennia (38°C) 
and hypothermia (29°C) was accompanied byno significant alteration in blood pressure. All experiments were 
characterised by an unvarying stability of the blood pressure and circulatory state. 
This experimental model failed to reproduce the rise in blood pressure that has been consistently 
observed to accompany treatment in humans1. 
Ironically, rapid decompression of the experimental animal did cause a 300/o rise in systolic and 
diastolic pressure (70.50 - 100/70 mmHg). 
DISCUSSION & CONCLUSION. 
While it was our original intention to investigate the changes in blood pressure, cardiac output 
and systemic and pulmonary vascular resistance in the vasodilated, fluid loaded pig in response to changes 
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in core temperature, ambient pressure FI Oi, initial attemps at Swan-Ganz catheterisation in the pig failed. 
Not only did these attemps fail but they showed us also that the further adaptation and control of this 
technique for use in the pressure vessel would require considerable time consuming development before it 
could be successfully applied. As the application of this technique would only become relevant once it was 
shown that the hypertensive response of the human patient to the induction of hypothermia and exposure to 
hyperbaria could be reproduce in our animal modeL further development in this direction was postponed 
dependent on such demonstration. 
Subsequent experimentation failed to reproduce any semblance of the blood pressure response 
manifest by humans in reaction to vasodilatation, fluid loading, cooling, compression and hyperoxia, we 
failed to attain the very first objective of this investigation, i.e. to validate our choice of the pig as 
an appropriate animal model. 
Further, though experimentation was limited, it is fair to infer that those observations we did make 
serve to refute the working hypothesis proposed, that the changes observed in humans subjected to these 
conditions follow an increase in peripheral vascular resistence due to the physical effects of hyperbaria 
on a peripheral vascular bed effectively rendered non-compliant by pharmacological paresis accompanied by 
excessive fluid loading, cardiac output at the same time being maintained or possibly increased. 
The same can be said for the first alternative hypothesis - hyperoxic vasoconstriction. 
In this light the most likely alternative hypothesis to explain the observed human phenomenon is that of a 
cardiovascular response to an increase in circulating endogenous catecholamines engendered by:-
1. Hypothermia. 
2. Inadequate depth of anaesthesia or the use of an inappropriate anaesthetic. 
3. Hyperbaria. 
The most appropriate experimental model for further investigation of this hypothesis is obviously 
the human patient himself who manifests this phenomenon. 
Paradoxically we are finally left to explain the 30%, increase in blood pressure induced in the 
vasodilted, cooled and fluid loaded animal by rapid decompression from 5 ATA. This can only be due to:-
a. A sudden increase in venous return with concomitant rise in cardiac output. 
b. A sudden increase in peripheral vascular resistance due to:-
1. physical reasons 
11. increase in endogenous catecholamines in response to eardrum pain from 
decompression. 
m. oxygen bends. 
Of all, perhaps the latter two are the most likely. If the former, it is as odd as the 
phenomenon we set out to investigate. It is perhaps worth seeing if the reaction is reproducible. 
It remains for me to thank most sincerely Ors. J.F .Nunn and M.J.Halsey - Directors respectively of 
the CRC Division of Anaesthesia and the HPNS Research Group- for inviting me to Wlde.rtake this investigation 
at Northwick Park and subventing it, and those CRC/HPNS staff* who were involved in the investigation for 
their help, expertise and time so willingly given. I am only sony that the outcome was not more positive. 
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THE CLINICAL USE OF HALOTHANE ANAESTHESIA DURING 
CARDIOPULMONARY BYPASS· FOR OPEN-HEART SURGERY 
BY 
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Children's Hospital and Groote Schuur Hospital, Cape Town, South Africa 
or of intravenous anaesthetic agents. Secondly, 
the easy control of the depth of anaesthesia 
obta:ned using small changes in the inhaled con-
centration seems to indicate that its concentration 
in the blood is readily alterable in either direction. 
Following the successful experimental use of 
halothane anaesthesia for cardiopulmonary bypass 
procedures in dogs (Bull et al, 1959) it was 
decided to extend its use to clinical practice for 
patients undergoing open heart surgery using the 
DeWall-Lillehei pump oxygenator, with halothane 
as the principal anaesthetic agent both before and 
during cxtracorporeal circulation. 
Twenty-eight consecutive cases have been 
anaesthetized in this way. 
METHOD OF ANAESTHESIA 
Premedication. 
Eighteen cases in the series received pento-
barbitone 3 mg/kg by mouth 2 hours before 
induction and pethidine 1 mg/kg together 
with atropine 0.6 mg (1/100 grain) by intramus-
cular injection 1 hour before anaesthesia. In the 
rema=ning ten cases pethidine was omitted and 
pentobarbitone alone was used. 
DURING open heart surgery with cardiopulmonary 
bypass, whilst extracorporeal circulation is in pro-
gress, the anaesthetist is faced with the problem 
of maintaining anaesthesia without access to the 
lungs. In addition, markedly altered blood circu-
lation raises problems with regard to the intra-
venous route of anaesthetic administration. At the 
commencement of perfusion, he is faced with the 
mixing of two blood volumes-that of the anaes-
thetized patient and that of the donor blood used 
to prime the pump oxygenator. This mixing 
inevitably causes marked alteration in the level 
of anaesthetic agents in the patient's circulation, 
unless some means of equiLbrating anaesthetic 
levels in both blood volumes can be achieved. In 
the lightly anaesthetized patient, the dilution of 
anaesthetic concentration occurring may have the 
undesirable effect of allowing excessive movement 
on the part of the patient : even return of con-
sciousness is not unknown. The addition of 
intravenous anaesthetic agents and relaxants to 
maintain an even level of anaesthesia is extremely 
difficult to judge and, as these agents are elimi-
nated relatively slowly from the body, control 
may be far from flexible. This makes the desired 
rapid postoperative recovery from the influence 
of anaesthetic agents and relaxants difficult to Induction. 
achieve, unless extremely fine judgment is exer- In all patients in this series anaesthesia was 
cised in their use. induced using nitrous oxide, oxygen and halo-
Certain properties of halothane led us to believe thane. Nitrous oxide and oxygen in the proportion 
that this agent might prove useful in overcoming of 70 per cent nitrous oxide to 30 per cent 
these difficulties. Firstly, the clinical use of halo- oxygen were delivered through a "Fluotec" 
thane for cardiac and thoracic surgery, not requir- vaporizer. At the commencement of induction the 
ing cardiopulmonary bypass, has shown us that halothane concentration was increased fairly 
it is capable of providing adequate and safe rapidly during the first 1 or 2 minutes to 1 per 
anaesthesia for these procedures when it is used cent and thereafter more slowly to 1.5 per cent. 
as the principal anaesthetic agent with nitrous After about 5 minutes, the larynx and trachea 
oxide and oxygen without the use of relaxants were sprayed with 2 or 4 per cent lignocaine, 
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the total dose of lignocaine never exceeding 2 
mg/kg body weight. Intubation was performed 
after a further 2 or 3 minutes of inhalation of 
1.5 per cent balothane, nitrous oxide and oxygen 
mixture. 
Maintenance. 
Anaesthesia was maintained with nitrous oxide 
70 per cent, oxygen 30 i:er cent, and halothane 1 
per cent using a high flowrate via a semiclosed 
system with carbon dioxide absorption. 
·spontaneous or assisted respiration was allowed 
up to the time of thoracotomy. Just prior to 
o~ning of the chest a very brief period of over-
ventilation invariably allowed full control of 
respiration to be achieved and in no case was any 
relaxant used. Controlled respiration was con-
tinued-the halothane concentration still at 1 per 
cent-up to the time of commencing cxtracor-
poreal circulation. During cxtracorporeal circu-
lation anaesthesia was ma 'ntained in the following 
manner. A Fluotec vaporizer was placed on the 
oxygen supply line to the DeWall bubble oxy-
genator, which was set up as described by . 
McKenzie and Barnard (1958), but included a 
stainless steel canister debubbler. During prim-
ing of the oxygenator and the helix reservoir 
with blood, this vaporizer was set at 1 per cent. 
However, oxygen flow during priming was of the 
order of 1 1./min and as the Fluotec vaporizer 
used in this series was the Mark I model, it is 
likely that the halothane concentration delivered 
with the oxygen was less than 1 per cent. During 
perfusion, oxygen flow through the Fluotec was 
always in excess of 4 1./min and so the concen-
tration of halothane delivered to the oxygenator 
was assumed to corresoond closely to the vaporizer 
setting (Mackay, 1957; Hill, 1958). In eighteen 
cases the Fluotec setting was maintained at 
1 per cent throughout perfusion and in the re-
maining ten cases the setting was deliberately 
altered from 1 per cent to O per cent. The oxygen 
to blood flow ratio through the o,:ygenator was 
in all cases appro'Cimately 2.5 or 3 to 1. Some 
variation of perfusion rate without corresnonding 
adjustment of oxygen flow dufr-1g individual 
perfusions makes it impossible to give this figu~e 
more accurately. 
At the conclusion of extracorporeal circulation, 
pulmonary ventilation was recommenced using 
nitrous oxide and oxygen only. In all but three 
cases this su.nced for maintenance during closure. 
In the three cases mentioned halothane 1 per cent 
was added for short periods as required. 
RESULTS 
The natures of the operations, the ages and the 
weights of the patients, the durations of extracor-
poreal circulation, the rates of perfusion and the 
mean perfusion pressures in each patient are given 
in table I. 
General. 
The premedication indicated proved satisfactory 
in all cases and the patients were either asleep or 
extremely drowsy. The omission of pethidine from 
premedication in some patients was not governed 
by any contraindication to its use and both types 
of premedication provided equally satisfactory 
sedation. 
During induction and intubation no difficulty 
was experienced. Anaesthesia was rapidly and 
smoothly achieved. Short-lived coughing during 
spraying of the larynx and trachea was not un-
common but laryngeal spasm was never encoun-
tered. During the period of surgery preliminary 
to extracorporeal circulation it was necessary to 
increase halothane concentrations to 1.5 per cent 
for short periods in two cases during the first 30 
minutes of anaesthesia. In all the other cases, 
1 per cent halothane provided adequate anaes-
thesia and allowed easy control of respiration 
during both extrathoracic and intrathoracic pre-
liminary surgery, prior to cardiopulmonary by-
pass. 
During bypass, no clinically detectable varia-
tion in the deptb of anaes!hesia occurred unless 
the halo!hane concentrat:on supplied to the oxy-
genator was altered. In the ten cases where such 
alteraticn was made, it app-..ared that 0.7 per cent 
was the critical level below which respiratory 
movements in the patient commenced. When a 
cha:,ge in the depth of anaesthesia was brought 
about by a!l alteration of the halothane concentra-
tion to the oxygenator, a period of five to ten 
minutes elapsed before tb:s became clinically 
obvious. By maintaining 1 per cent halothane 
with the oxygen to the bubble oxygcnator no 
respiratory or other movement on the part of 
the patients occurred except in two cases. In these 
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TABL£ I 
T ype Age Weight 
of defect (years) (kg) 
A.S.D. 8 21 
P.S. ... ... . .. 9 44 
V.S.D. 6 19 
V.S.D. 10 31 
Traumatic fistula 29 53 
E.C.D. 9 22 
P.S. 10 24 
M.S . . . . 37 43 
F . 13 32 
M.l. 30 60 
E.C.D. 10 23 
P.S. + A.S.D ... . 23 43 
P.S . ... 7 19 
A.S.D. 16 47 
P.S. ... . .. .. . 4 13 
P.S . ... ... ... 8 26 
V .S.D. + P.D.A. 4 14 
F. ... ... . .. 7 19 
E.C.D. 8 - 19 
V .S.D. + A.I. + P.I. 
+ T.I . 20 70 
V.S.D. 7 17 
V.S.D. 4 13 
F. 5 14 
M.I. .. . 44 45 
A.S.D. 8 19 
A.S.D. 10 33 
F. 16 51 
P.S . ... 9 26 
A.S.D .=Atrial septa! defect; 
V .S.D . = Ventricular septa! defect; 
M.I. = Mitra! incompetence; 
E.C.D.=Endocardial cushion defect; 
P.l.=Pulmonary incompetence; 
two cases three or four gentle diaphragmatic 
contract:ons occurred after five minutes of per-
fusion and then ceased. This was thought to be 
due to low halothane concc:itration achieved 
during priming of the pump oxygenator in these 
cases. In one other case diaphragmatic contrac-
tions occurred after twenty minutes of perfusion. 
This coincided with a temporary obstruction of 
the superior vcna caval catheter and was corrected 
as soon as the obstruction was relieved. 
Halothane levels in the blood. 
In four cases samples of arterial blood were 
taken for estimation of the halothanc content. All 
samples were taken from a cannula placed in the 
right internal mammary artery. Halothane esti-
mations were p:rformed by the method of 
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85 55 19 
100 60 53 
75 75 
50 60 48 
80 50 27 
90 40 44 




60 70 25 
80 55 
P.S.=Pulmonary stenosis; 
M.S. = Mitra! stenosis; 
F = Fallot's tetralogy; 
A.I.=Aortic incompetence; 
P.D.A.=Patent ductus aneriosus. 
Kench and E. J. Duncan (in press). The results 
of analysis arc given in figure 1. 
Blood gas wzlues and pH. 
Arterial and venous samples taken b:fore 
perfusion, during perfusion, at 20 minutes and 10 
minutes after perfusion, were subjected to analysis 
for oxygen saturation and carbon dioxide content. 
The arterial samples were all taken from the right 
internal mammary artery. Venous samples were 
obtained either from a catheter placed in the 
inferior vena cava via the saphenous vein, or from 
an arm vein. The result of these estimations is 
given in figure 2. The pH values of arterial blood 
samples taken at the same times as above in 
12 of these cases arc given in table II. The pH 
estimations were carried out on fresh arterial 
blood using the Beckman model "G" pH meter 
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FIG. 2 
Halothane values at O minutes on graph represent the 
level in arterial blood before the start of cardiopul-
monary bypass. Other points represent the levels at 
times indicated during bypass in four cases. 
by a simplified method (Turner, 1959). In three 
cases, simultaneous arterial samples and mixed 
venous samples from the venous well were 
obtained at known perfusion rates just after 
closure of the cardiac defect. Using the Fick 
principle, oxygen uptake was calculated from these 
values and gave the results indicated in table m. 
Perfusion pressures. 
Perfusion rates and mean perfusion pressures 
were as indicated in table I and in all except 
one case the perfusion pressures were monitored 
by a strain gauge attached to a catheter in the 
right internal mammary anery. 
Electroencephalograph. 
Electroencephalographic monitoring was avail-
able in all adult patients. No undue suppression 
of cortical activity attributable to the anaesthetic 
agent or technique was evident. This will be the 
subject of a further communication. 
0.1 
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TABLE II 
pH Total CO, m.equiv / 1. 
Nature of defect 






































13.52 21.24 14.35 
27.4 19.0 29.2 
22.6 16.1 24.6 
23.5' 16.0 22.3 
25.0 15.0 22.0 
22.2 13.9 19.1 
25.4 17.8 25.2 
pH values and carbon dioxide determinations are obtained from the same blood sample taken from 
the internal mammary artery in each case . Samples were taken just before bypass, during bypass, at 20 
minutes and IU minutes after bypass. 
TABLE 
Arterial 
Weight of Pump ·oxygen 
patient output saturation 
(kg) (ml / min) per cent 
33 2800 96 
19 1980 96 




















The oxygen uptake was calculated, using the Fick principle, from known pump output and arterial and 
venous oxygen content determined from percentage saturation and haemoglobin value. 
The heart. 
In the twenty-eight patients operated upon 
using halothane anaesthesia, the heart tolerated 
handling during various surgical procedures ex-
tremely well. Apart from occasional extrasystoles 
and short bouts of atrial fibrillation, no serious 
arrhythmias were noticed. 
The arterial pressures were continuously re-
corded by means of a polyethylene tube in the 
internal mammary artery and the inferior vena 
caval pressures by means of a polyethylene tube 
in this vessel. In none of the cases in this series 
were any unusual changes noticed which could 
suggest inadequate cardiac function. 
During total cardiopulmonary bypass the heart 
behaved normally. It tolerated potassium citrate 
asystole extremely well and took over adequately 
after the discontinuation of asystole and total 
bypass. 
Postperfusion. 
At the end of perfusion, ventilation of the lungs 
was recommenced using only nitrous oxide and 
oxygen. The blood pressure in all cases returned 
to near the level recorded before perfusion, 
provided that the patient's blood volume bad been 
satisfactorily maintained. In this connection it 
must be cmpbas:zcd that accurate assessment of 
blood loss throughout the operation must be 
energe~ically striven for aod any deficiency rapidly 
made good. Nitrous oxide and oxygen provided 
adequa,e anaesthesia at this stage and permitted 
controlled respiration until the closure of the 
chest, except in the three cases already referred 
to. All th: patients were awake and able to answer 
questions intelligibly within ten minutes of the 
end of anaesthesia. 
DISCUSSION 
The state of anaesthesia obtained with halothane, 
when used as des:ribed, has b:en entirely satis-
factory, both from the point of view of surgeon 
and of the anaesthetist. A degree of stability and 
control was achieved more easily than has been 
possible in our hands using thiopentone and 
relaxants in a series of thirty cases reported by 
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one of us (Ozinsky, 1959). There was no death 
in the series and no morbidity which could be 
attributed to the anaesthesia. As halothane is 
eliminated by the lungs there is the advantage 
that there need be no fears regarding circulatory, 
renal or hepatic elimination of this agent. 
Hypotcnsion before or after perfusion has 
not been of such a degree as to cause anxiety. A 
fall in systolic pressure of some 10 to 20 mm Hg 
from pre-anaesthetic levels is usual. Pressures 
during perfusion may remain somewhat lower 
than those which have been encountered with 
comparable perfusion rates using thiopentone and 
relaxants. This is probably due to the action of 
halothane on peripheral vessels described by Burn 
and Epstein (1959). If so, it is felt that this may 
be an advantage as it would indicate a lesser degree 
of per:pheral vasoconstriction from sympathomi-
mctic stimuli induced by reflexes brought about by 
the altered haemodynamics of total body perfusion 
under light anaesthesia. Such sympathetic stimuli 
may be a potent cause of metabolic acidosis 
(Griffiths ct al., 1939; DeWall et al., 1956). 
It is felt that some degree of vasodilatation is 
also beneficial in the immediate postperfusion 
stage because it allows the traumatized heart to 
take over initially against a diminished vascular 
resistance. 
The postoperative recovery and the electro-
encephalographic recordings have given no indi-
cation that cerebral hypoxia occurred in any case. 
Clinical observation also confirmed the existence 
of a good peripheral circulation as evidenced by 
good colour of conjunctivac and extremities 
throughout perfusion. 
Encephalocardiographic recordings and the 
observation of an experienced cardiac surgeon 
have given no indication of cardiac arrhythmias 
or increased myocardial instability which could 
be attributed to the anaesthesia. In cases in which 
elective cardiac arrest was produced with potas-
sium citrate (see table I) the resumption of normal 
rhythm was not delayed. In four cases in which 
ventricular fibrillation accompanied the termina-
tion of potassium citrate arrest, defibrillation was 
not difficult to achieve. 
There is no indication of any interference 
with gas exchange in the oxygenator. The 
three figures obtained for oxygen uptake, al-
though too few to provide conclusive evidence, 
appear to be satisfactory. There is no notable 
depression in oxyge!l. consumption, but it is 
interesting to speculate on the possible results of 
using higher blood anaesthetic concentrations. 
In one experime.it on a dog, one of us (A.B.B.) 
has d:liberatcly :i;roduced card:ac arrest during 
perfusion with blood containing a high halo-
thane content. This arrest was reversible on 
eliminating the halothanc via the pump oxy-
genator system, and the possibility remains that 
a general depression of all tissue metabolism may 
be attainable, thus permitting the use of lower 
perfusion rates when this state, has been achieved. 
The blood halothanc levels obtained show a 
satisfactory state of consistency throughout by-
pass. Clinical observation and e.c.g. monitoring 
have led us to the conclusion that 1 per cent halo-
thane provides adequate and saf c anaesthetic 
conditions. 
SUMMARY 
A technique of anaesthesia for open heart surgery 
using the Lillchci-DcWall pump oxygcnator is 
described. Halothanc, without intravenous agents, 
is used as the principal anaesthcstic agent and is 
administered via the lungs prior to, and during, 
cxtracorporcal circulation and via the bubble 
oxygcnator during cardiopulmonary bypass. The 
results obtained in twenty-eight unselected 
patients, in whom most types of open heart sur-
gery were undertaken, when anaesthetized in this 
way arc discussed. There was no mortality or 
·morbidity in this series. 
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RADIOTHERAPY WITHOUT TEARS 
BY 
G. G. liARRISON AND M. B. BENNET 
Departments of Anaesthesia and Radiotherapy, Groote Schuur Hospital, Cape Town, 
and University of Cape Town, South Africa 
SUMMARY 
A method of anaesthesia which has been us:d on 100 occasions for radiotherapy in infants 
and unco-operative small children is described. The method is applicable when the 
anaesthetist must remain outside the treatment room, and consists of the insufflation 
of nitrous oxide, oxygen and halothane through the side-arm of an oropharyngcal airway. 
This method overcomes the disadvantages of tracheal intubation or heavy sedation in 
cases in which therapy must be frequently repeated. 
Radiotherapy combined with surgery and cytotoxic 
drugs is currently accepted as the best treatment 
of certain malignant tumours of childhood. Such 
tumours include Wilms tumour, retinoblastoma, 
lymphoma, neuroblastoma and cerebral tumours. 
Radiotherapy is prolonged, consisting of sessions 
of irradiation of about 5 minutes, administered on 
alternate days for 21 to 28 days or more, depending 
on total dose desired. 
Considering the awesome aspect of the therapy 
machines together with the fact that no one may 
be with the patient during the period of irradia-
tion, it is surprising that the great majority submit 
to the complete course of therapy with little or no 
restraint and no sedation. 
Over the past three years 96 children have been 
so treated in this Unit. However, in a small 
number of patients in the infant-to-toddler age 
group of 1 ! to 5 years of age, patient co-operation 
may be impossible to obtain. In treating some 
lesions involving small fields such as retino-
blastoma, for which small beams are used, com-
plete immobility of the patient is absolutely 
essential for the accuracy and success of treat-
ment. Further, as these children have usually 
already suffered cnucleation of one eye they do 
not talte kindly to the proximity of a therapy 
machine to the other. Sedation of the patient 
becomes virtually a sine qua non. The provision of 
adequate sedation on such a regular basis poses 
many problems. If the infant is sedated sufficiently 
quently irritable for the best part of the day-no 
matter which of the conventional sedatives or 
tranquillizers is used. This would not matter much 
over a short period, but over a period of daily 
treatment as protracted as that needed for the 
radiotherapy the infant's nutrition may suffer 
greatly. Further, the infant often develops toler-
ance to the drug used. This results after a while 
in uncertainty of dose response. 
Basal narcosis with thiopentone sodium, or 
bromethol given rectally, though theoretically 
attractive as a method, has been found to be 
unsatisfactory in practice for several reasons. The 
children arc drowsy and irritable for a long period 
after bromethol. This is less so with thiopentone. 
Precision in dosage is difficult to achieve. Chronic 
usage of these drugs per rectum appears to cause 
proctitis and colitis with much secretion of mucus 
resulting in great uncertainty in the absorption of 
the drug. Accuracy of dosage becomes impossible 
after as few as five anaesthetics. 
Halothane anaesthesia (Bryce-Smith and 
O'Brien, 1956; Bull, du Plessis and Pretorius, 
1958) has certain characteristics which it appeared 
to us would help solve this problem. 
(1) Anaesthesia is rapidly and smoothly in-
duced, especially in infants. 
(2) Recovery is rapid and complete, especially 
after a short period of anaesthesia. Nausea 
and vomiting are rare accompaniments of 
halothane anaesthesia. A child may be fed 
soon after recovery of consciousness. 
to secure certain immobility during the period of 
therapy, it will be extremely drowsy and subse-
720 
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(3) The activity of pharyngeal and laryngeal re-
flexes is markedly reduced. 
(4) The drug is of sufficient potency to allow 
of easy maintenance of anaesthesia by an 
insufflation technique, thus obviating the 
need of an anaesthetic facepiece or endo-
tracheal tube. The former is undesirable 
from the aspect of the observation of the 
patient at a distance and the latter because 
of the possibility of laryngeal sequelae con-
sidering the frequent repetition of the pro-
cedure. 
(5) Halothane is non-explosive. 
We evolved the following simple method of 
anaesthesia for radiotherapy of infants, which we 
have now used successfully for the course of radio-
therapy of six patients, involving 100 treatment 
sessions (table I). If therapy is planned for early 
in the morning, breakfast is postponed until after 
721 
therapy. If therapy is planned for early in the 
afternoon, breakfast is given but lunch is postponed 
till after therapy so that a period of 4 hours is 
allowed to elapse from the last meal. Fony-five 
minutes before therapy, premcdication of atropine 
0.2-0.3 mg is given intramus:ularly, depending on 
TABLE I 
Pa1ie111s a11aes1hnized for radiotherapy. 1959-1962. 
No. of 
Age treatment 
Patient in years Tumour sessions 
MB 5 Rctinoblastoma 19 
YN 4 Rctinoblastoma 21 
BC It Retinoblastoma 20 
FA It Retinoblastoma I:? 
HO 3 Rhabdomvosarcoma 
of nasopharynx 12 
LB 3 Wilms 16 
6 100 
FIG. I 
The patient during therapy ( for retinoblastoma) as observed from control ba,·. Note abdomen 




the weight of the child. The infant is placed on 
the therapy table and anaesthesia is induced with 
nitrous oxide, oxygen a11d halothane from a stan-
dard Boyle machine and Fluotec vaporizer, deli-
vered by means of an infant-modified T-piece bag 
and facepiece (Cape Town System; Voss, 1963). 
The halotbane concentration is rapidly increased 
to 2 per cent. Anaesthesia of adequate depth, 
judged by absence of eyeball movement, small 
pupils, quiet respiration, absence of pharyngeal 
reflexes and loss of tone in the limbs (analogous 
to Guedel stage 3, plane II) is usually achieved in 
from 5 to 8 minutes. At this stage a Waters oro-
pharyngeal airway (with side-arm) is introduced 
and the delivery tubing from the Fluotec and Boyle 
machine, formerly attached to the bag assembly, is 
now attached to the Waters airway. When radia-
tion of the pharyngeal or mouth region is required, 
FIG. :! 
Close-up of head assembly showing Waters airway. tube 
for ar,aesthetic gases and cotton wool "butterfly". 
(Note : For therapy to pharyngeal growths, this airway 
should be non-metal to prevent radiation scatter.) 
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the airway should be non-metal, in order to avoid 
radiation scatter. The mouth is shut on the airway 
by means of adhesive tape. The child is now posi-
tioned with the head extended and the chest and 
abdomen uncovered to facilitate observations (figs. 
1 and 2). A small cotton wool "butterfly" is fixed 
over the Waters airway. If desired, a stethoscope 
with extended tubing may be fixed to the chest 
wall. This was done on the first ten o:casions on 
which this method was used. However, as the 
method proved so trouble-free, we deemed it saf c 
to omit. In the presence of continual visual obser-
vation of thorax and abdomen we have found the 
"butterfly" sufficient corroborative evidence of the 
state of ventilation. The halothane concentration 
is now reduced to 1 per cent. The radiotherapy 
machine is positioned and the radiotherapist and 
anaesthetist retire to the observation bay. Radio-
therapy is commenced. 
Throughout the period of therapy-usually only 
5 minutes-the anaesthetist observes the patient 
and the anaesthetic machine closely through the 
glass panel of the control bay. The child's respira-
tion is easily observed by correlating observations 
of the cotton wool butterfly with movements of the 
thorax and abdomen. If anything amiss is observed, 
the radiation is interrupted and the anaesthetist is 
able to reach the patient within a matter of seconds. 
In the 100 treatments here reported, such inter-
ruptions of therapy have not been necessary. 
At the conclusion of the treatment session anaes-
thesia is discontinued. The child regains conscious-
ness within 5 minutes and may be saf cly fed an 
hour later. 
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5.2 
RADIOTHERAPY WITHOUT TEARS 
RADIOTH~RAPIE "SANS PLEURS" 
SOMMAIRE 
Les auteurs signalent une mcthode d'anesthesie utilisee 
dans 100 cas de radiotbcrapie de bcbcs et d'enfants 
en bas age crispcs et causant des difficultes. La 
mcthode peut ctre employee lorsque l'anesthesiste a 
la possibilitc de rester hors de la piece de traitement. 
Cc demier consistc dans l'insufflation de protoxyde 
d'azotc, d'oxygenc ct d'halothane par une entree laterale 
d'une canalisation de gaz placee dans la region 
oropbaryngee. Cette mcthode vient a bout des incon-
venients de !'intubation tracbeale et evite une sedation 
trop brutalc dans les cas dans lesquels le traitement 
doit ctre repctc plusieurs fois. 
723 
STRAHLENTHERAPIE OHNE TRANEN 
ZUSAMMENFASSUNG 
Es wird cine Narkoscmethode, die bei 100 strahlen-
therapcutischen Eingriffen an Sauglingen und unruhigen 
Kleinkindcm angewendet wurde, beschricben. Die 
Methode ist brauchbar, wenn der Anisthesist auBcrhalb 
des Behandlungsraumes bleiben mutt Sic besteht in 
einer Bcatmung mit Lachgas, Sauerstoff und Halothane 
durch ein rechtwinkliges Yerbindungsstiick eines 
oropharyngealen Tubus. Diesc Methodc Uberwindet 
die Nachteile der trachealen Intubation oder starken 
Sedierung bei Fallen, bei dcnen die Thcrapie haufig 
wiederholt werden muO. 
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The effect of cardiac lesions on the action of 
suxamethonium 
GAISFORD G. HARRISON MBCh. B (eapc Town), FFARCS 
Dcpanment of Anzsthctics, University of 
Cape Town and Groote Schuur Hospital 
A paralysing dose of suxamethonium when injected rapidly intra-
venously, almost invariably produces marked muscle fasciculation, 
followed immediately by profound paralysis. However, the author 
formed the impression that when used to facilitate endotracheal 
intubation during the induction of general anresthesia in patients 
presenting for open heart surgery, a greater number of cases failed 
to fasciculate than is generally the case. To establish the validity or 
otherwise of this impression, the following simple investigation was 
carried out. 
METHODS 
In all adult patients presenting for open heart surgery, suxametho-
nium chloride in a standard dose of 50mg was used to facilitate endo-
tracheal intubation following the induction of general anresthesia 
with thiopentone sodium. This dose was injected rapidly intravenous-
ly into an ante-brachia} vein. The subsequent presence or absence 
of muscle fasciculation was recorded. When present, the quality of 
the fasciculation was noted as being (a) good to moderate or (b) 
poor. The time elapsing from injection of suxamethonium to onset 
of fasciculation was recorded. All these patients had previously 
been investigated by cardiac catheterization, including the use of 
dye dilution curves, by the Cardiac Clinic of Groote Schuur Hospital. 
Details of cardiac output and the characteristics of the dye dilution 
curves recorded at these investigations were examined in each case. 
These cardiac laboratory investigations had been done at periods 
varying from days to months before the patients presented for 
surgery. 
In another randomly selected group of patients presenting 
for general and ENT surgery, in whom the cardiovascular system 
*Based on a paper presented at the 45th South African Medical Congress, 1965 
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appeared clinically normal, similar observations were made as to 
the presence or absence and quality of muscle fasciculation following 
the injection of a standard dose of 50mg suxamethonium chloride. 
These patients constituted a control group. 
RESULTS 
The patients included in this investigation fell into tnree broad groups: 
I 23 patients who had atrio-septal defects. 
2 39 patients who had mitral valve disease which had resulted in 
incompetence or mixed incompetence and stenosis. Twelve of 
these patients had associated tricuspid incompetence while 4 
had aortic incompetence. Patients suffering from pure mitral 
stenosis who were treated by closed heart valvotomy were not 
included in this investigation. 
3 19 patients who had aortic valve disease which had resulted in 
stenosis and/or incompetence. One of these patients had asso-
ciated mitral stenosis. 
Patients suffering from other lesions such as Fallot's Tetralogy and 
pulmonary stenosis presented for cardiac surgery during this inves-
tigation, but were in insufficient numbers to warrant comment. 
Incidence of muscle fasciculation 
Observations relating to the incidence and quality of muscle fascicu-
lation in the patients in these 4 groups are presented in table 1. 
TABLE 1 
Qualiry of muscle fasciculation following IV suxamethonium 50mg 
'.!,; incidence in parenthesis 
QUALITY OF MUSCLE 
FASCICULATION 




A TRIO SEPT AL MITJlAL .Y AL VE AORTIC VAL VE CONTROL GROUP 
DEFECT DISEASE DISEASE 
23 
2 (8.7 %) 
2 (8.7%) 
19 (82.6 %) 
39 
•13 (33.3%) 






X2- 34.89 on 6 d.f. P<0,001 
•s auoc: TI f6 aaoc TI 
I auoc: Al 2 U10C Al 
39 
2 (5.1 %) 
1 (2.5%) 
36 (92.4 %) 
The differences in the incidence and quality of fasciculation shown 
here are statistically highly significant. From this table it will be seen 
that as many as one third of the patients with mitral incompetence 
failed to show muscle fasciculation following the administration of a 
standard dose of 50mg suxamethonium, while a further one third 
showed only poor muscle fasciculation. 
1t was noted further, that in 9 of the 13 patients with mitral incom-
petence who failed to fasciculate and in 7 of the 13 who showed only 
poor fasciculation, inadequate relaxation of the larynx and coughing 
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on intubation necessitated a further dose of suxamethonium. Of these 
16 patients 6 had associated tricuspid incompetence. A repeat dose of 
suxamethonium was necessary in only I case in a group of patients 
suffering from aortic valve disease and in none of those with atrio-







Incidence of repeat dose of suxamethonium 
Total No. in each group in parenthesis 
ATRIO SEPTAL MITRAL VALVE AORTIC VALVE 
DEFECT DISEASE DISEASE 
0 (2) •9 (13) 0 (2) 
0 (2) t7 (13) 1 (5) 
0 (19) 0 (13) 0 (12) 
•3 auoc TI f3 auocTI 
1 auocAI I usoc:AJ 





Looked at in another way dye dilution curves, used in the first in-
stance for diagnostic purposes, could be regarded as illustrating 
graphically the manner in terms of time and concentration in which 
any drug injected IV would reach the tissues. Certain parameters of the 
dye dilution curves of these patients were examined from this aspect. 
In recording dye dilution curves the site of injection of the dye 
used-in this case cardio green-and the distal site of sampling are 
varied to meet the diagnostic need. The one combination of injection 
site and sampling site, common to all the dye dilution curves exa-
mined, was injection of the dye into the main pulmonary artery with 
sampling via the brachia! artery. Only the parameters of this type of 
dye dilution curve were examined. The following features were noted: 
I General shape of the curve 
2 Presence or absence of recirculation curve 
3 Peak concentration of dye 
4 'Build up' time 
While the dye curves of those patients with atrio-septal defects 
differed from the normal only in the distortion of the disappearance 
slope, the curves of those patients with mitral incompetence showed 
marked deviations from the normal. In general, these showed: 
(a) prolonged build up times 
(b) low peak concentrations of dye 
(c) prolonged disappearance slope and 
(d) absence of recirculation curve 
These differences are illustrated in comparison with a normal curve 
in Figure I. In the patients with mitral incompetence, the effects of 
valve incompetence were usually associated with those of low cardiac 
output. The dye curves of those patients with aortic incompetence 
showed changes similar qualitatively to those with mitral incompetence 
but of a much lesser degree. 
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2 mitral incompetence 
A injection of dye 
A- B appearance time 
B-C 'build-up' time 
C peak concentrations reache9 
D recirculation curve 
nGURE l Specimen pulmonary artery- brachial artery dye dilution curves 
Build-Up Times 
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Measurement of'build-up' times alone revealed the differences shown 
in table 3. (It should be noted that the numbers in the three groups 
are not the same as in the previous tables, as dye curves were not 
available for all cases.) 
TABLE 3 
Dye dilution curve "build-up" time 
Mean lime seconds 
SD± 
Number of curves eumined 











In the group of patients with mitral incompetence, analysis of the 
incidence and quality of muscle fasciculation against the dye curve 
'build-up' time revealed a grossly prolonged mean 'build-up' time in 
those patients who failed to fasciculate as compared to those that did. 
(table 4). 
TABLE 4 
Dye dilution curve "build-up" time. Mitra/ l'Ofre disease only 
MUSCLE FASCICULATION 
Mean time seconds 
SD+ 















These differences in 'build-up' time, shown graphically in Figure 2, 
are, in each case, statistically highly significant on a one-way analysis 
of variance. The mean 'build-up' time in the patients with rnitral in-
competence who failed to show muscle fasciculation was 12.3 























FIGURE 2 Histogram of dye curve mean 'build-up• time 
Vol 21 
us to expect that 95 % of such patients with dye curve 'build-up' 
times in excess of J 0.6 seconds would fail to show fasciculation 
following injection of a 50mg dose of suxamethonium. 
In the case of the group of patients with aortic valve disease, though 
there is a difference in mean 'build-up' time between poor and good 
'fasciculaters', this difference is not significant in the numbers in this 
investigation. 
Circulation time 
At the time of induction of anresthesia, the time taken from injection 
of suxamethonium to th.e onset of muscle fasciculation was recorded. 
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This was regarded as a measure of the arm vein-muscle mass circu-
lation time. Results obtained in those patients who showed muscle 
fasciculation are recorded in table 5. 
TABLE 5 
Arm vein-muscle mass circulation time 
TIME IN SECONDS ATRIO SEPTAL MITRAL VALVE AORTIC VALVE CONTitOL QROUP 
DEFECT DISEASE DISEASE NO CARDIAC 




















Tested on a one way analysis of variance, the differences shown are 
statistically highly significant. 
As circulation time in general depends on cardiac output, we may 
perhaps conclude from the excessively slow mean circulation time 
displayed by patients who had mitral incompetence-over twice as 
long as that in patients with atri<rSeptal defects or the control group-
that this group of patients had the lowest cardiac output at the time of 
surgery. Though no direct measurement of cardiac output is made at 
the time of surgery, this parameter had been measured at the time of 
catheterization. As the time interval between cardiac catheterization 
and surgery varied widely between a few days and many months and 
the conditions under which the two measurements were made were 
different, it was not surprising that no good correlation could be 
established between cardiac output as measured during catheteriza-
tion and the suxamethonium circulation time at the time of surgery. 
However, the patients with mitral incompetence as a group, showed 
the lowest mean cardiac index {this difference being statistically 
significant) at the time of catheterization (table 6). 
TABLE 6 
Mean cardiac index of patients who showed fasciculation 
Mean cardiac index 1/min/mZ 
SD+ 

















Table 6 includes only those patients who showed muscle fascicu-
lation. If the patients who failed to show muscle fasciculation were 
included, the mean cardiac index of the patients with mitral incorri-
petence would be lower still. 
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DISCUSSION 
The lesion of mitral incompetence with the possible association of 
tricuspid incompetence appears to modify the response to the injec-
tion of a standard dose of 50mg of suxamethonium, a paralysing dose 
in the majority of adults. Of a group of patients with mitral incom-
petence, one third failed to show muscle fasciculation following the 
injection of suxamethonium. Further, in a high proportion of these 
the relaxation produced for intubation could be classed as inadequate, 
necessitating a repeat dose. 
The most probable reason for these observations lies in the effect 
the circulatory dynamics of this lesion have on the manner in terms 
of time and concentration in which the injected drug reaches the 
muscle mass. It has been established thatthevigourofmusclefascicu-
lation following the injection of suxamethonium appears to be 
determined by the .rate of onset of endplate depolarisation1. In 
general, the slower the injection, the less marked the intensity of 
the muscle fasciculation 2. Taking the dye curves displayed as a gra-
phic illustration of the manner in terms of time and concentration in 
which an intravenously injected drug would reach the tissues, it is 
shown here that 'the build-up' time to peak concentration of injected 
dye is much longer in patients with mitral incompetence than in the 
other groups of lesions mentioned-and much longer than that 
pertaining in the normal patient. The mean build-up time in the 
group of patients who failed to fasciculate was 12 seconds, six times 
longer than the normal. Also, the peak concentration of drug reached 
is lower. In addition, it must be remembered that the dye curves 
examined here were main pulmonary artery injections with brachial 
artery sampling, the injection therefore, being distal to the tricuspid 
valve. The 'build-up' time must be much longer if the injection site in 
a peripheral vein is associated with tricuspid incompetence. We also 
know that the enzymatic hydrolysis of suxamethonium by plasma 
cholinesterase is extremely rapid 3, particularly in the vascular com-
partment. The circulatory dynamics in severe mitral incompetence, 
with its associated large left atrium, congested pulomonary vascular 
bed and lower cardiac output, would seem to permit prolonged 
contact of intravenously injected suxamethonium with plasma in the 
vascular compartment before the drug finally reaches the muscle 
mass and the presence of tricuspid incompetence would compound 
this effect. The drug not only reaches the tissues more slowly with a 
lower peak concentration than normal, but it may well be that the 
actual quantity of active drug reaching the muscle mass is less. This 
effect might be anticipated to some extent in patients with severe aortic 
incompetence. However, in the group of patients presented here, the 
drug appeared to reach the tissues more rapidly, cardiac output was 
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better, 'build-up times' were more rapid and so by inference con-
tact of the drug with plasma was less in time. 
Implications 
The implications that follow from these observations are: 
I That if it is intended to use suxamethonium in patients with 
severe mitral incompetence - or perhaps severe incompetence 
of any heart valve - to ensure adequate relaxation and cough -
free intubation, a large dose, say I 00mg should be given ab initio, 
rather than the more usual 50mg. 
2 Following injection of suxamethonium, the anresthetist must be 
prepared to wait much longer than is usual- up to 2 minutes -
before conditions for intubation will be adequate. Where a 
cardiac catheterization investigation and dye dilution curve 
(pulmonary artery - brachia! artery) is available, if the build-
up time on such a curve is in excess of 10 seconds, one may 
venture the prediction that the patient will fail to show muscle 
fasciculation following a dose of 50mg suxamethonium and 
relaxation will be inadequate. 
3 When the anresthetist uses thiopentone sodium in a divided 
dose technique for induction of anresthesia in such patients, he 
must bear in mind the excessively slow circulation time demon-
strated, allowing adequate time to judge effects between indi-
vidual doses, if relative overdose and grave cardiovascular 
depression are to be avoided. 
SUMMARY 
Severe cardiac valvular lesions modify the clinical response to 
intravenously injected suxamethonium. 
I The time from injection to muscle fasciculation and subsequent 
relaxation in patients with such lesions is much longer than in 
controls. This is probably because of the slower circulation time 
consequent on reduced cardiac output in these patients. 
2 In the presence of severe valve incompetence, the degree of 
muscle fasciculation produced by suxamethonium is reduced, 
being entirely absent in many cases. This is particularly so in 
patients suffering from mitral incompetence. In this group of 
patients, as many as one third failed to fasciculate and in a 
further one third, extremely little muscle fasciculation was 
evident following administration of a standard dose of 50mg 
suxamethonium. 
3 An explanation of this reaction, based on the circulatory dy-
namics of these lesions is suggested and the clinical implications 
discussed . 
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LIGNOCAINE KINETICS DURING CARDIOPULMONARY BYPASS 
Optimum Dosage and the Effects of Haemodilution 
D. F. MORRELL AND G. 'G. HARRISON 
SUMMARY 
Lignocaine was administered to patients undergoing cardiopulmonary bypass at 28-29°C in bolus doses of 
1.5, 2.5 and 3.5 mgkg-1. Plasma concentrations greater than 1.5 µgml- 1 were found briefly and inconsis-
tently in patients receiving the usually recommended dose (l.5mgkg- 1), but reliably for 14min in those 
receiving 2. 5 mg kg- 1• The 3. 5 mg kg- 1 dose produced statistically and clinically significant decreases in 
mean arterial pressure. Examination of calculated kinetic parameters showed a two-fold decrease in Tim, 
two-fold increases in Tl and V- and unaltered C/p and Vp when compared with those of unanaesthetized, 
normothermic patients. The alteration in pharmacokinetics may be attributed largely to decreased binding to 
albumin following haemodilution. 
With the use of present methods of myocardial 
preservation during cardiopulmonary bypass 
(CPB), ventricular arrhythmias · at the end of the 
procedure pose less of a problem than previously. 
Antiarrhythmic agents arc seldom indicated, but on 
those occasions when they are required, lignocaine 
is selected most frequently. In normal subjects the 
effective plasma concentration of the drug against 
ventricular arrhythmias is greater than LS µgm1- 1 
(Grossman, Cooper and Frieden, 1969). This study 
was undertaken to determine the dose required to 
achieve this concentration during CPB. 
PATIENTS AND METHODS 
Twenty-four patients undergoing surgery for valve 
replacement or coronary artery bypass grafts were 
studied. 
Anaesthesia included the use of morphine, 
halothane and nitrous oxide in oxygen, following the 
induction of anaesthesia with sufficient thiopcntone 
to abolish the eyelash reflex. Neuromuscular block-
ade was produced (pancuronium) and ventilation 
controlled mechanically. The extracorporeal circu-
lation was powered by Sams Moduler roller pumps 
and used bubble oxygenators (Polystan Venothcrm 
VT 5000). The bypass technique included 
hacmodilution and cardioplcgia with moderate 
hypothermia (28-29°C). The pump priming vol-
ume was 3 litre of balanced salt solution (Plasmalytc 
D. F. MollJlEl.L., F.F.A.(S.A.); G. G. HAARISON, M.D., F.F.A.R.C.S. 
(ENG.); Department of Anaesthetics, Medical School, University 
of Cape Town Observatory 7925, Republic of South Africa; and 
Groote Schuur Hospital, Cape Town, Republic of South Africa. 
B), and pump flow was calculated on the basis of 2.4 
litrc/m2 body surface area. 
Blood-gas tensions, pH and plasma potassium 
concentration were kept constant throughout CPB. 
Once cardiovascular conditions had stabilized on 
CPB at 28-29°C, lignocaine was injected over 30 s 
to a port immediately below the bubble oxygenator. 
The bolus doses of lignocaine administered were (1) 
l.Smgkg-1 in 10 patients, (2) 2.Smgkg-1 in nine 
patients, and (3) 3.Smgkg-1 in five patients. The 
mean(± SD) doses for the three groups were 10S.S 
(±28.9), 163 (± 40.6), and 218.S (± 50) mg, respec-
tively. The largest dose was abandoned after use in 
five patients because of unacceptable decreases in 
mean arterial pressure (MAP). 
Blood samples were aspirated from the oxy-
genator debubbler at 2, 4, 6, 8, 10, 15, 20 and 
30 min after injection. Although we recognize the 
sampling period to be shorter than ideal for a phar-
macokinetic study, this limitation was required be-
cause of the duration of CPB. Plasma concentrations 
of lignocaine were assayed by gas-liquid 
chromatography (Morrell, Chappell and White, 
1982). Other biochemical measurements included 
total protein and albumin concentrations. 
From the plasma lignocainc assay data, coeffi-
cients and exponents for the concentration curve for 
each patient were calculated using the Fortran IV 
program CSTRIP (Sedman and Wagner, 1976), and 
pharmacokinctic parameters (table I) were calcu-
lated using formulae described by Wagner (1976). 
The R 2 value obtained from CSTRIP was always 
better than 0.98. 
(0 The Macmillan Press Ltd 1983 
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TABLE I. Pharmacokintric symbols 
r,· -ex phase hall-life (min) 
Tl • P phase hall-life (min) 
Clp • plasmaclcarancc(mlmin- 1kg-1) 
Vp • volumeofplasmacomparunent(mlkg-1) 
V" • apparent steady state distribution volume (ml 1cg- 1) 
~ • apparentvolumeofdistributionduringpphase(mlkg-1) 
RESULTS 
The mean plasma lignocainc decay curves following 
the three different doses arc shown in figure 1. A 
decrease to 1. 5 µg m1- 1 occurred within 3, 14 and 
more than 30 min following bolus injections of 1. 5, 
2.5 and 3.Smgkg-1, respectively. Only 60% of pa-
tients receiving the usually recommended dose of 
l.Smgkg-1 were found to have plasma concentra-
tions above 1. 5 µg m1-1 at 2 min, declining to 10% at 
4min. While the concentration of 1.5 µgmI- 1 was 
achieved for 4 min in all patients receiving the inter-
mediate-sized dose of 2. 5 mg kg-1, it was maintained 
at 30 min in 10% of this group. Following the 3. 5-
mg kg-1 bolus, lignocaine concentrations were grea-
ter than 1.5 µgmI- 1 in all patients for up to 20 min, 
and in 60% of patients remained so at 30 min. 
MAP did not change significantly in those pa-
tients receiving the two smaller doses but decreased 
on average by 20. 5% from the pre-injection pressure 
of 66mmHg in those receiving 3.5mgkg-1• The 
maximum individual decrease was 45% of the pre-
injection pressure. 
Hacmodilution resulted in a decrease in mean 
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scrum albumin concentration to 65% of its pre-
bypass value, which was itself at the lower limit of 
the normal range (table II). Scrum protein concent-
ration· did not alter during the experimental period. 
Pt · · "nacokinctic parameters are recorded in table 
III. 'i · · ·.!S~ represent the means of the values as 
calct· · , ~d for each patient. The clinically stable 
samp> ,;; period was limited to 30 min and, as a 
resuh :>ur c.alculated coefficients and exponents arc 
liable to error since a limited number of data points 
was obtained in the metabolic phase. Therefore, fn-
thc purpose of comparison with published work. 
recalculated the data of Rowland and colleag 
(1971) as if their sampling was discontinue 
30 min. The method used was to calculate from e 
data expected plasma concentrations at our samp,· 
ing times using the coefficients and exponents pro-
vided, and then to recalculate (using CSTRIP) the 
exponents and coefficients for the initial 30-min 
period. From these, pharmacokinetic parameters 
were derived. The original and recalculated data arc 
provided in table III, rows A and B. Comparison of 
the data from our 1.5-mgkg-1 bolus group (mean 
dose = 105. 5 mg) with theirs ( dose .. 100 mg) reveals 
a halving in T 1" and a doubling in Tl, V'" and V' in 
our data relative to theirs. Clp and Vp were the same. 
The extent of the error induced by the shonencd 
sampling period is evident when the original data 
from Rowland's work are compared with the recal-
culated data (table III, row A 11. row B), incurring an 
underestimate of half-lives and volumes of distribu-
tion and overestimate of clearance. 
DISCUSSION 
Although the pharmacokinetic behaviour of ligno-
cainc and its relevance to the development of effec-
tive dosage schedules have been well reviewed in 
patients with normal haemodynamics, heart failure 
and liver or renal disease (Benowitz and Meister, 
1978), we arc not aware of similar studies having 
been undertaken during CPB. Many factors which 
would influence pharmacokinetics are introduced 
such as anaesthetic and vasoactivc drugs, 
TABLE II. Serum prortin conunrrarions (glim- 1) before a,ul aft,r 
luumodilurion (mtan ± SD) 
Before 
FIG. 1. Computed plasma lignocaine decay curves following 3. S-, Total protein 





at each sampling time. 
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TABLE m. Pliamuu:oltnuric panimaen. Mean± SD of paninuun as ailculaud for .ach individual. 
A- °"6inal datafromRDwlalld alld c:oll«,pa (197l)for 100-"'6 bolu; B • A nailculaud fora 30-min lllfflplint 
period. 1 • Parrminer in 1.5-mgltg-1 bol1U group differs sipificantly from rltat in 3.S-ffllltg-1 bolu ,n,up 
(P < 0.05; Snulnt's t tar); 2 • Panimmr in 2.S-,ng 1cg-1 bo/111 grov.p differs sipifica,u/y from tliar in 3.5-mg 1cg- 1 
bol1U group (P < 0.005; StlliUnl's t tat) 
Dose 
(mgkg- 1) Tt Tl 
l.S 1.74±0.78 44.4±21 
2.S 1.38±0.6 31.8± 12 
3.S 1.02±0.3 21.4± 6.6 
A 8.8 92 
B 3.7 22.6 
Statistics 
hypothermia, dilution of red cell and protein con-
centrations, non-pulsatile flow, dccrcascd blood vis-
cosity and exclusion of the lung as a first-pass organ. 
Furthermore, whereas a total drug concentration of 
1.5 µgmI- 1 has been established as necessary for 
antiarrhythmic activity in the unanaestheti.zed pa-
tient, it is not axiomatic that this concentration 
applies following CPB. 
The main results of this study were the low initial 
and rapid decrease in plasma concentrations of lig-
nocaine during CPB. This is in keeping with the 
finding of altered distribution kinetics which were 
the two-fold dccrcasc in ~,. and two-fold increase in 













0 5 10 
C/p Vp v- v• 
21.7±7.2 S3S ± 22l 1158±279 1231 ±263 
26.7±8.1 371±220 945±219 1063±208 
25.l ± S.3 243± 61 666 ± 114 740± 124 
9.94 480 1080 1447 
20.S 493 629 667 
1 1, 2 1, 2 
reflected by Clp is unaltered, the increased Ti' 
caused by the increased volumes of distribution 
(Hull, 1981). The addition of an oxygcnator prime 
on a volume basis would not significantly increase 
volume of distribution as it would form part of VP 
which, for a 70-kg man receiving a 1.5-mgkg-1 
bolus, is of the order of 37 .5 litre. The additional 
3 litrc prime volume is thus less than 10% of V p and 
would require only an additional 4.5mg of ligno-
caine over and above the 105-mg bolus to achieve a 
concentration of l.SµgmI- 1• 
We feel that the explanation for the altered dis-
tribution kinetics can be attributed largely to an 
increase in the unbound pharmacodynamic fraction 
I 
C 
15 20 25 30 
Time (min ) 
FIG. 2. Curve A•Total lignocliue plasma concentration following 2.5-mgkg- 1 bolus. Curves Band 
C • Calculated unbound 1.ignoc:aine concentrations at albumin concentrations of 23 (B) md 3S g litre-1 (C). 
z • mean Vlllue for the group at each sampling time. 
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of lignocaine caused by the decrease in concentra-
tion of binding sites resulting from dilution of plas-
ma albumin. Actual measurements of this unbound 
fraction were not performed in our study, but esti-
mates may be made using published information. 
Drug binding to macromolecules (Koch-Weser and 
Sellers, 1976) is dependent on the total drug con-
centration, the macromolecular concentration, the 
number of binding sites per macromolecule and·the 
dissociation constant for the drug- macromolecule 
complex. Applying the constants derived by Tucker 
and co-workers (1970) for lignocaine-albumin 
binding, the calculated change in bound drug con-
centration following the injection of a 2.5-mgkg- 1 
bolus of lignocaine in our patients is shown in figure 
2. This records the decay curves for total and un-
bound drug at albumin concentrations of 35 and 
23 g litre-1, representing the pre-CPB and CPB con-
centrations in our patients. The 35% decrease in 
albumin concentration following haemodilution 
produced an almost constant 37% increase in un-
bound drug concentration over the whole range of 
total lignocaine concentrations encountered. 
Furthermore, an anti-arrhythmic total drug con-
centration of 1. 5 µg m1-1 corresponds to an unbound 
drug concentration of 0.45µgm1- 1 at an albumin 
concentration of 35 g litre-1• Figure 2 demonstrates 
also that hacmodilution to the extent of decreasing 
albumin concentration to 23 g litre-1 extends the 
time for which the unbound drug fraction is greater 
than 0.45 µgmI- 1 from 14to 26min. 
Our results indicate that, during CPB with 
haemodilution, the bolus loading dose of lignocaine 
with which to precede a continuous infusion is 
2.5mgkg- 1 rather than the more usually recom-
mended 1. 5 mg kg- 1• The larger dose produces grea-
ter and more sustained plasma concentrations with-
out incurring clinical changes in vascular resistance 
and MAP. 
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PHARMACOCINETIQUE DE LA LIGNOCAINE 
AU COURS DE LA CEC 
Posologu oPtimum et •ff•ts th l'lwmodilution 
RESUME 
De la lignocaine a etc administree a des patients IOumis a 
une CEC a 28-29"C, sous formed'injections directes de 1,5, 2,5 
et 3,5 mg 1q-1• Des conccntI1ltions plasmatiques superieure-a 
1,5 l'I mr I ont etc retrOUVCCS de f~n fugitive et incomtante 
chez !es patients 'l'f recevaient la posolc,sie preconiaec habitudle-
ment (l,5mgkg ), mais de faF. fiable pendant Um.in chez = qui recevaient 2,5mgkg- . La posolasic de 3,Smgq-1 
enttainait des diminutions 1tatistiquement et cliniquement lia· 
nificatives de la pression anerielle moyenne. L'examen de 
parametres cinctiques calculcs montrait une diminution de moitic 
de Tl a et des doublements de T/ et de v"', sans c:hanaement de la 
Clp ni du Vp par rappon a des patients normothermiques non 
anesthcsics. Les modifications des parami:tres pharmacocincti-
qucs pcuvcnt ettc l.argcment imputees a une diminution de la 
liaison a l'album.ine diie a l'hcmodilution. 
LIGNOCAIN: KINETIK WAHREND 
KARDIOPULMONALEM BYPASS 
Optimale Dosieru111 """ Eff•ltu au/ Hamodillllion 
ZUSAMMENFASSUNG 
Patienten wihrend kardiopulmonalcm Bypus bci 28-29-C 
erhielten Bolusdosen von 1,5, 2,5 und 3,5mgkg-1 Lignocain. 
Bei Patienten, die die iiblicherweise cmpfohlene Dom von 
1,5 mg 1q-1 erhalten hanen, wurden nur kurz und nicht iiberein-
stimmend PiumakonzentI1ltionen iiber 1,5 "'m1-1 aefunden, 
bci Patienten mit 2,5mgkg-1 jedoch zuverwaia iiber 14 Minu-
ten. Die Dom von 3,5 mgkg-1 verunachte einen ltatistisch und 
k1inisch signifikanten Abfall des mittleren aneriellen Drucb. 
Die Priifung der bcrcchneten kinetischen Parameter zeiite einen 
zweifachen Abfall von Tt, zwcifache Anstiege von Ti' und V"' 
und unverindcrte C/p und Vp im Vergleich mit nicht nar-
5A 
LIGNOCAINE KINETICS 
kotiaiertCD, normothermischCD PatiCDtCD. Die vcrindertc Pbar-
makolrinctik ist wahnchcinlich zum Gro6tcil auf die vcrringertc 
Albuminbindung durch Hiimodilution zuriickzufiihren. 
CINETICAS DE LA LIGNOCAINA DURANTE 
LA DESVIACION CARDIOPULMONAR 
Dons oprirtta y •ffflOS u la MM«lilucion 
SUMAIUO 
Sc administr6 lignocaina a paciCDtes IOIDCtidos a desviacion 
cardiopulmonar, a tcmperaturU de 28 a 29°C y CD dosis de l,S, 
2,S y 3,Smgkg-1. Sc cnconuaron concenu.ciones de plasma 
1177 
supcriores a l,Sµgml- 1 muy brevcmcntc y de forma irregular 
CD pacicntes que recibicron la dosis de l ,S ma q-1 normalmcntc 
rccomcndad•, pcro de fonna fiablc por Clpllcio de l4min CD 
aquellos quc recibieron 2,Smgkg- 1• La dosis de 3,Smgkg-1 
produjo diaminucioncs de la praion arterial media quc fucron 
lisnificativu tan to desdc cl punto de vista cstadiltico como desdc 
cl clinico. El CDIDCD de los puimetros cineticol calculados 
mostro UDa doblc diaminucion dd 7t•, UD doblc incrcmcntodcl 
T1I y V-, y Clp,y Vp lin altcracion alguna cuando IC c:omJmVOD 
con los de los pacicntes normotermicos aneatcliados. La variacion 
de los upectos farmacocineticos pucdcn auibuinc en sran medi-
da a la diaminucion de la lipzon a la albumina • raiz de la 
hcmodilucion. 
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EFFECT Of DURATION OF 
ANAESTHESIA ON APNOEA 
NEONATORUM AFTER CAESAREAN 
SECTION 
BY 
J. OZINSKY, l\f.B., Ch.B., D.A. 
AND 
G. G. HARRISON. F.F.A. R.C.S. 
Department of Anaesthesia, Unfrersity of Capetown 
In cases of caesarean section, many authorities (Clifford, 
1940; Gillies, 1950; Lull and Hingson, 1948; Ten 
Teachers, I 955 ; Queen Charlotte's Textbook of 
Obstetrics, 1951; Wylie, 1953) have emphasized the 
im1>ortance of delivering the child as soon after .the · 
induction of anaesthesia as possible, thereby minimizing 
the amount of anaesthetic agents passing to the foetus 
and there interfering with the normal onset of respira-
tion. We had gained the impression in clinical practice 
that the often unseemly haste was not justified. There-
fore infants delivered by caesarean section were inves-
tigated with special emphasis upon the relationship 
between the duration of the anaesthesia to which they 
might have been expose.cl and the delay in the onset of 
respiration. 
Method 
One hundred and two infants, the product of 100 consecu-
tive caesarean sections performed on mothers anaesthetized 
by one or ether of us over a period of six months, were studied. 
Indications for the s:ctions were varied, and are listed in 
Tables I and II. 
TABLE !.-Indications for Caesarean Sections 
Indication 
lncoordinate uterine action 
Pre-eclamptic toxaemia . . . . 
Disproportion or obstructed labour 
Placenta pracvia 
Elective 
Eclampsia . . I 
Oblique lie .. 
Diabetic elective : '. j 
Foetal distress . . . . . . 
Prolapsed cord . . . . . . I 
Strong labour in previous rupture j 
of uterus . . . . . . . . 1 
Carcinoma of cervix . . j 
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16 GQE 1 • •t 2! G 67 I GOE 20 0 H 17 GOE 16 70 C 68 GOE 14 0 E 18 · GOE 13 0 B 69 GOE 19 0 A 19 I GOE 9 O I H 70 GOEF 18 0 C 20 I GOE , 16 2 A 71 GOEF 8 I C 
21 ·1 PGOEFI 10 t A 72 GOEF 17 0 E 
23 CyGOE 16 13 I 74 GOE II O B 
22 · PGOEFI 6 12 B 73 GOE 10 7t A 
24 PGOEF 15 SBa D 75 GOE 9 0 C 2S I GOE 10 I L 76 GOEF 22 S E 
27 , GOE 20 ~ C 78 PGOEF 16 14 B 
26 GOE I 12t 2t I 77 GOE 12t O A 
28 I GOE 14t l C 79 GOEF 19 7 E 29 'I PGOEF S 1· H 80 PGOEF 18 8 C 30 PGOEF 4 90 C 81 GOE 10 t E 31 GOE IS O C 82 GOE 18 0 C 
32 GOE I It ·t I 83 GOE 1 13 17 B 33 GOEF 19 0 D 84 GOEF 18 0 C 34 GOE lit 7t D 85 PGOEF 17 12 B 3S GOE 17 5 D 86 GOE 121 9t E 36 GOEF 25 6 C 87 PGOEF 6 0 E 37 GOE 14 0 E 88 GOE 12 5 E 38 GOE 13 3 C 89 GOE 12 5 B 39 GOEF 13 0 J 90 GOE 1St ·2 I 40 GOEF 15 6 C 91 GOE 1St 4 E 41 PGOEF 13 13 C 92 GOE 16 0 E :i I gg~ 1; I~ ~ :! gg~ :: S~ i 
44 GOE 28 3 D 9S GOE 18 I J 4S GOE 19 8 C 96 GOE 8 t B 46 GOEF 12 SBb I 97 ChGOE 33t St K 47 GOE 6 0 J 98 GOE 11 0 B 48 GOE 7 0 J 99 GOE ,ot O C 49 GOE I 18t 
20
st I 100 GOE 23t 4 C SO GOEFI 19 E 101 GOE 14 O E SI GOE 10 6 I D 102 GOE IS O B 
I 
Ch-chloroform. Cy - cyclopropanc. E - etber. F-pllamine trieth-iodidc. G=nitrous oxide. O=oxyacn. P-thiopentone. SB-stillborn: (al case of placenta pracvia; (bl case of foetal distress; (c) case of "failed forceps" ; (di case of prolapsed cord. 
TAFLE III.-A11ces1hesia 
Anaesthetic Gallaminc Asents Jnduction Tricthiodidc Maintenance: 
N,O. o,. ether 81 16 I N. O. o .. and Chloroform .. I I ether "in all Cyclopropanc .. , I cases Thiopentone 17 16 
6.6 
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Premedication in all the i:ascs was i:onfined tr, atropine. 
· 100 gr. <0.65 mg.). However. several of the mothers had 
had sedatives within the accepted dangerous time limit-
for example. morphine Within four hours of delivery. ln 
all cases the baby was alive at the time of induction of 
anaesthesia. 
Anaesthesia (Tables II and Ill).-Anaesthesia was induced 
in 81 cases with nitrous oxide, oxygen, and ether: in I with 
cyclopropane: in I with chloroform : and in 17 with thio-
pentone sodium. Sixteen of the 17 were also given gallamine 
triethiodide, and so too were l 6 of those who had nitrous 
oxide, oxygen, and ether. In all cases maintenance was 
carried out with nitrous oxide. oxygen, and ether. 
Timing.-Two periods were measured (Table II) : (I) from 
start of induction of anaesthesia to delivery of the baby from 
the uterus, and (2) from delivery cf the baby from the uterus 
to establishment of continuing respirations. This end-point 
-the establishment of continuing n-spirations-was chosen 
instead of the more usual •· crying-time " or " breathing-
time;' ' because many of the infants would take one or two 
gasps or even cry once or twice and then cease breathing 
for a varying period before either dying <Baby 93) or beginning 
to breathe ·again. 
All infants were subjected to some degree of resuscitation. 
The measures adopted varied from simple wiping of the 
mouth to the administration of intragastric oxygen. We 
would commend the method of intragastric oxygenation 
(Akerren and Furstenberg, 1950), which we feel is what 
permitted Babies I 7 and 30 to survive. 
Results 
The results are listed in Table II and presented graphically 
in Figs. I and 2. 
Two sets of twins were born : Babies 47 and 48, and Babies 
52 and 53. Four babies are listed as never having breathed 
-Babies 24, 46, 63, and 93-though, in fact, Baby 93 gasped 
several times but never breathed continuously before dying. 
The results, excluding the four babies that died without 
breathing, were subjected to statistical analysis. When 
anaesthetic time was related to the delay in onset of continuing 
respirations, a correlation coefficient (r) cif 0. I 2 was obtained: 
t= 1.158, and with this value 0.25<P<0.30. This value of r 
does not differ significantly from zerc,, and therefore the 
evidence for the correlation is inadequate. 
The babies were divided into three groups according to 
whether they were exposed to anaesthesia lasting up to 10 
minutes and under, JO to I 5 minutes, or over 15 minutes 
(Fig. 2). The variability in the behaviour in delay in onset 
of continuing respirations of these three groups was similar: 
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FIG. 1.-Scattcrplot of time of exposure to anaesthetic related to 
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FJG. 2.-Histogram showing time of exposure to anaesthetic related to delay in 
onset of "continuing" respirations. The three groups arc similarly distributed 




Our results are apparently in conflict with established teaching. It appears that with duration of anaesthesia between 5 and 30 minutes there is no correlation between duration of anaesthesia to which the child is exposed and the delay in onset of respiration. However, closer investi-gation reveals : (I ) Our cas:s were almost entirely limited (93 out of 102) to th:>se exposed to anaesthesia for a dura-tion of 5 to 20 minutes. No comm.:nt can be made on what h1ppens outside these limits. /2) One hundred caesarean sections is not a very large sample on which to base dog-matic statements, as a large number of variables enter into the causation of apno:a neonatorum. However, even a trend towards prolongation of delay in breathing with increased time of exposure to anaesthesia is not evident. (3) All anaesthetics given to the mother may delay some-what the initial respirations of the infant (Cole er al., 1939). However, if the level of anaesthesia be kept light, the amount of anaesthetic passing to the infant may be kept to the minimum, and thus dangerous-from the point of view of respiratory activity-levels of ether in the blood (Smith and Barker, I 942) of the foetus be avoided. 
Conclusion and Summary 
In cases of caesarean section, provided that the child is extracted within 20 minutes of induction of anaes-thesia of the mother, we feel that a calm unhurried approach by the operating team will not adversely affect the child. I 02 infants born by caesarean section were investigated regarding the correlation between the duration of anaesthesia to which their mothers were exposed and the delay in breathing which the infants showed. When the duration of anaesthesia did nClt exceed 20 minutes, no such correlation was observed. 
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THE EFFECT OF INTRA-UTERINE ENVIRONMENT AND ANAESTHETIC FACTORS ON 
THE CONDITION OF THE BABY AFTER CAESAREAN SECTION* 
J. M . E. Di.: PLEss1s. M.B .. CH.B.. M.MED. (ANAES.) (CAPE ToWN), H . J. DU TorT. M .B .• CH.B .. M.MED. (ANAES.) 
(CAPE TOWN), G. G. HARRISON, M.D. (CAPE TOWN), FF.A.R.C.S. AND C. CRAIG. M.D. (CAPE TOWN), M.R.C.O.G .. 
Departments oJ Anaesthetics and Obstetric.1· and Gynaecology, University of Cape Town 
Much has been written about the effect of general anaes-
thesia on the depression of the baby after caesarean sec-
tion . Although general anaesthesia and its conduct must 
influence the condition of the baby at birth, the import-
ance of the pre-operative intra-uterine environment has 
often been disregarded. In an attempt to evaluate the 
relative importance of certain aspects of general anaes-
thesia. as opposed to that of the intra-uterine environment 
on the condition of the baby at birth following caesarean 
section, we undertook a survey of 1,011 caesarean sections 
performed in the Maternity Unit of the University of 
Cape Town Teaching Hospitals. These included emer-
gency and elective caesarean sections. All patients who 
had received opiate sedation within 6 hours of delivery, 
or avertin. were excluded from this survey. We also ex-
cluded 11 cases which resulted in stillbirth. The surgeons 
and anaesthetists involved were of both registrar and 
consultant status. The selection of the surgeon and anaes-
thetist was completely random, depending upon depart-
mental assignments at the time. 
The status of the baby was assessed by means of the 
Apgar score' determined at 1 min. and 5 min. after de-
livery. The Apgar score was reckoned out of a total of 8 
points. the points awarded for colour in Apgar's original 
description of this method being omitted.' This scoring 
was done by the paediatric registrar in attendance. or. 
when he was not present. by the anaesthetist. 
The incidence of the use of intubation and IPPR re-
quired during resuscitation of the baby was used as a 
separate additional factor in the evaluation of the con-
dition of the baby after delivery. The need for intubation 
and IPPR was assessed by the person directing the re-
suscitation of the baby and was instituted when the respi-
ratory function of the baby appeared grossly inadequate. 
or when the heart rate dropped below 100 beats / min. 
Anaesthetic Technique 
Certain aspects of the anaesthetic technique were stan-
dardized (Table l). All patients received 0-65 mg. of 
atropine intramuscularly or intravenously . . Endotracheal 
intubation was performed following the injection of suc-
cinylcholine. Anaesthesia was maintained with nitrous 
oxide and oxygen {25 % or greater) delivered by an IPPR 
technique with either carbon dioxide absorption or the 
• Based on a paper presented at the 46th South African Medical Congress 
(M.A.S.A.). Durban. July 1967. 
use of a non-return system. Muscular relaxation was ob-
tained with d-tubocurarine. 
TABLE I. ANAESTHETIC TECHNIQUE 










The induction agent used constituted the only variable 
in the anaesthetic technique. Induction· agents used were: 
1. Thiopentone in doses not exceeding 250 mg. 
2. Nitrous oxide with 25% oxygen. 
3. Methohexital in doses not in excess of 100 mg. 
The use of methohexital was a later introduction to this 
investigation. 
Assessment of Foetal Risk 
The foetal risk was based on an assessment of foetal 
maturity, the duration of labour, and the presence of 
signs of foetal distress. The pre-delivery intra-uterine en· 
vironment was judged as resulting in high, moderate or 
low foetal risk as follows: 
Group 1 - low risk : 
Foetal maturity >36 weeks 
Duration of labour <18 hours 
No foetal distress 
Group 2 - moderate risk: 
Foetal maturity >36 weeks 
Duration of labour >18<30 hours 
No foetal distress 
Group 3 - high risk : 
Foetal maturity <36 weeks 
Duration of labour >30 hours 
Foetal distress 
Placental insufficiency 
For the purpose of this study, the presence of meconium 
in any amount in the liquor and a foetal heart-rate below 
120 beats /min. were regarded as signs of foetal distress. 
A special anaesthetic card was devised to facilitate the 
collection of all the data required. The relevant details 
5.6 
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were then transferred to computer cards and the results 
were subjected to statistical analysis. One-way analysis of 
variance. Student"s t-test or chi-square technique were used 
where appropriate. 
RESULTS 
Induction -Delivery Interval and Mean Apgar Score 
The time interval between induction of anaesthesia and 
deliver •f the child is a variable - in this series a random 
one - wn1ch may affect the condition of the baby follow-
ing caesarean section. Dividing our cases into 2 groups 
on a time basis. namely those in which the induction de-
livery interval was Jess than 15 min. and those in which 
the induction delivery interval was in excess of 15 min. , 
we examined the effect that the length of this interval 
might have on the condition of the baby after delivery 
(Table II). 
TABLE JI . EFFECT OF INDUCTION-DELIVERY INTERVAL ON MEAN APGAR 
SCORE 
No. of cases . . 
Mean Apgar score l minute 
Difference 
Mean Apgar score 5 minutes 
Difference 
Induction-delivery interval 
< 15 minutes >15 minutes 
412 456 
5·61 5·56 
0·05 (not sig.) 
6·99 6·92 
0·07 (not sig.) 
In the past a similar investigation in our department 
had failed to show any correlation between the induction-
delivery interval and the time required to establish sus-
tained breathing of the baby after caesarean section.• 
This finding was confirmed in this study by a lack of 
difference between the mean Apgar scores in these 2 
groups of cases, both at 1 minute from delivery and at 5 
minutes. 
Because the induction-delivery interval could not be 
shown to have any influence on the condition of the baby 
after caesarean section, this factor was ignored in subse-
quent analyses, both groups being summed. 
Influence of Foetal Risk on Mean Apgar Score 
The effect that the pre-operative condition of the foetus 
(assessed in accordance with the clinical criteria described) 
had on the condition of the baby after caesarean section is 
reflected in Table III . It will be noted that a high pro-
TABLE 111. EFFECT Of FOETAL RISK Ot,; MEAN APGAR SCORE 
Foetal risk 
No. of cases .. 
Mean Apgar score 1 min. 
Difference 
Mean Apgar score 5 min. 
Difference 
1 2 3 
363 29 619 
6·67 6·17 4·93 
0·5 (1. 2) l ·24 (2, 3) 
(not sig.) (p<o-<JOJ) 
1·74(1 , 3) 
(p< O·OOI) 
7·59 7 ·55 6·60 
0·04 (1, 2) 0·95 (2, 3) 
(not sig.) (p<O·OOJ) 
0·99 (1, 3) 
(p< O·OOI) 
portion of cases (61 ~0 ) fell into the group classed as of 
high foetal risk. This may reflect the type of case met in 
hospital practice. as opposed to that in private practice ; 
but we have no comparative information on this point. 
At 1 min. the babies classed as of high foetal risk 
achieved the poorest Apgar score. The differences in mean 
score between this group and those in both low and mod-
erate foetal risk groups, are statistically significant. The 
small difference between these latter 2 groups is not sig-
nificant. 
At 5 min. the mean Apgar scores had improved. but the 
differences, though less. are still obvious and the pattern 
the same. The difference between the high risk foetus and 
those in the low and moderate risk groups is statistically 
significant. while the small difference between the last 2 
group; is not. 
We may infer from the above observations that the 
condition of the foetus in utero is of importance in deter-
mining the condition of the baby after delivery. This 
factor must be taken into account before a valid assess-
ment of the effect of anaesthetic factors may be made. 
Effect of Induction Agent on Mean Apgar Score 
As no statistically significant difference was apparent 
between those babies we had classed as of low or of 
moderate foetal risk, these 2 groups were summed in the 
subsequent analyses in which we examined the mean 
Apgar score achieved by the babies in relation to the agent 
used for the induction of anaesthesia, and in relation to 
the pre-operative assessment of foetal risk. 
In the group of babies regarded as of low and moderate 
foetal risk (Table IV), those whose mothers received thio-
TABLE IV. EFFECT OF INDUCTION AGENT ON MEAN APGAR SCORE 
(GROUPS 1 AND 2 COMBINED) 
Induction agent 
No. of cases .. 
Mean Apgar 1 min . .. 
Difference 
Mean Apgar 5 min .. . 
Difference 
Thio~n- Metho-
tone hexital N,O I 0, 
196 44 123 
6·40 6·60 7·14 
0·20 0·54 
(not sig.) (not sig.) 
0·74 
(p< O·Ol) 
7·37 7-91 7-83 
0·54 0·08 
(not sig.) (not sig.) 
0·46 
(not sig.) 
pentone achieved the lowest mean Apgar score at min., 
and those whose mothers received nitrous oxide and 
oxygen for the induction of anaesthesia the highest, while 
those whose mothers received methohexital fell between 
these two. Only the difference in score between those 
whose mothers received thiopentone and those whose 
mothers received nitrous oxide and oxygen, achieved 
statistical significance. 
At 5 min. all the babies had improved to such an extent 
that no statistically significant difference in mean Apgar 
score was apparent in relation to the agent used to induce 
anaesthesia. 
In babies of high foetal risk (Table V) this pattern of 
response of the mean Apgar score to the anaesthetic in-
duction agent is accentuated. Not only do the 'thiopen-
tone babies' achieve the lowest score at 1 min., but the 
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difference between this and that achieved by the 'mctho-
hexital babies' now achieves significance. As in the pre-
vious analysis, the difference in Apgar score between the 
'thiopentone babies' and the 'nitrous oxide babies' is 
statistically significant. Again no difference is apparent in 
the mean Apgar score of those babies whose mothers had 
received methohexital and those whose mothers had re-
ceived nitrous oxide and oxygen for induction of anaes-
thesia. 
TABLE V. EFFECT OF INDUCTION AGENT ON MEAN APGAR SCORE 
(GROUP 3) 
Thiopen- Metho-
Induction agent tone hexital N,0 /0, 
No. of cases . . 228 99 292 
Mean Apgar 1 min ... 4 ·43 5-19 5·24 
Difference 0·76 0·05 
(p<0·02) (not sig.) 
0·81 
(p<O·OOl) 
Mean Apgar 5 min ... 6·43 6·90 6·65 
0·47 0·25 
(not sig.) (not sig.) 
Difference 0 ·22 
(not sig.) 
At 5 min. the condition of the babies had again im-
proved to such an extent that no statistically significant 
difference was apparent between the mean Apgar score in 
relation to induction agent. 
As this improvement in Apgar score in the first S min. 
is, to some extent, a reflection of the efficacy of resusci-
tation of the baby, we then examined the incidence of the 
need in resuscitation for endotracheal intubation and 
!PPR in relation to our assessment of foetal risk and 
thereafter in relation to the induction agent used. 
Need for Intubation and IPPR in Relation to Foetal Risk 
and Induction Agent 
This analysis mirrored, to some extent, the results of 
the previous analyses. When analysed in relation to foetal 
risk (Table VI), it can be seen that more than 3 times as 
TABLE VI. EFFECT OF FOETAL RISK GRADING ON NEED 
FOR RESUSCITATION 
Foetal risk grading 
No IPPR 
IPPR 
Total cases : 1,011 
Foetal risk I + 2 
95 % (373)• 
5% (19) 
• Actual No. of cases in brackets. 
Foetal risk 3 
81 % (502) 
19% (117) 
(p<O·OOl) 
many babies who were graded pre-operatively as of high 
foetal risk needed resuscitation by intubation and !PPR 
than babies graded as of low or moderate foetal risk. 
When analysed in relation to the anaesthetic induction 
agent without consideration of the foetal risk (Table 
VII), no statistically significant difference is apparent in 
the proportion of babies needing resuscitation by intuba-
tion and !PPR. 
When, however, the mean Apgar scores in relation to 
induction agents are examined in those babies previously 
graded as of high foetal risk only (Table VIII), it appears 
that a higher proportion of those whose mothers received 
thiopentone, subsequently needed resuscitation by intuba-
tion and !PPR. The differences in these proportions just 
TABLE VII. EFFECT OF TNDUCTION AGENT ON NEED 
FOR RESUSCITATION 
Induction agent Inhalational 
No IPPR 88 % (375)• 
IPPR 12 % (52) 
Total cases : l ,Oll 
• Actual No. of cases in brackets. 
Methohexital 
87 % (125) 





failed to achieve an over-all statistical significance. But if 
those cases whose mothers received methohexital are ex-
cluded, it can be shown that the proportion of babies 
needing resuscitation after thiopentone is significantly 
greater than of those whose mothers received nitrous oxide 
and oxygen only for the induction of anaesthesia. 
TABLE VDl. EFFECT OF INDUCTION AGENT ON N1!1!D FOR 
RESUSCITATION IN FOETAL RlSIC (GROUP 3) 
Induction agent Inhalational Methohexita/ ThiopenJone 
No IPPR 84% (244)• 84% (83) 77Y, (175) 
IPPR 16% (48) 16% (16) 23% (53) 
Total cases : 619 not sig. 
• Actual No. of cases in brackets. 
CONCLUSION 
From this study we may infer that the most important 
single factor which determines the condition of the baby 
at birth after caesarean section, under well-conducted 
general anaesthesia, is the previous intra-uterine environ-
ment of the foetus. 
Any conclusions as to the comparative value of different 
anaesthetic agents or techniques must take this factor into 
consideration. 
A second inference that may be made from this study 
is that in those babies who may be graded pre-operatively 
as of high foetal risk, the use of thiopentone as an induc-
tion agent may be deleterious. It would appear that where 
an intravenous method of induction of anaesthesia is de-
sired, methohexital could be substituted with advantage. 
SUMMARY 
The effects of the intra-uterine environment and agents used 
to induce general anaesthesia for caesarean section, on the 
condition of the newborn baby as reflected by the Apgar score, 
were investigated in 1,011 babies. It was found that the intra-
uterine environment was of the greatest importance in influenc-
ing the Apgar score of the baby. 
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cooperation which made the collection of this data possible. 
We should also like to thank the heads of these departments, 
Profs. A. B. Bull and D. Davey, for their encouragement and 
advice; and Dr. J. G. Burger, Medical Superintendent of 
Groote Schuur Hospital, for permission to publish these 
findings. 
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CARBON DIOXIDE CONCENTRATIONS IN THE BOYLE'S 
TYPE ANAESTHETIC MACHINE* 
BY 
G. G. HARRISON AND C. S. JONES 
Department of Anaesthesia, University of Cape Town 
THE elimination of carbon dioxide and 
the concomitant regulation of the pH oi 
the blood is a respiratory function no less 
important than the uptake of oxygen. 
The elimination of carbon dioxide from 
anaesthetic aonospheres .and the concen-
trations of this gas normally reached in 
such aonospheres are problems which are 
engaging a considerable amount of atten-
tion at the present time. 
Schwartz, Alexander and Adriani 
(1953) have studied this problem for 
varying gas flows in the American type of 
anaesthetic rr..achine. We were unable to 
trace any work of a similar nature using 
the standard British Boyle's pattern 
anaesthetic machine, nor could the manu-
facturers of our machines supply us with 
experimental data. Molyneux and Pask 
(1951) have estimated the volume of 
backflow of expired gas:!s to the reservoir 
bag in a semi-closed circuit under certain 
theoretically deduced conditions, and we 
have therefore investigated the actual rise 
in carbon dioxide concentmtions in the 
same type of semi-closed circuit. 
Ringrose. Rowling and Harbcrd (1950) 
have developed a carbon dioxide indicator 
designed to make quantitative measure-
• This work was made possible by a Research Grant 
from the Fourcade Research Fund of the University 
of Cape Town. 
ments of this gas in anaesthetic aonos-
pheres. Extensive trials with this R.R.H. 
Indicator failed to give us reproducible 
analyses, and we were unable to demon-
strate any correlation between the values 
determined by this instrument and the 
values determined for the same gas 
samples when they were analyzed in the 
Haldane apparatus. Since no calibration 
curve could be constructed, use of the 
R.R.H. Indicator had to be abandoned. 
EXPERIMENT 
Using a standard Boyle's type anaes-
thetic machine, oxygen was delivered to 
conscious adult male volunteers at a flow 
rate of 8 !./ minute via a corrugated tube 
of capacity ± 650 ml and a Connell type 
mask fitting accurately to the subject's 
face (fig. 1). The reservoir bag of the 
circuit had a capacity of half a gallon 
(2,273 ml). The same machine was used 
in each experiment and gas sampling 
points were provided proximally at a point 
just distal to the reservoir bag (A) and 
distally at the mask itself (B). These 
sampling points are indicated in figure 1. 
The subjects were allowed to breathe 
from this apparatus for several minutes. 
During the sixth minute of breathing, 
two 10-ml gas samples were drawn from 
each of the two sampling points. Sampl-
162 
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Fig. I 
The type of anaesthetic machine ""hich was used in this investiµtion . The 
two sa:npling points are indicated by the letters. 
ing was achieved during the expiratory 
phase of several breaths, the samples 
being drawn into all-glass syringes lubri-
cated with glycerine. The syringes were 
then fined with gas-tight caps until their 
contents could be analyzed in duplicate 
on a standard Haldane apparatus by the 
usual technique (Lamb, 1930). The 
values given in table I represent the 
arithmetical means of duplicate analyses. 
TABLE I 
Volum:s p:r cent carbon diox;dc 
Exp:riment At 
number At mas!- reservoir hag 
I 5.1: 1.78 
:? 4.63 0.1 I 
J 4.70 O.JJ 
4 5. 11 O.:?:? 
5 5.:?I O.:?:? 
6 5.0, 0. 17 
7 5.39 I.:?! 
8 4.78 0.4Q 
9 5.: 7 O.J8 
JO 5.00 0. lh 
11 5.l h 0.74 
Mean 5.04 0.5, 
S.E. of Mean - 0.05 -0.0::? 
P < 0.01 < 0.01 
RESULTS 
The concentration of carbon dioxide in 
atmospheric air is of the order of 0.03 
vol. per cent (NTP) (pC0,=0.23 mm 
Hg) while the concentrations in alveolar 
air are accepted as being of the order of 
±6.0 vol. per cent (pC0,=45.6 mm Hg) 
under normal conditions. We performed 
13 experiments on 10 subjects but in 2 
experiments the subjects began hyper-
ventilating. This hyperventilation, which 
may of itself be significant, produced 
values, at the reservoir bag, which were 
8 times greater than the mean values for 
the CO, concentration for the whole 
series. The results of these two experi-
ments have been discarded and the results 
of the remaining 11 are set out in table I. 
In view of the increased dead-space 
produced by the mask, the values for the 
CO, concentrations at the mask (mean: 
5.04 vol. per cent=38.3 mm Hg pCO,) 
are to be expected. 
5.7 
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Of more significance are the values for 
the CO, concentrations at the proximal 
end of the corrugated tubing (capacity 
± 650 ml). The mean of 0.53 vol. per 
cent CO, (pCO, = 4.03 mm Hg) is 17 
times the value for room air. At this 
sampling point the value depends not 
only on the gas flow rate from the machine 
but also on the respiratory minute vol-
ume. It is apparent that under the 
conditions of these experiments a con-
BRffiSH JOURNAL OF ANAESTHESIA 
siderable degree of carbon dioxide 
accumulation occurs in this type of anaes-
thetic machine. 
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CHOICE OF AN ANAESTHETIC FACEPIECE 
BY 
G. G. HARRISON, J. 0ZINSKY AND C. S. }ONES 
The Department of Anaesthesia, University of Cape Town, South Africa 
THOUGH much time and attention has been 
devoted to the design of the anaesthetic facepiece, 
with regard to the requirements of simplicity of 
construction, ruggedness, ease of cleaning, com-
fon to the patient and goodness of fit, there are 
two other requirements which, although import-
ant, are seldom considered. These are (a) the 
mechanical deadspace which the facepiece adds 
to the anatomical deadspace of the patient and 
(b) the cost of the facepiece. 
which is critically dependent on the volume of 
effective alveolar ventilation, will be decreased, 
and thus the carbon dioxide content of the blood 
will rise. The clinical signs of this, certainly in 
the early stages, may be masked by anaesthesia. 
It is thus evident that the deadspacc of the face-
piece is a very important factor in inhalational 
anaesthesia, and especially so in systems, such as 
the Magill attachment, where carbon dioxide 
elimination depends on volume displacement, and 
in subjects such as children whose tidal volumes 
DEADSP ACE are small and approach the functional deadspacc. 
The average anatomical deadspace ·of a normal It is rather surprising that so little effort ap-
adult is approximately 150 ml. In calculating the pears to have been made, up to the present, to 
effective alveolar ventilation this anatomical dead- measure the mechanical deadspacc of anaesthetic 
space volume must be subtracted from the tidal faccpieccs. Gillespie (1948) suggested that the 
volume. The ratio between deadspace volume and approximate content of most anaesthetic masks 
tidal volume is very important for it governs both was 150 ml. Stephen (1952) reported that a 
the uptake of inspired gases and the excretion of child's facepiccc has a capacity of 250 ml and 
carbon dioxide. The closer this ratio approaches drew attention to the possibility of rcbrcathing. 
to unity the less effective is the alveolar ventila- Schwartz ct al. (1957) emphasized that an adult's 
tion. The conditions pertaining to clinical inhala- medium-sized anaesthetic mask has a volume of 
tional anaesthesia tend always to reduce the 120 ml and a child's mask has a volume of 40 ml. 
volume of effective alveolar ventilation. The res- Leigh and Bolton (1948) have pointed out that in 
piratory centre is depressed by narcotics and children and infants the mask and equipment 
anaesthetics and the tidal volume is consequently doubles or trebles the deadspacc. Vale (1958) re-
reduced (the patient breathing spontaneously). emphasizes this important fact by drawing attcn-
The functional deadspace (anatomical+apparatus tion to the capacity of an infant's anaesthetic 
deadspace) is invariably increased by the appara- mask and also to the measurements of anatomical 
tus used. deadspacc in children reported by Hall (1955). 
In any apparatus involving its use, the face- All these workers were content to measure or 
piece contributes the major proportion of this calculate the capacity of the facepiecc itself, 
increased deadspace, assuming flows of fresh although it is obvious that when fitted to the face 
gases are used which are adequate to eliminate of a subject some of that capacity will be occupied 
rebrcathing from the corrugated tubing (Moly- by the subject's physiognomy. This has been 
ncux and Pask, 1951). With the oxygen-rich gas taken into account by Clarke (1958) who fitted 
mixtures currently used in clinical anaesthetic under standard conditions a single no. 4 McKcs-
practice normal oxygenation may be maintained son facepicce to 25 male and 20 female cadavers, 
with subnormal volumes of effective alveolar and measured the dcadspace with the mask in 




of the facepiece varied between 76 and 107 ml 
for the males and between 87 and 110 ml for the 
females. To these figures he added 28-30 ml for 
the mechanical deadspace of the angled connector 
and expiratory valve usually found on the Magill · 
attachment. 
METHOD 
The same measurements as described by Clarke 
(1958) were carried out. The terminology "mech-
anical deadspace" is preferred to that of "poten-
tial deadspace" for the space measured. The use 
of the latter terminology by Clarke is based on 
2 . 3 
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the possibility of channelling within the mask in 
the same way as occurs within the bronchi, but 
until this is proven it should be assumed that the 
whole of the "mechanical deadspace" is operapvc 
with each respiration. The mechanical deadspace 
of nine adult size anaesthetic facepieces when 
applied to the faces of 21 adult subjects with full 
dentition-11 males and 10 females aged between 
25 and 35 years-was measured, using a modifi-
cation of a method suggested by Woolmer (1955). 
The nine masks comprised seven difiercnt types. 
These are illustrated in figure 1. 
The volume measured was that of the mask, 
• .· .. ·~· . .;%.,_,:.,.., "' . . ·~~- . 
4 
:8. ' . 
Fro. 1 
The anaesthetic facepieces used in the measurements reported. 
I. Draeger. Foregger type, size 3, M.9503 . 
., Draeger, Foregger type, size 4. M .9504. 
3. Foregger. Connell type. adult size. MCS :?:. 
4. Draeger. Draeger type. chrome base with detachable pad. size 4. M8155 and .M6:!0:!. 
5. Franklin . Rubber Co .. London; anaesthetic facepiece with detachable inflatable rubber 
pad. size 4. 
6. B.O.C. Connell type, size 5 • .MS:!07. 
7. .M.I.E. Everseal anaesthetic facepiece . size 3. 
8. B.O.C. Anaesthetic facepiece body with detachable inflatable pad. size 5. :!:! : 502 and 
:2 . 506. 
9. .M .I.E. Everseal anaesthetic facepiece. size 4. 
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Diagram of the mask, angle piece and valve piece 
assembly. 
angle piece and valve piece up to the expiratory 
valve of a standard Magill assembly (fig. 2A). 
The mask to be tested was assembled with a 
standard angle piece. The angle piece was 
occluded by a cork at the point to which the 
valve piece of the Magill assembly would overlap. 
Through this cork a glass tube with burette tap 
was led. The mask and angle piece as illustrated 
in figure 2B were now completely submerged in 
water in a large basin, the burette tap being open. 
When all the air was displaced from the system 
the subject, holding his breath, lowered his face 
into the water and fitted the mask firmly to his 
submerged face, excess water being displaced 
through the burette tap. The tap was then closed 
and the subject removed the mask assembly, still 
fitted to his face, from the water. Holding the 
mask horizontally, the subject now gently dis-
engaged his face from the mask, taking care not 
to spill any water. The water remaining in the 
facepiece was now carefully decanted through the 
burette tap into a measuring cylinder. The mean 
of two readings per mask per subject was re-
corded. The volume of the valve piece-the 
proximal end occluded by plasticine up to the 
expiratory valve (fig. 2c)-was measured separ-
ately; this volume then being added to the mean 
individual mask volume. The volume of the glass 




















































2 3 4 5 6 7 8 9 
95 100 145 147 150 167 152 212 190 
90 95 157 162 170 174 190 257 270 
81 89 155 142 159 157 185 257 235 
82 87 125 140 135 115 142 177 205 
80 89 144 140 155 165 165 207 192 
62 77 127 132 135 155 142 185 195 
77 95 152 132 160 167 155 197 217 
62 77 115 140 135 160 135 180 167 
70 77 130 125 125 150 155 165 185 
74 86 148 121135105 156 162 175 
81 86 101 124 134 94 166 187 203 
78 87 136 137 145 146 158 198 203 
10 7 17 11 14 27 17 31 28 
88 106 146 143 131 161138188 218 
86 88 146 148 148 161 178 211 248 
93 108 151 163 161 161188148 246 
68 73 108 133 131153148 158 173 
86 91 136 148 141168161203166 
71 86 138 141 133 151138186 166 
86 91 146 126 148 166 176 211 226 
73 91 133 141136166 136 183 146 
71 86 136 136 123 156 148 181 173 
81 91 138 136 133 161 143 173 186 
80 91137141138160 155 184 194 
8 10 11 JO 11 5 18 20 35 
78 89 137 139 141 153 157 191 198 
9 9 15 11 13 21 17 27 32 
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total to give the volume of the complete assembly 
(fig. 2A). 
RESULTS 
The results of measuring the mechanical dead-
space and the cost analysis are set out in tables I 
and II. The deadspace of the nine masks tested 
rariged from 62 to 270 ml with the mean value 
showing a range of from 78 (S.D. = 9) to 198 
(S.D. = 32) ml. 
The tables are arranged for convenience so that 
they read from least to greatest from left to right 
in terms of mean values. The ratio that these 
volumes bear to that of the anatomical deadspace 
-taken as 150 ml-is also appended. Note that 
masks 1 and 2 are different adult sizes of the 
same type of mask, as are masks 7 and 9. 
DISCUSSION 
It will be seen from table II · that of the masks 
tested, in all but one type-of which there were 
two sizes-the mechanical deadspace observed 
ranged from just less than to considerably more 
than the anatomical deadspace. This additional 
dcadspace will lead to a fall in the volume of 
effective alveolar ventilation and consequently to 
inefficient elimination of CO~. It must therefore 
contribute materially to the respiratory acidosis 
that often accompanies inhalational anaesthesia 
(Cullen, 1954; Watrous ct al., 1950; Dripps and 
Severinghaus, 1955). In choosing an anaesthetic 
facepiece, one with a low dcadspace volume 
should ideally be chosen. 
Though all the subjects tested show a wide 
range of dcadspace volumes over the nine masks 
tested (table I), only two sets of measurements 
consistently parallel the mean figures in progres-
sion from lowest volume to greatest. This is no 
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doubt due to variation in facial features. We re-
gret that we have no satisfactory method of 
typing faces by measurement of their parameters, 
though the type of face is undoubtedly of im-
portance in determining the volume of mechani-
cal deadspace in any particular mask, e.g. a small 
angular face will fit right into a large mask, leav-
ing much less deadspace than when the same 
mask is fitted to a large fiat or concave type of 
face. 
Cost is another factor that must be considered 
in choosing an anaesthetic facepiece. This is es-
pecially so wlicn equipping a large hospital. The 
costs of the faccpieces tested ranged from that of 
the cheapest up to nearly seven times that price 
(table II). 
In the work here reported we were able to take 
advantage of a request to test several types of 
anaesthetic facepieces-adult sizes only were sup-
plied-with a view to recommending one that 
should be adopted as a standard item of equip-
ment for an extensive hospital system. Since 
actual local costs are of no value to others, we 
have introduced them here by taking the lowest 
price of a mask as unity and expressing the prices 
of the other masks as multiples of this cost unit. 
It must be remembered that the final choice 
should also take into consideration the other re-
quirements mentioned earlier, viz. simplicity, rug-
gedness, case of cleaning, comfort to the patient 
and goodness of fit. In this respect it is of interest 
to note that our own tests of these masks included 
daily clinical use for a period of three months in 
a very busy general hospital. In this period one 
of the most expensive facepicces became worn 
and finally tom at the point of contact with the 
nasal bridge. 
TABLE II 
General table of re.vu!ts. 
Mask 2 3 4 s 6 7 8 9 
Deadspace overall mean ml 78 89 137 139 141 153 157 191 198 
S.D . 9 9 IS 11 13 21 17 27 . 3'.! 
Mask -deadspace/ •anatomical 
dead space o.s 0.6 0.9 0.9 0.9 1.0 1.0 1.3 1.3 
Cost factor 6.52 6.9 5.2 1.0 3.46 4.64 2.06 4.64 
•Taken a~ 150 ml. 
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SUMMARY 
Observations on the mechanical deadspace of 
seven types of mask assembled with angle piece 
and valve stock, reveal that in all but one of these 
this volume is approximately equal to or greater 
than the anatomical deadspace volume of an 
average adult. Patients anaesthetized with such 
masks might be expected to experience difficulty 
in the adequate elimination of carbon dioxide. 
This should be borne in mind when choosing an 
anaesthetic facepiece. 
It is also noted that the costs of facepieces vary 
greatly from each other. 
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MECHANICAL PULMONARY VENTILATION: INDICATIONS FOR ITS USES IN 
SURGICAL CASES* 
GAISFORD G. HARRISON, M.B., CH.B., F.F.A., R.C.S., D.A. R.C.P. & S., Senior Lecturer in Anaesthetics, University 
of Cape Town . and Anaesthetist, Groote Schuur Hospital, Cape Town 
In the widest sense we may say that mechanical ventilation 
in the lungs is indicated by respiratory failure-the condi-
tion where the respiratory gas exchange between the lungs 
and the blood falls below that between the tissues and the 
blood. 
PHYSIOLOGICAL CONSIDERATIONS 
The manner in which respiratory function may fail is best 
considered in terms of normal respiratory physiology. The 
processes concerned with the uptake of oxygen and the 
elimination of carbon dioxide by the lungs-and certain 
aspects of acid-base balance-may be considered1 as being 
(1) ventilation (the mass movement of air in and out of the 
lungs), (2) distribution (the distribution of the inspired air 
and the pulmonary blood flow within the lungs-these bear 
an optimal relationship to each other), (3) diffusi~n (the 
process by which O. and CO. are exchanged between 
alveolar air and the pulmonary· capillary . blood), (4) pul-
monary blood flow (the amount of blood brought into 
contact with the respiratory epithelium in unit time), and 
(5) blood gas transport. 
An understanding of the effects that derangements of 
these factors have on the arterial oxygen saturation and 
carbon-dioxide tension is essential for a clear understanding 
of respiratory failure. The first three are the mechanisms 
most relevant to clinical respiratory failure . 
(1) Ventilation 
If ventilation is impaired the amount of O. that can be 
taken up by the blood, and CO: excreted, is limited. 
If the shape of the dissociation curves of oxygen and 
carbon dioxide, and the consequent effect of alveolar 
ventilation on the blood content of these gases is considered 
(Fig. 1), it will be realized that the CO 2 tension in the 
arterial blood will be the first to reflect any change in 
ventilation, rising or falling proportionately with change in 
ventilation. Reduced tension of 0 2 in the alveolar air only 
leads to arterial oxygen desaturation of any moment where 
it has fallen quite markedly. But when it does reach this 
point where significant desaturation of arterial blood results 
it is on the slippery slope of the Eiger. Any further reduc-
tion in alveolar O. tension, as would result from a further 
decrease in ventilation, will result in gross and catastrophic 
arterial oxygen desaturation. This should serve to remind 
us that cyanosis is a sign of severe ventilatory impairment. 
It must be noted also that hyperventilation while breath-
ing air cannot increase the arterial oxygen saturation 
beyond 96 - 98 ~~ - its normal level. Remember, too. that 
with underventilation not only will there be the obvious 
respiratory acidosis, but the resultant tissue anoxia, leading 
to an increase in the fixed acids, will result also in a meta-
bolic acidosis. thus adding fuel to the acidotic flame . 
(2) and (3) Distribution and Diffusion 
These two factors may be grouped together. Derange-
•Based on a paper presented at the 44th South African Medical 
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Fig. 1. Effect of the volume of pulmonary ventilation on 
anerial CO2 tension (mm.Hg) and oxygen saturation (%). 
ments often occur together, and the changes produced in 
the arterial oxygen saturation and CO: tension are in the 
same direction. Derangements in distribution result in 
disturbance of the over-all ventilation/perfusion ratios in 
the Jung. The effects such changes have on the blood gas 
content are again dependent on the shape of the dissocia-
tion curves of the respective gases. Whereas the rise in CO2 
tension resulting from underventilation of a normally 
perfused lobule of lung may be compensated for by over-
ventilation of another normally perfused lobule-thus pre-
serving a normal total arterial CO. tension-the reduction 
in arterial oxygen saturation so resulting cannot be com-
pensated for by this mechanism. It can be corrected only 
by raising the inspired, and so alveolar, o. tension. De-
rangements of any moment, therefore, in the ventilation/ 
perfusion ratios in the lung always result in a lowered 
arterial oxygen saturation, possibly with a normal, not 
raised. arterial CO. tension, certainly in the early stages. 
With disturbances of diffusion, the differences in the 
relative solubilities of O. and CO. lead to an impairment 
of the o. uptake of the blood with no significant effect on 
the excretion of CO2 , and may thus lead to a similar blood 
gas picture of reduced arterial oxygen saturation with a 
normal CO, tension. 
As recently shown by Nunn and Payne,2 derangement of 
distribution produces detectable arterial oxygen desatura-
tion in the immediate postanaesthetic phase more often 
than we realize. 
The Work of Breathing 
Another aspect of pulmonary physiology that must be 
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considered is that of the work of breathing.9, is The total 
mechanical work of breathing in normal subjects at rest is 
about 0·6 kg.-m. per min.,1 with a metabolic cost to the 
patient of 1 - 3 ~ of the total oxygen intake (i.e. about 
0·5 ml. 0 : per litre of ventilation, or 4 ml. 0 2 per min). In 
patients with chronic lung or heart disease, the mechanical 
work of breathing, and consequently the metabolic cost to 
the patient, may be increased 5 - lOfold. As the rate of 
oxygen intake is also limited in these patients, the con-
sumption of oxygen by the respiratory muscles may 
severely restrict the amount of oxygen available to the rest 
of the body. If the compliance of the lungs is reduced, as 
it is for instance by postoperative pulmonary complications. 
the work involved in taking a normal breath is increased. 
It may therefore become more economical to the patient. 
in terms of energy expenditure. to take shallower and 
more frequent breaths. However, the smaller the tidal 
volume, the larger must be the total pulmonary ventilation 
to flush the dead space and maintain the level of effective 
alveolar ventilation. 
Changes Produced by Surgical Operations 
Another factor to be considered is the reduction in total 
lung capacity that has been shown to follow immediately 
after certain operations, even in the absence of recognizable 
pulmonary complications. This change, most marked after 
abdominal operations, is due to reduced efficiency of the 
respiratory musculature and pain in the operative wound. 
Anscombe and Buxtons found a mean reduction in total 
lung capacity after abdominal operation of 2-4 litres, with 
a mean reduction in vital capacity of 1 · 2 litres. These 
changes, for which a patient with normal pulmonary 
function compensates easily, may tip an emphysematous 
patient into respiratory insufficiency and failure. 
OBSERVATIONS AND SPECIAL INVESTIGATIONS FOR ASSESS-
MENT AND MANAGEMENT OF MECHANICAL 
PULMONARY VENTILATION 
Ideally, for assessing a patient as a candidate for mechani-
cal pulmonary ventilation and for correct management of 
that treatment once it is instituted, there should be on the 
spot special facilities for measuring (1) volume ventilation 
as regards (a) rate, (b) minute volume, and (c) tidal 
volume ; (2) arterial CO, tension; (3) arterial oxygen satu-
ration; and (4) pH. Though it is possible to conduct the 
management of patients on ventilators without these 
facilities. if they are available they remove much of the 
guesswork and empiricism that result from their absence. 
INDICATIONS FOR MECHANICAL PULMONARY VENTILATION 
Correlating with the physiological factors mentioned above, 
two distinct types of respiratory failure may be recognized 
-distinct certainly in their early stages, though in later 
stages features of the first type mentioned are predominant. 
These two types are failure of respiratory function due to 
(1) a failure of ventilation, or (2) abnormalities of ventila-
tion / perfusion and diffusion. 
1. Failure of Ventilation 
The cases that most often and most obviously call for 
the use of mechanical pulmonary ventilation are those in 
which the primary cause of respiratory insufficiency is a 
failure to move an adequate volume of air in and out of 
the lungs (i.e. failure of ventilation) . 
Clinically. this group of cases displays dyspnoea, sweat-
ing, and tachycardia, with an initially raised blood 
pressure. There is often skin vasodilation. Besides appear-
ing shallower than normal, the pattern of respiration is 
often abnormal. For example. it may manifest a tracheal 
tug or p:ualysis of intercostal muscles or diaphragm. Later, 
there will be cyanosis, mental confusion. large pupils, 
twitching, low blood pressure, cardiac arrhythmia, and ln 
the end coma and death. 
The four special investigations mentioned at the begin-
ning of this section will reveal : 
(a) A reduced volume of effective pulmonary ventilation. 
(b) A raised arterial CO, tension, usually very high. 
(c) Arterial oxygen desaturation on breathing air, which 
reverts to normal on breathing IOO ~o O •. 
(d) In severe cases the pH wi11 be lowered because of 
(i) respiratory acidosis and later (ii) metabolic acidosis 
from tissue anoxia. 
In surgical practice this group of cases would include : 
(1) Patients in whom there is a functional disturbance of 
the mechanism of ventilation, viz. : 
(a) Depression of the respiratory centre itself. This may 
be due to cerebral trauma or to the effects of centrally 
depressant drugs such as the opiates and other analgesics 
or the barbiturates. 
(b) Impairment of the peripheral transmission mecha-
nism of the respiratory impulses. The prime example of 
this circumstance, and the bogey of anaesthetists, is pro-
longed postoperative curarization from whatever cause. 
Postoperative ventilatory impairment may also happen in 
that · rara a vis the myasthenic patient and in patients 
suffering from certain myopathies and neuropathies. It 
is seen in the patient with a fractured spine causing para-
lysis of the diaphragm and/ or the intercostal muscles, 
according to the level of the fracture. Metabolic acidosi~ 
is becoming more obtrusive in surgical practice today as 
the cause of functional ventilatory impairment. 
(2) Patients in whom there is a mechanical or anatomical 
disturbance of ventilatory capacity, viz. : 
(a) One of the commonest conditions that we must con-
sider in this group is chronic obstructive lung disease or 
emphysema and chronic bronchitis. This is a composite 
disease that ultimately includes ventilatory / perfusion 
disturbances, but the basic pathology is bronchiolar ob-
struction. What so often finally renders the ventilatory 
capacity of the emphysematous patient inadequate is the 
association of one of the functional disturbances I have 
mentioned with emphysema. (Remember that the assess-
ment of adequacy of ventilation from the measurement of 
gross volume of ventilation alone may be fallacious in 
view of the increased physiological dead space in patients 
suffering from emphysema.) 
(b) A less common anatomical restriction of ventilatory 
capacity is that which may follow pulmonary resection,6, 6 
where the remaining functioning lung tissue would be just 
adequate. but is rendered inadequate in the immediate 
postoperative phase. 
In groups (a) and (b) the possibility of postoperative 
respiratory difficulty may be anticipated by pre-operative 
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studies of respiratory function . 
(c) Patients suffering from a critically crushed chest 
with multiple fractured ribs-an increasingly common 
phenomenon-are an important example of mechanical . 
restriction of ventilatory capacity. In these cases there is 
gross disturbance of the mechanics of the thoracic cage 
together with pulmonary contusion, leading to a marked 
ventilatory impairment. Many methods are described of 
achieving surgical fixation of the unstable flail chest wall. 
However. in many centres, surgical methods of stabilizing 
crushed chests have been abandoned in favour of the use 
of mechanical pulmonary ventilation.7·U 
2. Abnormalities of Ventilation I Perfusion and Diffusion 
In this second group of cases, in which respiratory failure 
is due to ventilation / perfusion disturbances and diffusion 
abnormalities, the indications for the use of mechanical 
pulmonary ventilation are not as clear cut, nor are 
they as common, as those in the first group. Together 
with the ventilation i perfusion abnormalities and disturb-
ances of diffusion, the increased work load of respiration 
that results from the lowered pulmonary compliance be-
comes an important aspect in these cases. An example of 
this type of respiratory failure is that which sometimes 
occurs after operations on the heart with cardiopulmonary 
bypass, particularly in patients who have had pulmonary 
hypertension. These patients manifest a respiratory 
distress10, 11, 14 of which the most obvious sign is tachypnoea 
and mild cyanosis. There is an obvious increase in the 
respiratory work needed, and performed, by the patient. 
The four special investigations will show the following 
changes, in contrast with those characteristic of cases in 
which the primary cause of respiratory insufficiency is 
failure of ventilation: 
(a) The volume of ventilation is increased.10, 11 Though 
tidal volume is decreased. the physiological dead space is 
also decreased12 and the frequency of respiration is 
markedly increased, with a resultant net increase in the 
total alveolar ventilation.1°. 1a 
(b) The arterial CO. tension may be normal. It is often 
not raised .lo. 11. 15 · 
(c) The arterial oxygen saturation is reduced on breath-
ing air. This will be incrt!ased on breathing 100% O., the 
degree depending on the amount of pulmonary veno-
arterial shunting due to atelectasis. 
(d} The pH may be normal. 
Changes of this type are illustrated in Fig. 2. This illu-
strates daily estimations of ventilatory parameters and 
arterial oxygen saturation on breathing air and pure 0, in 
the immediate postoperative period after operations on the 
heart with total body perfusion. This investigation was 
carried out at the British Postgraduate Medical School. 
Hammersmith Hospital. London.IO. is These changes are 
interesting in that they illustrate the failure of respiratory 
function without the failure, at least initially, of ventila-
tion per !,e . Later, if the condition worsens, ventilation will 
begin .to fail and the conditions of the common first type 
. of respiratory failure will supervene. 
In these cases, raising the inspired oxygen concentra-
tion. e.g. by use of an oxygen tent, is usually sufficient to 
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Fig. 2. Daily measurements of ventilatory parameters in 
the postoperative period after open heart surgery (means 
of 8 cases). These patients did not require mechanical 
pulmonary ventilation. (British Postgraduate Medical 
School, Hammersmith Hospital, London.IO, 18) 
f=frequency (breaths per minute). VT=tidal volume and 
V~P=physiological dead space (both in ml. BTPS). VE= 
rrunute volume and VA= alveolar ventilation (both in litres 
per minute BTPS). Sao,= arterial oxygen saturation (%). 
and the tachypnoea, with the increased work it demands, 
will decrease. However, in the severe cases where the 
patient is becoming exhausted, the institution of mechani-
cal pulmonary ventilation with high inspired oxygen con-
centration will benefit the patient. Such benefit results not 
only from the improved ventilation and diffusion but also, 
as the work of breathing is taken over by the pump, from 
the diversion to the general body economy of the oxygen 
formerly utilized by the overworked respiratory muscles. 
MANAGEMENT OF MECHANICAL PULMONARY VENTILATION 
Recent advances in the design, sensitivity and response 
time of triggering mechanisms of some of the mechanical · 
ventilators now available, make 'patient-triggered aug-
mented ventilation' the method of choice in many cases . 
requiring mechanical pulmonary ventilation today. 
Patient triggered augmented (PT A) ventilation has the 
advantage of being virtually 'self-monitored'. The mainte-
nance of the patient's spontaneous respiratory effort serves 
as a short-term safety mechanism for the emergencies that 
occur from time to time with this form of therapy. Further, 
the patient can communicate with his medical attendants 
by means of speech if the tracheotomy cuff is deflated. We 
regard PT A ventilation as indicated in all circumstances in 
which mechanical pulmonary ventilation is required in 
patierits in whom some respiratory muscular_ activity is 
6.9 
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TABLE I. PATIENTS TREATED WITH MECHANICAL PULMONARY VENTILATION 
DurotiOlf of 
T.vP<" of MPV and tr~atm~nt Putirnts Lesion Oprration lndicatiom+for MPJ' make of •~ntilniar (doys) Rtsult 
Open h~art o~rations 
Aortic and mitral ; ·alvc disease 
Mitral rcauraitation 




7 s 2 
3 
4 
Mi1ral cusp extension Pulmonary oedema 4 s Atrial septa! defect Repair of atrial septa! defect Thoracic scoliosis. Hypoventilation 14 s Mitra! valve disease. Pulmonary 
hypertension 
Mitra! valve prosthesis . Respiratory distress 14 s 





Mitral valve disease. Pulmonary 
hypertension 
Mitral . an~ .. tricuspid valve disease Mitra! valvotomy. Tricuspid valve Pulmonary oedema JPPR followed by 
PTA . Bird Respiratory distress PT A. Bird 
Prolon1ed low output. Cerebr~I dam- PTA. Bird 
6 D prosthesis 
Aortic and .mitial valve disease Aortic valve prosthesis Mitra! valve disease. Pulmonary Mitra! valve prosthesis 
hypertension 
Mitral and tricuspid valve disease Mitral prosthesis. Tricuspid amulo-
aae . Hypoventilation 







Mitral valvotomy - acute m !tral 
rcauraitation 
plasty . 
Matral prosthesis (after 4 days) Pulmonary oedema IPPR. Bird 
IPPR. Bird 
5 s 
Left ventricular aneurysm Excision Pulmonary oedema 
Closed heart operation 
4 s 
12 Mitral stenosis Mitra( valvotomy Pulmonary hypertension and emphy•· IPPR . Cyclator ema. Hypovcntilation 7 s 
Crushed chest 
13 Multiple fractured ribs. Head injury None 14 Fractured ribs. Fractured sternum. None 
Flail chest 
Flail chest IPPR. Cyclator JPPR. Cycla:or 
5 D 
6 D Coronary thrombosis 
I 5 Ne1lected fractured ribs None Flail chest . Gross bronchopneumonia IPPR. Bird 
General surgery 










Bronchoplcura1 fistula, pneumonia, 
and septicaemia 
Resection and 1raf1in1 
Laparotomy 
Nephrectomy 
Resection and 1raftina 
Insertion of thoracic under-water 
drain 
Emphysema. Prolon1ed curariution 
Emphysema. Prolon1ed curarization 
Prolon1ed curariution 
Emphysema. Cardiac failure 
















MPV - mechanical pulmonary ventilation. PT A = pa1ient-tri11ered au1mented ventilation . IPPR = intermittent-positive-pressure ventilation. S - survived (see text). D ~ died. 
present, provided that a negative-pressure phase (such as is 
necessary for triggering the ventilator) is not contraindi-
cated by such conditions as pulmonary oedema or flail 
chest. For the patients with respiratory distress characte· 
rized by tachypnoea, to match the patient's respiratory 
efforts it is essential to have a ventilator that has a very 
rapid response time and is capable of delivering very high 
flow rates of gas. (For this we use the Bird Mk.8 ventila· 
tor.) 
In the past 24 months we have had occasion to treat 20 
surgical patients with mechanical ventilation for varying 
periods postoperatively at Groote Schuur Hospital (fable 
I ). From this it may be noted that of these 20 patients, 9 
were treated with PT A ventilation. Of the 11 treated . by 
IPPR, 3 were so treated only because a ventilator con· 
sidered adequate for PT A ventilation was not available at 
the time. In the column Result, 'survived' (S) means that 
the patient survived beyond the period for which respira· 
tory assistance was necessary, while 'died ' (D) means that 
the patient died while still having mechanical pulmonary 
ventilation. 
As this paper is devoted to 'Indications', discussion of 
the results and complications encountered in these patients 
will be the subject of a future communication. 
SUMMARY 
Mechanical pulmonary ventilation is indicated by respiratory failure. viz. : 
(I) That in which the prime failure is of pulmonary ventila· tion. In this type there is: 
(a) Reduced pulmon.ary ventilation. 
(b) · Iner.eased arterial CO2 tension. 
(c) Decreased arterial oxyge11 saturation_ on breathing air, which reverts to normal on breathing 100 ~~ 0 ,. 
• (d) In !'ate cases a decrease in pH. 
(2) Less commonly, that in which the primary failure is one of ventilation /perfusion ratios and diffusion abnonnalities. This type may paradoxically show: 
(a) Increased pulmonary ventilation. 
(b} Normal arterial CO2 tension. 
(c) Arterial oxygen desaturation on breathing air, which may 
not necessarily be restored entirely to normal on breathing 100% o •. 
(d) The pH is usually normal. 
Special reference is made in this type to the increased work demand of respiration. 
Given a ventilator with the necessary sensitivity and rapid response time, patient-triggered augmented ventilation is con-sidered the method of choice for providing mechanical pul-monary ventilation. 
Some of the work on which this paper is based was per-formed during the tenure of a Nuffield Foundation Travelling Fellowship in Medicine and was performed in the Anaesthetic Department of the British Postgraduate Medical School, Hammersmith, London. 
I wish to thank Prof. I. H. Lcuw and Prof. C. N. Barnard, of Groote Schuur Hospital and the University of Cape Town, in whose units of General Surgery and Cardiothoracic Surgery respectively the patients here briefly reponed were treated. I wish also to thank Dr. I. G. Burger, Superintendent of Groote Schuur Hospital, for permission to publish these cases. 
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